Citrus Sinensis ID: 009654
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 529 | 2.2.26 [Sep-21-2011] | |||||||
| F4I114 | 714 | Probable serine/threonine | no | no | 0.903 | 0.669 | 0.477 | 1e-119 | |
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.542 | 0.501 | 0.656 | 1e-119 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.557 | 0.575 | 0.487 | 9e-82 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.512 | 0.536 | 0.517 | 3e-79 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.561 | 0.572 | 0.471 | 6e-79 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.514 | 0.530 | 0.506 | 9e-78 | |
| E1BB52 | 1512 | Cyclin-dependent kinase 1 | no | no | 0.595 | 0.208 | 0.403 | 2e-64 | |
| Q14004 | 1512 | Cyclin-dependent kinase 1 | yes | no | 0.538 | 0.188 | 0.426 | 4e-64 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.451 | 0.192 | 0.459 | 5e-64 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.538 | 0.188 | 0.426 | 6e-64 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 431 bits (1107), Expect = e-119, Method: Compositional matrix adjust.
Identities = 251/526 (47%), Positives = 333/526 (63%), Gaps = 48/526 (9%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI+ILRRLDHPN++KLEGLITSR+S S+YL+FEYMEHD+ GL S P I FSEAQIKC
Sbjct: 207 MAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKC 266
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLLHGLEHCHSRGVLHRDIKGSNLL+++ LK+ DFGLANF +QPLTSRVVT
Sbjct: 267 YMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVT 326
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP ++
Sbjct: 327 LWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEE 386
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP R T ++AL SE+
Sbjct: 387 YWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEF 446
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F+T P A D SSLP Y P KEID K +E+ ++K + ++++ +R+S K P
Sbjct: 447 FTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQVSRES----KAVPA 502
Query: 301 EDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 360
D N SL ++ R+ Q V N ++ + ++A+ I PL+
Sbjct: 503 PDS----------NAESLTSIQK-----RQGQHNQVSNSDKFNPGEDAASFRIE---PLK 544
Query: 361 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 420
T AK + S R+ + ++ P L T+ ++ R G
Sbjct: 545 SGT------AKDGHTRYGVSSVNRNGENVMMGSSRSPRKELRTQRSFVQR---------G 589
Query: 421 SRTDSRGHDSLEA---VKIAMLN-QWSQLERPDSFDASDGYHSQEL---SLALYQREEMA 473
+ SR +S+ A A+ N +W + DS++ ++G + L + +E
Sbjct: 590 TAQLSRFSNSVAARDGSHFAIANPRWFE----DSYNNNNGRQNGGAWSQRLVVKHKEFTK 645
Query: 474 TKRNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKS 519
K + ++ E++ SGPL+S +DE+L+ HERQI+ AVRK+
Sbjct: 646 HKESITVNGEKKERMHCSGPLVSAGGNLDEMLKEHERQIQLAVRKA 691
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1098), Expect = e-119, Method: Compositional matrix adjust.
Identities = 189/288 (65%), Positives = 238/288 (82%), Gaps = 1/288 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREIL+LRRLDHPN++KLEGL+TSR+SCS+YLVF+YM+HD+ GL S P +KFSE+++KC
Sbjct: 162 MAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKC 221
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA + H++P+TSRVVT
Sbjct: 222 LMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVT 281
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYR PELLLGATDYG +DLWS GC+ AELL G+PI+ GRTEVEQLHKI+KLCGSP +D
Sbjct: 282 LWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSED 341
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKK K H ++KP++PY S+RETFKD P +++ LI+ LLS+EP R TASAAL SE+
Sbjct: 342 YWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEF 401
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHR-EDARRKKVGGRVRGAETRKT 287
F+++PYAC+ + LP YPPSKEIDAK R E+ RR++ + +G RK
Sbjct: 402 FTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKN 449
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 9e-82, Method: Compositional matrix adjust.
Identities = 154/316 (48%), Positives = 208/316 (65%), Gaps = 21/316 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITS---------------RLSCSIYLVFEYMEHDITGLLS 47
REI IL++L H N+I+L+ ++TS + SIY+VFEYM+HD+TGL
Sbjct: 71 REIKILKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLAD 130
Query: 48 CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 107
P ++F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA +
Sbjct: 131 RPGMRFTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 190
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 167
+ H LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL
Sbjct: 191 SDHNGNLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQL 250
Query: 168 HKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
KIF+LCG+P + W +K+P FKPQ+P ++E+FK A++L+E +L+++P
Sbjct: 251 SKIFELCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDP 310
Query: 227 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRK 286
+R +A AL +EYF T P CD SLP Y S E K + +R+ A R+
Sbjct: 311 SQRISAKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQ-----AEEAAKRQ 365
Query: 287 TTRKSHGMSKLAPVED 302
+ S+L P+++
Sbjct: 366 KLQHPPPHSRLPPIQN 381
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 148/286 (51%), Positives = 191/286 (66%), Gaps = 15/286 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITS--------------RLSCSIYLVFEYMEHDITGLLSC 48
REI IL++L H N+I+L+ ++TS + IY+VFEYM+HD+TGL
Sbjct: 72 REIKILKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADR 131
Query: 49 PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 108
P ++F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA +
Sbjct: 132 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSH 191
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 168
H LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+FAELL KPIL G+ E EQL+
Sbjct: 192 DHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLN 251
Query: 169 KIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
KIF+LCGSP + W SK+P FKP +P +RE F+ A+ L+E +L ++P
Sbjct: 252 KIFELCGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPA 311
Query: 228 KRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 273
+R +A AL +EYF T P CD SLP Y S E K + +R+
Sbjct: 312 QRISAKDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQ 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 150/318 (47%), Positives = 201/318 (63%), Gaps = 21/318 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITS---------------RLSCSIYLVFEYMEHDITGLLS 47
REI IL++L H N+I+L+ ++TS + SIY+VFEYM+HD+TGL
Sbjct: 71 REIKILKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLAD 130
Query: 48 CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 107
P ++F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA +
Sbjct: 131 RPGMRFTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 190
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 167
H LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL
Sbjct: 191 NDHNGNLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQL 250
Query: 168 HKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
KIF +CG+P + W +K+P FKP + ++E FK A++L+E +L+++P
Sbjct: 251 SKIFDVCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDP 310
Query: 227 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRK 286
+R +A AL +EYF + P CD SLP Y S E K + R+ A R+
Sbjct: 311 AQRISAQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQ-----ADEAAKRQ 365
Query: 287 TTRKSHGMSKLAPVEDVA 304
T+ +L P++
Sbjct: 366 KTQHPQPHGRLPPIQQTG 383
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 291 bits (745), Expect = 9e-78, Method: Compositional matrix adjust.
Identities = 149/294 (50%), Positives = 192/294 (65%), Gaps = 22/294 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITS--------------RLSCSIYLVFEYMEHDITGLLSC 48
REI IL++L H N+I L+ ++TS + IY+VFEYM+HD+TGL
Sbjct: 72 REIKILKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADR 131
Query: 49 PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 108
P ++F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA +
Sbjct: 132 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSH 191
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 168
H LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+FAELL GKPIL G+TE EQL+
Sbjct: 192 DHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLN 251
Query: 169 KIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
KI++LCGSP + W SK+P K +P +RE ++ A+ L+E +L ++P
Sbjct: 252 KIYELCGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPS 311
Query: 228 KRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK-------HREDARRKK 274
+R A AL +EYF T P CD SLP Y S E K H E+A +K+
Sbjct: 312 QRICAKDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRHNEEAAKKQ 365
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (629), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 134/332 (40%), Positives = 193/332 (58%), Gaps = 17/332 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFS 54
REI ILR+L H +II ++ ++T + + YLVFEYM+HD+ GLL + F+
Sbjct: 752 REIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFN 811
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E IK +M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P
Sbjct: 812 ENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPY 871
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T++V+TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++C
Sbjct: 872 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRIC 931
Query: 175 GSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
GSP W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA
Sbjct: 932 GSPCPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAE 991
Query: 234 AALASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK-- 290
AL E+ +P LP++ E+ +K R RR+K G T K RK
Sbjct: 992 QALQCEFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTVKAPRKDL 1048
Query: 291 SHGM--SKLAPVEDVAVRTQFAKKINGHSLHI 320
S GM S+ + + V +Q + N ++ +
Sbjct: 1049 SLGMDDSRTSTPQSVLPSSQLKPQGNSNAAPV 1080
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14004|CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 127/298 (42%), Positives = 178/298 (59%), Gaps = 13/298 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFS 54
REI ILR+L H +II ++ ++T + + YLVFEYM+HD+ GLL + F+
Sbjct: 751 REIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFN 810
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E IK +M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P
Sbjct: 811 ENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPY 870
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T++V+TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++C
Sbjct: 871 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRIC 930
Query: 175 GSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
GSP W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA
Sbjct: 931 GSPCPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAE 990
Query: 234 AALASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 290
AL E+ +P LP++ E+ +K R RR+K G T K RK
Sbjct: 991 QALQCEFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 114/248 (45%), Positives = 161/248 (64%), Gaps = 9/248 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFS 54
REI ILR+L H +++ ++ ++T + + YLVFEYM+HD+ GLL ++FS
Sbjct: 756 REIKILRQLIHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFS 815
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E IK +M QL+ GLE+CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P
Sbjct: 816 EDHIKSFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPY 875
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T++V+TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I +LC
Sbjct: 876 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 935
Query: 175 GSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
GSP W KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA
Sbjct: 936 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAE 995
Query: 234 AALASEYF 241
L S++
Sbjct: 996 QTLQSDFL 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 127/298 (42%), Positives = 178/298 (59%), Gaps = 13/298 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFS 54
REI ILR+L H +II ++ ++T + + YLVFEYM+HD+ GLL + F+
Sbjct: 751 REIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFN 810
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E IK +M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P
Sbjct: 811 ENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPY 870
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T++V+TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++C
Sbjct: 871 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRIC 930
Query: 175 GSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
GSP W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA
Sbjct: 931 GSPCPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAE 990
Query: 234 AALASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 290
AL E+ +P LP++ E+ +K R RR+K G T K RK
Sbjct: 991 QALQCEFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDLSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 529 | ||||||
| 255547313 | 661 | ATP binding protein, putative [Ricinus c | 1.0 | 0.800 | 0.792 | 0.0 | |
| 356516828 | 677 | PREDICTED: probable serine/threonine-pro | 0.994 | 0.776 | 0.760 | 0.0 | |
| 297733936 | 686 | unnamed protein product [Vitis vinifera] | 0.986 | 0.760 | 0.777 | 0.0 | |
| 359491675 | 663 | PREDICTED: probable serine/threonine-pro | 0.986 | 0.787 | 0.777 | 0.0 | |
| 356508521 | 674 | PREDICTED: probable serine/threonine-pro | 0.994 | 0.780 | 0.758 | 0.0 | |
| 224119046 | 685 | predicted protein [Populus trichocarpa] | 0.994 | 0.767 | 0.781 | 0.0 | |
| 356565121 | 671 | PREDICTED: probable serine/threonine-pro | 0.990 | 0.780 | 0.729 | 0.0 | |
| 449439293 | 697 | PREDICTED: probable serine/threonine-pro | 0.992 | 0.753 | 0.731 | 0.0 | |
| 356511986 | 670 | PREDICTED: probable serine/threonine-pro | 0.990 | 0.782 | 0.719 | 0.0 | |
| 79346260 | 709 | protein kinase domain-containing protein | 0.994 | 0.741 | 0.693 | 0.0 |
| >gi|255547313|ref|XP_002514714.1| ATP binding protein, putative [Ricinus communis] gi|223546318|gb|EEF47820.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2203), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/530 (79%), Positives = 465/530 (87%), Gaps = 1/530 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILRRLDHPN++KL+GLITSRLSCSIYLVFEYMEHDITGLLSCPD++FSE+QIKC
Sbjct: 132 MAREILILRRLDHPNVMKLDGLITSRLSCSIYLVFEYMEHDITGLLSCPDVRFSESQIKC 191
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +TGHRQPLTSRVVT
Sbjct: 192 YMRQLLFGLEHCHSKGVMHRDIKGSNLLVNNEGMLKVGDFGLANFCHTGHRQPLTSRVVT 251
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+T+YG SVDLWSVGCVFAELL+GKP+LQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 252 LWYRPPELLLGSTEYGASVDLWSVGCVFAELLLGKPVLQGRTEVEQLHKIFKLCGSPPDE 311
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKKS+LPHATLFKPQQPYDSSLRE FKDLPTTAVNLIETLLSVEPYKR TAS+ALASEY
Sbjct: 312 YWKKSRLPHATLFKPQQPYDSSLREIFKDLPTTAVNLIETLLSVEPYKRGTASSALASEY 371
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F TKPYACD SSLP YPPSKEIDAK+RE+ARRKK GR RGAETRK RK G++KLAP
Sbjct: 372 FMTKPYACDPSSLPKYPPSKEIDAKNREEARRKKTSGRSRGAETRKPARKPGGINKLAPA 431
Query: 301 EDVAVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPL 359
ED R Q ++ ++ + K D SG E +K +D EE HVKNAS GDIPFSGPL
Sbjct: 432 EDATARIQGSQNSITTNVCLPKGVDAKSGGEARKASLDKLEEIFHVKNASQGDIPFSGPL 491
Query: 360 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 419
QVS+SSGFAWA+RRKDDAS+RSH+RSTSR + N LE S AL ++N+DSR+ ENGD I
Sbjct: 492 QVSSSSGFAWARRRKDDASVRSHSRSTSRSLINNGLENSTALQEKSNFDSRRRENGDAIY 551
Query: 420 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 479
G RT+SRGHDS E K A+ QWSQLERPDSFDAS+GYHSQELSLALYQREEM +RNNL
Sbjct: 552 GIRTNSRGHDSNEISKRALQKQWSQLERPDSFDASEGYHSQELSLALYQREEMEARRNNL 611
Query: 480 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 529
GFQDQG+KV+FSGPLLSQSHR+DELLERHERQIRQAVRKSWFQRGKK K
Sbjct: 612 GFQDQGDKVDFSGPLLSQSHRVDELLERHERQIRQAVRKSWFQRGKKHGK 661
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516828|ref|XP_003527095.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 841 bits (2172), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/530 (76%), Positives = 454/530 (85%), Gaps = 4/530 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS PDIKF+E QIKC
Sbjct: 151 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKC 210
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLANF N GHRQPLTSRVVT
Sbjct: 211 YMKQLLVGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANFVNPGHRQPLTSRVVT 270
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDYGP+VDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 271 LWYRPPELLLGSTDYGPAVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDE 330
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKKS+LPHATLFKPQQPYDS LR++FKDLP T+V+L++TLLS+EPYKR TA++AL+SEY
Sbjct: 331 YWKKSRLPHATLFKPQQPYDSCLRQSFKDLPVTSVHLLQTLLSIEPYKRGTATSALSSEY 390
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F TKPYACD SSLP+YPPSKEIDAKHRE++ RKK+ GRVRG ETRK +RK G +KLAP
Sbjct: 391 FKTKPYACDPSSLPVYPPSKEIDAKHREES-RKKISGRVRGTETRKPSRKPLGFNKLAPA 449
Query: 301 EDVAVRTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPL 359
ED+A +TQ + K+N S +L+++ G + QKP E+ASHVKNAS GDIP SGPL
Sbjct: 450 EDLASQTQTSHKVNARSFRVLEEERTKIGDKAQKPSSGKPEDASHVKNASQGDIPLSGPL 509
Query: 360 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 419
QVSTSSGFAWAK RKDD S RSH R+ SRG N LEP L++RNN D+R EN +
Sbjct: 510 QVSTSSGFAWAKSRKDDTSFRSHCRTISRGHTFNPLEP-CTLNSRNNLDTRNQENKEFSG 568
Query: 420 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 479
G T+SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS+ALY RE+ A+KR+NL
Sbjct: 569 GC-TNSRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSIALYHREDSASKRSNL 627
Query: 480 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 529
FQDQGEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 628 SFQDQGEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 677
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733936|emb|CBI15183.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2163), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/527 (77%), Positives = 461/527 (87%), Gaps = 5/527 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI ILRRLDHPNI+KL+GLITSRLSCSIYLVFEYMEHD++GL+SCPDIKFSE+Q+KC
Sbjct: 161 MAREITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKC 220
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVT
Sbjct: 221 YTKQLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVT 280
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+
Sbjct: 281 LWYRPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDE 340
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKKSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEY
Sbjct: 341 YWKKSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEY 400
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F TKPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P
Sbjct: 401 FKTKPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPA 458
Query: 301 EDVAVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPL 359
E+ +TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPL
Sbjct: 459 ENFTAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPL 518
Query: 360 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 419
QVSTSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ N
Sbjct: 519 QVSTSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSN 576
Query: 420 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 479
G RTDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L
Sbjct: 577 GGRTDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHL 636
Query: 480 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 526
+QDQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 637 SYQDQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 683
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491675|ref|XP_003634302.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 836 bits (2159), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/527 (77%), Positives = 461/527 (87%), Gaps = 5/527 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI ILRRLDHPNI+KL+GLITSRLSCSIYLVFEYMEHD++GL+SCPDIKFSE+Q+KC
Sbjct: 138 MAREITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKC 197
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVT
Sbjct: 198 YTKQLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVT 257
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+
Sbjct: 258 LWYRPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDE 317
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKKSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEY
Sbjct: 318 YWKKSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEY 377
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F TKPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P
Sbjct: 378 FKTKPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPA 435
Query: 301 EDVAVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPL 359
E+ +TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPL
Sbjct: 436 ENFTAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPL 495
Query: 360 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 419
QVSTSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ N
Sbjct: 496 QVSTSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSN 553
Query: 420 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 479
G RTDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L
Sbjct: 554 GGRTDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHL 613
Query: 480 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 526
+QDQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 614 SYQDQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 660
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508521|ref|XP_003523004.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/530 (75%), Positives = 453/530 (85%), Gaps = 4/530 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS PDIKF+E QIKC
Sbjct: 148 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKC 207
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLAN+ N+GHRQPLTSRVVT
Sbjct: 208 YMKQLLAGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANYVNSGHRQPLTSRVVT 267
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDY PSVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 268 LWYRPPELLLGSTDYDPSVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDE 327
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKKSKLPHATLFKP+QPYDS LR++FKDLPTT+V+L++TLLSVEPYKR TA++AL+SEY
Sbjct: 328 YWKKSKLPHATLFKPEQPYDSCLRQSFKDLPTTSVHLLQTLLSVEPYKRGTATSALSSEY 387
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F TKPYACD SSLP+YPPSKEIDAKHR D RKK+ GRVRG TRK +RK G +KLAP
Sbjct: 388 FKTKPYACDPSSLPVYPPSKEIDAKHR-DESRKKISGRVRGTATRKPSRKPLGFNKLAPA 446
Query: 301 EDVAVRTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPL 359
E +A +TQ ++K+NG S HIL+++++ G + QK E+A H+KNAS GDIP SGPL
Sbjct: 447 EGLASQTQTSQKVNGRSFHILEEEKIKIGDKAQKSSSGKPEDAFHMKNASQGDIPLSGPL 506
Query: 360 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 419
QVSTSSGFAWAK RKDD S RSH R+ SRG + NALEPS L+TRNN D+ EN +
Sbjct: 507 QVSTSSGFAWAKSRKDDTSFRSHCRTISRGHIFNALEPS-TLNTRNNLDTTNQENKEFC- 564
Query: 420 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 479
G +SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS ALY RE+ +KR+NL
Sbjct: 565 GRYPNSRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSTALYHREDSVSKRSNL 624
Query: 480 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 529
FQDQGEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 625 TFQDQGEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 674
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119046|ref|XP_002317972.1| predicted protein [Populus trichocarpa] gi|222858645|gb|EEE96192.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/530 (78%), Positives = 457/530 (86%), Gaps = 4/530 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILRRLDHPNI+KL+GLITSRLSCS+YLVFEYMEHDITGLLSCPD++FSE+QIKC
Sbjct: 159 MAREILILRRLDHPNIMKLDGLITSRLSCSLYLVFEYMEHDITGLLSCPDVRFSESQIKC 218
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GL+HCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +GHRQPLTSRVVT
Sbjct: 219 YMRQLLSGLDHCHSKGVMHRDIKGSNLLVNNEGILKVGDFGLANFCTSGHRQPLTSRVVT 278
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDYG SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 279 LWYRPPELLLGSTDYGASVDLWSVGCVFAELLLGKPILQGRTEVEQLHKIFKLCGSPPDE 338
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKKSKLPHATLFKPQQPYDS LRETFKDLPTTAVNLIETLLSVEPY R TA +ALASEY
Sbjct: 339 YWKKSKLPHATLFKPQQPYDSCLRETFKDLPTTAVNLIETLLSVEPYNRGTAFSALASEY 398
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
FSTKPYACD SSLP YPPSKEIDAK E+A RKK+ GR RG ETRK TRK +G+SKLAP
Sbjct: 399 FSTKPYACDPSSLPKYPPSKEIDAKKHEEAGRKKISGRGRGTETRKCTRKPYGISKLAPA 458
Query: 301 EDVAVRTQFAKKINGHSLHILK-DDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPL 359
ED+A R Q +IN ++ I K D SG E +KP +D EE H+KNAS GDIPFSGPL
Sbjct: 459 EDLAARIQCG-QINTSNMRIPKVRDGKSGGEARKPSLDKLEEIFHIKNASQGDIPFSGPL 517
Query: 360 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 419
QVS+SSGFAWAKRR DASIRSH+RS SRG N LEPS+ +NN DS++H NGD+I
Sbjct: 518 QVSSSSGFAWAKRRNGDASIRSHSRSISRGHSNNGLEPSS--EEKNNSDSKQHNNGDLIY 575
Query: 420 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 479
G RT+SRGH+S E K A+ QWSQ ERPDSFDAS+ YHSQELSLALYQRE M +KR+NL
Sbjct: 576 GVRTNSRGHNSYEISKFALQKQWSQFERPDSFDASEEYHSQELSLALYQREGMESKRSNL 635
Query: 480 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 529
FQDQ +KV+FSGPLLSQSHR+DELLERHER IRQAVRKSWF RGKK K
Sbjct: 636 VFQDQMDKVDFSGPLLSQSHRVDELLERHERHIRQAVRKSWFHRGKKHGK 685
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565121|ref|XP_003550793.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2066), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/528 (72%), Positives = 448/528 (84%), Gaps = 4/528 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI+ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL+ P+IKFSE+QIKC
Sbjct: 143 MAREIMILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLARPEIKFSESQIKC 202
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVT
Sbjct: 203 YMKQLLSGLEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVT 262
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+T YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++
Sbjct: 263 LWYRPPELLLGSTAYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEE 322
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKK++LPHATLFKPQQPYDSSLRETFKD + VNL++TLLSVEP KR TAS+AL+ EY
Sbjct: 323 YWKKTRLPHATLFKPQQPYDSSLRETFKDFHASTVNLLQTLLSVEPSKRGTASSALSLEY 382
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F KPYAC+ SSLPIYPPSKEIDAKH E++RRKK+GGR E+RK +RK +SKLAP
Sbjct: 383 FKIKPYACEPSSLPIYPPSKEIDAKHEEESRRKKIGGRACKPESRKPSRKPLALSKLAPA 442
Query: 301 EDVAVRTQFAKKINGHSLHILK-DDELSGREVQKPLVDNREEA-SHVKNASHGDIPFSGP 358
ED+ +TQ + K+N S HI+K +D + E K E+A S++KNAS DIPF GP
Sbjct: 443 EDLTSQTQTSHKMNDRSAHIIKQEDTNTCEEAPKQSSGKPEDASSYMKNASQVDIPFPGP 502
Query: 359 LQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDII 418
LQVS SSGFAWAKRR+DD S+RSH+RS SRG + N+LE ++ L++R+N +SR HEN +
Sbjct: 503 LQVSKSSGFAWAKRRRDDTSVRSHSRSISRGFIFNSLE-TSTLNSRDNSESRNHENKEFF 561
Query: 419 NGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNN 478
G+RT+SRG+ LE K+AM NQWS+ +RPDSFD D YHSQELSLA+Y R++ +KR+N
Sbjct: 562 -GARTNSRGNHLLEISKLAMQNQWSKFDRPDSFDTCDEYHSQELSLAIYNRQDSLSKRSN 620
Query: 479 LGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 526
L +QDQ EKVEFSGPLLSQ H +DELLERHER IR VR+SWFQRGKK
Sbjct: 621 LSYQDQEEKVEFSGPLLSQMHTVDELLERHERHIRHTVRRSWFQRGKK 668
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439293|ref|XP_004137420.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449486990|ref|XP_004157463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/525 (73%), Positives = 441/525 (84%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI+ILR LDHPNIIKLEGLITSRLSCSIYLVFEYM+HDITGLLSCPDI FSE+QIKC
Sbjct: 172 MAREIMILRGLDHPNIIKLEGLITSRLSCSIYLVFEYMDHDITGLLSCPDITFSESQIKC 231
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCHSRGV+HRDIKGSNLLVNNEGVLK+ADFGLANF NTGHRQPLTSRVVT
Sbjct: 232 YMKQLLSGLEHCHSRGVMHRDIKGSNLLVNNEGVLKVADFGLANFCNTGHRQPLTSRVVT 291
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDY SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 292 LWYRPPELLLGSTDYNASVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDE 351
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKKSKLPHATLFKPQ PY++ LR+TFKD P+T VNL+ETLLSVEPYKR AS+AL SEY
Sbjct: 352 YWKKSKLPHATLFKPQHPYNNCLRQTFKDHPSTTVNLLETLLSVEPYKRGVASSALISEY 411
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
FSTKPYACD SS+PIYPP+KEIDAK RE+ RRKK GR RG + R+ TRK G+SKLAP
Sbjct: 412 FSTKPYACDPSSMPIYPPNKEIDAKQREETRRKKGSGRSRGLDNRRLTRKHLGISKLAPA 471
Query: 301 EDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 360
ED++V + KI+ ++ ++ ++ + G E +K +D EE HVKN+S GDIPFSGPLQ
Sbjct: 472 EDLSVSARDLHKISINAQNLKEEKVIKGVEAEKMSMDKLEETIHVKNSSQGDIPFSGPLQ 531
Query: 361 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 420
VSTSSGFAWA+RR+DDASIR ++RS SRG +IN LE S LH+ +N DS+ HE D+ +
Sbjct: 532 VSTSSGFAWARRRRDDASIRCYSRSISRGHLINGLEDSTTLHSISNLDSKIHEKSDMSSI 591
Query: 421 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 480
SR+ S+GH+S E K+ M N W + ERPDSFD SD YHSQE + ALY R+E KR L
Sbjct: 592 SRSSSKGHESNERSKVVMRNPWGKFERPDSFDTSDEYHSQEFAAALYLRDEKEAKRKQLS 651
Query: 481 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGK 525
+QDQ +KVE+SGPLLSQS R+DELL+RHER IRQ VR+SWFQRGK
Sbjct: 652 YQDQVDKVEYSGPLLSQSSRVDELLDRHERHIRQTVRRSWFQRGK 696
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511986|ref|XP_003524702.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 792 bits (2045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/528 (71%), Positives = 446/528 (84%), Gaps = 4/528 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI+ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL+ P+IKFSE+QIKC
Sbjct: 142 MAREIMILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLARPEIKFSESQIKC 201
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL G+EHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVT
Sbjct: 202 YMKQLLSGIEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVT 261
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+T YG SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++
Sbjct: 262 LWYRPPELLLGSTAYGASVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEE 321
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWKK++LPHATLFKPQQPYDS LRETFKD ++VNL++TLLSVEP KR TAS+AL+ EY
Sbjct: 322 YWKKTRLPHATLFKPQQPYDSCLRETFKDFHASSVNLLQTLLSVEPSKRGTASSALSLEY 381
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
F TKPYACD SSLPIYPPSKEIDAK+ E++RRKK+GGR AE+RK +R +SKLAP
Sbjct: 382 FKTKPYACDPSSLPIYPPSKEIDAKNEEESRRKKIGGRACRAESRKPSRNPLALSKLAPA 441
Query: 301 EDVAVRTQFAKKINGHSLHILKDDEL-SGREVQKPLVDNREEA-SHVKNASHGDIPFSGP 358
ED++ +TQ ++K++ S+HI+K++ + E K E+A S++KNAS DIPF GP
Sbjct: 442 EDLSSQTQTSQKMDDRSVHIIKEENTNTCEEAPKQSSGKPEDASSYMKNASQVDIPFPGP 501
Query: 359 LQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDII 418
LQVS SSGFAWAKRR+DD S+RSH+RS SRG + N+ E S L++RNN +SR HEN
Sbjct: 502 LQVSKSSGFAWAKRRRDDTSVRSHSRSISRGYIFNSSETS-TLNSRNNSESRNHENKKFF 560
Query: 419 NGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNN 478
G+ +SRGHD LE K+AM NQWS+ +R DSFD D YHSQELS+ALY R++ +KR+N
Sbjct: 561 -GAHANSRGHDLLEISKLAMQNQWSKFDRLDSFDTCDEYHSQELSVALYNRQDSLSKRSN 619
Query: 479 LGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 526
L +QDQ EKVEFSGPLLSQ H +DELLERHE IR+ VR+SWFQRGKK
Sbjct: 620 LSYQDQAEKVEFSGPLLSQMHTVDELLERHESHIRRTVRRSWFQRGKK 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79346260|ref|NP_173302.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332191623|gb|AEE29744.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/532 (69%), Positives = 430/532 (80%), Gaps = 6/532 (1%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILR+L+HPNIIKLEG++TS+LSCSI+LVFEYMEHD+TGLLS PDI F+ QIKC
Sbjct: 175 MAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQIKC 234
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRVV 119
YM QLL GL+HCH+RGV+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRVV
Sbjct: 235 YMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRVV 294
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
TLWYRPPELLLGAT+YG SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP+
Sbjct: 295 TLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPPE 354
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRET--FKDLPTTAVNLIETLLSVEPYKRATASAALA 237
DYWKKSKLPHA LFKPQQ YD LRET K L +NLIETLLS++P+KR TAS AL
Sbjct: 355 DYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTALV 414
Query: 238 SEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRV-RGAETRKTTRKSHGMSK 296
S+YF++KP+ACD SSLP+Y PSKEIDAKHRED RKK+ G RG E+RK TRK +K
Sbjct: 415 SQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFAK 474
Query: 297 LAPVEDVAVRTQFAKKINGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPF 355
LAP EDV +Q +K NGHS+H + D ++QKP ++EASHVKNAS GD+PF
Sbjct: 475 LAPAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQGDVPF 534
Query: 356 SGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDS-RKHEN 414
SGPLQVS SSGFAWAKRRKDD +RSH RS SRG + N L PS A + DS +
Sbjct: 535 SGPLQVSVSSGFAWAKRRKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKNNEKE 594
Query: 415 GDIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMAT 474
+ +G RTDS+ ++ E +K++ML +W QLERPDSF SD YHSQELSL LYQREE A
Sbjct: 595 KEEKHGERTDSQDREAYEMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQREEKAA 654
Query: 475 KRNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 526
K +LG++D EK+EFSGPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 655 KLGHLGYEDNDEKIEFSGPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 529 | ||||||
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.994 | 0.741 | 0.684 | 3.9e-195 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.965 | 0.731 | 0.682 | 6.2e-188 | |
| TAIR|locus:2175743 | 644 | cdc2cAt "CDC2C" [Arabidopsis t | 0.508 | 0.417 | 0.732 | 1.2e-123 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.618 | 0.457 | 0.612 | 2.3e-114 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.769 | 0.631 | 0.507 | 1.4e-112 | |
| TAIR|locus:2140543 | 469 | AT4G10010 [Arabidopsis thalian | 0.508 | 0.573 | 0.695 | 1.5e-110 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.699 | 0.533 | 0.579 | 3.8e-110 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.674 | 0.482 | 0.550 | 3.1e-108 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.508 | 0.438 | 0.661 | 5.7e-107 | |
| TAIR|locus:504955609 | 629 | AT3G01085 [Arabidopsis thalian | 0.706 | 0.594 | 0.527 | 5.1e-106 |
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1890 (670.4 bits), Expect = 3.9e-195, P = 3.9e-195
Identities = 364/532 (68%), Positives = 425/532 (79%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILR+L+HPNIIKLEG++TS+LSCSI+LVFEYMEHD+TGLLS PDI F+ QIKC
Sbjct: 175 MAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQIKC 234
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRVV 119
YM QLL GL+HCH+RGV+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRVV
Sbjct: 235 YMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRVV 294
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
TLWYRPPELLLGAT+YG SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP+
Sbjct: 295 TLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPPE 354
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 237
DYWKKSKLPHA LFKPQQ YD LRET K L +NLIETLLS++P+KR TAS AL
Sbjct: 355 DYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTALV 414
Query: 238 SEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSK 296
S+YF++KP+ACD SSLP+Y PSKEIDAKHRED E+RK TRK +K
Sbjct: 415 SQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFAK 474
Query: 297 LAPVEDVAVRTQFAKKINGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPF 355
LAP EDV +Q +K NGHS+H + D ++QKP ++EASHVKNAS GD+PF
Sbjct: 475 LAPAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQGDVPF 534
Query: 356 SGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENG 415
SGPLQVS SSGFAWAKRRKDD +RSH RS SRG + N L PS A + DS+ +E
Sbjct: 535 SGPLQVSVSSGFAWAKRRKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKNNEKE 594
Query: 416 -DIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMAT 474
+ +G RTDS+ ++ E +K++ML +W QLERPDSF SD YHSQELSL LYQREE A
Sbjct: 595 KEEKHGERTDSQDREAYEMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQREEKAA 654
Query: 475 KRNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 526
K +LG++D EK+EFSGPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 655 KLGHLGYEDNDEKIEFSGPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1822 (646.4 bits), Expect = 6.2e-188, P = 6.2e-188
Identities = 363/532 (68%), Positives = 426/532 (80%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILRRL+HPNIIKLEGLITS+LSC+I LVFEYMEHD+TGLLS PDIKF+ QIKC
Sbjct: 165 MAREILILRRLNHPNIIKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKC 224
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQ-PLTSRV 118
YM QLL GL+HCHSRGV+HRDIKGSNLL++NEG+LK+ADFGLANFSN+ GH++ PLTSRV
Sbjct: 225 YMKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRV 284
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VTLWYRPPELLLGATDYG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP
Sbjct: 285 VTLWYRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPP 344
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
+DYWKKSKLPHA LFKPQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+AL S
Sbjct: 345 EDYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVS 404
Query: 239 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSKL 297
+YF+TKP+ACD SSLPIYPPSKEID KHR++A + RK +RK+H ++L
Sbjct: 405 QYFTTKPFACDPSSLPIYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRL 464
Query: 298 APVEDVAVRTQ-FAKKINGHSLH--ILKDDELSGREVQKPLVDNREEASHVKNASHGDIP 354
AP DV +T+ F K+I GH +H I D L G+ +Q PL ++EASHVK+AS GD+P
Sbjct: 465 AP--DVRHQTETFQKRI-GHLVHSSIESDARLCGK-LQNPLDHKKDEASHVKHASQGDVP 520
Query: 355 FSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSR--KH 412
FSGPLQVS S+ FAWAKR KDD +R H RS SRG + + S A + +++ +S+ K
Sbjct: 521 FSGPLQVSKSNSFAWAKREKDDVCVRVHNRSLSRGYIPSLSGHSPAFNGKSDVESKINKD 580
Query: 413 ENGDIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEM 472
E D +TDSRG +S E VK +ML QW QLERPDSF ASD YHSQELSL LYQR+EM
Sbjct: 581 EKED-----KTDSRGEESYEMVKRSMLKQWRQLERPDSFGASDEYHSQELSLGLYQRDEM 635
Query: 473 ATKR-NNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQR 523
A K NNLG G+K+EFSGPLLSQS+ +DELLERHER IR+ +RK WFQ+
Sbjct: 636 AKKMGNNLG---DGDKIEFSGPLLSQSYGVDELLERHERNIRKLIRKPWFQK 684
|
|
| TAIR|locus:2175743 cdc2cAt "CDC2C" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.2e-123, Sum P(2) = 1.2e-123
Identities = 197/269 (73%), Positives = 231/269 (85%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREILILR+L+HPNI+KLEG++TSR S SIYLVFEYMEHD+ GL S PDI+F+E QIKC
Sbjct: 149 MAREILILRKLNHPNIMKLEGIVTSRASSSIYLVFEYMEHDLAGLSSNPDIRFTEPQIKC 208
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCH RGV+HRDIK SN+LVNN+GVLKL DFGLAN ++ LTSRVVT
Sbjct: 209 YMKQLLWGLEHCHMRGVIHRDIKASNILVNNKGVLKLGDFGLANVVTPSNKNQLTSRVVT 268
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYR PELL+G+T YG SVDLWSVGCVFAE+L+GKPIL+GRTE+EQLHKI+KLCGSP D
Sbjct: 269 LWYRAPELLMGSTSYGVSVDLWSVGCVFAEILMGKPILKGRTEIEQLHKIYKLCGSPQDS 328
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
+WK++KLPHAT FKPQ Y+++LRE KDL T V L+ETLLS+EP KR TAS+AL SEY
Sbjct: 329 FWKRTKLPHATSFKPQHTYEATLRERCKDLSATGVYLLETLLSMEPDKRGTASSALNSEY 388
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHRED 269
F T+PYACD SSLP YPP+KE+DAK+R+D
Sbjct: 389 FLTRPYACDPSSLPKYPPNKEMDAKYRDD 417
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 2.3e-114, Sum P(2) = 2.3e-114
Identities = 202/330 (61%), Positives = 246/330 (74%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI+ILRRLDHPN++KLEGLITSR+S S+YL+FEYMEHD+ GL S P I FSEAQIKC
Sbjct: 207 MAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKC 266
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLLHGLEHCHSRGVLHRDIKGSNLL+++ LK+ DFGLANF +QPLTSRVVT
Sbjct: 267 YMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVT 326
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP ++
Sbjct: 327 LWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEE 386
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YWK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP R T ++AL SE+
Sbjct: 387 YWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEF 446
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPV 300
F+T P A D SSLP Y P KEID K +E+ ++++ +R+S + AP
Sbjct: 447 FTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQVSRESKAVP--APD 504
Query: 301 EDVAVRTQFAKKINGHSLHILKDDELSGRE 330
+ T K+ H+ + D+ + E
Sbjct: 505 SNAESLTSIQKRQGQHN-QVSNSDKFNPGE 533
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 1.4e-112, Sum P(2) = 1.4e-112
Identities = 215/424 (50%), Positives = 279/424 (65%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI+++RRLDHPN++KLEGLIT+ +S S+YLVFEYM+HD+ GL S P IKFSE Q+KC
Sbjct: 181 MAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQVKC 240
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GL HCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA F + + PLTSRVVT
Sbjct: 241 YMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVT 300
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLGA YG VDLWS GC+ EL GKPIL G+TEVEQLHKIFKLCGSP +D
Sbjct: 301 LWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTED 360
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YW+K KLP + F+P PY + E FKDLPT ++L+E LLS++P +R +A+ AL SEY
Sbjct: 361 YWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESEY 420
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPV 300
F T+P+ACD SSLP YPPSKEIDAK R+DA + +T R+SH + PV
Sbjct: 421 FRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQT-RRSHERKLIPPV 479
Query: 301 E------DVAVRTQFAKK-INGHSLHILKD----DELSGREVQK-PLVDNRE--EASHVK 346
+ AV + + + G+S ++D + SGR P++ NR ++VK
Sbjct: 480 KANNPSLSTAVENPYLRSCVPGNSQRQMQDMTCNNPTSGRVSHSGPMMKNRNLSRLTYVK 539
Query: 347 NASHGDIPFSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVI-NALEPSAALHTRN 405
+ + IP G+ + ++ D R R+ +R + N+ + + +
Sbjct: 540 DNAAPRIPSYRANSAGQGGGYVGSDQQMMDQQ-RKELRTFNRADTMDNSKRQTKIPNDPS 598
Query: 406 NYDS 409
YDS
Sbjct: 599 WYDS 602
|
|
| TAIR|locus:2140543 AT4G10010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1024 (365.5 bits), Expect = 1.5e-110, Sum P(2) = 1.5e-110
Identities = 187/269 (69%), Positives = 227/269 (84%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI ILR+LDHPN++KLE L+TS+LS S+YLVFEYMEHD++GL P +KF+E+QIKC
Sbjct: 20 MAREINILRKLDHPNVMKLECLVTSKLSGSLYLVFEYMEHDLSGLALRPGVKFTESQIKC 79
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCHSRG+LHRDIKG NLLVNN+GVLK+ DFGLAN + QPLTSRVVT
Sbjct: 80 YMKQLLSGLEHCHSRGILHRDIKGPNLLVNNDGVLKIGDFGLANIYHPEQDQPLTSRVVT 139
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYR PELLLGAT+YGP +DLWSVGC+ EL +GKPI+ GRTEVEQ+HKIFK CGSP DD
Sbjct: 140 LWYRAPELLLGATEYGPGIDLWSVGCILTELFLGKPIMPGRTEVEQMHKIFKFCGSPSDD 199
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YW+K+KLP AT FKPQQPY L ETFK+LP +A+ L++ LLS+EP KR TAS+ L+S++
Sbjct: 200 YWQKTKLPLATSFKPQQPYKRVLLETFKNLPPSALALVDKLLSLEPAKRGTASSTLSSKF 259
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHRED 269
F+ +P C++SSLP YPPSKE+DAK R++
Sbjct: 260 FTMEPLPCNVSSLPKYPPSKELDAKVRDE 288
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 3.8e-110, P = 3.8e-110
Identities = 227/392 (57%), Positives = 274/392 (69%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI ILRRLDHPNIIKLEGL+TSR+SCS+YLVFEYMEHD+ GL S P IKFSE+Q+KC
Sbjct: 178 MAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIKFSESQVKC 237
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y+ QLLHGL+HCHSRGVLHRDIKGSNLL++N GVLK+ADFGLA+F + QPLTSRVVT
Sbjct: 238 YLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSRVVT 297
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLGAT YG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP +D
Sbjct: 298 LWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPTED 357
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YW KS+LPHAT+FKP QPY + ETFK+ P A+ L+ETLLSV P R TA+AAL SE+
Sbjct: 358 YWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAALKSEF 417
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHR-EDAXXXXXXXXXXXAETRKTTRKSHGM-SKLA 298
FST+P CD SSLP YPPSKE+DA+ R E++ + R+ T++S + + A
Sbjct: 418 FSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQRHQERRGTKESRAIPAPDA 477
Query: 299 PVEDVAV----RTQFAKKINGHSLHILKDDELSGREVQKP------LVDNREEASHV--- 345
E VA ++Q + + ++ SG + P NRE ++
Sbjct: 478 NAELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPIDPPRPSSQAFEPNRESQGNIIPH 537
Query: 346 KNASHGDIPFSGPLQVSTSSGFAWAKRRKDDA 377
K ASH SGPL S S A +R D+
Sbjct: 538 KRASH-----SGPL--SRRSASAKGRRNYQDS 562
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
Identities = 200/363 (55%), Positives = 250/363 (68%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI+++RRLDHPN++KLEGLIT+ +S S+YLVFEYM+HD+ GL S P +KF+E Q+KC
Sbjct: 257 MAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHDLLGLSSLPGVKFTEPQVKC 316
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GLEHCHSRGVLHRDIKGSNLL++++GVLK+ADFGLA F + LTS VVT
Sbjct: 317 YMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFGLATFFDPAKSVSLTSHVVT 376
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLGA+ YG VDLWS GC+ EL GKPIL G+TEVEQLHKIFKLCGSP ++
Sbjct: 377 LWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGKTEVEQLHKIFKLCGSPTEN 436
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
YW+K KLP + FK PY + E FKD P + ++L+ETLLS++P R++A AL SEY
Sbjct: 437 YWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETLLSIDPDHRSSADRALESEY 496
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPV 300
F TKP+ACD S+LP YPPSKEIDAK R++A TR SH + PV
Sbjct: 497 FKTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQPMRAEKQERQDSMTRISHERKFVPPV 556
Query: 301 E-DVAVRTQFAKKINGHSLHILKDDELSGREVQKPL--VDNREEASHVKNASHG-DIPFS 356
+ + ++ K+ L D S +E + P V + + H +N G I S
Sbjct: 557 KANNSLSMTMEKQYK--DLRSRNDSFKSFKEERTPHGPVPDYQNMQHNRNNQTGVRISHS 614
Query: 357 GPL 359
GPL
Sbjct: 615 GPL 617
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 5.7e-107, Sum P(2) = 5.7e-107
Identities = 178/269 (66%), Positives = 225/269 (83%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MAREI ILR+LDHPN++KL+ L+TS+LS S++LVFEYMEHD++GL P +KF+E QIKC
Sbjct: 185 MAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKC 244
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+M QLL GLEHCHSRG+LHRDIKGSNLLVNN+GVLK+ DFGLA+F QPLTSRVVT
Sbjct: 245 FMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVT 304
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYR PELLLG+T+YGP++DLWSVGC+ AEL + KPI+ GRTEVEQ+HKIFKLCGSP ++
Sbjct: 305 LWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEE 364
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
+W +K P AT +KPQ PY L ETFK+L +++++L++ LLSVEP KR +AS+ L SE+
Sbjct: 365 FWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEF 424
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHRED 269
F+T+P C +SSLP YPPSKE+DAK R++
Sbjct: 425 FTTEPLPCHISSLPKYPPSKELDAKVRDE 453
|
|
| TAIR|locus:504955609 AT3G01085 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1021 (364.5 bits), Expect = 5.1e-106, Sum P(2) = 5.1e-106
Identities = 210/398 (52%), Positives = 277/398 (69%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+AREI+ILRRLDHPNI+KLEG+I SR S S+Y VF+YMEHD+ GL S PDIKF+EAQIKC
Sbjct: 159 IAREIMILRRLDHPNIMKLEGIIASRNSNSMYFVFDYMEHDLEGLCSSPDIKFTEAQIKC 218
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL G+EHCH RG++HRDIK +N+LVNN+GVLKLADFGLAN ++ LTSRVVT
Sbjct: 219 YMKQLLWGVEHCHLRGIMHRDIKAANILVNNKGVLKLADFGLANIVTPRNKNQLTSRVVT 278
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYR PELL+G+T Y SVDLWSVGCVFAE+L G+P+L+GRTE+EQLHKI+KL GSP ++
Sbjct: 279 LWYRAPELLMGSTSYSVSVDLWSVGCVFAEILTGRPLLKGRTEIEQLHKIYKLSGSPDEE 338
Query: 181 YWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
+W+K+KL P +F+PQ Y+ LRE F + P TA+NL+E LLS++P KR TAS+AL SE
Sbjct: 339 FWEKNKLHPQTKMFRPQHQYEGCLRERFDEFPKTAINLLENLLSIDPEKRGTASSALMSE 398
Query: 240 YFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAP 299
YF+T+PYACD S+LP YPP+KE+DAK+RE+ T+K G S+ A
Sbjct: 399 YFNTQPYACDPSTLPKYPPNKEMDAKYREELQRRRRVSIKK--RDNLATKKL-GKSRRAT 455
Query: 300 VEDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLV-DNREEASHVKNASHGDIPFSGP 358
V++ +L+ L + + +E + +V E S S + P++
Sbjct: 456 VKEPT------------NLNRLPTHQETKKEAETEIVVQTPSETSQATTRS--EFPYNSL 501
Query: 359 LQVST-SSGFAWA--KRRKDD--ASIRSHTRSTSRGQV 391
Q + +SGFAWA K+RK++ AS ++ + S V
Sbjct: 502 SQTTAPASGFAWAGTKKRKENDVASTLTYIQPGSASHV 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00120612 | hypothetical protein (686 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 529 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-135 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-101 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-99 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-96 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-90 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-90 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-90 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-78 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-77 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-76 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-74 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-71 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-69 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-68 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-63 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-62 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-62 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-62 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-61 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-61 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-60 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-59 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-59 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-59 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-57 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-56 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-56 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-53 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-53 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-52 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-51 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-51 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-50 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-50 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-50 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-50 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-50 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-48 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-48 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-47 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-46 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-46 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-45 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-45 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-45 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-44 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-43 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-42 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-38 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-33 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-33 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-17 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.002 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 393 bits (1011), Expect = e-135
Identities = 145/243 (59%), Positives = 187/243 (76%), Gaps = 2/243 (0%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
REI +L++L HPNI++L+ ++TS+ SIY+VFEYM+HD+TGLL P++KF+E+QIKC
Sbjct: 45 AIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC 104
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM QLL GL++ HS G+LHRDIKGSN+L+NN+GVLKLADFGLA + T+RV+T
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT 164
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPPELLLGAT YGP VD+WSVGC+ AEL +GKPI QG TE+EQL KIF+LCGSP D+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE 224
Query: 181 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPT-TAVNLIETLLSVEPYKRATASAALAS 238
W SKLP KP++PY LRE FK L +A++L++ LL+++P KR +A AL
Sbjct: 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284
Query: 239 EYF 241
EYF
Sbjct: 285 EYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 305 bits (784), Expect = e-101
Identities = 106/241 (43%), Positives = 144/241 (59%), Gaps = 7/241 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L HPNI+KL +I + +YLVFEY + D+ L S IK M
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIM 104
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
QLL GL +CHS +LHRD+K N+L+N +GVLKLADFGLA F T VVTL
Sbjct: 105 YQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTL 162
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR PE+LLG+ Y +VD+WSVGC+FAE++ GKP+ G +E++QL KIF++ G+P ++
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 182 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
W +KLP P+ P L + L ++L+ +L P KR +A AL Y
Sbjct: 223 WPGVTKLPDYKPTFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
Query: 241 F 241
F
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 302 bits (775), Expect = 2e-99
Identities = 115/253 (45%), Positives = 156/253 (61%), Gaps = 6/253 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L HPNII L + + +I LVFE+ME D+ ++ I + A IK YM
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYM 108
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
L GLE+ HS +LHRD+K +NLL+ ++GVLKLADFGLA + +R +T +VVT W
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRW 167
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
YR PELL GA YG VD+WSVGC+FAELL+ P L G ++++QL KIF+ G+P ++ W
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 183 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
+ LP FKP P L++ F A++L++ LL++ P KR TA AL YF
Sbjct: 228 PGVTSLPDYVEFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
Query: 242 STKPYACDLSSLP 254
S P S LP
Sbjct: 286 SNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 293 bits (751), Expect = 8e-96
Identities = 116/256 (45%), Positives = 161/256 (62%), Gaps = 17/256 (6%)
Query: 3 REILILRRLDHPNIIKLEGLI------TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEA 56
REI IL++L HPN++ L + + R S+Y+V YM+HD++GLL P +K +E+
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFS 106
QIKCYM QLL G+ + H +LHRDIK +N+L++N+G+LK+ADFGLA
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 107 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 166
G + T+ VVT WYRPPELLLG Y +VD+W +GCVFAE+ +PILQG+++++Q
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 167 LHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225
LH IFKLCG+P ++ W LP Y +L E F L ++L+ LLS++
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295
Query: 226 PYKRATASAALASEYF 241
PYKR TAS AL YF
Sbjct: 296 PYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 280 bits (717), Expect = 1e-90
Identities = 121/261 (46%), Positives = 166/261 (63%), Gaps = 12/261 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIK 59
REI +L L HPNI++L+ ++ + SI+LV EY E D+ LL P FSE+Q+K
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVK 111
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRV 118
C M QLL GL++ H ++HRD+K SNLL+ ++G LK+ADFGLA G +P+T +V
Sbjct: 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA--RTYGLPAKPMTPKV 169
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VTLWYR PELLLG T Y ++D+W+VGC+ AELL KP+L G++E+EQL I +L G+P
Sbjct: 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229
Query: 179 DDYWKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ W S LP F P+QPY ++L+ F L + L+ LL +P KRATA AL
Sbjct: 230 ESIWPGFSDLPLVGKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288
Query: 237 ASEYFSTKPYACDLSSLPIYP 257
S YF KP C+ +P +P
Sbjct: 289 ESSYFKEKPLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 277 bits (711), Expect = 6e-90
Identities = 120/247 (48%), Positives = 162/247 (65%), Gaps = 9/247 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFS 54
REI ILR+L+H NI+ L+ ++T + + YLVFEYM+HD+ GLL + FS
Sbjct: 55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS 114
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E IK +M QLL GL +CH + LHRDIK SN+L+NN+G +KLADFGLA N+ +P
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T++V+TLWYRPPELLLG YGP++D+WS GC+ EL KPI Q E+ QL I +LC
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234
Query: 175 GSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
GSP W KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294
Query: 234 AALASEY 240
AL S +
Sbjct: 295 EALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 6e-90
Identities = 109/243 (44%), Positives = 153/243 (62%), Gaps = 6/243 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI IL +L HPNI+ ++ ++ IY+V EY+EHD+ L+ F ++++KC M
Sbjct: 53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM 112
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
QLL G+ H H +LHRD+K SNLL+NN G+LK+ DFGLA + +P T VVTL
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVVTL 170
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR PELLLGA +Y ++D+WSVGC+FAELL KP+ G++E++QL+KIFKL G+P +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230
Query: 182 WKK-SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALAS 238
W S+LP A + + LR+ F L +L+ LL+ +P KR +A AL
Sbjct: 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
Query: 239 EYF 241
YF
Sbjct: 291 PYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 7e-78
Identities = 111/240 (46%), Positives = 148/240 (61%), Gaps = 4/240 (1%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L+HPNIIKL + + +YLVFE+M+ D+ L+ E+ IK Y+
Sbjct: 47 REIKLLKELNHPNIIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL 104
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QLL GL CHS G+LHRD+K NLL+N EGVLKLADFGLA + R P T VVT W
Sbjct: 105 YQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRW 163
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
YR PELLLG Y VD+WSVGC+FAELL +P+ G++E++QL KIF+ G+P + W
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW 223
Query: 183 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
K + L F + L + F + A++L+ +L +P+KR TA ALA YF
Sbjct: 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 6e-77
Identities = 99/244 (40%), Positives = 141/244 (57%), Gaps = 7/244 (2%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
REI L+ HP ++KL L LV EYM D++ +L + EAQ+K
Sbjct: 46 ALREIKALQACQHPYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKS 103
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
YM LL G+ + H+ G++HRD+K +NLL++ +GVLK+ADFGLA + + + +V T
Sbjct: 104 YMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT 163
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
WYR PELL GA Y P VDLW+VGC+FAELL G P+ G ++EQL +F+ G+P ++
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE 223
Query: 181 YWKK-SKLPHAT--LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
W + LP F +P L E F D A++L++ LL +P KR +A+ AL
Sbjct: 224 TWPGLTSLPDYNKITFPESKP--IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281
Query: 238 SEYF 241
YF
Sbjct: 282 HPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 2e-76
Identities = 113/256 (44%), Positives = 151/256 (58%), Gaps = 22/256 (8%)
Query: 3 REILILRRLDHPNIIKL------EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEA 56
REI IL+ L H N++ L + +R S YLVFE+ EHD+ GLLS ++KF+ +
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS 119
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQP 113
+IK M LL+GL + H +LHRD+K +N+L+ +G+LKLADFGLA + S
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
T+RVVTLWYRPPELLLG DYGP +D+W GC+ AE+ PI+QG TE QL I +L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 174 CGSPPDDYWKK-SKLPHATLFK----PQQPYD---SSLRETFKDLPTTAVNLIETLLSVE 225
CGS + W KL LFK PQ L+ KD A++LI+ LL ++
Sbjct: 240 CGSITPEVWPGVDKLE---LFKKMELPQGQKRKVKERLKPYVKDP--HALDLIDKLLVLD 294
Query: 226 PYKRATASAALASEYF 241
P KR A AL ++F
Sbjct: 295 PAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 2e-74
Identities = 106/266 (39%), Positives = 159/266 (59%), Gaps = 19/266 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE+ I+ + H NI+ L + I LV + M D+ ++ I+ +E+Q+KC +
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVD-RKIRLTESQVKCIL 125
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTG 109
Q+L+GL H +HRD+ +N+ +N++G+ K+ADFGLA
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
R+ +TS+VVTLWYR PELL+GA Y +VD+WSVGC+FAELL GKP+ G E++QL +
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 170 IFKLCGSPPDDYW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
IF+L G+P +D W + KLP T F P++P D L+ F + A++L+++LL + P +
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKD--LKTIFPNASDDAIDLLQSLLKLNPLE 303
Query: 229 RATASAALASEYFSTKPYACDLSSLP 254
R +A AL EYF + P CD S LP
Sbjct: 304 RISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 4e-71
Identities = 99/251 (39%), Positives = 148/251 (58%), Gaps = 18/251 (7%)
Query: 1 MAREILILRRLD---HPNIIKL----EGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIK 52
REI +L++L+ HPNI++L G T R + LVFE+++ D+ LS CP
Sbjct: 45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPG 103
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHR 111
IK M QLL G++ HS ++HRD+K N+LV ++G +K+ADFGLA +S
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--- 160
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
LTS VVTLWYR PE+LL ++ Y VD+WSVGC+FAEL +P+ +G +E +QL KIF
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219
Query: 172 KLCGSPPDDYW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
+ G P ++ W + LP ++ F P S + ++ ++L++ +L+ P+KR
Sbjct: 220 DVIGLPSEEEWPRNVSLPRSS-FPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276
Query: 231 TASAALASEYF 241
+A AL YF
Sbjct: 277 SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 6e-71
Identities = 103/245 (42%), Positives = 148/245 (60%), Gaps = 14/245 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITS--RLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIK 59
REI +L+ L+HPNI++L ++ S +L YLVFE+++ D+ + S P IK
Sbjct: 47 REISLLKELNHPNIVRLLDVVHSENKL----YLVFEFLDLDLKKYMDSSPLTGLDPPLIK 102
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Y+ QLL G+ +CHS VLHRD+K NLL++ EG LKLADFGLA R T VV
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVV 161
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
TLWYR PE+LLG+ Y VD+WS+GC+FAE++ +P+ G +E++QL +IF+ G+P +
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE 221
Query: 180 DYWKK-SKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
D W + LP +KP P L + +L ++L+ +L +P KR +A AAL
Sbjct: 222 DVWPGVTSLPD---YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278
Query: 237 ASEYF 241
YF
Sbjct: 279 QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 1e-70
Identities = 98/271 (36%), Positives = 146/271 (53%), Gaps = 19/271 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI +LR L H NII L ++ +Y+V E ME D+ ++ P ++ I+
Sbjct: 48 REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQ 106
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSR 117
++ Q+L GL++ HS V+HRD+K SN+LVN+ LK+ DFGLA + + LT
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
VVT WYR PELLL ++ Y ++D+WSVGC+FAELL KP+ GR ++QL+ I ++ G+P
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 178 PDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
++ K A + P L + F A++L+E +L +P KR TA A
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286
Query: 236 LASEYFSTKPYACDLSSLPIYPPSKEIDAKH 266
LA Y + ++ P E AK
Sbjct: 287 LAHPYLA-----------QLHDPEDEPVAKP 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 5e-69
Identities = 90/240 (37%), Positives = 128/240 (53%), Gaps = 32/240 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI IL++L HPNI++L + +YLV EY E D+ LL + SE + + Y
Sbjct: 46 REIKILKKLKHPNIVRLYDVFEDEDK--LYLVMEYCEGGDLFDLL-KKRGRLSEDEARFY 102
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ Q+L LE+ HS+G++HRD+K N+L++ +G +KLADFGLA + G + LT+ V T
Sbjct: 103 LRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTP 160
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
Y PE+LLG YG +VD+WS+G + ELL GKP G +QL ++FK G P +
Sbjct: 161 EYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPF 216
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
D+ A +LI LL +P KR TA AL +F
Sbjct: 217 PPP----------------------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 5e-68
Identities = 95/242 (39%), Positives = 122/242 (50%), Gaps = 29/242 (11%)
Query: 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKC 60
REI ILRRL HPNI++L +YLV EY E D+ LS SE + K
Sbjct: 46 RREIRILRRLSHPNIVRLIDAFED--KDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKK 102
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Q+L GLE+ HS G++HRD+K N+L++ GV+K+ADFGLA LT+ V T
Sbjct: 103 IALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTTFVGT 161
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK-LCGSPPD 179
WY PE+LLG YGP VD+WS+G + ELL GKP G ++QL I + L
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF 221
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
D K SS E KD LI+ L+ +P KR TA L
Sbjct: 222 DEPKW----------------SSGSEEAKD-------LIKKCLNKDPSKRPTAEEILQHP 258
Query: 240 YF 241
+F
Sbjct: 259 WF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 100/242 (41%), Positives = 143/242 (59%), Gaps = 7/242 (2%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-FSEAQIKC 60
RE+ LR+L +HPNI+KL+ + R + +Y VFEYME ++ L+ K FSE+ I+
Sbjct: 46 REVKSLRKLNEHPNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRS 103
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ Q+L GL H H G HRD+K NLLV+ V+K+ADFGLA R P T V T
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVST 161
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
WYR PE+LL +T Y VD+W++GC+ AEL +P+ G +E++QL+KI + G+P
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221
Query: 181 YWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
W + KL F+ Q +SL + + A++LI+ +L +P KR TAS AL
Sbjct: 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 240 YF 241
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 2e-62
Identities = 90/243 (37%), Positives = 133/243 (54%), Gaps = 7/243 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE+ +LR+L H NI+ L R +YLVFEY+E + LL ++ Y+
Sbjct: 49 REVKVLRQLRHENIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYI 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QLL + +CHS ++HRDIK N+LV+ GVLKL DFG A PLT V T W
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW 166
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP---- 178
YR PELL+G T+YG VD+W++GC+ AELL G+P+ G ++++QL+ I K G P
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
+ + + +P QP +S R + + A++ ++ L ++P +R T L
Sbjct: 227 ELFSSNPRFAGVAFPEPSQP-ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
Query: 239 EYF 241
YF
Sbjct: 286 PYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 7e-62
Identities = 106/246 (43%), Positives = 153/246 (62%), Gaps = 15/246 (6%)
Query: 3 REILILRRLDHPNIIKLEGLIT--SRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQ-I 58
REI +L+ L HPNI+ L+ ++ SRL YL+FE++ D+ L S P ++ +A+ +
Sbjct: 48 REISLLKELQHPNIVCLQDVLMQESRL----YLIFEFLSMDLKKYLDSLPKGQYMDAELV 103
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
K Y+ Q+L G+ CHSR VLHRD+K NLL++N+GV+KLADFGLA R T V
Sbjct: 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEV 162
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VTLWYR PE+LLG+ Y VD+WS+G +FAE+ KP+ G +E++QL +IF++ G+P
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPT 222
Query: 179 DDYWKK-SKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
+D W + LP +K P SLR K+L ++L+E +L +P KR +A A
Sbjct: 223 EDVWPGVTSLPD---YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279
Query: 236 LASEYF 241
L YF
Sbjct: 280 LNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 7e-62
Identities = 100/243 (41%), Positives = 141/243 (58%), Gaps = 10/243 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCY 61
REI +L+ L+HPNI+KL +I + +YLVFE++ D+ + + P IK Y
Sbjct: 48 REISLLKELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSY 105
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ QLL GL CHS VLHRD+K NLL+N EG +KLADFGLA R T VVTL
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTL 164
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR PE+LLG Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P +
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 224
Query: 182 WKK-SKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
W + LP +KP P + L +L+ +L +P KR +A AALA
Sbjct: 225 WPGVTSLPD---YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281
Query: 239 EYF 241
+F
Sbjct: 282 PFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 3e-61
Identities = 98/271 (36%), Positives = 142/271 (52%), Gaps = 37/271 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKF--------- 53
REI +LR L H N++ L + S+YL+F+Y EHD+ + IKF
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQI-----IKFHRQAKRVSI 105
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTG 109
+ +K + Q+L+G+ + HS VLHRD+K +N+LV E GV+K+ D GLA N
Sbjct: 106 PPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 110 HRQPLTSR--VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---- 163
+ VVT+WYR PELLLGA Y ++D+W++GC+FAELL +PI +GR
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225
Query: 164 -----VEQLHKIFKLCGSPPDDYWKK-SKLPH----ATLFKPQQPYDSSLR---ETFKDL 210
+QL +IF++ G+P + W K+P FK + +SL E K
Sbjct: 226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP 285
Query: 211 PTTAVNLIETLLSVEPYKRATASAALASEYF 241
+ +L+ LL +P KR TA AL YF
Sbjct: 286 DSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 3e-61
Identities = 101/276 (36%), Positives = 139/276 (50%), Gaps = 30/276 (10%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDIT-----GLLSCPDIKFSEA 56
REI+ L+ L DHPNI+KL +I + IYLVFEYME D+ +L +
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE-------DV 107
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQ 112
+ M QLL L++ HS V+HRD+K SN+L+N++ +KLADFGLA
Sbjct: 108 HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
LT V T WYR PE+LLG+T Y VD+WSVGC+ E+L+GKP+ G + + QL KI +
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 173 LCGSPPDDYWK--KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
+ G P + + KS L L E A++L++ LL P KR
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
Query: 231 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 266
TA AL Y + + PS E +
Sbjct: 288 TAEEALEHPYVA-----------QFHNPSDEPVLPY 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 1e-60
Identities = 96/248 (38%), Positives = 139/248 (56%), Gaps = 17/248 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCY 61
RE +L+ L H NI+ L +I ++ + + LVFEY++ D+ + C S ++ +
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLT--LVFEYLDTDLKQYMDDCGGG-LSMHNVRLF 108
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF----SNTGHRQPLTSR 117
+ QLL GL +CH R VLHRD+K NLL++ G LKLADFGLA S T ++
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-----YSNE 163
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGS 176
VVTLWYRPP++LLG+T+Y S+D+W VGC+F E+ G+P+ G T+V +QLHKIF++ G+
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT 223
Query: 177 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATAS 233
P ++ W S P + L D L L EP KR +A+
Sbjct: 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283
Query: 234 AALASEYF 241
A+ YF
Sbjct: 284 EAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 1e-59
Identities = 95/253 (37%), Positives = 136/253 (53%), Gaps = 29/253 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-----FSEAQ 57
REI +++ L H NI++L +I + + LVFEYM+ D+ + D
Sbjct: 47 REISLMKELKHENIVRLHDVIHTE--NKLMLVFEYMDKDLKKYM---DTHGVRGALDPNT 101
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTG 109
+K + QLL G+ CH VLHRD+K NLL+N G LKLADFGLA FSN
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-- 159
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
VVTLWYR P++LLG+ Y S+D+WSVGC+ AE++ G+P+ G +QL K
Sbjct: 160 -------EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
Query: 170 IFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
IF++ G+P + W S+LP P+ P L++ F ++L+ LL + P
Sbjct: 213 IFRIMGTPTESTWPGISQLPEYKPTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPEL 271
Query: 229 RATASAALASEYF 241
R +A AL +F
Sbjct: 272 RISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 2e-59
Identities = 101/241 (41%), Positives = 138/241 (57%), Gaps = 6/241 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L H NI++L ++ S + LVFEY + D+ + +K +M
Sbjct: 48 REICLLKELKHKNIVRLYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM 105
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QLL GL CHS VLHRD+K NLL+N G LKLADFGLA R ++ VVTLW
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLW 164
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
YRPP++L GA Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224
Query: 182 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
W SKLP + P P +SL L +T +L++ LL P +R +A AL Y
Sbjct: 225 WPGVSKLPDYKPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
Query: 241 F 241
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-59
Identities = 103/243 (42%), Positives = 148/243 (60%), Gaps = 9/243 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCY 61
REI +L+ + H NI++L+ ++ S +YLVFEY++ D+ + S PD + IK Y
Sbjct: 50 REISLLKEMQHGNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ Q+L G+ +CHS VLHRD+K NLL++ LKLADFGLA R T VVT
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVT 166
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYR PE+LLG+ Y VD+WSVGC+FAE++ KP+ G +E+++L KIF++ G+P ++
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 181 YWKK-SKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
W + LP + + F P D L L V+L+ +L ++P KR TA AAL
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKD--LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284
Query: 239 EYF 241
EYF
Sbjct: 285 EYF 287
|
Length = 294 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 3e-57
Identities = 97/264 (36%), Positives = 145/264 (54%), Gaps = 18/264 (6%)
Query: 3 REILILRRLDHPNIIKLEGLI--TSRLSCS-IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI +LR LDH N+I ++ ++ R + + +Y+V+E M+ D+ ++ S+ +
Sbjct: 53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQ 111
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
++ QLL GL++ HS VLHRD+K SNLL+N LK+ DFGLA ++ +T VV
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVV 170
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T WYR PELLL ++Y ++D+WSVGC+FAELL KP+ G+ V QL I +L GSP +
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230
Query: 180 DYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
+ + A + PY S F A++L+E +L +P KR T ALA
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290
Query: 238 SEYFSTKPYACDLSSLPIYPPSKE 261
Y + ++ PS E
Sbjct: 291 HPYLA-----------SLHDPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 103/253 (40%), Positives = 143/253 (56%), Gaps = 21/253 (8%)
Query: 3 REILILRRLDH-PNIIKL---EGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFS 54
REI +L+ L I++L E + S+YLVFEY++ D+ + P
Sbjct: 49 REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP 108
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA-NFSNTGHRQ 112
IK +M QLL G+ HCH GV+HRD+K NLLV+ + G+LK+AD GL FS
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----I 163
Query: 113 PL---TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
P+ T +VTLWYR PE+LLG+T Y VD+WSVGC+FAE+ +P+ G +E++QL
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223
Query: 170 IFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
IFKL G+P + W SKL F +P D L DL ++L++ +L +P K
Sbjct: 224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAK 281
Query: 229 RATASAALASEYF 241
R +A AAL YF
Sbjct: 282 RISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 89/240 (37%), Positives = 134/240 (55%), Gaps = 4/240 (1%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
REI LRRL HPNI++L ++ R + + LVFE M+ ++ L+ E ++K Y
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSY 105
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
M QLL L+H H G+ HRDIK N+L+ ++ +LKLADFG + + P T + T
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS--KPPYTEYISTR 162
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR PE LL YGP +D+W+VGCVF E+L P+ G E++Q+ KI + G+P +
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
KK + + + LR+ + ++L++ LL+ +P +R TA AL YF
Sbjct: 223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 84/248 (33%), Positives = 129/248 (52%), Gaps = 19/248 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L++L HPN++ L + R ++LVFEY +H + L E IK +
Sbjct: 49 REIRMLKQLKHPNLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKII 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
Q L + CH +HRD+K N+L+ +G +KL DFG A T V T W
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRW 165
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS------ 176
YR PELL+G T YGP VD+W++GCVFAELL G+P+ G+++V+QL+ I K G
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225
Query: 177 ---PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
+ ++K +P +P L F ++ + A++ ++ L ++P +R +
Sbjct: 226 QIFSTNQFFKGLSIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCE 278
Query: 234 AALASEYF 241
L YF
Sbjct: 279 ELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-53
Identities = 99/247 (40%), Positives = 145/247 (58%), Gaps = 18/247 (7%)
Query: 3 REILILRRLDHPNIIKLEGLI-TSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKC 60
RE+ +L+ L H NI+ L +I T R + LVFEY++ D+ L +C ++ S +K
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNL-MSMHNVKI 107
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+M QLL GL +CH R +LHRD+K NLL+N +G LKLADFGLA + + + ++ VVT
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVT 166
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
LWYRPP++LLG+T+Y +D+W VGC+ E+ G+P+ G T E+LH IF+L G+P ++
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226
Query: 181 YWKKSKLPHATLFKPQQPYD------SSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234
W P T + + Y L L T ++L+ +LL E R +A A
Sbjct: 227 TW-----PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281
Query: 235 ALASEYF 241
AL YF
Sbjct: 282 ALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 84/250 (33%), Positives = 131/250 (52%), Gaps = 12/250 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
RE+ ILR H NII + ++ +Y+V + ME D+ ++ D +E I+
Sbjct: 53 RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRY 111
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSR 117
++ QLL GL++ HS V+HRD+K SNLLVN + L++ DFG+A S T H+ +T
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
V T WYR PELLL +Y ++D+WSVGC+FAE+L + + G+ V QL I + GSP
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 178 PDDYWKKSKLPHA----TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
++ + +QP + F A++L+ +L +P +R T
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVP--WSKIFPKASPEALDLLSQMLQFDPEERITVE 289
Query: 234 AALASEYFST 243
AL + +
Sbjct: 290 QALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 94/264 (35%), Positives = 146/264 (55%), Gaps = 19/264 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ +DH N+I L + T S +YLV M D+ ++ C K S+ I
Sbjct: 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHI 120
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL++ HS G++HRD+K SN+ VN + LK+ DFGLA ++ +T V
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYV 176
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T WYR PE++L Y +VD+WSVGC+ AELL GK + G ++QL +I L G+P
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT----AVNLIETLLSVEPYKRATASA 234
++ +K A + P ++ FK++ + A++L+E +L ++P KR TA+
Sbjct: 237 EELLQKISSESARNYIQSLPQMP--KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294
Query: 235 ALASEYFSTKPYACDLSSLPIYPP 258
ALA Y Y D P+ PP
Sbjct: 295 ALAHPYL--AEYH-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 4e-51
Identities = 96/242 (39%), Positives = 140/242 (57%), Gaps = 8/242 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCY 61
RE+ +L+ L H NI+ L +I + S + LVFEY++ D+ L C + + +K +
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLT--LVFEYLDKDLKQYLDDCGNS-INMHNVKLF 109
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ QLL GL +CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTL
Sbjct: 110 LFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTL 168
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYRPP++LLG+TDY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228
Query: 182 WKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
W S + P+ D + L + L+ LL E KR +A A+
Sbjct: 229 WPGILSNEEFKSYNYPKYRADCLHNHAPR-LDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 240 YF 241
YF
Sbjct: 288 YF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 99/247 (40%), Positives = 142/247 (57%), Gaps = 14/247 (5%)
Query: 3 REILILRRL---DHPNIIKLEGLI-TSRL--SCSIYLVFEYMEHDITGLLS-CPDIKFSE 55
RE+ +L+RL DHPNI++L + TSR + LVFE+++ D+ L P
Sbjct: 48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPA 107
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
IK M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA + + LT
Sbjct: 108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALT 165
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
VVTLWYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G
Sbjct: 166 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224
Query: 176 SPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234
PP+D W + LP F P+ P ++ ++ + L+ +L+ P+KR +A
Sbjct: 225 LPPEDDWPRDVTLPRGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281
Query: 235 ALASEYF 241
AL +F
Sbjct: 282 ALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-50
Identities = 93/262 (35%), Positives = 133/262 (50%), Gaps = 37/262 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI ILRR H NII + +I S +Y+V E ME D+ L+ + S I+
Sbjct: 52 REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQ 109
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSR 117
++ Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA H LT
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
V T WYR PE++L + Y ++D+WSVGC+ AE+L +P+ G+ + QL+ I + G+P
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229
Query: 178 PDD------------YWK----KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221
+ Y K K K+P LF P A++L++ +
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLF----PNADPK----------ALDLLDKM 275
Query: 222 LSVEPYKRATASAALASEYFST 243
L+ P+KR T ALA Y
Sbjct: 276 LTFNPHKRITVEEALAHPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-50
Identities = 99/269 (36%), Positives = 147/269 (54%), Gaps = 34/269 (12%)
Query: 3 REILILRRLDHPNIIKLEGLI---TSRLSC---------SIYLVFEYMEHDITGLLSCPD 50
REI I+RRLDH NI+K+ ++ S L+ S+Y+V EYME D+ +L
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP 110
Query: 51 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA-----N 104
+ SE + +M QLL GL++ HS VLHRD+K +N+ +N E VLK+ DFGLA +
Sbjct: 111 L--SEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
Query: 105 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 164
+S+ G+ L+ +VT WYR P LLL +Y ++D+W+ GC+FAE+L GKP+ G E+
Sbjct: 169 YSHKGY---LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
Query: 165 EQLHKIFKLCGSPP-----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 219
EQ+ I + S P D + +P +P LR+ + A++ +E
Sbjct: 226 EQMQLILE---SVPVVREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPGVNPEALDFLE 281
Query: 220 TLLSVEPYKRATASAALASEYFSTKPYAC 248
+L+ P R TA AL Y S Y+C
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMS--CYSC 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-50
Identities = 100/245 (40%), Positives = 142/245 (57%), Gaps = 11/245 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE +L+ L H NI+ L +I ++ + + VFEYM D+ + ++ +M
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFM 109
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QLL GL + H + +LHRD+K NLL++ G LKLADFGLA + + Q +S VVTLW
Sbjct: 110 FQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLW 168
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDY 181
YRPP++LLGATDY ++D+W GC+F E+L G+P G ++V EQL KI+ + G P +D
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228
Query: 182 WKK-SKLPH--ATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAAL 236
W SKLP+ F P +P LR +K L P A +L +L + P R +A AL
Sbjct: 229 WPGVSKLPNYKPEWFLPCKP--QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286
Query: 237 ASEYF 241
YF
Sbjct: 287 LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 4e-50
Identities = 98/262 (37%), Positives = 149/262 (56%), Gaps = 24/262 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCY 61
RE+ +L+ L H NI+ L ++ + S+ LVFEY++ D+ + C +I S +K +
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNI-MSMHNVKIF 109
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ Q+L GL +CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTL
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTL 168
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYRPP++LLG+++Y +D+W VGC+F E+ G+P+ G T ++LH IF+L G+P ++
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228
Query: 182 W---------KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
W K P +KPQ + + R L T + L+ L E KR +A
Sbjct: 229 WPGISSNDEFKNYNFPK---YKPQPLINHAPR-----LDTEGIELLTKFLQYESKKRISA 280
Query: 233 SAALASEYFSTKPYACDLSSLP 254
A+ YF + + SLP
Sbjct: 281 EEAMKHAYF--RSLGTRIHSLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 96/257 (37%), Positives = 137/257 (53%), Gaps = 29/257 (11%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ-IK 59
RE+ +L+ L H NII L + S L IY V E + D+ LL+ + E Q I+
Sbjct: 56 TYRELKLLKHLRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFIQ 111
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
++ Q+L GL++ HS GV+HRD+K SN+L+N LK+ DFGLA + + +T V
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQ--MTGYVS 167
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T +YR PE++L Y VD+WS GC+FAE+L GKP+ G+ V Q I L G+PPD
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 180 DYWKK----------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
D LP + P E FK+ +A++L+E +L +P KR
Sbjct: 228 DVINTICSENTLRFVQSLPK----REPVP----FSEKFKNADPSAIDLLEKMLVFDPQKR 279
Query: 230 ATASAALASEYFSTKPY 246
+A+ ALA Y PY
Sbjct: 280 ISAAEALAHPYL--APY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 88/255 (34%), Positives = 139/255 (54%), Gaps = 23/255 (9%)
Query: 3 REILILRRL-DHPNIIKLEGL--ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
RE+ +LR H NI L + + +YL E ME D+ ++ ++A +
Sbjct: 50 RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQ 108
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQP 113
++ Q+L GL++ HS VLHRD+K NLLVN + LK+ DFGLA N G
Sbjct: 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF--- 165
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+T V T WYR PE++L Y ++D+WSVGC+ AELL KP+ +G+ V+QL++I ++
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225
Query: 174 CGSPPDDYWKKSKLPHA-----TL-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
G+P ++ + P A +L P++P++S F + A++L+E LL+ +P
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESI----FPNANPLALDLLEKLLAFDPT 281
Query: 228 KRATASAALASEYFS 242
KR + AL Y +
Sbjct: 282 KRISVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 2e-47
Identities = 86/242 (35%), Positives = 139/242 (57%), Gaps = 7/242 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L++L H N++ L + R +YLVFE+++H + L E++++ Y+
Sbjct: 49 REIRMLKQLRHENLVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
Q+L G+E CHS ++HRDIK N+LV+ GV+KL DFG A + T V T W
Sbjct: 107 FQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRW 165
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY- 181
YR PELL+G T YG +VD+W+VGC+ E+L G+P+ G ++++QL+ I K G+ +
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225
Query: 182 --WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
++K+ L A + P+ L + F L ++L + L ++P R ++S L E
Sbjct: 226 EIFQKNPL-FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284
Query: 240 YF 241
+F
Sbjct: 285 FF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-46
Identities = 100/248 (40%), Positives = 144/248 (58%), Gaps = 16/248 (6%)
Query: 3 REILILRRLD---HPNIIKLEGLIT-SRL--SCSIYLVFEYMEHDITGLLS-CPDIKFSE 55
RE+ +LR L+ HPN+++L + T SR + LVFE+++ D+T L P+
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 109
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
IK M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + + LT
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALT 167
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
S VVTLWYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G
Sbjct: 168 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226
Query: 176 SP-PDDYWKKSKLPHATLF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
P +D+ + LP K QP + + D+ +L+ L+ P KR +A
Sbjct: 227 LPGEEDWPRDVALPRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAY 282
Query: 234 AALASEYF 241
+AL+ YF
Sbjct: 283 SALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 97/250 (38%), Positives = 145/250 (58%), Gaps = 13/250 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE +L+ L H NI+ L +I ++ + + LVFEY+ D+ + +K ++
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFL 109
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QLL GL + H R +LHRD+K NLL+++ G LKLADFGLA + + ++ VVTLW
Sbjct: 110 FQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLW 168
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDY 181
YRPP++LLG+T+Y +D+W VGC+F E++ G G +++ QL +IF + G+P +D
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228
Query: 182 WKK-SKLPHATLFKPQQ--PYDS-SLRETFKDLPTT--AVNLIETLLSVEPYKRATASAA 235
W LPH FKP++ Y +LR+ + L A +L LL P R +A AA
Sbjct: 229 WPGVHSLPH---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA 285
Query: 236 LASEYFSTKP 245
L+ EYFS P
Sbjct: 286 LSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 89/246 (36%), Positives = 140/246 (56%), Gaps = 12/246 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + T LS YLV +M D+ L+ K SE +I
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRI 120
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL++ H+ G++HRD+K NL VN + LK+ DFGLA +++ +T V
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS----EMTGYV 176
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT WYR PE++L Y +VD+WSVGC+ AE+L GKP+ +G ++QL +I K+ G+P
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 179 DDYWKKSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
++ +K + A + + P R + AVN++E +L ++ R TA+ AL
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296
Query: 237 ASEYFS 242
A YF
Sbjct: 297 AHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 64/151 (42%), Positives = 91/151 (60%), Gaps = 5/151 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI IL++L+HPNI+KL G+ +YLV EY E + LL + K SE +I
Sbjct: 40 REIEILKKLNHPNIVKLYGVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRI 97
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ Q+L GLE+ HS G++HRD+K N+L+++ G +KLADFGL+ T + L + V T
Sbjct: 98 LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGT 156
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
Y PE+LLG Y D+WS+G + EL
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 99/289 (34%), Positives = 153/289 (52%), Gaps = 21/289 (7%)
Query: 3 REILILRRLDHPNIIKLEGLI---TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI +LR L HP+I++++ ++ + R IY+VFE ME D+ ++ D + +
Sbjct: 48 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQ 106
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 117
++ QLL L++ H+ V HRD+K N+L N + LK+ DFGLA F++T T
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 118 VVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
V T WYR PEL G+ + Y P++D+WS+GC+FAE+L GKP+ G+ V QL I L G
Sbjct: 167 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225
Query: 176 SPPDDYWKKSKLPHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+P + + + A + + +QP + F + A+ L+E LL+ +P R T
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 232 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR 280
A ALA YF L+ + P ++ I E RR+ VR
Sbjct: 284 AEEALADPYFK------GLAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 87/244 (35%), Positives = 133/244 (54%), Gaps = 7/244 (2%)
Query: 3 REILILRRLDHPNIIK-LEGLITSRLSC--SIYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
RE+ +L H N++ L+ L + IY+V E M+ D+ ++ P S +K
Sbjct: 48 RELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVK 106
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
++ Q+L GL++ HS G+LHRDIK NLLVN+ VLK+ DFGLA + +T VV
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T +YR PE+L+G+ Y +VD+WSVGC+FAELL + + Q ++ ++QL I L G+P
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 180 DYWKKS---KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ + + H + P L AV+L+ +L +P KR +A+ AL
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 237 ASEY 240
A Y
Sbjct: 287 AHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 8e-45
Identities = 93/265 (35%), Positives = 144/265 (54%), Gaps = 12/265 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + T S +YLV M D+ ++ C K S+ +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHV 120
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + QLL GL++ HS G++HRD+K SN+ VN + L++ DFGLA ++ +T V
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYV 176
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T WYR PE++L Y +VD+WSVGC+ AELL GK + G ++QL +I ++ G+P
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 179 DDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ KK HA + P+ L++ F+ A++L+E +L ++ KR +AS AL
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
Query: 237 ASEYFSTKPYACDLSSLPIYPPSKE 261
A YFS D Y S E
Sbjct: 297 AHPYFSQYHDPEDEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 89/246 (36%), Positives = 140/246 (56%), Gaps = 15/246 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + TS +S YLV YM+ D+ ++ P SE ++
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKV 119
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL++ HS G++HRD+K NL VN + LK+ DFGLA ++ +T V
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYV 175
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT WYR PE++L Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235
Query: 179 DDYWKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
++ +K + A + P+ P F AV+L+E +L ++ KR TA+ A
Sbjct: 236 PEFVQKLEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294
Query: 236 LASEYF 241
L YF
Sbjct: 295 LEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 98/271 (36%), Positives = 149/271 (54%), Gaps = 32/271 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFS 54
REI +LR L HPN+I L+ + S ++L+F+Y EHD+ ++ + ++
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGH 110
+K + Q+L G+ + H+ VLHRD+K +N+LV EG +K+AD G A N+
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 111 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----- 163
+ L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
Query: 164 ----VEQLHKIFKLCGSPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLP 211
+QL +IF + G P D W+ K+P H+TL F+ + SL E K P
Sbjct: 227 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 286
Query: 212 -TTAVNLIETLLSVEPYKRATASAALASEYF 241
+ A +L++ LL+++P KR T+ A+ YF
Sbjct: 287 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 85/246 (34%), Positives = 132/246 (53%), Gaps = 12/246 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + T S +YLV M D+ ++ C K ++ +
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV 122
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA ++ +T V
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYV 178
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T WYR PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
Query: 179 DDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ KK A + + F AV+L+E +L ++ KR TA+ AL
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 237 ASEYFS 242
A YF+
Sbjct: 299 AHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 99/271 (36%), Positives = 149/271 (54%), Gaps = 32/271 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFS 54
REI +LR L HPN+I L+ + S ++L+F+Y EHD+ ++ + ++
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP 106
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGH 110
+ +K + Q+L G+ + H+ VLHRD+K +N+LV EG +K+AD G A N+
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 111 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----- 163
+ L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
Query: 164 ----VEQLHKIFKLCGSPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLP 211
+QL +IF + G P D W+ K+P + TL F+ +SSL E K P
Sbjct: 227 NPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKP 286
Query: 212 TTAVN-LIETLLSVEPYKRATASAALASEYF 241
+ V L++ LL+++P KR T+ AL YF
Sbjct: 287 DSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 60/158 (37%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM-EHDITGLL-SCPDIKFSEAQIK 59
REI IL L HPNI++ G ++ + EY+ ++ LL K E I+
Sbjct: 47 EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIR 104
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRV 118
Y Q+L GL + HS G++HRDIKG+N+LV+++GV+KLADFG A + + S
Sbjct: 105 KYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
T ++ PE++ G +YG + D+WS+GC E+ GKP
Sbjct: 165 GTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 88/242 (36%), Positives = 126/242 (52%), Gaps = 6/242 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE+ +LR L NI++L+ R +YLVFEY+E ++ LL +++ Y+
Sbjct: 49 RELKMLRTLKQENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QL+ + CH ++HRDIK NLL+++ VLKL DFG A + G T V T W
Sbjct: 107 YQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW 166
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
YR PELLLGA YG +VD+WSVGC+ EL G+P+ G +E++QL I K+ G P +
Sbjct: 167 YRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225
Query: 183 K--KSKLPHATLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASE 239
K S L P + SL + L ++L++ LL + P R L
Sbjct: 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
Query: 240 YF 241
F
Sbjct: 286 AF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 79/264 (29%), Positives = 136/264 (51%), Gaps = 40/264 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIK--FSEA 56
RE+++++ ++H NII L + T + S +YLV E M+ ++ C I+
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANL-----CQVIQMDLDHE 118
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 116
++ + Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T
Sbjct: 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTP 176
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
VVT +YR PE++LG Y +VD+WSVGC+ E++ G + G ++Q +KI + G+
Sbjct: 177 YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235
Query: 177 PPDDYWKK--------------------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216
P D++ + +L LF P + L+ + A +
Sbjct: 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK------ASQARD 289
Query: 217 LIETLLSVEPYKRATASAALASEY 240
L+ +L ++P KR + AL Y
Sbjct: 290 LLSKMLVIDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 92/256 (35%), Positives = 138/256 (53%), Gaps = 26/256 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITS----RLSCSIYL----------VFEYMEHDITGLLSC 48
RE+LI++ L+H NII L+ + + +I+L V +YM+H +
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL 167
Query: 49 PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSN 107
P +K Y QL L + HS+ + HRD+K NLL++ N LKL DFG A
Sbjct: 168 PLF-----LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 167
G R S + + +YR PEL+LGAT+Y +DLWS+GC+ AE+++G PI G++ V+QL
Sbjct: 223 AGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
Query: 168 HKIFKLCGSPPDDYWKKSKLPHATL-FKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVE 225
+I ++ G+P +D K+ +A + F +P D L++ F K P A+N I L E
Sbjct: 281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKD--LKKVFPKGTPDDAINFISQFLKYE 338
Query: 226 PYKRATASAALASEYF 241
P KR ALA +F
Sbjct: 339 PLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 6e-36
Identities = 57/156 (36%), Positives = 88/156 (56%), Gaps = 8/156 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
EI IL++ HPNI+K G + +++V E+ + LL + +E+QI
Sbjct: 46 NEIQILKKCKHPNIVKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV 103
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVT 120
+LL GLE+ HS G++HRDIK +N+L+ ++G +KL DFGL+ S+T R + V T
Sbjct: 104 CKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGT 160
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
++ PE++ G Y D+WS+G EL GKP
Sbjct: 161 PYWMAPEVING-KPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 79/288 (27%), Positives = 122/288 (42%), Gaps = 36/288 (12%)
Query: 3 REILILRRLDHP-NIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDI--KFSEAQI 58
REI IL L+HP NI+KL S +YLV EY++ + LL SE++
Sbjct: 46 REIQILASLNHPPNIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEA 103
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF-----SNTGHRQ 112
+ Q+L LE+ HS+G++HRDIK N+L++ + V+KL DFGLA S +
Sbjct: 104 LFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163
Query: 113 PLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQL 167
++ V T Y PE+LLG + S D+WS+G ELL G P +G Q
Sbjct: 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
Query: 168 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
KI +P P + A +L++ LL+ +P
Sbjct: 224 LKIILELPTPSLASPLSPSNPE-------------------LISKAASDLLKKLLAKDPK 264
Query: 228 KRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKV 275
R ++S+ L+ + + S + P + +
Sbjct: 265 NRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 65/175 (37%), Positives = 97/175 (55%), Gaps = 18/175 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQ 57
+EI +L+ L HPNI+K G I + S S+Y++ EY E+ G L I F E+
Sbjct: 48 QEIDLLKNLKHPNIVKYIGSIET--SDSLYIILEYAEN---GSLR--QIIKKFGPFPESL 100
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 117
+ Y+ Q+L GL + H +GV+HRDIK +N+L +GV+KLADFG+A N + +
Sbjct: 101 VAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV- 159
Query: 118 VVTLWYRPPELLLGATDYGPSV--DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
V T ++ PE++ + G S D+WS+GC ELL G P + L +I
Sbjct: 160 VGTPYWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 82/258 (31%), Positives = 141/258 (54%), Gaps = 25/258 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+++L+ ++H NII L + T + S +YLV E M+ ++ ++ ++ ++
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERM 125
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T V
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYV 183
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT +YR PE++LG Y +VD+WSVGC+ EL+ G I QG ++Q +K+ + G+P
Sbjct: 184 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 179 DDYWKK--SKLPHATLFKPQQPYDSSLRETFKD--LP----------TTAVNLIETLLSV 224
++ + + + +PQ P S E F D P + A +L+ +L +
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 225 EPYKRATASAALASEYFS 242
+P KR + AL Y +
Sbjct: 302 DPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 80/249 (32%), Positives = 112/249 (44%), Gaps = 48/249 (19%)
Query: 3 REILILRRLDHPNIIKL-EGLITSRLSCSIYLVFEYMEHDITGLLS-------CPDIKFS 54
E+ IL++L+HPNIIK E + +V EY + G LS F
Sbjct: 48 NEVKILKKLNHPNIIKYYESFEEK---GKLCIVMEYAD---GGDLSQKIKKQKKEGKPFP 101
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQP 113
E QI + QL L++ HSR +LHRDIK N+ + + G++KL DFG++ S+T
Sbjct: 102 EEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VD 158
Query: 114 LTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
L VV T +Y PEL Y D+WS+GCV EL K +G +E KI K
Sbjct: 159 LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217
Query: 173 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
G P +P Y S LR NL+ +LL +P +R +
Sbjct: 218 --GQYP-------PIP--------SQYSSELR-----------NLVSSLLQKDPEERPSI 249
Query: 233 SAALASEYF 241
+ L S +
Sbjct: 250 AQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 5e-33
Identities = 79/280 (28%), Positives = 148/280 (52%), Gaps = 23/280 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+++++ ++H NII L + T + S +Y+V E M+ ++ ++ ++ ++
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERM 128
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T V
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 186
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT +YR PE++LG Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P
Sbjct: 187 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 179 DDYWKKSKLPHATLFKPQQPYDS-SLRETFKDL------------PTTAVNLIETLLSVE 225
++ KK + T + + Y S + F D+ + A +L+ +L ++
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 226 PYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 265
KR + AL Y + + + P P K++D +
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDER 345
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 83/280 (29%), Positives = 151/280 (53%), Gaps = 23/280 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+++++ ++H NII L + T + S +YLV E M+ ++ ++ ++ ++
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERM 121
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T V
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 179
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT +YR PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 179 DDYWKK----------SKLPHATLFKPQQPYDSSL---RETFKDLPTTAVNLIETLLSVE 225
++ KK ++ +A L P+ DS E K + A +L+ +L ++
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 226 PYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 265
P KR + AL Y + ++ + P K++D +
Sbjct: 299 PAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 44/258 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEYMEH-DITGLLSCPDIKFSEA 56
EILI++ HPNI+ +++V EYM+ +T +++ ++ +E
Sbjct: 64 NEILIMKDCKHPNIVDY-------YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP 116
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 116
QI ++L GLE+ HS+ V+HRDIK N+L++ +G +KLADFG A S
Sbjct: 117 QIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNS 175
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
V T ++ PE++ DYGP VD+WS+G + E+ G+P + L I G
Sbjct: 176 VVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GI 233
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
PP L + + P+ FKD + L +P KR +A L
Sbjct: 234 PP--------LKNPEKWSPE----------FKD-------FLNKCLVKDPEKRPSAEELL 268
Query: 237 ASEYFSTKPYACDLSSLP 254
+ AC
Sbjct: 269 QHPFLKK---ACPKEEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 73/236 (30%), Positives = 111/236 (47%), Gaps = 33/236 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+EI +L +L HPNI++ G T R ++Y+ E + + LL F E I+ Y
Sbjct: 51 QEIALLSKLQHPNIVQYLG--TEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLY 107
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
Q+L GLE+ H R +HRDIKG+N+LV+ GV+KLADFG+A S +
Sbjct: 108 TRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSP 165
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
++ PE++ YG + D+WS+GC E+ GKP +++E + +FK+ G +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKI-GRSKE-- 219
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
P P L A + I L +P R TA+ L
Sbjct: 220 ------------LPPIP---------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 6e-31
Identities = 75/232 (32%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 3 REILILRRLDHPNIIKLE-GLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQI 58
E IL R++HP I+KL T +YLV EY G L + +FSE +
Sbjct: 42 TERNILSRINHPFIVKLHYAFQTEE---KLYLVLEYAP---GGELFSHLSKEGRFSEERA 95
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSR 117
+ Y +++ LE+ HS G+++RD+K N+L++ +G +KL DFGLA S+ G R +
Sbjct: 96 RFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTF 153
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
T Y PE+LLG YG +VD WS+G + E+L GKP E KI K
Sbjct: 154 CGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----- 207
Query: 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
+ P + L A +LI LL +P KR
Sbjct: 208 -----DPLRFP-------------------EFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 71/251 (28%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 3 REILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKC 60
E +L RL+ HP IIKL T + ++Y V EY + ++ + E +
Sbjct: 50 IEKEVLTRLNGHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRF 106
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---------- 110
Y ++L LE+ HS+G++HRD+K N+L++ + +K+ DFG A +
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 111 ---------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161
R+ S V T Y PELL G S DLW++GC+ ++L GKP +G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
Query: 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221
E KI KL S P + P A +LIE L
Sbjct: 226 NEYLTFQKILKLEYSFP-----------------------------PNFPPDAKDLIEKL 256
Query: 222 LSVEPYKRATA 232
L ++P R
Sbjct: 257 LVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 47/235 (20%)
Query: 7 ILRRLDHPNIIKL-EGLITSRLSCSIYLVFEYMEH-DITGLLS---CPDIKFSEAQIKCY 61
IL + P ++KL + ++YLV EY+ D+ LL E + Y
Sbjct: 46 ILSQAQSPYVVKLYYSFQGKK---NLYLVMEYLPGGDLASLLENVGS----LDEDVARIY 98
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF------SNTGHRQPLT 115
+ +++ LE+ HS G++HRD+K N+L+++ G LKL DFGL+ N +
Sbjct: 99 IAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 116 SRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
R+V T Y PE++LG + +VD WS+GC+ E L+G P G T E I
Sbjct: 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
P+D ++ A++LI LL +P KR
Sbjct: 218 IEWPED---------------------------VEVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 21/220 (9%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+AREI +L+ L H NI++ G +I+L EY+ + LL+ F E ++
Sbjct: 53 LAREIALLKELQHENIVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYG-AFEETLVR 109
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQPL 114
++ Q+L GL + H+RG++HRDIKG+N+LV+N+G +K++DFG+ AN +T
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
S ++++ PE ++ T Y D+WS+GC+ E+L GK + QL IFK+
Sbjct: 170 PSLQGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGK---HPFPDCTQLQAIFKIG 225
Query: 175 G----SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210
P + ++ F+ D + R T +L
Sbjct: 226 ENASPEIPSNISSEAIDFLEKTFEI----DHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 4/180 (2%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+ EI L+ LDH NI++ G T+ SI+L EY+ G +F E ++
Sbjct: 55 LRSEIETLKDLDHLNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT--GHRQPLTSRV 118
+ Q+L GL + HS+G+LHRD+K NLLV+ +G+ K++DFG++ S+ + Q ++ +
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
W P + + Y VD+WS+GCV E+ G+ + + K+ +PP
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEA 56
+ RE+ LR + P ++K G I +V EYM+ D+ K E
Sbjct: 46 LLRELKTLRSCESPYVVKCYGAFYK--EGEISIVLEYMDGGSLADLLK----KVGKIPEP 99
Query: 57 QIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
+ Q+L GL++ H+ R ++HRDIK SNLL+N++G +K+ADFG++
Sbjct: 100 VLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-LDQCN 158
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
+ V T+ Y PE + G + Y + D+WS+G E +GK
Sbjct: 159 TFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 75/240 (31%), Positives = 111/240 (46%), Gaps = 38/240 (15%)
Query: 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKC 60
A E+ +L L HPN++K G+ R +Y+ EY + LL I E I+
Sbjct: 47 ADEMKVLELLKHPNLVKYYGVEVHREK--VYIFMEYCSGGTLEELLEHGRIL-DEHVIRV 103
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG----LANFSNTGHRQPLTS 116
Y QLL GL + HS G++HRDIK +N+ +++ GV+KL DFG L N + T + + S
Sbjct: 104 YTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE-VQS 162
Query: 117 RVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI-FKL 173
T Y PE++ G +G + D+WS+GCV E+ GK +E++ +I F +
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHV 219
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
KP P L KD ++ L +P KR TAS
Sbjct: 220 GAGH----------------KPPIPDSLQLSPEGKD-------FLDRCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 60/176 (34%), Positives = 87/176 (49%), Gaps = 11/176 (6%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIK--FSEAQIK 59
E+ ILR L HPNI++ I R + ++Y+V EY E D+ L+ C + E I
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108
Query: 60 CYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
+ QLL L CH+R VLHRD+K +N+ ++ +KL DFGLA
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFA 167
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ V T +Y PE L + Y D+WS+GC+ EL P R +++ KI
Sbjct: 168 KTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 63/183 (34%), Positives = 94/183 (51%), Gaps = 9/183 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+EI ++ RL+HP+II++ G ++++ E+M L F EA I Y
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYT 109
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA---NFSNTGHRQPLTSRV 118
QLL GL + H ++HRD+KG+NLL+++ G L++ADFG A TG + +
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS-- 176
T+ + PE+L G YG S D+WSVGCV E+ KP L IFK+ +
Sbjct: 170 GTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 177 PPD 179
P
Sbjct: 229 APS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 16/182 (8%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIK 59
EI +L+ L H I++ G + + SI++ EYM D +E +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGA----LTETVTR 107
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Y Q+L G+E+ HS ++HRDIKG+N+L ++ G +KL DFG + T + V
Sbjct: 108 KYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 120 --TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
T ++ PE++ G YG D+WSVGC E+L KP E E + IFK+ P
Sbjct: 168 TGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQP 223
Query: 178 PD 179
+
Sbjct: 224 TN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEA 56
+ +E+ + + +HPN++K ++LV Y+ DI S P EA
Sbjct: 46 LRKEVQAMSQCNHPNVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKS-SYPRGGLDEA 102
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLT 115
I + ++L GLE+ HS G +HRDIK N+L+ +G +K+ADFG+ A+ ++ G R
Sbjct: 103 IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
Query: 116 SRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ T + PE++ Y D+WS G EL G ++ L L
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--L 220
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
PP L +K Y S R+ +I L +P KR TA
Sbjct: 221 QNDPPS-------LETGADYK---KYSKSFRK-----------MISLCLQKDPSKRPTAE 259
Query: 234 AALASEYF 241
L ++F
Sbjct: 260 ELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 9e-23
Identities = 80/259 (30%), Positives = 107/259 (41%), Gaps = 68/259 (26%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFE-YMEHDITGLLSC-------PDIKFSE 55
EI + L H NI++ G S S F+ +ME G LS P +K +E
Sbjct: 55 EIALHSYLKHRNIVQYLG------SDSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNE 107
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR--- 111
I Y Q+L GL++ H ++HRDIKG N+LVN GV+K++DFG T R
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG------TSKRLAG 161
Query: 112 -QPLTSRVV-TLWYRPPELL-LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 168
P T TL Y PE++ G YG D+WS+GC E+ GKP
Sbjct: 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP------------ 209
Query: 169 KIFKLCGSPPDDYWKKSKLPHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETL 221
F G P A +FK P+ P + L A N I
Sbjct: 210 -PFIELGE-----------PQAAMFKVGMFKIHPEIP---------ESLSAEAKNFILRC 248
Query: 222 LSVEPYKRATASAALASEY 240
+P KRA+A L +
Sbjct: 249 FEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 21/168 (12%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEA 56
+ +EI L + P I K G + ++++ EY G SC D+ K E
Sbjct: 46 IQQEIQFLSQCRSPYITKYYG--SFLKGSKLWIIMEYC-----GGGSCLDLLKPGKLDET 98
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 116
I + ++L GLE+ H G +HRDIK +N+L++ EG +KLADFG++ G S
Sbjct: 99 YIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMS 153
Query: 117 R----VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160
+ V T ++ PE++ + Y D+WS+G EL G+P L
Sbjct: 154 KRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+ E IL+ L+HP ++ L + YLV + + D+ LS +KFSE Q+K
Sbjct: 47 VLNERRILQELNHPFLVNLWYSFQDEENM--YLVVDLLLGGDLRYHLS-QKVKFSEEQVK 103
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
++ +++ LE+ HS+G++HRDIK N+L++ +G + + DF +A TS
Sbjct: 104 FWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSG 161
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T Y PE+L Y +VD WS+G E L GK +G +
Sbjct: 162 TPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIR 207
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
D + + L+ + A++ I LL +P KR
Sbjct: 208 DQIRAKQETADVLYPATWSTE-------------AIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 66/238 (27%), Positives = 98/238 (41%), Gaps = 38/238 (15%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIK 59
EI+IL L HPNII + I + EY +D ++ F E +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEM--EYANGGTLYDK--IVRQKGQLFEEEMVL 104
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Y+ Q++ + + H G+LHRDIK N+ + G++KL DFG++ + + T V
Sbjct: 105 WYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VG 163
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T +Y PEL G Y D+W++GCV ELL K + + KI + +P
Sbjct: 164 TPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV 222
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
Y S L L+ +LL +P KR TA L
Sbjct: 223 S-----------------VYSSELIS-----------LVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCY 61
+EI IL++ D P I+K G + +++V EY ++ ++ + +E +I
Sbjct: 47 KEISILKQCDSPYIVKYYGSY--FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI 104
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 120
+ Q L GLE+ HS +HRDIK N+L+N EG KLADFG++ + V+ T
Sbjct: 105 LYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGT 162
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
++ PE++ Y D+WS+G E+ GKP
Sbjct: 163 PFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 5e-21
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSE 55
RE I+R+LDHPNI+KL G+ T + +V EYM G L + S
Sbjct: 48 FLREARIMRKLDHPNIVKLLGVCTEEEP--LMIVMEYMPG---GDLLDYLRKNRPKELSL 102
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
+ + + Q+ G+E+ S+ +HRD+ N LV V+K++DFGL+ +
Sbjct: 103 SDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK 162
Query: 116 SRVVTL-WYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ + W PE L + D+WS G + E+
Sbjct: 163 GGKLPIRWM-APESLKEGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 6e-21
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 25/182 (13%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
RE I+R+LDHPN++KL G+ T +Y+V EYME D+ L K S + +
Sbjct: 48 FLREARIMRKLDHPNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLL 105
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
+ Q+ G+E+ S+ +HRD+ N LV V+K++DFGL+ +
Sbjct: 106 SFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL 165
Query: 120 TL-WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
+ W PE L + D+WS G + L +IF L P
Sbjct: 166 PIRWM-APESLKEGK-FTSKSDVWSFGVL-------------------LWEIFTLGEQPY 204
Query: 179 DD 180
Sbjct: 205 PG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 73/239 (30%), Positives = 105/239 (43%), Gaps = 46/239 (19%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK----FSEAQI 58
R I++++ + P + KL S+ +YLV EY+ L IK E
Sbjct: 47 RAIMMIQG-ESPYVAKLYYSFQSK--DYLYLVMEYLNGGDCASL----IKTLGGLPEDWA 99
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR- 117
K Y+ +++ G+E H RG++HRDIK NLL++ G LKL DFGL+ R L ++
Sbjct: 100 KQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS-------RNGLENKK 152
Query: 118 -VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
V T Y PE +LG D D WS+GCV E L G P T
Sbjct: 153 FVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET-------------- 197
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
PD + + + P+ E + AV+LI LL ++P KR A+
Sbjct: 198 -PDAVFD--NILSRRINWPE--------EVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 74/263 (28%), Positives = 117/263 (44%), Gaps = 41/263 (15%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSC-SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
EIL++R HPNI+ + S L +++V EY+ +T +++ + E QI
Sbjct: 66 EILVMRENKHPNIVNY---LDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAV 120
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ L LE HS V+HRDIK N+L+ +G +KL DFG T + ++ V T
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTP 179
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
++ PE++ YGP VD+WS+G + E++ G+P + L+ I
Sbjct: 180 YWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------- 227
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
AT P+ L F+D + L ++ KR +A L +
Sbjct: 228 --------ATNGTPELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFL 272
Query: 242 S-TKPYACDLSSL-PIYPPSKEI 262
KP LSSL P+ +KE
Sbjct: 273 KIAKP----LSSLTPLIAAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 4e-20
Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQI 58
E I+++L HPNI++L G+ T +Y+V EYM G LL K + +
Sbjct: 50 EEASIMKKLSHPNIVRLLGVCTQGEP--LYIVTEYMPG---GDLLDFLRKHGEKLTLKDL 104
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+E+ S+ +HRD+ N LV V+K++DFGL+
Sbjct: 105 LQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 71/244 (29%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 3 REILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK-------- 52
+EI +L++LDHPN+IK L I + + +V E + D++ + IK
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENN---ELNIVLELADAGDLSRM-----IKHFKKQKRL 102
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGH 110
E I Y QL LEH HS+ ++HRDIK +N+ + GV+KL D GL F S T
Sbjct: 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHK 169
S V T +Y PE + Y D+WS+GC+ E+ + P + + L K
Sbjct: 163 AH---SLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
Query: 170 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
+ C PP P Y LR+ L+ ++ +P KR
Sbjct: 219 KIEKCDYPP---------------LPADHYSEELRD-----------LVSRCINPDPEKR 252
Query: 230 ATAS 233
S
Sbjct: 253 PDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQI 58
+EI +L+ HPNI+ G + +++V EY DI + P SE QI
Sbjct: 49 QEISMLKECRHPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQI 103
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSR 117
+ L GL + H G +HRDIKG+N+L+ +G +KLADFG+ A + T ++ S
Sbjct: 104 AYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSF 161
Query: 118 VVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP 156
+ T ++ PE+ Y D+W++G EL +P
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 48/257 (18%)
Query: 4 EILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQ 57
E++I+R HPNI+++ L+ L ++V E++E G L+ DI + +E Q
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDEL----WVVMEFLE---GGALT--DIVTHTRMNEEQ 116
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTS 116
I +L L H++GV+HRDIK ++L+ ++G +KL+DFG A S R+ S
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KS 174
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
V T ++ PE ++ YG VD+WS+G + E++ G+P ++ + +I
Sbjct: 175 LVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--L 231
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
PP K K H LR ++ +L +P +RATA+ L
Sbjct: 232 PP-----KLKNLHKV--------SPRLRS-----------FLDRMLVRDPAQRATAAELL 267
Query: 237 ASEYFSTKPYACDLSSL 253
+ + A SS+
Sbjct: 268 NHPFLAK---AGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 11/157 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDI-KFSEAQIKC 60
E IL +HP I+KL T + IY++ EY ++ +L D F E +
Sbjct: 42 SEKEILEECNHPFIVKLYR--TFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARF 97
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 119
Y+ ++ E+ H+RG+++RD+K NLL+++ G +KL DFG A +G + T
Sbjct: 98 YIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCG 154
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
T Y PE++L Y SVD WS+G + ELL G+P
Sbjct: 155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 5e-19
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 23/166 (13%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDI 51
+E ++++L HPN+++L G+ T +YLV EYME D+ L S
Sbjct: 43 FLKEARVMKKLGHPNVVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------NF 105
S + + Q+ G+E+ S+ +HRD+ N LV + V+K++DFGL+ ++
Sbjct: 101 TLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160
Query: 106 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
L R W PE L + D+WS G + E+
Sbjct: 161 YRKKTGGKLPIR----WM-APESLKDGI-FTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 29/165 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-------HDITGLLSCPDIKFSE 55
E IL+ + HP ++ L G + + ++YLV EY+ +G +F E
Sbjct: 50 NEKRILQSIRHPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPE 100
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
+ Y Q++ LE+ HS +++RD+K NLL++++G +K+ DFG A +
Sbjct: 101 PVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VK 152
Query: 116 SRVVTLW----YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
R TL Y PE++L YG +VD W++G + E+L G P
Sbjct: 153 GRTYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 50/245 (20%)
Query: 4 EILILRRLDHPNIIKL-EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIK---FSEAQI 58
EI IL ++HPNII E + + +V EY D++ +S K E +I
Sbjct: 49 EIRILASVNHPNIISYKEAFL---DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI 105
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQP 113
QLL GL+ H + +LHRD+K +N+L+ ++K+ D G++ N + T P
Sbjct: 106 WRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP 165
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
Y PE+ G Y D+WS+GC+ E+ P + R+ ++ L +K+
Sbjct: 166 H--------YMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLR--YKV 213
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
K +P Y L+ N I ++L V+P R
Sbjct: 214 QRG------KYPPIPPI--------YSQDLQ-----------NFIRSMLQVKPKLRPNCD 248
Query: 234 AALAS 238
LAS
Sbjct: 249 KILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 57/170 (33%), Positives = 85/170 (50%), Gaps = 9/170 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+E+ L++L HPN I+ +G + +LV EY + LL E +I
Sbjct: 70 KEVKFLQQLKHPNTIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAIT 127
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
+ L GL + HS ++HRDIK N+L+ G +KLADFG A+ S+ P S V T +
Sbjct: 128 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPY 182
Query: 123 YRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ PE++L + Y VD+WS+G EL KP L + L+ I
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 14/182 (7%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 63
EI +L+ L H I++ G + R ++ + EYM +E+ + Y
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSR 117
Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG R S
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR----SV 169
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
T ++ PE++ G YG D+WS+GC E+L KP E E + IFK+ P
Sbjct: 170 TGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQP 225
Query: 178 PD 179
+
Sbjct: 226 TN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 55/159 (34%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+E+ L++L HPN I+ +G + +LV EY + +L E +I
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKPLQEVEIAAIC 121
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
+ L GL + HS +HRDIK N+L+ G +KLADFG A+ + P S V T +
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPY 176
Query: 123 YRPPELLLGATD---YGPSVDLWSVGCVFAELLIGKPIL 158
+ PE++L A D Y VD+WS+G EL KP L
Sbjct: 177 WMAPEVIL-AMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 22/184 (11%)
Query: 4 EILILRRL-DHPNIIKLEGLITSRLSCS----IYLVFEYMEHD-----ITGLLSCPDIKF 53
E ILR+ +HPNI G + ++LV E + GL +
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RL 110
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQ 112
E I + + L GL + H V+HRDIKG N+L+ +KL DFG+ A +T R+
Sbjct: 111 KEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQ 166
+ + T ++ PE++ A D P D+WS+G EL GKP L +
Sbjct: 171 --NTFIGTPYWMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
Query: 167 LHKI 170
L KI
Sbjct: 227 LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 58/175 (33%), Positives = 92/175 (52%), Gaps = 10/175 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCP-DIKFSEAQIKC 60
+E+++L ++ HPNI+ + + + +++V EY + D+ ++ + FSE QI
Sbjct: 48 KEVILLAKMKHPNIVTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS 105
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVV 119
+ Q+ GL+H H R +LHRDIK N+ ++ G V KL DFG+A N T V
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VG 164
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T +Y PE+ Y D+WS+GCV EL K +G + QL + K+C
Sbjct: 165 TPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI ILR LDH NI+K +G+ S+ L+ EY+ + L + + ++ +
Sbjct: 55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTS 116
+Q+ G+++ S+ +HRD+ N+LV +E ++K++DFGLA ++P S
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ WY PE L + S D+WS G EL
Sbjct: 175 PI--FWY-APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 59/186 (31%), Positives = 81/186 (43%), Gaps = 34/186 (18%)
Query: 31 IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+YLV EYM D+ LL D+ F E + Y+ +L+ L+ H G +HRDIK N+L+
Sbjct: 76 LYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI 134
Query: 90 NNEGVLKLADFGLA----------NFSNTGHRQPLTSRVVTLW----------------- 122
+ +G +KLADFGL + N H V+
Sbjct: 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 123 -YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI--FKLC-GSPP 178
Y PE+L G T YG D WS+G + E+L G P T E +KI +K PP
Sbjct: 195 DYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP 253
Query: 179 DDYWKK 184
D
Sbjct: 254 DPPVSP 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 30/163 (18%)
Query: 30 SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 88
+YL EY+ D LL+ + SE + YM ++ ++ H G +HRD+K N L
Sbjct: 75 YLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFL 133
Query: 89 VNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 147
++ G +KL DFGL+ + S V + Y PE+L G Y +VD WS+GC+
Sbjct: 134 IDASGHIKLTDFGLSKGIVTYAN-----SVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCM 187
Query: 148 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD------YWKK 184
E L G P GS P++ YWK+
Sbjct: 188 LYEFLCGFP---------------PFSGSTPNETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 7e-18
Identities = 48/155 (30%), Positives = 81/155 (52%), Gaps = 6/155 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPD-IKFSEAQIKC 60
+E+ +L + HPNI++ + + ++Y+V +Y E D+ ++ + F E QI
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD 105
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ Q+ L+H H R +LHRDIK N+ + +G +KL DFG+A N+ T + T
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGT 164
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
+Y PE+ Y D+W++GCV E+ K
Sbjct: 165 PYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 56/170 (32%), Positives = 85/170 (50%), Gaps = 9/170 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+E+ L+R+ HPN I+ +G + +LV EY + LL E +I
Sbjct: 74 KEVKFLQRIKHPNSIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAIT 131
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
+ L GL + HS ++HRDIK N+L+ G +KLADFG A+ ++ P S V T +
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPY 186
Query: 123 YRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ PE++L + Y VD+WS+G EL KP L + L+ I
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 16/181 (8%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 62
EI +L+ L H I++ G + + ++ + E+M I L +E + Y
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYT 112
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTS 116
Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG + S
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG----MKS 168
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
T ++ PE++ G YG D+WSVGC E+L KP E E + IFK+
Sbjct: 169 VTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQ 224
Query: 177 P 177
P
Sbjct: 225 P 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 60/189 (31%), Positives = 97/189 (51%), Gaps = 20/189 (10%)
Query: 4 EILILRRL-DHPNIIKLEGLITSRLSCS---IYLVFEY-----MEHDITGLLSCPDIKFS 54
E IL+ L +HPN++K G+ ++LV E + + GLL C +
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLD 126
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQP 113
EA I + L GL+H H+ ++HRD+KG+N+L+ EG +KL DFG+ A ++T R+
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR- 185
Query: 114 LTSRVVTLWYRPPELLLGATDYGPS----VDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
+ V T ++ PE++ Y S D+WS+G EL G P L ++ +
Sbjct: 186 -NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKT 241
Query: 170 IFKLCGSPP 178
+FK+ +PP
Sbjct: 242 LFKIPRNPP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 2e-17
Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKC 60
EIL+++ L +PNI+ L + + +++V EY+ +T +++ C D EAQI
Sbjct: 66 EILVMKELKNPNIVNF--LDSFLVGDELFVVMEYLAGGSLTDVVTETCMD----EAQIAA 119
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ L LE H+ V+HRDIK N+L+ +G +KL DFG T + ++ V T
Sbjct: 120 VCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGT 178
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
++ PE++ YGP VD+WS+G + E++ G+P
Sbjct: 179 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 66/220 (30%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 62
EI +L+ L H I++ G + + + EYM I L +E + Y
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYT 112
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTS 116
Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG + S
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG----IKS 168
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
T ++ PE++ G YG D+WSV C E+L KP E E + IFK+
Sbjct: 169 VTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQ 224
Query: 177 PPDDYWKKSKLPHATL-----FKPQQPYDSSLRETFKDLP 211
P K LP F Q + R T + L
Sbjct: 225 P-----TKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCY 61
+EI IL+ L H NI+K +G + + + L+ EY+ + L P K + AQ+ +
Sbjct: 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLF 112
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTS 116
Q+ G+ + HS+ +HRD+ N+L++N+ ++K+ DFGLA GH R+ S
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
V WY L + + D+WS G ELL
Sbjct: 173 PV--FWYAVE--CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 58/167 (34%), Positives = 87/167 (52%), Gaps = 14/167 (8%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+ REI ILR ++HPN++K + + I ++ E+M+ G L I E +
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDG---GSLEGTHIA-DEQFLAD 172
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Q+L G+ + H R ++HRDIK SNLL+N+ +K+ADFG++ P S V T
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSVGT 231
Query: 121 LWYRPPE-----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGR 161
+ Y PE L GA D G + D+WS+G E +G+ P GR
Sbjct: 232 IAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+E+ L++L HPN I+ G + +LV EY + LL E +I
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
+ L GL + HS ++HRD+K N+L++ G++KL DFG A+ P V T +
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPY 176
Query: 123 YRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--P 178
+ PE++L + Y VD+WS+G EL KP L + L+ I + SP
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQ 235
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225
+W + F+ DS L++ +D PT+ V L + E
Sbjct: 236 SGHWSEY-------FR--NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 57/195 (29%), Positives = 81/195 (41%), Gaps = 35/195 (17%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL---LSCPDIKFSEAQ 57
+ RE+ IL + + P I+ G + + I + EYM D L L + E
Sbjct: 46 ILRELDILHKCNSPYIVGFYGAFYN--NGDISICMEYM--DGGSLDKILKEVQGRIPERI 101
Query: 58 IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNT 108
+ +L GL + H ++HRD+K SN+LVN+ G +KL DFG LA +
Sbjct: 102 LGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFV 160
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK----PILQGRTEV 164
G T Y PE + G DY D+WS+G EL G+ P +
Sbjct: 161 G----------TSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209
Query: 165 -EQLHKIFKLCGSPP 178
E L I PP
Sbjct: 210 FELLQYIVN--EPPP 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 39/119 (32%), Positives = 67/119 (56%), Gaps = 2/119 (1%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
+F E + + Y +++ GL+ H RG+++RD+K N+L+++EG +K+ADFG+
Sbjct: 92 RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGG 150
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
++ T Y PE+L YGP+VD W++G + E+L G+ +G E E I
Sbjct: 151 VTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 59/179 (32%), Positives = 94/179 (52%), Gaps = 20/179 (11%)
Query: 1 MAREILILRRLDHPNIIKL------EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKF 53
M R+IL ++HP I+KL EG +YL+ +++ D+ LS ++ F
Sbjct: 47 MERDILA--EVNHPFIVKLHYAFQTEG--------KLYLILDFLRGGDLFTRLS-KEVMF 95
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
+E +K Y+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ S H +
Sbjct: 96 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKK 154
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
S T+ Y PE ++ + S D WS G + E+L G QG+ E + I K
Sbjct: 155 AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 27/262 (10%)
Query: 2 AREILILRRLDHPNIIKLEGLIT-SRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
A E ILR ++HP+II+L+G T ++ +C L+ + D+ L+ + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKR-NIAICDILA 186
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+L +++ H ++HRDIK N+ +N+ G + L DFG A F + T
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 121 LWYRPPELLLGATD-YGPSVDLWSVGCVFAEL------LIGKPILQGRTEVE-QLHKIFK 172
+ PELL A D YGP+VD+WS G V E+ L K L G + + Q+ I +
Sbjct: 247 IATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
Query: 173 LCGSPPDDYWKKSKLPHATLFK---------PQQPYDSSLRETFKDLPTTAVNLIETLLS 223
G+ P+++ A L + ++P L +LP LI +L+
Sbjct: 305 RSGTHPNEFPID---AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361
Query: 224 VEPYKRATASAALASEYFSTKP 245
+ + R +A A L F P
Sbjct: 362 FDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS---EAQIKC 60
E+ +L+ L H NI++ G + SI+ ME G +S +F E
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIF-----MEFVPGGSISSILNRFGPLPEPVFCK 106
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLT 115
Y Q+L G+ + H+ V+HRDIKG+N+++ G++KL DFG A + H L
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
S T ++ PE ++ + YG D+WS+GC E+ GKP L +++L +F
Sbjct: 167 SMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 36/238 (15%)
Query: 30 SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 88
++YLV EY D+ LL+ + +F E + Y+ +L+ + H G +HRDIK N+L
Sbjct: 75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 89 VNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLW 142
++ G +KLADFG A + V T Y PE+L G YG D W
Sbjct: 135 IDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193
Query: 143 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-PQQPYDS 201
S+G + E++ G+ T + + I + K P+ P S
Sbjct: 194 SLGVIAYEMIYGRSPFHEGTSAKTYNNI----------------MNFQRFLKFPEDPKVS 237
Query: 202 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPS 259
S ++LI++LL +R +FS + +SLP + P+
Sbjct: 238 S----------DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPT 284
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 57/189 (30%), Positives = 97/189 (51%), Gaps = 20/189 (10%)
Query: 4 EILILRRL-DHPNIIKLEGLITSRLSCS---IYLVFEY-----MEHDITGLLSCPDIKFS 54
E IL+ L DHPN++K G+ + + ++LV E + + G L + +
Sbjct: 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RME 122
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQP 113
E I +++ L GL+H H +HRD+KG+N+L+ EG +KL DFG+ A ++T R+
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR- 181
Query: 114 LTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
+ V T ++ PE++ + Y D+WS+G EL G P L ++ +
Sbjct: 182 -NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRA 237
Query: 170 IFKLCGSPP 178
+FK+ +PP
Sbjct: 238 LFKIPRNPP 246
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 68/245 (27%), Positives = 99/245 (40%), Gaps = 42/245 (17%)
Query: 3 REILILRRLDH---PNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ 57
RE+ +L +L PNI K G L RL +++ EY E L +E
Sbjct: 48 REVALLSQLRQSQPPNITKYYGSYLKGPRL----WIIMEYAEGGSVRTLMKAG-PIAEKY 102
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLT 115
I + ++L L++ H GV+HRDIK +N+LV N G +KL DFG+A N+ R
Sbjct: 103 ISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
T ++ PE++ Y D+WS+G E+ G P + L
Sbjct: 163 G---TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLIP 215
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
KSK P Y LRE + L EP +R +A
Sbjct: 216 --------KSKPPRL----EDNGYSKLLRE-----------FVAACLDEEPKERLSAEEL 252
Query: 236 LASEY 240
L S++
Sbjct: 253 LKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 8/161 (4%)
Query: 12 DHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGL 69
+HP + L T + +++ V EY+ + + SC KF + Y +++ GL
Sbjct: 54 EHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGL 109
Query: 70 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 129
+ HS+G+++RD+K N+L++ +G +K+ADFG+ + G + T T Y PE+L
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-CGTPDYIAPEIL 168
Query: 130 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
LG Y SVD WS G + E+LIG+ G E E I
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
F EA+ Y Q++ GLEH H R +++RD+K N+L+++ G ++++D GLA +
Sbjct: 92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGK 149
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
+ R T Y PE+L G Y SVD +++GC E++ G+ + R E + ++ +
Sbjct: 150 KIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208
Query: 173 LCGSPPDDY 181
+Y
Sbjct: 209 RTLEMAVEY 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 67/237 (28%), Positives = 117/237 (49%), Gaps = 39/237 (16%)
Query: 4 EILILRRLDHPNIIKL--EGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKC 60
E++I+R H N++++ L+ L +++ E+++ +T ++S + +E QI
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL----WVLMEFLQGGALTDIVS--QTRLNEEQIAT 121
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV 119
+L L + HS+GV+HRDIK ++L+ +G +KL+DFG A S ++ S V
Sbjct: 122 VCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVG 179
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T ++ PE ++ T YG VD+WS+G + E++ G+P + V+ + +L SPP
Sbjct: 180 TPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP- 234
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
P P LR+ +E +L+ EP +RATA L
Sbjct: 235 --------PKLKNAHKISPV---LRD-----------FLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 46/130 (35%), Positives = 74/130 (56%), Gaps = 6/130 (4%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
FSE +++ Y +++ LEH H G+++RDIK N+L+++EG + L DFGL+ + ++
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP--ILQGR--TEVEQLH 168
S T+ Y PE++ G +G +VD WS+G + ELL G L+G T+ E
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 169 KIFKLCGSPP 178
+I K PP
Sbjct: 222 RILKC--DPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQI 58
RE+ I + P I+K G S SI + EY E I + + E +
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL 107
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+L GL + HSR ++HRDIK SN+L+ +G +KL DFG++ T
Sbjct: 108 GKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG-- 165
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
T +Y PE + G Y + D+WS+G E+
Sbjct: 166 -TSFYMAPERIQGKP-YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 4 EILILRRLDHPNIIKLEGL-ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
E +LRRL HP ++ L + + L+C LV D+ L AQ+
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TL 121
QLL +++ H G++HRDIK N+LVN + L DFG A F+ P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAE 150
PE+L G Y PSVD+WS G V E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 60/184 (32%), Positives = 85/184 (46%), Gaps = 15/184 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS-------E 55
+EI +L++L+HPN+IK +I L E G LS F E
Sbjct: 51 KEIDLLKQLNHPNVIKYYASFIEDNELNIVL-----ELADAGDLSRMIKHFKKQKRLIPE 105
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
+ Y QL LEH HSR V+HRDIK +N+ + GV+KL D GL F ++
Sbjct: 106 KTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAH 164
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLC 174
S V T +Y PE + Y D+WS+GC+ E+ + P + + L K + C
Sbjct: 165 SLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 223
Query: 175 GSPP 178
PP
Sbjct: 224 DYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 19/170 (11%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQ 64
+L+ + HP II+L T +Y++ EY+ + L + +FS + Y ++
Sbjct: 54 VLKEVSHPFIIRLFW--TEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASE 109
Query: 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW-- 122
++ LE+ HS+ +++RD+K N+L++ EG +KL DFG A + L R TL
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGT 161
Query: 123 --YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
Y PE ++ + + +VD W++G + E+L+G P KI
Sbjct: 162 PEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 74/263 (28%), Positives = 119/263 (45%), Gaps = 43/263 (16%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKC 60
EIL++R +PNI+ L + + +++V EY+ +T +++ C D E QI
Sbjct: 67 EILVMRENKNPNIVNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAA 120
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ L LE HS V+HRDIK N+L+ +G +KL DFG T + ++ V T
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGT 179
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
++ PE++ YGP VD+WS+G + E++ G+P + L+ I
Sbjct: 180 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---------- 228
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
AT P+ L F+D + L ++ KR +A L ++
Sbjct: 229 ---------ATNGTPELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQF 272
Query: 241 FS-TKPYACDLSSL-PIYPPSKE 261
KP LSSL P+ +KE
Sbjct: 273 LKIAKP----LSSLTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 11/182 (6%)
Query: 3 REILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK---FSEAQ 57
+EI +L++L+HPN+IK L+ I + +V E + D++ ++ + E
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDN---ELNIVLELADAGDLSQMIKYFKKQKRLIPERT 107
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 117
+ Y QL +EH HSR V+HRDIK +N+ + GV+KL D GL F ++ S
Sbjct: 108 VWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSL 166
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLCGS 176
V T +Y PE + Y D+WS+GC+ E+ + P + + L + + C
Sbjct: 167 VGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY 225
Query: 177 PP 178
PP
Sbjct: 226 PP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 47/182 (25%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
E ++ +L HPN+++L G+ T + I++V EYM + + L K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLT 115
+ + +E+ S G +HRD+ N LV + V+K++DFGLA + S+ G + P+
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTE---VEQLHKIF 171
+ PPE+ + + D+WS G + E+ GK + + VE + +
Sbjct: 167 -------WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 172 KL 173
+L
Sbjct: 219 RL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 55/183 (30%), Positives = 88/183 (48%), Gaps = 9/183 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK-FSEAQIKC 60
+E ++L ++ HPNI+ + + +Y+V EY + D+ + K F E I
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV 119
+ Q+ G++H H + VLHRDIK N+ + G +KL DFG A ++ G + V
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVG 162
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP-P 178
T +Y PPE+ Y D+WS+GC+ EL K Q + + K+ + P P
Sbjct: 163 TPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP 221
Query: 179 DDY 181
Y
Sbjct: 222 SHY 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 33/191 (17%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CP-----------DI 51
EI IL HPNI+ L Y + + E+ + L+ C +
Sbjct: 52 EIDILSECKHPNIVGL------------YEAY-FYENKLWILIEFCDGGALDSIMLELER 98
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
+E QI+ Q+L L HS V+HRD+K N+L+ +G +KLADFG++ N
Sbjct: 99 GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA-KNKSTL 157
Query: 112 QPLTSRVVTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 167
Q + + T ++ PE++ T Y D+WS+G EL +P E+ +
Sbjct: 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPM 214
Query: 168 HKIFKLCGSPP 178
+ K+ S P
Sbjct: 215 RVLLKILKSEP 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 53/158 (33%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+ +EI ILR L H NI+K +G+ T I L+ E++ + L K + Q
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPL 114
Y Q+ G+++ SR +HRD+ N+LV +E +K+ DFGL T + L
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
S V WY PE L+ + Y S D+WS G ELL
Sbjct: 173 DSPV--FWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 67/248 (27%), Positives = 98/248 (39%), Gaps = 72/248 (29%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
IL D+P ++KL S +YL+ EY+ D+ LL D F+E + +
Sbjct: 54 ILAEADNPWVVKL--------YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETR 104
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-------- 111
Y+ + + ++ H G +HRDIK NLL++ +G +KL+DFGL HR
Sbjct: 105 FYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 112 ------------QPLTS-RVVTLW----------------YRPPELLLGATDYGPSVDLW 142
+P++S R W Y PE+ L T Y D W
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWW 223
Query: 143 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 202
S+G + E+L+G P E KI WK+ TL P +
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQETYRKIIN---------WKE------TLQFPD---EVP 265
Query: 203 LRETFKDL 210
L KDL
Sbjct: 266 LSPEAKDL 273
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 41/119 (34%), Positives = 68/119 (57%), Gaps = 2/119 (1%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
+F EA+ + Y +++ GL+ H +G+++RD+K N+L++ +G +K+ADFG+ + G
Sbjct: 92 RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ ++ T Y PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 152 KA-STFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 51/156 (32%), Positives = 85/156 (54%), Gaps = 11/156 (7%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKC 60
EIL++R +PNI+ L + + +++V EY+ +T +++ C D E QI
Sbjct: 66 EILVMRENKNPNIVNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAA 119
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ L L+ HS V+HRDIK N+L+ +G +KL DFG T + ++ V T
Sbjct: 120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGT 178
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
++ PE++ YGP VD+WS+G + E++ G+P
Sbjct: 179 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 56/266 (21%)
Query: 4 EILILRRLDHPNIIKL-EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
E ++L+ ++HP++I++ + L++ ++C +V + D+ L+ Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS-NTGHRQPLTSRVVTL 121
Q+L GL + H++ ++HRD+K N+ +N+ + + D G A F L V T
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET- 222
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
PE+L Y D+WS G V E+L P IF+ S P++Y
Sbjct: 223 --NAPEVLARDK-YNSKADIWSAGIVLFEML-AYP-----------STIFEDPPSTPEEY 267
Query: 182 WKKSKLPHATLFK------------PQQPYDSSLRETF-------------------KDL 210
K H+ L K P+ P S L F +L
Sbjct: 268 VKSC---HSHLLKIISTLKVHPEEFPRDP-GSRLVRGFIEYASLERQPYTRYPCFQRVNL 323
Query: 211 PTTAVNLIETLLSVEPYKRATASAAL 236
P L+ +L+ + R +A L
Sbjct: 324 PIDGEFLVHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 49/155 (31%), Positives = 90/155 (58%), Gaps = 9/155 (5%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
E++I+R H N++++ + + +++V E++E +T +++ + +E QI
Sbjct: 67 EVVIMRDYQHENVVEMYN--SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVC 122
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 121
+L L H++GV+HRDIK ++L+ ++G +KL+DFG A S R+ S V T
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTP 180
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
++ PE L+ YGP VD+WS+G + E++ G+P
Sbjct: 181 YWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E I+ + DHPNII+LEG++T I + EYME+ + L D KF+ Q+
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMI--ITEYMENGSLDKFLRENDGKFTVGQLVGM 111
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL--------ANFSNTGHRQP 113
+ + G+++ +HRD+ N+LVN+ V K++DFGL A ++ G + P
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P + + + D+WS G V E++
Sbjct: 172 I------RWTAPEAIAYRK--FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 47/130 (36%), Positives = 66/130 (50%), Gaps = 6/130 (4%)
Query: 31 IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+Y+V EYM D+ L+S DI E + Y +++ L+ HS G +HRD+K N+L+
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175
Query: 90 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVGC 146
+ G LKLADFG + + V T Y PE+L G YG D WSVG
Sbjct: 176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 147 VFAELLIGKP 156
E+L+G
Sbjct: 236 FLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 35/104 (33%), Positives = 63/104 (60%), Gaps = 1/104 (0%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
F+E++++ Y+ +++ L+H H G+++RDIK N+L+++EG + L DFGL+
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 112 QPLTSRVVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIG 154
+ S T+ Y PE++ G + + +VD WS+G + ELL G
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 44/113 (38%), Positives = 72/113 (63%), Gaps = 6/113 (5%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHR 111
FSEA+++ Y +++ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---K 150
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 163
+P S V T Y PE+L Y S D +S+GC+ +LL G P Q +T+
Sbjct: 151 KPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 62
E I+ + DHPNII LEG++T S + ++ E+ME+ + L D +F+ Q+ +
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-----SNTGHRQPLTSR 117
+ G+++ +HRD+ N+LVN+ V K++DFGL+ F S+ + L +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P + + + D+WS G V E++
Sbjct: 173 IPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 44/113 (38%), Positives = 72/113 (63%), Gaps = 6/113 (5%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHR 111
FSE +++ Y +++ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS +
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---K 150
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 163
+P S V T Y PE+L T Y S D +S+GC+ +LL G P Q +T+
Sbjct: 151 KPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 35/111 (31%), Positives = 60/111 (54%), Gaps = 3/111 (2%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
F E + Y ++ GLE H +++RD+K N+L+++ G ++++D GLA G +
Sbjct: 99 FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 163
+ RV T+ Y PE ++ Y S D W +GC+ E++ GK + R E
Sbjct: 157 TIRGRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 65/266 (24%), Positives = 100/266 (37%), Gaps = 61/266 (22%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLL-SCPDIKFSEAQIKCY 61
E IL LDHP + L + + LV +Y ++ LL P SE + Y
Sbjct: 51 EQEILATLDHPFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY 108
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------NFS 106
++L LE+ H G+++RD+K N+L++ G + L+DF L+ S
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 107 NTGHRQPLTSRVV-------------TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153
+ S T Y PE++ G +G +VD W++G + E+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLY 227
Query: 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 213
G +G E I + P P SS +
Sbjct: 228 GTTPFKGSNRDETFSNIL-----------------KKEVTFPGSPPVSS----------S 260
Query: 214 AVNLIETLLSVEPYKRATASAALASE 239
A +LI LL +P KR S A+E
Sbjct: 261 ARDLIRKLLVKDPSKR-LGSKRGAAE 285
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 27/174 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDI 51
R HP ++ L +C + V EY M H T +
Sbjct: 51 RIFETANSERHPFLVNL-------FACFQTEDHVCFVMEYAAGGDLMMHIHTDV------ 97
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
FSE + Y ++ GL++ H +++RD+K NLL++ EG +K+ADFGL G
Sbjct: 98 -FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFG 155
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 165
++ T + PE+L T Y +VD W +G + E+L+G+ G E E
Sbjct: 156 DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E I+ + DHPNII LEG++T S + +V EYME+ + L D +F+ Q+
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQ 112
+ + G+++ G +HRD+ N+LVN+ V K++DFGL A ++ G +
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
P+ W P + + + D+WS G V E++
Sbjct: 172 PIR------WTAPEA--IAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 4 EILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYMEHDITGLLS------CPDIKFSEA 56
E +L+ L HPNII+ E + + ++ +V EY G L+ C + E
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDK---ALMIVMEYAP---GGTLAEYIQKRCNSL-LDED 101
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLT 115
I + Q+L L H H++ +LHRD+K N+L++ ++ V+K+ DFG++ +
Sbjct: 102 TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAY 159
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
+ V T Y PEL G Y D+W++GCV EL K + + KI
Sbjct: 160 TVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF 218
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
+P D Y LR+ LI ++L+++P KR S
Sbjct: 219 APISDR-----------------YSPDLRQ-----------LILSMLNLDPSKRPQLSQI 250
Query: 236 LA 237
+A
Sbjct: 251 MA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 56/185 (30%), Positives = 87/185 (47%), Gaps = 28/185 (15%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
E ++ +L HP +++L G+ T R I LVFE+MEH ++ L KFS+ +
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLT 115
+ G+ + S V+HRD+ N LV V+K++DFG+ F S+TG + P+
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGC----VFAELLIGKPILQGRTE---VEQLH 168
W P Y D+WS G VF+E GK + R+ VE ++
Sbjct: 167 ------WSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSE---GKTPYENRSNSEVVETIN 215
Query: 169 KIFKL 173
F+L
Sbjct: 216 AGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 63/248 (25%), Positives = 117/248 (47%), Gaps = 36/248 (14%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
E++I+R H N++ + + + +++V E++E +T +++ + +E QI
Sbjct: 69 EVVIMRDYHHENVVDMYN--SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVC 124
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TL 121
+L L + H++GV+HRDIK ++L+ ++G +KL+DFG + P +V T
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTP 182
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
++ PE ++ YG VD+WS+G + E++ G+P ++ + +I D+
Sbjct: 183 YWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------RDNL 234
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
+ K H SS+ F DL +L EP +RATA L +
Sbjct: 235 PPRVKDSHKV---------SSVLRGFLDL----------MLVREPSQRATAQELLQHPFL 275
Query: 242 S-TKPYAC 248
P +C
Sbjct: 276 KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 31/198 (15%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----------DIK 52
EI IL +HP I+KL G I + F CP D
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEF------------CPGGAVDAIMLELDRG 106
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
+E QI+ Q+L L++ HS ++HRD+K N+L+ +G +KLADFG++ N Q
Sbjct: 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQ 165
Query: 113 PLTSRVVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 168
S + T ++ PE+++ T Y D+WS+G E+ +P E+ +
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMR 222
Query: 169 KIFKLCGSPPDDYWKKSK 186
+ K+ S P + SK
Sbjct: 223 VLLKIAKSEPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 52/162 (32%), Positives = 90/162 (55%), Gaps = 17/162 (10%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCS-IYLVFEYMEHDITGLLSCPDI----KFSE 55
+ +EI +L + D P + K G S L + ++++ EY+ G S D+ F E
Sbjct: 49 IQQEITVLSQCDSPYVTKYYG---SYLKGTKLWIIMEYL-----GGGSALDLLRAGPFDE 100
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 114
QI + ++L GL++ HS +HRDIK +N+L++ +G +KLADFG+A ++T ++
Sbjct: 101 FQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-- 158
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
+ V T ++ PE++ + Y D+WS+G EL G+P
Sbjct: 159 NTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 42/121 (34%), Positives = 64/121 (52%), Gaps = 6/121 (4%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
KF E Y ++ GL HS+G+++RD+K N++++ EG +K+ADFG+ + G
Sbjct: 97 KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154
Query: 112 QPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
T+R T Y PE++ YG SVD W+ G + E+L G+P G E E
Sbjct: 155 -GKTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 170 I 170
I
Sbjct: 213 I 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 6/136 (4%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
KF E Q Y ++ GL H RG+++RD+K N+++++EG +K+ADFG+
Sbjct: 97 KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--- 153
Query: 112 QPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
+T+R T Y PE ++ YG SVD W+ G + E+L G+P G E E
Sbjct: 154 DGVTTRTFCGTPDYIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 170 IFKLCGSPPDDYWKKS 185
I + S P K++
Sbjct: 213 IMEHNVSYPKSLSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI IL+ L H NI+K +G+ S ++ LV EY+ + + L + ++ Y
Sbjct: 54 REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY 113
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTS 116
+Q+ G+E+ S+ +HRD+ N+LV +E +K+ DFGL R+P S
Sbjct: 114 ASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 117 RVVTLWYRPPELLLGATDYGPSV--DLWSVGCVFAEL 151
+ WY P L T+ SV D+WS G V EL
Sbjct: 174 PI--FWYAPESL----TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEY-------MEHDITGLLSCPDIKFSEAQIK 59
IL + HP I+ L + + +YL+ EY M + G+ F E
Sbjct: 53 ILEAVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGI-------FMEDTAC 103
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Y++++ LEH H +G+++RD+K N+L++ +G +KL DFGL S H +T
Sbjct: 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFC 161
Query: 120 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
T+ Y PE+L+ + +G +VD WS+G + ++L G P + + KI K
Sbjct: 162 GTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 37/111 (33%), Positives = 61/111 (54%), Gaps = 3/111 (2%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
F E + Y ++L GLE H ++RD+K N+L+++ G ++++D GLA G +
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 163
+ RV T+ Y PE +L Y S D W +GC+ E++ G+ +GR E
Sbjct: 157 SIRGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 50/129 (38%), Positives = 70/129 (54%), Gaps = 8/129 (6%)
Query: 31 IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+Y+V EYM D+ L+S D+ E K Y +++ L+ HS G++HRD+K N+L+
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDV--PEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 175
Query: 90 NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVG 145
+ G LKLADFG TG + T+ V T Y PE+L G YG D WSVG
Sbjct: 176 DKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 146 CVFAELLIG 154
E+L+G
Sbjct: 235 VFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
EI IL DHPNI+KL L +++++ E+ + ++ + +E QI+
Sbjct: 52 EIDILASCDHPNIVKL--LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVC 109
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
Q L L + H ++HRD+K N+L +G +KLADFG++ NT Q S + T +
Sbjct: 110 KQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY 168
Query: 123 YRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
+ PE+++ T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEP 225
Query: 179 DDYWKKSK 186
+ S+
Sbjct: 226 PTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 54/182 (29%), Positives = 79/182 (43%), Gaps = 26/182 (14%)
Query: 3 REILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQ 57
E +L +LD II+ E + + +V EY E H + L E Q
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQ 102
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGH 110
+ + Q+L GL H HS+ +LHRDIK NL ++ +K+ D G+A NF+NT
Sbjct: 103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-- 160
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
V T +Y PE L Y D+W++G V E GK + + KI
Sbjct: 161 ------IVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213
Query: 171 FK 172
+
Sbjct: 214 IR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 8/210 (3%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+ +EI +L + D P I + G + ++++ EY+ L P E I
Sbjct: 49 IQQEITVLSQCDSPYITRYYG--SYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIAT 105
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ ++L GL++ HS +HRDIK +N+L++ +G +KLADFG+A + T
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 165
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
W P + A D+ D+WS+G EL G+P + L I K SPP
Sbjct: 166 FWMAPEVIKQSAYDF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPPTL 221
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDL 210
+ SK P + D R T K+L
Sbjct: 222 EGQYSK-PFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-13
Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEA----QIK 59
EIL L RL+H NI+K+E ++ R + Y++ + + D+ + + + Q +
Sbjct: 213 EILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLT-SR 117
M QLL +E+ H + ++HRDIK N+ +N +G + L DFG A F R+
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK--EREAFDYGW 328
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
V T+ PE+L G Y D+WS G + ++L
Sbjct: 329 VGTVATNSPEILAGDG-YCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 54/156 (34%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 31 IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+Y+V EYM D+ L+S D+ E + Y +++ L+ HS G +HRD+K N+L+
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDV--PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175
Query: 90 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVGC 146
+ G LKLADFG N + V T Y PE+L G YG D WSVG
Sbjct: 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 147 VFAELLIGKPILQGRTEVEQLHKIF--KLCGSPPDD 180
E+L+G + V KI K + PDD
Sbjct: 236 FLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 34/105 (32%), Positives = 60/105 (57%), Gaps = 1/105 (0%)
Query: 51 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 110
+F E +++ Y +++ LEH H G+++RDIK N+L+++ G + L DFGL+ +
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159
Query: 111 RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIG 154
+ S T+ Y P+++ G + +VD WS+G + ELL G
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIK 59
E +L +LDHP I+K R + I + EY E L SE Q+
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVC 109
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
+ QLL G+ + H R +LHRD+K N+ + N +LK+ DFG++ G T+
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTG 167
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
T +Y PE L Y D+WS+GC+ E+
Sbjct: 168 TPYYMSPE-ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTG 109
+F ++ + Y +LL LE+ H V++RD+K N+L++ +G + L DFGL N +
Sbjct: 89 RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
T Y PELLLG Y +VD W++G + E+L G P E K
Sbjct: 149 KTNTFCG---TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK 204
Query: 170 IFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLS---V 224
I + PD + + +K L P + + + K+ P + + LL
Sbjct: 205 ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQ 264
Query: 225 EPYKRATASAA----LASEYFSTKP 245
P+K A +SA E+ KP
Sbjct: 265 PPFKPAVSSAIDTSNFDEEFTREKP 289
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 2/119 (1%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
KF E + + Y ++ L H GV++RD+K N+L++ EG KLADFG+ +
Sbjct: 92 KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNG 150
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
T+ T Y PE +L +YGPSVD W++G + E++ G+P + E + I
Sbjct: 151 VTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 39/247 (15%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSE 55
+ +EI +++ H NI+ G SR +++ EY G S DI SE
Sbjct: 53 IQQEIFMVKECKHCNIVAYFGSYLSREK--LWICMEY-----CGGGSLQDIYHVTGPLSE 105
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
QI + L GL + HS+G +HRDIKG+N+L+ + G +KLADFG+A T
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRK 164
Query: 116 SRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
S + T ++ PE+ + Y D+W+VG EL +P + + L + K
Sbjct: 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS 224
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
PP K K ++ F N ++ L+ P KR TA
Sbjct: 225 NFQPPK---LKDKTKWSSTFH---------------------NFVKISLTKNPKKRPTAE 260
Query: 234 AALASEY 240
L +
Sbjct: 261 RLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-13
Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 3 REILILRRLDHPNIIKL--EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
RE + RL HPNI+ L G L ++ VFEY+ + D +
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGL---LFAVFEYVPGRTLREVLAADGALPAGETGR 83
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGH-----RQ 112
M Q+L L H++G++HRD+K N++V+ GV K+ DFG+
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 113 PLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
T+ V+ T Y PE L G P+ DL++ G +F E L G+ ++QG + E L++
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 6/123 (4%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
+F EA+ + Y ++ L H +G+++RD+K N+L+++EG KLADFG+ G
Sbjct: 92 RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC---KEGIF 148
Query: 112 QPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
T+ T Y PE +L YGPSVD W++G + E+L G + E +
Sbjct: 149 NGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207
Query: 170 IFK 172
I
Sbjct: 208 ILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 9e-13
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 10/211 (4%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+ +EI +L + D P + K G + ++++ EY+ L P E QI
Sbjct: 49 IQQEITVLSQCDSPYVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIAT 105
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVV 119
+ ++L GL++ HS +HRDIK +N+L++ G +KLADFG+A ++T ++ + V
Sbjct: 106 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVG 163
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T ++ PE ++ + Y D+WS+G EL G+P +E+ + +F + + P
Sbjct: 164 TPFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP---PHSELHPMKVLFLIPKNNPP 219
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210
P + + S R T K+L
Sbjct: 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 4/153 (2%)
Query: 3 REILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
R IL+ LD P I+ L+ + + +YLV +YM + +FSE + K Y
Sbjct: 44 RNILVRTLLDESPFIVGLK--FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY 101
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ +L+ LEH H +++RD+K N+L++ G + L DFGL+ +N + + T
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTT 160
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154
Y PE+LL Y VD WS+G + E+ G
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 2/110 (1%)
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y +++ GL+ HS+G+++RD+K N++++ +G +K+ADFG+ + G + ++ T
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGT 159
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
Y PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 17/157 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQ 57
+EI++++ H NI+ G R +++ E+ G S DI SE+Q
Sbjct: 55 QEIIMMKDCKHSNIVAYFGSYLRR--DKLWICMEF-----CGGGSLQDIYHVTGPLSESQ 107
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTS 116
I + L GL + HS+G +HRDIKG+N+L+ + G +KLADFG+ A + T ++ S
Sbjct: 108 IAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KS 165
Query: 117 RVVTLWYRPPEL--LLGATDYGPSVDLWSVGCVFAEL 151
+ T ++ PE+ + Y D+W+VG EL
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 38/135 (28%), Positives = 72/135 (53%), Gaps = 3/135 (2%)
Query: 50 DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 109
+ F E + Y ++ GLE H +++RD+K N+L+++ G ++++D GLA G
Sbjct: 96 EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
Q + RV T+ Y PE++ Y S D W++GC+ E++ G+ Q R + + +
Sbjct: 156 --QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212
Query: 170 IFKLCGSPPDDYWKK 184
+ +L ++Y +K
Sbjct: 213 VERLVKEVQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI--------TGLLSCPDIKFSE 55
E ++ +L HP +++L G+ T + +Y+V E+ME+ G LS D+ S
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLS-KDMLLSM 105
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNT 108
Q C G+E+ +HRD+ N LV++ GV+K++DFG+ + S++
Sbjct: 106 CQDVC------EGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC----VFAE 150
G + P+ + PPE+ + Y D+WS G VF E
Sbjct: 160 GAKFPVK-------WSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 5/145 (3%)
Query: 31 IYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+YLV +Y + D+ LLS + + E + Y+ +++ + H +HRDIK N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135
Query: 90 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD----YGPSVDLWSVG 145
+ G ++LADFG N + V T Y PE+L D YGP D WS+G
Sbjct: 136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 146 CVFAELLIGKPILQGRTEVEQLHKI 170
E+L G+ + VE KI
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 6/105 (5%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
F+E + + Y +++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL G
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISD 148
Query: 113 PLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
T + T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 149 GATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 37/170 (21%)
Query: 4 EILILRRLDHPNIIKLEG--LITSRLS-CSIYL------VFEYMEHDITGLLSCPDIKFS 54
E+ IL + D P II G + +R+S C+ ++ V+ + + G ++ +K
Sbjct: 49 ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVK-- 106
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
GL + S +LHRD+K SN+LVN G +KL DFG++ Q +
Sbjct: 107 -------------GLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-------TQLV 146
Query: 115 TS----RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQ 159
S V T Y PE + G YG D+WS+G F EL +G+ P Q
Sbjct: 147 NSIAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 62
E IL++ DHPNI+KL G+ T R IY+V E + D L + Q+ +
Sbjct: 42 EARILKQYDHPNIVKLIGVCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFA 99
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTS 116
G+ + S+ +HRD+ N LV VLK++DFG++ +S++G +Q
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ---- 155
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL----LIGKPILQGRTEVEQLHKIFK 172
+ W P L G Y D+WS G + E + P + + EQ+ K ++
Sbjct: 156 -IPIKWTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR 212
Query: 173 LCGSP--PDDYWK 183
+ PDD +K
Sbjct: 213 MSCPQKCPDDVYK 225
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 43/121 (35%), Positives = 63/121 (52%), Gaps = 15/121 (12%)
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN---FSNT-----GH 110
+ Y + + LE+ H+ G++HRD+K NLL+ + G +KL DFGL+ S T GH
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 111 -----RQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 164
R+ L +V T Y PE++L YG VD W++G + E L+G G T
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
Query: 165 E 165
E
Sbjct: 223 E 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 16/182 (8%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCY 61
E ++ +L H N+++L G+I L +Y+V E M + L + S Q+ +
Sbjct: 49 ETAVMTKLHHKNLVRLLGVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ G+E+ S+ ++HRD+ N+LV+ +GV K++DFGLA G S++
Sbjct: 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVK 162
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK---PILQGRTEVEQLHKIFKLCGSP 177
W P L + D+WS G + E+ G+ P + + E + K +++ P
Sbjct: 163 WTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EP 218
Query: 178 PD 179
P+
Sbjct: 219 PE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 31/167 (18%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 63
E ++ +L H +++L G+ T + IY+V EYM + C E + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSN------GCLLNYLREHGKRFQPS 100
Query: 64 QLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTG 109
QLL G+ + S+ +HRD+ N LV+++G +K++DFGL+ + S+ G
Sbjct: 101 QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 155
+ P+ + PPE+LL + + D+W+ G + E+ +GK
Sbjct: 161 SKFPVR-------WSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 30 SIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 88
++YLV +Y + D+ LLS + + E + Y+ +++ ++ H +HRDIK N+L
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 89 VNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLWYRPPELLLGATD----YGPSVDLWS 143
++ G ++LADFG G Q + V T Y PE+L D YGP D WS
Sbjct: 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAMEDGKGKYGPECDWWS 193
Query: 144 VGCVFAELLIGKPILQGRTEVEQLHKIF 171
+G E+L G+ + VE KI
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI--KFSEAQ-I 58
+EI I+ RL +PNII+L G+ S + ++ EYME+ D+ LS +I F+ A I
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 59 KC-------YMN-QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 110
YM Q+ G+++ S +HRD+ N LV N +K+ADFG++ +G
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 111 RQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153
+ R V W +LLG + + D+W+ G E+
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 10/107 (9%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNT 108
FSE + + Y +++ L + HS V++RD+K NL+++ +G +K+ DFGL + T
Sbjct: 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
+ + T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 152 -----MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 51/224 (22%)
Query: 30 SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 88
++YL+ E++ D+ LL D SE + Y+ + + ++ H G +HRDIK NLL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 89 VNNEGVLKLADFGLAN----------FSNTGH------------------------RQPL 114
++ +G +KL+DFGL + N H RQ
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
S V T Y PE+ + T Y D WS+G + E+LIG P T E K+
Sbjct: 194 YSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN-- 250
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 218
WK++ +F P+ P ++ T + N I
Sbjct: 251 -------WKET-----LVFPPEVPISEKAKDLILRFCTDSENRI 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+E IL++ DHPNI+KL G+ + IY+V E + LL+ ++ + ++ +
Sbjct: 41 QEAEILKQYDHPNIVKLIGVCVQKQP--IYIVMELVPGG--SLLTF--LRKKKNRLT--V 92
Query: 63 NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-------FSNT 108
+LL G+E+ S+ +HRD+ N LV VLK++DFG++ +
Sbjct: 93 KKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150
G +Q + W P L G Y D+WS G + E
Sbjct: 153 GLKQ-----IPIKWTAPEALNYGR--YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 45/174 (25%), Positives = 69/174 (39%), Gaps = 36/174 (20%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH---------------------- 40
+E ++ L HPNI+ L G+ T ++FEY+ H
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTC--MLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 41 -DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 99
+ L C D QI G+E+ S +HRD+ N LV +K++D
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAA-------GMEYLSSHHFVHRDLAARNCLVGEGLTVKISD 167
Query: 100 FGLAN--FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
FGL+ +S +R S + W P +L G + D+WS G V E+
Sbjct: 168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 38/121 (31%), Positives = 63/121 (52%), Gaps = 2/121 (1%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
+F E Y ++ GL HS+G+++RD+K N+++++EG +K+ADFG+ N
Sbjct: 97 RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDG 155
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+ T Y PE ++ YG SVD W+ G + E+L G+ +G E E I
Sbjct: 156 VTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
Query: 172 K 172
+
Sbjct: 215 E 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSEAQ-- 57
RE +L H NI+K G+ T +VFEYMEH D+ L PD F ++
Sbjct: 57 REAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 58 --IKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FS 106
+ ++QLL G+ + S+ +HRD+ N LV + V+K+ DFG++ ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174
Query: 107 NTGHRQPLTSRVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAEL 151
+R ++ + + PPE ++ Y D+WS G V E+
Sbjct: 175 TDYYRVG-GHTMLPIRWMPPESIM----YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 12 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 71
+HP ++ L + ++ V EY+ K E + Y ++ L +
Sbjct: 54 NHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELL 129
H RG+++RD+K N+L+++EG +KL D+G+ G R T+ T Y PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 130 LGATDYGPSVDLWSVGCVFAELLIGK 155
G DYG SVD W++G + E++ G+
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 20/159 (12%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
E I+ + H NII+LEG++T I + EYME+ + L D +FS Q+ +
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGML 113
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQP 113
+ G+++ +HRD+ N+LVN+ K++DFGL ++ +G + P
Sbjct: 114 RGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P + + + D+WS G V E++
Sbjct: 174 IR------WTAPEA--IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 5/145 (3%)
Query: 31 IYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+YLV +Y + D+ LLS + + E + Y+ +++ ++ H G +HRDIK N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 90 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD----YGPSVDLWSVG 145
+ G ++LADFG V T Y PE+L D YGP D WS+G
Sbjct: 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLG 195
Query: 146 CVFAELLIGKPILQGRTEVEQLHKI 170
E+L G+ + VE KI
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 47/207 (22%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQL 65
IL D+ ++KL + + ++Y V +Y+ D+ LL I F E + Y+ +L
Sbjct: 54 ILAEADNEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAEL 110
Query: 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-----------SNTGHRQ-- 112
+E H G +HRDIK N+L++ +G +KL DFGL HRQ
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 113 ----------------PLTSR-------------VVTLWYRPPELLLGATDYGPSVDLWS 143
PL R V T Y PE+LL T Y D WS
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWS 229
Query: 144 VGCVFAELLIGKPILQGRTEVEQLHKI 170
VG + E+L+G+P T E K+
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 1 MAREILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYM--EHDITGLLSCPDIKFSEAQ 57
+A+E IL L HP I+ + +Y + E++ T L +F
Sbjct: 65 VAQEKSILMELSHPFIVNMMCSFQDEN---RVYFLLEFVVGGELFTHLRKAG--RFPNDV 119
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 117
K Y +L+ E+ HS+ +++RD+K NLL++N+G +K+ DFG A + + R
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDR 171
Query: 118 VVTLW----YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
TL Y PE ++ + +G +VD W++G + E + G P
Sbjct: 172 TFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 49/190 (25%)
Query: 30 SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 88
++Y V +Y+ D+ LL I F E + Y+ +L +E H G +HRDIK N+L
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 89 VNNEGVLKLADFGLA-----------------------NFSN---------TGHR-QPLT 115
++ +G +KL DFGL +FSN G R +PL
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLE 193
Query: 116 SR-------------VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
R V T Y PE+LL T Y D WSVG + E+L+G+P +T
Sbjct: 194 RRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252
Query: 163 EVEQLHKIFK 172
+E K+
Sbjct: 253 PLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 55/216 (25%)
Query: 30 SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 88
++YL+ E++ D+ LL D +E + + Y+ + + ++ H G +HRDIK NLL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL 133
Query: 89 VNNEGVLKLADFGLAN----------FSNTGH------------------------RQPL 114
++++G +KL+DFGL + N H RQ
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
S V T Y PE+ + T Y D WS+G + E+LIG P T E K+
Sbjct: 194 FSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN-- 250
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210
WK++ +F P+ P + E KDL
Sbjct: 251 -------WKET-----LIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 28/173 (16%)
Query: 3 REILILRRLDHPNIIKLEGL-ITSRLSCSIYLVFEYME--------------------HD 41
RE ++ DHPNI+KL G+ + C L+FEYM H
Sbjct: 57 REAALMAEFDHPNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113
Query: 42 ITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 99
+ C + S + C Q+ G+ + R +HRD+ N LV V+K+AD
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 173
Query: 100 FGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
FGL+ N + + + + + + + PPE + Y D+W+ G V E+
Sbjct: 174 FGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 8e-11
Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 31/193 (16%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DIT-GLLSCPDI--KFSEAQIK 59
E+ ++R L H NI++ ++ + +Y++ E+ + D++ + C + K E I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 60 CYMNQLLHGLEHCHS-------RGVLHRDIKGSNLLV-----------------NNEGVL 95
QLLH L +CH+ VLHRD+K N+ + N +
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 96 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIG 154
K+ DFGL+ N G S V T +Y PELLL T Y D+W++GC+ EL G
Sbjct: 182 KIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 155 KPILQGRTEVEQL 167
K QL
Sbjct: 240 KTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 33/142 (23%)
Query: 68 GLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQPLTSRV 118
LE+ HS+ V+HRD+K SN+L+N G +KL DFG +A + G +
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP------ 168
Query: 119 VTLWYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLC 174
Y PE + + Y D+WS+G EL G+ P +T +QL ++ +
Sbjct: 169 ----YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-- 222
Query: 175 GSPPDDYWKKSKLPHATLFKPQ 196
P +LP F P+
Sbjct: 223 EPSP-------QLPAEK-FSPE 236
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y Q+ G+ H HS +++RD+K N+L++++G +L+D GLA G + +T R T
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGT 157
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
Y PE+L Y VD +++GC E++ G+
Sbjct: 158 NGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 25/169 (14%)
Query: 1 MAREILILR-RLDHPNIIK-----LEGLITSRLSCSIYLVFEYM------EHDITGLLSC 48
+ E+ I++ +L HPNI++ LE RL Y+V + + EH + L
Sbjct: 55 IVSEVTIIKEQLRHPNIVRYYKTFLEN---DRL----YIVMDLIEGAPLGEHFNS--LKE 105
Query: 49 PDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 107
+F+E +I Q++ L + H + ++HRD+ +N+++ + + + DFGLA
Sbjct: 106 KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--Q 163
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
LTS V T+ Y PE++ YG D+W+ GC+ ++ +P
Sbjct: 164 KQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 36/111 (32%), Positives = 61/111 (54%), Gaps = 2/111 (1%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
F E + Y Q++ GLEH H R +++RD+K N+L++N+G ++++D GLA G +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 163
T + PELL G +Y SVD +++G E++ + + R E
Sbjct: 154 T-KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 29/166 (17%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCS-IYLVFEYMEHDITGLLSCPDI-------KFSE 55
EI+ R+L HPNI+ TS + S +Y+V M + SC D+ E
Sbjct: 49 EIITSRQLQHPNILPYV---TSFIVDSELYVVSPLMAYG-----SCEDLLKTHFPEGLPE 100
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQ-- 112
I + +L+ L++ HS+G +HR +K S++L++ +G + L+ + + G RQ
Sbjct: 101 LAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160
Query: 113 ---PLTSRVVTLWYRPPELL----LGATDYGPSVDLWSVGCVFAEL 151
S V L + PE+L G Y D++SVG EL
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQG---YNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 51 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTG 109
+ F E ++ Q++ L+ HSR ++HRD+K +N+ + G++KL DFG + +S++
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
+S T +Y PE L Y D+WS+G + ELL LH+
Sbjct: 224 SLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELL-------------TLHR 269
Query: 170 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
FK P + ++ L+ P+ + K L++ LLS P R
Sbjct: 270 PFK---GP-----SQREIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALR 314
Query: 230 ATASAALASEYF 241
T L +E+
Sbjct: 315 PTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E IL++ HPNI++L G+ T + IY+V E ++ D L + ++
Sbjct: 42 QEARILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQM 99
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLT 115
+ G+E+ S+ +HRD+ N LV + VLK++DFG++ +++TG +
Sbjct: 100 VENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK--- 156
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150
++ W P L G Y D+WS G + E
Sbjct: 157 -QIPVKWTAPEALNYGR--YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 20/109 (18%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFE---------YMEHDITGLLSCPDIKFS 54
E I+R+ DHP+I+KL G+IT +++V E Y++ + L I +
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILY- 112
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Y QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 113 -----SY--QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 35/82 (42%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 136
++HRD+K SN+LVN+ G +KL DFG+ S S V T Y PE L G T Y
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQG-THYT 176
Query: 137 PSVDLWSVGCVFAELLIGK-PI 157
D+WS+G E+ IG+ PI
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 4/171 (2%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
M+ ++L+ + HP ++ L + + + +Y V +Y+ + F E + +
Sbjct: 43 MSERNVLLKNVKHPFLVGLH--FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF 100
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y ++ L + HS +++RD+K N+L++++G + L DFGL N H ++ T
Sbjct: 101 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGT 159
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
Y PE +L Y +VD W +G V E+L G P R E I
Sbjct: 160 PEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 28/105 (26%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E +++ + HPN+++L G+ T Y++ E+M + ++ L + + A + Y
Sbjct: 51 KEAAVMKEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 108
Query: 62 M-NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 105
M Q+ +E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 109 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 47/210 (22%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH--------DITG-LLSCPDIKFS 54
E I+++L H +++L +++ IY+V EYM D G L P++
Sbjct: 51 EAQIMKKLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SN 107
AQ+ G+ + +HRD++ +N+LV + V K+ADFGLA +
Sbjct: 108 AAQVAA-------GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTE 163
G + P+ W P L G + D+WS G + EL+ + P + R
Sbjct: 161 QGAKFPIK------WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212
Query: 164 VEQLHKIFKL-C--GSPPDDY------WKK 184
+EQ+ + +++ C P + WKK
Sbjct: 213 LEQVERGYRMPCPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 35/235 (14%)
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS---NTGH 110
SEA I + L GL + H G +HR+IK S++L++ +G++ L+ GL++ G
Sbjct: 99 SEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQ 156
Query: 111 RQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 164
+ P S V W P L Y D++SVG EL G+ Q
Sbjct: 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT 216
Query: 165 EQLHKIFKLCGSPPDDYWKKSKLPH--ATLFKPQQPYDSSLRETF--------------- 207
+ L + K PP + P + + Q DS + E+
Sbjct: 217 QMLLQKLK---GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR 273
Query: 208 ----KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 258
K NL+E L +P KR +AS+ L+ +F S L + PP
Sbjct: 274 TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E I+++L H +++L + + IY+V EYM + L + K
Sbjct: 50 QEAQIMKKLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD 107
Query: 62 MN-QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
M Q+ G+ + SR +HRD+ N+LV V K+ADFGLA
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167
Query: 121 LWYRPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 170
+ + PE A +YG D+WS G + E++ G+ G T E L ++
Sbjct: 168 IKWTAPE----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 52/177 (29%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--FSEAQIKC 60
REI IL+ + H II L + R ++ +V + D L + D Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCD---LFTYVDRSGPLPLEQAIT 189
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVV 119
+LL L + H RG++HRD+K N+ ++ L DFG A + P
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 120 TLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPIL---QGRTEVEQLHKIFK 172
TL PELL A D Y D+WS G V E+ + L Q ++ QL I +
Sbjct: 250 TLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 6/106 (5%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
K E + Y ++ L H RG+++RD+K N+L++ EG +KL D+G+ G R
Sbjct: 92 KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC---KEGIR 148
Query: 112 QPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
T+ T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 149 PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 41/132 (31%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 24 TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 83
TSRL +LV EY+ K E + Y ++ L H RG+++RD+K
Sbjct: 68 TSRL----FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLK 123
Query: 84 GSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143
N+L++ +G +KL D+G+ G ++ T Y PE+L G +YG SVD W+
Sbjct: 124 LDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWA 181
Query: 144 VGCVFAELLIGK 155
+G + E++ G+
Sbjct: 182 LGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 2/103 (1%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
FSE + + Y +++ L++ HS +++RD+K NL+++ +G +K+ DFGL T
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAA 150
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
+ + T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 151 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCY 61
E ++ L HPN+++L G++ +Y+V EYM + L S + AQ +
Sbjct: 50 EASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ G+E+ + +HRD+ N+LV+ + V K++DFGLA ++ G + ++
Sbjct: 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVK 164
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
W P L + D+WS G + E+
Sbjct: 165 WTAPEALREK--KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHR 111
E I ++L GL H H+ V+HRDIKG N+L+ +KL DFG+ A T R
Sbjct: 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVE 165
+ + + T ++ PE++ A D P D+WS+G E+ G P L ++
Sbjct: 178 R--NTFIGTPYWMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMH 230
Query: 166 QLHKIFKLCGSPP 178
+ +F + +PP
Sbjct: 231 PMRALFLIPRNPP 243
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 34/185 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLV---------FEYMEHDITGLLSCPDIKF 53
E I+++L HP +I+L + T L IY+V EY++ L P +
Sbjct: 50 AEAQIMKKLRHPKLIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID 107
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------S 106
AQ+ M L ++ +HRD+ N+LV + K+ADFGLA +
Sbjct: 108 MAAQVASGMAYL-------EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160
Query: 107 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 165
G + P+ W P L + D+WS G + E++ G+ G T E
Sbjct: 161 REGAKFPIK------WTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
Query: 166 QLHKI 170
L ++
Sbjct: 213 VLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 37/180 (20%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 63
E ++++L HP +++L ++T IY++ EYME+ S D + IK +N
Sbjct: 51 EANLMKQLQHPRLVRLYAVVTQE---PIYIITEYMENG-----SLVDFLKTPEGIKLTIN 102
Query: 64 QLL-------HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTG 109
+L+ G+ + +HRD++ +N+LV+ K+ADFGLA + G
Sbjct: 103 KLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKPILQGRTEVE 165
+ P+ W P A +YG D+WS G + E++ G+ G T E
Sbjct: 163 AKFPIK------WTAPE-----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC-YMNQL 65
IL ++HP + L G + + +YLV E++ + +F + C Y Q+
Sbjct: 84 ILNYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQI 140
Query: 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 125
+ E+ S +++RD+K NLL++ +G +K+ DFG A +T R TL P
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--------RTYTLCGTP 192
Query: 126 ----PELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
PE+LL +G + D W++G E+L+G P
Sbjct: 193 EYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 50/193 (25%), Positives = 75/193 (38%), Gaps = 44/193 (22%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS---------CPDIK 52
+E+ IL RL PNI +L G+ T + + EYME+ D+ L + K
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCM--IMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 53 FSEAQIKCYM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL------ANF 105
YM Q+ G+ + S +HRD+ N LV +K+ADFG+ +++
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 106 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 165
R PL R W +LLG + D+W+ G
Sbjct: 186 YRVQGRAPLPIR----WMAWESVLLGK--FTTKSDVWAFGVT------------------ 221
Query: 166 QLHKIFKLCGSPP 178
L +I LC P
Sbjct: 222 -LWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
E L L + DH NI++LEG+IT ++ +V EYM + + L + + Q+ +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTL 121
L G+++ G +H+ + +LVN++ V K++ F L + ++ + L
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
W P + + + D+WS G V E++
Sbjct: 174 WAAPEAIQYH--HFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 36/106 (33%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
FSE + + Y +++ L++ HS + V++RD+K NL+++ +G +K+ DFGL G +
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIK 148
Query: 112 QPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
T + T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 149 DGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 8/173 (4%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MA ++L+ + HP ++ L + + + +Y V +++ + F E + +
Sbjct: 43 MAERNVLLKNVKHPFLVGLH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF 100
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y ++ L + HS +++RD+K N+L++++G + L DFGL T+ T
Sbjct: 101 YAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGT 159
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ----LHK 169
Y PE++ Y +VD W +G V E+L G P R E LHK
Sbjct: 160 PEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 122
++L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T +
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 176
Query: 123 YRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPIL 158
+ PE++ A D P DLWS+G E+ G P L
Sbjct: 177 WMAPEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 2/118 (1%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
F E + + Y ++ L + HS +++RD+K N+L++++G + L DFGL H +
Sbjct: 93 FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSK 151
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
++ T Y PE+L Y +VD W +G V E+L G P R E I
Sbjct: 152 TTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 10/181 (5%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
MA ++L+ L HP ++ L + + + +Y V +Y+ + F E + +
Sbjct: 43 MAERNVLLKNLKHPFLVGLH--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF 100
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y ++ + + HS +++RD+K N+L++++G + L DFGL + ++ T
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGT 159
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-----LHKIFKLCG 175
Y PE +L Y +VD W +G V E+L G P R +V Q LHK +L G
Sbjct: 160 PEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPG 217
Query: 176 S 176
Sbjct: 218 G 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 48/187 (25%), Positives = 73/187 (39%), Gaps = 49/187 (26%)
Query: 31 IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+YL+ E++ D+ +L D FSE + YM + + +E H G +HRDIK N+L+
Sbjct: 76 LYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI 134
Query: 90 NNEGVLKLADFGLAN-----FSNTGHRQPLTSRVVT------------------------ 120
+ G +KL+DFGL+ + +++ L +
Sbjct: 135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQI 194
Query: 121 -LW----------------YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 163
W Y PE+ L YG D WS+G + E LIG P
Sbjct: 195 ATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENS 253
Query: 164 VEQLHKI 170
E KI
Sbjct: 254 HETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 65/206 (31%), Positives = 91/206 (44%), Gaps = 31/206 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDIKFS 54
RE+ +L + P I+ G S SI MEH G L P+
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKEAKRIPEEILG 106
Query: 55 EAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
+ I +L GL + + ++HRD+K SN+LVN+ G +KL DFG+ S
Sbjct: 107 KVSIA-----VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSM 158
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFK 172
S V T Y PE L G T Y D+WS+G EL IG+ PI + ++L IF
Sbjct: 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF- 214
Query: 173 LCGSPPDDYWKKSKLPHATLFKPQQP 198
G P D + PH+ +P+ P
Sbjct: 215 --GRPVVD--GEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 3/111 (2%)
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
F E + Y +L GLE +++RD+K N+L+++ G ++++D GLA G
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 163
+ RV T+ Y PE++ Y S D W +GC+ E++ G+ + R E
Sbjct: 158 -VRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 7/173 (4%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+E+ L+RL H ++I L + + +Y++ E ME + L P+ +
Sbjct: 49 FQKEVQALKRLRHKHLISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASL 106
Query: 60 CYMN-QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
M Q+ G+ + + +HRD+ N+LV + V K+ADFGLA ++
Sbjct: 107 IDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 170
W P G + D+WS G + E+ G+ G E +I
Sbjct: 167 PYKWTAPEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 28/158 (17%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEA 56
RE ++ +LDHP I++L G+ + LV E L +I +
Sbjct: 43 FLREASVMAQLDHPCIVRLIGVC---KGEPLMLVMELAPLGPLLKY--LKKRREIP--VS 95
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSN------ 107
+K +Q+ G+ + S+ +HRD+ N+L+ N K++DFG++ +
Sbjct: 96 DLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 145
T R PL WY P + G D+WS G
Sbjct: 156 TAGRWPLK------WYAPECINYGKFSS--KSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 19/164 (11%)
Query: 3 REILILRRLDHPNIIKLEGL-ITSRLSCSIYLVFEYME----------HDITGLLSCPDI 51
+EI I+ RL PNII+L + ITS C ++ EYME H+ D+
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLC---MITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 52 KFSEAQIKCYM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 110
+M Q+ G+++ S +HRD+ N LV +K+ADFG++ +G
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 111 RQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ R V W +LLG + + D+W+ G E+L
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLW 122
Q+L + H HS+ ++HRDIK +N+L+ + G++KL DFG + ++ T + T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
Y PE+ Y D++S+G + ELL K G E +HK
Sbjct: 211 YVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 40/164 (24%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC------------P 49
RE +L L H +I+K G+ + +VFEYM+H D+ L
Sbjct: 56 REAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113
Query: 50 DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNT 108
+ +++Q+ Q+ G+ + S+ +HRD+ N LV ++K+ DFG++ + +T
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ + ++ + + PPE ++ + D+WS+G V E+
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 28/181 (15%)
Query: 13 HPNIIKLEGLITSRLSCSIYLVFEY-----------------MEH--DITGLLSCPDIKF 53
H NII L G T +Y++ EY ME+ DI + PD +
Sbjct: 80 HKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV---PDEQM 134
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQ 112
+ + Q+ G+E+ S+ +HRD+ N+LV V+K+ADFGLA + +N + +
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIF 171
T+ + + + PE L Y D+WS G + E+ +G G VE+L K+
Sbjct: 195 KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLL 252
Query: 172 K 172
K
Sbjct: 253 K 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 48/155 (30%), Positives = 66/155 (42%), Gaps = 25/155 (16%)
Query: 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLW 122
LH L+ H GV+HRD+K SN+L++ G +KL DFG++ S R +
Sbjct: 127 LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA----- 179
Query: 123 YRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 178
Y PE + Y D+WS+G EL G+ P +TE E L KI + PP
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE--EPP 237
Query: 179 DDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLP 211
LP F P D L + + P
Sbjct: 238 -------SLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 14 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKF---SEAQIKCYMNQLLHGLE 70
PN++ L I S S ++LV ++ E G L KF E +K + +++ L+
Sbjct: 45 PNMVCLHKYIVSEDS--VFLVLQHAE---GGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 71 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 130
H G++ RD+ +N+L+++ G ++L F +S V Y PE +
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEV--EDSCDGEAVENMYCAPE-VG 154
Query: 131 GATDYGPSVDLWSVGCVFAELLIGKPILQ 159
G ++ + D WS+G + ELL GK +++
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 57/240 (23%), Positives = 95/240 (39%), Gaps = 33/240 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKF-SEAQIKC 60
+E +L +L HPNI+ +Y+V + E D+ L K E Q+
Sbjct: 48 QEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ Q+ L++ H + +LHRD+K N+ + ++K+ D G+A ++ + T
Sbjct: 107 WFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGT 165
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
+Y PE L Y D+W++GC E+ K + +++I
Sbjct: 166 PYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII--------- 215
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
+ KL P P KD LI T+LS P KR + + L Y
Sbjct: 216 ---EGKL-------PPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 2/110 (1%)
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 122
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + N + + T+ + +
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
+ PE L Y D+WS G + E+ VE+L K+ K
Sbjct: 202 WMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSE-AQIKC 60
+E I+++L H ++ L +++ IY+V E+M + + L D K+ + Q+
Sbjct: 50 QEAQIMKKLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD 106
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQP 113
Q+ G+ + +HRD++ +N+LV + V K+ADFGLA + G + P
Sbjct: 107 MAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHK 169
+ W P L G + D+WS G + EL+ + P + R +EQ+ +
Sbjct: 167 IK------WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
Query: 170 IFKL 173
+++
Sbjct: 219 GYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 29/192 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSE----AQI 58
+E ++++L H +++L +++ IY+V EYM LL + + Q+
Sbjct: 50 QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQL 104
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHR 111
Q+ G+ + +HRD++ +N+LV V K+ADFGLA + G +
Sbjct: 105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 164
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQL 167
P+ W P L G + D+WS G + EL + P + R ++Q+
Sbjct: 165 FPIK------WTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
Query: 168 HKIFKLCGSPPD 179
+ +++ PP+
Sbjct: 217 ERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 29/74 (39%), Positives = 46/74 (62%), Gaps = 2/74 (2%)
Query: 31 IYLVFEYM-EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 89
+YLV EY+ D+ LL F E Y++++ L++ H G++HRD+K N+L+
Sbjct: 79 VYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137
Query: 90 NNEGVLKLADFGLA 103
+NEG +KL DFGL+
Sbjct: 138 SNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIY----LVFEYMEH-DITGLL------SCPDI 51
E + ++ DHPN+++L G+ + Y ++ +M+H D+ L CP
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTG 109
++ +K +M + G+E+ S+ +HRD+ N ++N + +ADFGL+ ++
Sbjct: 109 LPTQMLVK-FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY 167
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
+RQ +++ W L Y D+WS G E+
Sbjct: 168 YRQGRIAKMPVKWIAIES--LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCY 61
E +++ L H ++KL ++T IY++ E+M + L S K ++ +
Sbjct: 51 EANVMKTLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
Q+ G+ R +HRD++ +N+LV+ V K+ADFGLA +
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 122 WYRPPELLLGATDYGP---SVDLWSVGCVFAELL 152
+ PE A ++G D+WS G + E++
Sbjct: 168 KWTAPE----AINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 53/165 (32%), Positives = 74/165 (44%), Gaps = 24/165 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDIKFS 54
RE+ +L + P I+ G S SI MEH G L P+
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPEQILG 106
Query: 55 EAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
+ I ++ GL + + ++HRD+K SN+LVN+ G +KL DFG+ S
Sbjct: 107 KVSIA-----VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSM 158
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PI 157
S V T Y PE L G T Y D+WS+G E+ IG+ PI
Sbjct: 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 34/171 (19%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIK 59
E+ IL + P I+ G + ++Y+ EYM+ + + E ++
Sbjct: 49 ELDILHKAVSPYIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGI-PEDVLR 105
Query: 60 CYMNQLLHGL-----EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTG 109
++ GL EH ++HRD+K +N+LVN G +KL DFG+ A+ + T
Sbjct: 106 RITYAVVKGLKFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161
Query: 110 HRQPLTSRVVTLWYRPPELL--LGATD---YGPSVDLWSVGCVFAELLIGK 155
+ Y PE + G Y D+WS+G E+ +G+
Sbjct: 162 --------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 63
E ++ +L H N+++L G+I +Y+V EYM S D S + +
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAKG-----SLVDYLRSRGRSVLGGD 102
Query: 64 QLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 116
LL +E+ + +HRD+ N+LV+ + V K++DFGL +++ T
Sbjct: 103 CLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TG 159
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK------PILQGRTEVEQLHK 169
++ W P L + D+WS G + E+ G+ P+ VE+ +K
Sbjct: 160 KLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 217
Query: 170 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210
+ G PP Y + K D++ R +F L
Sbjct: 218 MDAPDGCPPVVY---------DVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 48/188 (25%), Positives = 74/188 (39%), Gaps = 49/188 (26%)
Query: 30 SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 88
++Y V +Y+ D+ LL ++ F E + Y+ +L +E H G +HRDIK N+L
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133
Query: 89 VNNEGVLKLADFGLAN----------FSNTGHRQPLTSRVVTLW---------------- 122
++ +G +KL DFGL + H + + LW
Sbjct: 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLE 193
Query: 123 --------------------YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
Y PE+LL Y D WSVG + E+L+G+P T
Sbjct: 194 QRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPFLAPT 252
Query: 163 EVEQLHKI 170
E K+
Sbjct: 253 PTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 29/171 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSE---- 55
RE +L L H +I++ G+ T + +VFEYM H D+ L PD K
Sbjct: 56 REAELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113
Query: 56 --------AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---- 103
Q+ +Q+ G+ + S +HRD+ N LV V+K+ DFG++
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173
Query: 104 --NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
++ G R L R + PPE +L + D+WS G V E+
Sbjct: 174 STDYYRVGGRTMLPIR-----WMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 25/183 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKF------ 53
RE +L L H +I+K G+ + +VFEYM+H D+ L PD
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113
Query: 54 SEAQIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-- 104
+A+ + ++Q+LH G+ + S+ +HRD+ N LV ++K+ DFG++
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173
Query: 105 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK-PILQ-GR 161
+S +R + + W PPE ++ + D+WS G + E+ GK P Q
Sbjct: 174 YSTDYYRVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231
Query: 162 TEV 164
TEV
Sbjct: 232 TEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 15/99 (15%)
Query: 63 NQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTS 116
++ GL + ++ ++HRDIK SN+LVN+ G +KL DFG++ + ++T
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-------- 161
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
V T Y PE + G Y D+WS+G EL +GK
Sbjct: 162 FVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 33/74 (44%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTS 116
IK M Q+L GL H G++HRDIK NLLV +G +K+ DFG A TG + PL
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 117 RVVTLWYRPPELLL 130
++ Y PPE L+
Sbjct: 371 -MLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 11/105 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQ 57
+E I+ LDH N+I+L G++ L+ + +V E + LL F +
Sbjct: 45 KEAAIMHSLDHENLIRLYGVV---LTHPLMMVTELAP--LGSLLDRLRKDALGH-FLIST 98
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 102
+ Y Q+ +G+ + S+ +HRD+ N+L+ ++ +K+ DFGL
Sbjct: 99 LCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGL 143
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 4 EILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQ-IKC 60
E+ I+ L +H NI+ L G T + I ++ EY + D+ L F + +
Sbjct: 88 ELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQP 113
+ Q+ G+ S+ +HRD+ N+L+ + ++K+ DFGLA N+ G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG---- 201
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
+R+ W P + Y D+WS G + E+
Sbjct: 202 -NARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 13 HPNIIKLEGLITSRLSCSIYLVFEYME----------HDITGLLSC------PDIKFSEA 56
H NII L G T +Y++ EY G+ C P+ + S
Sbjct: 83 HKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLT 115
+ Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + + + + T
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 172
+ + + + PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 201 NGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 53/240 (22%)
Query: 4 EILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEH-------------------DIT 43
E+ +++ + H NII L G+ T +Y++ EY DIT
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 44 ----GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 99
LS D+ + C Q+ G+E+ SR +HRD+ N+LV + V+K+AD
Sbjct: 125 KVPEEQLSFKDL------VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIAD 177
Query: 100 FGLANFSN--TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI---- 153
FGLA + +++ R+ W P L Y D+WS G + E+
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGS 235
Query: 154 ---GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210
G P+ + + + H++ K + Y + HA P Q R TFK L
Sbjct: 236 PYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAV---PTQ------RPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 3 REILILRRLDHPNIIKLEGL-ITSRLSCSI---YLVFEYMEH-DITGLLSCPDI-----K 52
RE ++ DHPN+IKL G+ + SR + ++ +M+H D+ L I
Sbjct: 50 REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT 109
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH 110
+ +M + G+E+ S+ +HRD+ N ++N + +ADFGL+ +S +
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY 169
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
RQ S++ W L Y D+W+ G E++
Sbjct: 170 RQGCASKLPVKWLALES--LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 14/162 (8%)
Query: 3 REILILRRLDHPNIIKLEGL-ITSRLSCSI---YLVFEYMEH-DITGLLSCPDI-----K 52
E ++ DHPN++KL G+ + I ++ +M+H D+ L + K
Sbjct: 50 SEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK 109
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH 110
+ +M + G+E+ +R +HRD+ N ++ + + +ADFGL+ +S +
Sbjct: 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY 169
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
RQ +++ W L Y D+W+ G E+
Sbjct: 170 RQGRIAKMPVKWIAIES--LADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 23/168 (13%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIK 59
M RE I+ +LD+P I+++ G+ + ++ LV E + LS + + + +
Sbjct: 42 MMREAEIMHQLDNPYIVRMIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVV 98
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---------SNTGH 110
M+Q+ G+++ + +HRD+ N+L+ N+ K++DFGL+ + +
Sbjct: 99 ELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 156
+ PL WY P + + D+WS G E KP
Sbjct: 159 KWPLK------WYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 25/186 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKF 53
+E ++ +HPNI+KL G+ L+ Y++ E ME D+ L P +
Sbjct: 48 KEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105
Query: 54 SE-AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN--F 105
E I + + LE H +HRD+ N LV+ +G V+K+ DFGLA +
Sbjct: 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162
Query: 106 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEV 164
+ +R+ + W P LL G + D+WS G + E+L +G+
Sbjct: 163 KSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
Query: 165 EQLHKI 170
E L +
Sbjct: 221 EVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY- 61
E ++ +DHP++++L G+ LS + L+ + M LL ++ + I
Sbjct: 58 DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLG--CLLDY--VRNHKDNIGSQY 110
Query: 62 -MN---QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS- 116
+N Q+ G+ + + ++HRD+ N+LV +K+ DFGLA + ++
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 117 -RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+V W +L Y D+WS G EL+
Sbjct: 171 GKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 8e-07
Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 35/158 (22%)
Query: 12 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIKCYMN 63
D+PN IKL +T+ L + L+ +Y++ D+ K SEA++K +
Sbjct: 67 DNPNFIKLYYSVTT-LKGHV-LIMDYIK--------DGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNT-----GHRQPLTSR 117
QL+ L H ++H DIK N+L + + + L D+GL T G
Sbjct: 117 QLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-------- 168
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
TL Y PE + G +Y S D W+VG + ELL GK
Sbjct: 169 --TLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 36/180 (20%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM---------EHDITGLLSCPD-IKF 53
E +++ L H +++L ++T IY++ EYM + D G + P I F
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------S 106
S Q+ G+ + + +HRD++ +N+LV+ + K+ADFGLA +
Sbjct: 109 SA--------QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
Query: 107 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 165
G + P+ W P + G+ + D+WS G + E++ GK G + +
Sbjct: 161 REGAKFPIK------WTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 28/167 (16%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 63
E LI+ +DHP++++L G+ LS +I LV + M H LL + +N
Sbjct: 59 EALIMASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGC--LLDYVHEHKDNIGSQLLLN 113
Query: 64 ---QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTGHRQ 112
Q+ G+ + R ++HRD+ N+LV + +K+ DFGLA ++ G +
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 113 PLTSRVVT-LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 156
P+ + + YR + D+WS G EL+ GKP
Sbjct: 174 PIKWMALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 13/108 (12%)
Query: 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP---PELLLGAT 133
++HRD+K SN+L++ G +KL DFG++ G ++ RP PE + +
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 134 DYGPSV--DLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 178
G V D+WS+G E+ GK P + + +QL ++ K G PP
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 18/107 (16%)
Query: 13 HPNIIKLEGLITSRLSCSIYLVFEYMEHD-----------ITGLLSCPDIKFSEAQIKCY 61
H NII L G+ T +Y+V EY H S D + E +
Sbjct: 75 HKNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 62 -----MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+E S+ +HRD+ N+LV + V+K+ADFGLA
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 117
CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P + Y D+WS G + E+
Sbjct: 238 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 25/172 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E+ IL RL PNII+L G+ + ++ EYME+ D+ LS + E
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 62 MNQ-----------LLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ LLH G+++ S +HRD+ N LV +K+ADFG++
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 104 NFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153
G + R V W +L+G + + D+W+ G E+L+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 117
CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P + Y D+WS G + E+
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 29/102 (28%), Positives = 53/102 (51%), Gaps = 2/102 (1%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E +I++ HPN++ L G I S +V YM+H D+ + + + +
Sbjct: 45 KEGIIMKDFSHPNVLSLLG-ICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF 103
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+E+ S+ +HRD+ N +++ +K+ADFGLA
Sbjct: 104 GLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCP--DIKFS-- 54
+E ++ L HPNI+ L G++T + ++FEY+ H+ ++ P D+ S
Sbjct: 56 QEASLMAELHHPNIVCLLGVVTQEQ--PVCMLFEYLNQGDLHEFL-IMRSPHSDVGCSSD 112
Query: 55 -EAQIKCYMN---------QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104
+ +K ++ Q+ G+E+ S +H+D+ N+L+ + +K++D GL+
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 105 --FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+S +R S + W P ++ G + D+WS G V E+
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL----------SCPDI 51
E ++ RL HPNI+ L G++T S ++F Y H D+ L S D
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLS--MIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 52 KFSEAQIKC-----YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-- 104
K ++ ++ + Q+ G+E S V+H+D+ N+LV ++ +K++D GL
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 105 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
++ ++ S + W P ++ G + D+WS G V E+
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 30/164 (18%), Positives = 68/164 (41%), Gaps = 22/164 (13%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM--------------EHDITGLLSCP 49
E +++ + ++++L G++ S +V E M E + L P
Sbjct: 59 EASVMKEFNCHHVVRLLGVV-STGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 50 DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNT 108
++ + ++ G+ + ++ +HRD+ N +V + +K+ DFG+ + T
Sbjct: 117 TLQ----KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ + ++ + + PE L + D+WS G V E+
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 66/289 (22%), Positives = 107/289 (37%), Gaps = 53/289 (18%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--FSEAQIKCY 61
E+ + + +HPNI+ + +++V +M + L C SE I
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQ-------- 112
+ +L L++ H G +HR +K S++L++ +G + L+ GL +N S H Q
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDF 164
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK------PILQGRTEVEQ 166
P S V W P L Y D++SVG EL G P Q E
Sbjct: 165 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--- 221
Query: 167 LHKIFKLCGS----------PPDDYWKK----------SKLPHATLFKPQQPYDSSLRET 206
KL G+ P ++ K + + +P +SS
Sbjct: 222 -----KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNG-ESSSHPY 275
Query: 207 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLP 254
+ + +E L P R +AS L +F K A + +LP
Sbjct: 276 NRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIK--------F 53
RE+ + R+L H N+++L GL R + Y++ EY + D+ L K
Sbjct: 57 RELDMFRKLSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
S Q Q+ G++H + +HRD+ N LV+++ +K++ L+
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
L + ++ L + PE + D+ D+WS G + E+
Sbjct: 175 LRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 117
Y Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
+ W P + Y D+WS G + E+
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 1/71 (1%)
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
R T+ V T YR PE++LG + S D+WS+GC+ EL GK + +E LH +
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
Query: 171 FKLCGSPPDDY 181
K G P ++
Sbjct: 358 EKTLGRLPSEW 368
|
Length = 467 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 36/175 (20%), Positives = 73/175 (41%), Gaps = 30/175 (17%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------------- 40
E +L++++HP++IKL G + + L+ EY ++
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110
Query: 41 DITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 99
+ L PD + + + + Q+ G+++ ++HRD+ N+LV +K++D
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISD 170
Query: 100 FGLAN--FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
FGL+ + + + R+ W L Y D+WS G + E++
Sbjct: 171 FGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI-------- 51
A E+ +L +L HPNII L G R +YL EY H ++ L +
Sbjct: 55 AGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 112
Query: 52 -------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104
S Q+ + + G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 113 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
Query: 105 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
++ + R+ W L + Y + D+WS G + E++
Sbjct: 173 GQEVYVKKTM-GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 34/169 (20%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLL----SCPDIKFSEAQI 58
E LI+ + +H NI++L G+ RL +++ E M D+ L P+ S
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLT-- 114
Query: 59 KCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA----- 103
M LL G ++ +HRDI N L+ +G V K+ADFG+A
Sbjct: 115 ---MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 104 -NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
++ G R L + + PPE L + D+WS G + E+
Sbjct: 172 ASYYRKGGRAMLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 9 RRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMN---Q 64
R L HPNI++ G + LVFEY E D+ LS +Q+ +
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLW 122
+ G+ H H LH D+ N + ++ +K+ D+G+ S T + V L
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLR 166
Query: 123 YRPPEL-------LLGATDYGPSVDLWSVGCVFAELL 152
+ PEL L+ A PS ++W++G EL
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPS-NVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 18/102 (17%)
Query: 68 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN----------------TGHR 111
+E+ HS+GVLHRD+K N+L+ G + + D+G A F
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 112 QPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ ++V T Y PE LLG S D++++G + ++L
Sbjct: 185 MTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI-------- 51
A E+ +L +L HPNII L G +R +Y+ EY + ++ L +
Sbjct: 50 AGELEVLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107
Query: 52 -------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104
+ Q+ + + + G+++ + +HRD+ N+LV K+ADFGL+
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
Query: 105 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
++ + R+ W L + Y D+WS G + E++
Sbjct: 168 GEEVYVKKTM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 60/253 (23%), Positives = 98/253 (38%), Gaps = 69/253 (27%)
Query: 32 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 91
Y V Y+ + L + + I+ M Q+L L+ HS G++HRD+K N++ +
Sbjct: 233 YNVEPYLLGKVQDLPKGLERE--NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 92 E-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG------------------- 131
G K+ D G A V + Y P E LL
Sbjct: 291 GSGSFKIIDLGAA-----------ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 339
Query: 132 ----ATDYGPSV---------DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
AT P + D++S G +F ++ P L+ + + Q ++ K
Sbjct: 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAF--PNLRSDSNLIQFNRQLKRN---- 393
Query: 179 DDY----WKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTA-VNLIETLLSVEPYKRAT 231
DY W+K P A+ LR F+ DL A L+++++ + +R +
Sbjct: 394 -DYDLVAWRKLVEPRAS---------PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443
Query: 232 ASAALASEYFSTK 244
A AALA YF +
Sbjct: 444 AKAALAHPYFDRE 456
|
Length = 566 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 16/96 (16%)
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH------RQPLT 115
Q+ G+ + H RGV+H+DI N +++ E +K+ D L+ F H +P+
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151
W L+ +Y + D+WS G + EL
Sbjct: 185 ------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 22/169 (13%)
Query: 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI------- 51
A E+ +L +L HPNII L G R +YL EY H ++ L +
Sbjct: 42 FAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 52 --------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
S Q+ + + G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159
Query: 104 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
++ + R+ W L + Y + D+WS G + E++
Sbjct: 160 RGQEVYVKKTM-GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 35/153 (22%), Positives = 67/153 (43%), Gaps = 12/153 (7%)
Query: 5 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN- 63
+L + LDH I++L G+ S+ LV + LL + +N
Sbjct: 60 MLAMGSLDHAYIVRLLGICPG---ASLQLVTQLSPLG--SLLDHVRQHRDSLDPQRLLNW 114
Query: 64 --QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT- 120
Q+ G+ + ++HR++ N+L+ ++ ++++ADFG+A+ ++ S T
Sbjct: 115 CVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174
Query: 121 -LWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
W +L G Y D+WS G E++
Sbjct: 175 IKWMALESILFGR--YTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 22/125 (17%)
Query: 47 SCPDIKFSEAQIKCYMN------QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 100
+ D +E+ YM+ Q+ +G+E S+ +HRD+ N+L+ ++K+ DF
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF 283
Query: 101 GLA-------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL-- 151
GLA N+ + G S + L + PE + Y D+WS G + E+
Sbjct: 284 GLARDIMRDSNYISKG------STFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFT 336
Query: 152 LIGKP 156
L G P
Sbjct: 337 LGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVV 119
Q+ G++ S+ +HRD+ N+L+ + V K+ DFGLA N SN + +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG--NARLP 277
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 155
W P + Y D+WS G + E+ +GK
Sbjct: 278 VKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGK 312
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 42/191 (21%), Positives = 80/191 (41%), Gaps = 23/191 (12%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+ RE ++++LD+P I+++ G+ + S LV E E + +E I
Sbjct: 43 LLREANVMQQLDNPYIVRMIGICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITE 99
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--------FSNTGH-R 111
++Q+ G+++ +HRD+ N+L+ + K++DFGL+ + H +
Sbjct: 100 LVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGR-TEVEQLH 168
P+ WY P + + D+WS G + E KP + EV Q+
Sbjct: 160 WPVK------WYAPE--CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211
Query: 169 KIFKLCGSPPD 179
+ + P
Sbjct: 212 ESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 33/152 (21%), Positives = 64/152 (42%), Gaps = 8/152 (5%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 62
E ++ +D+P++ +L G+ L+ ++ L+ + M + + + +
Sbjct: 59 EAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVT 120
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA + +V
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
W +L Y D+WS G EL+
Sbjct: 176 KWMALESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 16/156 (10%)
Query: 9 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH 67
R L+HPN+++ G S LV E+ D+ L ++ K + ++
Sbjct: 50 RELNHPNVLQCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC 107
Query: 68 ----GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTL 121
GL H +H D+ N + + +K+ D+GLA +T V L
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPL 166
Query: 122 WYRPPELL------LGATDYGPSVDLWSVGCVFAEL 151
+ PEL+ L D ++WS+G EL
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 529 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.65 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.65 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.63 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.62 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.61 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.48 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.4 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.39 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.71 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.57 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.23 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.2 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.19 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.14 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.85 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.82 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.63 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.43 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.11 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.79 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.73 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.15 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.84 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.26 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.26 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.07 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.82 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.86 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 92.88 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.05 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 91.54 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.07 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 90.66 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.64 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 90.01 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.78 | |
| PLN02236 | 344 | choline kinase | 89.77 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 89.34 | |
| PTZ00296 | 442 | choline kinase; Provisional | 87.64 | |
| PF13202 | 25 | EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ | 87.08 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 86.89 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 84.77 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 84.38 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 84.15 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-69 Score=555.04 Aligned_cols=276 Identities=72% Similarity=1.227 Sum_probs=268.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.|||.||++|+|||||+|.++.+++..+.+|||||||++||.+++..+..+|++.+++|||+||+.||+|||++||+||
T Consensus 163 ~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHR 242 (560)
T KOG0600|consen 163 AIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHR 242 (560)
T ss_pred HHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeec
Confidence 46999999999999999999999998778999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||.+|||||++|.+||+|||||+++.......+|.+|.|+||+|||+|+|...|+.++||||+||||.||+.|+|+|+|
T Consensus 243 DIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 243 DIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred cccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 99999999999999999999999999988878899999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.++++|+++|+++||+|.+++|...++|+.+.|++..+|.+.+.+.++.+|..+.+|+..||++||.+|+||.++|+|+|
T Consensus 323 ~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 323 RTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred ccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCCCChhHHhhhhHHHHhhhhc
Q 009654 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 276 (529)
Q Consensus 241 f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (529)
|++.|.+|+++.+|.|++.+|+++|.+.+.++...+
T Consensus 403 F~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~ 438 (560)
T KOG0600|consen 403 FTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKG 438 (560)
T ss_pred cccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccc
Confidence 999999999999999999999999999888777653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=439.29 Aligned_cols=260 Identities=44% Similarity=0.776 Sum_probs=236.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
+|||.||.+++|||||.+.++.....-+.+|||||||++++..++..-..+|...++++++.|||.||+|||.+.|+|||
T Consensus 123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRD 202 (419)
T KOG0663|consen 123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRD 202 (419)
T ss_pred HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecc
Confidence 59999999999999999999999887889999999999999888876667999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
||++|+|+++.|.+||+|||+|+.++.. ..++|..+.|+||+|||+|++...|+.++||||+|||++||++++|.|+|.
T Consensus 203 LK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 203 LKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred cchhheeeccCCcEEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999998865 457899999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccc--cCCCCCCCcchhhhhccCC--cHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHAT--LFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~--~~~~~~~~~~~l~~~~~~~--s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+|+.+|++.+|.|.+..|.....++.. ...+..+|. .+...|..+ ++...+|+..+|.+||.+|+||.++|+
T Consensus 282 sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn-~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYN-NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCch-hhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 999999999999999999999997665533 233444443 556666655 499999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCChhHH
Q 009654 238 SEYFSTKPYACDLSSLPIYPPSKEID 263 (529)
Q Consensus 238 h~~f~~~~~~~~~~~~p~~~~~~~~~ 263 (529)
|+||...|.++++..+|.+|...+.+
T Consensus 361 h~~F~e~P~p~~P~~~Pt~P~k~~~~ 386 (419)
T KOG0663|consen 361 HEYFRETPLPIDPSMFPTWPAKSEQQ 386 (419)
T ss_pred ccccccCCCCCChhhcCCCccccccc
Confidence 99999999999999999999865433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-54 Score=409.06 Aligned_cols=252 Identities=42% Similarity=0.759 Sum_probs=226.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
+|||++|+.|+|||||.|.++|-. ..++.||+|||+.++...+......|+..+++.|+.+++.||+|||++.|+|||
T Consensus 49 lREIK~Lqel~h~nIi~LiD~F~~--~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRD 126 (318)
T KOG0659|consen 49 LREIKLLQELKHPNIIELIDVFPH--KSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRD 126 (318)
T ss_pred HHHHHHHHHccCcchhhhhhhccC--CCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhccc
Confidence 699999999999999999999988 578999999999999999988999999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||.|+||+.+|.+||+|||+|+.+.... ...+..+.|.||+|||+|+|++.|+..+||||+|||++||+.|.|.|+|+
T Consensus 127 lKPnNLLis~~g~lKiADFGLAr~f~~p~-~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 127 LKPNNLLISSDGQLKIADFGLARFFGSPN-RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred CCccceEEcCCCcEEeecccchhccCCCC-cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 99999999999999999999999998654 34455589999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhcc-CCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~-~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
++.+|+..|+..+|.|.++.|+.. .+|....+.. .+. ..+...|...+.++.|||.+||.+||.+|+|+.|+|+|+|
T Consensus 206 sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~-~P~-~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 206 SDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ-FPK-PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred chHHHHHHHHHHcCCCCcccCccccccccHHHHhc-CCC-CccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 999999999999999999999884 4555444431 111 1233478889999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCCC
Q 009654 241 FSTKPYACDLSSLPIYPP 258 (529)
Q Consensus 241 f~~~~~~~~~~~~p~~~~ 258 (529)
|++.|.+++++.+|....
T Consensus 284 f~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 284 FKSLPLPTPPSKLPIPST 301 (318)
T ss_pred hhcCCCCCChhhCcCCcc
Confidence 999999888877766433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=422.20 Aligned_cols=240 Identities=40% Similarity=0.705 Sum_probs=219.6
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+|||.-|++|+ |||||+|++++.+.. ..+|+|||||++++..++..++..|+++.++.||.||+.||+|+|.+|+.||
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~-~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR 134 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDND-RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR 134 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccC-ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 58999999998 999999999998853 3999999999999999998888899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||+.....|||+|||+|+..... .++|.++.|.||+|||+|+....|+.++||||+|||++|+++-+|+|+|
T Consensus 135 DlKPENiLi~~~~~iKiaDFGLARev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 135 DLKPENILISGNDVIKIADFGLAREVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred cCChhheEecccceeEecccccccccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 99999999998889999999999987654 5899999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhc-cCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~-~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.++.+++.+|...+|.|..+.|.. ..+.....|.-.+--...+...++..+.++.+||.+||.+||.+||||.++|+||
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 999999999999999999998887 4444444454444445567788888999999999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
||...
T Consensus 293 ffq~~ 297 (538)
T KOG0661|consen 293 FFQVG 297 (538)
T ss_pred ccccc
Confidence 99864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=397.08 Aligned_cols=237 Identities=34% Similarity=0.634 Sum_probs=212.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
+|||++|++|.|||+|.|+++|.. ...+|||||||++..+..+......++++.++.|++|++.|+.|||+++++|||
T Consensus 49 lREIrmLKqLkH~NLVnLiEVFrr--krklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRD 126 (396)
T KOG0593|consen 49 LREIRMLKQLKHENLVNLIEVFRR--KRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRD 126 (396)
T ss_pred HHHHHHHHhcccchHHHHHHHHHh--cceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeeccc
Confidence 599999999999999999999976 578999999999999998877666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||||||+|+.... ....+|.++.|.||+|||++.|...|+.++||||+||++.||++|.|.|+|.
T Consensus 127 IKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 127 IKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred CChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 999999999999999999999998874 2357899999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCch---hhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 162 TEVEQLHKIFKLCGSPPDD---YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~---~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
++.+++..|.+.+|...+. .|......+... .|...-...+...++.++..+.||+.+||..||.+|++.+++|.|
T Consensus 206 SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~-lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 206 SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR-LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred chHHHHHHHHHHHcccCHHHHHHhccCCceeeee-cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 9999999999999987653 344444333332 244444566788889999999999999999999999999999999
Q ss_pred cccC
Q 009654 239 EYFS 242 (529)
Q Consensus 239 ~~f~ 242 (529)
+||.
T Consensus 285 ~yFd 288 (396)
T KOG0593|consen 285 PYFD 288 (396)
T ss_pred hHHH
Confidence 9994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=410.20 Aligned_cols=216 Identities=32% Similarity=0.494 Sum_probs=187.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|++||++|+|||||+++++|+. ..+.||||||++||.|.......+.+.+..-+.+++|||.||.|||++||+|||
T Consensus 224 ~~EieILkkL~HP~IV~~~d~f~~--~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRD 301 (475)
T KOG0615|consen 224 QNEIEILKKLSHPNIVRIKDFFEV--PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRD 301 (475)
T ss_pred HHHHHHHHhcCCCCEEEEeeeeec--CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence 589999999999999999999998 578899999999976666666777899999999999999999999999999999
Q ss_pred CCCCcEEEccC---CcEEEeccccccccCCCCCCCccccccccccCCcccccCC--CCCCCcchhhhhhHHHHHHHhCCC
Q 009654 82 IKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 82 IKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||+|||++.+ ..+||+|||+|++.+.. ..+.+.||||.|.|||++.+. ..|..++||||+|||||.+|+|.|
T Consensus 302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 302 IKPENILLSNDAEDCLLKITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred CCcceEEeccCCcceEEEecccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 99999999876 56999999999988754 567889999999999999643 345669999999999999999999
Q ss_pred CCCCCCHHH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 157 ILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 157 pf~g~~~~~-~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
||.+..... ..++|.+....+.+ ..|..+++++++||.+||.+||++|||++||
T Consensus 380 PFS~~~~~~sl~eQI~~G~y~f~p-------------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 380 PFSEEYTDPSLKEQILKGRYAFGP-------------------------LQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred CcccccCCccHHHHHhcCcccccC-------------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 998765444 67777663333322 2346799999999999999999999999999
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
|+||||+..|.
T Consensus 435 L~hpW~~~~~~ 445 (475)
T KOG0615|consen 435 LNHPWFKDAPC 445 (475)
T ss_pred hcChhhhcccc
Confidence 99999997553
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=393.81 Aligned_cols=241 Identities=38% Similarity=0.663 Sum_probs=209.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEc---cCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITS---RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~---~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.||+++|+.++|+|||.+++++.. ..-..+|+|+|+|+.++...+. ....|++..+..+++|||.||.|+|+.||+
T Consensus 69 lRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnVi 147 (359)
T KOG0660|consen 69 LRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVI 147 (359)
T ss_pred HHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhccccc
Confidence 589999999999999999999876 3356899999999888776664 344699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCC-CCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
||||||+|+|++.+..+||||||+|+..... ....+|.++.|.||+|||++.....|+.++||||+||||+|||+|+|.
T Consensus 148 HRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkpl 227 (359)
T KOG0660|consen 148 HRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPL 227 (359)
T ss_pred ccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCC
Confidence 9999999999999999999999999977532 234568999999999999999989999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCcccc------CCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL------FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~------~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
|+|.+..+|+..|...+|.|+++.+....-..+.. ..+.. .+...|+..++.++|||++||.+||.+|+|
T Consensus 228 FpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~----~f~~~fp~a~p~AidLlekmL~fdP~kRit 303 (359)
T KOG0660|consen 228 FPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQ----PFSSIFPNANPLAIDLLEKMLVFDPKKRIT 303 (359)
T ss_pred CCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCC----CHHHHcCCCCHHHHHHHHHHhccCccccCC
Confidence 99999999999999999999988766644211111 12222 346788999999999999999999999999
Q ss_pred HHHHHhccccCCCCCC
Q 009654 232 ASAALASEYFSTKPYA 247 (529)
Q Consensus 232 a~e~L~h~~f~~~~~~ 247 (529)
++|||+|||+.....+
T Consensus 304 a~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 304 AEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHhcChhhhhhcCC
Confidence 9999999999865443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=408.80 Aligned_cols=211 Identities=31% Similarity=0.481 Sum_probs=192.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+||+|.++|+|||||+++++|+| .+++|||+|+|..+.+..+....+.|+|.+++.|++||+.||.|||+++|+||
T Consensus 65 v~~EIeIHr~L~HpnIV~f~~~FED--s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHR 142 (592)
T KOG0575|consen 65 VLNEIEIHRSLKHPNIVQFYHFFED--SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHR 142 (592)
T ss_pred HHHHHHHHHhcCCCcEEeeeeEeec--CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceec
Confidence 3689999999999999999999999 68999999999998888877788899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||..||||+.+.+|||+|||||+....+. ....+.||||.|+|||++.+ ..++..+||||+|||||.||+|+|||+.
T Consensus 143 DLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 143 DLKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ccchhheeecCcCcEEecccceeeeecCcc-cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 999999999999999999999999887543 23456799999999999985 5699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+.+|...-...| ..++.++++||.+||..||.+|||++++|.|+|
T Consensus 221 k~vkety~~Ik~~~Y~~P-----------------------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 221 KTVKETYNKIKLNEYSMP-----------------------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred chHHHHHHHHHhcCcccc-----------------------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 999999999977433322 368999999999999999999999999999999
Q ss_pred cCCC
Q 009654 241 FSTK 244 (529)
Q Consensus 241 f~~~ 244 (529)
|+..
T Consensus 272 f~~g 275 (592)
T KOG0575|consen 272 FKSG 275 (592)
T ss_pred hhCC
Confidence 9654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=368.91 Aligned_cols=244 Identities=31% Similarity=0.458 Sum_probs=203.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.||+.|.+.|+|||||+|++.+.+ ....|||||+|+|+.+-.-+.....++|..+.++++|||++|.|||.+|||||
T Consensus 57 l~rEarIC~~LqHP~IvrL~~ti~~--~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHR 134 (355)
T KOG0033|consen 57 LEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHR 134 (355)
T ss_pred HHHHHHHHHhcCCCcEeehhhhhcc--cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceec
Confidence 4689999999999999999999887 57899999999996554333344678999999999999999999999999999
Q ss_pred CCCCCcEEEccC---CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 81 DIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 81 DIKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|+||.|+|+-.. ..+||+|||+|...+.+ .....++|||.|||||++.. ..|+..+|||++|||||.||.|.+|
T Consensus 135 DvkP~nllLASK~~~A~vKL~~FGvAi~l~~g--~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 135 DLKPENLLLASKAKGAAVKLADFGLAIEVNDG--EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred cCChhheeeeeccCCCceeecccceEEEeCCc--cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCC
Confidence 999999999643 45999999999887733 46678899999999999976 5699999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.|.+...+++.|++.....+..+ |+.+++++++||++||..||.+|+|+.|+|+
T Consensus 212 F~~~~~~rlye~I~~g~yd~~~~~-------------------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 212 FWDEDQHRLYEQIKAGAYDYPSPE-------------------------WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCccHHHHHHHHhccccCCCCcc-------------------------cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 999999999999988554444333 4689999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCChhHHhhhhHHHHhhhhcCcc
Q 009654 238 SEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRV 279 (529)
Q Consensus 238 h~~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (529)
|||+.+...... ...-...++...+.+++|+.++..+
T Consensus 267 HpWi~~r~~~As-----~~H~~dtvd~lrkfNarRKLKgavL 303 (355)
T KOG0033|consen 267 HPWICNRERVAS-----AIHRQDTVDCLKKFNARRKLKGAIL 303 (355)
T ss_pred CchhcchHHHHH-----HhhhHHHHHHHHHhhHHHHHHHHHH
Confidence 999986432211 2233445677777777777654433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=378.52 Aligned_cols=244 Identities=42% Similarity=0.760 Sum_probs=212.1
Q ss_pred HHHHHHHHhCCCCC-ccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPN-IIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~Hpn-Ivkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~---~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.|||.+|+.|+|+| ||+|++++.... ...+||||||++.++..++.... ..++...++.+|+||+.||+|||
T Consensus 58 iREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H 137 (323)
T KOG0594|consen 58 IREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH 137 (323)
T ss_pred hHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 69999999999999 999999998742 13899999999999888765444 46888999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
++||+||||||.||||++.|.+||+|||+|+.+.-+. ..++..++|.||+|||+|++...|+..+||||+|||++||++
T Consensus 138 ~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~ 216 (323)
T KOG0594|consen 138 SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT 216 (323)
T ss_pred hCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence 9999999999999999999999999999999776432 347788999999999999999899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+++.|+|.++.+++..|++.+|.|.++.|+... ++......+...-...+...++..++++.+|+.+||+++|.+|+||
T Consensus 217 ~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa 296 (323)
T KOG0594|consen 217 RRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA 296 (323)
T ss_pred CCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH
Confidence 999999999999999999999999999998854 3333222222222445667777888899999999999999999999
Q ss_pred HHHHhccccCCCCC
Q 009654 233 SAALASEYFSTKPY 246 (529)
Q Consensus 233 ~e~L~h~~f~~~~~ 246 (529)
..+|.||||...+.
T Consensus 297 ~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 297 KGALTHPYFSELPE 310 (323)
T ss_pred HHHhcChhhccccc
Confidence 99999999987543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=378.53 Aligned_cols=239 Identities=40% Similarity=0.675 Sum_probs=203.6
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCC---eEEEEEeccCCCchhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSC---SIYLVFEYMEHDITGLLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~---~~~lV~E~~~g~ll~~~~~---~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
+|++||+.++|||||+|.-+|....+. +..+|||||+.++...+.. .+.+++.-.++-|++||++||.|||+.|
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~ 145 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG 145 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC
Confidence 799999999999999999888775544 4568999999988876652 4568999999999999999999999999
Q ss_pred CcccCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 77 VLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 77 IvHrDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|+||||||.|||+|.+ |.+||||||.|+....+. +..++..|..|+|||+++|++.|+.++||||+|||++||+-|+
T Consensus 146 IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~ 223 (364)
T KOG0658|consen 146 ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ 223 (364)
T ss_pred cccCCCChheEEEcCCCCeEEeccCCcceeeccCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC
Confidence 9999999999999987 999999999999887653 4577888999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhh-hhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR-ETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~-~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
|.|+|++..+|+..|.+.+|.|..+.....+......-.|+.. ...+. -....+++++.+|+.++|.++|.+|.++.+
T Consensus 224 plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik-~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~ 302 (364)
T KOG0658|consen 224 PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIK-AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE 302 (364)
T ss_pred cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccc-cccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence 9999999999999999999999987665544322111111111 11111 244678999999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|.||||...
T Consensus 303 ~l~h~fFdel 312 (364)
T KOG0658|consen 303 ALAHPFFDEL 312 (364)
T ss_pred HhcchhhHHh
Confidence 9999999764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.82 Aligned_cols=214 Identities=32% Similarity=0.490 Sum_probs=193.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.||+++ .||||++|.++|++ +..+|+|||+|+.|.+.+++.....++|.+.+.+|+||++|++|||.++||||
T Consensus 70 ~~Ev~ILRqv~GHP~II~l~D~yes--~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHR 147 (411)
T KOG0599|consen 70 RQEISILRQVMGHPYIIDLQDVYES--DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHR 147 (411)
T ss_pred HHHHHHHHHhcCCCcEEEeeeeccC--cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 4799999999 79999999999998 67899999999988777777777889999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc-----CCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||+|||++++.++||+|||+++.+.++ ..+...||||+|+|||.+. +...|+..+|+||+|||+|.||.|.
T Consensus 148 DLKpENILlddn~~i~isDFGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 148 DLKPENILLDDNMNIKISDFGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred ccChhheeeccccceEEeccceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999988776 4678899999999999985 3456999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|||.-+...-.+..|+..-..+. .+.|.+++.+++|||.+||++||.+|+|+.|+
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~-------------------------speWadis~~~KdLIsrlLqVdp~~Ritake~ 280 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFR-------------------------SPEWADISATVKDLISRLLQVDPTKRITAKEA 280 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccC-------------------------CcchhhccccHHHHHHHHHeeCchhcccHHHH
Confidence 99999999999999988544433 34457899999999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|.||||...
T Consensus 281 LaHpff~q~ 289 (411)
T KOG0599|consen 281 LAHPFFIQI 289 (411)
T ss_pred hcChHHHHH
Confidence 999999653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=387.95 Aligned_cols=216 Identities=27% Similarity=0.459 Sum_probs=195.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+||-||+.|.||||+.||+++++ ...+|+|+||++||-+..++...++|++.++++|++||+.||.|||..+|+||
T Consensus 59 IerEIviMkLi~HpnVl~LydVwe~--~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHR 136 (786)
T KOG0588|consen 59 IEREIVIMKLIEHPNVLRLYDVWEN--KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHR 136 (786)
T ss_pred hhhhhHHHHHhcCCCeeeeeeeecc--CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceec
Confidence 4689999999999999999999988 67999999999998777777788899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|+||+..+.|||+|||+|....++ ..+.+.||+|.|.+||++.|..+.+.++||||||||||.||+|+.||++
T Consensus 137 DLKpENlLLd~~~nIKIADFGMAsLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 137 DLKPENLLLDVKNNIKIADFGMASLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred cCCchhhhhhcccCEeeeccceeecccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877655 3567789999999999999988779999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
++-..++.++... .+ ++...+|.++.+||.+||.+||.+|+|.+++++|||
T Consensus 215 dNir~LLlKV~~G--~f---------------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 215 DNIRVLLLKVQRG--VF---------------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ccHHHHHHHHHcC--cc---------------------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 9999999998773 32 222579999999999999999999999999999999
Q ss_pred cCCCCCCCC
Q 009654 241 FSTKPYACD 249 (529)
Q Consensus 241 f~~~~~~~~ 249 (529)
+.....+..
T Consensus 266 l~g~~~~~~ 274 (786)
T KOG0588|consen 266 LSGYTSLPS 274 (786)
T ss_pred hhcCCCCCh
Confidence 987554433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=364.08 Aligned_cols=211 Identities=29% Similarity=0.422 Sum_probs=185.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvH 79 (529)
+.||++||+.++|||||++|+.|.+... .++|+||||+++.|+.+....++++|.....++.+|+.||.|||. ++|+|
T Consensus 124 i~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIH 202 (364)
T KOG0581|consen 124 ILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIH 202 (364)
T ss_pred HHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeee
Confidence 3699999999999999999999999533 699999999999999888777899999999999999999999995 99999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||||+..|.|||||||.+...... ...+.+||..|||||.+.+ ..|+.++||||||+.++||++|+.||.
T Consensus 203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred ccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCC
Confidence 999999999999999999999999876553 5578899999999999988 469999999999999999999999998
Q ss_pred CC-----CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhcc-CCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 160 GR-----TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 160 g~-----~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~-~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
.. ...+++..|.. +.|| . + .. .+|+++++||..||..||.+|+|+.
T Consensus 279 ~~~~~~~~~~~Ll~~Iv~--~ppP-~------l-------------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~ 330 (364)
T KOG0581|consen 279 PPNPPYLDIFELLCAIVD--EPPP-R------L-------------------PEGEFSPEFRSFVSCCLRKDPSERPSAK 330 (364)
T ss_pred CcCCCCCCHHHHHHHHhc--CCCC-C------C-------------------CcccCCHHHHHHHHHHhcCCcccCCCHH
Confidence 74 45566666643 3332 1 0 01 4899999999999999999999999
Q ss_pred HHHhccccCCC
Q 009654 234 AALASEYFSTK 244 (529)
Q Consensus 234 e~L~h~~f~~~ 244 (529)
++|+|||++..
T Consensus 331 qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 331 QLLQHPFIKKF 341 (364)
T ss_pred HHhcCHHHhhc
Confidence 99999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=347.57 Aligned_cols=245 Identities=42% Similarity=0.784 Sum_probs=208.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
+|||.||..|.|+||+.|+++|.... ..++||||++|++++.+++.....+|+..+++.+|++|+.||.|+|..
T Consensus 64 lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~ 143 (376)
T KOG0669|consen 64 LREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN 143 (376)
T ss_pred HHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh
Confidence 58999999999999999999875422 346999999999999999999989999999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCC---CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
.|+|||+|+.|+||+.+|.+||+|||+++.+.... ...++.++.|+||++||+++|.+.|+++.|||..|||+.||+
T Consensus 144 kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw 223 (376)
T KOG0669|consen 144 KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW 223 (376)
T ss_pred hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence 99999999999999999999999999997765322 234778899999999999999999999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC-CCccccC--C--CCCCCcchhhhhcc--CCcHHHHHHHHHhccCC
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLF--K--PQQPYDSSLRETFK--DLPTTAVNLIETLLSVE 225 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~~--~--~~~~~~~~l~~~~~--~~s~~~~dLi~~mL~~d 225 (529)
++.|.|.|+++..+++.|..+||+...+.|+... +|-.... . +...+. .+....+ --++++.|||++||.+|
T Consensus 224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~r-kv~n~~kp~~kd~~a~dLle~ll~~D 302 (376)
T KOG0669|consen 224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKR-KVKNRLKPYVKDDEALDLLEKLLKLD 302 (376)
T ss_pred ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhh-hhhhhcccccCChhHHHHHHHHhccC
Confidence 9999999999999999999999999999998743 3321111 1 111111 1112222 12568999999999999
Q ss_pred CCCCcCHHHHHhccccCCCCCC
Q 009654 226 PYKRATASAALASEYFSTKPYA 247 (529)
Q Consensus 226 P~kR~ta~e~L~h~~f~~~~~~ 247 (529)
|.+|++++++|+|.||...|.+
T Consensus 303 P~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 303 PTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccCcchHhhhchhhhhcCCcc
Confidence 9999999999999999987764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=373.21 Aligned_cols=209 Identities=35% Similarity=0.561 Sum_probs=184.9
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.|||.+|+++. ||||+++++++.. ...+|||||||.| +++..+.. .+++.|.+++.+|+||++||+|||++||+|
T Consensus 67 ~rEi~~~~~~~~HpnI~~l~ev~~t--~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~H 143 (370)
T KOG0583|consen 67 KREISILRRLRSHPNIIRLLEVFAT--PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVH 143 (370)
T ss_pred HHHHHHHHHhccCCCEeEEEEEEec--CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEee
Confidence 48999999998 9999999999998 4569999999998 55555554 889999999999999999999999999999
Q ss_pred cCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCC-CCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+|||++.+ +.+||+|||++.... .....+.+.|||+.|+|||++.+.. +-+.++||||||||||.|++|+.|
T Consensus 144 RDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 144 RDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred CCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 9999999999999 999999999998774 2234677889999999999998866 446899999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCC-cHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~-s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
|...+....+.+|.+..-..| ..+ ++++++||.+||..||.+|+|+.+++
T Consensus 223 F~d~~~~~l~~ki~~~~~~~p-----------------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 223 FDDSNVPNLYRKIRKGEFKIP-----------------------------SYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCccHHHHHHHHhcCCccCC-----------------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 999998888888766322211 234 89999999999999999999999999
Q ss_pred hccccCC
Q 009654 237 ASEYFST 243 (529)
Q Consensus 237 ~h~~f~~ 243 (529)
.||||+.
T Consensus 274 ~h~w~~~ 280 (370)
T KOG0583|consen 274 EHPWFQK 280 (370)
T ss_pred hChhhcc
Confidence 9999997
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.59 Aligned_cols=239 Identities=40% Similarity=0.715 Sum_probs=213.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.|||-+|+.|.|.|||+++++..+ ...+-+|||||..++..++..-++.++.+.++.+|.|++.||.+||+++++|||
T Consensus 49 lreicllkelkhknivrl~dvlhs--dkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrd 126 (292)
T KOG0662|consen 49 LREICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRD 126 (292)
T ss_pred HHHHHHHHHhhhcceeehhhhhcc--CceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhcc
Confidence 589999999999999999999877 568999999999999888888888999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~g 160 (529)
|||.|+||+.+|.+|++|||+++.++-.. ..+...+.|.||++|.+++|..-|+.+.|+||.|||++|+.. |+|.|+|
T Consensus 127 lkpqnllin~ngelkladfglarafgipv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 127 LKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred CCcceEEeccCCcEEecccchhhhcCCce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 99999999999999999999999887542 234455789999999999999999999999999999999985 8999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+++.+|+..+|.|.++.|+...-...-..-|.-+....+....+.+....+||+.++|.-+|.+|++|+++|+|||
T Consensus 206 ~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy 285 (292)
T KOG0662|consen 206 NDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY 285 (292)
T ss_pred CcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence 99999999999999999999998854333333334444445677888899999999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|..
T Consensus 286 f~d 288 (292)
T KOG0662|consen 286 FSD 288 (292)
T ss_pred ccc
Confidence 975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.47 Aligned_cols=245 Identities=40% Similarity=0.738 Sum_probs=204.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.|||.+++.|+|||||.|..+|... ...++|++||.+++++..+.. ....++...++.++.|||.|+.|||++-|
T Consensus 75 cREiaL~REl~h~nvi~Lv~Vfl~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWv 153 (438)
T KOG0666|consen 75 CREIALLRELKHPNVISLVKVFLSH-DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWV 153 (438)
T ss_pred HHHHHHHHHhcCCcchhHHHHHhcc-CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhhe
Confidence 4899999999999999999999875 578999999999999987652 23468899999999999999999999999
Q ss_pred cccCCCCCcEEEccC----CcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 78 LHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 78 vHrDIKp~NILl~~~----g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
+||||||.||||..+ |.|||+|||+++.+...-.. .....+.|.||+|||+|+|+..|++++||||+|||++||
T Consensus 154 lHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl 233 (438)
T KOG0666|consen 154 LHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL 233 (438)
T ss_pred eeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence 999999999999877 89999999999988754322 223567899999999999999999999999999999999
Q ss_pred HhCCCCCCCCC---------HHHHHHHHHHHcCCCCchhhhcc-CCCcc-ccCC--CCCCCcc----hhhhhccCCcHHH
Q 009654 152 LIGKPILQGRT---------EVEQLHKIFKLCGSPPDDYWKKS-KLPHA-TLFK--PQQPYDS----SLRETFKDLPTTA 214 (529)
Q Consensus 152 ltG~~pf~g~~---------~~~~~~~I~~~~g~p~~~~~~~~-~l~~~-~~~~--~~~~~~~----~l~~~~~~~s~~~ 214 (529)
|+-.|+|.|.. ..+++.+|++++|.|.+..|... ++|+. .... +...|.. .+...++.-++.+
T Consensus 234 Ltl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a 313 (438)
T KOG0666|consen 234 LTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSA 313 (438)
T ss_pred HccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchH
Confidence 99999998863 35789999999999999999874 34433 1111 0011222 1234445567779
Q ss_pred HHHHHHhccCCCCCCcCHHHHHhccccCCCCCC
Q 009654 215 VNLIETLLSVEPYKRATASAALASEYFSTKPYA 247 (529)
Q Consensus 215 ~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~~ 247 (529)
.+||.+||.+||.+|+|++++|+|+||+..+.+
T Consensus 314 ~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 314 LDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 999999999999999999999999999987543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=367.97 Aligned_cols=214 Identities=33% Similarity=0.517 Sum_probs=191.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|=.+|.+| .||.||+||-.|+| ...+|+|+||+++|.+..++.+-+.|++..++.|+.||+.||+|||++|||||
T Consensus 121 ~~Ek~~l~~L~~hPgivkLy~TFQD--~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHR 198 (604)
T KOG0592|consen 121 TREKEALTQLSGHPGIVKLYFTFQD--EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHR 198 (604)
T ss_pred hHHHHHHHHhhCCCCeEEEEEEeec--ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceec
Confidence 4688899999 89999999999999 57899999999987766667777899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC------------CccccccccccCCcccccCCCCCCCcchhhhhhHHH
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 148 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~------------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il 148 (529)
||||+||||+.+|.+||+|||.|+.+.+.... ...+.|||..|.+||+|.. ...++.+|||+|||||
T Consensus 199 DlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCil 277 (604)
T KOG0592|consen 199 DLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCIL 277 (604)
T ss_pred cCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHH
Confidence 99999999999999999999999887543211 1145799999999999976 4689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 149 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 149 ~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
|.|+.|.|||.+.++--.+++|+++-..++ +.+|+.++|||+++|..||.+
T Consensus 278 yQmlaG~PPFra~NeyliFqkI~~l~y~fp-----------------------------~~fp~~a~dLv~KLLv~dp~~ 328 (604)
T KOG0592|consen 278 YQMLAGQPPFRAANEYLIFQKIQALDYEFP-----------------------------EGFPEDARDLIKKLLVRDPSD 328 (604)
T ss_pred HHHhcCCCCCccccHHHHHHHHHHhcccCC-----------------------------CCCCHHHHHHHHHHHccCccc
Confidence 999999999999999999999999766554 467899999999999999999
Q ss_pred CcCHHHHHhccccCCCCCC
Q 009654 229 RATASAALASEYFSTKPYA 247 (529)
Q Consensus 229 R~ta~e~L~h~~f~~~~~~ 247 (529)
|+|+.++-+||||....|.
T Consensus 329 Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 329 RLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred cccHHHHhhCcccccCChh
Confidence 9999999999999887664
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.27 Aligned_cols=214 Identities=29% Similarity=0.458 Sum_probs=190.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
..|..||.+++||.||+++-.|++ ...+|||+||+.||.|...+.+.+.|+|..++.|+..|+.||.|||++||||||
T Consensus 73 ~~Er~IL~~v~hPFiv~l~ysFQt--~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRD 150 (357)
T KOG0598|consen 73 KAERNILSKIKHPFIVKLIYSFQT--EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRD 150 (357)
T ss_pred HHHHHHHHhCCCCcEeeeEEeccc--CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 579999999999999999999998 679999999999998888888888999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||||.+|.++|+|||+|+...... ....+.|||+.|||||++.+. .|+.++|.|||||++|+||+|.|||.+.
T Consensus 151 lKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 151 LKPENILLDEQGHIKLTDFGLCKEDLKDG-DATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred CCHHHeeecCCCcEEEeccccchhcccCC-CccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 99999999999999999999998554332 234567999999999999885 6999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc----CHHHHHh
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAALA 237 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~----ta~e~L~ 237 (529)
+....+.+|.+.-...++ .-++.++++||.++|..||++|. .+.++-+
T Consensus 229 ~~~~~~~~I~~~k~~~~p----------------------------~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 229 DVKKMYDKILKGKLPLPP----------------------------GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred cHHHHHHHHhcCcCCCCC----------------------------ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 999999999773211111 23788999999999999999995 7999999
Q ss_pred ccccCCCCCC
Q 009654 238 SEYFSTKPYA 247 (529)
Q Consensus 238 h~~f~~~~~~ 247 (529)
||||....|.
T Consensus 281 HpfF~~inW~ 290 (357)
T KOG0598|consen 281 HPFFKGINWE 290 (357)
T ss_pred CcccccCCHH
Confidence 9999987663
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=360.37 Aligned_cols=215 Identities=33% Similarity=0.509 Sum_probs=187.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~-l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+||.||++|+|||||+|+++..+...+.+|||+|||..+-+...- .++. |++.+++.|+++++.||+|||.+||+||
T Consensus 156 ~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR 234 (576)
T KOG0585|consen 156 RREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHR 234 (576)
T ss_pred HHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 5899999999999999999999999899999999999987665543 3445 9999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCC----CCCccccccccccCCcccccCC---CCCCCcchhhhhhHHHHHHHh
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGH----RQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~---~~y~~~~DIWSlG~il~ellt 153 (529)
||||+|+||+.+|.+||+|||.+..+..+. ...+...+|||.|+|||++.+. ...+.+.||||+||+||.|+.
T Consensus 235 DIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf 314 (576)
T KOG0585|consen 235 DIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF 314 (576)
T ss_pred ccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh
Confidence 999999999999999999999998763221 1233447999999999999772 345789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
|+.||.++...+.+.+|...--.+| ..+++.+.++|||.+||+.||++|+++.
T Consensus 315 G~~PF~~~~~~~l~~KIvn~pL~fP---------------------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~ 367 (576)
T KOG0585|consen 315 GQLPFFDDFELELFDKIVNDPLEFP---------------------------ENPEINEDLKDLIKRLLEKDPEQRITLP 367 (576)
T ss_pred ccCCcccchHHHHHHHHhcCcccCC---------------------------CcccccHHHHHHHHHHhhcChhheeehh
Confidence 9999999999999999977432222 1246788999999999999999999999
Q ss_pred HHHhccccCCC
Q 009654 234 AALASEYFSTK 244 (529)
Q Consensus 234 e~L~h~~f~~~ 244 (529)
++..|||.+..
T Consensus 368 ~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 368 DIKLHPWVTRD 378 (576)
T ss_pred hheecceeccC
Confidence 99999999764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=348.87 Aligned_cols=236 Identities=40% Similarity=0.738 Sum_probs=197.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+||||+++++...+......+++..+..++.||+.||+|||++||+|||
T Consensus 51 ~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~d 128 (288)
T cd07871 51 IREVSLLKNLKHANIVTLHDIIHT--ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128 (288)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 589999999999999999999987 568999999999987776665555789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...|+.++||||+||++|+|++|++||.+.
T Consensus 129 lkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 129 LKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred CCHHHEEECCCCCEEECcCcceeeccCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997654321 22345578999999999987667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCcc--ccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~--~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+..+.+..+....+.++.+.|........ ....+... ...+......++.++++||.+||++||.+|||+.++|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 208 TVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR-AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred CHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccC-CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 99999999999999999988876332110 00111111 1112233457889999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 287 ~f 288 (288)
T cd07871 287 YF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=337.83 Aligned_cols=211 Identities=26% Similarity=0.423 Sum_probs=190.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|..||+.+.||.|++|++.|.+ ...+||||||++|+.+..+..+.++|++..++.|+.||+.||+|||+++|++||
T Consensus 92 ~nEk~vL~~v~~PFlv~l~~t~~d--~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRD 169 (355)
T KOG0616|consen 92 HNEKRVLKAVSHPFLVKLYGTFKD--NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRD 169 (355)
T ss_pred hhHHHHHhhccCceeEEEEEeecc--CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeecc
Confidence 479999999999999999999888 689999999999988887777888999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||||.+|.+||+|||+|+..... ..+.||||.|+|||++.. +.|+.++|.|||||++|||++|.|||.+.
T Consensus 170 LKPENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 170 LKPENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred CChHHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 9999999999999999999999876542 457799999999999987 57999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+....+++|.+.--.+| ..+++++++||.++|++|-.+|. -..++.
T Consensus 245 ~~~~iY~KI~~~~v~fP-----------------------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk 295 (355)
T KOG0616|consen 245 NPIQIYEKILEGKVKFP-----------------------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIK 295 (355)
T ss_pred ChHHHHHHHHhCcccCC-----------------------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccc
Confidence 99999999987433322 35788999999999999999993 467899
Q ss_pred hccccCCCCCCC
Q 009654 237 ASEYFSTKPYAC 248 (529)
Q Consensus 237 ~h~~f~~~~~~~ 248 (529)
.||||+...|..
T Consensus 296 ~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 296 NHPWFKGVDWEA 307 (355)
T ss_pred cCcccccccHHH
Confidence 999999877753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=363.11 Aligned_cols=212 Identities=29% Similarity=0.527 Sum_probs=187.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+||.+|+.++|||||++++.|.. .+.+|+|||||+|+.|.++.. ...++|.+++++++.+|.||+|||.+||+||
T Consensus 317 ilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWVVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHr 393 (550)
T KOG0578|consen 317 LLNEILVMRDLHHPNIVNFLDSYLV--GDELWVVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHR 393 (550)
T ss_pred hHHHHHHHHhccchHHHHHHHHhcc--cceeEEEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeee
Confidence 4689999999999999999999887 478999999999988877764 3469999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||.+|||+..+|.+||+|||+|..+..... .-.+.+|||+|||||++.. ..|++++||||||++++||+-|.|||-.
T Consensus 394 DIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 394 DIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred ccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC
Confidence 9999999999999999999999988776542 4456799999999999976 5699999999999999999999999998
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+....+..|.. .|.|.-. ....+|+.++|||.+||+.|+.+|++|.|+|+|||
T Consensus 472 E~PlrAlyLIa~-ng~P~lk-------------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 472 ENPLRALYLIAT-NGTPKLK-------------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred CChHHHHHHHhh-cCCCCcC-------------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 888888877755 3544321 12468999999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|+.
T Consensus 526 l~~ 528 (550)
T KOG0578|consen 526 LKM 528 (550)
T ss_pred hhh
Confidence 954
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=354.49 Aligned_cols=227 Identities=32% Similarity=0.492 Sum_probs=191.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
..|=.||...++|+||+||..|++ ..++||||||++||.+..++.....|++..++.|+.+++.||+.+|+.|++|||
T Consensus 189 ~aERdiL~~~ds~~vVKLyYsFQD--~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRD 266 (550)
T KOG0605|consen 189 RAERDILAEVDSPWVVKLYYSFQD--KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRD 266 (550)
T ss_pred HHHHHHhhhcCCCcEEEEEEEecC--CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCccccc
Confidence 357788888999999999999999 689999999999977776666777999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCC----------------------CCC------------------------CCcc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNT----------------------GHR------------------------QPLT 115 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~----------------------~~~------------------------~~~~ 115 (529)
|||+|+|||..|.+||+|||||+-+.. ... ....
T Consensus 267 IKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 267 IKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred CChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 999999999999999999999843211 000 0123
Q ss_pred ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc-CCCccccCC
Q 009654 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFK 194 (529)
Q Consensus 116 ~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~-~l~~~~~~~ 194 (529)
+.+|||.|+|||+|.+. .|+..||.||||||+||||.|.|||.+.+..+.+.+|.. |... ..|.
T Consensus 347 StVGTPDYiAPEVll~k-gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP~----- 411 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLGK-GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFPE----- 411 (550)
T ss_pred cccCCccccchHHHhcC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCCC-----
Confidence 56899999999999984 599999999999999999999999999999999999977 2210 1111
Q ss_pred CCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC---HHHHHhccccCCCCCCCCCCCCCCCCC
Q 009654 195 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 258 (529)
Q Consensus 195 ~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t---a~e~L~h~~f~~~~~~~~~~~~p~~~~ 258 (529)
-..++++++|||.+||+ ||++|+- +.||-+||||+...|..--...|.+.|
T Consensus 412 ------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 412 ------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred ------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence 12567999999999999 9999974 999999999999988765555555555
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=346.22 Aligned_cols=213 Identities=31% Similarity=0.484 Sum_probs=185.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
..||+||+.|+|||||.|++++.+ .+.+|||||||.||.|..++...+.++|..++.+|.||+.||++||+++|+|||
T Consensus 57 ~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRD 134 (429)
T KOG0595|consen 57 LSEIKILKELKHPNIVRLLDCIED--DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRD 134 (429)
T ss_pred HHHHHHHHhcCCcceeeEEEEEec--CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 579999999999999999999988 679999999999988887777788999999999999999999999999999999
Q ss_pred CCCCcEEEccC------CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 82 IKGSNLLVNNE------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 82 IKp~NILl~~~------g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|||.||||+.. -.+||+|||+|+...++ ....+.||+|.|||||++.. ..|+.++|+||+|+|||+|++|+
T Consensus 135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~--~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQPG--SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred CCcceEEeccCCCCCCCceEEecccchhhhCCch--hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCC
Confidence 99999999875 35899999999998765 34567899999999999964 57999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||...+..+.+..|.+.....+. ....++....+|+..+|..+|.+|.+..+-
T Consensus 212 ~Pf~a~t~~eL~~~~~k~~~~~~~--------------------------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 212 PPFDAETPKELLLYIKKGNEIVPV--------------------------LPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred CCccccCHHHHHHHHhccccccCc--------------------------hhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 999999999999877552221110 012356667799999999999999999999
Q ss_pred HhccccCCCC
Q 009654 236 LASEYFSTKP 245 (529)
Q Consensus 236 L~h~~f~~~~ 245 (529)
+.|++....|
T Consensus 266 ~~~~~l~~~p 275 (429)
T KOG0595|consen 266 FDHPFLAANP 275 (429)
T ss_pred hhhhhcccCc
Confidence 9999987654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=344.46 Aligned_cols=241 Identities=38% Similarity=0.666 Sum_probs=194.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ...+|+|||||.++++..+......+++..++.++.||+.||+|||++||+|||
T Consensus 51 ~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~d 128 (303)
T cd07869 51 IREASLLKGLKHANIVLLHDIIHT--KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRD 128 (303)
T ss_pred HHHHHHHhhCCCCCcCeEEEEEec--CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999987 568999999999988887766666799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.
T Consensus 129 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 129 LKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543321 23345678999999999987667899999999999999999999999885
Q ss_pred C-HHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCcchhhhhcc--CCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 162 T-EVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 162 ~-~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~--~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
. ..+.+..+....+.+....|..... +......-.......+...+. .++..+.+||.+||+.||.+|||+.++|+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 208 KDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 4 4567778888888887777765321 110000000001122222222 35678999999999999999999999999
Q ss_pred ccccCCCC
Q 009654 238 SEYFSTKP 245 (529)
Q Consensus 238 h~~f~~~~ 245 (529)
||||+..+
T Consensus 288 h~~f~~~~ 295 (303)
T cd07869 288 HEYFSDLP 295 (303)
T ss_pred CcccccCC
Confidence 99998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=340.30 Aligned_cols=236 Identities=37% Similarity=0.635 Sum_probs=193.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. ...+|+||||++++++..+......+++..++.++.||+.||.|||+.||+|||
T Consensus 48 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~d 125 (287)
T cd07848 48 LRELKMLRTLKQENIVELKEAFRR--RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRD 125 (287)
T ss_pred HHHHHHHHhCCCccccchhhhEec--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999987 578999999999998887765566799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++...............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.
T Consensus 126 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred CCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654333334456789999999999774 5899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCC---CccccCCCCCCCc-chhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKL---PHATLFKPQQPYD-SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l---~~~~~~~~~~~~~-~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
+..+.+..+....+..+...+..... .+...+ +..... .........+|.++++||.+||++||++|||+.++|+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 205 SEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF-PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc-CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 98888888888888776554432110 000000 000000 1112223457899999999999999999999999999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 284 hp~f 287 (287)
T cd07848 284 HPAF 287 (287)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.53 Aligned_cols=214 Identities=36% Similarity=0.530 Sum_probs=187.7
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+||.||++|. |||||.++++|++ ...+|||||+|.|+.+...+... .++|..+..+++||+.++.|||+.||+||
T Consensus 83 ~~Ev~il~~l~~hpniv~l~~~~e~--~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHr 159 (382)
T KOG0032|consen 83 RREVAILQQLSGHPNIVQLKDAFED--PDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHR 159 (382)
T ss_pred HHHHHHHHhccCCCCEEEEEEEEEc--CCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceec
Confidence 58999999997 9999999999999 56999999999986555444333 49999999999999999999999999999
Q ss_pred CCCCCcEEEccC----CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~----g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+|||+... +.+|++|||++..... ...+...+||+.|+|||++.. ..|+..+||||+|||+|.|++|.+
T Consensus 160 DlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 160 DLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred cCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCC
Confidence 999999999643 4799999999998876 346778899999999999975 569999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.++.+...+|...-..++ .+.|+.++..+++||.+||..||.+|+|+.++|
T Consensus 237 PF~~~~~~~~~~~i~~~~~~f~-------------------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 237 PFWGETEFEIFLAILRGDFDFT-------------------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred CCcCCChhHHHHHHHcCCCCCC-------------------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 9999999999888866433333 344578999999999999999999999999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+|||++....
T Consensus 292 ~HpWi~~~~~ 301 (382)
T KOG0032|consen 292 QHPWIKSIGE 301 (382)
T ss_pred cCccccCCcc
Confidence 9999986533
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=334.29 Aligned_cols=202 Identities=29% Similarity=0.441 Sum_probs=172.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHH--C
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHS--R 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~--~ 75 (529)
..||.+|++|+|||||++++.-..+....++||||||++|.+..++ .....++|..++.++.||+.||.+||+ .
T Consensus 66 v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~ 145 (375)
T KOG0591|consen 66 VKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP 145 (375)
T ss_pred HHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc
Confidence 5799999999999999999843333356699999999986555433 355679999999999999999999999 4
Q ss_pred C--CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 76 G--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 76 g--IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
. |+||||||.||+|+.+|.+||+|||+++++... .....+.+|||+||+||++.+ ..|+.++||||+||++|||+.
T Consensus 146 r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMca 223 (375)
T KOG0591|consen 146 RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCA 223 (375)
T ss_pred ccceeeccCcchheEEcCCCceeeccchhHhHhcch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHh
Confidence 5 999999999999999999999999999988764 345678899999999999987 569999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
-++||.|++-.++..+|...-.+|-++ ..+|.++..||..|+++||..||+.
T Consensus 224 L~~PF~g~n~~~L~~KI~qgd~~~~p~---------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 224 LQSPFYGDNLLSLCKKIEQGDYPPLPD---------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cCCCcccccHHHHHHHHHcCCCCCCcH---------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 999999999888888886632221110 2467889999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.91 Aligned_cols=254 Identities=46% Similarity=0.824 Sum_probs=213.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+.....+|+||||+++++...+......+++.++..++.||+.||.|||+.||+|||
T Consensus 54 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 133 (309)
T cd07845 54 LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRD 133 (309)
T ss_pred hHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 47999999999999999999998755567999999999877766655456799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||+++.++.+||+|||++....... ...+...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.
T Consensus 134 l~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 134 LKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCHHHEEECCCCCEEECccceeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998665432 22334456889999999987667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCC-CccccCC-CCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~~-~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+..+.+..+...++.+....|..... +....+. +..++ ..+...+..+++.+.+||.+||+.||++|||+.++|.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 213 SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred CHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 99999999999999988887765322 2111111 11222 233444556799999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCCCC
Q 009654 240 YFSTKPYACDLSSLPIYP 257 (529)
Q Consensus 240 ~f~~~~~~~~~~~~p~~~ 257 (529)
||...+.++.+..+|.+|
T Consensus 292 ~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 292 YFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred hhccCCCCCCCCcCCCCC
Confidence 999999999888888765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=344.11 Aligned_cols=217 Identities=33% Similarity=0.460 Sum_probs=176.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~-~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+||.||++|+|||||+++|.........++|+|||+.++.+..++...+ +|+|..++.|.+||+.||.|||++||+|
T Consensus 61 l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH 140 (313)
T KOG0198|consen 61 LEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVH 140 (313)
T ss_pred HHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 368999999999999999999765542237999999999988876665544 8999999999999999999999999999
Q ss_pred cCCCCCcEEEcc-CCcEEEeccccccccCC--CCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNN-EGVLKLADFGLANFSNT--GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~-~g~vKl~DFGla~~~~~--~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||||+||||+. ++.+||+|||++..... ..........||+.|||||++......+.++|||||||++.||+||.+
T Consensus 141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 999999999999 79999999999987663 112234467899999999999852223459999999999999999999
Q ss_pred CCCCC-CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 157 ILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 157 pf~g~-~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
||... ...+.+-.|......| .....+|++++++|.+||..||++||||.++
T Consensus 221 PW~~~~~~~~~~~~ig~~~~~P---------------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL 273 (313)
T KOG0198|consen 221 PWSEFFEEAEALLLIGREDSLP---------------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL 273 (313)
T ss_pred cchhhcchHHHHHHHhccCCCC---------------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 99873 3333333332211011 1124589999999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|.|||.+..
T Consensus 274 L~hpf~~~~ 282 (313)
T KOG0198|consen 274 LEHPFLKQN 282 (313)
T ss_pred hhChhhhcc
Confidence 999999764
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=340.70 Aligned_cols=240 Identities=37% Similarity=0.715 Sum_probs=189.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--------~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+|++|+||||++++++|.+.....+|+||||+.+++...+.. ....+++..++.++.||+.||.|||
T Consensus 46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 125 (317)
T cd07868 46 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125 (317)
T ss_pred HHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999998766678999999999877665431 2235899999999999999999999
Q ss_pred HCCCcccCCCCCcEEE----ccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHH
Q 009654 74 SRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 147 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl----~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~i 147 (529)
++||+||||||+|||+ +..+.+||+|||++........ ......++|+.|+|||++.+...|+.++||||+|||
T Consensus 126 ~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 205 (317)
T cd07868 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205 (317)
T ss_pred hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHH
Confidence 9999999999999999 4557899999999987653321 123456789999999999886779999999999999
Q ss_pred HHHHHhCCCCCCCCCH---------HHHHHHHHHHcCCCCchhhhccCC-Ccccc----CC----CCCCCcchhhhhccC
Q 009654 148 FAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSKL-PHATL----FK----PQQPYDSSLRETFKD 209 (529)
Q Consensus 148 l~elltG~~pf~g~~~---------~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~----~~----~~~~~~~~l~~~~~~ 209 (529)
+|+|++|.+||.+... .+++..++...|.|....|..... +.... +. ........+......
T Consensus 206 l~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (317)
T cd07868 206 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 285 (317)
T ss_pred HHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCC
Confidence 9999999999976543 467888999999988887766321 11000 00 000011111111223
Q ss_pred CcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 210 LPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 210 ~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
.+..+++||.+||++||.+|||+.++|+||||
T Consensus 286 ~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 286 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 56779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.22 Aligned_cols=241 Identities=37% Similarity=0.693 Sum_probs=199.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.. .+.+|+||||+++++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 52 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~d 129 (309)
T cd07872 52 IREVSLLKDLKHANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129 (309)
T ss_pred HHHHHHHHhCCCCCcceEEEEEee--CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999987 568999999999988877766566789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.
T Consensus 130 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 130 LKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred CCHHHEEECCCCCEEECccccceecCCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654322 12234567999999999987667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC-cchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY-DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~-~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+.+..+....+.+....|................+ ...+....+.++.++++||.+||..||.+|||+.++|+|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 99999999999999998888865332111000000011 11123344678999999999999999999999999999999
Q ss_pred cCCCC
Q 009654 241 FSTKP 245 (529)
Q Consensus 241 f~~~~ 245 (529)
|+..+
T Consensus 289 ~~~~~ 293 (309)
T cd07872 289 FRSLG 293 (309)
T ss_pred hhhcc
Confidence 98643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.07 Aligned_cols=214 Identities=34% Similarity=0.531 Sum_probs=189.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+||+|++.|+|||||.+++.|+. ..++|+|+|||.|++. .++..++.++|+++..++.|++.||.|||+++|+||
T Consensus 48 l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vVte~a~g~L~-~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhr 124 (808)
T KOG0597|consen 48 LRQEVRILRSLKHPNIVEMLESFET--SAHLWVVTEYAVGDLF-TILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHR 124 (808)
T ss_pred HHHHHHHHHhcCCcchhhHHHhhcc--cceEEEEehhhhhhHH-HHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 3589999999999999999999998 6799999999999654 445678899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|+||.|||++..|.+|+||||+|+..... ...++...|||.|||||++.+ ..|+..+|+||||||+|||++|+|||..
T Consensus 125 d~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 125 DMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred cCCcceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 99999999999999999999999977653 356678899999999999986 5799999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
....+....|...--.|| ..++..++.||..+|..||.+|+|=.++|.|||
T Consensus 203 ~si~~Lv~~I~~d~v~~p-----------------------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 203 RSITQLVKSILKDPVKPP-----------------------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred HHHHHHHHHHhcCCCCCc-----------------------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 888888888855211111 257889999999999999999999999999999
Q ss_pred cCCCCCCC
Q 009654 241 FSTKPYAC 248 (529)
Q Consensus 241 f~~~~~~~ 248 (529)
++......
T Consensus 254 ~k~~~~~~ 261 (808)
T KOG0597|consen 254 WKGKINIA 261 (808)
T ss_pred Hhhhhhhh
Confidence 98754443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.04 Aligned_cols=244 Identities=34% Similarity=0.608 Sum_probs=194.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+.|+||||+++++++.... ...+|+|||||++++...+. ....+++..+..++.||+.||.|||++||+
T Consensus 47 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 125 (338)
T cd07859 47 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVF 125 (338)
T ss_pred HHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 57999999999999999999886532 23589999999887766554 445799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCC--CCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHHhCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||||+|||++.++.+||+|||++....... .......++|+.|+|||++.+. ..|+.++|||||||++|+|++|+
T Consensus 126 H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~ 205 (338)
T cd07859 126 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205 (338)
T ss_pred cCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999997543221 1122456789999999998652 46899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccC--CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~--~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
+||.+.+...++..+....|.++...+..........+ .........+...++.+++.+.+||.+||+.||++|||+.
T Consensus 206 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 285 (338)
T cd07859 206 PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285 (338)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHH
Confidence 99999999999998988888887665443211100000 0000011123445567889999999999999999999999
Q ss_pred HHHhccccCCCCC
Q 009654 234 AALASEYFSTKPY 246 (529)
Q Consensus 234 e~L~h~~f~~~~~ 246 (529)
++|+||||+....
T Consensus 286 e~l~hp~f~~~~~ 298 (338)
T cd07859 286 EALADPYFKGLAK 298 (338)
T ss_pred HHhcCchhhhcCc
Confidence 9999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.88 Aligned_cols=242 Identities=34% Similarity=0.584 Sum_probs=192.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc------CCCeEEEEEeccCCCchhhhc---CCCCCCCHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR------LSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~------~~~~~~lV~E~~~g~ll~~~~---~~~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
.+|+.+|+.|+|||||+++++|... ....+|+|||||++++...+. .....+++..++.++.||+.||.||
T Consensus 107 ~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL 186 (440)
T PTZ00036 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186 (440)
T ss_pred HHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3799999999999999999987542 123578999999997765442 3456799999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEccCC-cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 73 HSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 73 H~~gIvHrDIKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
|++||+||||||+||||+.++ .+||+|||+++...... .....++|+.|+|||++.+...|+.++||||||||||+|
T Consensus 187 H~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred HHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999998664 79999999998664432 234567899999999998777799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc-cCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 ltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++|.+||.+.+..+++..|...+|.|+.+.+............+. .....+...+ ...|+++++||.+||.+||.+|+
T Consensus 265 ltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ 343 (440)
T PTZ00036 265 ILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343 (440)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc
Confidence 999999999999999999999999887665543211100000011 0111222333 24788999999999999999999
Q ss_pred CHHHHHhccccCCCCC
Q 009654 231 TASAALASEYFSTKPY 246 (529)
Q Consensus 231 ta~e~L~h~~f~~~~~ 246 (529)
|+.++|+||||.....
T Consensus 344 ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 344 NPIEALADPFFDDLRD 359 (440)
T ss_pred CHHHHhCChhHHhhhc
Confidence 9999999999986433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=324.86 Aligned_cols=216 Identities=27% Similarity=0.367 Sum_probs=180.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.||+++-... .|||||.++++|+.. ....+.||||.|+||.|...+. .+..|+|.++..|++||..||.|||+.+
T Consensus 102 RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n 181 (400)
T KOG0604|consen 102 RREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN 181 (400)
T ss_pred HhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc
Confidence 4789888777 799999999998753 2457889999999965554433 3456999999999999999999999999
Q ss_pred CcccCCCCCcEEEccC---CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 77 VLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 77 IvHrDIKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
|.||||||+|+|+... ..+||+|||+|+..... ..+.+.|.||+|.|||++- ...|+..+|+||+|||+|.|||
T Consensus 182 IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLC 258 (400)
T KOG0604|consen 182 IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_pred hhhccCChhheeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhc
Confidence 9999999999999754 56999999999865542 3567889999999999984 4679999999999999999999
Q ss_pred CCCCCCCCCH----HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 154 GKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 154 G~~pf~g~~~----~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|.|||..+.. ...-.+|......+|...| ..+|+.++|||+.||..+|.+|
T Consensus 259 GyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW-------------------------s~VSe~aKdlIR~LLkt~PteR 313 (400)
T KOG0604|consen 259 GYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW-------------------------SCVSEAAKDLIRKLLKTEPTER 313 (400)
T ss_pred CCCcccccCCccCChhHHhHhhccCccCCChhH-------------------------hHHHHHHHHHHHHHhcCCchhh
Confidence 9999987643 3345666665555554444 5799999999999999999999
Q ss_pred cCHHHHHhccccCCCC
Q 009654 230 ATASAALASEYFSTKP 245 (529)
Q Consensus 230 ~ta~e~L~h~~f~~~~ 245 (529)
+|+.++++|||+...+
T Consensus 314 lTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 314 LTIEEVMDHPWINQYE 329 (400)
T ss_pred eeHHHhhcCchhcccc
Confidence 9999999999998643
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.73 Aligned_cols=241 Identities=27% Similarity=0.430 Sum_probs=187.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||+++++|.. ....|+|||++.+++...+.. ...+++.+++.++.||+.||.|||++||+|||
T Consensus 131 ~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrD 207 (391)
T PHA03212 131 ATEAHILRAINHPSIIQLKGTFTY--NKFTCLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRD 207 (391)
T ss_pred HHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 589999999999999999999987 568999999999877666543 45789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.++.+||+|||++..............+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.
T Consensus 208 iKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 208 IKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred CChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 99999999999999999999997544332233445689999999999976 46899999999999999999999776543
Q ss_pred -------CHHHHHHHHHHHcCCCCchhhhccCCCccccC------CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 162 -------TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF------KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 162 -------~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~------~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
....++..|....|.++..++..........+ ....+...........++.++.+||.+||++||.+
T Consensus 287 ~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~ 366 (391)
T PHA03212 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHH 366 (391)
T ss_pred ccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhh
Confidence 23467778888888776543211000000000 00000111111222356888999999999999999
Q ss_pred CcCHHHHHhccccCCCCC
Q 009654 229 RATASAALASEYFSTKPY 246 (529)
Q Consensus 229 R~ta~e~L~h~~f~~~~~ 246 (529)
||||.++|+||||...+.
T Consensus 367 Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 367 RPSAEALLDFAAFQDIPD 384 (391)
T ss_pred CCCHHHHhcChhhccCCC
Confidence 999999999999987543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=330.94 Aligned_cols=235 Identities=40% Similarity=0.697 Sum_probs=191.4
Q ss_pred HHHHHHHHhC---CCCCccceeeEEEc---cCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL---DHPNIIKLEGLITS---RLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L---~HpnIvkl~~~~~~---~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+++.| +||||+++++++.. .....+|+||||+.+++...+.. ....+++.++..++.||+.||.|||+
T Consensus 49 ~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~ 128 (290)
T cd07862 49 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128 (290)
T ss_pred HHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4688888776 69999999999863 12457899999999877766643 33468999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 129 ~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g 205 (290)
T cd07862 129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRR 205 (290)
T ss_pred CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcC
Confidence 99999999999999999999999999999766433 23345678999999999976 4589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.+..+.+..|...++.+.+..|..........+.+.. ...+....+.+++.+++||.+||+.||++|||+.+
T Consensus 206 ~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 206 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCC--CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 9999999999999999999988877666542211111111111 11233445678999999999999999999999999
Q ss_pred HHhcccc
Q 009654 235 ALASEYF 241 (529)
Q Consensus 235 ~L~h~~f 241 (529)
+|+||||
T Consensus 284 ~l~hp~f 290 (290)
T cd07862 284 ALSHPYF 290 (290)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.25 Aligned_cols=212 Identities=29% Similarity=0.550 Sum_probs=192.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+..|+.+.|||||+||+++.. ...+|||+|+-++ ++.++++.....++|+.+++|+.||+.|+.|||+..|||
T Consensus 64 lfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVH 141 (864)
T KOG4717|consen 64 LFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVH 141 (864)
T ss_pred HHHHHHHHHHhcCcCeeeeeehhcc--cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhc
Confidence 4689999999999999999999877 5789999999987 677778778888999999999999999999999999999
Q ss_pred cCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 80 RDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||||+|+.+.+ -|.|||+|||++..+.++ ..+++.||++.|-|||+|+|..+.-+++||||||||||-|+||++||
T Consensus 142 RDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF 219 (864)
T KOG4717|consen 142 RDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF 219 (864)
T ss_pred ccCCcceeEEeeecCceEeeeccccccCCCc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence 999999998765 499999999999999887 46788999999999999999876778999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+..++.+.+..|+.+-..-| ..++.+++|||.+||..||.+|.+.++|..+
T Consensus 220 qeANDSETLTmImDCKYtvP-----------------------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 220 QEANDSETLTMIMDCKYTVP-----------------------------SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccccchhhhhhhhcccccCc-----------------------------hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 99999999999988654433 3578999999999999999999999999999
Q ss_pred cccCCCC
Q 009654 239 EYFSTKP 245 (529)
Q Consensus 239 ~~f~~~~ 245 (529)
+|++...
T Consensus 271 ~Wlq~~D 277 (864)
T KOG4717|consen 271 SWLQAGD 277 (864)
T ss_pred ccccCCC
Confidence 9998653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=333.85 Aligned_cols=208 Identities=28% Similarity=0.464 Sum_probs=188.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.|||+||..|+|||||.+|++|+. .+.+.|||||..++.|.+++...+.|+|.+++.|++||.+|+.|||.++|+||
T Consensus 100 IRREIeIMSsLNHPhII~IyEVFEN--kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHR 177 (668)
T KOG0611|consen 100 IRREIEIMSSLNHPHIIQIYEVFEN--KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHR 177 (668)
T ss_pred HHHHHHHHhhcCCCceeehhhhhcC--CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceec
Confidence 3689999999999999999999988 67899999999997777777777899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||.+|||+|.++++||+|||++.++... ..+++.||+|-|.+||++.|..+-++.+|.|||||+||.|+.|..||+|
T Consensus 178 DLKLENILLD~N~NiKIADFGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 178 DLKLENILLDQNNNIKIADFGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred ccchhheeecCCCCeeeeccchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 99999999999999999999999998765 3678899999999999999987779999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+....+.+|......- +.-|.++.-||+.||-+||++|.|+.++-.|=|
T Consensus 256 ~Dhk~lvrQIs~GaYrE------------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 256 RDHKRLVRQISRGAYRE------------------------------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred chHHHHHHHhhcccccC------------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 99999988886632211 245677899999999999999999999999866
Q ss_pred cC
Q 009654 241 FS 242 (529)
Q Consensus 241 f~ 242 (529)
.+
T Consensus 306 vN 307 (668)
T KOG0611|consen 306 VN 307 (668)
T ss_pred ee
Confidence 64
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.46 Aligned_cols=238 Identities=27% Similarity=0.510 Sum_probs=192.8
Q ss_pred HHHHHHHhCC-C-----CCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 3 REILILRRLD-H-----PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 3 rEi~iL~~L~-H-----pnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.||.||..|+ | -|||+++++|.. .+++|||+|+++-+|..++... -..|+...++.++.|||.||..||+.
T Consensus 231 ~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l 308 (586)
T KOG0667|consen 231 IEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL 308 (586)
T ss_pred HHHHHHHHHhccCCCCCeeEEEeeecccc--ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5999999996 3 499999999999 5799999999999998877643 34599999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCC--cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 76 GVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
||||+||||+||||.+.+ .|||+|||++++.... ..+++.+..|+|||+++| ..|+.++||||||||++||++
T Consensus 309 ~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~----vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~t 383 (586)
T KOG0667|consen 309 GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR----VYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFT 383 (586)
T ss_pred CeeeccCChhheeeccCCcCceeEEecccccccCCc----ceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhc
Confidence 999999999999998754 6999999999987653 337788999999999999 469999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCc----c--------ccCC------------------CC--CC-Cc
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH----A--------TLFK------------------PQ--QP-YD 200 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~----~--------~~~~------------------~~--~~-~~ 200 (529)
|.|+|+|.++.+|+..|++.+|.|+.......+-.+ . .... .. .+ -.
T Consensus 384 G~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~ 463 (586)
T KOG0667|consen 384 GEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGS 463 (586)
T ss_pred CccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCC
Confidence 999999999999999999999999975433211100 0 0000 00 01 11
Q ss_pred chhhhhcc-CCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCCCCC
Q 009654 201 SSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 247 (529)
Q Consensus 201 ~~l~~~~~-~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~~ 247 (529)
+.+...+. .-...+.|||.+||.+||.+|+|+.++|+||||+.....
T Consensus 464 ~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 464 RSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred cccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccccc
Confidence 12222222 234457999999999999999999999999999965443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.62 Aligned_cols=243 Identities=35% Similarity=0.554 Sum_probs=196.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC---CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~---~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+.++||||+++++++..... ..+|+||||+.+++...+. ....+++..+..++.||+.||.|||++||+
T Consensus 47 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 125 (372)
T cd07853 47 FRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125 (372)
T ss_pred HHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 579999999999999999999877421 2789999999987766654 345799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+|||++.++.+||+|||++...........+..++|++|+|||++.+...|+.++||||+|||+|+|++|++||
T Consensus 126 H~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 205 (372)
T cd07853 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205 (372)
T ss_pred CCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998765443334455678999999999988777899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCc-cc--cCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-AT--LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~-~~--~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.+.+..+++..|...+|.++...+....... .. ......+....+.......++++.+||.+||+.||.+|||+.++
T Consensus 206 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 285 (372)
T cd07853 206 QAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA 285 (372)
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 9999999999999999988765443211000 00 00000011111112234568899999999999999999999999
Q ss_pred HhccccCCCC
Q 009654 236 LASEYFSTKP 245 (529)
Q Consensus 236 L~h~~f~~~~ 245 (529)
|.||||....
T Consensus 286 l~hp~~~~~~ 295 (372)
T cd07853 286 LAHPYLDEGR 295 (372)
T ss_pred hcCHhhCCCc
Confidence 9999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=338.31 Aligned_cols=211 Identities=25% Similarity=0.382 Sum_probs=180.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+ .+.+||||||++++.+...+.....+++.++..++.||+.||+|||++||+|||
T Consensus 43 ~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD 120 (323)
T cd05571 43 LTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120 (323)
T ss_pred HHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 479999999999999999999988 578999999999987766666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 99999999999999999999987543221 22345679999999999976 45899999999999999999999999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+.......+... .+ .....+++++.+||.+||..||++|| ++.++|
T Consensus 199 ~~~~~~~~~~~~--~~---------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 249 (323)
T cd05571 199 DHEKLFELILME--EI---------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIM 249 (323)
T ss_pred CHHHHHHHHHcC--CC---------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHH
Confidence 777666665331 10 00135788999999999999999999 899999
Q ss_pred hccccCCCC
Q 009654 237 ASEYFSTKP 245 (529)
Q Consensus 237 ~h~~f~~~~ 245 (529)
+||||....
T Consensus 250 ~h~~f~~~~ 258 (323)
T cd05571 250 EHRFFASIN 258 (323)
T ss_pred cCCCcCCCC
Confidence 999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.46 Aligned_cols=239 Identities=39% Similarity=0.711 Sum_probs=197.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ...+|+||||+.+++...+......+++..+..++.||+.||.|||++||+|+|
T Consensus 52 ~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~d 129 (301)
T cd07873 52 IREVSLLKDLKHANIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129 (301)
T ss_pred HHHHHHHHhcCCCCcceEEEEEec--CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 479999999999999999999987 578999999999888777766566799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.
T Consensus 130 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 130 LKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CCHHHEEECCCCcEEECcCcchhccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654322 12234467899999999987667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+++..+....+.+....|....-... ..+.........+......+++.+++||.+||+.||.+|||+.++|+|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 209 TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 99999999999999988887764211000 00000000111223334578999999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|..
T Consensus 289 f~~ 291 (301)
T cd07873 289 FHC 291 (301)
T ss_pred ccc
Confidence 974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.51 Aligned_cols=237 Identities=40% Similarity=0.682 Sum_probs=195.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+|+||++++++..+......+++..++.++.||+.||.|||++||+|||
T Consensus 47 ~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~d 124 (284)
T cd07839 47 LREICLLKELKHKNIVRLYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124 (284)
T ss_pred hHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence 579999999999999999999987 568999999999988877765566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC-CCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p-f~g 160 (529)
|||+||+++.++.+||+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|..| |.+
T Consensus 125 l~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 125 LKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CCHHHEEEcCCCcEEECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99999999999999999999997654432 2234456789999999998766789999999999999999998765 677
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+..++..++.+....|............+..+....+....+.+++++.+||.+||..||.+|||+.++|.|||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 204 NDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred CCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 78888899999988888777665422111111111112222234455678999999999999999999999999999999
Q ss_pred c
Q 009654 241 F 241 (529)
Q Consensus 241 f 241 (529)
|
T Consensus 284 f 284 (284)
T cd07839 284 F 284 (284)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.31 Aligned_cols=240 Identities=36% Similarity=0.686 Sum_probs=187.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--------~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+|++|+||||+++++++.......+|+||||+++++...+.. ....+++..+..++.||+.||.|||
T Consensus 46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH 125 (317)
T cd07867 46 CREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125 (317)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999997765678999999999987665431 2235899999999999999999999
Q ss_pred HCCCcccCCCCCcEEE----ccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHH
Q 009654 74 SRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 147 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl----~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~i 147 (529)
++||+||||||+|||+ +.++.+||+|||+++....... ......++|+.|+|||++.+...++.++||||+||+
T Consensus 126 ~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 205 (317)
T cd07867 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205 (317)
T ss_pred hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHH
Confidence 9999999999999999 4567899999999987654321 123455789999999999876678999999999999
Q ss_pred HHHHHhCCCCCCCCCH---------HHHHHHHHHHcCCCCchhhhccCCC-cccc----CCC----CCCCcchhhhhccC
Q 009654 148 FAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSKLP-HATL----FKP----QQPYDSSLRETFKD 209 (529)
Q Consensus 148 l~elltG~~pf~g~~~---------~~~~~~I~~~~g~p~~~~~~~~~l~-~~~~----~~~----~~~~~~~l~~~~~~ 209 (529)
+|+|++|.+||.+..+ ..++..++..+|.+....|...... .... +.. ..............
T Consensus 206 l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (317)
T cd07867 206 FAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVK 285 (317)
T ss_pred HHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCC
Confidence 9999999999976542 4567788888898888777653211 0000 000 00000011111123
Q ss_pred CcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 210 LPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 210 ~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
.+..+++||.+||+.||.+|||+.|+|+||||
T Consensus 286 ~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 286 PDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 46678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.16 Aligned_cols=210 Identities=26% Similarity=0.358 Sum_probs=182.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+|||||||.++.+..++.....+++..+..++.||+.||.|||++||+|||
T Consensus 79 ~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 156 (340)
T PTZ00426 79 FSERKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156 (340)
T ss_pred HHHHHHHHhCCCCCCcceEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccC
Confidence 479999999999999999999988 578999999999877776666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.+|.+||+|||++...... ....+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+.
T Consensus 157 Lkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 157 LKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCHHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 9999999999999999999999865432 235578999999999976 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+....+..+....... ...+++.+.+||.+||+.||.+|+ |+++++
T Consensus 232 ~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 232 EPLLIYQKILEGIIYF-----------------------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred CHHHHHHHHhcCCCCC-----------------------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 8877777775421111 134678899999999999999995 899999
Q ss_pred hccccCCCCCC
Q 009654 237 ASEYFSTKPYA 247 (529)
Q Consensus 237 ~h~~f~~~~~~ 247 (529)
+||||....|.
T Consensus 283 ~hp~f~~~~~~ 293 (340)
T PTZ00426 283 EHPWFGNIDWV 293 (340)
T ss_pred cCCCcCCCCHH
Confidence 99999876553
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.99 Aligned_cols=210 Identities=28% Similarity=0.412 Sum_probs=179.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||++++++|.+ ...+|||||||+++.+..++.....+++..+..++.||+.||.|||++||+|||
T Consensus 41 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrD 118 (312)
T cd05585 41 LAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118 (312)
T ss_pred HHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 479999999999999999999987 578999999999977766665667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.
T Consensus 119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 119 LKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred CCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 99999999999999999999987543221 22345678999999999976 46899999999999999999999999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc---CHHHHHhc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALAS 238 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~---ta~e~L~h 238 (529)
+..+.+..+... .+ .....+++++.+||.+||..||.+|+ ++.++|.|
T Consensus 197 ~~~~~~~~~~~~--~~---------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 197 NVNEMYRKILQE--PL---------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHcC--CC---------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 877777666441 10 01135788999999999999999997 58999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||...
T Consensus 248 p~~~~~ 253 (312)
T cd05585 248 PFFSQL 253 (312)
T ss_pred CCcCCC
Confidence 999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.73 Aligned_cols=237 Identities=40% Similarity=0.736 Sum_probs=193.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.++++++||||+++++++.+ ...+|+||||+++++...+.. ....+++.+++.++.||+.||.|||++||+|
T Consensus 47 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 124 (285)
T cd07861 47 IREISLLKELQHPNIVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124 (285)
T ss_pred HHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 579999999999999999999987 578999999999876665532 2357999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||||+|||++.+|.+||+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 125 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 125 RDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred cCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999987654322 223344678999999998776678999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+..+....+....+.+....|....................+......+++++++||.+||+.||.+|||+.++|.||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~ 283 (285)
T cd07861 204 GDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283 (285)
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence 99998888888888888877777542211110000000011122334567899999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 284 ~~ 285 (285)
T cd07861 284 YF 285 (285)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=330.41 Aligned_cols=209 Identities=26% Similarity=0.365 Sum_probs=180.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+ ...+|+||||++++.+..++.....+++..+..++.||+.||+|||++||+|||
T Consensus 49 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 126 (291)
T cd05612 49 HNEKRVLKEVSHPFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126 (291)
T ss_pred HHHHHHHHhCCCCcHhhhHhhhcc--CCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 579999999999999999999887 578999999999877666655666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.+|.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 127 lkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 127 LKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred CCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998765432 234578999999999876 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L 236 (529)
+..+.+..+... .+. ....++..+++||.+||+.||.+|++ +.+++
T Consensus 202 ~~~~~~~~i~~~--~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 202 NPFGIYEKILAG--KLE---------------------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred CHHHHHHHHHhC--CcC---------------------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 888877777542 110 01246788999999999999999995 99999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||....|
T Consensus 253 ~h~~~~~~~~ 262 (291)
T cd05612 253 NHRWFKSVDW 262 (291)
T ss_pred cCccccCCCH
Confidence 9999986544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.24 Aligned_cols=208 Identities=26% Similarity=0.388 Sum_probs=179.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ .+.+|+|||||.++.+...+.....+++..+..++.||+.||+|||++||+|||
T Consensus 66 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~d 143 (329)
T PTZ00263 66 AQEKSILMELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRD 143 (329)
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEc--CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 579999999999999999999988 578999999999876665555666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 144 lkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 144 LKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred CCHHHEEECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999766432 234578999999999976 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L 236 (529)
+..+.+..|.. +.+. + ...++..+++||.+||+.||.+|++ +.+++
T Consensus 219 ~~~~~~~~i~~--~~~~--------------------~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 219 TPFRIYEKILA--GRLK--------------------F-------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CHHHHHHHHhc--CCcC--------------------C-------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 88777777644 1110 0 0236788999999999999999997 79999
Q ss_pred hccccCCCC
Q 009654 237 ASEYFSTKP 245 (529)
Q Consensus 237 ~h~~f~~~~ 245 (529)
.||||....
T Consensus 270 ~hp~f~~~~ 278 (329)
T PTZ00263 270 NHPYFHGAN 278 (329)
T ss_pred cCCccCCCC
Confidence 999998643
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=322.11 Aligned_cols=235 Identities=39% Similarity=0.705 Sum_probs=191.5
Q ss_pred HHHHHHHHhC---CCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL---DHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L---~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~-~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+++.| +||||+++++++.+.. ...+++||||+.+++...+... ...+++.+++.++.||+.||.|||+
T Consensus 47 ~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 126 (288)
T cd07863 47 VREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126 (288)
T ss_pred HHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3688888776 7999999999886521 3568999999998776665432 3458999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus 127 ~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g 203 (288)
T cd07863 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRR 203 (288)
T ss_pred CCeecCCCCHHHEEECCCCCEEECccCccccccCc--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhC
Confidence 99999999999999999999999999999866432 22345578999999999976 4589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+....+.+.++....+.+....|..........+.+.. ...+....+.++..+.+||.+||+.||.+|||+.+
T Consensus 204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 281 (288)
T cd07863 204 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281 (288)
T ss_pred CcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCC--CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence 9999999999999999998888877666542211111111111 12334555678999999999999999999999999
Q ss_pred HHhcccc
Q 009654 235 ALASEYF 241 (529)
Q Consensus 235 ~L~h~~f 241 (529)
+|.||||
T Consensus 282 ~l~hp~f 288 (288)
T cd07863 282 ALQHPFF 288 (288)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.84 Aligned_cols=223 Identities=26% Similarity=0.407 Sum_probs=182.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+..|+.++|||||+++..|.. ...+|+||.||.+|.+..++. -...|+|..++.+++++|.||.|||.+|.+
T Consensus 71 l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~I 148 (516)
T KOG0582|consen 71 LRKEVQTMSLIDHPNIVTYHCSFVV--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHI 148 (516)
T ss_pred HHHHHHHhhhcCCCCcceEEEEEEe--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCce
Confidence 4689999999999999999999998 579999999999977665543 123499999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCC-CC--CccccccccccCCcccc-cCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQ--PLTSRVVTLWYRPPELL-LGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~--~~~~~~gt~~Y~APE~l-~~~~~y~~~~DIWSlG~il~elltG 154 (529)
|||||+.||||+.+|.|||+|||.+....... .. .+...+||++|||||++ .....|+.++||||||++..||.+|
T Consensus 149 HRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G 228 (516)
T KOG0582|consen 149 HRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG 228 (516)
T ss_pred ecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence 99999999999999999999999976543322 11 22456899999999995 4445799999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
..||..-.....+..- +.+.||.-. ....+ .+..+.++..++.+|..||..||.+||||++
T Consensus 229 ~aPf~k~pPmkvLl~t--Lqn~pp~~~------------t~~~~-----~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 229 HAPFSKYPPMKVLLLT--LQNDPPTLL------------TSGLD-----KDEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred CCCcccCChHHHHHHH--hcCCCCCcc------------cccCC-----hHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 9999877776655433 335554211 00001 2334567889999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|+|+||+..
T Consensus 290 Llkh~FFk~~ 299 (516)
T KOG0582|consen 290 LLKHAFFKKA 299 (516)
T ss_pred HhccHHHhhc
Confidence 9999999864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.18 Aligned_cols=237 Identities=33% Similarity=0.622 Sum_probs=187.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC----CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~----~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.++||||++++++|..... ..+|+||||+++++...+. ..+++..+..++.||+.||.|||++||
T Consensus 68 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i 144 (359)
T cd07876 68 YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGI 144 (359)
T ss_pred HHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 579999999999999999999875321 3589999999998776653 358999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.+|.+||+|||++...... .......+|+.|+|||++.+ ..|+.++|||||||++|+|++|.+|
T Consensus 145 vHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~p 221 (359)
T cd07876 145 IHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVI 221 (359)
T ss_pred ccCCCCHHHEEECCCCCEEEecCCCccccccC--ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999755332 23345678999999999977 4589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccC--C---CCCCCcc--------hhhhhccCCcHHHHHHHHHhccC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--K---PQQPYDS--------SLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~--~---~~~~~~~--------~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
|.+.+..+.+..+.+..+.+...++........... . +...+.. .........++.+++||.+||..
T Consensus 222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 301 (359)
T cd07876 222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301 (359)
T ss_pred CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhcc
Confidence 999999999999999888887655433110000000 0 0000000 00111123567899999999999
Q ss_pred CCCCCcCHHHHHhccccCCC
Q 009654 225 EPYKRATASAALASEYFSTK 244 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~ 244 (529)
||++|||+.|+|+||||...
T Consensus 302 dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 302 DPDKRISVDEALRHPYITVW 321 (359)
T ss_pred CcccCCCHHHHhcCchhhhh
Confidence 99999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=335.05 Aligned_cols=237 Identities=31% Similarity=0.587 Sum_probs=188.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+++.++||||+++++++.... ...+|+||||+++++...+. ..+++..+..++.||+.||.|||++||
T Consensus 71 ~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i 147 (364)
T cd07875 71 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGI 147 (364)
T ss_pred HHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 47999999999999999999886532 24689999999998776653 258899999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 148 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~p 224 (364)
T cd07875 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVL 224 (364)
T ss_pred ecCCCCHHHEEECCCCcEEEEeCCCccccCCC--CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999999765432 22345678999999999977 4589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC---------c----chhhhhccCCcHHHHHHHHHhccC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY---------D----SSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~---------~----~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
|.+.+..+.+.++....+.|...++................+ . ..........+..+++||.+||..
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 304 (364)
T cd07875 225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304 (364)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence 999999999999999988887665544221100000000000 0 000111223467899999999999
Q ss_pred CCCCCcCHHHHHhccccCCC
Q 009654 225 EPYKRATASAALASEYFSTK 244 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~ 244 (529)
||.+|||+.++|+||||...
T Consensus 305 dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 305 DASKRISVDEALQHPYINVW 324 (364)
T ss_pred CcccCCCHHHHhcCcccccc
Confidence 99999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=322.54 Aligned_cols=227 Identities=30% Similarity=0.392 Sum_probs=190.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
..|-+||..|+||.+++||..|+. ...+|||||||.|+.+..+. .+++.|++..++.|+..|+.||+|||-.|||+
T Consensus 125 ~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivY 202 (459)
T KOG0610|consen 125 QTEREILSLLDHPFLPTLYASFET--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVY 202 (459)
T ss_pred HHHHHHHHhcCCCccchhhheeec--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceee
Confidence 358899999999999999999998 67999999999997666544 45677999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCC---------------------------------C-C---------------
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNT---------------------------------G-H--------------- 110 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~---------------------------------~-~--------------- 110 (529)
|||||+||||-++|.|-|+||.|+..... . .
T Consensus 203 RDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~ 282 (459)
T KOG0610|consen 203 RDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPE 282 (459)
T ss_pred ccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchh
Confidence 99999999999999999999998732210 0 0
Q ss_pred ------CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 009654 111 ------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 184 (529)
Q Consensus 111 ------~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~ 184 (529)
.....+.|||-.|+|||++.| ...+.++|.|+|||+|||||.|..||.|.+..+.+.+|...--.+|+
T Consensus 283 ~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~----- 356 (459)
T KOG0610|consen 283 LVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE----- 356 (459)
T ss_pred hhcCCCCccccccccccccccceeeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-----
Confidence 011234688999999999988 45899999999999999999999999999999999998653222211
Q ss_pred cCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC----HHHHHhccccCCCCCCCCCCCCCCCCC
Q 009654 185 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT----ASAALASEYFSTKPYACDLSSLPIYPP 258 (529)
Q Consensus 185 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t----a~e~L~h~~f~~~~~~~~~~~~p~~~~ 258 (529)
.+.++..++|||+++|..||.+|+- |.||-+||||....|+.....-|.+.|
T Consensus 357 ----------------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP 412 (459)
T KOG0610|consen 357 ----------------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP 412 (459)
T ss_pred ----------------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence 1257789999999999999999998 999999999999999865555555533
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=331.89 Aligned_cols=211 Identities=25% Similarity=0.397 Sum_probs=179.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+||||||++++.+.........+++.++..++.||+.||+|||++||+|||
T Consensus 43 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 120 (328)
T cd05593 43 LTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120 (328)
T ss_pred HHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 579999999999999999999987 578999999999987776666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.++.+||+|||++...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 121 ikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 121 LKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 9999999999999999999998754322 122345678999999999976 45899999999999999999999999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+..+....+... .+ .....+++++.+||.+||..||.+|+ ++.++|
T Consensus 199 ~~~~~~~~~~~~--~~---------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 199 DHEKLFELILME--DI---------------------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred CHHHHHHHhccC--Cc---------------------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 776666555321 10 00135788999999999999999997 899999
Q ss_pred hccccCCCC
Q 009654 237 ASEYFSTKP 245 (529)
Q Consensus 237 ~h~~f~~~~ 245 (529)
+|+||....
T Consensus 250 ~h~~~~~~~ 258 (328)
T cd05593 250 RHSFFTGVN 258 (328)
T ss_pred cCCCcCCCC
Confidence 999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=331.05 Aligned_cols=211 Identities=26% Similarity=0.389 Sum_probs=180.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||++++++|.+ ...+|||||||+++.+..+......+++..++.++.||+.||.|||++||+|||
T Consensus 43 ~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 120 (323)
T cd05595 43 VTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120 (323)
T ss_pred HHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 479999999999999999999987 578999999999987776666666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 121 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543221 22344678999999999976 46899999999999999999999999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+.......+....... ...+++++.+||.+||..||.+|+ ++.++|
T Consensus 199 ~~~~~~~~~~~~~~~~-----------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l 249 (323)
T cd05595 199 DHERLFELILMEEIRF-----------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 249 (323)
T ss_pred CHHHHHHHHhcCCCCC-----------------------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHH
Confidence 8777766664311110 135788999999999999999998 999999
Q ss_pred hccccCCCC
Q 009654 237 ASEYFSTKP 245 (529)
Q Consensus 237 ~h~~f~~~~ 245 (529)
+|+||....
T Consensus 250 ~h~~~~~~~ 258 (323)
T cd05595 250 EHRFFLSIN 258 (323)
T ss_pred cCCCcCCCC
Confidence 999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=330.80 Aligned_cols=237 Identities=36% Similarity=0.640 Sum_probs=191.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|++++||||++++++|.... ...+|+++|++.+++...+. ...+++.++..++.||+.||.|||++||
T Consensus 62 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i 139 (343)
T cd07878 62 YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGI 139 (343)
T ss_pred HHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 47999999999999999999886421 24579999999776654442 3479999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||++..... .....++|+.|+|||++.+...|+.++|||||||++|+|++|.+|
T Consensus 140 vHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 215 (343)
T cd07878 140 IHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215 (343)
T ss_pred ecccCChhhEEECCCCCEEEcCCccceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999999999976543 234567899999999998766789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--CCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~--~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+..+.+..+....+.++...+..........+.... .....+...+...++.+.+||.+||..||.+|||+.++
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el 295 (343)
T cd07878 216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295 (343)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 9999999999999988888776654332111110000000 00112344455678889999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|.||||...
T Consensus 296 l~hp~~~~~ 304 (343)
T cd07878 296 LAHPYFSQY 304 (343)
T ss_pred hcCcchhcc
Confidence 999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=330.64 Aligned_cols=217 Identities=27% Similarity=0.370 Sum_probs=183.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+|||||||+++.+..++.....+++.+++.++.||+.||.|||++||+|||
T Consensus 49 ~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 126 (333)
T cd05600 49 LTERDILTTTKSEWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126 (333)
T ss_pred HHHHHHHHhCCCCCCccEEEEEEc--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 579999999999999999999987 578999999999987777766667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++..... .....+||+.|+|||++.+. .|+.++||||||||+|+|++|.+||.+.
T Consensus 127 lkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 127 LKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred CCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCC
Confidence 999999999999999999999976543 23456789999999999874 6899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+..+......... +.. ......++.++.+||.+||..+|.+|+++.++++||||
T Consensus 202 ~~~~~~~~i~~~~~~~~~---------------~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~ 260 (333)
T cd05600 202 TPNETWENLKYWKETLQR---------------PVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF 260 (333)
T ss_pred CHHHHHHHHHhccccccC---------------CCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence 888877776542211100 000 00013578999999999999999999999999999999
Q ss_pred CCCCC
Q 009654 242 STKPY 246 (529)
Q Consensus 242 ~~~~~ 246 (529)
....+
T Consensus 261 ~~~~~ 265 (333)
T cd05600 261 KEVDW 265 (333)
T ss_pred CCCCH
Confidence 87544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.42 Aligned_cols=221 Identities=25% Similarity=0.371 Sum_probs=187.3
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.||++++.++ .|+||++|+++|++ ...+|||||-|.|+.+-..+.+.+.|+|.++..+.+.|+.||.+||.+||.|
T Consensus 122 vfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAH 199 (463)
T KOG0607|consen 122 VFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAH 199 (463)
T ss_pred HHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCccc
Confidence 36899999999 79999999999999 6789999999999776666667779999999999999999999999999999
Q ss_pred cCCCCCcEEEccC---CcEEEeccccccccC------CCCCCCccccccccccCCccccc----CCCCCCCcchhhhhhH
Q 009654 80 RDIKGSNLLVNNE---GVLKLADFGLANFSN------TGHRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGC 146 (529)
Q Consensus 80 rDIKp~NILl~~~---g~vKl~DFGla~~~~------~~~~~~~~~~~gt~~Y~APE~l~----~~~~y~~~~DIWSlG~ 146 (529)
|||||+|||-... ..||||||.+..-+. +.....+.+.+|+..|||||++. ....|+..+|+|||||
T Consensus 200 RDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGv 279 (463)
T KOG0607|consen 200 RDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGV 279 (463)
T ss_pred ccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHH
Confidence 9999999998655 359999998874322 22223456779999999999973 3457999999999999
Q ss_pred HHHHHHhCCCCCCCCC---------------HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCc
Q 009654 147 VFAELLIGKPILQGRT---------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 211 (529)
Q Consensus 147 il~elltG~~pf~g~~---------------~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s 211 (529)
|||.||+|++||.|.- ...+++.|.+.-..+|+..| ..+|
T Consensus 280 IlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW-------------------------ahIS 334 (463)
T KOG0607|consen 280 ILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW-------------------------AHIS 334 (463)
T ss_pred HHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh-------------------------HHhh
Confidence 9999999999998752 34567778776666665555 5799
Q ss_pred HHHHHHHHHhccCCCCCCcCHHHHHhccccCCCCCCC
Q 009654 212 TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 248 (529)
Q Consensus 212 ~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~~~ 248 (529)
.+++|||..+|..|+.+|.++.++|+|||+......+
T Consensus 335 ~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 335 SEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred HHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 9999999999999999999999999999998654433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=307.94 Aligned_cols=208 Identities=34% Similarity=0.532 Sum_probs=184.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCc-hhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI-TGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~l-l~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.|||+|-..|+||||+++|++|.+ ...+||++||...+. +..+. .+..+|++..++.|++|++.||.|||..+|+
T Consensus 69 lrREiEIqs~L~hpnilrlY~~fhd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VI 146 (281)
T KOG0580|consen 69 LRREIEIQSHLRHPNILRLYGYFHD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVI 146 (281)
T ss_pred hhheeEeecccCCccHHhhhhheec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcc
Confidence 4689999999999999999999998 578999999998754 44444 3667899999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+|+|++.+|.+||+|||.+.....+ .-.+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.|||
T Consensus 147 hRdiKpenlLlg~~~~lkiAdfGwsV~~p~~---kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppF 222 (281)
T KOG0580|consen 147 HRDIKPENLLLGSAGELKIADFGWSVHAPSN---KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPF 222 (281)
T ss_pred cCCCCHHHhccCCCCCeeccCCCceeecCCC---CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCch
Confidence 9999999999999999999999998655432 3356799999999999987 56999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
...+..+.+++|.+.--..| ..++.++.|||.+||..+|.+|.+..+++.|
T Consensus 223 es~~~~etYkrI~k~~~~~p-----------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 223 ESQSHSETYKRIRKVDLKFP-----------------------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hhhhhHHHHHHHHHccccCC-----------------------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 99999999999987433222 3689999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
||+..
T Consensus 274 pwI~a 278 (281)
T KOG0580|consen 274 PWIVA 278 (281)
T ss_pred HHHHh
Confidence 99864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.32 Aligned_cols=216 Identities=29% Similarity=0.434 Sum_probs=179.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||++++++|.+ ...+|||||||+++.+..++.....|++.+++.++.||+.||+|||++||+|||
T Consensus 49 ~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~D 126 (364)
T cd05599 49 RAERDILAEADNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRD 126 (364)
T ss_pred HHHHHHHHhCCCCCCcceEEEEEc--CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 479999999999999999999988 678999999999877766655566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCC-------------------------------------CccccccccccC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-------------------------------------PLTSRVVTLWYR 124 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~-------------------------------------~~~~~~gt~~Y~ 124 (529)
|||+||||+.+|.+||+|||++......... .....+||+.|+
T Consensus 127 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 206 (364)
T cd05599 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI 206 (364)
T ss_pred CCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcccc
Confidence 9999999999999999999998654321100 111347899999
Q ss_pred CcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhh
Q 009654 125 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR 204 (529)
Q Consensus 125 APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~ 204 (529)
|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+........ +.
T Consensus 207 aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------~~---- 261 (364)
T cd05599 207 APEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ--------------------FP---- 261 (364)
T ss_pred CHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC--------------------CC----
Confidence 9999876 4689999999999999999999999999888877777654211100 00
Q ss_pred hhccCCcHHHHHHHHHhccCCCCCCcC---HHHHHhccccCCCCC
Q 009654 205 ETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 246 (529)
Q Consensus 205 ~~~~~~s~~~~dLi~~mL~~dP~kR~t---a~e~L~h~~f~~~~~ 246 (529)
....+++++++||.+||. +|.+|++ +.++|.||||+...|
T Consensus 262 -~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 262 -DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred -CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 012478899999999996 9999998 999999999987544
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=334.11 Aligned_cols=216 Identities=26% Similarity=0.375 Sum_probs=178.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++.+.+ ...+|||||||+++.+..++.....+++.+++.++.||+.||+|||++||+|||
T Consensus 49 ~~E~~il~~~~~~~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrD 126 (363)
T cd05628 49 RAERDILVEADSLWVVKMFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126 (363)
T ss_pred HHHHHHHHhCCCCCcceEEEEEec--CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecC
Confidence 469999999999999999999988 578999999999977766665667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCC----------------------------------CCccccccccccCCcc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHR----------------------------------QPLTSRVVTLWYRPPE 127 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~Y~APE 127 (529)
|||+||||+.+|.+||+|||+++....... ......+||+.|+|||
T Consensus 127 lKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 206 (363)
T cd05628 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206 (363)
T ss_pred CCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHH
Confidence 999999999999999999999875432110 0113458999999999
Q ss_pred cccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc
Q 009654 128 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 128 ~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 207 (529)
++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+.+|........ +. ..
T Consensus 207 ~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------~p-----~~ 260 (363)
T cd05628 207 VFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI--------------------FP-----PE 260 (363)
T ss_pred HHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc--------------------CC-----Cc
Confidence 9976 4589999999999999999999999999998888887765221110 00 01
Q ss_pred cCCcHHHHHHHHHhccCCCCC---CcCHHHHHhccccCCCCC
Q 009654 208 KDLPTTAVNLIETLLSVEPYK---RATASAALASEYFSTKPY 246 (529)
Q Consensus 208 ~~~s~~~~dLi~~mL~~dP~k---R~ta~e~L~h~~f~~~~~ 246 (529)
..+++++++||.+|+. +|.+ ||++.++++||||....|
T Consensus 261 ~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 261 VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 2478899999999886 5554 579999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.73 Aligned_cols=210 Identities=28% Similarity=0.433 Sum_probs=179.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||++++++|.. .+.+|+||||+.++.+...+...+.+++..+..++.||+.||.|||++||+|||
T Consensus 48 ~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 125 (323)
T cd05584 48 KAERNILEAVKHPFIVDLIYAFQT--GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRD 125 (323)
T ss_pred HHHHHHHHhCCCCchhceeeEEec--CCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 479999999999999999999987 568999999999977766666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 126 LKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999987543221 22334578999999999976 45889999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+....+..+... .. .....+++.+.+||.+||..||++|+ ++.+++
T Consensus 204 ~~~~~~~~~~~~--~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 204 NRKKTIDKILKG--KL---------------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred CHHHHHHHHHcC--CC---------------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 887777766542 11 01134688899999999999999999 899999
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
.||||...
T Consensus 255 ~h~~~~~~ 262 (323)
T cd05584 255 SHPFFRHV 262 (323)
T ss_pred cCCCcCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=316.45 Aligned_cols=239 Identities=39% Similarity=0.715 Sum_probs=196.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+||||+.+++...+......+++.++..++.||+.||.|||+.||+|+|
T Consensus 47 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 124 (286)
T cd07832 47 LREIKALQACQHPYVVKLLDVFPH--GSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124 (286)
T ss_pred HHHHHHHHhCCCCCCcceeeEEec--CCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999988 578999999994455555544456799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||+++.++.++|+|||++...............++.+|+|||++.+...++.++||||+||++|+|++|.++|.+.
T Consensus 125 l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred cCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 99999999999999999999998765443233445678999999999977666899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+.+..+...++.+....|........ ............+...+++++..+.+||.+||..||.+|||+.++|.|||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 205 NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred CHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 99999999999988887766654322110 00000011111234556778899999999999999999999999999999
Q ss_pred cC
Q 009654 241 FS 242 (529)
Q Consensus 241 f~ 242 (529)
|.
T Consensus 285 ~~ 286 (286)
T cd07832 285 FT 286 (286)
T ss_pred cC
Confidence 94
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=330.06 Aligned_cols=213 Identities=28% Similarity=0.407 Sum_probs=175.6
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.+ +||||+++++++.. ...+|+|||||+++.+..++.....+++.+++.++.||+.||.|||++||+||
T Consensus 52 ~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr 129 (332)
T cd05614 52 RTERNVLEHVRQSPFLVTLHYAFQT--EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYR 129 (332)
T ss_pred HHHHHHHHhccCCCCcccEEEEEec--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence 4699999999 69999999999887 57899999999997666555556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+++.+...........+||+.|+|||++.+...++.++||||||||+|+|++|..||.+
T Consensus 130 Dlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 130 DIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 99999999999999999999999865443333334567999999999998766689999999999999999999999975
Q ss_pred CCHH----HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----C
Q 009654 161 RTEV----EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----T 231 (529)
Q Consensus 161 ~~~~----~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----t 231 (529)
.... .....+.. ..+ .....+++.+.+||.+||..||++|+ +
T Consensus 210 ~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 260 (332)
T cd05614 210 EGERNTQSEVSRRILK--CDP---------------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260 (332)
T ss_pred CCCCCCHHHHHHHHhc--CCC---------------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 4322 22222211 000 01135788999999999999999999 8
Q ss_pred HHHHHhccccCCCC
Q 009654 232 ASAALASEYFSTKP 245 (529)
Q Consensus 232 a~e~L~h~~f~~~~ 245 (529)
++++++||||+...
T Consensus 261 ~~~~l~h~~~~~~~ 274 (332)
T cd05614 261 ASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHcCCCcCCCC
Confidence 89999999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.47 Aligned_cols=215 Identities=23% Similarity=0.374 Sum_probs=177.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++++||||+++++++.+ .+.+|+|||||+++.+.... .....+++..+..++.||+.||+|||+.||+|
T Consensus 48 ~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH 125 (285)
T cd05631 48 LNEKRILEKVNSRFVVSLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125 (285)
T ss_pred HHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence 479999999999999999999887 56899999999987665433 23346999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.
T Consensus 126 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 126 RDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred CCCCHHHEEECCCCCEEEeeCCCcEEcCCC--CeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999765432 22345678999999999976 468999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e 234 (529)
+.........+...+..... .....++.++.+||.+||+.||.+|++ +++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05631 203 KRKERVKREEVDRRVKEDQE-------------------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAG 257 (285)
T ss_pred CCCcchhHHHHHHHhhcccc-------------------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH
Confidence 87654444333332221110 112357889999999999999999997 999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
+++||||....+
T Consensus 258 ~~~h~~~~~~~~ 269 (285)
T cd05631 258 VKQHPIFKNINF 269 (285)
T ss_pred HhcCHhhcCCCH
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.09 Aligned_cols=217 Identities=26% Similarity=0.369 Sum_probs=182.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ .+.+|||||||+++.+..++.. ..+++..+..++.||+.||+|||++||+|||
T Consensus 91 ~~e~~il~~~~h~~iv~~~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 167 (370)
T cd05596 91 WEERDIMAHANSEWIVQLHYAFQD--DKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRD 167 (370)
T ss_pred HHHHHHHHhCCCCCcceEEEEEec--CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 479999999999999999999987 5789999999998766655543 4689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC---CCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.++.+||+|||++..............+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||
T Consensus 168 Lkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred CCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 999999999999999999999976654322233456799999999998653 24789999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAAL 236 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e~L 236 (529)
.+.+....+.+|........ + .....++.++++||.+||..+|.+ |+|+.++|
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~--------------------~-----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell 302 (370)
T cd05596 248 YADSLVGTYSKIMDHKNSLT--------------------F-----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIK 302 (370)
T ss_pred CCCCHHHHHHHHHcCCCcCC--------------------C-----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence 99988888877755211110 0 011357899999999999999988 99999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 303 ~h~~~~~~~~ 312 (370)
T cd05596 303 SHPFFKNDQW 312 (370)
T ss_pred cCcccCCCCh
Confidence 9999997655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.53 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=184.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.|-.|+... +||.+++|+.+|+. ..++|+||||+.||.+..++ ....|++..++.|+..|+.||.|||++|||||
T Consensus 416 ~~EkrI~~la~~HPFL~~L~~~fQT--~~~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYR 492 (694)
T KOG0694|consen 416 MCEKRIFELANRHPFLVNLFSCFQT--KEHLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYR 492 (694)
T ss_pred HHHHHHHHHhccCCeEeeccccccc--CCeEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceee
Confidence 4688888888 59999999999999 68999999999998744443 44689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||.+|||||.+|.+||+|||+|+..... .....+.||||.|+|||+|.+ ..|+.++|.|||||+|||||.|.+||.|
T Consensus 493 DlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 493 DLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred ecchhheEEcccCcEEecccccccccCCC-CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999855422 224567899999999999988 5699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~ 235 (529)
+++.+.+..|...-- .|+ ..+|.+++++|++||..||++|+- +.++
T Consensus 571 ddEee~FdsI~~d~~----------------------~yP-------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i 621 (694)
T KOG0694|consen 571 DDEEEVFDSIVNDEV----------------------RYP-------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDI 621 (694)
T ss_pred CCHHHHHHHHhcCCC----------------------CCC-------CcccHHHHHHHHHHhccCcccccCCCCCCchhh
Confidence 999999999966211 111 358999999999999999999985 6899
Q ss_pred HhccccCCCCCC
Q 009654 236 LASEYFSTKPYA 247 (529)
Q Consensus 236 L~h~~f~~~~~~ 247 (529)
.+||||+...|.
T Consensus 622 ~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 622 KKHPFFRSIDWD 633 (694)
T ss_pred hhCCccccCCHH
Confidence 999999987664
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.62 Aligned_cols=216 Identities=31% Similarity=0.409 Sum_probs=177.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++|||||+++++|.+ ...+|||||||+++.+..++.....+++..++.++.||+.||+|||++||+|||
T Consensus 49 ~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrD 126 (382)
T cd05625 49 KAERDILAEADNEWVVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126 (382)
T ss_pred HHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 579999999999999999999988 578999999999876665555556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC----------------------------------------------CCCcc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH----------------------------------------------RQPLT 115 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~----------------------------------------------~~~~~ 115 (529)
|||+||||+.+|.+||+|||++..+.... .....
T Consensus 127 lKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206 (382)
T ss_pred CCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence 99999999999999999999975321000 00112
Q ss_pred ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCC
Q 009654 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 195 (529)
Q Consensus 116 ~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~ 195 (529)
..+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+...++........
T Consensus 207 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 268 (382)
T cd05625 207 SLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH----------------- 268 (382)
T ss_pred ccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC-----------------
Confidence 3478999999999976 4689999999999999999999999999888777766654211110
Q ss_pred CCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC---HHHHHhccccCCCCC
Q 009654 196 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 246 (529)
Q Consensus 196 ~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t---a~e~L~h~~f~~~~~ 246 (529)
......+++++++||.+|+ .+|.+|++ +.+++.||||+...+
T Consensus 269 --------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 269 --------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred --------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 0011357899999999986 59999997 999999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.92 Aligned_cols=208 Identities=31% Similarity=0.440 Sum_probs=177.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-C
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRG-V 77 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~g-I 77 (529)
|.+|+.+|.+|+|||||+++|++.+.. ..++||||||++|.+..+... ...|+...+..++.||+.|++|||+++ |
T Consensus 86 f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~i 164 (362)
T KOG0192|consen 86 FRREASLLSRLRHPNIVQFYGACTSPP-GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPI 164 (362)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCe
Confidence 468999999999999999999998842 278999999999888866654 678999999999999999999999999 9
Q ss_pred cccCCCCCcEEEccCC-cEEEeccccccccCCCCCCCccccccccccCCcccccC-CCCCCCcchhhhhhHHHHHHHhCC
Q 009654 78 LHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 78 vHrDIKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|||||||+||||+.++ ++||+|||+++...... ...+...||+.|||||++.+ ...|+.++||||||++||||++|.
T Consensus 165 IHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~ 243 (362)
T KOG0192|consen 165 IHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGE 243 (362)
T ss_pred eecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCC
Confidence 9999999999999997 99999999998776432 34555789999999999985 357999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.||.+.........+....-.|+ ....+++.+..||.+||..||.+||+..++
T Consensus 244 ~Pf~~~~~~~~~~~v~~~~~Rp~---------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei 296 (362)
T KOG0192|consen 244 IPFEDLAPVQVASAVVVGGLRPP---------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEI 296 (362)
T ss_pred CCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence 99999988555555433222211 012388899999999999999999999998
Q ss_pred Hh
Q 009654 236 LA 237 (529)
Q Consensus 236 L~ 237 (529)
+.
T Consensus 297 ~~ 298 (362)
T KOG0192|consen 297 VS 298 (362)
T ss_pred HH
Confidence 74
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=330.13 Aligned_cols=217 Identities=26% Similarity=0.365 Sum_probs=180.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.+ ...+|||||||+++.+..++. ....+++..+..++.||+.||.|||++||+||
T Consensus 49 ~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~ 126 (330)
T cd05601 49 EEERDILSISNSPWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126 (330)
T ss_pred HHHHHHHHhCCCCCCcceeeEEec--CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence 578999999999999999999987 578999999998866655443 33689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC-----CCCCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||+||||+.+|.+||+|||++...............+|+.|+|||++.. ...|+.++||||||||+|+|++|.
T Consensus 127 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (330)
T cd05601 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206 (330)
T ss_pred cCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC
Confidence 999999999999999999999998765433222334578999999999863 345789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.||.+.+....+.+|........ + .....++.++.+||.+||. ||.+|||+.++
T Consensus 207 ~Pf~~~~~~~~~~~i~~~~~~~~--------------------~-----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l 260 (330)
T cd05601 207 SPFHEGTSAKTYNNIMNFQRFLK--------------------F-----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260 (330)
T ss_pred CCCCCCCHHHHHHHHHcCCCccC--------------------C-----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHH
Confidence 99999888887777755311100 0 0113578899999999998 99999999999
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
+.||||....|
T Consensus 261 ~~h~~~~~~~~ 271 (330)
T cd05601 261 CCHPFFSKIDW 271 (330)
T ss_pred hCCCCcCCCCH
Confidence 99999987544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.49 Aligned_cols=212 Identities=25% Similarity=0.400 Sum_probs=179.8
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++..+ +||||+++++++.+ ...+|||||||+++.+..++.....+++..+..++.||+.||.|||++||+||
T Consensus 43 ~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~ 120 (320)
T cd05590 43 MTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120 (320)
T ss_pred HHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 4688888877 79999999999987 57899999999997776666566789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+
T Consensus 121 dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred CCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 999999999999999999999987543221 22345578999999999876 4689999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH------HH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SA 234 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta------~e 234 (529)
.+..+.+..|....... ...++.++.+||.+||+.||.+|+++ .+
T Consensus 199 ~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~ 249 (320)
T cd05590 199 ENEDDLFEAILNDEVVY-----------------------------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEA 249 (320)
T ss_pred CCHHHHHHHHhcCCCCC-----------------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHH
Confidence 99888877775411110 12468889999999999999999998 99
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
++.||||....|
T Consensus 250 ~~~h~~f~~~~~ 261 (320)
T cd05590 250 ILRHPFFKELDW 261 (320)
T ss_pred HHcCCCcCCCCH
Confidence 999999986443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=328.16 Aligned_cols=211 Identities=25% Similarity=0.375 Sum_probs=178.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvHr 80 (529)
.+|+.+++.++||||+++++++.+ ...+|||||||+++.+.........+++.++..++.||+.||.|||+ .||+||
T Consensus 43 ~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 43 LTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred HHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 468999999999999999999987 57899999999998777666666789999999999999999999997 799999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||||+|++|..||.+
T Consensus 121 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred CCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCC
Confidence 999999999999999999999987533221 22344578999999999976 4689999999999999999999999998
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~ 235 (529)
.+..+....+....... ...+++++.+||.+||+.||.+|+ ++.++
T Consensus 199 ~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~i 249 (325)
T cd05594 199 QDHEKLFELILMEEIRF-----------------------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEI 249 (325)
T ss_pred CCHHHHHHHHhcCCCCC-----------------------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHH
Confidence 88766666653311100 134788999999999999999997 99999
Q ss_pred HhccccCCCC
Q 009654 236 LASEYFSTKP 245 (529)
Q Consensus 236 L~h~~f~~~~ 245 (529)
|+||||....
T Consensus 250 l~h~~~~~~~ 259 (325)
T cd05594 250 MQHKFFAGIV 259 (325)
T ss_pred hcCCCcCCCC
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.78 Aligned_cols=237 Identities=32% Similarity=0.592 Sum_probs=188.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+++.++||||+++++++.... ...+|+|||||++++...+. ..+++..+..++.||+.||.|||++||
T Consensus 64 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~gi 140 (355)
T cd07874 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGI 140 (355)
T ss_pred HHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 47999999999999999999986532 24689999999998776653 258999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.++.+||+|||++...... .......+|+.|+|||++.+ ..|+.++|||||||++|+|++|+.|
T Consensus 141 vHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p 217 (355)
T cd07874 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKIL 217 (355)
T ss_pred ccCCCChHHEEECCCCCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999765433 22345678999999999976 4589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC---------cc----hhhhhccCCcHHHHHHHHHhccC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY---------DS----SLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~---------~~----~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
|.+.+..+.+..+....+.+..+++................+ .. .........+..+++||.+||..
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 297 (355)
T cd07874 218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297 (355)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcC
Confidence 999999999999888888877665543211000000000000 00 00111233567889999999999
Q ss_pred CCCCCcCHHHHHhccccCCC
Q 009654 225 EPYKRATASAALASEYFSTK 244 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~ 244 (529)
||.+|||+.++|+||||...
T Consensus 298 dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 298 DPAKRISVDEALQHPYINVW 317 (355)
T ss_pred CchhcCCHHHHhcCcchhcc
Confidence 99999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.73 Aligned_cols=216 Identities=28% Similarity=0.401 Sum_probs=176.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++|||||+++++|.+ ...+|||||||+++.+..++.....+++..++.++.||+.||+|||++||+|||
T Consensus 49 ~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrD 126 (377)
T cd05629 49 KAERDVLAESDSPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126 (377)
T ss_pred HHHHHHHHhCCCCCcceEEEEEEc--CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 579999999999999999999988 578999999999876665555566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCC----------------------------------------------Ccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----------------------------------------------PLT 115 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~----------------------------------------------~~~ 115 (529)
|||+||||+.++.+||+|||+++.+...... ...
T Consensus 127 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (377)
T cd05629 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY 206 (377)
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc
Confidence 9999999999999999999998633210000 001
Q ss_pred ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCC
Q 009654 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 195 (529)
Q Consensus 116 ~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~ 195 (529)
..+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+.+..|........ +
T Consensus 207 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~-------- 269 (377)
T cd05629 207 STVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY--------F-------- 269 (377)
T ss_pred ccCCCccccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC--------C--------
Confidence 2478999999999976 4689999999999999999999999999888777777754211110 0
Q ss_pred CCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC---cCHHHHHhccccCCCCC
Q 009654 196 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---ATASAALASEYFSTKPY 246 (529)
Q Consensus 196 ~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR---~ta~e~L~h~~f~~~~~ 246 (529)
.....++.++++||.+||. +|.+| +|+.++|.||||+...+
T Consensus 270 ---------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 270 ---------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred ---------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0012468899999999997 77775 59999999999986433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.15 Aligned_cols=217 Identities=29% Similarity=0.391 Sum_probs=176.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ .+.+|||||||+++.+..++.....+++..++.++.||+.||+|||+.||+|||
T Consensus 49 ~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrD 126 (381)
T cd05626 49 KAERDILAEADNEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126 (381)
T ss_pred HHHHHHHHhcCCCCeeeeEEEEec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Confidence 579999999999999999999987 578999999999877666555566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCC----------------------------------------------CCcc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHR----------------------------------------------QPLT 115 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~----------------------------------------------~~~~ 115 (529)
|||+||||+.++.+||+|||++..+..... ....
T Consensus 127 lKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (381)
T cd05626 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206 (381)
T ss_pred CcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccc
Confidence 999999999999999999999754311000 0112
Q ss_pred ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCC
Q 009654 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 195 (529)
Q Consensus 116 ~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~ 195 (529)
..+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+...++........
T Consensus 207 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 268 (381)
T cd05626 207 SLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH----------------- 268 (381)
T ss_pred cccCCccccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC-----------------
Confidence 4579999999999976 4589999999999999999999999998887776666643211110
Q ss_pred CCCCcchhhhhccCCcHHHHHHHHHhccCC--CCCCcCHHHHHhccccCCCCC
Q 009654 196 QQPYDSSLRETFKDLPTTAVNLIETLLSVE--PYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 196 ~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d--P~kR~ta~e~L~h~~f~~~~~ 246 (529)
......+++++++||.+||..+ |..|+++.++|.||||....+
T Consensus 269 --------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 269 --------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 0011357899999999977554 445999999999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=316.88 Aligned_cols=239 Identities=45% Similarity=0.800 Sum_probs=196.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+.....+||||||+.+++...+......+++.++..++.||+.||.|||+.||+|+|
T Consensus 52 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~d 131 (293)
T cd07843 52 LREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131 (293)
T ss_pred HHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 47999999999999999999988754479999999999876666655455799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 132 l~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 132 LKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred CCHHHEEECCCCcEEEeecCceeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999988665432 23344567899999999877666789999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCcchhhhhccC--CcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKD--LPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~~~~~~~~~~~l~~~~~~--~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+..+.+.+++..++.+....|.... ++..............+...++. +++.+.+||.+||+.||++|||+.|+|.|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 9999999999999998887776532 22221111111111223344444 48899999999999999999999999999
Q ss_pred ccc
Q 009654 239 EYF 241 (529)
Q Consensus 239 ~~f 241 (529)
|||
T Consensus 291 ~~f 293 (293)
T cd07843 291 PYF 293 (293)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.68 Aligned_cols=236 Identities=33% Similarity=0.622 Sum_probs=196.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.||..++..+.|+|||+++.+|+... ...+|+|||||.+++...+. -.++.+.+..++.|+++|+.|||+.||
T Consensus 63 ~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~I 139 (369)
T KOG0665|consen 63 YRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGI 139 (369)
T ss_pred hhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcce
Confidence 47999999999999999999998643 24689999999998877665 367889999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||+++.++.+||.|||+|+..... -.++.+++|..|+|||++.+.. |.+.+||||+|||+.||++|...
T Consensus 140 ihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vl 216 (369)
T KOG0665|consen 140 IHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVL 216 (369)
T ss_pred eecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEE
Confidence 99999999999999999999999999876654 4678899999999999999865 99999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCc-chhhhhc------------cCCcHHHHHHHHHhccC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-SSLRETF------------KDLPTTAVNLIETLLSV 224 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~-~~l~~~~------------~~~s~~~~dLi~~mL~~ 224 (529)
|+|.+..+++.+|.+.+|.|.+.|..+..-.......+...|. ....+.+ +.-+..+++|+.+||..
T Consensus 217 f~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi 296 (369)
T KOG0665|consen 217 FPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVI 296 (369)
T ss_pred ecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhcc
Confidence 9999999999999999999998887663221111111111111 0111111 12234589999999999
Q ss_pred CCCCCcCHHHHHhccccCC
Q 009654 225 EPYKRATASAALASEYFST 243 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~ 243 (529)
||++|+++.++|.||||+-
T Consensus 297 ~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 297 DPEKRISVDDALRHPYIKV 315 (369)
T ss_pred ChhhcccHHHHhcCCeeee
Confidence 9999999999999999983
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=332.36 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=186.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||+++++|.. ...+|+|||++.++++..+ .....+++.++..++.||+.||.|||++||+|||
T Consensus 134 ~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrD 210 (392)
T PHA03207 134 GREIDILKTISHRAIINLIHAYRW--KSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRD 210 (392)
T ss_pred HHHHHHHHhcCCCCccceeeeEee--CCEEEEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 589999999999999999999987 5689999999998887766 4456899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||+||||+.++.+||+|||++......... .....+||+.|+|||++.+ ..|+.++||||||||||+|++|+.||.+
T Consensus 211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999765543221 2234578999999999976 4589999999999999999999999987
Q ss_pred CC---HHHHHHHHHHHcCCCCchhhhccCCCcc-----ccCCCCCCCcchhhhh--ccCCcHHHHHHHHHhccCCCCCCc
Q 009654 161 RT---EVEQLHKIFKLCGSPPDDYWKKSKLPHA-----TLFKPQQPYDSSLRET--FKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 161 ~~---~~~~~~~I~~~~g~p~~~~~~~~~l~~~-----~~~~~~~~~~~~l~~~--~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
.. ....+..|.+.++..+..+......... .......++. +... -..++.++.+||.+||.+||.+||
T Consensus 290 ~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp 367 (392)
T PHA03207 290 KQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT--IPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367 (392)
T ss_pred CCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcc--ccchhhccCcchhHHHHHHHHhccChhhCC
Confidence 53 4567777777777655433211100000 0000000110 0001 124677899999999999999999
Q ss_pred CHHHHHhccccCCCCC
Q 009654 231 TASAALASEYFSTKPY 246 (529)
Q Consensus 231 ta~e~L~h~~f~~~~~ 246 (529)
|+.++|.||||...|+
T Consensus 368 sa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 368 SAQDILSLPLFTKEPI 383 (392)
T ss_pred CHHHHhhCchhhccch
Confidence 9999999999987654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.18 Aligned_cols=216 Identities=32% Similarity=0.451 Sum_probs=181.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|..++||||+++++++.+ ...+|+|||||+++.+..++.....+++..++.++.||+.||+|||++||+|||
T Consensus 49 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~D 126 (350)
T cd05573 49 RAERDILADADSPWIVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRD 126 (350)
T ss_pred HHHHHHHHhcCCCCccchhhheec--CCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 579999999999999999999987 578999999999876665555557899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC----------------------------CCCccccccccccCCcccccCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH----------------------------RQPLTSRVVTLWYRPPELLLGAT 133 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~----------------------------~~~~~~~~gt~~Y~APE~l~~~~ 133 (529)
|||+||||+.++.+||+|||++....... .......+||+.|+|||++.+.
T Consensus 127 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 205 (350)
T cd05573 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT- 205 (350)
T ss_pred CCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-
Confidence 99999999999999999999997665432 1123455789999999999774
Q ss_pred CCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHH
Q 009654 134 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 213 (529)
Q Consensus 134 ~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~ 213 (529)
.++.++||||||||||+|++|++||.+.+..+...++........ + .....++++
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------~-----------------p~~~~~~~~ 260 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLR--------F-----------------PPDPPVSPE 260 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCccc--------C-----------------CCCCCCCHH
Confidence 689999999999999999999999999888777777755211110 0 001237899
Q ss_pred HHHHHHHhccCCCCCCcC-HHHHHhccccCCCCC
Q 009654 214 AVNLIETLLSVEPYKRAT-ASAALASEYFSTKPY 246 (529)
Q Consensus 214 ~~dLi~~mL~~dP~kR~t-a~e~L~h~~f~~~~~ 246 (529)
+.+||.+||. ||.+|++ +.++|+||||....|
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 9999999997 9999999 999999999987554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=315.77 Aligned_cols=243 Identities=45% Similarity=0.777 Sum_probs=197.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+||||+.+++...+......+++..+..++.||+.||.|||++||+|+|
T Consensus 50 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 127 (298)
T cd07841 50 LREIKLLQELKHPNIIGLLDVFGH--KSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD 127 (298)
T ss_pred HHHHHHHhhcCCCCChhhhheeec--CCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Confidence 469999999999999999999988 578999999995555555443334799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+|||++.++.++|+|||++....... .......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.
T Consensus 128 l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 128 LKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred CChhhEEEcCCCCEEEccceeeeeccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 99999999999999999999998765432 22334456889999999877667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+.+.++...++.+....|.... ++........ -...+...+..++..+.+||.+||..||.+|||+.++|.|+|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 207 SDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPF--PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred ccHHHHHHHHHHcCCCchhhhhhccccccccccccc--CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 9989899998888888776665422 1111111111 112234455678899999999999999999999999999999
Q ss_pred cCCCCCCCC
Q 009654 241 FSTKPYACD 249 (529)
Q Consensus 241 f~~~~~~~~ 249 (529)
|...+.+..
T Consensus 285 ~~~~~~~~~ 293 (298)
T cd07841 285 FSNDPAPTP 293 (298)
T ss_pred ccCCCCCCC
Confidence 998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.11 Aligned_cols=217 Identities=27% Similarity=0.368 Sum_probs=179.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+|||||+++.+..++.. ..+++.++..++.||+.||+|||++||+|||
T Consensus 91 ~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrD 167 (370)
T cd05621 91 WEERDIMAFANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167 (370)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 479999999999999999999987 5789999999998766655543 3689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC---CCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.++.+||+|||++..............+||+.|+|||++.+.. .++.++|||||||+||+|++|.+||
T Consensus 168 LKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred CCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 9999999999999999999999876543322334567999999999997532 3789999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAAL 236 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e~L 236 (529)
.+.+....+.+|......+. + .....++..+++||.+||..++.+ |+|+.++|
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~--------------------~-----p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l 302 (370)
T cd05621 248 YADSLVGTYSKIMDHKNSLN--------------------F-----PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIK 302 (370)
T ss_pred CCCCHHHHHHHHHhCCcccC--------------------C-----CCcccCCHHHHHHHHHHccCchhccCCCCHHHHh
Confidence 99998888888765322111 0 001257889999999999865544 88999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 303 ~hp~~~~~~~ 312 (370)
T cd05621 303 QHPFFKNDQW 312 (370)
T ss_pred cCcccCCCCc
Confidence 9999987443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.57 Aligned_cols=237 Identities=38% Similarity=0.660 Sum_probs=192.6
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++++ +||||+++++++.+.....+|+||||++++++..+......+++.++..++.||+.||.|||+.||+||
T Consensus 45 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 124 (282)
T cd07831 45 LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR 124 (282)
T ss_pred HHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 3689999999 599999999999885447899999999998888776655679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|+||+++. +.+||+|||++...... .......+++.|+|||++.+...++.++||||+||++|+|++|.+||.+
T Consensus 125 dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 125 DIKPENILIKD-DILKLADFGSCRGIYSK--PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred ccCHHHEEEcC-CCeEEEecccccccccC--CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 99999999999 99999999999766432 2233456789999999876655678999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+..+....+.++...+..........+.........+......++..+.+||.+||..||.+|||+.++|+|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 202 TNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 99999999998888887764432211111111111111112233344578999999999999999999999999999999
Q ss_pred c
Q 009654 241 F 241 (529)
Q Consensus 241 f 241 (529)
|
T Consensus 282 ~ 282 (282)
T cd07831 282 F 282 (282)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=323.96 Aligned_cols=212 Identities=27% Similarity=0.398 Sum_probs=179.8
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
..|+.+|..+ +||||++++++|.+ ...+|||||||+++.+...+.....+++..+..++.||+.||.|||++||+||
T Consensus 43 ~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 120 (321)
T cd05591 43 MTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120 (321)
T ss_pred HHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 4688888876 89999999999988 56899999999997776555566689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+
T Consensus 121 Dikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 121 DLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred CCCHHHeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCC
Confidence 999999999999999999999987543221 22345578999999999876 4689999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-------CHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-------TAS 233 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-------ta~ 233 (529)
.+..+.+..|....-.. ...++.++.+||.+||+.||.+|+ ++.
T Consensus 199 ~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~ 249 (321)
T cd05591 199 DNEDDLFESILHDDVLY-----------------------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGED 249 (321)
T ss_pred CCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHH
Confidence 99888887775421100 023678899999999999999999 999
Q ss_pred HHHhccccCCCCC
Q 009654 234 AALASEYFSTKPY 246 (529)
Q Consensus 234 e~L~h~~f~~~~~ 246 (529)
++++||||....|
T Consensus 250 ~~~~hp~~~~~~~ 262 (321)
T cd05591 250 AIKQHPFFKEIDW 262 (321)
T ss_pred HHhcCCccCCCCH
Confidence 9999999976433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.82 Aligned_cols=216 Identities=30% Similarity=0.389 Sum_probs=177.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++.|.+ .+.+|||||||+++.+..++...+.+++..++.++.||+.||+|||++||+|||
T Consensus 49 ~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrD 126 (376)
T cd05598 49 KAERDILAEADNEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126 (376)
T ss_pred HHHHHHHHhCCCCCcceEEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 579999999999999999999988 579999999999877776665666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC------------------------------------------CCCcccccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH------------------------------------------RQPLTSRVV 119 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~------------------------------------------~~~~~~~~g 119 (529)
|||+|||++.++.+||+|||+|..+.... .......+|
T Consensus 127 lkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 206 (376)
T cd05598 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVG 206 (376)
T ss_pred CCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCC
Confidence 99999999999999999999975331000 001123478
Q ss_pred ccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC
Q 009654 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 199 (529)
Q Consensus 120 t~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~ 199 (529)
|+.|+|||++.+ ..++.++||||||||||+|++|++||.+.+..+....+........
T Consensus 207 t~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------- 264 (376)
T cd05598 207 TPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH--------------------- 264 (376)
T ss_pred CccccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc---------------------
Confidence 999999999976 4589999999999999999999999999887776666543111100
Q ss_pred cchhhhhccCCcHHHHHHHHHhccCCCCCCc---CHHHHHhccccCCCCC
Q 009654 200 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKPY 246 (529)
Q Consensus 200 ~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~---ta~e~L~h~~f~~~~~ 246 (529)
......+++++.+||.+|+ .+|.+|+ |+.++++||||....+
T Consensus 265 ----~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 265 ----IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred ----CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 0011357889999999977 5999999 9999999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.36 Aligned_cols=210 Identities=29% Similarity=0.430 Sum_probs=179.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+...+.....+++.++..++.||+.||.|||++||+|||
T Consensus 46 ~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 123 (318)
T cd05582 46 KMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 123 (318)
T ss_pred HHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence 469999999999999999999987 578999999999876665555566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.
T Consensus 124 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 124 LKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCC
Confidence 99999999999999999999987654321 22345678999999999976 45889999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L 236 (529)
+..+.+..+...... ....+++.+.+||.+||+.||.+||| +.+++
T Consensus 202 ~~~~~~~~i~~~~~~-----------------------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~ 252 (318)
T cd05582 202 DRKETMTMILKAKLG-----------------------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIK 252 (318)
T ss_pred CHHHHHHHHHcCCCC-----------------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh
Confidence 887777776442111 01347888999999999999999999 78899
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
.||||...
T Consensus 253 ~~~~~~~~ 260 (318)
T cd05582 253 RHPFFSTI 260 (318)
T ss_pred CCCCcCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.01 Aligned_cols=237 Identities=38% Similarity=0.687 Sum_probs=191.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||+.+++...+......+++..++.++.||+.||.|||++||+|||
T Consensus 51 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~d 128 (291)
T cd07844 51 IREASLLKDLKHANIVTLHDIIHT--KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRD 128 (291)
T ss_pred HHHHHHHhhCCCcceeeEEEEEec--CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 479999999999999999999987 578999999999877766655555789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......++..|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 129 l~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 129 LKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred CCHHHEEEcCCCCEEECccccccccCCCC-ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543221 11223356889999999877666899999999999999999999999877
Q ss_pred C-HHHHHHHHHHHcCCCCchhhhccCCCcccc-CCCCCCCcchhhhhccCCc--HHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 162 T-EVEQLHKIFKLCGSPPDDYWKKSKLPHATL-FKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 162 ~-~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~s--~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
. ..+++..+.+..+.+....|.......... ......-...+...+..++ ..+.+||.+||+.||.+|||+.++|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 208 TDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 6 667888888888888877776533211000 0000001122334444555 88999999999999999999999999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 288 ~~~f 291 (291)
T cd07844 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=314.81 Aligned_cols=217 Identities=24% Similarity=0.342 Sum_probs=175.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+||||+++++++.. ...+|+|||||+++.+...+ .....+++..+..++.||+.||.|||++||
T Consensus 41 ~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 118 (280)
T cd05608 41 MVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118 (280)
T ss_pred HHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 469999999999999999999887 56899999999987765433 234579999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 119 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p 196 (280)
T cd05608 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGP 196 (280)
T ss_pred ccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999997654432 12334578999999999987 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TA 232 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta 232 (529)
|.+.........+.......+ ......++..+.+||.+||+.||++|+ |+
T Consensus 197 f~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 251 (280)
T cd05608 197 FRARGEKVENKELKQRILNDS-------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC 251 (280)
T ss_pred CCCCCcchhHHHHHHhhcccC-------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence 987543322222222111110 011135788999999999999999999 89
Q ss_pred HHHHhccccCCCCCC
Q 009654 233 SAALASEYFSTKPYA 247 (529)
Q Consensus 233 ~e~L~h~~f~~~~~~ 247 (529)
+++++||||+...|.
T Consensus 252 ~~~l~h~~~~~~~~~ 266 (280)
T cd05608 252 DGLRTHPLFRDLNWR 266 (280)
T ss_pred HHHhcChhhhcCCHh
Confidence 999999999875554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.67 Aligned_cols=240 Identities=60% Similarity=1.074 Sum_probs=203.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+.....+|+||||+++++...+......+++.++..++.||+.||+|||+.|++|+|
T Consensus 46 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~d 125 (287)
T cd07840 46 IREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRD 125 (287)
T ss_pred HHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 57999999999999999999998743378999999999877777665556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+|||+++++.+||+|||++...........+...++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.
T Consensus 126 l~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 126 IKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred CcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998776543333445567899999998877667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCcchhhhhccCC-cHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~~~~~~~~~~~l~~~~~~~-s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+....+..+...++.+....|.... +.....+.+.......+...+..+ +..+.++|.+||+.+|.+||++.++|.||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 206 TELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred ChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 9999999999999998877776532 222223334444445555566665 99999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 286 ~~ 287 (287)
T cd07840 286 YF 287 (287)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=313.90 Aligned_cols=236 Identities=41% Similarity=0.747 Sum_probs=191.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++++||||+++++++.+ ...+|+||||+.+++...+.. ....+++.++..++.||+.||+|||+.||+|+
T Consensus 47 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~ 124 (284)
T cd07860 47 IREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124 (284)
T ss_pred HHHHHHHHhcCCCCCcchhhhccc--CCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 579999999999999999999877 568999999998776655432 34578999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|+||+++.++.+||+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+
T Consensus 125 ~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 125 DLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred CCCHHHEEECCCCCEEEeeccchhhcccCc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999987654322 2233446789999999987766678999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.++.+.+.++.+..+.+....|..... +......+.. -...+....+.+++++++||.+||+.||.+|||+.++|+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW-ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccc-cccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 999888888888888887666643211 0000000000 01122334456889999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 283 ~f 284 (284)
T cd07860 283 FF 284 (284)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.43 Aligned_cols=240 Identities=48% Similarity=0.885 Sum_probs=197.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|+++|+.++||||+++++++.+.. ...+|+||||+.+++...+......+++.++..++.||+.||.|||++
T Consensus 55 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~ 134 (311)
T cd07866 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134 (311)
T ss_pred HHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 57999999999999999999876532 235899999999988877776667899999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCCC----------CCccccccccccCCcccccCCCCCCCcchhhhhh
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 145 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~----------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG 145 (529)
||+|+||||+|||++.++.+||+|||++........ ...+...+++.|+|||++.+...++.++||||+|
T Consensus 135 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 214 (311)
T cd07866 135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214 (311)
T ss_pred CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHH
Confidence 999999999999999999999999999976543211 1223446789999999987766689999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 146 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 146 ~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
||+|+|++|++||.+.+.......++..++.+.+..|..... +..............+...+..+++.+.+||.+||..
T Consensus 215 ~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 294 (311)
T cd07866 215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294 (311)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc
Confidence 999999999999999999999999999999887766654321 1111111122233445556677888999999999999
Q ss_pred CCCCCcCHHHHHhcccc
Q 009654 225 EPYKRATASAALASEYF 241 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f 241 (529)
||.+|||+.++|.||||
T Consensus 295 ~p~~R~t~~ell~~~~f 311 (311)
T cd07866 295 DPYKRLTASDALEHPYF 311 (311)
T ss_pred CcccCcCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=321.14 Aligned_cols=211 Identities=25% Similarity=0.421 Sum_probs=176.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
..|+.+|..+ +||||+++++++.+ .+.+|||||||.++.+...+.....+++.++..++.||+.||+|||++||+||
T Consensus 43 ~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr 120 (316)
T cd05620 43 MVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120 (316)
T ss_pred HHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 3577788765 99999999999987 57899999999987766555566789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+
T Consensus 121 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986432211 23345678999999999976 4689999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH-HHHHhcc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASE 239 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta-~e~L~h~ 239 (529)
.+..+.+..+... .+. + ...++.++++||.+||..||.+|+++ +++++||
T Consensus 199 ~~~~~~~~~~~~~--~~~--------------------~-------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 199 DDEDELFESIRVD--TPH--------------------Y-------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred CCHHHHHHHHHhC--CCC--------------------C-------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 8887777666431 110 0 02367889999999999999999998 5788999
Q ss_pred ccCCCC
Q 009654 240 YFSTKP 245 (529)
Q Consensus 240 ~f~~~~ 245 (529)
||....
T Consensus 250 ~f~~~~ 255 (316)
T cd05620 250 FFKTIN 255 (316)
T ss_pred CcCCCC
Confidence 998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=320.53 Aligned_cols=210 Identities=26% Similarity=0.442 Sum_probs=176.1
Q ss_pred HHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.|+.++..+ +||||+++++++.. ...+|+|||||+++.+..++.....+++.++..++.||+.||.|||++||+|||
T Consensus 44 ~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~d 121 (316)
T cd05592 44 VERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121 (316)
T ss_pred HHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 466777655 89999999999987 578999999999977776665666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.
T Consensus 122 lkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 122 LKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997543322 23345678999999999976 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH-HHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta-~e~L~h~~ 240 (529)
+..+.+..+...... + ...++.++.+||.+||..||.+|+++ .++++|||
T Consensus 200 ~~~~~~~~i~~~~~~----------------------~-------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 200 DEDELFDSILNDRPH----------------------F-------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred CHHHHHHHHHcCCCC----------------------C-------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence 887777766431110 0 12468889999999999999999986 58889999
Q ss_pred cCCCC
Q 009654 241 FSTKP 245 (529)
Q Consensus 241 f~~~~ 245 (529)
|....
T Consensus 251 ~~~~~ 255 (316)
T cd05592 251 FRGID 255 (316)
T ss_pred cCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.11 Aligned_cols=210 Identities=26% Similarity=0.354 Sum_probs=175.8
Q ss_pred HHHHHHH---HhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILIL---RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL---~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.++ +.++||||+++++++.+ ...+|+|||||+++.+..... ...+++.++..++.||+.||.|||++||+
T Consensus 47 ~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iv 123 (324)
T cd05589 47 MCEKRIFETANSERHPFLVNLFACFQT--EDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIV 123 (324)
T ss_pred HHHHHHHHhccccCCCChhceeeEEEc--CCEEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 3455554 56789999999999987 578999999999977765553 34799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 124 Hrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf 201 (324)
T cd05589 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF 201 (324)
T ss_pred ecCCCHHHeEECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987543221 22345678999999999976 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TAS 233 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~ 233 (529)
.+.+..+.+..+....... ...++..+.+||.+||..||.+|| ++.
T Consensus 202 ~~~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 252 (324)
T cd05589 202 PGDDEEEVFDSIVNDEVRY-----------------------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAE 252 (324)
T ss_pred CCCCHHHHHHHHHhCCCCC-----------------------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHH
Confidence 9998888777765421111 134788999999999999999999 799
Q ss_pred HHHhccccCCCC
Q 009654 234 AALASEYFSTKP 245 (529)
Q Consensus 234 e~L~h~~f~~~~ 245 (529)
++++||||....
T Consensus 253 ~l~~~~~f~~~~ 264 (324)
T cd05589 253 DVKKQPFFRDIN 264 (324)
T ss_pred HHhhCCCcCCCC
Confidence 999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.47 Aligned_cols=206 Identities=25% Similarity=0.400 Sum_probs=174.9
Q ss_pred HHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 009654 7 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 86 (529)
Q Consensus 7 iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~N 86 (529)
+++.++||||+++++++.+ ...+|+|||||+++.+..++.....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 49 ~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~N 126 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQT--ADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPEN 126 (323)
T ss_pred HHhhCCCCCCCCeeEEEEe--CCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHH
Confidence 5678999999999999987 57899999999997776666666789999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHH
Q 009654 87 LLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 166 (529)
Q Consensus 87 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~ 166 (529)
|||+.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.
T Consensus 127 Ill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 204 (323)
T cd05575 127 ILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204 (323)
T ss_pred eEECCCCcEEEeccCCCcccccCC-CccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHH
Confidence 999999999999999987533221 22345578999999999876 4589999999999999999999999999887777
Q ss_pred HHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH----HHHHhccccC
Q 009654 167 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFS 242 (529)
Q Consensus 167 ~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta----~e~L~h~~f~ 242 (529)
+..+.... . .....++..+.+||.+||+.||.+|+++ .++++||||.
T Consensus 205 ~~~i~~~~--~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~ 255 (323)
T cd05575 205 YDNILNKP--L---------------------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255 (323)
T ss_pred HHHHHcCC--C---------------------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence 77764411 0 1113578899999999999999999998 6999999998
Q ss_pred CCC
Q 009654 243 TKP 245 (529)
Q Consensus 243 ~~~ 245 (529)
...
T Consensus 256 ~~~ 258 (323)
T cd05575 256 SIN 258 (323)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.46 Aligned_cols=212 Identities=26% Similarity=0.437 Sum_probs=179.4
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.+ +||||+++++++.+ .+.+|+|||||+++.+...+.....+++.++..++.||+.||.|||++||+||
T Consensus 43 ~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~ 120 (318)
T cd05570 43 MTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120 (318)
T ss_pred HHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEcc
Confidence 4688899888 79999999999987 56899999999997777666666689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+
T Consensus 121 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred CCCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 999999999999999999999986532221 22334578999999999976 4589999999999999999999999998
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH-----HHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta-----~e~ 235 (529)
.+..+.+..+...... ....++..+.+||.+||..||.+|||+ .++
T Consensus 199 ~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~l 249 (318)
T cd05570 199 DDEDELFQSILEDEVR-----------------------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDI 249 (318)
T ss_pred CCHHHHHHHHHcCCCC-----------------------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence 8877776666431100 012478899999999999999999999 999
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
+.||||+...|
T Consensus 250 l~~~~~~~~~~ 260 (318)
T cd05570 250 KGHPFFREIDW 260 (318)
T ss_pred hcCCCcCCCCH
Confidence 99999986433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.99 Aligned_cols=238 Identities=23% Similarity=0.295 Sum_probs=177.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~-gIvH 79 (529)
+.+|+.+|++++||||+++++++.+ ...+|+||||++++.+..++.....+++..+..++.||+.||.|||+. +|+|
T Consensus 50 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH 127 (331)
T cd06649 50 IIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMH 127 (331)
T ss_pred HHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence 3589999999999999999999987 568999999999977776666666799999999999999999999986 6999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+|||++.++.+||+|||++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 128 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred CCCChhhEEEcCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998765432 2334578999999999976 458999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhcc-CCCc--cccCC----CCCCCcc---h---h-h---h--hccCCcHHHHHHHHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKS-KLPH--ATLFK----PQQPYDS---S---L-R---E--TFKDLPTTAVNLIET 220 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~-~l~~--~~~~~----~~~~~~~---~---l-~---~--~~~~~s~~~~dLi~~ 220 (529)
+.+..+....+...........+... ..+. ..... ...+... . + . . ....+++++++||.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (331)
T cd06649 204 PPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK 283 (331)
T ss_pred CCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHH
Confidence 77665543332111100000000000 0000 00000 0000000 0 0 0 0 012468899999999
Q ss_pred hccCCCCCCcCHHHHHhccccCCC
Q 009654 221 LLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 221 mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
||..||++|||+.++|+||||+..
T Consensus 284 ~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 284 CLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HccCCcccCCCHHHHhcChHHhhc
Confidence 999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=327.99 Aligned_cols=217 Identities=26% Similarity=0.384 Sum_probs=179.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|..++||||+++++.+.+ ...+|||||||+++.+..++.....+++..++.++.||+.||+|||++||+|||
T Consensus 49 ~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrD 126 (360)
T cd05627 49 RAERDILVEADGAWVVKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126 (360)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccC
Confidence 469999999999999999999987 578999999999977776665667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCC----------------------------------CCccccccccccCCcc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHR----------------------------------QPLTSRVVTLWYRPPE 127 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~Y~APE 127 (529)
|||+||||+.+|.+||+|||++........ ......+||+.|+|||
T Consensus 127 Lkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 206 (360)
T cd05627 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206 (360)
T ss_pred CCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHH
Confidence 999999999999999999999875432110 0112457999999999
Q ss_pred cccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc
Q 009654 128 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 128 ~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 207 (529)
++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+.+|........ +. ..
T Consensus 207 ~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------~p-----~~ 260 (360)
T cd05627 207 VFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV--------------------FP-----PE 260 (360)
T ss_pred HHcC-CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCcee--------------------cC-----CC
Confidence 9976 4689999999999999999999999999888887777754211100 00 01
Q ss_pred cCCcHHHHHHHHHhccCCCCCCc---CHHHHHhccccCCCCCC
Q 009654 208 KDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKPYA 247 (529)
Q Consensus 208 ~~~s~~~~dLi~~mL~~dP~kR~---ta~e~L~h~~f~~~~~~ 247 (529)
..+++++++||.+|+ .||.+|+ ++.++++||||....|.
T Consensus 261 ~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 261 VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 247889999999987 5999998 48999999999986654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.22 Aligned_cols=240 Identities=49% Similarity=0.905 Sum_probs=199.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC--------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL--------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~--------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+++.++||||+++++++.+.. ...+||||||++++++..+......+++.++..++.||+.||.|||
T Consensus 54 ~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH 133 (302)
T cd07864 54 IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133 (302)
T ss_pred HHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999987642 2379999999999887777665567999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
+.||+|+||||+||++++++.+||+|||++...............++..|+|||++.+...++.++|||||||++|+|++
T Consensus 134 ~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~ 213 (302)
T cd07864 134 KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213 (302)
T ss_pred hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999987654332333344568889999998765567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|++||...+..+.+..+...++.+....|..... +......+.......+...+..+|..+.+||.+||..||.+|||+
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 293 (302)
T cd07864 214 KKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293 (302)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9999999999999999999999888776654221 111111222223344556667789999999999999999999999
Q ss_pred HHHHhcccc
Q 009654 233 SAALASEYF 241 (529)
Q Consensus 233 ~e~L~h~~f 241 (529)
.++|.||||
T Consensus 294 ~~il~~~~~ 302 (302)
T cd07864 294 EEALNSPWL 302 (302)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=307.61 Aligned_cols=236 Identities=34% Similarity=0.638 Sum_probs=189.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.. ...+|+||||++++++..+......+++.++..++.||+.||.|||++||+|+|
T Consensus 48 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~d 125 (286)
T cd07847 48 LREIRMLKQLKHPNLVNLIEVFRR--KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125 (286)
T ss_pred HHHHHHHHhCCCCCEeeeeeEEee--CCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 579999999999999999999987 578999999999998887766666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||+++.++.+||+|||++........ ......++.+|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 126 VKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred CChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654321 2234567899999999877667899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCch---hhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 162 TEVEQLHKIFKLCGSPPDD---YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~---~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+..+.+..+....+..... .|......... ..+...-...+...+..++..+.+||.+||+.||++|||+.++|.|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 205 SDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL-SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcccccccccc-cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 8887777776655543221 11111100000 0011111112334456789999999999999999999999999999
Q ss_pred ccc
Q 009654 239 EYF 241 (529)
Q Consensus 239 ~~f 241 (529)
|||
T Consensus 284 ~~f 286 (286)
T cd07847 284 PYF 286 (286)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.85 Aligned_cols=248 Identities=42% Similarity=0.785 Sum_probs=202.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.. ...+|+||||+.+++...+. ....+++..+..++.||+.||.|||+.||+|+|
T Consensus 68 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 68 LRELKIMNEIKHENIMGLVDVYVE--GDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred HHHHHHHHhCCCcceeeeeEEEec--CCcEEEEEeccccCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 479999999999999999999987 57899999999987666554 445799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCC-------------CCCCccccccccccCCcccccCCCCCCCcchhhhhhHHH
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTG-------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 148 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~-------------~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il 148 (529)
|+|+||+++.++.+||+|||++...... .........+++.|+|||++.+...++.++|||||||++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999765411 111223345688999999998766689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 149 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 149 ~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
|+|++|.+||.+.+..+.+..+...++.+....|..... +....+.. .....+...+...+..+.+||.+||+.||.
T Consensus 225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTP--RKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCc--CCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 999999999999999999999999999888776654321 11111111 112233445567889999999999999999
Q ss_pred CCcCHHHHHhccccCCCCCCCCCCCCC
Q 009654 228 KRATASAALASEYFSTKPYACDLSSLP 254 (529)
Q Consensus 228 kR~ta~e~L~h~~f~~~~~~~~~~~~p 254 (529)
+|||++++|.||||...+..+.+..+|
T Consensus 303 ~R~s~~~~l~~~~~~~~~~~~~~~~~~ 329 (335)
T PTZ00024 303 ERISAKEALKHEYFKSDPLPCDPSQLP 329 (335)
T ss_pred hccCHHHHhcCcccCCCCCCCCcccCC
Confidence 999999999999999887776655443
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.01 Aligned_cols=212 Identities=22% Similarity=0.398 Sum_probs=171.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.+ +||||++++++|.+ ...+|||||||+++.+..+......+++..+..++.||+.||.|||++||+||
T Consensus 43 ~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 120 (329)
T cd05588 43 QTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120 (329)
T ss_pred HHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 4789999999 79999999999988 57899999999997766555556789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++...... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||..
T Consensus 121 dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCCHHHeEECCCCCEEECcCccccccccC-CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccc
Confidence 99999999999999999999998643221 122345678999999999976 4689999999999999999999999963
Q ss_pred CCH--------HH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 161 RTE--------VE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 161 ~~~--------~~-~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
... .+ ..+.+... .+ .....++..+.+||.+||+.||.+|+|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~--~~---------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 199 VGMSDNPDQNTEDYLFQVILEK--QI---------------------------RIPRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred ccccccccccchHHHHHHHHcC--CC---------------------------CCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 211 11 11222110 00 011357888999999999999999987
Q ss_pred ------HHHHHhccccCCCCC
Q 009654 232 ------ASAALASEYFSTKPY 246 (529)
Q Consensus 232 ------a~e~L~h~~f~~~~~ 246 (529)
+.++++||||....|
T Consensus 250 ~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 250 CHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred CCCCCCHHHHhcCCCCCCCCH
Confidence 789999999976443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.86 Aligned_cols=237 Identities=36% Similarity=0.689 Sum_probs=194.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~--~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.++++++||||+++++++.+ .+.+||||||+++++...+.... ..+++.++..++.||+.||.|||+.||+|
T Consensus 46 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h 123 (284)
T cd07836 46 IREISLMKELKHENIVRLHDVIHT--ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123 (284)
T ss_pred HHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 479999999999999999999988 56889999999998777654332 46999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||++++++.++|+|||++....... .......+++.|++||++.+...++.++|||||||++|+|++|.+||.
T Consensus 124 ~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 124 RDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred CCCCHHHEEECCCCcEEEeecchhhhhcCCc-cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997654321 122345678999999998776668999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+..+.+..+....+.|....|....................+....+.++..++++|.+||+.||.+||++.++|+||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 282 (284)
T cd07836 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282 (284)
T ss_pred CCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 99999999999998888887777653321111100000111222334456789999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 283 ~f 284 (284)
T cd07836 283 WF 284 (284)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=323.46 Aligned_cols=211 Identities=27% Similarity=0.375 Sum_probs=176.7
Q ss_pred HHHHHHHhC---CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 3 REILILRRL---DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 3 rEi~iL~~L---~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+|..++..+ +||||+++++++.+ ...+|+||||++++.+...+.....+++..++.++.||+.||+|||++||+|
T Consensus 42 ~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivH 119 (330)
T cd05586 42 GERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119 (330)
T ss_pred HHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 466677665 79999999999988 5789999999998766655556678999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||||+.++.+||+|||++....... ......+||+.|+|||++.+...|+.++||||||||+|+|++|..||.
T Consensus 120 rDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 120 RDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred ccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 9999999999999999999999987543321 223456799999999999876668999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc----CHHHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAA 235 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~----ta~e~ 235 (529)
+.+..+.+..|.......+ ...+++++.+||.+||+.||.+|| ++.++
T Consensus 199 ~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~l 250 (330)
T cd05586 199 AEDTQQMYRNIAFGKVRFP----------------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVEL 250 (330)
T ss_pred CCCHHHHHHHHHcCCCCCC----------------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHH
Confidence 9887777666643110000 023688899999999999999998 79999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
++||||...
T Consensus 251 l~h~~~~~~ 259 (330)
T cd05586 251 KEHPFFADI 259 (330)
T ss_pred hcCccccCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=325.02 Aligned_cols=210 Identities=28% Similarity=0.424 Sum_probs=187.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.++++|.|||||.+++.|... ++.+||||+||+|+.+...+ . ++..|+|+.+..|+.||+.||.|||+++|+|
T Consensus 51 ~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLH 129 (426)
T KOG0589|consen 51 IQEMDLLSKLLHPNIVEYKDSFEED-GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLH 129 (426)
T ss_pred HHHHHHHHhccCCCeeeeccchhcC-CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 5799999999999999999999884 45599999999997776544 3 3367999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||+.|||++.++.|||+|||+|+...+.. ....+.+|||.|+.||++.+ .+|+.++|||||||++|||++-+++|.
T Consensus 130 RDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 130 RDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred ccchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccC
Confidence 9999999999999999999999999887653 24557899999999999987 569999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+....+.+|+..+..|-+ ..++.+++.||..||..+|..||++.++|.+|
T Consensus 208 a~~m~~Li~ki~~~~~~Plp----------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 208 ASNMSELILKINRGLYSPLP----------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ccchHHHHHHHhhccCCCCC----------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 99999999999987655432 35688899999999999999999999999997
Q ss_pred ccC
Q 009654 240 YFS 242 (529)
Q Consensus 240 ~f~ 242 (529)
...
T Consensus 260 ~l~ 262 (426)
T KOG0589|consen 260 HLL 262 (426)
T ss_pred hhh
Confidence 765
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.76 Aligned_cols=217 Identities=27% Similarity=0.358 Sum_probs=179.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+|||||+++.+..++.. ..+++..+..++.||+.||+|||++||+|||
T Consensus 91 ~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 167 (371)
T cd05622 91 WEERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167 (371)
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 478999999999999999999987 5789999999998766655543 4689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC---CCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.+|.+||+|||++..............+||+.|+|||++.+.. .|+.++|||||||++|+|++|.+||
T Consensus 168 Lkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 9999999999999999999999876543222334567999999999997532 3789999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAAL 236 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e~L 236 (529)
.+.+....+.+|.......+ ......++..+++||..||..++.+ |+++.+++
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~ 302 (371)
T cd05622 248 YADSLVGTYSKIMNHKNSLT-------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 302 (371)
T ss_pred CCCCHHHHHHHHHcCCCccc-------------------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHh
Confidence 99988888877765221110 0112368899999999999844433 78999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+|+||+..++
T Consensus 303 ~h~~~~~~~~ 312 (371)
T cd05622 303 RHLFFKNDQW 312 (371)
T ss_pred cCcccCCCCh
Confidence 9999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.50 Aligned_cols=207 Identities=25% Similarity=0.385 Sum_probs=175.9
Q ss_pred HHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 009654 6 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGS 85 (529)
Q Consensus 6 ~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~ 85 (529)
.+++.++||||+++++++.+ .+.+|+|||||+++.+..++.....+++..+..++.||+.||.|||++||+||||||+
T Consensus 48 ~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~ 125 (325)
T cd05602 48 VLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 125 (325)
T ss_pred HHHHhCCCCCCCceeEEEEc--CCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence 35678899999999999987 5789999999999777766666678999999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHH
Q 009654 86 NLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 165 (529)
Q Consensus 86 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~ 165 (529)
|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 126 Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 203 (325)
T cd05602 126 NILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203 (325)
T ss_pred HeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999987543221 22345678999999999976 468999999999999999999999999988888
Q ss_pred HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH----HHHhcccc
Q 009654 166 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS----AALASEYF 241 (529)
Q Consensus 166 ~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~----e~L~h~~f 241 (529)
.+..+...... ..+.++..+.+||.+||+.||.+|+++. ++++|+||
T Consensus 204 ~~~~i~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 204 MYDNILNKPLQ-----------------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred HHHHHHhCCcC-----------------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence 77776542110 1136788999999999999999999876 89999999
Q ss_pred CCCC
Q 009654 242 STKP 245 (529)
Q Consensus 242 ~~~~ 245 (529)
....
T Consensus 255 ~~~~ 258 (325)
T cd05602 255 SPIN 258 (325)
T ss_pred CCCC
Confidence 7543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.09 Aligned_cols=237 Identities=22% Similarity=0.330 Sum_probs=182.9
Q ss_pred HHHHHHHHhCCCC------CccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 009654 2 AREILILRRLDHP------NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS- 74 (529)
Q Consensus 2 ~rEi~iL~~L~Hp------nIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~- 74 (529)
.+|+.+++.+.|. +|++++++|... ...+|||||++.++++..+.. ...+++.+++.++.||+.||+|||+
T Consensus 173 ~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~ 250 (467)
T PTZ00284 173 KIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTE 250 (467)
T ss_pred HHHHHHHHHHhhcCcccCcceeeeEEEEEcC-CceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 3588888887554 588999988764 468999999998877776653 4579999999999999999999998
Q ss_pred CCCcccCCCCCcEEEccCC----------------cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCc
Q 009654 75 RGVLHRDIKGSNLLVNNEG----------------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 138 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g----------------~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~ 138 (529)
.||+||||||+||||+.++ .+||+|||++..... ..+..+||+.|+|||++.+ ..|+.+
T Consensus 251 ~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-~~~~~~ 325 (467)
T PTZ00284 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-LGWMYS 325 (467)
T ss_pred CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhc-CCCCcH
Confidence 5999999999999998765 499999998864322 2345689999999999987 459999
Q ss_pred chhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccc-cCCCC----CCCcc-hhhh-----hc
Q 009654 139 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT-LFKPQ----QPYDS-SLRE-----TF 207 (529)
Q Consensus 139 ~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~-~~~~~----~~~~~-~l~~-----~~ 207 (529)
+||||||||||||++|++||.+.+..+++..|.+.+|.++..++......... .+... ..+.. .+.. .+
T Consensus 326 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (467)
T PTZ00284 326 TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405 (467)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccch
Confidence 99999999999999999999999999999999999998886654332111000 00000 00000 0000 00
Q ss_pred --cCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCCC
Q 009654 208 --KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 245 (529)
Q Consensus 208 --~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~ 245 (529)
...++.+.|||.+||++||.+|||+.|+|+||||....
T Consensus 406 ~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred hhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 01245688999999999999999999999999998643
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.06 Aligned_cols=237 Identities=22% Similarity=0.357 Sum_probs=179.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.. ....|+||||+.+++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 105 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 182 (357)
T PHA03209 105 LIEAMLLQNVNHPSVIRMKDTLVS--GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182 (357)
T ss_pred HHHHHHHHhCCCCCCcChhheEEe--CCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 479999999999999999999987 568899999999988887776677899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC-CCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~-~pf~g 160 (529)
|||+|||++.++.+||+|||++...... .......||+.|+|||++.+ ..|+.++|||||||++|+|+++. ++|.+
T Consensus 183 lkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 183 VKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred CCHHHEEECCCCCEEEecCccccccccC--cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 9999999999999999999998754322 12334578999999999977 45899999999999999999854 55543
Q ss_pred CC---------HHHHHHHHHHHcCCCCchhhhccCCCccc-----cCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCC
Q 009654 161 RT---------EVEQLHKIFKLCGSPPDDYWKKSKLPHAT-----LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226 (529)
Q Consensus 161 ~~---------~~~~~~~I~~~~g~p~~~~~~~~~l~~~~-----~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP 226 (529)
.. ....+..+....+..+..+.......... ......++..........++.++.+||.+||+.||
T Consensus 260 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 339 (357)
T PHA03209 260 PPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDA 339 (357)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCc
Confidence 21 12344555555554443322100000000 00000111111111123678889999999999999
Q ss_pred CCCcCHHHHHhccccCC
Q 009654 227 YKRATASAALASEYFST 243 (529)
Q Consensus 227 ~kR~ta~e~L~h~~f~~ 243 (529)
.+|||+.|+|+||||++
T Consensus 340 ~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 340 AMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccCcCHHHHhcCchhcc
Confidence 99999999999999974
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.02 Aligned_cols=211 Identities=28% Similarity=0.403 Sum_probs=177.5
Q ss_pred HHHHHHHHhCCCC-CccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHP-NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~Hp-nIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|..++|+ +|+++++++.+ .+.+|+|||||+++.+...+.....+++.++..++.||+.||.|||++||+||
T Consensus 48 ~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~ 125 (324)
T cd05587 48 MVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125 (324)
T ss_pred HHHHHHHHhcCCCCceeeeEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 4688999999764 68889998887 56899999999987776666566689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||+|||+|+|++|++||.+
T Consensus 126 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 126 DLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred CCCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986432211 12334578999999999976 4589999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH-----HHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta-----~e~ 235 (529)
.+..+.+..|....... ...++.++++||.+||..||.+|+++ .++
T Consensus 204 ~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (324)
T cd05587 204 EDEDELFQSIMEHNVSY-----------------------------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDI 254 (324)
T ss_pred CCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence 98888887775421111 13578899999999999999999986 899
Q ss_pred HhccccCCCC
Q 009654 236 LASEYFSTKP 245 (529)
Q Consensus 236 L~h~~f~~~~ 245 (529)
++||||....
T Consensus 255 ~~hp~~~~~~ 264 (324)
T cd05587 255 REHAFFRRID 264 (324)
T ss_pred hcCCCcCCCC
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.12 Aligned_cols=213 Identities=28% Similarity=0.405 Sum_probs=169.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|+.++||||+++++++.+ .+.+|+|||||+++.+... ..+++..+..++.||+.||.|||++||+||
T Consensus 119 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 192 (353)
T PLN00034 119 ICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHR 192 (353)
T ss_pred HHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 3589999999999999999999987 5789999999998765432 245788899999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC----CCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+||||+.++.+||+|||++..+.... ......+||+.|+|||++... ..++.++||||||||+|+|++|+.
T Consensus 193 Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 193 DIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred CCCHHHEEEcCCCCEEEcccccceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999998664321 223456889999999988431 234678999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||......+....+........ ......++.++++||.+||..||++|||+.++|
T Consensus 272 pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 272 PFGVGRQGDWASLMCAICMSQP-------------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred CCCCCCCccHHHHHHHHhccCC-------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 9974332222221111111100 011135788999999999999999999999999
Q ss_pred hccccCCCC
Q 009654 237 ASEYFSTKP 245 (529)
Q Consensus 237 ~h~~f~~~~ 245 (529)
+||||....
T Consensus 327 ~hp~~~~~~ 335 (353)
T PLN00034 327 QHPFILRAQ 335 (353)
T ss_pred cCcccccCC
Confidence 999998753
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=310.05 Aligned_cols=240 Identities=43% Similarity=0.747 Sum_probs=190.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|+.++++++||||+++++++.... ...+|+||||+.+++...+......+++.++..++.||+.||.|||++
T Consensus 59 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 138 (310)
T cd07865 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138 (310)
T ss_pred HHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 47999999999999999999887632 245799999999988777766666899999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
||+|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+...++.++||||+||++|+|+
T Consensus 139 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~ 218 (310)
T cd07865 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218 (310)
T ss_pred CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999976643221 12234567889999999877666889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCcchhhhhc--cCCcHHHHHHHHHhccCCCCCC
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~--~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+|.+||.+.+.......+...+|..+.+.|........ ................+ ...+..+++||.+||..||.+|
T Consensus 219 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R 298 (310)
T cd07865 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKR 298 (310)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhc
Confidence 99999999999889999999999887776654321110 00000000111111111 1236778999999999999999
Q ss_pred cCHHHHHhcccc
Q 009654 230 ATASAALASEYF 241 (529)
Q Consensus 230 ~ta~e~L~h~~f 241 (529)
||++++|+||||
T Consensus 299 ~t~~e~l~h~~f 310 (310)
T cd07865 299 IDADTALNHDFF 310 (310)
T ss_pred cCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.60 Aligned_cols=212 Identities=28% Similarity=0.451 Sum_probs=177.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
..|+.+++.+ +||||+++++++.+ ...+||||||++++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 43 ~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHr 120 (316)
T cd05619 43 MVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120 (316)
T ss_pred HHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence 3577888765 99999999999988 56899999999987776665555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.+
T Consensus 121 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 121 DLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987543221 12345578999999999976 4589999999999999999999999998
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH-HHHhcc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASE 239 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~-e~L~h~ 239 (529)
.+..+.+..+... .+. + ...++.++++||.+||..||.+|+++. ++++||
T Consensus 199 ~~~~~~~~~i~~~--~~~--------------------~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05619 199 HDEEELFQSIRMD--NPC--------------------Y-------PRWLTREAKDILVKLFVREPERRLGVKGDIRQHP 249 (316)
T ss_pred CCHHHHHHHHHhC--CCC--------------------C-------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence 8877776665331 110 0 023678899999999999999999996 899999
Q ss_pred ccCCCCC
Q 009654 240 YFSTKPY 246 (529)
Q Consensus 240 ~f~~~~~ 246 (529)
||....|
T Consensus 250 ~~~~~~~ 256 (316)
T cd05619 250 FFREIDW 256 (316)
T ss_pred ccCCCCH
Confidence 9987544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=318.09 Aligned_cols=219 Identities=25% Similarity=0.346 Sum_probs=178.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||++++++|.+ ...+|+||||++++.+..++ .....+++..+..++.||+.||+|||++||+||
T Consensus 49 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 126 (331)
T cd05597 49 REERDVLVNGDRRWITNLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126 (331)
T ss_pred HHHHHHHHhCCCCCCCceEEEEec--CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEC
Confidence 468999999999999999999987 57899999999886655444 335679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+||||+.++.+||+|||++..............+||+.|+|||++.+ ...++.++|||||||++|+|++|+.
T Consensus 127 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 206 (331)
T cd05597 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred CCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCC
Confidence 999999999999999999999987655433222233578999999999863 2457889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e 234 (529)
||.+.+..+.+..|........ +......++..+++||.+||+.++.+ |+++.+
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~ 262 (331)
T cd05597 207 PFYAESLVETYGKIMNHKEHFQ------------------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQD 262 (331)
T ss_pred CCCCCCHHHHHHHHHcCCCccc------------------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 9999888777777654211110 00112348899999999999765554 789999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
+|+||||....|
T Consensus 263 ~l~hp~~~~~~~ 274 (331)
T cd05597 263 FKDHPFFEGIDW 274 (331)
T ss_pred HhcCCCCCCCCH
Confidence 999999987544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.85 Aligned_cols=212 Identities=23% Similarity=0.407 Sum_probs=171.4
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++.++ +||||+++++++.+ .+.+|||||||+++.+.........+++..++.++.||+.||.|||++||+||
T Consensus 43 ~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 120 (329)
T cd05618 43 QTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120 (329)
T ss_pred HHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 4688888877 89999999999988 57899999999997776665566689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||..
T Consensus 121 Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCcc
Confidence 999999999999999999999987532221 22345678999999999976 4589999999999999999999999952
Q ss_pred CC---------HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 161 RT---------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 161 ~~---------~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
.. .......+.... ......++..+.+||.+||+.||.+|+|
T Consensus 199 ~~~~~~~~~~~~~~~~~~i~~~~-----------------------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 199 VGSSDNPDQNTEDYLFQVILEKQ-----------------------------IRIPRSLSVKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred CCCcCCcccccHHHHHHHHhcCC-----------------------------CCCCCCCCHHHHHHHHHHhcCCHHHcCC
Confidence 11 111112221100 0011357888999999999999999998
Q ss_pred ------HHHHHhccccCCCCC
Q 009654 232 ------ASAALASEYFSTKPY 246 (529)
Q Consensus 232 ------a~e~L~h~~f~~~~~ 246 (529)
+.++++||||....|
T Consensus 250 ~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 250 CHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred CCCCCCHHHHhcCCCCCCCCH
Confidence 589999999986543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.86 Aligned_cols=239 Identities=26% Similarity=0.374 Sum_probs=177.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||++++++.. ....|||||++.++++..+......+++.++..++.||+.||.|||++||+|||
T Consensus 208 ~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrD 285 (461)
T PHA03211 208 VHEARLLRRLSHPAVLALLDVRVV--GGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRD 285 (461)
T ss_pred HHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECc
Confidence 579999999999999999999877 568999999999888877766556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC-C
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-Q 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf-~ 159 (529)
|||+||||+.++.+||+|||+++........ .....+||+.|+|||++.+ ..|+.++||||||||||||++|..++ .
T Consensus 286 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred CCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 9999999999999999999999865432211 1224578999999999977 45899999999999999999987544 3
Q ss_pred CCC------HHHHHHHHHHHcCCCCchhhhcc--CCC----ccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 160 GRT------EVEQLHKIFKLCGSPPDDYWKKS--KLP----HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 160 g~~------~~~~~~~I~~~~g~p~~~~~~~~--~l~----~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
+.. ...++.+++...+.....+-... .+. ..........+.......+..++.++.+||.+||+.||.
T Consensus 365 ~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~ 444 (461)
T PHA03211 365 ASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGA 444 (461)
T ss_pred CCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChh
Confidence 221 12445555554433221110000 000 000000000111111122335677899999999999999
Q ss_pred CCcCHHHHHhccccCC
Q 009654 228 KRATASAALASEYFST 243 (529)
Q Consensus 228 kR~ta~e~L~h~~f~~ 243 (529)
+|||+.|+|+||||+.
T Consensus 445 ~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 445 RRPSAAELLRLPLFQS 460 (461)
T ss_pred hCcCHHHHhhCcccCC
Confidence 9999999999999974
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=308.06 Aligned_cols=239 Identities=41% Similarity=0.768 Sum_probs=193.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++++++||||+++++++.+ ...+|+||||+++++...+.. ....+++..+..++.||+.||+|||++||+|+
T Consensus 49 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~ 126 (294)
T PLN00009 49 IREISLLKEMQHGNIVRLQDVVHS--EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR 126 (294)
T ss_pred HHHHHHHHhccCCCEeeEEEEEec--CCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 479999999999999999999987 578999999999877766543 33347889999999999999999999999999
Q ss_pred CCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||+|+||+++. ++.+||+|||++...... ....+...+++.|+|||++.+...++.++||||+||++|+|++|.+||.
T Consensus 127 dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 127 DLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred CCCcceEEEECCCCEEEEcccccccccCCC-ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999985 457999999999765432 1223445678999999998776668999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+.+..+.+.+++...+.+....|.... ++......+.. ....+....+.+++.+.++|.+||+.+|++||++.++|.|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 206 GDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKW-PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccC-CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999988988888776422 11111100100 0112233346788999999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||...
T Consensus 285 ~~~~~~ 290 (294)
T PLN00009 285 EYFKDL 290 (294)
T ss_pred chHhHH
Confidence 999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=318.34 Aligned_cols=239 Identities=31% Similarity=0.590 Sum_probs=189.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.++++++||||++++++|.... ...+|+|||||.+++...+.. .+++.++..++.||+.||+|||++||
T Consensus 63 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi 139 (353)
T cd07850 63 YRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGI 139 (353)
T ss_pred HHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 47999999999999999999987532 245799999999877766543 38999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 140 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p 216 (353)
T cd07850 140 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVL 216 (353)
T ss_pred eeCCCCHHHEEECCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999999998664431 2334567899999999977 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCC--------------CCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--------------PQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
|.+.+....+.++...+|.|+.+++............ +...+...........+..+++||.+||.
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 296 (353)
T cd07850 217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296 (353)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcC
Confidence 9999999999999999998877654432111000000 00001100011122457789999999999
Q ss_pred CCCCCCcCHHHHHhccccCCCCC
Q 009654 224 VEPYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h~~f~~~~~ 246 (529)
.||.+|||+.++|.||||..+-.
T Consensus 297 ~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 297 IDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred CChhhCcCHHHHhcChhHhhccC
Confidence 99999999999999999985433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.88 Aligned_cols=210 Identities=24% Similarity=0.369 Sum_probs=176.0
Q ss_pred HHHH-HHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REIL-ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi~-iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
+|+. +++.++||||+++++++.. .+.+|||||||.++.+...+.....+++.++..++.||+.||+|||++||+|||
T Consensus 44 ~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~D 121 (325)
T cd05604 44 AERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121 (325)
T ss_pred HHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 3443 5777899999999999987 578999999999987766666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++...... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.
T Consensus 122 lkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 122 LKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred CCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCC
Confidence 9999999999999999999998753322 122345678999999999976 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH----HHHHh
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALA 237 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta----~e~L~ 237 (529)
+..+.+..+... .. ...+.++..+.++|.+||..||.+||++ .++++
T Consensus 200 ~~~~~~~~~~~~--~~---------------------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 200 DVAEMYDNILHK--PL---------------------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred CHHHHHHHHHcC--Cc---------------------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 877777666441 10 0113577889999999999999999976 59999
Q ss_pred ccccCCCC
Q 009654 238 SEYFSTKP 245 (529)
Q Consensus 238 h~~f~~~~ 245 (529)
||||....
T Consensus 251 h~~f~~~~ 258 (325)
T cd05604 251 HPFFESLS 258 (325)
T ss_pred CCCcCCCC
Confidence 99998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.94 Aligned_cols=212 Identities=25% Similarity=0.368 Sum_probs=179.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
..|+.++..+ +||+|+++++++.+ .+.+||||||++++.+...+.....+++.++..++.||+.||+|||++||+||
T Consensus 48 ~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 125 (323)
T cd05616 48 MVEKRVLALSGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125 (323)
T ss_pred HHHHHHHHhccCCCeEeeEEEEEec--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence 3577888877 68999999999987 57899999999987776655556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+
T Consensus 126 Dlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred CCCHHHeEECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 999999999999999999999987543221 22345678999999999976 4689999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~ 235 (529)
.+..+.+..|....... ...++.++.+||.+||+.||.+|++ ..++
T Consensus 204 ~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i 254 (323)
T cd05616 204 EDEDELFQSIMEHNVAY-----------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 254 (323)
T ss_pred CCHHHHHHHHHhCCCCC-----------------------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHH
Confidence 98888887775521111 1357889999999999999999998 4899
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
++|+||....|
T Consensus 255 ~~h~~~~~~~~ 265 (323)
T cd05616 255 KEHAFFRYIDW 265 (323)
T ss_pred hcCCCcCCCCH
Confidence 99999986544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=310.10 Aligned_cols=216 Identities=24% Similarity=0.386 Sum_probs=177.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.|+||||+++++++.+ .+.+|+|||||+++.+..... ....+++..+..++.||+.||.|||+.||+|
T Consensus 48 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 125 (285)
T cd05605 48 LNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125 (285)
T ss_pred HHHHHHHHhcCCCCEeeeeeeecC--CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence 479999999999999999999987 568999999999876654432 2346999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||++++++.++|+|||++....... .....++|+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 126 ~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred cCCCHHHEEECCCCCEEEeeCCCceecCCCC--ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999987654322 2234578999999999976 458999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e 234 (529)
+.+.......+.......+. .....++..+.+||.+||..||.+|| ++.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05605 203 QRKEKVKREEVERRVKEDQE-------------------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEE 257 (285)
T ss_pred CCchhhHHHHHHHHhhhccc-------------------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHH
Confidence 87765544444332111110 11135788899999999999999999 9999
Q ss_pred HHhccccCCCCCC
Q 009654 235 ALASEYFSTKPYA 247 (529)
Q Consensus 235 ~L~h~~f~~~~~~ 247 (529)
+++||||....|.
T Consensus 258 l~~~~~~~~~~~~ 270 (285)
T cd05605 258 VKAHPFFRTANFK 270 (285)
T ss_pred HhcCcCccCCCHH
Confidence 9999999875553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=307.35 Aligned_cols=237 Identities=35% Similarity=0.637 Sum_probs=192.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+|+||||++++++..+......+++.++..++.||+.||.|||+.||+|+|
T Consensus 48 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~ 125 (286)
T cd07846 48 MREIRMLKQLRHENLVNLIEVFRR--KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125 (286)
T ss_pred HHHHHHHHhcCCcchhhHHHhccc--CCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 579999999999999999999977 678999999999988887765566799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... ...+...++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.
T Consensus 126 l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 126 IKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987654432 23345568999999999977566889999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccC-C-CccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSK-L-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~-l-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+..+.+..+....+......-.... . .......+...........++.++..+.+||.+||..+|.+|||+.++|+|+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 8888888887766654322110000 0 0000111222222334455678899999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 285 ~~ 286 (286)
T cd07846 285 FF 286 (286)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.84 Aligned_cols=238 Identities=37% Similarity=0.687 Sum_probs=193.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+ .+.+|+||||++++++..+......+++.++..++.||+.||.|||++||+|+|
T Consensus 48 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~d 125 (288)
T cd07833 48 LREVKVLRQLRHENIVNLKEAFRR--KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125 (288)
T ss_pred HHHHHHHHhcCCCCeeehhheEEE--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999987 578999999999988887766666799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.+||+|||++..............+++.+|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 126 l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 126 IKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998766543334455678999999999987657899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCC-Cc-cccCCCCCCCcchhhhhccC-CcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKL-PH-ATLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l-~~-~~~~~~~~~~~~~l~~~~~~-~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+..+.+..+...++..+...+..... +. .....+...-...+...++. ++.++++||.+||..+|++|||+.++++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 88888888888777766543322110 00 00000011111122223333 48999999999999999999999999999
Q ss_pred ccc
Q 009654 239 EYF 241 (529)
Q Consensus 239 ~~f 241 (529)
|||
T Consensus 286 ~~f 288 (288)
T cd07833 286 PYF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.48 Aligned_cols=236 Identities=40% Similarity=0.765 Sum_probs=191.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.+ ....|+||||+++.+...+.... ..+++..+..++.||+.||.|||+++++|+
T Consensus 46 ~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~ 123 (283)
T cd07835 46 IREISLLKELNHPNIVRLLDVVHS--ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR 123 (283)
T ss_pred HHHHHHHHhcCCCCccCHhheecc--CCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence 579999999999999999999987 57899999999876655543322 468999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|+||+++.++.++|+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+
T Consensus 124 dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 124 DLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred CCCHHHEEEcCCCcEEEeecccccccCCCc-cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987654321 1223446689999999987755688999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.+....+.++++..+.+....|........ ....+... ..........++..+.+||.+||+.||.+|||+.++|.||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 203 DSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 999888888888888887776654322110 00000000 1122334567889999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 282 ~~ 283 (283)
T cd07835 282 YF 283 (283)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.77 Aligned_cols=209 Identities=24% Similarity=0.383 Sum_probs=173.8
Q ss_pred HHH-HHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REI-LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi-~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
+|+ .+++.++||||+++++++.+ ...+|||||||+++.+...+.....+++.++..++.||+.||.|||++||+|||
T Consensus 44 ~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~D 121 (321)
T cd05603 44 AERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121 (321)
T ss_pred HHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 344 46788999999999999987 578999999999977766555666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.
T Consensus 122 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 122 LKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred CCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 99999999999999999999987532221 22344578999999999876 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH----HHHHh
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALA 237 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta----~e~L~ 237 (529)
+.......+... +. ......+..+.+||.+||..||.+|+++ .++++
T Consensus 200 ~~~~~~~~i~~~---~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 200 DVSQMYDNILHK---PL--------------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred CHHHHHHHHhcC---CC--------------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 877766665431 10 0113467789999999999999999875 59999
Q ss_pred ccccCCC
Q 009654 238 SEYFSTK 244 (529)
Q Consensus 238 h~~f~~~ 244 (529)
|+||...
T Consensus 251 ~~~~~~~ 257 (321)
T cd05603 251 HVFFSPI 257 (321)
T ss_pred CCCcCCC
Confidence 9999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.62 Aligned_cols=211 Identities=26% Similarity=0.381 Sum_probs=178.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.++|||||+++++|.. .+.+|||||||+++.+...+ .....|++.++..++.||+.||.|||++||
T Consensus 113 ~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i 190 (478)
T PTZ00267 113 RSELHCLAACDHFGIVKHFDDFKS--DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM 190 (478)
T ss_pred HHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 479999999999999999999988 57899999999987665332 234579999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
+||||||+||||+.++.+||+|||++..+..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+
T Consensus 191 vHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~ 269 (478)
T PTZ00267 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHR 269 (478)
T ss_pred EECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987654321 12345578999999999876 468999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+..+......+ ....++.++.+||.+||..||++|||+.++|
T Consensus 270 Pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 270 PFKGPSQREIMQQVLYGKYDP----------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred CCCCCCHHHHHHHHHhCCCCC----------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 999988877777765421110 0124678899999999999999999999999
Q ss_pred hccccCC
Q 009654 237 ASEYFST 243 (529)
Q Consensus 237 ~h~~f~~ 243 (529)
.|+|++.
T Consensus 322 ~~~~~~~ 328 (478)
T PTZ00267 322 HTEFLKY 328 (478)
T ss_pred hCHHHHH
Confidence 9999863
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.01 Aligned_cols=237 Identities=38% Similarity=0.636 Sum_probs=185.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ....|+||||+.++++..+......+++.++..++.||+.||.|||+.||+|+|
T Consensus 51 ~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~d 128 (291)
T cd07870 51 IREASLLKGLKHANIVLLHDIIHT--KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128 (291)
T ss_pred HHHHHHHHhcCCCCEeEEEEEEec--CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 479999999999999999999987 568999999999888877665556789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.
T Consensus 129 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 129 LKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CChHHEEEcCCCcEEEeccccccccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999987543321 12234467899999999977666889999999999999999999999875
Q ss_pred C-HHHHHHHHHHHcCCCCchhhhccCCCcccc-CCCCCCCcchhhhhcc--CCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 162 T-EVEQLHKIFKLCGSPPDDYWKKSKLPHATL-FKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 162 ~-~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~--~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
+ ..+.+..+....|.|.+..|......+... ..........+...+. ..+..+.+||.+||..||.+|||+.++|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 208 SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 4 446777777777877766554321111000 0000000111222222 23678999999999999999999999999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 288 h~~~ 291 (291)
T cd07870 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=310.42 Aligned_cols=240 Identities=39% Similarity=0.708 Sum_probs=188.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+++.++||||+++++++.+.....+|+||||++++++..+.. ....+++..+..++.||+.||.|||+.||
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 129 (316)
T cd07842 50 CREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWV 129 (316)
T ss_pred HHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 57999999999999999999999865578999999999887765432 22378999999999999999999999999
Q ss_pred cccCCCCCcEEEcc----CCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 78 LHRDIKGSNLLVNN----EGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 78 vHrDIKp~NILl~~----~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
+||||||+|||++. ++.+||+|||++........ .......+|++|+|||++.+...++.++|||||||++|+|
T Consensus 130 ~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l 209 (316)
T cd07842 130 LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209 (316)
T ss_pred eeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999 89999999999986643321 1223456789999999988766789999999999999999
Q ss_pred HhCCCCCCCCCHH---------HHHHHHHHHcCCCCchhhhccC-CCcccc---CCCCCCCc-ch---hhhhccCCcHHH
Q 009654 152 LIGKPILQGRTEV---------EQLHKIFKLCGSPPDDYWKKSK-LPHATL---FKPQQPYD-SS---LRETFKDLPTTA 214 (529)
Q Consensus 152 ltG~~pf~g~~~~---------~~~~~I~~~~g~p~~~~~~~~~-l~~~~~---~~~~~~~~-~~---l~~~~~~~s~~~ 214 (529)
++|++||.+.... ..+..++..++.+....|.... ++.... ......+. .. ..+.+...+..+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (316)
T cd07842 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289 (316)
T ss_pred HhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHH
Confidence 9999999876543 4667778888877766664321 111110 00111111 11 122223678899
Q ss_pred HHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 215 VNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 215 ~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
.++|.+||..||++|||+.+++.||||
T Consensus 290 ~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 290 FDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.88 Aligned_cols=210 Identities=28% Similarity=0.428 Sum_probs=174.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+|+||++++.+..++.....+++..+..++.||+.||.|||+.||+|+|
T Consensus 52 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~d 129 (263)
T cd06625 52 ECEIQLLKNLQHERIVQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129 (263)
T ss_pred HHHHHHHHhCCCCCeeeeEEEEcc--CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 579999999999999999999988 569999999999877766555556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCc--cccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+||+++.++.++|+|||++........... ....++..|+|||++.+. .++.++|||||||++|+|++|++||.
T Consensus 130 l~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred CCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 999999999999999999999876543211111 334678899999999874 48999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+..+...++......+ .....++..+.+||.+||..+|.+|||+.++|+|+
T Consensus 209 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 209 EFEAMAAIFKIATQPTNP---------------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccchHHHHHHHhccCCCC---------------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 776655554443211110 11135788899999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 262 ~~ 263 (263)
T cd06625 262 FV 263 (263)
T ss_pred CC
Confidence 98
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=315.40 Aligned_cols=219 Identities=24% Similarity=0.338 Sum_probs=178.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++..++||||+++++++.+ ...+|||||||+++.+..++ .....+++..++.++.||+.||.|||++||+||
T Consensus 49 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHr 126 (332)
T cd05623 49 REERDVLVNGDNQWITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR 126 (332)
T ss_pred HHHHHHHhhCCCCCEeeEEEEEec--CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 468899999999999999999987 57899999999986665444 335679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+|||++.++.+||+|||++..............+||+.|+|||++.+ ...|+.++|||||||+||+|++|++
T Consensus 127 Dlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206 (332)
T ss_pred CCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence 999999999999999999999987654332222334578999999999863 3458999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e 234 (529)
||.+.+..+.+.+|.......+ + ......+++++++||.+||+.++.. |+++.+
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~--------------------~----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~ 262 (332)
T cd05623 207 PFYAESLVETYGKIMNHKERFQ--------------------F----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIED 262 (332)
T ss_pred CCCCCCHHHHHHHHhCCCcccc--------------------C----CCccccCCHHHHHHHHHHccChhhhcCCCCHHH
Confidence 9999888887777754211110 0 0112467899999999999775555 689999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
+++||||....|
T Consensus 263 ~~~h~~f~~~~~ 274 (332)
T cd05623 263 FKQHPFFTGIDW 274 (332)
T ss_pred HhCCCCcCCCCH
Confidence 999999986544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.55 Aligned_cols=205 Identities=22% Similarity=0.219 Sum_probs=174.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEc--cCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITS--RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~--~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIv 78 (529)
.+|+.+|++++|||||++++++.+ .....+++|||||+++.+..++.....+++.....++.|++.||.|||+ .+++
T Consensus 66 ~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 145 (283)
T PHA02988 66 ENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP 145 (283)
T ss_pred HHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCC
Confidence 589999999999999999999877 4446789999999998777776666789999999999999999999998 4999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~elltG~~p 157 (529)
||||||+|||++.++.+||+|||++...... ....++|+.|+|||++.+. ..|+.++|||||||++|||++|..|
T Consensus 146 Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~P 221 (283)
T PHA02988 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221 (283)
T ss_pred CCcCChhhEEECCCCcEEEcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCC
Confidence 9999999999999999999999998765432 2345678999999998652 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+......++ ....+++.+++||.+||+.||.+|||+.++|+
T Consensus 222 f~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 222 FENLTTKEIYDLIINKNNSLK---------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCCCHHHHHHHHHhcCCCCC---------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 998887777776654222211 00246889999999999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.20 Aligned_cols=237 Identities=46% Similarity=0.798 Sum_probs=196.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+ ...+|+||||+++++...+......+++.++..++.||+.||.|||+.||+|+|
T Consensus 46 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~d 123 (283)
T cd05118 46 LREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123 (283)
T ss_pred HHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 579999999999999999999887 578999999999988777766567899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||+++.++.+||+|||.+....... .......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.
T Consensus 124 l~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 124 LKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred cCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997765542 23344567889999999987657899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCC-ccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~-~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+.+..+....+.+....|...... ......-............+.++..+++||.+||..||.+||++.++|.|||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 203 SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred CHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 999999999888888776666543210 0000000001111223445678999999999999999999999999999999
Q ss_pred c
Q 009654 241 F 241 (529)
Q Consensus 241 f 241 (529)
|
T Consensus 283 ~ 283 (283)
T cd05118 283 F 283 (283)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=331.98 Aligned_cols=237 Identities=25% Similarity=0.342 Sum_probs=178.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|++|+|||||++++++.+ ....|+|+|++.++++..+... .......+++.++.||+.||.|||++||
T Consensus 211 ~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gI 288 (501)
T PHA03210 211 ENEILALGRLNHENILKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKL 288 (501)
T ss_pred HHHHHHHHhCCCCCcCcEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 589999999999999999999988 5688999999998887765432 2234567888999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC-
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP- 156 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~- 156 (529)
+||||||+||||+.++.+||+|||++..+...........+||+.|+|||++.+ ..|+.++||||||||||||++|..
T Consensus 289 iHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999998775443333345689999999999977 458999999999999999999875
Q ss_pred CCCC--CCHHHHHHHHHHHcCCCCchhhhcc----CCCccccCCCCCCCcchhhhhc--cCCcHHHHHHHHHhccCCCCC
Q 009654 157 ILQG--RTEVEQLHKIFKLCGSPPDDYWKKS----KLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 157 pf~g--~~~~~~~~~I~~~~g~p~~~~~~~~----~l~~~~~~~~~~~~~~~l~~~~--~~~s~~~~dLi~~mL~~dP~k 228 (529)
||.+ .....++.+++..++.+..++.... .......+... ...+...+ ..++.++.++|.+||.+||.+
T Consensus 368 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~ 444 (501)
T PHA03210 368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA---GHSVPPLIRNLGLPADFEYPLVKMLTFDWHL 444 (501)
T ss_pred CccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccC---ccchhhHHHhcCCChHHHHHHHHHhccCccc
Confidence 4432 2445666666665554333211100 00000000000 00111111 246788999999999999999
Q ss_pred CcCHHHHHhccccCCC
Q 009654 229 RATASAALASEYFSTK 244 (529)
Q Consensus 229 R~ta~e~L~h~~f~~~ 244 (529)
|||+.|+|.||||...
T Consensus 445 Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 445 RPGAAELLALPLFSAE 460 (501)
T ss_pred CcCHHHHhhChhhhcC
Confidence 9999999999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.28 Aligned_cols=239 Identities=39% Similarity=0.710 Sum_probs=190.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCC---CeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~---~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+++.+ +||||+++++++..... ..+|+||||+++++...+... ...+++..+..++.||+.||.|||
T Consensus 48 ~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH 127 (295)
T cd07837 48 LREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127 (295)
T ss_pred HHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5799999999 56999999999876421 238999999999877665432 346899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
++||+||||+|+||+++. ++.+||+|||++..+.... ...+...++++|+|||++.+...++.++|||||||++|+|+
T Consensus 128 ~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 206 (295)
T cd07837 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206 (295)
T ss_pred HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH
Confidence 999999999999999998 8899999999987654321 22334467899999999877667899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+|.+||.+.++.+.+.+++...+.++...|............+.. -...+....+.++..+.+||.+||..||.+|||+
T Consensus 207 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~ 285 (295)
T cd07837 207 RKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285 (295)
T ss_pred cCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence 999999999999999999988888777666432111000000000 0112233446789999999999999999999999
Q ss_pred HHHHhccccC
Q 009654 233 SAALASEYFS 242 (529)
Q Consensus 233 ~e~L~h~~f~ 242 (529)
.++|.||||+
T Consensus 286 ~eil~~~~~~ 295 (295)
T cd07837 286 KAALTHPYFD 295 (295)
T ss_pred HHHhcCCCcC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.23 Aligned_cols=213 Identities=23% Similarity=0.412 Sum_probs=172.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++.++ +||||+++++++.+ ...+|||||||+++.+..++.....+++.+++.++.||+.||+|||++||+||
T Consensus 43 ~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHr 120 (327)
T cd05617 43 QTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120 (327)
T ss_pred HHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 4788999888 79999999999987 57899999999997776655556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||..
T Consensus 121 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 999999999999999999999987532211 22345678999999999976 4689999999999999999999999964
Q ss_pred CC------HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC---
Q 009654 161 RT------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT--- 231 (529)
Q Consensus 161 ~~------~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t--- 231 (529)
.. ..+.+..+.. ..+. .....++..+.+||.+||+.||.+|++
T Consensus 199 ~~~~~~~~~~~~~~~~~~--~~~~--------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 250 (327)
T cd05617 199 ITDNPDMNTEDYLFQVIL--EKPI--------------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQP 250 (327)
T ss_pred cCCCcccccHHHHHHHHH--hCCC--------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCC
Confidence 32 1112222111 1110 011347888999999999999999998
Q ss_pred ---HHHHHhccccCCCCC
Q 009654 232 ---ASAALASEYFSTKPY 246 (529)
Q Consensus 232 ---a~e~L~h~~f~~~~~ 246 (529)
..++++||||....|
T Consensus 251 ~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 251 QTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred CCCHHHHHcCCCCCCCCH
Confidence 579999999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.75 Aligned_cols=242 Identities=33% Similarity=0.606 Sum_probs=194.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++|+||||++++++|... ....+|+||||+.+++...+. ....+++..+..++.||+.||.|||++||+|
T Consensus 52 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 130 (334)
T cd07855 52 LRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIH 130 (334)
T ss_pred HHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4799999999999999999987643 245789999999887655554 4456999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||||+|||++.+|.+||+|||++........ ......+++.+|+|||++.+...++.++||||+||++|+|++|++
T Consensus 131 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 131 RDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred CCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence 99999999999999999999999876543211 122345789999999998765668999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcc----ccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA----TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~----~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
||.+.+...++..+....|.|+...+....-... ..+..... ..+...++.++.++.++|.+||+.||.+|||+
T Consensus 211 pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 288 (334)
T cd07855 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQP--VPWSKIFPKASPEALDLLSQMLQFDPEERITV 288 (334)
T ss_pred ccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCC--CCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence 9999999999999999999988766543211000 00111111 11234456789999999999999999999999
Q ss_pred HHHHhccccCCCCC
Q 009654 233 SAALASEYFSTKPY 246 (529)
Q Consensus 233 ~e~L~h~~f~~~~~ 246 (529)
.++|.||||...+.
T Consensus 289 ~~~l~~~~~~~~~~ 302 (334)
T cd07855 289 EQALQHPFLAQYHD 302 (334)
T ss_pred HHHHhChhhhhccC
Confidence 99999999986544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=303.70 Aligned_cols=216 Identities=23% Similarity=0.360 Sum_probs=172.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
..|+++|++++||||+++++++.+ ...+|+||||++++.+..+. .....+++..+..++.||+.||+|||+.||+|
T Consensus 41 ~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 118 (277)
T cd05607 41 LLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118 (277)
T ss_pred HHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 359999999999999999999987 57899999999987665443 23345899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+|||++.++.++|+|||++....... ......+|+.|+|||++.+.. ++.++||||+||++|+|++|.+||.
T Consensus 119 ~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred ccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987665432 234457899999999997744 9999999999999999999999997
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH----HHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAA 235 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta----~e~ 235 (529)
+.........+....-... .......++.++++||.+||+.||.+||++ .++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 196 DHKEKVAKEELKRRTLEDE------------------------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCcchhhHHHHHHHhhccc------------------------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 6543221111111100000 000113578899999999999999999999 778
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
+.|+||+...+
T Consensus 252 ~~h~~f~~~~~ 262 (277)
T cd05607 252 RKHEFFKTINF 262 (277)
T ss_pred hcChhhcCCCH
Confidence 89999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.79 Aligned_cols=212 Identities=28% Similarity=0.400 Sum_probs=178.0
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
..|+.++..+. ||+|+++++++.+ .+.+|||||||+++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 48 ~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHr 125 (323)
T cd05615 48 MVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125 (323)
T ss_pred HHHHHHHHhccCCCchhheeeEEec--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 46888888885 6788889999887 56899999999987777666666789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+
T Consensus 126 Dikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred CCCHHHeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987543221 12234568999999999876 4589999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~ 235 (529)
.+....+..|....... ...++.++.+||.+||..||.+|++ ..++
T Consensus 204 ~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i 254 (323)
T cd05615 204 EDEDELFQSIMEHNVSY-----------------------------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDI 254 (323)
T ss_pred CCHHHHHHHHHhCCCCC-----------------------------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHH
Confidence 88887777775521111 1356788999999999999999997 5799
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
++||||....|
T Consensus 255 ~~h~~f~~~~~ 265 (323)
T cd05615 255 REHAFFRRIDW 265 (323)
T ss_pred hcCcccCCCCH
Confidence 99999987544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=300.75 Aligned_cols=237 Identities=42% Similarity=0.738 Sum_probs=196.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+||||+++++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 46 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~ 123 (282)
T cd07829 46 LREISLLKELKHPNIVKLLDVIHT--ERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRD 123 (282)
T ss_pred HHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 469999999999999999999987 478999999999876666654445799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.
T Consensus 124 l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 124 LKPQNILINRDGVLKLADFGLARAFGIPL-RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred CChheEEEcCCCCEEEecCCcccccCCCc-cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999997665432 23334456889999999977657899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+.++...++.+.+..|........................++.++..+.++|.+||..||++||++.+++.||||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 99999999999999998887765332210000000011122345566778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.48 Aligned_cols=241 Identities=40% Similarity=0.672 Sum_probs=193.2
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++++| +||||+++++++.......+|+||||+.+++...+.. . .+++..+..++.||+.||.|||+.||+||
T Consensus 54 ~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~ 131 (337)
T cd07852 54 FREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA-N-ILEDVHKRYIMYQLLKALKYIHSGNVIHR 131 (337)
T ss_pred hHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 4799999999 9999999999987654567899999999866555533 2 78999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCC----CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHR----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+|||++.++.+||+|||++........ ......++|++|+|||++.+...++.++|||||||++|+|++|++
T Consensus 132 dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~ 211 (337)
T cd07852 132 DLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211 (337)
T ss_pred CCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999976543321 123345789999999998776678899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCC--CCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
||.+....+....+....+.++...|.....+....+. ....-.......++.++.++.+||.+||+.||.+|||+.+
T Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~ 291 (337)
T cd07852 212 LFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291 (337)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHH
Confidence 99999988889998888887776554432111000000 0000011223445668999999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|+||||...
T Consensus 292 il~~~~~~~~ 301 (337)
T cd07852 292 ALEHPYVAQF 301 (337)
T ss_pred HhhChhhhhh
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.85 Aligned_cols=211 Identities=27% Similarity=0.424 Sum_probs=181.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+||.+|.++++|||.++|+.|.. ...++++||||.|+.+..++..+..+.|.++..++++++.||.|||.++.+||
T Consensus 58 iqqei~~Ls~~~~~~it~yygsyl~--g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHr 135 (467)
T KOG0201|consen 58 IQQEISVLSQCDSPNITEYYGSYLK--GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHR 135 (467)
T ss_pred HHHHHHHHHhcCcchHHhhhhheee--cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecc
Confidence 3589999999999999999999998 67899999999998888887777777999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||+.|||+..+|.+||+|||.+.......... .+.+|||.||||||+.+ ..|+.++||||||++.+||++|.||+..
T Consensus 136 DIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 136 DIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred cccccceeEeccCcEEEEecceeeeeechhhcc-ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 999999999999999999999997765543333 67799999999999985 6799999999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
...+..+-.|-+ .+ ...+. ..+++.+++||..||+.||+.||+|.++|+|+|
T Consensus 214 ~hPmrvlflIpk---~~----------------------PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 214 LHPMRVLFLIPK---SA----------------------PPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred cCcceEEEeccC---CC----------------------CCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 655332222211 11 11111 268899999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
++.
T Consensus 266 Ik~ 268 (467)
T KOG0201|consen 266 IKR 268 (467)
T ss_pred HHh
Confidence 986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.15 Aligned_cols=243 Identities=35% Similarity=0.596 Sum_probs=192.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++++||||+++++++.... ...+|+|+||+++++...+. ...+++..+..++.||+.||.|||++||+
T Consensus 51 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~iv 128 (336)
T cd07849 51 LREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVL 128 (336)
T ss_pred HHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46999999999999999999876532 24689999999987766553 34799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+...++.++||||+||++|+|++|++
T Consensus 129 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~ 208 (336)
T cd07849 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208 (336)
T ss_pred ccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999876543211 122345789999999998765668999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCC--CCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~--~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
||.+.+....+..+....+.++.+.|..........+.. .......+....+.+++++.+||.+||+.||++|||+.+
T Consensus 209 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 209 LFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 999998888888888888887766554322111000000 000111122334567889999999999999999999999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
+|+||||.....
T Consensus 289 ~l~hp~~~~~~~ 300 (336)
T cd07849 289 ALAHPYLEQYHD 300 (336)
T ss_pred HhcCccccccCC
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.63 Aligned_cols=219 Identities=24% Similarity=0.346 Sum_probs=178.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++..++||||+++++++.+ .+.+|||||||.|+.+..++.. ...+++..+..++.||+.||+|||++||+||
T Consensus 49 ~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHr 126 (331)
T cd05624 49 REERNVLVNGDCQWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHR 126 (331)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 468899999999999999999987 5789999999998766655433 5689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC----CCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+||||+.++.+||+|||++..............+||+.|+|||++.+. ..++.++|||||||+||+|++|++
T Consensus 127 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~ 206 (331)
T cd05624 127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred cCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCC
Confidence 9999999999999999999999976654322222345789999999998642 357889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e 234 (529)
||.+.+..+.+.+|......++ + ...+..+++++++||.+||+.++.+ |+++.+
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~--------------------~----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~ 262 (331)
T cd05624 207 PFYAESLVETYGKIMNHEERFQ--------------------F----PSHITDVSEEAKDLIQRLICSRERRLGQNGIED 262 (331)
T ss_pred CccCCCHHHHHHHHHcCCCccc--------------------C----CCccccCCHHHHHHHHHHccCchhhcCCCCHHH
Confidence 9998888777777654211110 0 1112457899999999999976655 569999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
+++|+||....|
T Consensus 263 ~~~h~~f~~~~~ 274 (331)
T cd05624 263 FKKHAFFEGIDW 274 (331)
T ss_pred HhcCCCcCCCCH
Confidence 999999986443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=317.58 Aligned_cols=214 Identities=26% Similarity=0.423 Sum_probs=181.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+-||.||..++||+||+|++.|.. .+.++|+.|||.||-.+.++ .-+..|++.++..+++|+|.||.|||+++|+||
T Consensus 77 lVEIeILa~CdHP~ivkLl~ayy~--enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHR 154 (1187)
T KOG0579|consen 77 LVEIEILAECDHPVIVKLLSAYYF--ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHR 154 (1187)
T ss_pred hhhhhhhhcCCChHHHHHHHHHhc--cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhh
Confidence 459999999999999999998877 57899999999998887554 345579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc----CCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||..|||+.-+|.|+|+|||.+..... ..+.-.+..|||+|||||++. ...+|+.++||||||++|.||..+.|
T Consensus 155 DLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 155 DLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred hccccceEEEecCcEeeecccccccchh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 9999999999999999999999854332 123345679999999999984 34679999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
|-..-+.+-.+-+|.+ ..|| . +.. ....+..+.|+|.+||..||..||+++++|
T Consensus 234 PHhelnpMRVllKiaK--SePP-T-----------Llq------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 234 PHHELNPMRVLLKIAK--SEPP-T-----------LLQ------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred CccccchHHHHHHHhh--cCCC-c-----------ccC------------cchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 9988888888877755 2222 1 111 123567789999999999999999999999
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
+||||++.
T Consensus 288 ~Hpfv~~~ 295 (1187)
T KOG0579|consen 288 KHPFVQNA 295 (1187)
T ss_pred hCcccccC
Confidence 99999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.02 Aligned_cols=238 Identities=24% Similarity=0.334 Sum_probs=175.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~-gIvH 79 (529)
+.+|+.+|++|+||||++++++|.+ ...+||||||+.++.+..++.....+++..+..++.||+.||.|||+. +|+|
T Consensus 50 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH 127 (333)
T cd06650 50 IIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 127 (333)
T ss_pred HHHHHHHHHHCCCCcccceeEEEEE--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence 3589999999999999999999988 578999999999877776655566799999999999999999999985 7999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+|||++.++.+||+|||++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 128 ~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998755332 2234578999999999976 458999999999999999999999998
Q ss_pred CCCHHHHHHHHHH-HcCCCCchhhhccCCCcc---ccCCCCC-CCcc--hhhh--------h--ccCCcHHHHHHHHHhc
Q 009654 160 GRTEVEQLHKIFK-LCGSPPDDYWKKSKLPHA---TLFKPQQ-PYDS--SLRE--------T--FKDLPTTAVNLIETLL 222 (529)
Q Consensus 160 g~~~~~~~~~I~~-~~g~p~~~~~~~~~l~~~---~~~~~~~-~~~~--~l~~--------~--~~~~s~~~~dLi~~mL 222 (529)
.....+....+.. ..+.+..........+.. ..+.+.. +... .+.. . ...++.++++||.+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 283 (333)
T cd06650 204 PPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCL 283 (333)
T ss_pred CcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhc
Confidence 7655333222110 011111100000000000 0000000 0000 0000 0 0136788999999999
Q ss_pred cCCCCCCcCHHHHHhccccCCC
Q 009654 223 SVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
+.||++|||+.++|.|+||+..
T Consensus 284 ~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 284 IKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCcccCcCHHHHhhCHHHhcC
Confidence 9999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.40 Aligned_cols=243 Identities=38% Similarity=0.634 Sum_probs=198.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
+.+|+.+|+.++||||+++++++.... ...+|+||||+.+++...+. ....+++..+..++.||+.||.|||++||
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~gi 124 (330)
T cd07834 46 ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANV 124 (330)
T ss_pred HHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 357999999999999999999987742 24789999999987655554 34489999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
+|+||||+|||++.++.++|+|||++........ .......+|++|+|||++.+...++.++||||+||++|+|++|.
T Consensus 125 ~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~ 204 (330)
T cd07834 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204 (330)
T ss_pred ecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987654321 12345577999999999987657899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCC--CCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~--~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
+||.+.+..+.+..+....+.++...|..........+.. ...-...+......++..+.+||.+||+.+|.+|||+.
T Consensus 205 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 284 (330)
T cd07834 205 PLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284 (330)
T ss_pred CCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence 9999999999999999999988877665322111111100 01111223445567899999999999999999999999
Q ss_pred HHHhccccCCC
Q 009654 234 AALASEYFSTK 244 (529)
Q Consensus 234 e~L~h~~f~~~ 244 (529)
++|.||||...
T Consensus 285 ~ll~~~~~~~~ 295 (330)
T cd07834 285 EALAHPYLAQL 295 (330)
T ss_pred HHHhCccHHhh
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.43 Aligned_cols=243 Identities=38% Similarity=0.651 Sum_probs=193.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+.++||||+++++++.... ...+|||+||+.+++...+. ....+++..+..++.||+.||.|||++||+
T Consensus 52 ~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~ 130 (337)
T cd07858 52 LREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVL 130 (337)
T ss_pred HHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 46999999999999999999886532 14589999999987665554 445799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+|||++.++.+||+|||++....... .......++..|+|||++.....++.++|||||||++|+|++|++||
T Consensus 131 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 209 (337)
T cd07858 131 HRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209 (337)
T ss_pred cCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999997654322 22345577999999999876556899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC--cchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~--~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
.+.+....+..+....|.++.+.|..........+....+. .......++.+++++++||.+||+.||++|||+.++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell 289 (337)
T cd07858 210 PGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289 (337)
T ss_pred CCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHH
Confidence 99998888999999888887665532111110000000000 0112344567899999999999999999999999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||.....
T Consensus 290 ~h~~~~~~~~ 299 (337)
T cd07858 290 AHPYLASLHD 299 (337)
T ss_pred cCcchhhhcC
Confidence 9999986433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.75 Aligned_cols=203 Identities=28% Similarity=0.447 Sum_probs=171.2
Q ss_pred HHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
+|+.++... +||||+++++.+.+ ..++|+|||++.|+.+...+.....+. .++..|+.+|+.+|.|||++||||||
T Consensus 364 ~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRD 440 (612)
T KOG0603|consen 364 DEIPISLLVRDHPNIVKSHDVYED--GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRD 440 (612)
T ss_pred cccchhhhhcCCCcceeecceecC--CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecC
Confidence 577677666 89999999999988 689999999999976665554444455 88899999999999999999999999
Q ss_pred CCCCcEEE-ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 82 IKGSNLLV-NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 82 IKp~NILl-~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||+|||+ ++.|.++|+|||.+...... +.+.+.|..|.|||++.. ..|+++|||||||++||+||+|+.||..
T Consensus 441 Lkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 441 LKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred CChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 99999999 58899999999999766543 445578999999999984 6799999999999999999999999986
Q ss_pred CCHH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 161 RTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 161 ~~~~-~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.... +++.+| +.++.. ..+|.++++||.+||++||.+|+++.+++.||
T Consensus 516 ~P~~~ei~~~i----~~~~~s---------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 516 HPAGIEIHTRI----QMPKFS---------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred CCchHHHHHhh----cCCccc---------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 5544 333333 433211 36899999999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
||...
T Consensus 565 w~~~~ 569 (612)
T KOG0603|consen 565 WFLSH 569 (612)
T ss_pred chhcC
Confidence 99443
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.39 Aligned_cols=213 Identities=25% Similarity=0.369 Sum_probs=176.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.. ....|+||||++++.+..+. .....+++..+..++.||+.||.|||+.||+||
T Consensus 50 ~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~ 127 (282)
T cd06643 50 MVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127 (282)
T ss_pred HHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 579999999999999999999987 56899999999997776543 345679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+|||++.++.+||+|||++....... .......+|+.|+|||++.. ...++.++||||+|||+|+|++|.+
T Consensus 128 dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~ 206 (282)
T cd06643 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206 (282)
T ss_pred CCCcccEEEccCCCEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCC
Confidence 999999999999999999999987553321 22334568999999999842 2457889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+....+.... ++. ......++.++.+||.+||+.||.+|||+.++|
T Consensus 207 p~~~~~~~~~~~~~~~~~--~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 207 PHHELNPMRVLLKIAKSE--PPT------------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CccccCHHHHHHHHhhcC--CCC------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 999887766666654321 110 001134678899999999999999999999999
Q ss_pred hccccCC
Q 009654 237 ASEYFST 243 (529)
Q Consensus 237 ~h~~f~~ 243 (529)
+||||+.
T Consensus 261 ~~~~~~~ 267 (282)
T cd06643 261 QHPFVTV 267 (282)
T ss_pred cCCCEec
Confidence 9999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.57 Aligned_cols=241 Identities=27% Similarity=0.422 Sum_probs=200.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~--~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
++|-.||.+++.|.||.|--.|++ .+.+|+||..|.||.+...+...+ .|+|+.+..|+.+|+.||++||+.+||+
T Consensus 233 LnEk~iL~kV~s~FiVslaYAfeT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVY 310 (591)
T KOG0986|consen 233 LNEKQILEKVSSPFIVSLAYAFET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVY 310 (591)
T ss_pred hHHHHHHHHhccCcEEEEeeeecC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceee
Confidence 478899999999999999878877 689999999999988887765554 7999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+|||+|+.|.++|.|+|+|..+..+ .+.+.++||.+|||||++.+.. |+.++|.|||||+||||+.|+.||.
T Consensus 311 RDLKPeNILLDd~GhvRISDLGLAvei~~g--~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 311 RDLKPENILLDDHGHVRISDLGLAVEIPEG--KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred ccCChhheeeccCCCeEeeccceEEecCCC--CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchh
Confidence 999999999999999999999999988765 4678889999999999998855 9999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e 234 (529)
...+..-...+-+..-.-+. +.-..+++++++|.+.+|..||.+|. .+++
T Consensus 388 ~~KeKvk~eEvdrr~~~~~~-------------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~e 442 (591)
T KOG0986|consen 388 QRKEKVKREEVDRRTLEDPE-------------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQE 442 (591)
T ss_pred hhhhhhhHHHHHHHHhcchh-------------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcch
Confidence 76554443333332222111 11146899999999999999999996 5889
Q ss_pred HHhccccCCCCCCC---CCCCCCCCCCChhHHhhhhHHHHh
Q 009654 235 ALASEYFSTKPYAC---DLSSLPIYPPSKEIDAKHREDARR 272 (529)
Q Consensus 235 ~L~h~~f~~~~~~~---~~~~~p~~~~~~~~~~~~~~~~~~ 272 (529)
+-+||||+...|.. ..-..|..|+..++-++...+...
T Consensus 443 vk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeq 483 (591)
T KOG0986|consen 443 VKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQ 483 (591)
T ss_pred hhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhh
Confidence 99999999987753 223446667777887777665543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=302.09 Aligned_cols=213 Identities=24% Similarity=0.398 Sum_probs=172.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++++|+||+.+++.+.+ .+.+|+||||+.++.+..++ .....+++.++..++.||+.||.|||+.||+|
T Consensus 48 ~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH 125 (285)
T cd05630 48 LNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125 (285)
T ss_pred HHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence 469999999999999999999887 56899999999987665443 23346999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||+++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.
T Consensus 126 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred CCCCHHHEEECCCCCEEEeeccceeecCCCc--cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987654322 2334578999999999976 458999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e 234 (529)
+.................+ ......+++++.+||.+||+.||.+|+| +.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~ 257 (285)
T cd05630 203 QRKKKIKREEVERLVKEVQ-------------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE 257 (285)
T ss_pred CCCccchHHHHHhhhhhhh-------------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHH
Confidence 7543222211111111100 0112357888999999999999999999 999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+++||||...
T Consensus 258 ~~~h~~~~~~ 267 (285)
T cd05630 258 VKEHPLFKQI 267 (285)
T ss_pred HHcChhhhcc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.29 Aligned_cols=211 Identities=28% Similarity=0.497 Sum_probs=187.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.||++||+.|+|||||+++.++.. ...+|+||||+.++.+..++...+++.+..++.++.|++++++|||+++||||
T Consensus 102 ~~rev~imk~l~HPnIvkl~~v~~t--~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHr 179 (596)
T KOG0586|consen 102 LGREVDIMKSLNHPNIVKLFSVIET--EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHR 179 (596)
T ss_pred HHHHHHHHHhcCCcceeeeeeeeee--cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceecc
Confidence 3589999999999999999999988 57999999999998888888888899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||.+||||+.+.++||+|||++.++..+ ..+.+.||++.|.|||++.+..+.++.+|+||+|++||.|++|..||+|
T Consensus 180 dLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 180 DLKAENILLDENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ccchhhcccccccceeeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999999999999999998865 4567889999999999999988779999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+-.+.-..... |..- ..--++.++.+||++||.++|.+|++.+++..|.|
T Consensus 258 ~~lk~Lr~rvl~--gk~r---------------------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 258 QNLKELRPRVLR--GKYR---------------------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cccccccchhee--eeec---------------------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 886665544322 1110 01236788999999999999999999999999999
Q ss_pred cCCC
Q 009654 241 FSTK 244 (529)
Q Consensus 241 f~~~ 244 (529)
....
T Consensus 309 ~n~~ 312 (596)
T KOG0586|consen 309 RNDL 312 (596)
T ss_pred cchh
Confidence 9754
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.11 Aligned_cols=238 Identities=23% Similarity=0.319 Sum_probs=172.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+++.++||||++++++|.. .+.+|+|||||+++.+..++. ....+++..++.++.||+.||.|||++||+|
T Consensus 47 ~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 124 (327)
T cd08227 47 QGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124 (327)
T ss_pred HHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 469999999999999999999988 578999999999877765543 2346899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCC-CCCC-----CccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHH
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQ-----PLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~-~~~~-----~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~ell 152 (529)
|||||+|||++.++.++++||+.+..... +... .....+++..|+|||++.+. ..|+.++||||+||++|+|+
T Consensus 125 ~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 204 (327)
T cd08227 125 RSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 204 (327)
T ss_pred CCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999986543221 1000 01123567889999999753 35899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCch---------hhhc--------cCCCccccCC-CCC-CCcchhhhhccCCcHH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDD---------YWKK--------SKLPHATLFK-PQQ-PYDSSLRETFKDLPTT 213 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~---------~~~~--------~~l~~~~~~~-~~~-~~~~~l~~~~~~~s~~ 213 (529)
+|.+||.+............ +..+.. .+.. .......... ... ............+++.
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 205 NGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HCCCCCCCcchhHHHHHHhc--CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 99999987655443333222 221100 0000 0000000000 000 0000111223456889
Q ss_pred HHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 214 AVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 214 ~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
+.+||.+||+.||++|||+.++|+||||+.
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.37 Aligned_cols=244 Identities=36% Similarity=0.594 Sum_probs=199.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCC---CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~---~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
+.+|+++|.-++|.|++..+++.+-.+. ..+|+|+|+|..++...+..+ ..++...++-+++||+.||.|||+.||
T Consensus 99 vFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~I 177 (449)
T KOG0664|consen 99 VFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANI 177 (449)
T ss_pred HHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcch
Confidence 3689999999999999999988765432 246899999998876665544 489999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||.|+|++.+..+||||||+++.........++..+.|.+|+|||+|.|.+.|+.++||||+|||+.|||..+-+
T Consensus 178 LHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL 257 (449)
T KOG0664|consen 178 LHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL 257 (449)
T ss_pred hhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh
Confidence 99999999999999999999999999998887777888889999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCC---CccccCCCCCCCcchhhhhc--cCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKL---PHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l---~~~~~~~~~~~~~~~l~~~~--~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|+..+..+++..|.+++|.|..+....... .|...-.+..+--..+...- .+-..++.+++..||.+||.+|++.
T Consensus 258 FQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~ 337 (449)
T KOG0664|consen 258 FQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV 337 (449)
T ss_pred hhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH
Confidence 999999999999999999998664332111 00000001111101111100 1334568999999999999999999
Q ss_pred HHHHhccccCCCC
Q 009654 233 SAALASEYFSTKP 245 (529)
Q Consensus 233 ~e~L~h~~f~~~~ 245 (529)
.++|.|++.....
T Consensus 338 ~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 338 EEALQHRYLEEGR 350 (449)
T ss_pred hhhcccccccccc
Confidence 9999999986543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=308.70 Aligned_cols=240 Identities=37% Similarity=0.654 Sum_probs=193.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC----CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~----~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.++++++||||+++++++..... ..+|+|+||+.+++...+. ...+++.++..++.||+.||.|||+.||
T Consensus 62 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi 139 (343)
T cd07851 62 YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGI 139 (343)
T ss_pred HHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 479999999999999999998765321 3589999999776655553 2479999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||+++.++.+||+|||++...... .....++..|+|||++.+...++.++|||||||++|+|++|++|
T Consensus 140 ~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p 215 (343)
T cd07851 140 IHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215 (343)
T ss_pred ecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432 34457789999999987655688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC--CcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~--~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+..+.+..+...++.+++..|.+........+....+ -...+...+..++..+.+||.+||+.||.+|||+.++
T Consensus 216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el 295 (343)
T cd07851 216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295 (343)
T ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence 99999999999999998888877665432211111100000 0112233445678999999999999999999999999
Q ss_pred HhccccCCCCCC
Q 009654 236 LASEYFSTKPYA 247 (529)
Q Consensus 236 L~h~~f~~~~~~ 247 (529)
|.||||......
T Consensus 296 l~h~~~~~~~~~ 307 (343)
T cd07851 296 LAHPYLAEYHDP 307 (343)
T ss_pred hcCCCccccCCC
Confidence 999999865443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.41 Aligned_cols=238 Identities=33% Similarity=0.610 Sum_probs=191.6
Q ss_pred CHHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.|||.||..|. |||||+|+++..+..+....|||||+.+.....+. ..|+.-.++.|+.+||.||.|||++||+|
T Consensus 79 IkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImH 155 (338)
T KOG0668|consen 79 IKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMH 155 (338)
T ss_pred HHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence 369999999995 99999999999998889999999999985444432 26888999999999999999999999999
Q ss_pred cCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC-CC
Q 009654 80 RDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PI 157 (529)
Q Consensus 80 rDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~-~p 157 (529)
||+||.|++||.. -.++|+|||+|.++.++. .+..++.+.+|-.||+|.....|+.+-|||||||+|+.|+..+ |.
T Consensus 156 RDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 156 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred ccCCcceeeechhhceeeeeecchHhhcCCCc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence 9999999999976 469999999999998863 5677889999999999999888999999999999999999876 55
Q ss_pred CCCCCHHHHHHHHHHHcCCCCch-hhhccCCCccccCC------CCCCCcchhhhhc-cCCcHHHHHHHHHhccCCCCCC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDD-YWKKSKLPHATLFK------PQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~-~~~~~~l~~~~~~~------~~~~~~~~l~~~~-~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|.|.+.-+|+-+|.+.+|.-.-. +..+..+.-...|. ...++...+...- .-+++++.|||.++|.+|-.+|
T Consensus 234 FhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeR 313 (338)
T KOG0668|consen 234 FHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQER 313 (338)
T ss_pred cCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccc
Confidence 67999999999999999874321 22222211111111 0111111111111 2357999999999999999999
Q ss_pred cCHHHHHhccccCC
Q 009654 230 ATASAALASEYFST 243 (529)
Q Consensus 230 ~ta~e~L~h~~f~~ 243 (529)
+||.|++.||||..
T Consensus 314 lTakEam~HpyF~~ 327 (338)
T KOG0668|consen 314 LTAKEAMAHPYFAP 327 (338)
T ss_pred cchHHHhcCchHHH
Confidence 99999999999974
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=293.82 Aligned_cols=209 Identities=30% Similarity=0.553 Sum_probs=173.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+||||++++.+..++.....+++..+..++.||+.||.|||+.||+|||
T Consensus 54 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~d 131 (267)
T cd06628 54 AREIALLKELQHENIVQYLGSSLD--ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRD 131 (267)
T ss_pred HHHHHHHHhcCCCCeeeEEEEEEe--CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCccccc
Confidence 579999999999999999999887 568999999999977766665566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCC-----CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHR-----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|+|+||+++.++.++|+|||++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..
T Consensus 132 i~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~ 210 (267)
T cd06628 132 IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKH 210 (267)
T ss_pred CCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCC
Confidence 999999999999999999999876642111 01122357889999999876 457889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+....+..+.... .+ .....++..+.+||.+||+.||.+||++.++|
T Consensus 211 p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 262 (267)
T cd06628 211 PFPDCTQLQAIFKIGENA--SP--------------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262 (267)
T ss_pred CCCCccHHHHHHHHhccC--CC--------------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 998876655554443311 00 01135788899999999999999999999999
Q ss_pred hcccc
Q 009654 237 ASEYF 241 (529)
Q Consensus 237 ~h~~f 241 (529)
+||||
T Consensus 263 ~~~~~ 267 (267)
T cd06628 263 KHPFL 267 (267)
T ss_pred hCCCC
Confidence 99998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.81 Aligned_cols=220 Identities=28% Similarity=0.372 Sum_probs=180.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+++|+.++||||+++++.+.+ ...+|+||||+.++.+..++. ....+++..+..++.||+.||.|||+.||+|
T Consensus 49 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 126 (316)
T cd05574 49 LTEQEILATLDHPFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126 (316)
T ss_pred HHHHHHHHhCCCCCchhheeeeec--CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 579999999999999999999887 578999999999866655443 3357999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC----------------------------CccccccccccCCcccccC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----------------------------PLTSRVVTLWYRPPELLLG 131 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~----------------------------~~~~~~gt~~Y~APE~l~~ 131 (529)
+||||+||+|+.++.++|+|||++......... .....+||..|+|||++.+
T Consensus 127 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 206 (316)
T cd05574 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206 (316)
T ss_pred cCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC
Confidence 999999999999999999999998654322110 1113467889999999976
Q ss_pred CCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCc
Q 009654 132 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 211 (529)
Q Consensus 132 ~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s 211 (529)
..++.++|||||||++|+|++|..||.+.+....+..+....... .....++
T Consensus 207 -~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~ 258 (316)
T cd05574 207 -DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTF---------------------------PGSPPVS 258 (316)
T ss_pred -CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccC---------------------------CCccccC
Confidence 457899999999999999999999999888777776654311110 0012378
Q ss_pred HHHHHHHHHhccCCCCCCcC----HHHHHhccccCCCCCCCCCC
Q 009654 212 TTAVNLIETLLSVEPYKRAT----ASAALASEYFSTKPYACDLS 251 (529)
Q Consensus 212 ~~~~dLi~~mL~~dP~kR~t----a~e~L~h~~f~~~~~~~~~~ 251 (529)
..+.+||.+||..||++||| +.++|.||||+...|+....
T Consensus 259 ~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence 89999999999999999999 99999999999877765433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.24 Aligned_cols=205 Identities=25% Similarity=0.398 Sum_probs=176.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+||.||++|+|+|||+++++++.. ..+|||||||..|.|. ++.. ....+...+...++.||++|++||+++++|
T Consensus 248 f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~I 325 (468)
T KOG0197|consen 248 FLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYI 325 (468)
T ss_pred HHHHHHHHHhCcccCeEEEEEEEecC--CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCcc
Confidence 56899999999999999999999884 4799999999986555 4443 466799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||-..||||+++..+||+|||+|+....+.............|.|||.+.. ..++.++|||||||+||||+| |+.|
T Consensus 326 HRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~p 404 (468)
T KOG0197|consen 326 HRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVP 404 (468)
T ss_pred chhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCC
Confidence 99999999999999999999999999766654433444445778999999976 459999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
|.+.+..+.+..+.+..--|. ...+|+++.+||..||..+|++|||...+.
T Consensus 405 y~~msn~ev~~~le~GyRlp~----------------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 405 YPGMSNEEVLELLERGYRLPR----------------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCHHHHHHHHhccCcCCC----------------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999877432221 146899999999999999999999998654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.74 Aligned_cols=238 Identities=36% Similarity=0.633 Sum_probs=190.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+++.++||||+++++++.... ...+|+|+||+...+.... ...+++..+..++.||+.||.|||++||
T Consensus 62 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i 138 (342)
T cd07879 62 YRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGI 138 (342)
T ss_pred HHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 57999999999999999999987532 1357999999987544332 3368999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|
T Consensus 139 ~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~p 214 (342)
T cd07879 139 IHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTL 214 (342)
T ss_pred ccCCCCHHHEEECCCCCEEEeeCCCCcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432 223456789999999987755689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCC--CCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ--QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~--~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+....+..+....|.+.+.++..........+... ......+...++.++..+++||.+||+.||.+||++.++
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~ 294 (342)
T cd07879 215 FKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999998889999998888777665544322111111000 001122334456788999999999999999999999999
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
|.||||.....
T Consensus 295 l~h~~f~~~~~ 305 (342)
T cd07879 295 LEHPYFDSFRD 305 (342)
T ss_pred hcCcchhhccc
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.15 Aligned_cols=210 Identities=28% Similarity=0.436 Sum_probs=178.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+++|++++||||+++++++.+ ...+|+||||+.++.+..++.....+++..+..++.||+.||.|||+.||+|+|
T Consensus 49 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~d 126 (290)
T cd05580 49 LNEKRILQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRD 126 (290)
T ss_pred HHHHHHHHhCCCCCccceeeEEEc--CCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence 579999999999999999999987 578999999998776666655567899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|.||||+.++.+||+|||++...... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.
T Consensus 127 l~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 127 LKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998766543 2344689999999998763 5789999999999999999999999887
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+..+....+.. +.++ ....++..++++|.+||..||.+|+ ++.+++
T Consensus 202 ~~~~~~~~~~~--~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 202 NPIQIYEKILE--GKVR---------------------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CHHHHHHHHhc--CCcc---------------------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 76666665542 1110 0124578899999999999999999 999999
Q ss_pred hccccCCCCCC
Q 009654 237 ASEYFSTKPYA 247 (529)
Q Consensus 237 ~h~~f~~~~~~ 247 (529)
+||||....|.
T Consensus 253 ~~~~~~~~~~~ 263 (290)
T cd05580 253 NHPWFAGIDWI 263 (290)
T ss_pred cCcccccCCHH
Confidence 99999876654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.87 Aligned_cols=215 Identities=24% Similarity=0.397 Sum_probs=177.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.|+|+||+.+++.+.+ .+.+|+||||+.++.+..... ....+++..+..++.||+.||.|||+.||+|
T Consensus 48 ~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH 125 (285)
T cd05632 48 LNEKQILEKVNSQFVVNLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125 (285)
T ss_pred HHHHHHHHHcCCcCceeEEEEEec--CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 479999999999999999999887 568999999999876654432 3346999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||+++.++.+||+|||++...... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 126 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 126 RDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred cCCCHHHEEECCCCCEEEecCCcceecCCC--CcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998755332 22345578999999999976 458999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e 234 (529)
+.........+......... .....++.++.+||.+||+.||++||| +.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05632 203 GRKEKVKREEVDRRVLETEE-------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE 257 (285)
T ss_pred CCCHHHHHHHHHHhhhcccc-------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHH
Confidence 87766555555432222110 011357888999999999999999999 899
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
++.|+||...++
T Consensus 258 l~~~~~~~~~~~ 269 (285)
T cd05632 258 VKRHPFFRNMNF 269 (285)
T ss_pred HHcChhhhcCCH
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=294.68 Aligned_cols=214 Identities=32% Similarity=0.476 Sum_probs=175.1
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
+|+.++++++||||+++++++.+ ...+|+||||+.++.+..++.....+++.++..++.||+.||.+||++||+|+||
T Consensus 47 ~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~di 124 (260)
T PF00069_consen 47 REIKILRRLRHPNIVQILDVFQD--DNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDI 124 (260)
T ss_dssp HHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSB
T ss_pred hhhhccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 58999999999999999999988 6789999999999655544445568999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~ 162 (529)
||+|||++.++.++|+|||.+.... ..........+|+.|+|||++.....++.++|||||||++|+|++|..||....
T Consensus 125 kp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 125 KPENILLDENGEVKLIDFGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp SGGGEEESTTSEEEESSGTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999987642 122344566789999999998734578999999999999999999999999875
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
..+....+.+.........+ ......+..+.+||.+||+.||++|||+.++++||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 204 SDDQLEIIEKILKRPLPSSS----------------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHHHHTHHHHHT----------------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred chhhhhhhhhcccccccccc----------------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 44444444443322111100 0011234789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=293.63 Aligned_cols=212 Identities=26% Similarity=0.375 Sum_probs=171.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..+....+.+++.++..++.||+.||.|||++||+|+|
T Consensus 54 ~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 131 (267)
T cd06645 54 QQEIIMMKDCKHSNIVAYFGSYLR--RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131 (267)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999987 578999999999977776665666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc--CCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+||+++.++.+||+|||++....... .......+++.|+|||++. ....++.++|||||||++|+|++|.+||.
T Consensus 132 lkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 132 IKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCHHHEEECCCCCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 99999999999999999999987654321 2223457899999999974 22458889999999999999999999987
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.......+..+......++ . ......++..+.+||.+||..||++|||+.++|+||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~--~----------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 211 DLHPMRALFLMTKSNFQPP--K----------------------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred cccchhhHHhhhccCCCCC--c----------------------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 6554443333222110000 0 000124678899999999999999999999999999
Q ss_pred c
Q 009654 240 Y 240 (529)
Q Consensus 240 ~ 240 (529)
|
T Consensus 267 ~ 267 (267)
T cd06645 267 F 267 (267)
T ss_pred C
Confidence 8
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=295.96 Aligned_cols=213 Identities=27% Similarity=0.423 Sum_probs=175.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+||||+++++++.+ ...+|+||||++++.+..+.. ....+++.++..++.||+.||.|||++||+|+
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~ 127 (280)
T cd06611 50 MVEIDILSECKHPNIVGLYEAYFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127 (280)
T ss_pred HHHHHHHHhCCCCceeEEEEEEec--CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 579999999999999999999987 578999999999977765543 34579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+||+++.++.++|+|||++....... .......+|+.|+|||++.. ...++.++|||||||++|+|++|.+
T Consensus 128 dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred CCChhhEEECCCCCEEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999987554321 12234568999999999852 2347789999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+....+.++.. +.++. ......++.++.+||.+||..||.+||++.++|
T Consensus 207 p~~~~~~~~~~~~~~~--~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 207 PHHELNPMRVLLKILK--SEPPT------------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred CcccCCHHHHHHHHhc--CCCCC------------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 9988776666655533 11110 000124678899999999999999999999999
Q ss_pred hccccCC
Q 009654 237 ASEYFST 243 (529)
Q Consensus 237 ~h~~f~~ 243 (529)
+||||..
T Consensus 261 ~~~~~~~ 267 (280)
T cd06611 261 KHPFVSD 267 (280)
T ss_pred cChhhcc
Confidence 9999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.74 Aligned_cols=211 Identities=27% Similarity=0.435 Sum_probs=175.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+ .+.+|+||||++++.+..++.....+++..+..++.||+.||+|||+.||+|+|
T Consensus 50 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 127 (265)
T cd06631 50 QEEVDLLKSLKHVNIVQYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127 (265)
T ss_pred HHHHHHHHhcCCCCEeeEeeEeec--CCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 579999999999999999999987 578999999999987776666666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCC-----CCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTG-----HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~-----~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|+|+||+++.++.++|+|||++...... .........++..|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 128 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 206 (265)
T cd06631 128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKP 206 (265)
T ss_pred cCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999998754321 1112234567899999999876 458899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||...+.......+....+..+ .....++.++.++|.+||..+|.+|||+.++|
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 207 PLASMDRLAAMFYIGAHRGLMP--------------------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred ccccCChHHHHHHhhhccCCCC--------------------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 9987766555444433211111 11135788899999999999999999999999
Q ss_pred hcccc
Q 009654 237 ASEYF 241 (529)
Q Consensus 237 ~h~~f 241 (529)
.||||
T Consensus 261 ~~~~~ 265 (265)
T cd06631 261 RHDFL 265 (265)
T ss_pred cCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.56 Aligned_cols=208 Identities=23% Similarity=0.366 Sum_probs=163.8
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC------------------------------
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP------------------------------ 49 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~------------------------------ 49 (529)
+.+|+.+|+.+ +|||||++++++... ...+|+|||||+++.+..++..
T Consensus 57 ~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (338)
T cd05102 57 LMSELKILIHIGNHLNVVNLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDR 135 (338)
T ss_pred HHHHHHHHHHhccCcceeeEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccc
Confidence 35799999999 899999999988764 4578999999998666533321
Q ss_pred --------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEE
Q 009654 50 --------------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 97 (529)
Q Consensus 50 --------------------------------~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl 97 (529)
...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl 215 (338)
T cd05102 136 RIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI 215 (338)
T ss_pred ccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEE
Confidence 124888999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcC
Q 009654 98 ADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCG 175 (529)
Q Consensus 98 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g 175 (529)
+|||+++....... .......+++.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+....+.+...... +
T Consensus 216 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~ 293 (338)
T cd05102 216 CDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-G 293 (338)
T ss_pred eecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-C
Confidence 99999976533211 11123345688999999976 458999999999999999997 99999886544443333221 1
Q ss_pred CCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 176 ~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 294 ~~~--------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 294 TRM--------------------------RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCC--------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 110 001356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.53 Aligned_cols=234 Identities=24% Similarity=0.289 Sum_probs=175.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvHr 80 (529)
.+|+++|++++||||++++++|.+ .+.+|+||||++++.+..++.....+++..+..++.||+.||.|||+ .+|+|+
T Consensus 47 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~ 124 (308)
T cd06615 47 IRELKVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124 (308)
T ss_pred HHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEEC
Confidence 579999999999999999999988 57899999999997777666566789999999999999999999997 699999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++...... .....++++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 125 dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred CCChHHEEEecCCcEEEccCCCccccccc---ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998655332 2234578999999999876 4588999999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC---Ccchhh---------hhccCCcHHHHHHHHHhccCCCCC
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP---YDSSLR---------ETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~---~~~~l~---------~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
.+..... .++....... .+................ ....+. .....++.++++||.+||..||++
T Consensus 201 ~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 277 (308)
T cd06615 201 PDAKELE-AMFGRPVSEG--EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKE 277 (308)
T ss_pred cchhhHH-HhhcCccccc--cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhh
Confidence 6643332 2222111000 000000000000000000 000000 001136788999999999999999
Q ss_pred CcCHHHHHhccccCCC
Q 009654 229 RATASAALASEYFSTK 244 (529)
Q Consensus 229 R~ta~e~L~h~~f~~~ 244 (529)
|||+.++|+||||...
T Consensus 278 Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 278 RADLKELTKHPFIKRA 293 (308)
T ss_pred CcCHHHHhcChhhhhc
Confidence 9999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=298.50 Aligned_cols=219 Identities=26% Similarity=0.353 Sum_probs=179.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. .+.+|+||||++|+.+..++.....+++..+..++.||+.||.|||++||+|||
T Consensus 49 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 126 (305)
T cd05609 49 FVERDILTFAENPFVVSMFCSFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRD 126 (305)
T ss_pred HHHHHHHHhCCCCCeeeeEEEEec--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 479999999999999999999987 568999999999977776665556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCC--------------CccccccccccCCcccccCCCCCCCcchhhhhhHH
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 147 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~--------------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~i 147 (529)
|||+||+++.++.+||+|||+++........ ......++..|+|||.+.+ ..++.++|||||||+
T Consensus 127 l~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~v 205 (305)
T cd05609 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGII 205 (305)
T ss_pred CchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHH
Confidence 9999999999999999999998642211000 1112356889999999876 458999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 148 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 148 l~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
+|+|++|..||.+.+..+.+..+.......+. ....++.++.+||.+||+.||.
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~P~ 259 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPE--------------------------GDEALPADAQDLISRLLRQNPL 259 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC--------------------------ccccCCHHHHHHHHHHhccChh
Confidence 99999999999988877766665442111110 0024788899999999999999
Q ss_pred CCcC---HHHHHhccccCCCCCCCC
Q 009654 228 KRAT---ASAALASEYFSTKPYACD 249 (529)
Q Consensus 228 kR~t---a~e~L~h~~f~~~~~~~~ 249 (529)
+||+ +.++|+||||...+++..
T Consensus 260 ~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 260 ERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred hccCccCHHHHHhCccccCCCHHHH
Confidence 9998 799999999987666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.31 Aligned_cols=213 Identities=27% Similarity=0.486 Sum_probs=169.7
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+||.+|.+| +|.+||+|++|-.. .+.+||||||=+.+|...+.........-.++.|.+|||.+|.++|++||||
T Consensus 406 y~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVH 483 (677)
T KOG0596|consen 406 YRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVH 483 (677)
T ss_pred HHHHHHHHHHhcCCceEEEEeeeecc--CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceee
Confidence 46899999999 79999999998776 6799999999999998888766655665689999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCc-cccccccccCCcccccCCC----------CCCCcchhhhhhHHH
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGAT----------DYGPSVDLWSVGCVF 148 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~----------~y~~~~DIWSlG~il 148 (529)
.||||.|+|+- .|.+||+|||+|..+..+..... .+.+||+.||+||.+.... ..+.++|||||||||
T Consensus 484 SDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCIL 562 (677)
T KOG0596|consen 484 SDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCIL 562 (677)
T ss_pred cCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHH
Confidence 99999999986 48999999999998876543332 3679999999999996422 146789999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCc--HHHHHHHHHhccCCC
Q 009654 149 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEP 226 (529)
Q Consensus 149 ~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s--~~~~dLi~~mL~~dP 226 (529)
|+|+.|++||..- ..++.++... -.|.. .-.|+.+| .+++++|+.||..||
T Consensus 563 YqMvYgktPf~~~--~n~~aKl~aI-~~P~~------------------------~Iefp~~~~~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 563 YQMVYGKTPFGQI--INQIAKLHAI-TDPNH------------------------EIEFPDIPENDELIDVMKCCLARDP 615 (677)
T ss_pred HHHHhcCCchHHH--HHHHHHHHhh-cCCCc------------------------cccccCCCCchHHHHHHHHHHhcCc
Confidence 9999999999532 1223333221 11110 00112222 238999999999999
Q ss_pred CCCcCHHHHHhccccCC
Q 009654 227 YKRATASAALASEYFST 243 (529)
Q Consensus 227 ~kR~ta~e~L~h~~f~~ 243 (529)
.+|||+.++|+|||..-
T Consensus 616 kkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 616 KKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCcHHHhcCccccc
Confidence 99999999999999974
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=289.25 Aligned_cols=209 Identities=24% Similarity=0.394 Sum_probs=172.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.++++++||||+++++.+... .+.+|+||||++++.+...+. ....+++.++..++.||+.||.+||+.||+|
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H 125 (257)
T cd08223 47 EQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125 (257)
T ss_pred HHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 5799999999999999999887643 457899999999865554432 2346899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||||+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 126 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred cCCCchhEEEecCCcEEEecccceEEecccC-CccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999997664322 22334567899999999876 458899999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+.......+... ..+ .....+++.+.+||.+||+.||.+|||+.++|+||
T Consensus 204 ~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 255 (257)
T cd08223 204 AKDMNSLVYRIIEG--KLP--------------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255 (257)
T ss_pred CCCHHHHHHHHHhc--CCC--------------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 87766655554331 110 00135778899999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 256 ~~ 257 (257)
T cd08223 256 YI 257 (257)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=330.31 Aligned_cols=225 Identities=31% Similarity=0.425 Sum_probs=192.7
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.|=.||---+.+=|++|+-.|+| ..++|+|||||+| +++.++..-+ +++|.-++.|+..|+.||.-+|+.|+||||
T Consensus 124 EERDimv~~ns~Wiv~LhyAFQD--~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRD 200 (1317)
T KOG0612|consen 124 EERDIMVFGNSEWIVQLHYAFQD--ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRD 200 (1317)
T ss_pred HHhHHHHcCCcHHHHHHHHHhcC--ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceecc
Confidence 45567766788899999999999 6899999999998 5555555545 899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc----CCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||+|||||..|.|||+|||.|-....+........||||.|++||+|. +...|+..||.||+||++||||+|..|
T Consensus 201 iKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 201 IKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred CCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 9999999999999999999999877755555556779999999999994 224699999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHH--cCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC---H
Q 009654 158 LQGRTEVEQLHKIFKL--CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---A 232 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~--~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t---a 232 (529)
|.+++-++.+-+|+.. +-.+|++ .++|+++++||+++| .+|+.|.. +
T Consensus 281 FYadslveTY~KIm~hk~~l~FP~~---------------------------~~VSeeakdLI~~ll-~~~e~RLgrngi 332 (1317)
T KOG0612|consen 281 FYADSLVETYGKIMNHKESLSFPDE---------------------------TDVSEEAKDLIEALL-CDREVRLGRNGI 332 (1317)
T ss_pred chHHHHHHHHHHHhchhhhcCCCcc---------------------------cccCHHHHHHHHHHh-cChhhhcccccH
Confidence 9999999999999874 1122111 258999999999988 67999998 9
Q ss_pred HHHHhccccCCCCCCCCCCCCCCCCC
Q 009654 233 SAALASEYFSTKPYACDLSSLPIYPP 258 (529)
Q Consensus 233 ~e~L~h~~f~~~~~~~~~~~~p~~~~ 258 (529)
.++-.||||...+|..-....|++.|
T Consensus 333 edik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 333 EDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred HHHHhCccccCCChhhhhhcCCCCCC
Confidence 99999999999999766666677766
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=288.46 Aligned_cols=208 Identities=26% Similarity=0.358 Sum_probs=174.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.++||||+++++++.+ .+.+|+||||++++.+..++.. ...+++..+..++.||+.||.|||+.||+|
T Consensus 47 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h 124 (256)
T cd08529 47 IDEARVLAKLDSSYIIRYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH 124 (256)
T ss_pred HHHHHHHHhcCCCCeehheeeecc--CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 579999999999999999999987 5789999999998666544422 457999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||||+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.
T Consensus 125 ~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred CCCCcceEEEeCCCCEEEcccccceeccCcc-chhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999988665432 12234467899999999976 458899999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
..+..+....+... ..+ .....++..+.++|.+||+.+|++||++.+++.||
T Consensus 203 ~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 203 ANNQGALILKIIRG--VFP--------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred CCCHHHHHHHHHcC--CCC--------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 88876666665441 111 00124678899999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
|+
T Consensus 255 ~~ 256 (256)
T cd08529 255 SL 256 (256)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=291.41 Aligned_cols=212 Identities=26% Similarity=0.385 Sum_probs=169.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+++ +||||+++++++.... ...+|+||||+.++.+..+... ...+++..+..++.||+.||.|||+
T Consensus 50 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~ 129 (272)
T cd06637 50 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129 (272)
T ss_pred HHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 5799999999 7999999999987642 2468999999998666654432 3468999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHH
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~e 150 (529)
+||+|+||||+||+++.++.+||+|||++....... .......+++.|+|||++.+ ...|+.++||||+||++|+
T Consensus 130 ~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred CCCccCCCCHHHEEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999999987654321 22344578999999999863 2357889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 151 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 151 lltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
|++|.+||...........+... +. . ......++..+.+||.+||..||.+||
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~---~~---------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLIPRN---PA---------------------P---RLKSKKWSKKFQSFIESCLVKNHSQRP 261 (272)
T ss_pred HHhCCCCccccCHHHHHHHHhcC---CC---------------------C---CCCCCCcCHHHHHHHHHHcCCChhhCC
Confidence 99999999766554443333110 00 0 001135678899999999999999999
Q ss_pred CHHHHHhcccc
Q 009654 231 TASAALASEYF 241 (529)
Q Consensus 231 ta~e~L~h~~f 241 (529)
|+.++|+||||
T Consensus 262 t~~~il~~~~~ 272 (272)
T cd06637 262 TTEQLMKHPFI 272 (272)
T ss_pred CHHHHhhCCCC
Confidence 99999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=294.81 Aligned_cols=214 Identities=28% Similarity=0.410 Sum_probs=174.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.. ...+|+||||++++.+..+. .....+++..+..++.||+.+|.|||++||+||
T Consensus 57 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~ 134 (292)
T cd06644 57 MVEIEILATCNHPYIVKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134 (292)
T ss_pred HHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeec
Confidence 579999999999999999999887 56899999999997776443 345579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+||+++.++.+||+|||++....... .......+++.|+|||++.+ ...++.++|||||||++|+|++|.+
T Consensus 135 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213 (292)
T ss_pred CCCcceEEEcCCCCEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCC
Confidence 999999999999999999999986543321 22234567899999999853 2347889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+....+.++.. +.++. ......++.++.+||.+||..||++||++.++|
T Consensus 214 p~~~~~~~~~~~~~~~--~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 214 PHHELNPMRVLLKIAK--SEPPT------------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred CCccccHHHHHHHHhc--CCCcc------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 9988776555544432 11100 001135678899999999999999999999999
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
+||||...
T Consensus 268 ~~~~~~~~ 275 (292)
T cd06644 268 EHPFVSSV 275 (292)
T ss_pred cCcccccc
Confidence 99999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=302.49 Aligned_cols=237 Identities=37% Similarity=0.660 Sum_probs=188.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC----CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~----~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.++||||+++++++..... ..+|+||||+.+++...+ . ...+++..+..++.||+.||.|||+.||
T Consensus 62 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~-~-~~~l~~~~~~~i~~qi~~al~~LH~~gi 139 (343)
T cd07880 62 YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-K-HEKLSEDRIQFLVYQMLKGLKYIHAAGI 139 (343)
T ss_pred HHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 479999999999999999999876422 356999999965554443 2 3479999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||+++.++.+||+|||++...... .....+++.|+|||++.+...++.++|+|||||++|+|++|.+|
T Consensus 140 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p 215 (343)
T cd07880 140 IHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215 (343)
T ss_pred ecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432 23446789999999997655688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCC-C-CCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ-Q-PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~-~-~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+....+..+.+..+.++..++..........+... . .....+...+..+++.+.+||.+||+.||.+|||+.++
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 216 FKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 999988888888888777776655443221110000000 0 00112234456788999999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|.||||...
T Consensus 296 l~~~~~~~~ 304 (343)
T cd07880 296 LAHPYFEEF 304 (343)
T ss_pred hcCccHhhh
Confidence 999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=290.34 Aligned_cols=214 Identities=29% Similarity=0.430 Sum_probs=177.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++.....+++.++..++.||+.||.|||++|++|+
T Consensus 40 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~ 117 (262)
T cd05572 40 IFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117 (262)
T ss_pred HHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence 3579999999999999999999887 56899999999987777666566679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|+||+++.++.++|+|||++....... ......+++.|++||++.+ ..++.++|+||+||++|+|++|.+||.+
T Consensus 118 dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 999999999999999999999997665432 2234467899999999865 4588999999999999999999999987
Q ss_pred CC--HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HH
Q 009654 161 RT--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----AS 233 (529)
Q Consensus 161 ~~--~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~ 233 (529)
.. ..+.+..+......+. + ...++.++.++|.+||..||.+|+| +.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~--------------------~-------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKLE--------------------F-------PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CCCCHHHHHHHHhccCCCCC--------------------C-------CcccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 76 5555555542111110 0 0234788999999999999999999 99
Q ss_pred HHHhccccCCCCC
Q 009654 234 AALASEYFSTKPY 246 (529)
Q Consensus 234 e~L~h~~f~~~~~ 246 (529)
++++||||+...|
T Consensus 248 ~l~~~~~~~~~~~ 260 (262)
T cd05572 248 DIKKHKWFNGFDW 260 (262)
T ss_pred HHhcChhhhCCCC
Confidence 9999999986433
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=291.46 Aligned_cols=212 Identities=27% Similarity=0.435 Sum_probs=170.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+.....+|+||||++++.+..++.....+++..+..++.||+.||.|||+.||+|+|
T Consensus 52 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~ 131 (266)
T cd06651 52 ECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRD 131 (266)
T ss_pred HHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 57999999999999999999987755578999999999876665555556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC--CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+||+++.++.+||+|||++....... ........++..|+|||++.+ ..++.++||||+||++|+|++|++||.
T Consensus 132 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 132 IKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred CCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999987543211 111223457889999999876 458899999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.....+.+..+......+ .....+++.+.+|| +||..+|++||++.++|.||
T Consensus 211 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 211 EYEAMAAIFKIATQPTNP---------------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred ccchHHHHHHHhcCCCCC---------------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 765555444332211000 00124677789999 67778999999999999999
Q ss_pred ccC
Q 009654 240 YFS 242 (529)
Q Consensus 240 ~f~ 242 (529)
||+
T Consensus 263 ~~~ 265 (266)
T cd06651 263 FAQ 265 (266)
T ss_pred ccc
Confidence 996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.22 Aligned_cols=213 Identities=24% Similarity=0.435 Sum_probs=177.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++.+.. .+..|+||||++++.+..++. ...+++.++..++.||+.||.|||++||+|||
T Consensus 67 ~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~d 143 (292)
T cd06658 67 FNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143 (292)
T ss_pred HHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecC
Confidence 579999999999999999999887 578999999999987776653 34789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred CCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987554321 22334578999999999865 45889999999999999999999999887
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+....+..+....... ......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 222 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 275 (292)
T cd06658 222 PPLQAMRRIRDNLPPR--------------------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275 (292)
T ss_pred CHHHHHHHHHhcCCCc--------------------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 7766655543311110 00112467889999999999999999999999999999
Q ss_pred CCCC
Q 009654 242 STKP 245 (529)
Q Consensus 242 ~~~~ 245 (529)
...+
T Consensus 276 ~~~~ 279 (292)
T cd06658 276 KLAG 279 (292)
T ss_pred hccC
Confidence 8654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=296.91 Aligned_cols=212 Identities=27% Similarity=0.463 Sum_probs=177.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. ...+|+||||+.++.+..++.. ..+++.++..++.||+.||+|||++||+|+|
T Consensus 64 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~d 140 (296)
T cd06655 64 INEILVMKELKNPNIVNFLDSFLV--GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRD 140 (296)
T ss_pred HHHHHHHHhcCCCceeeeeeeEec--CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 579999999999999999999987 5789999999999877766543 3689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||+++.++.+||+|||++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 141 L~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred CCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876544321 2234468899999999876 45889999999999999999999999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+....+..+... +.+. ......+++.+.+||.+||..||.+|||+.++++||||
T Consensus 219 ~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 219 NPLRALYLIATN-GTPE-------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred CHHHHHHHHHhc-CCcc-------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 776665555331 1111 01113578889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
...
T Consensus 273 ~~~ 275 (296)
T cd06655 273 KLA 275 (296)
T ss_pred hhc
Confidence 853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=291.66 Aligned_cols=236 Identities=41% Similarity=0.715 Sum_probs=192.2
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+..+++++ ||||+++++++.+ ....|+||||+.+++...+.... ..+++.++..++.||+.+|.|||++||+|
T Consensus 45 ~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H 122 (283)
T cd07830 45 LREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122 (283)
T ss_pred HHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46899999998 9999999999987 67899999999777776665433 47899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+|+||+++.++.++|+|||++...... .......++..|+|||++.+...++.++|+|||||++|+|++|.+||.
T Consensus 123 ~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 123 RDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred CCCChhhEEEcCCCCEEEeecccceeccCC--CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 999999999999999999999999765432 223445788999999998766668999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCcccc-CCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+.+..+.+.++....+.+....|.......... ..-.......+...+...+..+++||.+||..||.+|||+.+++.|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 201 GSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 999999999999988888776665432111000 0000000112233444557889999999999999999999999999
Q ss_pred ccc
Q 009654 239 EYF 241 (529)
Q Consensus 239 ~~f 241 (529)
|||
T Consensus 281 ~~~ 283 (283)
T cd07830 281 PYF 283 (283)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=294.29 Aligned_cols=214 Identities=21% Similarity=0.354 Sum_probs=174.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHS-RGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~---~~~l~e~~~~~i~~Qll~gL~~LH~-~gI 77 (529)
.+|+.+|++++||||+++++++.. ...+|+|||||+++.+..++.. ...+++..+..++.||+.||.|||+ .||
T Consensus 47 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i 124 (286)
T cd06622 47 IMELDILHKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124 (286)
T ss_pred HHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 579999999999999999999887 5789999999999777655433 2479999999999999999999997 599
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC-----CCCCcchhhhhhHHHHHHH
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-----~y~~~~DIWSlG~il~ell 152 (529)
+|+||||+||+++.++.+||+|||++...... ......+++.|+|||++.+.. .++.++|||||||++|+|+
T Consensus 125 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~ 201 (286)
T cd06622 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201 (286)
T ss_pred eeCCCCHHHEEECCCCCEEEeecCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence 99999999999999999999999998765332 223446788999999985432 3688999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+|..||...........+.......+. .....++.++.+||.+||..+|.+||++
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (286)
T cd06622 202 LGRYPYPPETYANIFAQLSAIVDGDPP-------------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTY 256 (286)
T ss_pred hCCCCCCCcchhhHHHHHHHHhhcCCC-------------------------CCCcccCHHHHHHHHHHcccCcccCCCH
Confidence 999999876555444443332222111 1123578899999999999999999999
Q ss_pred HHHHhccccCCCC
Q 009654 233 SAALASEYFSTKP 245 (529)
Q Consensus 233 ~e~L~h~~f~~~~ 245 (529)
.+++.||||....
T Consensus 257 ~~l~~~~~~~~~~ 269 (286)
T cd06622 257 AQLLEHPWLVKYK 269 (286)
T ss_pred HHHhcChhhhhcc
Confidence 9999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=291.27 Aligned_cols=211 Identities=28% Similarity=0.445 Sum_probs=176.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+|+||++++.+..++... ++++..+..++.||+.||.|||++||+|+|
T Consensus 47 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~d 123 (274)
T cd06609 47 QQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRD 123 (274)
T ss_pred HHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 579999999999999999999887 57899999999997666655443 899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......+++.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.
T Consensus 124 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 124 IKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred CCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999999998765432 1233456788999999997744 899999999999999999999999877
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+.......+... .++. . . ...++.++.++|.+||..||.+|||+.++++||||
T Consensus 202 ~~~~~~~~~~~~--~~~~-----------------~------~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 202 HPMRVLFLIPKN--NPPS-----------------L------E--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred chHHHHHHhhhc--CCCC-----------------C------c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 665555444331 1100 0 0 01268889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
...
T Consensus 255 ~~~ 257 (274)
T cd06609 255 KKA 257 (274)
T ss_pred cCC
Confidence 863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=331.92 Aligned_cols=214 Identities=28% Similarity=0.420 Sum_probs=172.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSR- 75 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~- 75 (529)
|.+|+.+|++|+|||||+++++|.+.....+|||||||+++.|..++. ....|++..++.|+.||+.||.|||+.
T Consensus 59 ~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g 138 (1021)
T PTZ00266 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138 (1021)
T ss_pred HHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcc
Confidence 357999999999999999999997765678999999999865554332 235799999999999999999999985
Q ss_pred ------CCcccCCCCCcEEEcc-----------------CCcEEEeccccccccCCCCCCCccccccccccCCcccccCC
Q 009654 76 ------GVLHRDIKGSNLLVNN-----------------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 132 (529)
Q Consensus 76 ------gIvHrDIKp~NILl~~-----------------~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 132 (529)
+|+||||||+||||+. .+.+||+|||++....... .....++|+.|+|||++.+.
T Consensus 139 ~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge 216 (1021)
T PTZ00266 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHE 216 (1021)
T ss_pred cccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhcc
Confidence 4999999999999964 2358999999997664321 23455789999999998653
Q ss_pred -CCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCc
Q 009654 133 -TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 211 (529)
Q Consensus 133 -~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s 211 (529)
..++.++||||||||||+|++|.+||........+..+.... +. ..+..++
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~--------------------------lpi~~~S 268 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PD--------------------------LPIKGKS 268 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CC--------------------------CCcCCCC
Confidence 458899999999999999999999998766555443332211 10 0013467
Q ss_pred HHHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 212 TTAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 212 ~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
.++.+||..||..+|.+|||+.++|.|+||...
T Consensus 269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 269 KELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 889999999999999999999999999999854
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=296.45 Aligned_cols=212 Identities=27% Similarity=0.458 Sum_probs=174.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++. ...+++.++..++.||+.||.|||+.||+|||
T Consensus 65 ~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~d 141 (296)
T cd06654 65 INEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141 (296)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEeecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 579999999999999999999987 568999999999877766553 34689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 142 Lkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred CCHHHEEEcCCCCEEECccccchhccccc-cccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654322 12234578899999999876 45789999999999999999999999887
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+....+..+... +.++. .....++..+.+||.+||..||.+|||+.++|.||||
T Consensus 220 ~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 220 NPLRALYLIATN-GTPEL-------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred CHHHhHHHHhcC-CCCCC-------------------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 765544433221 11100 0113577889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
...
T Consensus 274 ~~~ 276 (296)
T cd06654 274 KIA 276 (296)
T ss_pred hcc
Confidence 753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.97 Aligned_cols=211 Identities=25% Similarity=0.383 Sum_probs=184.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--Cc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g--Iv 78 (529)
|..||.+|+.|.|||||++|.++.+..+.++-+|+|+|..|.|..+..+.++++...++.|++|||.||.|||++. |+
T Consensus 88 ~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPII 167 (632)
T KOG0584|consen 88 LYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPII 167 (632)
T ss_pred HHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCcc
Confidence 4679999999999999999999999877889999999999999988888889999999999999999999999996 99
Q ss_pred ccCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 79 HRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||.+||+|+.+ |.|||+|+|||+...... ....+|||.|||||++. ..|++.+||||||+++.||+|+..|
T Consensus 168 HRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYP 242 (632)
T KOG0584|consen 168 HRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYP 242 (632)
T ss_pred ccccccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCC
Confidence 99999999999876 899999999999876543 45579999999999997 4799999999999999999999999
Q ss_pred CCCCCHH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 158 LQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 158 f~g~~~~-~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
|...+.. .+++++.. |..|..+. +--.+++++||.+||.. ...|+|+.|+|
T Consensus 243 YsEC~n~AQIYKKV~S--GiKP~sl~-------------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 243 YSECTNPAQIYKKVTS--GIKPAALS-------------------------KVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred hhhhCCHHHHHHHHHc--CCCHHHhh-------------------------ccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 9776544 45555544 55443321 12267899999999999 99999999999
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
+||||...
T Consensus 295 ~d~Ff~~d 302 (632)
T KOG0584|consen 295 KDPFFDED 302 (632)
T ss_pred hChhhccc
Confidence 99999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.09 Aligned_cols=241 Identities=35% Similarity=0.604 Sum_probs=190.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEc--cCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITS--RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~--~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+++++ +||||+++++.+.. .....+|+++||+.+++...+. ....+++..++.++.||+.||.|||++||+
T Consensus 49 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~giv 127 (332)
T cd07857 49 LRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVL 127 (332)
T ss_pred HHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4799999999 69999999987543 1235689999999987666554 455799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+...++.++||||+||++|+|++|.
T Consensus 128 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~ 207 (332)
T cd07857 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207 (332)
T ss_pred cCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999976543221 11234578999999999876567899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCC---CCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK---PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~---~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+||.+.+....+..++...|.++.+.+.....+....+. ...+ ...+...++.++..+.+||.+||+.||.+|||+
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 286 (332)
T cd07857 208 PVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286 (332)
T ss_pred cCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 999999999999999999998876654432211100000 0000 011223345678899999999999999999999
Q ss_pred HHHHhccccCCC
Q 009654 233 SAALASEYFSTK 244 (529)
Q Consensus 233 ~e~L~h~~f~~~ 244 (529)
.++|.||||...
T Consensus 287 ~~ll~~~~~~~~ 298 (332)
T cd07857 287 EEALEHPYLAIW 298 (332)
T ss_pred HHHhcChhhhhh
Confidence 999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=287.91 Aligned_cols=212 Identities=28% Similarity=0.390 Sum_probs=174.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++++++||||+++++++.+ ...+|+||||++++.+..+.... ..+++.++..++.||+.||.|||++||+|+
T Consensus 48 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~ 125 (262)
T cd06613 48 QQEISMLKECRHPNIVAYFGSYLR--RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125 (262)
T ss_pred HHHHHHHHhCCCCChhceEEEEEe--CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceec
Confidence 579999999999999999999887 57899999999997777655443 689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC--CCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||+|+||+++.++.+||+|||++....... .......++..|+|||++.+. ..++.++|||||||++|+|++|.+||
T Consensus 126 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~ 204 (262)
T cd06613 126 DIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204 (262)
T ss_pred CCChhhEEECCCCCEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999987654321 122345678899999998653 25788999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+.......+......++. ......++.++.+||.+||..||.+|||+.++|.|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 205 FDLHPMRALFLISKSNFPPPK------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCCCHHHHHHHHHhccCCCcc------------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 887766655544331111100 00012457789999999999999999999999999
Q ss_pred cc
Q 009654 239 EY 240 (529)
Q Consensus 239 ~~ 240 (529)
+|
T Consensus 261 ~~ 262 (262)
T cd06613 261 PF 262 (262)
T ss_pred CC
Confidence 98
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.78 Aligned_cols=235 Identities=38% Similarity=0.687 Sum_probs=186.4
Q ss_pred HHHHHHHHhC---CCCCccceeeEEEccCC---CeEEEEEeccCCCchhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL---DHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L---~HpnIvkl~~~~~~~~~---~~~~lV~E~~~g~ll~~~~~~-~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+++++ +||||+++++++.+... ..+|+||||+.+++...+... ...+++.++..++.||+.||.|||+
T Consensus 46 ~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~ 125 (287)
T cd07838 46 LREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125 (287)
T ss_pred HHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3688887776 69999999999987422 249999999998766655432 2369999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
.||+|+||+|+||+++.++.+||+|||++....... ......+++.|+|||++.+. .++.++||||+||++|+|++|
T Consensus 126 ~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~ 202 (287)
T cd07838 126 HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRR 202 (287)
T ss_pred CCeeeccCChhhEEEccCCCEEEeccCcceeccCCc--ccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhC
Confidence 999999999999999999999999999987664331 22344578899999999774 588999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.+..+.+.++....+.+....|..........+.. ..........+.+++.+.+||.+||+.||.+||++.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 280 (287)
T cd07838 203 RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPS--YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280 (287)
T ss_pred CCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccc--ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence 99999999999999998877776555554322110111111 0111223444567889999999999999999999999
Q ss_pred HHhcccc
Q 009654 235 ALASEYF 241 (529)
Q Consensus 235 ~L~h~~f 241 (529)
+|.||||
T Consensus 281 il~~~~~ 287 (287)
T cd07838 281 ALQHPYF 287 (287)
T ss_pred HhcCcCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.81 Aligned_cols=212 Identities=26% Similarity=0.402 Sum_probs=185.9
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
.|-++|+...||.+..|.-.|+. .+.+|+||||+.|+.|...+.+...|+|..++.|...|++||.|||+++||+|||
T Consensus 217 TE~RVL~~~~HPFLt~LKYsFQt--~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDl 294 (516)
T KOG0690|consen 217 TENRVLQNCRHPFLTSLKYSFQT--QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDL 294 (516)
T ss_pred hHHHHHHhccCcHHHHhhhhhcc--CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeec
Confidence 46789999999999999888887 6799999999999888877777778999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~ 162 (529)
|.+|+|+|.+|.|||+|||+|+..-.. .....+.||||.|+|||+|.. ..|+.++|.|.+||++|||+||+.||...+
T Consensus 295 KLENLlLDkDGHIKitDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 295 KLENLLLDKDGHIKITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred hhhhheeccCCceEeeecccchhcccc-cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccc
Confidence 999999999999999999999754322 234567899999999999976 679999999999999999999999999888
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHHh
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALA 237 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L~ 237 (529)
...++..|.-.--.+| ..++++++.||..+|..||.+|. .|.|+.+
T Consensus 373 h~kLFeLIl~ed~kFP-----------------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 373 HEKLFELILMEDLKFP-----------------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred hhHHHHHHHhhhccCC-----------------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 8777777755322221 36899999999999999999997 4899999
Q ss_pred ccccCCCCCC
Q 009654 238 SEYFSTKPYA 247 (529)
Q Consensus 238 h~~f~~~~~~ 247 (529)
|+||....|.
T Consensus 424 h~FF~~v~W~ 433 (516)
T KOG0690|consen 424 HRFFASVDWE 433 (516)
T ss_pred hhhhccCCHH
Confidence 9999987764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.28 Aligned_cols=240 Identities=37% Similarity=0.639 Sum_probs=182.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC------------CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS------------CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 69 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~------------~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL 69 (529)
.+|+.+|++++||||+++++++..... ..+|+||||+++++...+. ...+++..++.++.||+.||
T Consensus 50 ~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL 127 (342)
T cd07854 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGL 127 (342)
T ss_pred HHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHH
Confidence 579999999999999999988765322 3579999999986655443 34799999999999999999
Q ss_pred HHHHHCCCcccCCCCCcEEEcc-CCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhH
Q 009654 70 EHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 146 (529)
Q Consensus 70 ~~LH~~gIvHrDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~ 146 (529)
.|||+.||+||||||+||+++. ++.+||+|||++........ .......++..|+|||++.+...++.++|||||||
T Consensus 128 ~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (342)
T cd07854 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 207 (342)
T ss_pred HHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHH
Confidence 9999999999999999999975 45789999999876543211 11223467889999998876567889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc--CCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 147 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS--KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 147 il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~--~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
++|+|++|++||.+.+..+....+...........+... .++.. ...........+....+.++.++++||.+||+.
T Consensus 208 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 286 (342)
T cd07854 208 IFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTF 286 (342)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCC
Confidence 999999999999999888887777665433322111110 00000 000011111223344567889999999999999
Q ss_pred CCCCCcCHHHHHhccccCCC
Q 009654 225 EPYKRATASAALASEYFSTK 244 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~ 244 (529)
||.+|||+.++|.||||+..
T Consensus 287 dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 287 NPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CchhccCHHHHhCCCccccc
Confidence 99999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=288.73 Aligned_cols=216 Identities=26% Similarity=0.431 Sum_probs=176.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~---~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
+.+|+.+|+.++||||+++++.+.. ...+|+||||++++.+..++.. ...+++..+..++.||+.||.|||++||
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i 123 (267)
T cd06610 46 LRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123 (267)
T ss_pred HHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3589999999999999999999887 5789999999998766655432 2468999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCC---CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+|+||+|+||++++++.++|+|||++......... .....+++..|+|||++.....++.++|+|||||++|+|++|
T Consensus 124 ~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g 203 (267)
T cd06610 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203 (267)
T ss_pred ecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence 99999999999999999999999998766543222 123346789999999997755689999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
..||...+....+.++... .++ . +. . ...+..+++.+.+||.+||..||.+|||+.+
T Consensus 204 ~~p~~~~~~~~~~~~~~~~--~~~-~------------~~----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 204 AAPYSKYPPMKVLMLTLQN--DPP-S------------LE----T----GADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred CCCccccChhhhHHHHhcC--CCC-C------------cC----C----ccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999877766555554331 111 0 00 0 0013467899999999999999999999999
Q ss_pred HHhcccc
Q 009654 235 ALASEYF 241 (529)
Q Consensus 235 ~L~h~~f 241 (529)
+|.||||
T Consensus 261 ll~~p~~ 267 (267)
T cd06610 261 LLKHKFF 267 (267)
T ss_pred HhhCCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=291.87 Aligned_cols=210 Identities=25% Similarity=0.363 Sum_probs=169.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.. ....++||||++++.+... ..+++..+..++.||+.||.|||+.||+|+|
T Consensus 47 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 120 (279)
T cd06619 47 MSELEILYKCDSPYIIGFYGAFFV--ENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120 (279)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCC
Confidence 579999999999999999999988 5689999999999877654 2578999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.++|+|||++...... .....++|..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 121 lkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 121 VKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 9999999999999999999999765432 2334578999999999976 45899999999999999999999999653
Q ss_pred CHHH---HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 162 TEVE---QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 162 ~~~~---~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
...+ ....+......... + ......+++++++||.+||..||.+||++.++|+|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~---------------~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 197 QKNQGSLMPLQLLQCIVDEDP---------------P--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cccccccchHHHHHHHhccCC---------------C--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2111 00111111111000 0 00013467889999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||...
T Consensus 254 ~~~~~~ 259 (279)
T cd06619 254 PFIVQY 259 (279)
T ss_pred cccccc
Confidence 999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=286.73 Aligned_cols=211 Identities=27% Similarity=0.443 Sum_probs=172.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.++++++||||+++++++.+ ...+|+|+||+.++.+..++ .....+++..+..++.||+.||.|||+.||+|
T Consensus 45 ~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H 122 (256)
T cd06612 45 IIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122 (256)
T ss_pred HHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3589999999999999999999988 57899999999987666554 34567899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+|+||+++.++.+||+|||++....... .......++..|+|||++.+. .++.++||||+|||+|+|++|++||.
T Consensus 123 ~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~ 200 (256)
T cd06612 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYS 200 (256)
T ss_pred CCCCcceEEECCCCcEEEcccccchhcccCc-cccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987665432 122334578899999998764 68999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
..+.......+.. ..... ......++..+.+||.+||..||.+|||+.++|.||
T Consensus 201 ~~~~~~~~~~~~~---~~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~ 254 (256)
T cd06612 201 DIHPMRAIFMIPN---KPPPT-----------------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254 (256)
T ss_pred Ccchhhhhhhhcc---CCCCC-----------------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence 7665444333211 00000 001124678899999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 255 ~~ 256 (256)
T cd06612 255 FI 256 (256)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=296.23 Aligned_cols=237 Identities=24% Similarity=0.321 Sum_probs=174.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|+.++||||+++++++.+ ...+|++|||++++.+..++.. ...+++..+..++.||+.||.|||++||+
T Consensus 46 ~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~iv 123 (314)
T cd08216 46 LQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI 123 (314)
T ss_pred HHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3589999999999999999999987 5689999999998777655432 34689999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC------CCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHH
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~el 151 (529)
||||||+|||++.++.+||+|||.+........ .......++..|+|||++.+. ..|+.++||||+||++|+|
T Consensus 124 H~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el 203 (314)
T cd08216 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203 (314)
T ss_pred cCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHH
Confidence 999999999999999999999998865432111 111234567889999998653 3588999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcccc---------CCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 152 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL---------FKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 152 ltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~---------~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
++|.+||........+.... .+..+. .+.....+.... ..+.... .........++.++.+||.+||
T Consensus 204 ~~g~~pf~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 279 (314)
T cd08216 204 ANGHVPFKDMPATQMLLEKV--RGTVPC-LLDKSTYPLYEDSMSQSRSSNEHPNNRD-SVDHPYTRTFSEHFHQFVELCL 279 (314)
T ss_pred HhCCCCCCCCCHHHHHHHHH--hccCcc-ccccCchhhhcCCcCcccccccccchhh-hhhcchhhHHHHHHHHHHHHHh
Confidence 99999998766544332221 222211 011100000000 0000000 0001111345678999999999
Q ss_pred cCCCCCCcCHHHHHhccccCC
Q 009654 223 SVEPYKRATASAALASEYFST 243 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h~~f~~ 243 (529)
..||.+|||+.++|+||||+.
T Consensus 280 ~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 280 QRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred hcCCCcCcCHHHHhcCchHhh
Confidence 999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=290.24 Aligned_cols=212 Identities=28% Similarity=0.383 Sum_probs=169.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.. ...+|+||||++++.+..+......+++.++..++.||+.||.|||+.||+|||
T Consensus 54 ~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 131 (267)
T cd06646 54 QQEIFMVKECKHCNIVAYFGSYLS--REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131 (267)
T ss_pred HHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 579999999999999999999987 568999999999977776555566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+||+++.++.+||+|||++....... .......+++.|+|||.+.. ...++.++||||+||++|+|++|.+||.
T Consensus 132 l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 132 IKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCHHHEEECCCCCEEECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999997654321 12234567899999998853 3347889999999999999999999997
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.....+....+......++ . ......++..+.+||.+||..||++|||++++|+|+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~------------------~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 211 DLHPMRALFLMSKSNFQPP------------------K------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccchhhhheeeecCCCCCC------------------C------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 5544332222211000000 0 001124678999999999999999999999999998
Q ss_pred c
Q 009654 240 Y 240 (529)
Q Consensus 240 ~ 240 (529)
|
T Consensus 267 ~ 267 (267)
T cd06646 267 F 267 (267)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=291.75 Aligned_cols=215 Identities=27% Similarity=0.389 Sum_probs=173.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~--~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++++||||+++++++.. .+.+|+||||++++.+..++... ..+++.++..++.||+.||.|||+.||+|
T Consensus 41 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H 118 (277)
T cd05577 41 LNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118 (277)
T ss_pred HHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 479999999999999999999987 56899999999987666544333 36999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+|+||+++.++.+||+|||++...... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 119 ~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 119 RDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred CCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccCCCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 999999999999999999999998765432 223345678899999998764 48999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e 234 (529)
+.........+....-..+ ......+++.+.++|.+||+.||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 250 (277)
T cd05577 196 QRKEKVEKEELKRRTLEMA-------------------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADE 250 (277)
T ss_pred CCcccccHHHHHhcccccc-------------------------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHH
Confidence 7654222222211100000 111235688999999999999999999 9999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
++.||||....|
T Consensus 251 ll~h~~~~~~~~ 262 (277)
T cd05577 251 VREHPLFKDLNW 262 (277)
T ss_pred HHhChhhhcCCh
Confidence 999999987655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=295.12 Aligned_cols=214 Identities=26% Similarity=0.475 Sum_probs=178.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. ...+|+||||++++.+..+.. ...+++..+..++.||+.||.|||++||+|||
T Consensus 66 ~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~d 142 (297)
T cd06659 66 FNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142 (297)
T ss_pred HHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 579999999999999999999887 578999999999877766553 34789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......++++.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 143 l~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 143 IKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred CCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987554322 12234578999999999976 45899999999999999999999999887
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+..+.. .+.. . ......++..+.++|.+||+.+|.+||++.++++||||
T Consensus 221 ~~~~~~~~~~~---~~~~-~----------------------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 221 SPVQAMKRLRD---SPPP-K----------------------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred CHHHHHHHHhc---cCCC-C----------------------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 77666655422 1100 0 01123577889999999999999999999999999999
Q ss_pred CCCCC
Q 009654 242 STKPY 246 (529)
Q Consensus 242 ~~~~~ 246 (529)
.+...
T Consensus 275 ~~~~~ 279 (297)
T cd06659 275 LQTGL 279 (297)
T ss_pred ccCCC
Confidence 87543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.00 Aligned_cols=237 Identities=35% Similarity=0.617 Sum_probs=186.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.++++++||||+++++++.... ...+|+|++++.+++...+. ...+++..+..++.||+.||.|||++||
T Consensus 64 ~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i 141 (345)
T cd07877 64 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADI 141 (345)
T ss_pred HHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 47999999999999999999886432 24578999998666544443 2369999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||+++.++.+||+|||++..... ......+|++|+|||++.+...++.++||||+||++|+|++|.+|
T Consensus 142 vH~dlkp~NIll~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 217 (345)
T cd07877 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217 (345)
T ss_pred eecCCChHHEEEcCCCCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432 223457789999999987756689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCC--CCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ--QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~--~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+....+..+....+.++...+..........+... ..........+...++.+++||.+||..||.+|+|+.++
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 297 (345)
T cd07877 218 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 297 (345)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence 999888888888888888776665433221100000000 000011122233578899999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|.||||...
T Consensus 298 l~h~~f~~~ 306 (345)
T cd07877 298 LAHAYFAQY 306 (345)
T ss_pred hcChhhhhc
Confidence 999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=292.27 Aligned_cols=205 Identities=25% Similarity=0.376 Sum_probs=165.6
Q ss_pred CCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 009654 11 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 90 (529)
Q Consensus 11 L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~ 90 (529)
.+||||+.+++++.. .+.+|+||||++++.+..++.....+++.++..++.||+.||.|||+.||+||||||+|||++
T Consensus 54 ~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~ 131 (279)
T cd05633 54 GDCPFIVCMTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131 (279)
T ss_pred CCCCcEeEEEEEEec--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC
Confidence 479999999999987 568999999999987776666666899999999999999999999999999999999999999
Q ss_pred cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Q 009654 91 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170 (529)
Q Consensus 91 ~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I 170 (529)
.++.++|+|||++...... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+...... ..+
T Consensus 132 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~ 207 (279)
T cd05633 132 EHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI 207 (279)
T ss_pred CCCCEEEccCCcceecccc---CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHH
Confidence 9999999999998755432 123346899999999986545689999999999999999999999976432211 111
Q ss_pred HHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHHhccccCCCC
Q 009654 171 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKP 245 (529)
Q Consensus 171 ~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L~h~~f~~~~ 245 (529)
.......+ ......++.++.++|.+||..||.+|+ |+.++++||||+...
T Consensus 208 ~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 208 DRMTLTVN-------------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHHhhcCC-------------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 11100000 011235788999999999999999999 699999999998754
Q ss_pred C
Q 009654 246 Y 246 (529)
Q Consensus 246 ~ 246 (529)
+
T Consensus 263 ~ 263 (279)
T cd05633 263 W 263 (279)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=287.68 Aligned_cols=215 Identities=28% Similarity=0.516 Sum_probs=173.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||+.++.+..++.....+++..+..++.||+.||.|||++|++|+|
T Consensus 56 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 133 (272)
T cd06629 56 RSEIETLKDLDHLNIVQYLGFETT--EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRD 133 (272)
T ss_pred HHHHHHHHhcCCCCcceEEEEecc--CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecC
Confidence 469999999999999999999887 578999999999977766655556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCC-CCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+||+++.++.++|+|||++........ .......++..|+|||++.... .++.++|+|||||++|+|++|..||.
T Consensus 134 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 134 LKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred CChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999875432211 1123346788999999987643 47899999999999999999999997
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.....+.+..+......+. .. ......++..+.+||.+||..+|.+|||+.++|+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~--------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 214 DEEAIAAMFKLGNKRSAPP--------------------IP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred CcchHHHHHHhhccccCCc--------------------CC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 6555444433322111100 00 112246789999999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 271 ~~ 272 (272)
T cd06629 271 FI 272 (272)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.11 Aligned_cols=214 Identities=26% Similarity=0.396 Sum_probs=171.9
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
+.+|+.+++++ +||||+++++++.+.. ...+|+||||++++.+..+.. .+..+++..+..++.||+.||.|
T Consensus 49 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~ 128 (275)
T cd06608 49 IKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128 (275)
T ss_pred HHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 35799999999 7999999999997643 346899999999866654432 24679999999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCV 147 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~i 147 (529)
||+.||+|+||+|+||+++.++.+||+|||++....... .......+++.|+|||++.. ...++.++||||||||
T Consensus 129 lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred HhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 999999999999999999999999999999987654322 22334568999999998853 2347889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 148 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 148 l~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
||+|++|.+||.+......+..+... .++ . ......++..+++||.+||..||.
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-~-----------------------~~~~~~~~~~~~~li~~~l~~dp~ 261 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRN--PPP-T-----------------------LKSPENWSKKFNDFISECLIKNYE 261 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhcc--CCC-C-----------------------CCchhhcCHHHHHHHHHHhhcChh
Confidence 99999999999876655555544331 110 0 000123678899999999999999
Q ss_pred CCcCHHHHHhcccc
Q 009654 228 KRATASAALASEYF 241 (529)
Q Consensus 228 kR~ta~e~L~h~~f 241 (529)
+|||+.++++|||+
T Consensus 262 ~Rpt~~~ll~~~~~ 275 (275)
T cd06608 262 QRPFMEELLEHPFI 275 (275)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.66 Aligned_cols=213 Identities=24% Similarity=0.332 Sum_probs=175.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC------CeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS------CSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~------~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+|..++|+||+++++.+..... ..+++||||++++.+..++. ....+++..+..++.||+.||.|
T Consensus 79 ~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~ 158 (496)
T PTZ00283 79 QAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158 (496)
T ss_pred HHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 579999999999999999887754321 24789999999866654332 23579999999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||++||+||||||+||||+.++.+||+|||+++.+..... ......+||+.|+|||++.+ ..|+.++||||||||||+
T Consensus 159 lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilye 237 (496)
T PTZ00283 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYE 237 (496)
T ss_pred HHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999986643211 12335678999999999976 458999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 151 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 151 lltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
|++|..||.+.+..+.+..+...... .....+++++.+||.+||+.||.+||
T Consensus 238 LltG~~Pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~L~~dP~~RP 289 (496)
T PTZ00283 238 LLTLKRPFDGENMEEVMHKTLAGRYD----------------------------PLPPSISPEMQEIVTALLSSDPKRRP 289 (496)
T ss_pred HHHCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcccChhhCc
Confidence 99999999998877777766442111 01135788999999999999999999
Q ss_pred CHHHHHhccccCC
Q 009654 231 TASAALASEYFST 243 (529)
Q Consensus 231 ta~e~L~h~~f~~ 243 (529)
++.++|+|||++.
T Consensus 290 s~~ell~~p~~~~ 302 (496)
T PTZ00283 290 SSSKLLNMPICKL 302 (496)
T ss_pred CHHHHHhCHHHHH
Confidence 9999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.84 Aligned_cols=209 Identities=31% Similarity=0.472 Sum_probs=182.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
++.||..|++|.|||+|.+.++|.. ..+.|||||||-|.-.+++-...+++.+.+++.|..+.|.||.|||+++.|||
T Consensus 73 IlKEVrFL~~l~HPntieYkgCyLr--e~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHR 150 (948)
T KOG0577|consen 73 ILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHR 150 (948)
T ss_pred HHHHHHHHHhccCCCcccccceeec--cchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhh
Confidence 4689999999999999999999988 46789999999997666666667799999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||..|||+.+.|.|||+|||.|.+..+ ..+.+|||+||||||++. ...|+-++||||||++..||...+||+
T Consensus 151 DiKAGNILLse~g~VKLaDFGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 151 DIKAGNILLSEPGLVKLADFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred hccccceEecCCCeeeeccccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 9999999999999999999999976654 478899999999999953 347999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
...+.+..+..|-.. .+|.- . -...+..++.|+..||..-|.+|||++++|.|
T Consensus 226 FnMNAMSALYHIAQN-esPtL------------------------q--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 226 FNMNAMSALYHIAQN-ESPTL------------------------Q--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred cCchHHHHHHHHHhc-CCCCC------------------------C--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 988888877777441 22210 0 13457789999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
+|...
T Consensus 279 ~fv~R 283 (948)
T KOG0577|consen 279 RFVLR 283 (948)
T ss_pred chhcc
Confidence 99875
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.81 Aligned_cols=209 Identities=29% Similarity=0.476 Sum_probs=174.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ....|+||||+.+++...+......+++.++..++.||+.||.|||+.||+|+|
T Consensus 63 ~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~d 140 (307)
T cd06607 63 IKEVRFLQQLRHPNTIEYKGCYLR--EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140 (307)
T ss_pred HHHHHHHHhCCCCCEEEEEEEEEe--CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 579999999999999999999987 568999999999988777665556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+||+++.++.+||+|||++...... ....+++.|+|||++.+ ...++.++||||+||++|+|++|.+||.
T Consensus 141 l~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 141 IKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999998765432 34467889999999853 3458899999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+.......+.. ..++. . ....++..+++||.+||+.||.+||++.+++.||
T Consensus 216 ~~~~~~~~~~~~~--~~~~~-------------------~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 216 NMNAMSALYHIAQ--NDSPT-------------------L------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CccHHHHHHHHhc--CCCCC-------------------C------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 8776655444322 11100 0 0123577899999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
||...
T Consensus 269 ~~~~~ 273 (307)
T cd06607 269 FVLRE 273 (307)
T ss_pred hhccc
Confidence 99853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.19 Aligned_cols=213 Identities=26% Similarity=0.485 Sum_probs=177.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. .+..|+|+||++++.+..+... .++++.++..++.||+.||+|||++||+|||
T Consensus 64 ~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d 140 (285)
T cd06648 64 FNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140 (285)
T ss_pred HHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 579999999999999999999887 5789999999998777766544 5799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.
T Consensus 141 l~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred CChhhEEEcCCCcEEEcccccchhhccCC-cccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 99999999999999999999887554321 12233568999999999876 45899999999999999999999999888
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+....+..+... .++. ......++..+.+||.+||..+|.+|||+.++|+|+||
T Consensus 219 ~~~~~~~~~~~~--~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 219 PPLQAMKRIRDN--LPPK------------------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred CHHHHHHHHHhc--CCCC------------------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence 777766665432 1110 00012477889999999999999999999999999999
Q ss_pred CCCC
Q 009654 242 STKP 245 (529)
Q Consensus 242 ~~~~ 245 (529)
....
T Consensus 273 ~~~~ 276 (285)
T cd06648 273 AKAG 276 (285)
T ss_pred ccCC
Confidence 8643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.36 Aligned_cols=206 Identities=21% Similarity=0.301 Sum_probs=169.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++++||||+++++++.. ...+||||||++++.+..+. .....+++.++..++.||+.||+|||++||+|
T Consensus 53 ~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH 130 (266)
T cd05064 53 FLAEALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH 130 (266)
T ss_pred HHHHHHHHhcCCCCCcCeEEEEEec--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 3579999999999999999999987 56899999999998777554 33457999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+|++|||.+...............++..|+|||++.+ ..++.++||||+||++|+|++ |.+||
T Consensus 131 ~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~ 209 (266)
T cd05064 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred ccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCc
Confidence 9999999999999999999999876543221111112234678999999876 468999999999999999775 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+..+.+..+......+ ....+|..+.+++.+||+.+|.+|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 210 WDMSGQDVIKAVEDGFRLP----------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CcCCHHHHHHHHHCCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9888877777664321111 11357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.51 Aligned_cols=207 Identities=24% Similarity=0.358 Sum_probs=169.5
Q ss_pred HHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 009654 6 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGS 85 (529)
Q Consensus 6 ~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~ 85 (529)
.+++.++||||+++++++.+ .+.+|+||||+.|+.+..++.....+++.+++.++.||+.||.|||+.+|+||||||+
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ 126 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPA 126 (278)
T ss_pred HHHHhCCCCcEeeeeeeeec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHH
Confidence 34455689999999999987 5689999999999877766666678999999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHH-
Q 009654 86 NLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV- 164 (529)
Q Consensus 86 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~- 164 (529)
||+++.++.+||+|||++..+... .....+++..|+|||++.+...++.++||||+||++|+|++|..||.+....
T Consensus 127 nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~ 203 (278)
T cd05606 127 NILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203 (278)
T ss_pred HEEECCCCCEEEccCcCccccCcc---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc
Confidence 999999999999999998755432 1234578999999999976556899999999999999999999999876322
Q ss_pred --HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHHh
Q 009654 165 --EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALA 237 (529)
Q Consensus 165 --~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L~ 237 (529)
.....+.. .. ......++..+.+||.+||..+|.+|+ ++.++++
T Consensus 204 ~~~~~~~~~~---~~--------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 204 KHEIDRMTLT---MA--------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hHHHHHHhhc---cC--------------------------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 21111110 00 011134688999999999999999999 9999999
Q ss_pred ccccCCCCC
Q 009654 238 SEYFSTKPY 246 (529)
Q Consensus 238 h~~f~~~~~ 246 (529)
||||+...|
T Consensus 255 ~~~~~~~~~ 263 (278)
T cd05606 255 HPFFRSLDW 263 (278)
T ss_pred CccccCCCc
Confidence 999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=286.68 Aligned_cols=213 Identities=31% Similarity=0.466 Sum_probs=176.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++.+.. ...+|+||||+.++.+..++.....+++..+..++.||+.||.|||++||+|+|
T Consensus 41 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 118 (265)
T cd05579 41 LTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118 (265)
T ss_pred HHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCC
Confidence 578999999999999999999887 678999999999866665555545899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCC-------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHR-------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
|+|+||+++.++.++|+|||++........ .......++..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 119 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g 197 (265)
T cd05579 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVG 197 (265)
T ss_pred CCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhC
Confidence 999999999999999999999875543211 122344678899999998764 488999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH--
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-- 232 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta-- 232 (529)
.+||...+..+....+......++ ....++..+.+||.+||+.+|.+|||+
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (265)
T cd05579 198 IPPFHGETPEEIFQNILNGKIEWP---------------------------EDVEVSDEAIDLISKLLVPDPEKRLGAKS 250 (265)
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCC---------------------------ccccCCHHHHHHHHHHhcCCHhhcCCCcc
Confidence 999988887776666544111110 001258889999999999999999999
Q ss_pred -HHHHhccccCCC
Q 009654 233 -SAALASEYFSTK 244 (529)
Q Consensus 233 -~e~L~h~~f~~~ 244 (529)
.++|+||||+..
T Consensus 251 ~~~~l~~~~~~~~ 263 (265)
T cd05579 251 IEEIKNHPFFKGI 263 (265)
T ss_pred HHHHhcCccccCC
Confidence 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=283.29 Aligned_cols=208 Identities=29% Similarity=0.476 Sum_probs=176.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++++||||+++++++.+ .+.+++|||||+++.+..++.. ...+++.++..++.||+.||.|||+.||+|
T Consensus 47 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 124 (256)
T cd08221 47 LNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124 (256)
T ss_pred HHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 579999999999999999999988 5789999999998655544432 356899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+|+||+++.++.+||+|||++....... .......+++.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 125 ~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred cCCChHhEEEeCCCCEEECcCcceEEccccc-ccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999997664432 123445789999999998764 47889999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+..+....+.. +.++. ....++.++.++|.+||..+|.+||++.++|+|+
T Consensus 203 ~~~~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 203 ATNPLNLVVKIVQ--GNYTP--------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCHHHHHHHHHc--CCCCC--------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 8887777777643 22210 0135788899999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
|+
T Consensus 255 ~l 256 (256)
T cd08221 255 LL 256 (256)
T ss_pred CC
Confidence 86
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=288.32 Aligned_cols=215 Identities=31% Similarity=0.508 Sum_probs=172.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+||||+++++++.+ ...+++||||+.++.+..++.....+++..+..++.||+.||.|||++||+|+
T Consensus 50 ~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~ 127 (268)
T cd06630 50 LRKEIRLMARLNHPHIIRMLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127 (268)
T ss_pred HHHHHHHHHHcCCCceehhhceecc--CCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3579999999999999999999987 57899999999998777666556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCC-cEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEG-VLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g-~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||+|+||+++.++ .+||+|||++........ .......+|..|+|||++.+ ..++.++||||+||++|+|++|.+
T Consensus 128 ~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~ 206 (268)
T cd06630 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKP 206 (268)
T ss_pred CCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCC
Confidence 9999999998776 599999999876643211 11123467889999999876 458899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||...........+........ . ......+++++.++|.+||..+|.+|||+.++|
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~---------------~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 207 PWNAEKHSNHLALIFKIASATT---------------A---------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred CCCCCCCcchHHHHHHHhccCC---------------C---------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 9975543333333322110000 0 011135788899999999999999999999999
Q ss_pred hccccC
Q 009654 237 ASEYFS 242 (529)
Q Consensus 237 ~h~~f~ 242 (529)
+||||+
T Consensus 263 ~~~~~~ 268 (268)
T cd06630 263 KHPVFR 268 (268)
T ss_pred cCcccC
Confidence 999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.05 Aligned_cols=207 Identities=23% Similarity=0.335 Sum_probs=170.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC----------------CCCCHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQ 64 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~----------------~~l~e~~~~~i~~Q 64 (529)
|.+|+.+|+.++||||+++++++.+ ....|++|||++++.+..++... ..+++.++..++.|
T Consensus 55 ~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 132 (283)
T cd05048 55 FRQEAELMSDLQHPNIVCLLGVCTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132 (283)
T ss_pred HHHHHHHHHhcCCcccceEEEEEcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHH
Confidence 3579999999999999999999887 56789999999986655443221 46889999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||++||+|+||||+|||+++++.+||+|||++........ .......+++.|+|||++.+ ..++.++||||
T Consensus 133 l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~s 211 (283)
T cd05048 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWS 211 (283)
T ss_pred HHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHH
Confidence 99999999999999999999999999999999999999976543221 12234466889999999876 45899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|+|++ |..||.+.+..+....|... .++ .....+|.++.+|+.+||
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~~~~~i~~~--~~~--------------------------~~~~~~~~~~~~l~~~c~ 263 (283)
T cd05048 212 FGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR--QLL--------------------------PCPEDCPARVYALMIECW 263 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CcC--------------------------CCcccCCHHHHHHHHHHc
Confidence 9999999998 99999988877766665431 110 011357899999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
+.||.+|||+.+++++
T Consensus 264 ~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 264 NEIPARRPRFKDIHTR 279 (283)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=283.43 Aligned_cols=209 Identities=33% Similarity=0.491 Sum_probs=174.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+|+|+||++++.+..++.....+++.++..++.||+.||.|||+.||+|+|
T Consensus 50 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 127 (258)
T cd06632 50 EQEIALLSKLQHPNIVQYLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127 (258)
T ss_pred HHHHHHHHhcCCCCchheeeeEec--CCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 579999999999999999999887 578999999999877776665556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.+||+|||++....... ......+++.|+|||.+.....++.++|+|||||++|+|++|.+||...
T Consensus 128 l~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 128 IKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred CCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999999987654432 2345568899999999866434889999999999999999999999876
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
...+....+......+ .....+++.+.+||.+||..+|.+|||+.++|.|||+
T Consensus 206 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 206 EGVAAVFKIGRSKELP---------------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cHHHHHHHHHhcccCC---------------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 6555544443211110 1113578889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=295.12 Aligned_cols=234 Identities=38% Similarity=0.658 Sum_probs=188.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||++++++|... ...+|+||||+.+++...+. ...+++..+..++.||+.||.|||+.||+|||
T Consensus 57 ~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~d 133 (328)
T cd07856 57 YRELKLLKHLRHENIISLSDIFISP-LEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133 (328)
T ss_pred HHHHHHHHhcCCCCeeeEeeeEecC-CCcEEEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 4799999999999999999998764 35789999999876554443 34689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+|||++.++.+||+|||++..... ......+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 134 l~p~Nili~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 134 LKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CCHHHEeECCCCCEEeCccccccccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875433 2234567889999999876567899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccc----cCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHAT----LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~----~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
........+.+.+|.++++.+......... ...... .......++.++..+.++|.+||+.+|++|||+.++|.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 210 DHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE--PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccC--CCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 888888888888888887655432111000 000000 11122344678899999999999999999999999999
Q ss_pred ccccCCC
Q 009654 238 SEYFSTK 244 (529)
Q Consensus 238 h~~f~~~ 244 (529)
||||...
T Consensus 288 ~~~~~~~ 294 (328)
T cd07856 288 HPYLAPY 294 (328)
T ss_pred CCccccc
Confidence 9999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=289.24 Aligned_cols=212 Identities=25% Similarity=0.389 Sum_probs=169.7
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEcc----CCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSR----LSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~----~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+++++ +||||+++++++... ....+|+||||+.++.+..++. ....+++..+..++.||+.||.|||+
T Consensus 60 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 139 (282)
T cd06636 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139 (282)
T ss_pred HHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4688999999 799999999998642 2457899999999866654442 33468899999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHH
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~e 150 (529)
.||+|+||+|+||+++.++.++|+|||++....... .......+++.|+|||++.. ...++.++|||||||++|+
T Consensus 140 ~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence 999999999999999999999999999987554221 12234578999999999853 2357889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 151 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 151 lltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
|++|.+||.+......+..+.... ++ ......++..+.+||.+||+.||.+||
T Consensus 219 l~~g~~p~~~~~~~~~~~~~~~~~--~~-------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (282)
T cd06636 219 MAEGAPPLCDMHPMRALFLIPRNP--PP-------------------------KLKSKKWSKKFIDFIEGCLVKNYLSRP 271 (282)
T ss_pred HHhCCCCccccCHHhhhhhHhhCC--CC-------------------------CCcccccCHHHHHHHHHHhCCChhhCc
Confidence 999999998766554444332210 00 001135788999999999999999999
Q ss_pred CHHHHHhcccc
Q 009654 231 TASAALASEYF 241 (529)
Q Consensus 231 ta~e~L~h~~f 241 (529)
|+.++|+||||
T Consensus 272 ~~~ell~~~~~ 282 (282)
T cd06636 272 STEQLLKHPFI 282 (282)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.98 Aligned_cols=212 Identities=26% Similarity=0.446 Sum_probs=173.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. ...+|+||||++++.+..+... ..+++.++..++.||+.||.|||+.||+|||
T Consensus 64 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~d 140 (297)
T cd06656 64 INEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140 (297)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEec--CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 579999999999999999999987 5789999999999777765533 4689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.
T Consensus 141 L~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred CCHHHEEECCCCCEEECcCccceEccCCc-cCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654332 12234578899999999876 45889999999999999999999999876
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+....+..+.. .+.++. .....++..+.+||.+||..||.+||++.++|+||||
T Consensus 219 ~~~~~~~~~~~-~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 219 NPLRALYLIAT-NGTPEL-------------------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred Ccchheeeecc-CCCCCC-------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 55443322211 111110 0113567889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
...
T Consensus 273 ~~~ 275 (297)
T cd06656 273 KLA 275 (297)
T ss_pred ccc
Confidence 853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=282.29 Aligned_cols=206 Identities=23% Similarity=0.365 Sum_probs=169.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|+.++||||+++++++.+ ...+|+||||++++.+..++ .....+++..+..++.||+.||.|||++||+|
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 123 (256)
T cd05114 46 FIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123 (256)
T ss_pred HHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3579999999999999999999877 56899999999986555444 33457899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+||+++.++.+||+|||++...............++..|+|||++.+ ..++.++|||||||++|+|++ |++||
T Consensus 124 ~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~ 202 (256)
T cd05114 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPF 202 (256)
T ss_pred cccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999987654332222223345668999999875 458999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+..+.+..+......+. ....+..+.+||.+||..||.+|||+.++++
T Consensus 203 ~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 203 EKKSNYEVVEMISRGFRLYR----------------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCHHHHHHHHHCCCCCCC----------------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 98888777777754211100 0135678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=284.37 Aligned_cols=208 Identities=32% Similarity=0.441 Sum_probs=171.5
Q ss_pred HHHH-HHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 4 EILI-LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 4 Ei~i-L~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
|..+ +..++||||+++++++.. .+.+|+||||++++.+..++.....+++..+..++.||+.||.|||+.||+|+||
T Consensus 46 e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl 123 (260)
T cd05611 46 ERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123 (260)
T ss_pred HHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 4444 344599999999999987 5789999999999877766666668999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~ 162 (529)
+|+||+++.++.+||+|||++..... .....+++.|+|||.+.+. .++.++||||||||+|+|++|.+||.+.+
T Consensus 124 ~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 124 KPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred CHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999875432 1234678899999998774 48999999999999999999999999888
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC---HHHHHhcc
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASE 239 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t---a~e~L~h~ 239 (529)
....+..+.......+ ......+++.+.++|.+||+.||.+||| +.++|.||
T Consensus 198 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 198 PDAVFDNILSRRINWP-------------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred HHHHHHHHHhcccCCC-------------------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 7766666543211110 0111357899999999999999999994 58999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
||+..
T Consensus 253 ~~~~~ 257 (260)
T cd05611 253 FFKSI 257 (260)
T ss_pred HhhcC
Confidence 99764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=292.40 Aligned_cols=234 Identities=26% Similarity=0.487 Sum_probs=181.8
Q ss_pred HHHHHHHhCCC--C----CccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 3 REILILRRLDH--P----NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 3 rEi~iL~~L~H--p----nIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
-||++|.+|.+ | -+|.+.++|.- .+++|||+|.++-++.+.+-. .-.+|+...++.+.+||+.++++||+.
T Consensus 134 iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~ 211 (415)
T KOG0671|consen 134 IEIEVLQKINESDPNGKFRCVQMRDWFDY--RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL 211 (415)
T ss_pred HHHHHHHHHHhcCCCCceEEEeeehhhhc--cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc
Confidence 48999999932 3 36777777877 579999999999877776654 445799999999999999999999999
Q ss_pred CCcccCCCCCcEEEcc--------------------CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCC
Q 009654 76 GVLHRDIKGSNLLVNN--------------------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 135 (529)
Q Consensus 76 gIvHrDIKp~NILl~~--------------------~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y 135 (529)
+++|-||||+|||+.+ +..|+|+|||.|++....+ ...+.|..|+|||++++ ..+
T Consensus 212 kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGw 286 (415)
T KOG0671|consen 212 KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGW 286 (415)
T ss_pred ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheec-cCc
Confidence 9999999999999842 2248999999998876543 56788999999999998 569
Q ss_pred CCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc---------CCCccccCCCC-CCC----cc
Q 009654 136 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS---------KLPHATLFKPQ-QPY----DS 201 (529)
Q Consensus 136 ~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~---------~l~~~~~~~~~-~~~----~~ 201 (529)
+..+||||+||||+||++|..+|++....|.+..+...+|.+|.....+. .+......... ..| ..
T Consensus 287 S~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ck 366 (415)
T KOG0671|consen 287 SQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCK 366 (415)
T ss_pred CCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCc
Confidence 99999999999999999999999999999999999999998775433222 11111111000 000 00
Q ss_pred hhhhhccCC---cHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 202 SLRETFKDL---PTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 202 ~l~~~~~~~---s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
.+......- ...+.|||++||.+||.+|+|+.|||.||||+.
T Consensus 367 pl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 367 PLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred cHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 111111112 234789999999999999999999999999985
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=288.65 Aligned_cols=214 Identities=28% Similarity=0.423 Sum_probs=171.1
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+++++ +||||+++++++.... ...+|+||||++++.+..+. .....+++..+..++.||+.||+|||
T Consensus 66 ~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 145 (291)
T cd06639 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145 (291)
T ss_pred HHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4799999999 8999999999987532 24689999999987665443 23457999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC----CCCCcchhhhhhHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFA 149 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~y~~~~DIWSlG~il~ 149 (529)
+.||+|+||||+||+++.++.+||+|||++........ ......++..|+|||++.... .++.++||||||||+|
T Consensus 146 ~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~ 224 (291)
T cd06639 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI 224 (291)
T ss_pred hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHH
Confidence 99999999999999999999999999999876543221 122346789999999985432 3688999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 150 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 150 elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+|++|++||........+..+.. +.++ .. .....++..+.+||.+||..||++|
T Consensus 225 el~~g~~p~~~~~~~~~~~~~~~--~~~~-~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~R 278 (291)
T cd06639 225 ELGDGDPPLFDMHPVKTLFKIPR--NPPP-TL-----------------------LHPEKWCRSFNHFISQCLIKDFEAR 278 (291)
T ss_pred HHhhCCCCCCCCcHHHHHHHHhc--CCCC-CC-----------------------CcccccCHHHHHHHHHHhhcChhhC
Confidence 99999999988766555544432 1110 00 0012356789999999999999999
Q ss_pred cCHHHHHhccccC
Q 009654 230 ATASAALASEYFS 242 (529)
Q Consensus 230 ~ta~e~L~h~~f~ 242 (529)
|++.++|+||||+
T Consensus 279 ps~~~il~~~~~~ 291 (291)
T cd06639 279 PSVTHLLEHPFIK 291 (291)
T ss_pred cCHHHHhcCcccC
Confidence 9999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=284.83 Aligned_cols=212 Identities=26% Similarity=0.416 Sum_probs=171.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+.....+|+||||++++.+..++.....+++..+..++.||+.||.|||++||+|+|
T Consensus 52 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~d 131 (265)
T cd06652 52 ECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRD 131 (265)
T ss_pred HHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 57999999999999999999987755567899999999876665554556789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC--CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+|||++.++.++|+|||++....... ........++..|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 132 l~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 132 IKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred CCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999987543211 112234467899999999876 458999999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+......+..+. ..+... .....++..+.++|.+|| .+|++||+++++++||
T Consensus 211 ~~~~~~~~~~~~---~~~~~~------------------------~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~ 262 (265)
T cd06652 211 EFEAMAAIFKIA---TQPTNP------------------------VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHT 262 (265)
T ss_pred ccchHHHHHHHh---cCCCCC------------------------CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCc
Confidence 765555444332 111100 011246778899999999 5999999999999999
Q ss_pred ccC
Q 009654 240 YFS 242 (529)
Q Consensus 240 ~f~ 242 (529)
|+.
T Consensus 263 ~~~ 265 (265)
T cd06652 263 FVH 265 (265)
T ss_pred ccC
Confidence 984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=290.68 Aligned_cols=209 Identities=29% Similarity=0.464 Sum_probs=176.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ....|+||||+.++++..+......+++.++..++.||+.+|.|||++||+|+|
T Consensus 69 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~d 146 (313)
T cd06633 69 IKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146 (313)
T ss_pred HHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999988 578999999999988777766666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+||+++.++.+||+|||++..... .....++..|+|||++.. ...++.++|||||||++|+|++|.+||.
T Consensus 147 l~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 147 IKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred CChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998854322 234567899999999853 2458889999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+....+..+... .++. .....++..+++||.+||+.+|.+||++.++|.||
T Consensus 222 ~~~~~~~~~~~~~~--~~~~-------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 222 NMNAMSALYHIAQN--DSPT-------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred CCChHHHHHHHHhc--CCCC-------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 87776666655331 1110 00134677899999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
||...
T Consensus 275 ~~~~~ 279 (313)
T cd06633 275 FVRRD 279 (313)
T ss_pred ccCCC
Confidence 99864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=286.05 Aligned_cols=206 Identities=27% Similarity=0.388 Sum_probs=164.9
Q ss_pred HHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 4 EILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 4 Ei~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
|+.+...+ +||||+++++.|.. .+.+|+||||++++.+..++.....+++.++..++.||+.||.|||+.||+||||
T Consensus 58 e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 135 (267)
T PHA03390 58 EPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDI 135 (267)
T ss_pred hHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 44444434 79999999999988 5689999999998666655545558999999999999999999999999999999
Q ss_pred CCCcEEEccCC-cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 83 KGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 83 Kp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
||+||+++.++ .++|+|||++...... ....++..|+|||++.+ ..++.++||||+||++|+|++|..||.+.
T Consensus 136 ~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 136 KLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred CHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999988 9999999998765432 23467899999999976 45899999999999999999999999865
Q ss_pred CHHHH-HHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-HHHHHhcc
Q 009654 162 TEVEQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASE 239 (529)
Q Consensus 162 ~~~~~-~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-a~e~L~h~ 239 (529)
...+. ...+......+ ...++.+++.+.+||.+||+.||.+|++ ++++|+||
T Consensus 210 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 210 EDEELDLESLLKRQQKK--------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred CcchhhHHHHHHhhccc--------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 43321 11121111000 0112368899999999999999999996 59999999
Q ss_pred ccCC
Q 009654 240 YFST 243 (529)
Q Consensus 240 ~f~~ 243 (529)
||..
T Consensus 264 ~~~~ 267 (267)
T PHA03390 264 FLKI 267 (267)
T ss_pred cccC
Confidence 9963
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.33 Aligned_cols=205 Identities=23% Similarity=0.345 Sum_probs=174.6
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
.+|+-|++|+|||||++.|+|+. ...+|||||||..+-|..++.....++......|.++|+.|+.|||.+.||||||
T Consensus 161 TdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDL 238 (904)
T KOG4721|consen 161 TDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDL 238 (904)
T ss_pred hhHHHHHhccCcceeeEeeeecC--CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhcc
Confidence 47899999999999999999987 6789999999999888887777889999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~ 162 (529)
|.-||||..+..|||+|||.++..... ....+.+||..|||||++.. ...++++|||||||||||||||.-||..-+
T Consensus 239 KSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 239 KSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred CCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccc
Confidence 999999999999999999999876543 34557899999999999976 569999999999999999999999997543
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
... |+-.+|... ..| .....+|+.++-||+.||+-.|..||+..++|.|-
T Consensus 316 ssA----IIwGVGsNs------L~L-----------------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 316 SSA----IIWGVGSNS------LHL-----------------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred hhe----eEEeccCCc------ccc-----------------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 322 222223311 011 11246889999999999999999999999999883
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.20 Aligned_cols=212 Identities=26% Similarity=0.428 Sum_probs=182.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.||.+++||.||.|.-.|+. ...+|+|||-+.|+.|..++ ...++|++...+.++.|||.||.|||-+||+|
T Consensus 610 lR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvH 687 (888)
T KOG4236|consen 610 LRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVH 687 (888)
T ss_pred HHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceee
Confidence 3579999999999999999999988 67899999999999999665 56789999999999999999999999999999
Q ss_pred cCCCCCcEEEccCC---cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g---~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
+||||+|||+.... .+||||||+|+++++.. ...+.+|||.|+|||+|.. ..|+..-||||+|||+|.-|+|..
T Consensus 688 CDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTF 764 (888)
T KOG4236|consen 688 CDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTF 764 (888)
T ss_pred ccCCchheeeccCCCCCceeeccccceeecchhh--hhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccc
Confidence 99999999997653 59999999999998653 3467899999999999976 569999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||..+.+ +-.+|.+..--+|.. .|..++++++|||..+|++.-.+|.|+...|
T Consensus 765 PFNEdEd--IndQIQNAaFMyPp~-------------------------PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 765 PFNEDED--INDQIQNAAFMYPPN-------------------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCCCccc--hhHHhhccccccCCC-------------------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 9965433 233343322222222 2468999999999999999999999999999
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
.|||++..
T Consensus 818 sh~Wlq~y 825 (888)
T KOG4236|consen 818 SHPWLQDY 825 (888)
T ss_pred cchhhhcc
Confidence 99999853
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.64 Aligned_cols=215 Identities=29% Similarity=0.499 Sum_probs=174.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKF--SEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l--~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
+..||.+-++|.|.|||+++|.+.. ++++-|.||-++||.+..+ ...-+++ .|..+..|.+|||+||.|||++.|
T Consensus 619 LhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~I 696 (1226)
T KOG4279|consen 619 LHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKI 696 (1226)
T ss_pred HHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcce
Confidence 3579999999999999999999766 6788899999999877754 4556778 899999999999999999999999
Q ss_pred cccCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCccccc-CCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 78 LHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 78 vHrDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||||.+|+||+. .|.+||.|||.++....-. ....+..||+.|||||++. |.+.|+.++|||||||++.||.||+
T Consensus 697 VHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGr 775 (1226)
T KOG4279|consen 697 VHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGR 775 (1226)
T ss_pred eeccccCCcEEEeeccceEEecccccchhhccCC-ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCC
Confidence 99999999999986 5899999999998765432 2233568999999999994 5568999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|||....... ..+|+. |- |+...+.+ ..++.+++.+|.+|+.+||.+||+|.++
T Consensus 776 PPF~Elgspq--AAMFkV-Gm----------------yKvHP~iP-------eelsaeak~FilrcFepd~~~R~sA~~L 829 (1226)
T KOG4279|consen 776 PPFVELGSPQ--AAMFKV-GM----------------YKVHPPIP-------EELSAEAKNFILRCFEPDPCDRPSAKDL 829 (1226)
T ss_pred CCeeecCChh--Hhhhhh-cc----------------eecCCCCc-------HHHHHHHHHHHHHHcCCCcccCccHHHh
Confidence 9996432111 112221 11 11112211 3577889999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|..||++..
T Consensus 830 L~DpFlq~~ 838 (1226)
T KOG4279|consen 830 LQDPFLQHN 838 (1226)
T ss_pred ccCcccccC
Confidence 999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=287.87 Aligned_cols=213 Identities=26% Similarity=0.486 Sum_probs=177.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. .+..|+||||++++.+..+.. ...+++..+..++.||+.||+|||+.||+|+|
T Consensus 65 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~d 141 (292)
T cd06657 65 FNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141 (292)
T ss_pred HHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 579999999999999999999987 578999999999977776653 34789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.
T Consensus 142 l~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred CCHHHEEECCCCCEEEcccccceeccccc-ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987554321 12234567899999998865 45789999999999999999999999987
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
...+.+..+.... ++ . ......++..+.++|.+||..||.+||++.++|.||||
T Consensus 220 ~~~~~~~~~~~~~--~~-~-----------------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 220 PPLKAMKMIRDNL--PP-K-----------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred CHHHHHHHHHhhC--Cc-c-----------------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHH
Confidence 7766665553311 10 0 01123568889999999999999999999999999999
Q ss_pred CCCC
Q 009654 242 STKP 245 (529)
Q Consensus 242 ~~~~ 245 (529)
....
T Consensus 274 ~~~~ 277 (292)
T cd06657 274 AKAG 277 (292)
T ss_pred hccC
Confidence 8654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=284.77 Aligned_cols=207 Identities=29% Similarity=0.431 Sum_probs=172.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|++++++++||||+++++++.+ ...+|+|+||+.++.+...+.....+++.++..++.||+.||.|||++||+|+|
T Consensus 48 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~d 125 (258)
T cd05578 48 LNERRILQELNHPFLVNLWYSFQD--EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125 (258)
T ss_pred HHHHHHHHhCCCCChHHHHHhhcC--CCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 579999999999999999999877 678999999999977776665556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...
T Consensus 126 l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 202 (258)
T cd05578 126 IKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGH 202 (258)
T ss_pred CCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987665432 2234567889999999876 44899999999999999999999999877
Q ss_pred CH--HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH--HHHHh
Q 009654 162 TE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA--SAALA 237 (529)
Q Consensus 162 ~~--~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta--~e~L~ 237 (529)
+. .+.+...... ..+ .....++..+.++|.+||..||.+|+++ .++++
T Consensus 203 ~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 203 SRTIRDQIRAKQET-ADV---------------------------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CccHHHHHHHHhcc-ccc---------------------------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 64 2222222110 000 1113467889999999999999999999 99999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 255 ~~~~ 258 (258)
T cd05578 255 HPYF 258 (258)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=285.73 Aligned_cols=213 Identities=29% Similarity=0.444 Sum_probs=169.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEcc---CCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSR---LSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~---~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+++.+ +||||+++++++... ....+|+||||++++.+..++ .....+++..+..++.||+.||.|||
T Consensus 62 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 141 (286)
T cd06638 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141 (286)
T ss_pred HHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH
Confidence 4699999999 799999999987532 246799999999987665432 23457899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~ 149 (529)
+++|+||||||+||+++.++.+||+|||++....... .......+++.|+|||++.. ...|+.++||||+||++|
T Consensus 142 ~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~ 220 (286)
T cd06638 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI 220 (286)
T ss_pred hCCccccCCCHHhEEECCCCCEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHH
Confidence 9999999999999999999999999999987654322 12234568999999999853 234788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 150 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 150 elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+|++|.+||.+......+..+... .++. . .....++..+.+||.+||+.||.+|
T Consensus 221 el~~g~~p~~~~~~~~~~~~~~~~--~~~~------------~------------~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd06638 221 ELGDGDPPLADLHPMRALFKIPRN--PPPT------------L------------HQPELWSNEFNDFIRKCLTKDYEKR 274 (286)
T ss_pred HHhcCCCCCCCCchhHHHhhcccc--CCCc------------c------------cCCCCcCHHHHHHHHHHccCCcccC
Confidence 999999999876654444333211 0000 0 0012356789999999999999999
Q ss_pred cCHHHHHhcccc
Q 009654 230 ATASAALASEYF 241 (529)
Q Consensus 230 ~ta~e~L~h~~f 241 (529)
||+.++|+|+||
T Consensus 275 ps~~ell~~~~~ 286 (286)
T cd06638 275 PTVSDLLQHVFI 286 (286)
T ss_pred CCHHHHhhcccC
Confidence 999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=287.21 Aligned_cols=217 Identities=26% Similarity=0.376 Sum_probs=170.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
+.+|+++|++|+||||++++++|.+...+.+|+||||++++.+..+. .....+++..+..++.||+.||.|||+.|
T Consensus 46 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ 125 (287)
T cd06621 46 ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125 (287)
T ss_pred HHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 36899999999999999999999776567899999999986555332 23456899999999999999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++||||||||+|+|++|..
T Consensus 126 i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~ 201 (287)
T cd06621 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRF 201 (287)
T ss_pred cccCCCCHHHEEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987554321 123456889999999876 458999999999999999999999
Q ss_pred CCCCCC-----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 157 ILQGRT-----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 157 pf~g~~-----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
||.... ..+....+... .... + +.. ...-..+++.+.+||.+||..||.+|||
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~---~~~~------~-------~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt 259 (287)
T cd06621 202 PFPPEGEPPLGPIELLSYIVNM---PNPE------L-------KDE------PGNGIKWSEEFKDFIKQCLEKDPTRRPT 259 (287)
T ss_pred CCCcccCCCCChHHHHHHHhcC---Cchh------h-------ccC------CCCCCchHHHHHHHHHHHcCCCcccCCC
Confidence 998652 22332222110 0000 0 000 0000135678999999999999999999
Q ss_pred HHHHHhccccCC
Q 009654 232 ASAALASEYFST 243 (529)
Q Consensus 232 a~e~L~h~~f~~ 243 (529)
+.+++.||||++
T Consensus 260 ~~eil~~~~~~~ 271 (287)
T cd06621 260 PWDMLEHPWIKA 271 (287)
T ss_pred HHHHHhCccccc
Confidence 999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.56 Aligned_cols=209 Identities=29% Similarity=0.454 Sum_probs=175.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ....||||||+.++++..+.....++++.++..++.||+.||.|||++||+|||
T Consensus 73 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~d 150 (317)
T cd06635 73 IKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150 (317)
T ss_pred HHHHHHHHhCCCCCEEEEEEEEee--CCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 579999999999999999999987 568899999999987776655566799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+||+++.++.+||+|||++...... ....+++.|+|||++.. ...++.++||||+||++|+|++|.+||.
T Consensus 151 L~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 151 IKAGNILLTEPGQVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CCcccEEECCCCCEEEecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998654332 34467889999999852 2458899999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+....+..+......+. ....++..+.+||.+||+.+|.+||++.++++|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 226 NMNAMSALYHIAQNESPTL---------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CccHHHHHHHHHhccCCCC---------------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 8776666665544211110 0124677899999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
|+...
T Consensus 279 ~~~~~ 283 (317)
T cd06635 279 FVLRE 283 (317)
T ss_pred hhhcc
Confidence 99653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=283.68 Aligned_cols=212 Identities=29% Similarity=0.404 Sum_probs=166.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCC--CHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKF--SEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l--~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
+.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++. ....+ ++..+..++.||+.||.|||+.||
T Consensus 52 ~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 129 (268)
T cd06624 52 LHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129 (268)
T ss_pred HHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCE
Confidence 3589999999999999999999887 578999999999866665443 33455 889999999999999999999999
Q ss_pred cccCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHHhCC
Q 009654 78 LHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 78 vHrDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~elltG~ 155 (529)
+||||||+||+++. ++.++|+|||++....... .......+++.|+|||++.+. ..++.++||||+||++|+|++|.
T Consensus 130 ~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~ 208 (268)
T cd06624 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208 (268)
T ss_pred eecCCCHHHEEEcCCCCeEEEecchhheecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999976 6789999999987654322 222344678999999998653 34789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||................... ......+++++.+||.+||+.+|.+|||+.++
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 262 (268)
T cd06624 209 PPFIELGEPQAAMFKVGMFKIH--------------------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262 (268)
T ss_pred CCCccccChhhhHhhhhhhccC--------------------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 9997543221111000000000 00113577889999999999999999999999
Q ss_pred Hhcccc
Q 009654 236 LASEYF 241 (529)
Q Consensus 236 L~h~~f 241 (529)
+.||||
T Consensus 263 l~~~~~ 268 (268)
T cd06624 263 LQDPFL 268 (268)
T ss_pred HhCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=285.49 Aligned_cols=210 Identities=27% Similarity=0.419 Sum_probs=170.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH-CCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHS-RGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~-~gIv 78 (529)
+.+|+.++++++||||+++++++.. .+.+|+|+||+++..+..++... ..+++..+..++.||+.||+|||+ .|++
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~ 123 (265)
T cd06605 46 ILRELDILHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123 (265)
T ss_pred HHHHHHHHHHCCCCchhhhheeeec--CCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCee
Confidence 3579999999999999999999988 57899999999976666555433 689999999999999999999999 9999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|+||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus 124 H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~ 199 (265)
T cd06605 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPY 199 (265)
T ss_pred cCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876543211 12567889999999976 46899999999999999999999999
Q ss_pred CCCC-----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 159 QGRT-----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 159 ~g~~-----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
.... ..+.+..+.. +.++ . .+ . ..++.++++||.+||..||.+|||+.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~--~~~~-~----------------~~------~--~~~~~~~~~li~~~l~~~p~~Rpt~~ 252 (265)
T cd06605 200 PPENDPPDGIFELLQYIVN--EPPP-R----------------LP------S--GKFSPDFQDFVNLCLIKDPRERPSYK 252 (265)
T ss_pred CccccccccHHHHHHHHhc--CCCC-C----------------CC------h--hhcCHHHHHHHHHHcCCCchhCcCHH
Confidence 6542 2233333321 1110 0 00 0 12788899999999999999999999
Q ss_pred HHHhccccCC
Q 009654 234 AALASEYFST 243 (529)
Q Consensus 234 e~L~h~~f~~ 243 (529)
++|.||||+.
T Consensus 253 ~ll~~~~~~~ 262 (265)
T cd06605 253 ELLEHPFIKK 262 (265)
T ss_pred HHhhCchhhc
Confidence 9999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=279.86 Aligned_cols=214 Identities=31% Similarity=0.471 Sum_probs=172.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+++.++||||+++++++.+ .+.+|+|+||++++.+..+......+++..+..++.||+.||.|||+.||+|+
T Consensus 46 ~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~ 123 (264)
T cd06626 46 IADEMKVLELLKHPNLVKYYGVEVH--REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123 (264)
T ss_pred HHHHHHHHHhCCCCChhheeeeEec--CCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 3579999999999999999999876 57899999999998777776666678999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCC---ccccccccccCCcccccCCC--CCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP---LTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~--~y~~~~DIWSlG~il~elltG~ 155 (529)
||+|+||+++.++.+||+|||++.......... .....+++.|+|||++.+.. .++.++||||+||++|+|++|.
T Consensus 124 dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~ 203 (264)
T cd06626 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203 (264)
T ss_pred CCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCC
Confidence 999999999999999999999987765432211 11346788999999997643 3788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+............. +..+. ...+..++..+.+||.+||+.+|.+|||+.++
T Consensus 204 ~pf~~~~~~~~~~~~~~~-~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 204 RPWSELDNEFQIMFHVGA-GHKPP------------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred CCccCCcchHHHHHHHhc-CCCCC------------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 999765332222222111 11110 01123468889999999999999999999999
Q ss_pred Hhcccc
Q 009654 236 LASEYF 241 (529)
Q Consensus 236 L~h~~f 241 (529)
+.|||+
T Consensus 259 ~~~~~~ 264 (264)
T cd06626 259 LQHPFV 264 (264)
T ss_pred hcCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=280.96 Aligned_cols=208 Identities=27% Similarity=0.497 Sum_probs=172.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.++++++||||+++++++.+ ...+|+||||+.++.+..... ....+++.++..++.||+.||.|||++|++|
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 124 (256)
T cd08218 47 RKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124 (256)
T ss_pred HHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 579999999999999999999987 578999999999855544332 2336899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+|+|||++.++.++|+|||++....... .......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.
T Consensus 125 ~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-ELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred CCCCHHHEEEcCCCCEEEeeccceeecCcch-hhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCcc
Confidence 9999999999999999999999997654321 112234578899999998764 57889999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
..+..+....+.. +..+. ....++.++.++|.+||+.+|.+||++.++|+||
T Consensus 203 ~~~~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 203 AGNMKNLVLKIIR--GSYPP--------------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred CCCHHHHHHHHhc--CCCCC--------------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 8777776666643 22110 1135688899999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 255 ~~ 256 (256)
T cd08218 255 FI 256 (256)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=284.80 Aligned_cols=211 Identities=28% Similarity=0.443 Sum_probs=175.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+||||||++++.+..++.. .++++.++..++.||+.||.|||+.+++|+|
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~d 126 (277)
T cd06640 50 QQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126 (277)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcC
Confidence 579999999999999999999988 5789999999999776655543 4799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.
T Consensus 127 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred CChhhEEEcCCCCEEEcccccceeccCCc-cccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999997654322 12234467889999999876 45789999999999999999999999877
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+.......+.. +.++ .....++..+.+||.+||..+|.+||++.++|.|+||
T Consensus 205 ~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 205 HPMRVLFLIPK--NNPP--------------------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred ChHhHhhhhhc--CCCC--------------------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 66554443311 1110 1113467889999999999999999999999999999
Q ss_pred CCCC
Q 009654 242 STKP 245 (529)
Q Consensus 242 ~~~~ 245 (529)
....
T Consensus 257 ~~~~ 260 (277)
T cd06640 257 VKNA 260 (277)
T ss_pred hhcc
Confidence 7643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=289.05 Aligned_cols=213 Identities=22% Similarity=0.280 Sum_probs=165.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-------------------CCCCCHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-------------------DIKFSEAQIKCY 61 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-------------------~~~l~e~~~~~i 61 (529)
|.+|+.+|.+|+||||+++++++.+ ...+||||||+.++.+..++.. ...+++.++..+
T Consensus 66 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 143 (304)
T cd05096 66 FLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHV 143 (304)
T ss_pred HHHHHHHHhhcCCCCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHH
Confidence 3589999999999999999999987 4679999999998655543321 124788899999
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcch
Q 009654 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 140 (529)
Q Consensus 62 ~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~D 140 (529)
+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......... .....++..|+|||++.+ ..++.++|
T Consensus 144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 222 (304)
T cd05096 144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASD 222 (304)
T ss_pred HHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhh
Confidence 9999999999999999999999999999999999999999997654332111 123345788999999876 45899999
Q ss_pred hhhhhHHHHHHHh--CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHH
Q 009654 141 LWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 218 (529)
Q Consensus 141 IWSlG~il~ellt--G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi 218 (529)
||||||++|+|++ +..||.+.+..+.+..+....-......+ ......+|..+.+||
T Consensus 223 v~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li 281 (304)
T cd05096 223 VWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY---------------------LFRPPPCPQGLYELM 281 (304)
T ss_pred hHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc---------------------ccCCCCCCHHHHHHH
Confidence 9999999999986 56788877766665554332111000000 001135688899999
Q ss_pred HHhccCCCCCCcCHHHHHh
Q 009654 219 ETLLSVEPYKRATASAALA 237 (529)
Q Consensus 219 ~~mL~~dP~kR~ta~e~L~ 237 (529)
.+||..||.+|||+.++.+
T Consensus 282 ~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 282 LQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHccCCchhCcCHHHHHH
Confidence 9999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=283.97 Aligned_cols=206 Identities=24% Similarity=0.358 Sum_probs=169.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--------------CCCCCHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--------------DIKFSEAQIKCYMNQLL 66 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--------------~~~l~e~~~~~i~~Qll 66 (529)
+.+|+++|+.++||||+++++++.. ....|+||||++++.+..++.. ...+++.++..++.||+
T Consensus 55 ~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 132 (280)
T cd05049 55 FEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132 (280)
T ss_pred HHHHHHHHHhcCCCCchheeeEEec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHH
Confidence 3579999999999999999999988 5789999999998766654422 23588999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhh
Q 009654 67 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 145 (529)
Q Consensus 67 ~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG 145 (529)
.||.|||++||+||||||+|||++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++||||||
T Consensus 133 ~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG 211 (280)
T cd05049 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFG 211 (280)
T ss_pred HHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHH
Confidence 999999999999999999999999999999999999875433211 11123345788999999976 4589999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 146 CVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 146 ~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
|++|+|++ |..||.+.+..+.+..+.. +.++ .....++..+.+||.+||+.
T Consensus 212 ~il~e~~~~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~ 263 (280)
T cd05049 212 VVLWEIFTYGKQPWYGLSNEEVIECITQ--GRLL--------------------------QRPRTCPSEVYDIMLGCWKR 263 (280)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCcC--------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 99999998 9999988877776666643 1111 00125788899999999999
Q ss_pred CCCCCcCHHHHHh
Q 009654 225 EPYKRATASAALA 237 (529)
Q Consensus 225 dP~kR~ta~e~L~ 237 (529)
||.+|||+.++++
T Consensus 264 ~p~~Rp~~~eil~ 276 (280)
T cd05049 264 DPQQRINIKDIHE 276 (280)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=284.61 Aligned_cols=212 Identities=28% Similarity=0.459 Sum_probs=174.2
Q ss_pred HHHHHHHHhCC---CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLD---HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~---HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+++++. ||||+++++++.+ ...+|+||||++++.+..+... ..+++..+..++.||+.||.|||+.||+
T Consensus 47 ~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~ 123 (277)
T cd06917 47 QREVALLSQLRQSQPPNITKYYGSYLK--GPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVI 123 (277)
T ss_pred HHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 47999999996 9999999999887 5789999999999777665544 3799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+...++.++|+|||||++|+|++|.+||
T Consensus 124 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~ 202 (277)
T cd06917 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202 (277)
T ss_pred cCCcCHHHEEEcCCCCEEEccCCceeecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765432 22334578899999999876566889999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+.......+... .++ . .. ...++.++.++|.+||..||.+|||+.+++.|
T Consensus 203 ~~~~~~~~~~~~~~~--~~~-----------------~--~~------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 203 SDVDAFRAMMLIPKS--KPP-----------------R--LE------DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCChhhhhhccccC--CCC-----------------C--CC------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 876654433322110 000 0 00 01367889999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
+||+..
T Consensus 256 ~~~~~~ 261 (277)
T cd06917 256 KWIKAH 261 (277)
T ss_pred hHhhcc
Confidence 999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=280.46 Aligned_cols=210 Identities=31% Similarity=0.469 Sum_probs=173.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHH----
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCH---- 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH---- 73 (529)
.+|+.+|+.++||||+++++++.......+|+||||++++.+..++. ....+++.++..++.||+.||.|||
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 126 (265)
T cd08217 47 VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126 (265)
T ss_pred HHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcc
Confidence 46999999999999999999887765678999999999865554332 2467999999999999999999999
Q ss_pred -HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 74 -SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 74 -~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
+.+|+|+||+|+||+++.++.+||+|||++....... .......+++.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 127 ~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~ 204 (265)
T cd08217 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELC 204 (265)
T ss_pred ccCcceecCCCHHHEEEecCCCEEEecccccccccCCc-ccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998765432 11234578999999999876 44889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+|..||.+.+.......+.. +.++ .....++..+.+||.+||..+|.+|||+
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 256 (265)
T cd08217 205 ALSPPFTARNQLQLASKIKE--GKFR--------------------------RIPYRYSSELNEVIKSMLNVDPDKRPST 256 (265)
T ss_pred HCCCcccCcCHHHHHHHHhc--CCCC--------------------------CCccccCHHHHHHHHHHccCCcccCCCH
Confidence 99999998775555544432 1110 0112567889999999999999999999
Q ss_pred HHHHhcccc
Q 009654 233 SAALASEYF 241 (529)
Q Consensus 233 ~e~L~h~~f 241 (529)
.++|+|||+
T Consensus 257 ~~il~~~~~ 265 (265)
T cd08217 257 EELLQLPLI 265 (265)
T ss_pred HHHhhCCCC
Confidence 999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=281.63 Aligned_cols=206 Identities=19% Similarity=0.306 Sum_probs=167.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.++||||+++++++.. ...+|+||||++++.+..++. ....+++..+..++.||+.||.|||++||+|
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H 127 (263)
T cd05052 50 LKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127 (263)
T ss_pred HHHHHHHHhCCCCChhheEEEEcC--CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 579999999999999999999877 568899999999866654432 2346899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||+++++.+||+|||++................+..|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 128 ~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred cccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999997665432111122233667999998866 458899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+.... .+ .....+|.++.+||.+||..||++|||+.++++.
T Consensus 207 ~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 207 PGIDLSQVYELLEKGY--RM--------------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CCCCHHHHHHHHHCCC--CC--------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 9887766655553311 00 0113578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=289.08 Aligned_cols=209 Identities=29% Similarity=0.459 Sum_probs=174.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ....|+||||+.+++...+......+++.++..++.||+.||.|||+.||+|||
T Consensus 63 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~d 140 (308)
T cd06634 63 IKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140 (308)
T ss_pred HHHHHHHHhCCCCCcccEEEEEEc--CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 479999999999999999999987 578999999999877776655566799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|+|+|||++.++.+||+|||++...... ....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.
T Consensus 141 l~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 141 VKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999998765432 34467889999999853 2457889999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+..+....+... ..+. .....++..+.+||.+||..+|.+||++.+++.|+
T Consensus 216 ~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 216 NMNAMSALYHIAQN-ESPA--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cccHHHHHHHHhhc-CCCC--------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 76655554444321 1110 00125678899999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
|+...
T Consensus 269 ~~~~~ 273 (308)
T cd06634 269 FVLRE 273 (308)
T ss_pred ccccc
Confidence 99863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=281.59 Aligned_cols=207 Identities=22% Similarity=0.348 Sum_probs=168.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.++++++||||+++++++.+ ...+|+||||+.++.+..++ .....+++.++..++.||+.||.|||+.||+|
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 123 (256)
T cd05113 46 FIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123 (256)
T ss_pred HHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3579999999999999999999877 45789999999986555444 33447999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
+||||+|||++.++.+||+|||.+...............++..|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus 124 ~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~ 202 (256)
T cd05113 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPY 202 (256)
T ss_pred cccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCc
Confidence 99999999999999999999999876543321111223346789999999763 58999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
...+..+....+......+. ....+..++++|.+||..||.+|||+.++|.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 203 ERFNNSETVEKVSQGLRLYR----------------------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CcCCHHHHHHHHhcCCCCCC----------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 88777666666544211100 02357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=280.58 Aligned_cols=206 Identities=23% Similarity=0.344 Sum_probs=167.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++ .....+++..+..++.||+.||.|||++||+||
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 124 (256)
T cd05059 47 IEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124 (256)
T ss_pred HHHHHHHHhCCCCCEEEEEEEEcC--CCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 579999999999999999999877 56899999999886555443 334578999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~ 159 (529)
||||+||+++.++.+||+|||+++..............++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.
T Consensus 125 dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred cccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 999999999999999999999987654322111112233467999999876 458999999999999999998 899998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+.+..+....+...... .....+|..+.+|+.+||..+|++|||+.++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 204 RFSNSEVVESVSAGYRL----------------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 88777666655331110 0113468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=279.16 Aligned_cols=208 Identities=27% Similarity=0.415 Sum_probs=172.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|+.++||||+++++.+.. ...+|+||||++++.+..++.. ...+++..+..++.|++.+|.|||++||+
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 123 (256)
T cd08220 46 AQNECQVLKLLSHPNIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123 (256)
T ss_pred HHHHHHHHhhCCCCchhheeeeEec--CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3579999999999999999999877 5789999999998666554432 34589999999999999999999999999
Q ss_pred ccCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 79 HRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|+||+|+||+++.+ +.+||+|||++....... ......++..|+|||.+.+ ..++.++||||+||++|+|++|..|
T Consensus 124 h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~ 200 (256)
T cd08220 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRA 200 (256)
T ss_pred cCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCC
Confidence 99999999999865 468999999998665432 2233567899999999976 4578999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+.......+......+ ....++..+.+||.+||..||.+|||+.++|+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 201 FEAANLPALVLKIMSGTFAP----------------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred cccCchHHHHHHHHhcCCCC----------------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 98877766665554311110 11246888999999999999999999999999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 253 ~p~~ 256 (256)
T cd08220 253 QPIC 256 (256)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=293.50 Aligned_cols=238 Identities=23% Similarity=0.317 Sum_probs=171.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+++.++||||++++++|.. ...+|+||||+.++.+..++.. ...+++..+..++.||+.||+|||+.||+
T Consensus 46 ~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv 123 (328)
T cd08226 46 LQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123 (328)
T ss_pred HHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3578999999999999999999988 5689999999998665544432 23589999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCC-CCC-----ccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHH
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQP-----LTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~-----~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~el 151 (529)
||||||+|||++.++.++++||+.+....... ... .....++..|+|||++.+. ..|+.++||||+||++|+|
T Consensus 124 HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el 203 (328)
T cd08226 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACEL 203 (328)
T ss_pred cCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999998653322110 000 0112345679999999764 3478999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcccc-C-C----C---------------CCCCcchhhhhccCC
Q 009654 152 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL-F-K----P---------------QQPYDSSLRETFKDL 210 (529)
Q Consensus 152 ltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~-~-~----~---------------~~~~~~~l~~~~~~~ 210 (529)
++|.+||.+......+..+.......+ |.....+.... + . . .......-......+
T Consensus 204 ~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (328)
T cd08226 204 ATGRVPFQDMLRTQMLLQKLKGPPYSP---LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280 (328)
T ss_pred HhCCCCCCCcChHHHHHHHhcCCCCCC---ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhh
Confidence 999999988766555544433211111 11100000000 0 0 0 000000001112346
Q ss_pred cHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 211 PTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 211 s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
+..+++||.+||+.||++|||+.++|+||||..
T Consensus 281 ~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 281 SPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 788999999999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=286.50 Aligned_cols=214 Identities=20% Similarity=0.318 Sum_probs=169.2
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL----SCPDIKFSEAQIKCYMNQLLHGLEHCHSR- 75 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~----~~~~~~l~e~~~~~i~~Qll~gL~~LH~~- 75 (529)
.+|+.+|.++. ||||+++++++.. ....|+||||+...+.... ......+++..+..++.|++.||+|||+.
T Consensus 50 ~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~ 127 (288)
T cd06616 50 LMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127 (288)
T ss_pred HHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 57999999995 9999999999877 5678999999987543322 12346799999999999999999999975
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC--CCCCCcchhhhhhHHHHHHHh
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il~ellt 153 (529)
||+||||||+|||++.++.+||+|||++....... ......+++.|+|||++.+. ..++.++||||+||++|+|++
T Consensus 128 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 205 (288)
T cd06616 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205 (288)
T ss_pred CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh
Confidence 99999999999999999999999999987654321 22334678999999999765 368999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcC-CCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCG-SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g-~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|++||.... .....+.+... .++. . . ......++.++.+||.+||+.||.+|||+
T Consensus 206 g~~p~~~~~--~~~~~~~~~~~~~~~~-~------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 261 (288)
T cd06616 206 GKFPYPKWN--SVFDQLTQVVKGDPPI-L------------------S---NSEEREFSPSFVNFINLCLIKDESKRPKY 261 (288)
T ss_pred CCCCchhcc--hHHHHHhhhcCCCCCc-C------------------C---CcCCCccCHHHHHHHHHHccCChhhCcCH
Confidence 999997654 22222222221 1110 0 0 01113578899999999999999999999
Q ss_pred HHHHhccccCC
Q 009654 233 SAALASEYFST 243 (529)
Q Consensus 233 ~e~L~h~~f~~ 243 (529)
.+++.||||..
T Consensus 262 ~~i~~~~~~~~ 272 (288)
T cd06616 262 KELLEHPFIKD 272 (288)
T ss_pred HHHhcChhhhc
Confidence 99999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=282.28 Aligned_cols=200 Identities=19% Similarity=0.275 Sum_probs=161.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.++||||+++++++.. ....|+||||++++.+..+.. ....+++..+..++.||+.||+|||++||+||
T Consensus 52 ~~~~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 129 (262)
T cd05077 52 FETASMMRQVSHKHIVLLYGVCVR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHG 129 (262)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECC
Confidence 568899999999999999999887 467899999999987776554 34579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCc-------EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH-
Q 009654 81 DIKGSNLLVNNEGV-------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL- 152 (529)
Q Consensus 81 DIKp~NILl~~~g~-------vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell- 152 (529)
||||+||||+.++. +|++|||++...... ....++..|+|||++.....++.++|||||||++|+|+
T Consensus 130 dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~ 204 (262)
T cd05077 130 NVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY 204 (262)
T ss_pred CCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHh
Confidence 99999999987664 899999998654322 23467888999999875567899999999999999998
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
.|.+||.+....+.. .+.. +.. ......+.++.+||.+||+.||.+||++
T Consensus 205 ~~~~p~~~~~~~~~~-~~~~--~~~---------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~ 254 (262)
T cd05077 205 NGEIPLKDKTLAEKE-RFYE--GQC---------------------------MLVTPSCKELADLMTHCMNYDPNQRPFF 254 (262)
T ss_pred CCCCCCCCcchhHHH-HHHh--cCc---------------------------cCCCCChHHHHHHHHHHcCCChhhCcCH
Confidence 588888766543322 1111 000 0011245678999999999999999999
Q ss_pred HHHHhc
Q 009654 233 SAALAS 238 (529)
Q Consensus 233 ~e~L~h 238 (529)
.++|++
T Consensus 255 ~~il~~ 260 (262)
T cd05077 255 RAIMRD 260 (262)
T ss_pred HHHHHh
Confidence 999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=285.71 Aligned_cols=209 Identities=28% Similarity=0.420 Sum_probs=171.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.. .+.+|+||||++++.+..+.. ...+++..+..++.||+.||.|||++||+|+|
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~d 126 (277)
T cd06642 50 QQEITVLSQCDSPYITRYYGSYLK--GTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRD 126 (277)
T ss_pred HHHHHHHHcCCCCccHhhhccccc--CCceEEEEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccC
Confidence 579999999999999999999987 578999999999876665554 34789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 127 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred CChheEEEeCCCCEEEccccccccccCcc-hhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999987654322 11223467889999999876 45889999999999999999999999765
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
........+.. +.++ .....++.++.+||.+||..+|.+|||+.++|+||||
T Consensus 205 ~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 205 HPMRVLFLIPK--NSPP--------------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred chhhHHhhhhc--CCCC--------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 54443332211 1000 0012467889999999999999999999999999999
Q ss_pred CC
Q 009654 242 ST 243 (529)
Q Consensus 242 ~~ 243 (529)
..
T Consensus 257 ~~ 258 (277)
T cd06642 257 TR 258 (277)
T ss_pred HH
Confidence 74
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=284.10 Aligned_cols=211 Identities=22% Similarity=0.393 Sum_probs=167.6
Q ss_pred HHHHH-HHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CC
Q 009654 3 REILI-LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GV 77 (529)
Q Consensus 3 rEi~i-L~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~---~~~~~l~e~~~~~i~~Qll~gL~~LH~~-gI 77 (529)
+|+.+ ++.++||||+++++++.. ...+|+||||+++++...+. .....+++..+..++.||+.||.|||++ +|
T Consensus 48 ~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i 125 (283)
T cd06617 48 MDLDISMRSVDCPYTVTFYGALFR--EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125 (283)
T ss_pred HHHHHHHHHcCCCCeeeeeEEEec--CCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 45554 666799999999999987 56799999999986655432 2445799999999999999999999998 99
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC---CCCCCcchhhhhhHHHHHHHhC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~y~~~~DIWSlG~il~elltG 154 (529)
+||||||+|||++.++.+||+|||++....... ..+...++..|+|||++.+. ..++.++|+|||||++|+|++|
T Consensus 126 ~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (283)
T cd06617 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203 (283)
T ss_pred ecCCCCHHHEEECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhC
Confidence 999999999999999999999999987654321 22335678999999988652 3478899999999999999999
Q ss_pred CCCCCCC-CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 155 KPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 155 ~~pf~g~-~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
..||... +..+.+..+.. +..+. + ....+|.++.+||.+||..+|.+|||+.
T Consensus 204 ~~p~~~~~~~~~~~~~~~~--~~~~~-------------------~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 256 (283)
T cd06617 204 RFPYDSWKTPFQQLKQVVE--EPSPQ-------------------L------PAEKFSPEFQDFVNKCLKKNYKERPNYP 256 (283)
T ss_pred CCCCCccccCHHHHHHHHh--cCCCC-------------------C------CccccCHHHHHHHHHHccCChhhCcCHH
Confidence 9999642 33344444332 11100 0 0124788999999999999999999999
Q ss_pred HHHhccccCCC
Q 009654 234 AALASEYFSTK 244 (529)
Q Consensus 234 e~L~h~~f~~~ 244 (529)
++++||||...
T Consensus 257 ~il~~~~~~~~ 267 (283)
T cd06617 257 ELLQHPFFELH 267 (283)
T ss_pred HHhcCchhhhc
Confidence 99999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.47 Aligned_cols=206 Identities=23% Similarity=0.363 Sum_probs=168.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-------------CCCCCHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-------------DIKFSEAQIKCYMNQLLH 67 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-------------~~~l~e~~~~~i~~Qll~ 67 (529)
+.+|+.+|++++||||+++++++.. .+.+|+||||++++.+..++.. ...+++.++..++.||+.
T Consensus 54 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~ 131 (288)
T cd05093 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131 (288)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHH
Confidence 3579999999999999999999987 5789999999998666544321 235899999999999999
Q ss_pred HHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhH
Q 009654 68 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 146 (529)
Q Consensus 68 gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~ 146 (529)
||+|||++||+||||||+|||++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||
T Consensus 132 aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~ 210 (288)
T cd05093 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGV 210 (288)
T ss_pred HHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHH
Confidence 99999999999999999999999999999999999976543221 11123345778999999876 46899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 147 VFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 147 il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
++|+|++ |.+||.+.+..+.+..+.. +.+. .....++.++.+||.+||+.|
T Consensus 211 il~~l~t~g~~p~~~~~~~~~~~~i~~--~~~~--------------------------~~~~~~~~~l~~li~~~l~~~ 262 (288)
T cd05093 211 VLWEIFTYGKQPWYQLSNNEVIECITQ--GRVL--------------------------QRPRTCPKEVYDLMLGCWQRE 262 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHc--CCcC--------------------------CCCCCCCHHHHHHHHHHccCC
Confidence 9999998 9999988877776666644 2111 001246788999999999999
Q ss_pred CCCCcCHHHHHh
Q 009654 226 PYKRATASAALA 237 (529)
Q Consensus 226 P~kR~ta~e~L~ 237 (529)
|.+|||+.+++.
T Consensus 263 p~~Rpt~~~v~~ 274 (288)
T cd05093 263 PHMRLNIKEIHS 274 (288)
T ss_pred hhhCCCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=283.60 Aligned_cols=211 Identities=26% Similarity=0.378 Sum_probs=172.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvH 79 (529)
+.+|+++++.++||||+++++++.+ ...+|+||||++++.+..++...+.+++..+..++.||+.+|.|||+ .||+|
T Consensus 50 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H 127 (284)
T cd06620 50 ILRELQIMHECRSPYIVSFYGAFLN--ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127 (284)
T ss_pred HHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 3579999999999999999999988 57899999999998777666666689999999999999999999997 69999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+|+||+++.++.++|+|||++...... .....+++..|+|||++.+. .++.++||||+||++|+|++|.+||.
T Consensus 128 ~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~ 203 (284)
T cd06620 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFA 203 (284)
T ss_pred cCCCHHHEEECCCCcEEEccCCcccchhhh---ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999998654322 12245789999999998764 68899999999999999999999998
Q ss_pred CCCHH-----------HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 160 GRTEV-----------EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 160 g~~~~-----------~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
..... +.+..+.. ..+. .. ....++..+.+||.+||+.||.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------------------~~------~~~~~~~~~~~li~~~l~~dp~~ 256 (284)
T cd06620 204 FSNIDDDGQDDPMGILDLLQQIVQ---EPPP------------------RL------PSSDFPEDLRDFVDACLLKDPTE 256 (284)
T ss_pred ccchhhhhhhhhhHHHHHHHHHhh---ccCC------------------CC------CchhcCHHHHHHHHHHhcCCccc
Confidence 65442 11111111 0000 00 00136788999999999999999
Q ss_pred CcCHHHHHhccccCCC
Q 009654 229 RATASAALASEYFSTK 244 (529)
Q Consensus 229 R~ta~e~L~h~~f~~~ 244 (529)
|||+.++++|+||...
T Consensus 257 Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 257 RPTPQQLCAMPPFIQA 272 (284)
T ss_pred CcCHHHHhcCcccccc
Confidence 9999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.01 Aligned_cols=205 Identities=20% Similarity=0.320 Sum_probs=168.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++ .....+++..+..++.||+.||+|||+.|++|
T Consensus 49 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H 126 (261)
T cd05072 49 LEEANLMKTLQHDKLVRLYAVVTK--EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126 (261)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 579999999999999999999877 56789999999876555443 23457899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+||+++.++.+||+|||++...............++..|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 127 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred cccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 9999999999999999999999998765432222233345678999999876 458899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+..+....+...... .....++.++.+||.+||..+|++|||++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 206 PGMSNSDVMSALQRGYRM----------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 988777766666432111 111357888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=285.33 Aligned_cols=218 Identities=24% Similarity=0.402 Sum_probs=174.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+++ +||||++++++|.. ...+|+||||++++.+...+.....+++..+..++.||+.||.|||+.||+||
T Consensus 52 ~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~ 129 (290)
T cd05613 52 RTERQVLEHIRQSPFLVTLHYAFQT--DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYR 129 (290)
T ss_pred HHHHHHHHhcccCCChhceeeEeec--CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 4699999999 69999999999887 56899999999987666555556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||+|+|||++.++.+||+|||++...............++..|+|||.+.+. ..++.++|||||||++|+|++|..||.
T Consensus 130 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred CCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999976654332333345689999999998753 247889999999999999999999997
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e 234 (529)
..........+...+.... .++ ...+++.+.+||.+||..||.+|+ ++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~------------------~~~-------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~ 264 (290)
T cd05613 210 VDGEKNSQAEISRRILKSE------------------PPY-------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADE 264 (290)
T ss_pred cCCccccHHHHHHHhhccC------------------CCC-------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 5433222222222110000 001 134678899999999999999997 8999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
++.||||....|
T Consensus 265 l~~~~~~~~~~~ 276 (290)
T cd05613 265 IKKHPFFQKINW 276 (290)
T ss_pred HHcCcccccCCH
Confidence 999999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=277.84 Aligned_cols=205 Identities=23% Similarity=0.326 Sum_probs=167.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++++||||+++++++.. ...+|+||||+.++.+..++.. ...+++.++..++.||+.||.|||+.||+|
T Consensus 49 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 126 (261)
T cd05068 49 LAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126 (261)
T ss_pred HHHHHHHHHCCCCCccceeEEEec--CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 579999999999999999999877 5678999999977555544332 246899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+||+++.++.+||+|||++................+..|+|||++.+ ..++.++|||||||++|+|++ |++||
T Consensus 127 ~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~ 205 (261)
T cd05068 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY 205 (261)
T ss_pred ccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999998765322111112223467999998876 458999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+....+..+......+ ....++..+.+||.+||+.+|.+||++.+++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 206 PGMTNAEVLQQVDQGYRMP----------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCHHHHHHHHHcCCCCC----------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9888777776664321110 01246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=276.46 Aligned_cols=206 Identities=23% Similarity=0.338 Sum_probs=164.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|+.++||||+++++++.+ ...+||||||+.++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 40 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 117 (252)
T cd05084 40 FLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117 (252)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3679999999999999999999987 56899999999986665444 34456899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCc-cccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||||+|||++.++.+||+|||++........... .....+..|+|||.+.+ ..++.++||||||||+|+|++ |.+|
T Consensus 118 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred cccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999875443211110 11122456999999876 458999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|...+.......+.... +. .....++..+.+||.+||+.||++|||+.++++
T Consensus 197 ~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 197 YANLSNQQTREAIEQGV--RL--------------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ccccCHHHHHHHHHcCC--CC--------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 98776655544443211 10 001246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=297.67 Aligned_cols=206 Identities=22% Similarity=0.307 Sum_probs=163.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--------------------------------
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-------------------------------- 48 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-------------------------------- 48 (529)
.+|+.+|+.| +|||||++++++.+ .+.+|+|||||.++.+..++.
T Consensus 89 ~~E~~il~~l~~h~nIv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (374)
T cd05106 89 MSELKILSHLGQHKNIVNLLGACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKY 166 (374)
T ss_pred HHHHHHHHhhccCCceeeEeeEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccc
Confidence 5799999999 89999999999987 568999999999865543321
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 009654 49 --------------------------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 90 (529)
Q Consensus 49 --------------------------------------~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~ 90 (529)
...++++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~ 246 (374)
T cd05106 167 IRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT 246 (374)
T ss_pred ccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe
Confidence 113578899999999999999999999999999999999999
Q ss_pred cCCcEEEeccccccccCCCCCCCc-cccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHH
Q 009654 91 NEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 168 (529)
Q Consensus 91 ~~g~vKl~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~ 168 (529)
.++.+||+|||+++.......... ....+++.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+......+.
T Consensus 247 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~ 325 (374)
T cd05106 247 DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325 (374)
T ss_pred CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH
Confidence 999999999999976543321111 12234667999999876 458999999999999999997 999998765544444
Q ss_pred HHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 169 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 169 ~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+......+. ....+++++.+||.+||+.||.+|||+.++++
T Consensus 326 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 326 KMVKRGYQMS---------------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcccCcc---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4333111110 00235789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=283.49 Aligned_cols=205 Identities=22% Similarity=0.350 Sum_probs=167.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQL 65 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Ql 65 (529)
.+|+.++++++||||+++++++.+ .+.+++||||++++.+..++.. ...+++..+..++.||
T Consensus 55 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 132 (291)
T cd05094 55 QREAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132 (291)
T ss_pred HHHHHHHhcCCCCCcceEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHH
Confidence 579999999999999999999987 5679999999998666654422 2358999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 66 l~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
+.||.|||++||+||||||+|||++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||
T Consensus 133 ~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 211 (291)
T cd05094 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSF 211 (291)
T ss_pred HHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHH
Confidence 9999999999999999999999999999999999999976543221 11223456788999999876 458999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
|||+|+|++ |.+||...+..+.+..+.. +..+ .....+|..+.+||.+||+
T Consensus 212 G~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~ 263 (291)
T cd05094 212 GVILWEIFTYGKQPWFQLSNTEVIECITQ--GRVL--------------------------ERPRVCPKEVYDIMLGCWQ 263 (291)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhC--CCCC--------------------------CCCccCCHHHHHHHHHHcc
Confidence 999999998 9999988777666555433 1110 0112467889999999999
Q ss_pred CCCCCCcCHHHHHh
Q 009654 224 VEPYKRATASAALA 237 (529)
Q Consensus 224 ~dP~kR~ta~e~L~ 237 (529)
.||.+|||+.++++
T Consensus 264 ~~P~~Rpt~~~v~~ 277 (291)
T cd05094 264 REPQQRLNIKEIYK 277 (291)
T ss_pred cChhhCcCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=276.97 Aligned_cols=208 Identities=29% Similarity=0.483 Sum_probs=171.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+++.++||||+++++++.+ ...+|+|+||++++.+..+... ...+++..+..++.||+.||.|||+.+|+|
T Consensus 47 ~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H 124 (257)
T cd08225 47 KKEVILLAKMKHPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILH 124 (257)
T ss_pred HHHHHHHHhCCCCChhhhhheecc--CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 579999999999999999999877 5789999999998665544322 235899999999999999999999999999
Q ss_pred cCCCCCcEEEccCC-cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 80 RDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
+||||+||+++.++ .+||+|||.+....... .......+++.|+|||++.+. .++.++|+|||||++|+|++|..||
T Consensus 125 ~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 202 (257)
T cd08225 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPF 202 (257)
T ss_pred ccCCHHHEEEcCCCCeEEecccccchhccCCc-ccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999886 46999999987665432 122334678999999988763 5889999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+... .. ....+.++.++.++|.+||..+|++|||+.++|+|
T Consensus 203 ~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 203 EGNNLHQLVLKICQG--YF--------------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCccHHHHHHHHhcc--cC--------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 887766655544321 10 01113567889999999999999999999999999
Q ss_pred ccc
Q 009654 239 EYF 241 (529)
Q Consensus 239 ~~f 241 (529)
|||
T Consensus 255 ~~~ 257 (257)
T cd08225 255 PFL 257 (257)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=277.44 Aligned_cols=204 Identities=21% Similarity=0.272 Sum_probs=167.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.. ...++||||++++.+..++.....+++..+..++.||+.||+|||++||+|||
T Consensus 44 ~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 120 (257)
T cd05116 44 LREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120 (257)
T ss_pred HHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 578999999999999999998754 46799999999876665555556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||.|||++.++.+||+|||++......... ......+++.|+|||++.. ..++.++|||||||++|||++ |.+||
T Consensus 121 lkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~ 199 (257)
T cd05116 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPY 199 (257)
T ss_pred cchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999766433211 1122234578999998865 458899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+..+....+..... + .....+++++.+||.+||+.||.+||+++++..
T Consensus 200 ~~~~~~~~~~~i~~~~~-~---------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 200 KGMKGNEVTQMIESGER-M---------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCHHHHHHHHHCCCC-C---------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 98877777666643111 1 011357889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=278.23 Aligned_cols=211 Identities=27% Similarity=0.417 Sum_probs=172.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+.....+++||||++++.+...+.....+++..+..++.||+.||.|||++||+|+|
T Consensus 52 ~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~d 131 (264)
T cd06653 52 ECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRD 131 (264)
T ss_pred HHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 57999999999999999999988765567999999999876665554555789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC--CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+||+++.++.++|+|||++....... ........++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.
T Consensus 132 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 132 IKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred CCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999997653211 112234567899999999976 457899999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+....+.+.++. ..+.. ......+++.+.++|.+||. +|..|||+.++|.||
T Consensus 211 ~~~~~~~~~~~~---~~~~~------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 211 EYEAMAAIFKIA---TQPTK------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred ccCHHHHHHHHH---cCCCC------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 776655554442 22110 00113578889999999998 579999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
|.
T Consensus 263 ~~ 264 (264)
T cd06653 263 FV 264 (264)
T ss_pred CC
Confidence 84
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=280.57 Aligned_cols=200 Identities=21% Similarity=0.253 Sum_probs=161.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.+ .+..|||||||+++.+..++. ....+++..+..++.||+.||+|||++||+||
T Consensus 64 ~~~~~~~~~l~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 141 (274)
T cd05076 64 FETASLMSQVSHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHG 141 (274)
T ss_pred HHHHHHHhcCCCCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCC
Confidence 468899999999999999999987 568899999999987775553 45679999999999999999999999999999
Q ss_pred CCCCCcEEEccCC-------cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH-
Q 009654 81 DIKGSNLLVNNEG-------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL- 152 (529)
Q Consensus 81 DIKp~NILl~~~g-------~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell- 152 (529)
||||+|||++..+ .+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999997644 3899999987543221 23456788999999876567899999999999999985
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+|.+||.+.+..+....+... ... ....++.+.+||.+||+.+|.+|||+
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~-~~~-----------------------------~~~~~~~~~~li~~cl~~~p~~Rps~ 266 (274)
T cd05076 217 DGEVPLKERTPSEKERFYEKK-HRL-----------------------------PEPSCKELATLISQCLTYEPTQRPSF 266 (274)
T ss_pred CCCCCccccChHHHHHHHHhc-cCC-----------------------------CCCCChHHHHHHHHHcccChhhCcCH
Confidence 699999877654433222110 000 01234678999999999999999999
Q ss_pred HHHHhc
Q 009654 233 SAALAS 238 (529)
Q Consensus 233 ~e~L~h 238 (529)
.++|++
T Consensus 267 ~~il~~ 272 (274)
T cd05076 267 RTILRD 272 (274)
T ss_pred HHHHHh
Confidence 999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=274.66 Aligned_cols=206 Identities=26% Similarity=0.390 Sum_probs=171.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP---------DIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~---------~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++.. ...+++.++..++.||+.||+||
T Consensus 44 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l 121 (262)
T cd00192 44 LKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121 (262)
T ss_pred HHHHHHHhhcCCCChheeeeeecC--CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999999999999987 6789999999977655544433 36899999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 73 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 73 H~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
|++||+|+||+|+||+++.++.+||+|||.+........ .......+++.|+|||.+... .++.++|||||||++|+|
T Consensus 122 H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l 200 (262)
T cd00192 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred HcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHH
Confidence 999999999999999999999999999999987654321 122344568899999998764 689999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 lt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++ |.+||.+.+..+....+.. +... .....+|.++.++|.+||..||.+||
T Consensus 201 ~~~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd00192 201 FTLGATPYPGLSNEEVLEYLRK--GYRL--------------------------PKPEYCPDELYELMLSCWQLDPEDRP 252 (262)
T ss_pred HhcCCCCCCCCCHHHHHHHHHc--CCCC--------------------------CCCccCChHHHHHHHHHccCCcccCc
Confidence 99 6999998877776666643 1110 11134688999999999999999999
Q ss_pred CHHHHHhc
Q 009654 231 TASAALAS 238 (529)
Q Consensus 231 ta~e~L~h 238 (529)
|+.+++++
T Consensus 253 s~~~l~~~ 260 (262)
T cd00192 253 TFSELVER 260 (262)
T ss_pred CHHHHHHh
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=273.59 Aligned_cols=208 Identities=32% Similarity=0.529 Sum_probs=175.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|++++++++||||+++++++.+ ...+|+||||++++.+..+......+++..+..++.|++.||.|||+.||+|+|
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~d 124 (254)
T cd06627 47 MQEIDLLKNLKHPNIVKYIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRD 124 (254)
T ss_pred HHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCC
Confidence 589999999999999999999887 578999999999977776665557899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||...
T Consensus 125 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 125 IKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred CCHHHEEECCCCCEEEeccccceecCCCcc-cccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999987765332 12345678999999998764 4889999999999999999999999876
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+......++.. ...+ .....++..+.++|.+||..+|++|||+.++|.||||
T Consensus 203 ~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 203 NPMAALFRIVQ--DDHP--------------------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred cHHHHHHHHhc--cCCC--------------------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 65554444321 1000 0113568889999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.38 Aligned_cols=209 Identities=23% Similarity=0.380 Sum_probs=161.9
Q ss_pred CHHHHHHHHhCC-CCCccceee-EEEccC----CCeEEEEEeccCC-Cchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLD-HPNIIKLEG-LITSRL----SCSIYLVFEYMEH-DITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 1 ~~rEi~iL~~L~-HpnIvkl~~-~~~~~~----~~~~~lV~E~~~g-~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
+.+||.+|++|. |||||.+++ ....+. ...++|.||||.| ++++.+. .-..+|+|.+++.||.|+++||.+|
T Consensus 81 v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~m 160 (738)
T KOG1989|consen 81 VKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAM 160 (738)
T ss_pred HHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHH
Confidence 368999999995 999999999 333221 2457899999995 6666543 1234599999999999999999999
Q ss_pred HHCC--CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCc--------cccccccccCCccccc--CCCCCCCcch
Q 009654 73 HSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--------TSRVVTLWYRPPELLL--GATDYGPSVD 140 (529)
Q Consensus 73 H~~g--IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~--------~~~~gt~~Y~APE~l~--~~~~y~~~~D 140 (529)
|... |+|||||-+||||+.+|.+||||||.|+-......... -...-|+.|+|||++. .....++++|
T Consensus 161 H~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsD 240 (738)
T KOG1989|consen 161 HYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSD 240 (738)
T ss_pred hcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhH
Confidence 9998 99999999999999999999999999974432211100 0123489999999983 3456799999
Q ss_pred hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHH
Q 009654 141 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 220 (529)
Q Consensus 141 IWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~ 220 (529)
||||||+||-|+....||++.....++..- ..+ ..++.++..+++||..
T Consensus 241 IWALGclLYkLCy~t~PFe~sg~laIlng~----Y~~---------------------------P~~p~ys~~l~~LI~~ 289 (738)
T KOG1989|consen 241 IWALGCLLYKLCYFTTPFEESGKLAILNGN----YSF---------------------------PPFPNYSDRLKDLIRT 289 (738)
T ss_pred HHHHHHHHHHHHHhCCCcCcCcceeEEecc----ccC---------------------------CCCccHHHHHHHHHHH
Confidence 999999999999999999865333322211 111 1224678889999999
Q ss_pred hccCCCCCCcCHHHHHhccc
Q 009654 221 LLSVEPYKRATASAALASEY 240 (529)
Q Consensus 221 mL~~dP~kR~ta~e~L~h~~ 240 (529)
||..||.+||++-+++.+-+
T Consensus 290 mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 290 MLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred HhccCcccCCCHHHHHHHHH
Confidence 99999999999999987543
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=286.56 Aligned_cols=212 Identities=27% Similarity=0.459 Sum_probs=174.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. ...+|+|+||++++.+..+... ..+++.++..++.||+.||.|||++||+|+|
T Consensus 64 ~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~d 140 (293)
T cd06647 64 INEILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 140 (293)
T ss_pred HHHHHHHhhcCCCCeeehhheeee--CCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeecc
Confidence 579999999999999999999987 5689999999998766655533 3689999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.+||+|||++........ ......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...
T Consensus 141 L~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred CCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876544321 2233468899999999876 45889999999999999999999999877
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+..+.. .+.+. ......++..+.+||.+||..+|.+||++.+++.|+||
T Consensus 219 ~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 219 NPLRALYLIAT-NGTPE-------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred Chhhheeehhc-CCCCC-------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 66554433321 01110 00123467889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
+..
T Consensus 273 ~~~ 275 (293)
T cd06647 273 KIA 275 (293)
T ss_pred hcC
Confidence 853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=279.91 Aligned_cols=206 Identities=16% Similarity=0.257 Sum_probs=165.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------CCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++.. ...+++..+..++.||+.||.|
T Consensus 57 ~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (277)
T cd05062 57 LNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY 134 (277)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 579999999999999999999876 5689999999998766654422 1236788899999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||+.|++|+||||+|||++.++.++|+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+
T Consensus 135 lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~e 213 (277)
T cd05062 135 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWE 213 (277)
T ss_pred HHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHH
Confidence 99999999999999999999999999999998755432111 1122345788999999876 458999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+.+..+.+..+... ..+ .....++..+.+||.+||+.||.+|
T Consensus 214 l~~~~~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R 265 (277)
T cd05062 214 IATLAEQPYQGMSNEQVLRFVMEG--GLL--------------------------DKPDNCPDMLFELMRMCWQYNPKMR 265 (277)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHHHHcCCChhhC
Confidence 998 78999888776666555331 110 0012467889999999999999999
Q ss_pred cCHHHHHhc
Q 009654 230 ATASAALAS 238 (529)
Q Consensus 230 ~ta~e~L~h 238 (529)
||+.+++++
T Consensus 266 ps~~e~l~~ 274 (277)
T cd05062 266 PSFLEIISS 274 (277)
T ss_pred cCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=285.24 Aligned_cols=215 Identities=25% Similarity=0.427 Sum_probs=178.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+..||.||++++.|+||++|+.|.- ...+|||||||..+....+ ..+.+.|+|.++..+++..|.||+|||...-+|
T Consensus 75 IIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIH 152 (502)
T KOG0574|consen 75 IIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIH 152 (502)
T ss_pred HHHHHHHHHHcCCchhhhhhhhhcc--CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 3589999999999999999998876 5689999999998766655 457788999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||..|||++.+|..||+|||.|-...... ...++..|||.|||||++.. -.|+..+||||||++..||..|+|||.
T Consensus 153 RDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 153 RDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred hhcccccEEEcccchhhhhhccccchhhhhH-HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcc
Confidence 9999999999999999999999986554321 23356789999999999976 359999999999999999999999997
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.... ..||-.--.||+.|- .....+.++-|+|++||...|++|.||.++++|+
T Consensus 231 DIHPM---RAIFMIPT~PPPTF~-----------------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 231 DIHPM---RAIFMIPTKPPPTFK-----------------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred ccccc---ceeEeccCCCCCCCC-----------------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 64433 334333333433220 1123577889999999999999999999999999
Q ss_pred ccCCCC
Q 009654 240 YFSTKP 245 (529)
Q Consensus 240 ~f~~~~ 245 (529)
|+++.+
T Consensus 285 FiknA~ 290 (502)
T KOG0574|consen 285 FIKNAP 290 (502)
T ss_pred hhcCCC
Confidence 999754
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=281.61 Aligned_cols=212 Identities=31% Similarity=0.519 Sum_probs=175.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~-~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.++||||+++++++.. ...+|+|+||++++.+..+..... .+++.++..++.||+.||.|||+.||+|+
T Consensus 63 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~ 140 (286)
T cd06614 63 INEILIMKDCKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140 (286)
T ss_pred HHHHHHHHHCCCCCeeEEEEEEEE--CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence 579999999999999999999988 578999999999766665554443 89999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++|+||||||+|+|++|..||.+
T Consensus 141 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred CCChhhEEEcCCCCEEECccchhhhhccch-hhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986554321 12233457889999999876 4589999999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.........+... +.+. ......++..+.+||.+||+.+|.+|||+.++|.|+|
T Consensus 219 ~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 219 EPPLRALFLITTK-GIPP-------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred CCHHHHHHHHHhc-CCCC-------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 7766555544331 1110 0011247888999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|+.
T Consensus 273 ~~~ 275 (286)
T cd06614 273 LKK 275 (286)
T ss_pred hhc
Confidence 986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.34 Aligned_cols=208 Identities=34% Similarity=0.512 Sum_probs=174.5
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++++. ||||+++++++.+ ...+|+||||++++.+..++.....+++..+..++.||+.||.|||+.|++|+
T Consensus 49 ~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~ 126 (280)
T cd05581 49 KIEKEVLTRLNGHPGIIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR 126 (280)
T ss_pred HHHHHHHHhcccCCCchhHHHHhcC--CceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 57899999998 9999999999877 57899999999876666555555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCC-------------------CCccccccccccCCcccccCCCCCCCcchh
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHR-------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDL 141 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~-------------------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DI 141 (529)
||+|+||+++.++.++|+|||++........ .......++..|+|||++.+ ..++.++||
T Consensus 127 dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di 205 (280)
T cd05581 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDL 205 (280)
T ss_pred CCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhH
Confidence 9999999999999999999999876653321 11223456889999998876 458889999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 142 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 142 WSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
|||||++++|++|.+||...+....+..+....... ...+++.+.+||.+|
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~ 256 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF-----------------------------PPNFPPDAKDLIEKL 256 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCC-----------------------------CCccCHHHHHHHHHH
Confidence 999999999999999999887666665554321111 124588899999999
Q ss_pred ccCCCCCCcCH----HHHHhcccc
Q 009654 222 LSVEPYKRATA----SAALASEYF 241 (529)
Q Consensus 222 L~~dP~kR~ta----~e~L~h~~f 241 (529)
|+.||.+|||+ .++|+||||
T Consensus 257 l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 257 LVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=275.92 Aligned_cols=205 Identities=28% Similarity=0.469 Sum_probs=168.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+++.++||||+++++.+.+ .+.+|+||||++++.+. .+.. ....+++..+..++.||+.||.|||++||+|
T Consensus 46 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 123 (255)
T cd08219 46 RKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123 (255)
T ss_pred HHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 479999999999999999999987 57999999999985444 3322 3446899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||||+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 124 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred CCCCcceEEECCCCcEEEcccCcceeecccc-cccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCC
Confidence 9999999999999999999999987654321 12234568899999999876 458999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+.+.......+.. +... .....++..+.+||.+||+.||.+|||+.++|.-
T Consensus 202 ~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 202 ANSWKNLILKVCQ--GSYK--------------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCHHHHHHHHhc--CCCC--------------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8776666555533 1110 0012467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=325.96 Aligned_cols=214 Identities=31% Similarity=0.493 Sum_probs=178.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|..|.|||||++|++-.++ ..+||.||||++|.+..+...+.-.+|.-..-|..|++.||.|||++|||||
T Consensus 1281 i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHR 1358 (1509)
T KOG4645|consen 1281 IAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHR 1358 (1509)
T ss_pred hHHHHHHHHhccCccccccCceeecH--HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceec
Confidence 36899999999999999999998774 5789999999999999888777778899999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCC---CCCccccccccccCCcccccCCC--CCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~--~y~~~~DIWSlG~il~elltG~ 155 (529)
||||.||||+.+|.+|++|||.|..+.... ...+....||+.|||||++.+.. ..+-++||||||||+.||+||+
T Consensus 1359 DIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1359 DIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred CCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence 999999999999999999999998775432 12345679999999999998754 3567999999999999999999
Q ss_pred CCCCCCC-HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 156 PILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 156 ~pf~g~~-~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.||..-+ +-.++.++-. |.- |+.| ..++.+.+|+|++||.-||++|.++.|
T Consensus 1439 rPW~~~dne~aIMy~V~~--gh~-----------------Pq~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1439 RPWAELDNEWAIMYHVAA--GHK-----------------PQIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred CchhhccchhHHHhHHhc--cCC-----------------CCCc---------hhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 9996433 3233333211 221 1111 248899999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|+|.|-+..
T Consensus 1491 lle~~f~~~~ 1500 (1509)
T KOG4645|consen 1491 LLEHAFGKSC 1500 (1509)
T ss_pred HHHhhccccc
Confidence 9999987654
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=276.10 Aligned_cols=211 Identities=29% Similarity=0.456 Sum_probs=174.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvH 79 (529)
+.+|+.++.+++||||+++++++.. ...+|+||||++++.+..++.....+++..+..++.||+.||.|||+ .|++|
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H 123 (264)
T cd06623 46 LLRELKTLRSCESPYVVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123 (264)
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCcc
Confidence 3579999999999999999999987 57899999999987777666555789999999999999999999999 99999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.
T Consensus 124 ~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 124 RDIKPSNLLINSKGEVKIADFGISKVLENTL-DQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred CCCCHHHEEECCCCCEEEccCccceecccCC-CcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999998665432 12234567899999999876 468899999999999999999999998
Q ss_pred CCC---HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccC-CcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 160 GRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 160 g~~---~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~-~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
... ..+....+.. .... ..... ++..+.++|.+||..+|.+|||+.++
T Consensus 202 ~~~~~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 253 (264)
T cd06623 202 PPGQPSFFELMQAICD---GPPP-------------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAEL 253 (264)
T ss_pred cccccCHHHHHHHHhc---CCCC-------------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 764 3333333321 1100 00123 78899999999999999999999999
Q ss_pred HhccccCC
Q 009654 236 LASEYFST 243 (529)
Q Consensus 236 L~h~~f~~ 243 (529)
|+||||+.
T Consensus 254 l~~~~~~~ 261 (264)
T cd06623 254 LQHPFIKK 261 (264)
T ss_pred HhCHHHHh
Confidence 99999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=272.67 Aligned_cols=206 Identities=24% Similarity=0.339 Sum_probs=166.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..+ ......+++..+..++.|++.+|.|||++|++||
T Consensus 40 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~ 117 (250)
T cd05085 40 LSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117 (250)
T ss_pred HHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 579999999999999999999987 4678999999998655544 3344568999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~ 159 (529)
||||+||+++.++.+||+|||++...............+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 118 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred ccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999987544322111122234567999999865 458899999999999999998 999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+.+.......+.... .. .....++..+.+|+.+||+.+|++|||+.++++.
T Consensus 197 ~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 197 GMTNQQAREQVEKGY--RM--------------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred CCCHHHHHHHHHcCC--CC--------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 887766555553311 00 0113578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.90 Aligned_cols=208 Identities=21% Similarity=0.337 Sum_probs=162.7
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCC-----------------------------
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCP----------------------------- 49 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~----------------------------- 49 (529)
+.+|+.+|+.| +|||||++++++.+ ....|+|||||+++.+. .+...
T Consensus 85 ~~~Ei~il~~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (375)
T cd05104 85 LMSELKVLSYLGNHINIVNLLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC 162 (375)
T ss_pred HHHHHHHHHHhcCCcceeeeeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence 35899999999 89999999999987 56789999999985443 32211
Q ss_pred ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 009654 50 ---------------------------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKG 84 (529)
Q Consensus 50 ---------------------------------------------~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp 84 (529)
...+++..+..++.||+.||.|||++||+||||||
T Consensus 163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 242 (375)
T cd05104 163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA 242 (375)
T ss_pred hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch
Confidence 12578899999999999999999999999999999
Q ss_pred CcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCCCCC
Q 009654 85 SNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT 162 (529)
Q Consensus 85 ~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~g~~ 162 (529)
+|||++.++.+||+|||++.......... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+..
T Consensus 243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 243 RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred hhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999997654332111 112334667999999976 458999999999999999998 899998765
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
....+.++... +..+ ......+.++.+||.+||+.||++|||+.++++.
T Consensus 322 ~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 322 VDSKFYKMIKE-GYRM--------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred chHHHHHHHHh-CccC--------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 44433333221 1000 0012357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=275.92 Aligned_cols=205 Identities=22% Similarity=0.334 Sum_probs=166.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++++||||+++++++.. ..+|+||||++++.+..++. ....+++.++..++.||+.||.|||++||+
T Consensus 48 ~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~ 124 (260)
T cd05070 48 FLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124 (260)
T ss_pred HHHHHHHHHhcCCCceEEEEeEECC---CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3589999999999999999998754 45899999999866554432 234689999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||+++.++.++|+|||++...............++..|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 125 H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p 203 (260)
T cd05070 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred cCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999997654432111222334668999998865 458899999999999999999 8999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+.... .+ .....++..+.+||.+||..||.+|||+.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 204 YPGMNNREVLEQVERGY-RM---------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCHHHHHHHHHcCC-CC---------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99888777666654311 10 011356788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=280.98 Aligned_cols=206 Identities=24% Similarity=0.380 Sum_probs=166.6
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----------------CCCCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----------------CPDIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----------------~~~~~l~e~~~~~i~~Q 64 (529)
.+|+.+++++ +||||+++++++.. ...+|+||||+.++.+..++ .....+++..+..++.|
T Consensus 63 ~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 140 (293)
T cd05053 63 VSEMEMMKMIGKHKNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ 140 (293)
T ss_pred HHHHHHHHhhcCCCCeeeEEEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence 5799999999 89999999999877 56799999999986665443 23456899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||+.||+||||||+|||++.++.+||+|||++........ .......++..|+|||++.+ ..++.++||||
T Consensus 141 i~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 219 (293)
T cd05053 141 VARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWS 219 (293)
T ss_pred HHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceee
Confidence 99999999999999999999999999999999999999986543221 11122234677999998866 45899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
||||+|+|++ |..||.+.+..+....+.... .+ .....++..+.+||.+||
T Consensus 220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l 271 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY--RM--------------------------EKPQNCTQELYHLMRDCW 271 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--cC--------------------------CCCCCCCHHHHHHHHHHc
Confidence 9999999997 999998877666555543211 00 001246788999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
..||++|||+.++|++
T Consensus 272 ~~~p~~Rps~~eil~~ 287 (293)
T cd05053 272 HEVPSQRPTFKQLVED 287 (293)
T ss_pred ccCcccCcCHHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=280.04 Aligned_cols=212 Identities=17% Similarity=0.276 Sum_probs=169.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------CCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+++.++||||+++++++.+ ....|+||||+.++.+..++.. ...++...+..++.||+.||.|
T Consensus 57 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (288)
T cd05061 57 LNEASVMKGFTCHHVVRLLGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 134 (288)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 578999999999999999999877 4678999999998666644421 1235677899999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||++||+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|+
T Consensus 135 lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~e 213 (288)
T cd05061 135 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWE 213 (288)
T ss_pred HHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHH
Confidence 99999999999999999999999999999998755432211 1122345678999999876 458999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+.+..+....+.. +... .....+++.+.+||.+||+.||.+|
T Consensus 214 l~~~~~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R 265 (288)
T cd05061 214 ITSLAEQPYQGLSNEQVLKFVMD--GGYL--------------------------DQPDNCPERVTDLMRMCWQFNPKMR 265 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHc--CCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhHC
Confidence 998 7899988777665555432 1110 0012457889999999999999999
Q ss_pred cCHHHHHh------ccccCCC
Q 009654 230 ATASAALA------SEYFSTK 244 (529)
Q Consensus 230 ~ta~e~L~------h~~f~~~ 244 (529)
||+.++++ ||||...
T Consensus 266 ps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 266 PTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred cCHHHHHHHHHhhcCCCCCCC
Confidence 99999987 8888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=279.66 Aligned_cols=207 Identities=20% Similarity=0.343 Sum_probs=166.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-C----------------CCCCCHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-P----------------DIKFSEAQIKCYMN 63 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~----------------~~~l~e~~~~~i~~ 63 (529)
+.+|+.+|+.++||||+++++++.. ....|+||||+.++.+..++. . ...+++.++..++.
T Consensus 54 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 131 (283)
T cd05090 54 FQQEASLMAELHHPNIVCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131 (283)
T ss_pred HHHHHHHHhhCCCCCeeeEEEEEec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence 3579999999999999999999887 567899999999865544331 1 12478999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhh
Q 009654 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLW 142 (529)
Q Consensus 64 Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIW 142 (529)
||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......++..|+|||++.+ ..++.++|||
T Consensus 132 ~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~ 210 (283)
T cd05090 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIW 210 (283)
T ss_pred HHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhH
Confidence 999999999999999999999999999999999999999976543221 11223345678999999876 4589999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 143 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 143 SlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
||||++|+|++ |.+||.+....+....+.... .+ .....+++.+.++|.+|
T Consensus 211 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~c 262 (283)
T cd05090 211 SFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LL---------------------------PCSEDCPPRMYSLMTEC 262 (283)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999998 999998877666655553311 10 01135788899999999
Q ss_pred ccCCCCCCcCHHHHHhc
Q 009654 222 LSVEPYKRATASAALAS 238 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~h 238 (529)
|+.||.+||++.+++++
T Consensus 263 l~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 263 WQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cccCcccCcCHHHHHHH
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=276.07 Aligned_cols=200 Identities=19% Similarity=0.195 Sum_probs=160.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.++||||+++++++.. ....|+|||||.++.+..++ .....+++..+..++.||+.||+|||+.||+||
T Consensus 47 ~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~ 124 (258)
T cd05078 47 FEAASMMSQLSHKHLVLNYGVCVC--GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHG 124 (258)
T ss_pred HHHHHHHHhCCCCChhheeeEEEe--CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 468899999999999999999987 46789999999997766554 344468999999999999999999999999999
Q ss_pred CCCCCcEEEccCCc--------EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 81 DIKGSNLLVNNEGV--------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 81 DIKp~NILl~~~g~--------vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
||||+|||++.++. ++++|||++...... ....+++.|+|||++.+...++.++|||||||++|+|+
T Consensus 125 dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~ 199 (258)
T cd05078 125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF 199 (258)
T ss_pred CCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999987754 699999988654332 23467889999999987666899999999999999999
Q ss_pred hC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 153 IG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 153 tG-~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
+| .+||...+........ ...... ....+.++.+||.+||+.||++|||
T Consensus 200 ~g~~~~~~~~~~~~~~~~~-~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rps 249 (258)
T cd05078 200 SGGDKPLSALDSQKKLQFY-EDRHQL-----------------------------PAPKWTELANLINQCMDYEPDFRPS 249 (258)
T ss_pred cCCCCChhhccHHHHHHHH-HccccC-----------------------------CCCCcHHHHHHHHHHhccChhhCCC
Confidence 98 4777655544432211 110000 0134567899999999999999999
Q ss_pred HHHHHhc
Q 009654 232 ASAALAS 238 (529)
Q Consensus 232 a~e~L~h 238 (529)
+.++++.
T Consensus 250 ~~~il~~ 256 (258)
T cd05078 250 FRAIIRD 256 (258)
T ss_pred HHHHHHh
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=275.63 Aligned_cols=207 Identities=25% Similarity=0.392 Sum_probs=169.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++++||||+++++++.. ...+|+||||++++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 52 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H 129 (266)
T cd05033 52 FLTEASIMGQFDHPNIIRLEGVVTK--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH 129 (266)
T ss_pred HHHHHHHHHhCCCCCcceEeEEEec--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3579999999999999999999877 56799999999986666544 44557999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
+||||+|||++.++.++|+|||++......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..|
T Consensus 130 ~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p 208 (266)
T cd05033 130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred CCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999877522111 1112234678999999876 458999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|...+..+....+......+ ....++..+.+|+.+||+.+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 209 YWDMSNQDVIKAVEDGYRLP----------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVS 260 (266)
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 98777766666654321111 01256788999999999999999999999987
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
+
T Consensus 261 ~ 261 (266)
T cd05033 261 T 261 (266)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=279.43 Aligned_cols=206 Identities=23% Similarity=0.345 Sum_probs=166.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC---------------CCCCHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD---------------IKFSEAQIKCYMNQL 65 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~---------------~~l~e~~~~~i~~Ql 65 (529)
+.+|+.+++.++||||+++++++.+ .+.+|+||||+.++.+..++... ..+++..+..++.||
T Consensus 54 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 131 (280)
T cd05092 54 FQREAELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131 (280)
T ss_pred HHHHHHHHhcCCCCCCceEEEEEec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHH
Confidence 3579999999999999999999887 56799999999986665443221 358999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 66 l~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
+.||.|||++||+||||||+|||+++++.+||+|||++......... ......+++.|+|||++.+ ..++.++|||||
T Consensus 132 ~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 210 (280)
T cd05092 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSF 210 (280)
T ss_pred HHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHH
Confidence 99999999999999999999999999999999999998755332111 1122334678999999876 458999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
||++|+|++ |.+||...+..+.+..+... .+. .....+|+.+.+||.+||+
T Consensus 211 G~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~cl~ 262 (280)
T cd05092 211 GVVLWEIFTYGKQPWYQLSNTEAIECITQG--REL--------------------------ERPRTCPPEVYAIMQGCWQ 262 (280)
T ss_pred HHHHHHHHcCCCCCCccCCHHHHHHHHHcC--ccC--------------------------CCCCCCCHHHHHHHHHHcc
Confidence 999999998 99999887777666655331 110 0113578889999999999
Q ss_pred CCCCCCcCHHHHHh
Q 009654 224 VEPYKRATASAALA 237 (529)
Q Consensus 224 ~dP~kR~ta~e~L~ 237 (529)
.||.+||++.++++
T Consensus 263 ~~P~~Rp~~~~l~~ 276 (280)
T cd05092 263 REPQQRMVIKDIHS 276 (280)
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.54 Aligned_cols=235 Identities=31% Similarity=0.564 Sum_probs=189.3
Q ss_pred HHHHHHHHhCC------CCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD------HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~------HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
++|++||++|. --++|+|+..|.. .+++|||||-+.-+|-..+. ..+..|....++.|++||+.||..|-
T Consensus 476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~h--knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK 553 (752)
T KOG0670|consen 476 LKELEILKKLNDADPEDKFHCLRLFRHFKH--KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK 553 (752)
T ss_pred hHHHHHHHHhhccCchhhhHHHHHHHHhhh--cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH
Confidence 47999999993 3589999998887 57999999999887766553 35567899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
..||+|.||||+|||++.. ..+||||||.|.+.+.. ..+.+.++..|+|||+++| ..|+...|+||+||+||||+
T Consensus 554 ~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElY 629 (752)
T KOG0670|consen 554 KCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELY 629 (752)
T ss_pred hcCeeecccCccceEeccCcceeeeccCccccccccc---cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEee
Confidence 9999999999999999876 56899999999887765 4677788999999999999 45999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCc-------------------------cccCCCCCCCcchhhhhc
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-------------------------ATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~-------------------------~~~~~~~~~~~~~l~~~~ 207 (529)
||+-.|+|.+....+...+.+-|.+|.....+..+.. ....+|...+...+...
T Consensus 630 tGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~- 708 (752)
T KOG0670|consen 630 TGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV- 708 (752)
T ss_pred ccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc-
Confidence 9999999999999999999999998864433322110 00011212222111110
Q ss_pred cCCc-------HHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 208 KDLP-------TTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 208 ~~~s-------~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
..+| ..+++||.+||..||++|+|+.+||+||||+.
T Consensus 709 q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 709 QRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred CCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 1122 34789999999999999999999999999974
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=278.93 Aligned_cols=206 Identities=22% Similarity=0.335 Sum_probs=167.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----------------CCCCCCHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQL 65 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----------------~~~~l~e~~~~~i~~Ql 65 (529)
.+|+.+++.++||||+++++++.+ ....++++||+.++.+..++. ....+++..+..++.||
T Consensus 56 ~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql 133 (283)
T cd05091 56 KHEAMMRSRLQHPNIVCLLGVVTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQI 133 (283)
T ss_pred HHHHHHHhcCCCCCcCeEEEEEcC--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence 579999999999999999999987 467899999999865554331 12358889999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 66 l~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
+.||.|||++||+||||||+|||+++++.+||+|||+++....... .......+++.|+|||++.+ ..++.++|||||
T Consensus 134 ~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~sl 212 (283)
T cd05091 134 AAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSY 212 (283)
T ss_pred HHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHH
Confidence 9999999999999999999999999999999999999876543221 11223345788999999876 358999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
||++|||++ |.+||.+.+..+.+..+......+ ...+++..+.+||..||+
T Consensus 213 G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~cl~ 264 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP----------------------------CPDDCPAWVYTLMLECWN 264 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC----------------------------CCCCCCHHHHHHHHHHhC
Confidence 999999998 889999888777776664421110 013578889999999999
Q ss_pred CCCCCCcCHHHHHhc
Q 009654 224 VEPYKRATASAALAS 238 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h 238 (529)
.+|.+||++.+++..
T Consensus 265 ~~p~~RP~~~~i~~~ 279 (283)
T cd05091 265 EFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcccCCCHHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=276.13 Aligned_cols=208 Identities=20% Similarity=0.289 Sum_probs=164.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhc------CCCCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~------~~~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+|+.++||||+++++++.... ....++||||+.++.+..+. .....+++..+..++.||+.||.|
T Consensus 48 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 127 (272)
T cd05075 48 LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEY 127 (272)
T ss_pred HHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999764321 23579999999986554332 123458999999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||++||+||||||+|||++.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++|||||||++|+
T Consensus 128 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~e 206 (272)
T cd05075 128 LSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWE 206 (272)
T ss_pred HHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998764332111 122245678999999876 468999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+....+....+.. +... .....++..+.+||.+||+.||.+|
T Consensus 207 l~~~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R 258 (272)
T cd05075 207 IATRGQTPYPGVENSEIYDYLRQ--GNRL--------------------------KQPPDCLDGLYSLMSSCWLLNPKDR 258 (272)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHc--CCCC--------------------------CCCCCCCHHHHHHHHHHcCCCcccC
Confidence 999 8999998777666555533 1110 0013567889999999999999999
Q ss_pred cCHHHHHhc
Q 009654 230 ATASAALAS 238 (529)
Q Consensus 230 ~ta~e~L~h 238 (529)
||+.++++.
T Consensus 259 ps~~~l~~~ 267 (272)
T cd05075 259 PSFETLRCE 267 (272)
T ss_pred cCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=275.65 Aligned_cols=205 Identities=23% Similarity=0.324 Sum_probs=166.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+++.++||||+++++++.. ...|+||||++++.+..++. ....+++..+..++.||+.||.|||+.||+
T Consensus 48 ~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~ 124 (262)
T cd05071 48 FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124 (262)
T ss_pred HHHHHHHHHhCCCCCcceEEEEECC---CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3579999999999999999998754 45799999999865554443 234689999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||+++.++.+||+|||.+...............++..|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 125 H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p 203 (262)
T cd05071 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP 203 (262)
T ss_pred ccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999997665432222223345678999998865 458999999999999999999 8999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+... .+. .....++..+.+||.+||+.||.+|||+.++++
T Consensus 204 ~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 204 YPGMVNREVLDQVERG--YRM--------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCChHHHHHHHhcC--CCC--------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9888777766665331 110 001357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=279.07 Aligned_cols=207 Identities=22% Similarity=0.334 Sum_probs=164.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-------IKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-------~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
+.+|+.+++.++||||+++++++.+ ....|+||||++++.+..++... ..+++.++..++.||+.||+|||
T Consensus 56 ~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH 133 (277)
T cd05036 56 FLMEALIMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133 (277)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3579999999999999999998877 45789999999886666543222 25899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCC---cEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g---~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
++||+||||||+|||++.++ .+||+|||++......... .......+..|+|||++.+ ..++.++||||||||+|
T Consensus 134 ~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~ 212 (277)
T cd05036 134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLW 212 (277)
T ss_pred HCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHH
Confidence 99999999999999998765 5999999999765322111 1112233567999999976 45899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 150 ELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 150 ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
+|++ |..||.+.+..+....+... ..+ .....++..+.+||.+||+.+|.+
T Consensus 213 el~~~g~~pf~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~ 264 (277)
T cd05036 213 EIFSLGYMPYPGRTNQEVMEFVTGG-GRL---------------------------DPPKGCPGPVYRIMTDCWQHTPED 264 (277)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCCccc
Confidence 9997 99999988776655544321 110 001356888999999999999999
Q ss_pred CcCHHHHHhc
Q 009654 229 RATASAALAS 238 (529)
Q Consensus 229 R~ta~e~L~h 238 (529)
|||+.++|+|
T Consensus 265 Rps~~~vl~~ 274 (277)
T cd05036 265 RPNFATILER 274 (277)
T ss_pred CcCHHHHHHH
Confidence 9999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=274.34 Aligned_cols=204 Identities=21% Similarity=0.268 Sum_probs=165.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.. ..+++||||+.++.+..++.....+++..+..++.||+.||.|||..||+|+|
T Consensus 44 ~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~d 120 (257)
T cd05060 44 LREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRD 120 (257)
T ss_pred HHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccC
Confidence 579999999999999999998764 46899999999866665555555899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCc--cccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||+|||++.++.+||+|||++........... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||
T Consensus 121 i~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred cccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999986644322111 11123467999999866 458999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
...+..+....+... .+. .....++..+++||.+||..||.+|||+.++++
T Consensus 200 ~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 200 GEMKGAEVIAMLESG--ERL--------------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ccCCHHHHHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 887776655554321 100 011356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=272.85 Aligned_cols=208 Identities=31% Similarity=0.459 Sum_probs=173.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+++++.++||||+++++.+.. ...+|+|+||++++.+...... ...+++.++..++.||+.||.|||++|+
T Consensus 47 ~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 124 (258)
T cd08215 47 LNEVKILKKLNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124 (258)
T ss_pred HHHHHHHHhcCCCChhheEEEEec--CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 579999999999999999999987 4789999999998665544322 3689999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..|
T Consensus 125 ~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p 202 (258)
T cd08215 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHP 202 (258)
T ss_pred ecccCChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999997765432 12234577899999998876 4588999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|...+..+....+...... .....++..+.++|.+||..+|.+|||+.++|+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 203 FEGENLLELALKILKGQYP----------------------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCcHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9877755555544331100 001256788999999999999999999999999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 255 ~~~~ 258 (258)
T cd08215 255 SPFI 258 (258)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=273.32 Aligned_cols=207 Identities=34% Similarity=0.495 Sum_probs=173.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++.+.+ ...+|+||||+.++.+..+......+++.++..++.||+.||.|||+.+++|+|
T Consensus 41 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~ 118 (250)
T cd05123 41 LTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRD 118 (250)
T ss_pred HHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 578999999999999999999887 678999999997766655555555799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......++..|++||.+.+ ..++.++|+|||||++|+|++|..||...
T Consensus 119 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 119 LKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999987664431 12334567889999999876 34788999999999999999999999877
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH---HHHHhc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA---SAALAS 238 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta---~e~L~h 238 (529)
........+.. +.++ ....++..+.++|.+||..||.+|||+ .++++|
T Consensus 197 ~~~~~~~~~~~--~~~~---------------------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 197 DRKEIYEKILK--DPLR---------------------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CHHHHHHHHhc--CCCC---------------------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 76555555533 1110 012357889999999999999999999 999999
Q ss_pred ccc
Q 009654 239 EYF 241 (529)
Q Consensus 239 ~~f 241 (529)
|||
T Consensus 248 ~~f 250 (250)
T cd05123 248 PFF 250 (250)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=278.66 Aligned_cols=210 Identities=29% Similarity=0.440 Sum_probs=174.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+||||++++.+..++.. ..+++..+..++.||+.+|.|||+.||+|+|
T Consensus 50 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~d 126 (277)
T cd06641 50 QQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRD 126 (277)
T ss_pred HHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCC
Confidence 579999999999999999999987 5789999999998776665543 4789999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.
T Consensus 127 l~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred CCHHhEEECCCCCEEEeecccceecccch-hhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999987654321 12233467889999999865 45788999999999999999999999876
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+.......+.. +.++ .....++.++.++|.+||..+|.+||++.++|+||||
T Consensus 205 ~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 256 (277)
T cd06641 205 HPMKVLFLIPK--NNPP--------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256 (277)
T ss_pred chHHHHHHHhc--CCCC--------------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 65555544422 1110 0113578889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
...
T Consensus 257 ~~~ 259 (277)
T cd06641 257 VRF 259 (277)
T ss_pred hhh
Confidence 863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=270.45 Aligned_cols=208 Identities=31% Similarity=0.487 Sum_probs=172.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++++++||||+++++++.. ....|+|+||++++.+..+.... ..+++..+..++.||+.||.+||++|++|+
T Consensus 45 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~ 122 (253)
T cd05122 45 INEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122 (253)
T ss_pred HHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence 579999999999999999999987 46899999999976666554333 689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+. .++.++||||||||+|+|++|.+||..
T Consensus 123 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 199 (253)
T cd05122 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSE 199 (253)
T ss_pred CCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987655321 3345678999999998764 488999999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+....+..+.. ...+.. + ....++..+.++|.+||..||.+|||+.++|.|||
T Consensus 200 ~~~~~~~~~~~~--~~~~~~-----------------~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 200 LPPMKALFKIAT--NGPPGL-----------------R-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CchHHHHHHHHh--cCCCCc-----------------C-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 765555544432 111000 0 00124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=281.62 Aligned_cols=204 Identities=23% Similarity=0.304 Sum_probs=163.8
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.++.++ +||||+++++++.+ .+.+|+||||++++.+..++.. ...+++..+..++.|
T Consensus 50 ~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 127 (297)
T cd05089 50 AGELEVLCKLGHHPNIINLLGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127 (297)
T ss_pred HHHHHHHHhhcCCCchhheEEEEcc--CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHH
Confidence 5799999999 79999999999877 5679999999998655544322 135889999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
|+.||+|||++||+||||||+|||++.++.+||+|||++....... .......+..|+|||++.+ ..++.++|||||
T Consensus 128 i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSl 204 (297)
T cd05089 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSF 204 (297)
T ss_pred HHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHH
Confidence 9999999999999999999999999999999999999986432211 1111223557999999876 458999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
||++|+|++ |.+||.+.+..+....+...... .....++..+.+||.+||.
T Consensus 205 G~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~ 256 (297)
T cd05089 205 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM----------------------------EKPRNCDDEVYELMRQCWR 256 (297)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcC
Confidence 999999997 99999988877766655331100 0113578889999999999
Q ss_pred CCCCCCcCHHHHHhc
Q 009654 224 VEPYKRATASAALAS 238 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h 238 (529)
.+|.+|||++++++.
T Consensus 257 ~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 257 DRPYERPPFAQISVQ 271 (297)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=276.64 Aligned_cols=205 Identities=17% Similarity=0.272 Sum_probs=166.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------CCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+|+.++||||+++++++.+ ...+|+||||++++.+..++.. ...+++..+..++.||+.||.|
T Consensus 57 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 134 (277)
T cd05032 57 LNEASVMKEFNCHHVVRLLGVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134 (277)
T ss_pred HHHHHHHHhCCCCceeEEEEEEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 579999999999999999999987 5789999999987666544321 2347888999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||+.||+||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|+
T Consensus 135 lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e 213 (277)
T cd05032 135 LAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWE 213 (277)
T ss_pred HHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHH
Confidence 9999999999999999999999999999999876543221 12233456788999999865 458999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+.+..+....+.. +... .....++..+.+||.+||+.+|++|
T Consensus 214 l~t~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R 265 (277)
T cd05032 214 MATLAEQPYQGLSNEEVLKFVID--GGHL--------------------------DLPENCPDKLLELMRMCWQYNPKMR 265 (277)
T ss_pred hhccCCCCCccCCHHHHHHHHhc--CCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhC
Confidence 998 9999998887766655532 1110 0012357889999999999999999
Q ss_pred cCHHHHHh
Q 009654 230 ATASAALA 237 (529)
Q Consensus 230 ~ta~e~L~ 237 (529)
||+.+++.
T Consensus 266 pt~~~l~~ 273 (277)
T cd05032 266 PTFLEIVS 273 (277)
T ss_pred CCHHHHHH
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=273.76 Aligned_cols=204 Identities=22% Similarity=0.326 Sum_probs=169.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.|+||||+++++++.+ ...+|+||||++++.+..++. ....+++.++..++.||+.||.|||++||+|
T Consensus 50 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h 127 (261)
T cd05148 50 QKEVQALKRLRHKHLISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127 (261)
T ss_pred HHHHHHHhcCCCcchhheeeeEec--CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 579999999999999999999887 567999999999865554433 3456899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
+||||+|||++.++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 128 ~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~ 205 (261)
T cd05148 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPY 205 (261)
T ss_pred cccCcceEEEcCCceEEEccccchhhcCCccc-cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999976643321 1223445778999999866 468899999999999999998 89999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+..+.+..+......+ ....+++.+.++|.+||..||.+|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 206 PGMNNHEVYDQITAGYRMP----------------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CcCCHHHHHHHHHhCCcCC----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9888777777665311110 11357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=274.66 Aligned_cols=205 Identities=20% Similarity=0.284 Sum_probs=165.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+||||+++++++.. ..+|+||||++++.+..+. .....+++.++..++.||+.||.|||++||+|
T Consensus 42 ~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 118 (257)
T cd05115 42 MMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118 (257)
T ss_pred HHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeee
Confidence 3589999999999999999998754 4689999999986666444 34567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+|||++.++.+||+|||++......... ..+...+++.|+|||++.+ ..++.++|||||||++|+|++ |.+
T Consensus 119 ~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred cccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999765433211 1122233578999999875 458899999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+....+....+.. +..+ .....+++++.+||.+||..||++||++.+++
T Consensus 198 p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~ 249 (257)
T cd05115 198 PYKKMKGPEVMSFIEQ--GKRL--------------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVE 249 (257)
T ss_pred CcCcCCHHHHHHHHHC--CCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9988877666655533 1110 00134688999999999999999999999987
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 250 ~ 250 (257)
T cd05115 250 E 250 (257)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=276.65 Aligned_cols=210 Identities=18% Similarity=0.226 Sum_probs=162.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----DIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-----~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.+++.++||||+++++.+.. ...+|+||||++++.+..++.. ...+++..+..++.||+.||+|||++|
T Consensus 43 ~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (269)
T cd05042 43 LQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120 (269)
T ss_pred HHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 579999999999999999999887 5689999999998766654422 123567889999999999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccC------CCCCCCcchhhhhhHHHH
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~------~~~y~~~~DIWSlG~il~ 149 (529)
|+||||||+|||++.++.+||+|||++........ .......+++.|+|||++.. ...++.++|||||||++|
T Consensus 121 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~ 200 (269)
T cd05042 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMW 200 (269)
T ss_pred EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHH
Confidence 99999999999999999999999999865432211 11123345678999999743 235688999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 150 ELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 150 ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
+|++ |.+||......+.+..+......... . ......++..+.+++..|+ .||++
T Consensus 201 el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~--------------~~~~~~~~~~~~~~~~~~~-~dp~~ 256 (269)
T cd05042 201 ELFTAADQPYPDLSDEQVLKQVVREQDIKLP---------K--------------PQLDLKYSDRWYEVMQFCW-LDPET 256 (269)
T ss_pred HHHhCCCCCCCcCCHHHHHHHHhhccCccCC---------C--------------CcccccCCHHHHHHHHHHh-cCccc
Confidence 9999 78999888777766665442211100 0 0011357788899999998 69999
Q ss_pred CcCHHHHHh
Q 009654 229 RATASAALA 237 (529)
Q Consensus 229 R~ta~e~L~ 237 (529)
|||+.++++
T Consensus 257 Rpt~~~v~~ 265 (269)
T cd05042 257 RPTAEEVHE 265 (269)
T ss_pred ccCHHHHHH
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=274.29 Aligned_cols=204 Identities=23% Similarity=0.346 Sum_probs=165.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.++||||+++++++.. ...|+||||+.++.+. .+.. ....+++..+..++.||+.||.|||+.||+|
T Consensus 49 ~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H 125 (260)
T cd05069 49 LQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125 (260)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 579999999999999999998754 4679999999985444 4432 2345899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
+||||+||++++++.++|+|||++...............++..|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 126 ~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~ 204 (260)
T cd05069 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred cccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997664432222223345678999998876 458999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+..+....+.... .+ .....++..+.+||.+||..||.+||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 205 PGMVNREVLEQVERGY-RM---------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCHHHHHHHHHcCC-CC---------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9888777766653311 10 011356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=283.63 Aligned_cols=204 Identities=26% Similarity=0.339 Sum_probs=163.1
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.+|.++ +||||+++++++.+ ...+|+||||++++.+..++.. ...+++.++..++.|
T Consensus 55 ~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 132 (303)
T cd05088 55 AGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132 (303)
T ss_pred HHHHHHHHHhcCCCCcceEEEEECC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHH
Confidence 5799999999 89999999999877 5689999999998655443321 235899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
|+.||+|||++||+||||||+|||++.++.+||+|||++....... .......+..|+|||++.+ ..++.++|||||
T Consensus 133 i~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 209 (303)
T cd05088 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSY 209 (303)
T ss_pred HHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhh
Confidence 9999999999999999999999999999999999999986432111 1112234667999998865 458999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
||++|+|++ |.+||.+.+..+....+... ... .....++..+.+||.+||+
T Consensus 210 G~il~ellt~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~ 261 (303)
T cd05088 210 GVLLWEIVSLGGTPYCGMTCAELYEKLPQG--YRL--------------------------EKPLNCDDEVYDLMRQCWR 261 (303)
T ss_pred hhHHHHHHhcCCCCcccCChHHHHHHHhcC--CcC--------------------------CCCCCCCHHHHHHHHHHcC
Confidence 999999998 99999887766655544220 000 0012467889999999999
Q ss_pred CCCCCCcCHHHHHhc
Q 009654 224 VEPYKRATASAALAS 238 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h 238 (529)
.+|.+||++.++|.+
T Consensus 262 ~~p~~Rp~~~~il~~ 276 (303)
T cd05088 262 EKPYERPSFAQILVS 276 (303)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=270.55 Aligned_cols=213 Identities=35% Similarity=0.542 Sum_probs=172.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.++++++||||+++++++.+.....+|+|+||++++.+..+......+++.++..++.|++.||.|||+.|++|+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~ 125 (260)
T cd06606 46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125 (260)
T ss_pred HHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 35799999999999999999999874337899999999887666655555589999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.
T Consensus 126 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred CCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876654210 12345678999999998764 48999999999999999999999998
Q ss_pred CCC-HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 160 GRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 160 g~~-~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
... .......+.. .... ......++..+.+||.+||..||.+||++.++|.|
T Consensus 205 ~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 205 ELGNPMAALYKIGS-SGEP--------------------------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCchHHHHHhccc-cCCC--------------------------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 765 2222222111 0000 01113458889999999999999999999999999
Q ss_pred ccc
Q 009654 239 EYF 241 (529)
Q Consensus 239 ~~f 241 (529)
|||
T Consensus 258 ~~~ 260 (260)
T cd06606 258 PFL 260 (260)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=286.56 Aligned_cols=208 Identities=22% Similarity=0.323 Sum_probs=164.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-------------------------------
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP------------------------------- 49 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~------------------------------- 49 (529)
.+|+.+++++ +||||+++++++... ...+|+||||+.++.+..++..
T Consensus 58 ~~E~~~~~~l~~h~niv~~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (337)
T cd05054 58 MTELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSV 136 (337)
T ss_pred HHHHHHHHhhccCcchhheeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccC
Confidence 4799999999 899999999988764 4678999999998666533311
Q ss_pred ------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEec
Q 009654 50 ------------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 99 (529)
Q Consensus 50 ------------------------------~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~D 99 (529)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~D 216 (337)
T cd05054 137 SSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 216 (337)
T ss_pred CccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEec
Confidence 12688999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCC
Q 009654 100 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 177 (529)
Q Consensus 100 FGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p 177 (529)
||++........ .......++..|+|||++.+ ..++.++|||||||+||+|++ |.+||.+....+.+...... +..
T Consensus 217 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~ 294 (337)
T cd05054 217 FGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GTR 294 (337)
T ss_pred cccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-cCC
Confidence 999986543221 11223345678999999977 458999999999999999998 99999876544443333221 110
Q ss_pred CchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 178 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
. .....+++++.+|+.+||+.+|++||++.+++++
T Consensus 295 ~--------------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 M--------------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred C--------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0012467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.64 Aligned_cols=206 Identities=23% Similarity=0.306 Sum_probs=168.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~-~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++++||||+++++++.+ ..+|+||||++++.+...+ ... ..+++..+..++.||+.||.|||++||+
T Consensus 43 ~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 119 (257)
T cd05040 43 FLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119 (257)
T ss_pred HHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 3579999999999999999999876 6789999999876555443 323 4789999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK 155 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~ 155 (529)
|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.
T Consensus 120 H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~ 198 (257)
T cd05040 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGE 198 (257)
T ss_pred ccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876442211 1112356788999998865 458999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+..+....+....... .....+|..+.+||.+||..+|++|||+.++
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 199 EPWAGLSGSQILKKIDKEGERL---------------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred CCCCCCCHHHHHHHHHhcCCcC---------------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 9998888877777664411100 0012467889999999999999999999999
Q ss_pred Hh
Q 009654 236 LA 237 (529)
Q Consensus 236 L~ 237 (529)
++
T Consensus 252 ~~ 253 (257)
T cd05040 252 RE 253 (257)
T ss_pred HH
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=272.97 Aligned_cols=203 Identities=18% Similarity=0.312 Sum_probs=164.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~-~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.++++++||||+++++++... ...+|+||||++++.+..++ .. ...+++..+..++.||+.||+|||++||+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 124 (256)
T cd05082 46 FLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124 (256)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 35799999999999999999986553 45789999999985555433 22 23489999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||+++.++.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 125 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p 199 (256)
T cd05082 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred ccccchheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987543321 22344678999999866 458899999999999999997 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|...+..+....+... .++ .....+++.+.+||.+||..+|.+|||+.++++
T Consensus 200 ~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 200 YPRIPLKDVVPRVEKG--YKM--------------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCHHHHHHHHhcC--CCC--------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9877766655555331 110 011357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=279.01 Aligned_cols=212 Identities=20% Similarity=0.272 Sum_probs=167.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC-----------CCCHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----------KFSEAQIKCYMNQLLHGLE 70 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~-----------~l~e~~~~~i~~Qll~gL~ 70 (529)
.+|+.+|++|+||||+++++++.. ...+|+||||+.++.+..++.... .+++..+..++.||+.||.
T Consensus 67 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~ 144 (296)
T cd05051 67 LKEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMR 144 (296)
T ss_pred HHHHHHHHhcCCCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHH
Confidence 579999999999999999999987 468999999999866654443322 6899999999999999999
Q ss_pred HHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 71 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 71 ~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
|||++||+||||||+||+++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|
T Consensus 145 ~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ 223 (296)
T cd05051 145 YLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLW 223 (296)
T ss_pred HHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHH
Confidence 99999999999999999999999999999999875543221 11223455788999999876 35899999999999999
Q ss_pred HHHh--CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 150 ELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 150 ellt--G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
+|++ |..||...+..+.+..+.......... . .......+|.++.+||.+||+.||.
T Consensus 224 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~-------------~~~~~~~~~~~l~~li~~cl~~~p~ 282 (296)
T cd05051 224 EILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ--------I-------------YLPRPPNCPKDIYELMLECWRRDEE 282 (296)
T ss_pred HHHhcCCCCCCCCcChHHHHHHHHhcccccccc--------c-------------cCCCccCCCHHHHHHHHHHhccChh
Confidence 9998 778898777766666554421111000 0 0011134678999999999999999
Q ss_pred CCcCHHHHHh
Q 009654 228 KRATASAALA 237 (529)
Q Consensus 228 kR~ta~e~L~ 237 (529)
+|||+.++++
T Consensus 283 ~Rpt~~el~~ 292 (296)
T cd05051 283 DRPTFREIHL 292 (296)
T ss_pred cCCCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=273.08 Aligned_cols=206 Identities=24% Similarity=0.347 Sum_probs=168.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.++++++||||+++++++.+ ...+|+||||++++.+..++.. ...+++.++..++.||+.||.|||++||+
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~ 125 (261)
T cd05034 48 FLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125 (261)
T ss_pred HHHHHHHHhhCCCCCEeeeeeeeec--CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 3579999999999999999999877 4679999999998665544432 24689999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|+||||+||+|+.++.+||+|||++................+..|+|||.+.+ ..++.++||||+||++|+|++ |++|
T Consensus 126 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p 204 (261)
T cd05034 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVP 204 (261)
T ss_pred cCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987665322111122234568999999876 458999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+....+..+......+ ....++.++.++|.+||..+|.+||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 205 YPGMTNREVLEQVERGYRMP----------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99888777777764421111 01245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=275.74 Aligned_cols=208 Identities=22% Similarity=0.381 Sum_probs=168.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC---------CCCHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI---------KFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~---------~l~e~~~~~i~~Qll~gL~~ 71 (529)
+.+|+.+|++++||||+++++++.+ ....|+||||++++.+..++.... .+++.++..++.||+.||.|
T Consensus 55 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~ 132 (275)
T cd05046 55 FRRELDMFRKLSHKNVVRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132 (275)
T ss_pred HHHHHHHHHhcCCcceeeeEEEECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999999999999877 567899999999866665543332 68999999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
||+.||+||||||+|||++.++.++|+|||++...............++..|+|||.+.+. .++.++|||||||++|+|
T Consensus 133 LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l 211 (275)
T cd05046 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEV 211 (275)
T ss_pred hhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999999865433222233344667889999998763 478999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 lt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++ |.+||.+.+....+..+.. +... | .....+|..+.++|.+||+.||.+||
T Consensus 212 ~~~~~~p~~~~~~~~~~~~~~~--~~~~---~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp 264 (275)
T cd05046 212 FTQGELPFYGLSDEEVLNRLQA--GKLE---L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRP 264 (275)
T ss_pred HhCCCCCccccchHHHHHHHHc--CCcC---C----------------------CCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 98 8889987766665555432 1110 0 01135788999999999999999999
Q ss_pred CHHHHHhc
Q 009654 231 TASAALAS 238 (529)
Q Consensus 231 ta~e~L~h 238 (529)
|+.++++.
T Consensus 265 ~~~~~l~~ 272 (275)
T cd05046 265 SFSELVSA 272 (275)
T ss_pred CHHHHHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.86 Aligned_cols=208 Identities=20% Similarity=0.284 Sum_probs=166.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC----CeEEEEEeccCCCchhhhc------CCCCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~----~~~~lV~E~~~g~ll~~~~------~~~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+|+.++||||+++++++..... ...++||||+.++.+..++ .....+++..+..++.||+.||.|
T Consensus 49 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~ 128 (273)
T cd05035 49 LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128 (273)
T ss_pred HHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHH
Confidence 579999999999999999998765321 3479999999986665433 123468999999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||++||+||||||+||++++++.+||+|||+++......... ......+..|+|||++.+ ..++.++|||||||++||
T Consensus 129 lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 129 LSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred HHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHH
Confidence 999999999999999999999999999999997654332111 112234678999999865 468999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+.+..+.+..+.. +... .....++..+.++|.+||+.||.+|
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R 259 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRH--GNRL--------------------------KQPEDCLDELYDLMYSCWRADPKDR 259 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHc--CCCC--------------------------CCCcCCCHHHHHHHHHHcCCChhhC
Confidence 999 8999988877666655533 1110 0113578889999999999999999
Q ss_pred cCHHHHHhc
Q 009654 230 ATASAALAS 238 (529)
Q Consensus 230 ~ta~e~L~h 238 (529)
||+.+++++
T Consensus 260 p~~~e~~~~ 268 (273)
T cd05035 260 PTFTKLREV 268 (273)
T ss_pred cCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=278.64 Aligned_cols=214 Identities=26% Similarity=0.409 Sum_probs=171.1
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|.++ +||||+++++.+.. ...+|+||||+.++.+.........+++..+..++.||+.+|.|||+.|++||
T Consensus 52 ~~E~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~ 129 (288)
T cd05583 52 RTERQVLEAVRRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYR 129 (288)
T ss_pred HHHHHHHHhccCCcchhhhheeeec--CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 4799999999 69999999999877 56899999999987666555555679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC-CCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||+|.||+++.++.++|+|||++..+............+++.|+|||.+.+.. .++.++|||||||++|+|++|..||.
T Consensus 130 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999998765443222222346789999999986643 36889999999999999999999996
Q ss_pred CCCHH----HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC---H
Q 009654 160 GRTEV----EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---A 232 (529)
Q Consensus 160 g~~~~----~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t---a 232 (529)
..... +..+.+.... + .....++..+.+||.+||+.||++||| +
T Consensus 210 ~~~~~~~~~~~~~~~~~~~--~---------------------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 210 VDGEQNSQSEISRRILKSK--P---------------------------PFPKTMSAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred cCcccchHHHHHHHHHccC--C---------------------------CCCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence 44322 2222221110 0 001246788999999999999999998 5
Q ss_pred HHHHhccccCCCCC
Q 009654 233 SAALASEYFSTKPY 246 (529)
Q Consensus 233 ~e~L~h~~f~~~~~ 246 (529)
.++|+||||+...|
T Consensus 261 ~~~l~~~~~~~~~~ 274 (288)
T cd05583 261 DEIKNHPFFQGIDW 274 (288)
T ss_pred HHHhcCcccccCCH
Confidence 67799999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.08 Aligned_cols=206 Identities=22% Similarity=0.329 Sum_probs=165.1
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+++ +||||+++++++.. .+.+|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++||+
T Consensus 86 ~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~iv 163 (302)
T cd05055 86 MSELKIMSHLGNHENIVNLLGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI 163 (302)
T ss_pred HHHHHHHHhccCCCCcceEEEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 5799999999 89999999999887 5679999999998655544322 23489999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|+||||+|||++.++.+||+|||++......... ......+++.|+|||++.+. .++.++||||+||++|+|++ |.+
T Consensus 164 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~ 242 (302)
T cd05055 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSN 242 (302)
T ss_pred hhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999765432211 11223457889999998764 48999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+....+.+..+... +..+ .....+++.+.+||.+||+.+|++|||+.+++
T Consensus 243 p~~~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell 295 (302)
T cd05055 243 PYPGMPVDSKFYKLIKE-GYRM--------------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295 (302)
T ss_pred CcCCCCchHHHHHHHHc-CCcC--------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 99887765555444331 1100 00124678899999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 296 ~ 296 (302)
T cd05055 296 Q 296 (302)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=291.37 Aligned_cols=215 Identities=26% Similarity=0.359 Sum_probs=191.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
..|=.||..++.|.||+||..|.+ +.++|++||-|-|+.+=.++...+.|++..++.|+..+++|++|||++||++||
T Consensus 468 ~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRD 545 (732)
T KOG0614|consen 468 FSERNIMMECRSDFIVRLYRTFRD--SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRD 545 (732)
T ss_pred HhHHHHHHhcCchHHHHHHHHhcc--chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceecc
Confidence 457889999999999999999988 689999999999877666667778999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|+|++.+|-+||.|||+|+.+..+. ...+.||||.|.|||+++. ...+.++|.||||+++||||+|.|||.|.
T Consensus 546 LKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 546 LKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred CChhheeeccCCceEEeehhhHHHhccCC--ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999988764 4467899999999999987 45899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L 236 (529)
+++..+..|.+.+... +....++..+.+||+++...+|.+|.- +.++-
T Consensus 623 dpmktYn~ILkGid~i---------------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk 675 (732)
T KOG0614|consen 623 DPMKTYNLILKGIDKI---------------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIK 675 (732)
T ss_pred chHHHHHHHHhhhhhh---------------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHH
Confidence 9999999998854321 112468889999999999999999976 89999
Q ss_pred hccccCCCCCCC
Q 009654 237 ASEYFSTKPYAC 248 (529)
Q Consensus 237 ~h~~f~~~~~~~ 248 (529)
+|.||..-.|..
T Consensus 676 kH~Wf~gfdweg 687 (732)
T KOG0614|consen 676 KHRWFEGFDWEG 687 (732)
T ss_pred hhhhhhcCChhh
Confidence 999998876643
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=271.19 Aligned_cols=207 Identities=25% Similarity=0.390 Sum_probs=168.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+++|++++||||+++++++.. ...+|+||||++++.+..+. .....+++..+..++.||+.||+|||+.||+|
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h 123 (256)
T cd05112 46 FIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123 (256)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3579999999999999999999877 46789999999987666544 34457899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
+||||+||+++.++.+||+|||++...............++..|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 124 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~ 202 (256)
T cd05112 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPY 202 (256)
T ss_pred cccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999987654332111223344678999999876 458899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
......+.+..+.+....+ . ....+..+.+|+.+||+.+|.+|||+.++++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~----------------------~------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 203 ENRSNSEVVETINAGFRLY----------------------K------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CcCCHHHHHHHHhCCCCCC----------------------C------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 8877777666653311000 0 02357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=273.40 Aligned_cols=205 Identities=23% Similarity=0.346 Sum_probs=168.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++++++||||+++++++.+ ...+|+||||++++.+..++ .....+++.++..++.|++.||+|||+.||+|+
T Consensus 54 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 131 (268)
T cd05063 54 LSEASIMGQFSHHNIIRLEGVVTK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR 131 (268)
T ss_pred HHHHHHHhcCCCCCeeEEEEEEcc--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 579999999999999999999987 56889999999987776554 344679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccc--cccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~--~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||+||+++.++.+||+|||++...........+. ...++.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 132 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p 210 (268)
T cd05063 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERP 210 (268)
T ss_pred ccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999987664322111111 123457999999876 458999999999999999997 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....|......+ ....++..+.+||.+||..+|.+||++.++++
T Consensus 211 ~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 211 YWDMSNHEVMKAINDGFRLP----------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCcCCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 98888777777664421111 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=277.80 Aligned_cols=205 Identities=21% Similarity=0.306 Sum_probs=165.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC------------------------CCCCCCHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC------------------------PDIKFSEAQ 57 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~------------------------~~~~l~e~~ 57 (529)
.+|+.+|+.|+||||+++++.+.. .+..|+||||+.++.+..++. ....+++..
T Consensus 51 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 128 (290)
T cd05045 51 LSEFNLLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD 128 (290)
T ss_pred HHHHHHHhhCCCCCEeeEEEEEec--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHH
Confidence 579999999999999999999887 567899999999876654432 123588999
Q ss_pred HHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCC
Q 009654 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYG 136 (529)
Q Consensus 58 ~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~ 136 (529)
+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++........ .......++..|+|||.+.+ ..++
T Consensus 129 ~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~ 207 (290)
T cd05045 129 LISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYT 207 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcc
Confidence 999999999999999999999999999999999999999999999976533211 11122345678999998866 4589
Q ss_pred CcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHH
Q 009654 137 PSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 215 (529)
Q Consensus 137 ~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~ 215 (529)
.++|||||||++|+|++ |.+||.+....+....+...... .....++.++.
T Consensus 208 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~ 259 (290)
T cd05045 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM----------------------------ERPENCSEEMY 259 (290)
T ss_pred hHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----------------------------CCCCCCCHHHH
Confidence 99999999999999998 99999888766655544221100 01135678899
Q ss_pred HHHHHhccCCCCCCcCHHHHHh
Q 009654 216 NLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 216 dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
+||.+||+.||.+||++.++++
T Consensus 260 ~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 260 NLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.74 Aligned_cols=206 Identities=28% Similarity=0.445 Sum_probs=165.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.++||||+++++++.+ .+.+|+||||++++.+..+. .....+++.++..++.||+.||.|||++||
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 127 (267)
T cd08228 50 VKEIDLLKQLNHPNVIKYLDSFIE--DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127 (267)
T ss_pred HHHHHHHHhCCCcceeeeeeeEEE--CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 579999999999999999999987 56899999999986665433 234468999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+|+||||+|||++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..|
T Consensus 128 ~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p 205 (267)
T cd08228 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred eCCCCCHHHEEEcCCCCEEECccccceeccchh-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999988665322 12234467889999999876 4588999999999999999999999
Q ss_pred CCCCCH--HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~--~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|..... .+....+ ..++.++. ....++..+.+||.+||..+|.+||++.++
T Consensus 206 ~~~~~~~~~~~~~~~-~~~~~~~~--------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~v 258 (267)
T cd08228 206 FYGDKMNLFSLCQKI-EQCDYPPL--------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258 (267)
T ss_pred CccccccHHHHHHHH-hcCCCCCC--------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence 865432 2222222 22222210 012467889999999999999999999999
Q ss_pred Hhc
Q 009654 236 LAS 238 (529)
Q Consensus 236 L~h 238 (529)
|+.
T Consensus 259 l~~ 261 (267)
T cd08228 259 HQI 261 (267)
T ss_pred HHH
Confidence 963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=273.90 Aligned_cols=206 Identities=25% Similarity=0.372 Sum_probs=166.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+++.++||||+++++++.+ ...|+||||++++.+..++. ....+++.++..++.||+.||+|||+.|++|
T Consensus 54 ~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H 130 (270)
T cd05056 54 FLQEAYIMRQFDHPHIVKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH 130 (270)
T ss_pred HHHHHHHHHhCCCCchhceeEEEcC---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3579999999999999999998876 35789999999866654443 3446899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
+||||+|||++.++.+||+|||++...........+...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||
T Consensus 131 ~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf 209 (270)
T cd05056 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPF 209 (270)
T ss_pred cccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999987654432111222234567999998865 468999999999999999986 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+... ... .....+|..+.+||.+||..+|.+|||+.+++..
T Consensus 210 ~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 210 QGVKNNDVIGRIENG--ERL--------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCCHHHHHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 988877766655331 110 0113578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=275.51 Aligned_cols=220 Identities=24% Similarity=0.307 Sum_probs=164.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.......+|+||||+.++.+..++.. ..+++.++..++.||+.||.|||++||+|||
T Consensus 54 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~d 132 (283)
T cd05080 54 KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRD 132 (283)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 579999999999999999999877555679999999999777665543 3699999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 133 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 133 LAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred cChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999766432211 1122345677999999876 458999999999999999999999986
Q ss_pred CCCHHHHHHHHHHH-cCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 160 GRTEVEQLHKIFKL-CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 160 g~~~~~~~~~I~~~-~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
..... +..+... .+......+.. ... .... ......++..+.+|+.+||+.||++|||+.+++.
T Consensus 212 ~~~~~--~~~~~~~~~~~~~~~~~~~--~~~---~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 212 SPPKK--FEEMIGPKQGQMTVVRLIE--LLE---RGMR-------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCcch--hhhhhcccccccchhhhhh--hhh---cCCC-------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 43321 1111110 00000000000 000 0000 0012357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=281.71 Aligned_cols=205 Identities=19% Similarity=0.287 Sum_probs=163.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.. ...++|+||+.++.+. .+......+++..+..++.||+.||+|||++||+||
T Consensus 57 ~~e~~~l~~l~h~niv~~~g~~~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~ 133 (316)
T cd05108 57 LDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHR 133 (316)
T ss_pred HHHHHHHHhCCCCCCCeEEEEEcC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 579999999999999999999876 3578999999986554 444445578999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
||||+|||++.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 134 dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred ccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999876543221 1122334678999999876 468999999999999999997 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+....+.. .+......++ ....++.++.+||.+||..||.+|||+.+++.+
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 213 DGIPASEIS-SILEKGERLP---------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCHHHHH-HHHhCCCCCC---------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 887655543 3322111110 012356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=271.65 Aligned_cols=205 Identities=22% Similarity=0.379 Sum_probs=166.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++++||||+++++++.. ..+|+||||+.++.+..++ .....+++.++..++.||+.||+|||+.||+
T Consensus 48 ~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~ 124 (260)
T cd05067 48 FLAEANLMKQLQHPRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124 (260)
T ss_pred HHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence 3579999999999999999998754 4689999999886554433 2345789999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||+++.++.++|+|||++...............++..|+|||++.+ ..++.++|||||||++|+|++ |++|
T Consensus 125 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p 203 (260)
T cd05067 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIP 203 (260)
T ss_pred cccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999997665332222223345678999999865 458899999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+......+ ....++.++.+||.+||+.+|++|||+++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 204 YPGMTNPEVIQNLERGYRMP----------------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCChHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99888776666553311110 11346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=274.39 Aligned_cols=204 Identities=26% Similarity=0.339 Sum_probs=162.1
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.++.++ +||||+++++++.. ...+|+||||++++.+..++.. ...+++.++..++.|
T Consensus 43 ~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 120 (270)
T cd05047 43 AGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120 (270)
T ss_pred HHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHH
Confidence 4799999999 89999999999987 4678999999997655543321 125889999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
|+.||+|||+.||+||||||+|||++.++.+||+|||++....... .......+..|+|||++.+ ..++.++|||||
T Consensus 121 i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~sl 197 (270)
T cd05047 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSY 197 (270)
T ss_pred HHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHH
Confidence 9999999999999999999999999999999999999985322111 1112233567999998865 458999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
||++|+|++ |.+||.+.+..+.+..+... ... .....++.++.+||.+||.
T Consensus 198 G~il~el~~~g~~pf~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~ 249 (270)
T cd05047 198 GVLLWEIVSLGGTPYCGMTCAELYEKLPQG--YRL--------------------------EKPLNCDDEVYDLMRQCWR 249 (270)
T ss_pred HHHHHHHHcCCCCCccccCHHHHHHHHhCC--CCC--------------------------CCCCcCCHHHHHHHHHHcc
Confidence 999999997 99999887766655554221 000 0112467889999999999
Q ss_pred CCCCCCcCHHHHHhc
Q 009654 224 VEPYKRATASAALAS 238 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h 238 (529)
.||.+|||+.+++..
T Consensus 250 ~~p~~Rps~~~il~~ 264 (270)
T cd05047 250 EKPYERPSFAQILVS 264 (270)
T ss_pred cChhhCCCHHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=274.30 Aligned_cols=199 Identities=24% Similarity=0.335 Sum_probs=159.8
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
+|...+....||||+++++++.+ ...+|+||||++++.+..+......+++..+..++.||+.||.|||+.||+||||
T Consensus 34 ~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 111 (237)
T cd05576 34 RERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL 111 (237)
T ss_pred hHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 45556666689999999999987 5789999999998766655444557999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~ 162 (529)
||+||+++.++.++++|||++...... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||....
T Consensus 112 kp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~ 186 (237)
T cd05576 112 NPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHP 186 (237)
T ss_pred CHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCc
Confidence 999999999999999999987655432 223455778999998865 458899999999999999999998875321
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH-----HHHHh
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALA 237 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta-----~e~L~ 237 (529)
.. +.. . . . ......+++.+++||.+||+.||.+|+|+ .++++
T Consensus 187 ~~-----~~~---~--------------~------~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 233 (237)
T cd05576 187 SG-----INT---H--------------T------T-----LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS 233 (237)
T ss_pred hh-----ccc---c--------------c------c-----cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHc
Confidence 10 000 0 0 0 00113468889999999999999999996 99999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 234 h~~~ 237 (237)
T cd05576 234 HPFF 237 (237)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=278.28 Aligned_cols=206 Identities=23% Similarity=0.327 Sum_probs=167.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.+++.+ +||||+++++++.. ...+|+||||+.++.+..++.. ...++..++..++.|
T Consensus 68 ~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 145 (304)
T cd05101 68 VSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQ 145 (304)
T ss_pred HHHHHHHHhhccCCCchheeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHH
Confidence 5799999999 89999999999987 5689999999998665544321 235788899999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||++||+||||||+|||++.++.+||+|||++.......... .....+++.|+|||++.+ ..|+.++||||
T Consensus 146 i~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 224 (304)
T cd05101 146 VARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWS 224 (304)
T ss_pred HHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHH
Confidence 9999999999999999999999999999999999999998664322111 122345678999999976 45899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|+|++ |.+||.+.+..+....+... ... .....++..+++||.+||
T Consensus 225 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~cl 276 (304)
T cd05101 225 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEG--HRM--------------------------DKPANCTNELYMMMRDCW 276 (304)
T ss_pred HHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHHHHc
Confidence 9999999998 88999888777766655321 100 001357889999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
..+|.+|||+.++|+.
T Consensus 277 ~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 277 HAIPSHRPTFKQLVED 292 (304)
T ss_pred ccChhhCCCHHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=272.84 Aligned_cols=206 Identities=25% Similarity=0.395 Sum_probs=167.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++++||||+++++++.+ ...+|+||||++++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 52 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h 129 (267)
T cd05066 52 FLSEASIMGQFDHPNIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH 129 (267)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEec--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 3579999999999999999999977 56899999999986665443 34457899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCcc--ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT--SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+|||++.++.++|+|||++...........+ ...++..|+|||++.+ ..++.++|+|||||++|++++ |..
T Consensus 130 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~ 208 (267)
T cd05066 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGER 208 (267)
T ss_pred hhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999866543221111 1223568999999976 458999999999999999886 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+....+.+....+ ....+++.+.+|+.+||+.+|.+||++.+++
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 260 (267)
T cd05066 209 PYWEMSNQDVIKAIEEGYRLP----------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIV 260 (267)
T ss_pred CcccCCHHHHHHHHhCCCcCC----------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHH
Confidence 998877766666654321110 0124688899999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 261 ~ 261 (267)
T cd05066 261 S 261 (267)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=272.24 Aligned_cols=205 Identities=29% Similarity=0.457 Sum_probs=164.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+++.++||||+++++++.+ .+.+|+||||++++.+..++. ....+++..+..++.||+.||.|||++||
T Consensus 50 ~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 127 (267)
T cd08229 50 IKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127 (267)
T ss_pred HHHHHHHHHccCCchhhhhheeEe--CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 579999999999999999999987 568999999999866554332 34568999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus 128 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p 205 (267)
T cd08229 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCCCHHHEEEcCCCCEEECcchhhhccccCC-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987664332 22234568899999999866 4588999999999999999999999
Q ss_pred CCCCCHH--HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEV--EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~--~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.... +....+.. ...++ .....++..+.+||.+||..||.+|||+.++
T Consensus 206 ~~~~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 258 (267)
T cd08229 206 FYGDKMNLYSLCKKIEQ-CDYPP--------------------------LPSDHYSEELRQLVNMCINPDPEKRPDITYV 258 (267)
T ss_pred cccccchHHHHhhhhhc-CCCCC--------------------------CCcccccHHHHHHHHHhcCCCcccCCCHHHH
Confidence 9765432 22222221 11110 0012478889999999999999999999988
Q ss_pred Hh
Q 009654 236 LA 237 (529)
Q Consensus 236 L~ 237 (529)
++
T Consensus 259 ~~ 260 (267)
T cd08229 259 YD 260 (267)
T ss_pred HH
Confidence 75
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.82 Aligned_cols=207 Identities=26% Similarity=0.463 Sum_probs=169.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++ .....+++.++..++.||+.||.|||+.||
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i 127 (260)
T cd08222 50 NQEAQLLSKLDHPAIVKFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127 (260)
T ss_pred HHHHHHHHhCCCCcHHHHHHHHhc--CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 368999999999999999999887 46799999999986665433 234579999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+|+||+|+||+++. +.+||+|||++....... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..|
T Consensus 128 ~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~ 204 (260)
T cd08222 128 LHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHA 204 (260)
T ss_pred cccCCChhheEeec-CCEeecccCceeecCCCc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999975 679999999987654322 12223457889999998865 4578899999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+.......+.. +.++ .....++.++.++|.+||..||.+||++.++|+
T Consensus 205 ~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 205 FEGQNFLSVVLRIVE--GPTP--------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCccHHHHHHHHHc--CCCC--------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 987776665555533 1111 001356788999999999999999999999999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||||
T Consensus 257 ~~~~ 260 (260)
T cd08222 257 NPFI 260 (260)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=278.95 Aligned_cols=205 Identities=23% Similarity=0.337 Sum_probs=165.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.+++++ +||||+++++++.+ ...+|+||||+.++.+..++.. ...+++.++..++.|
T Consensus 65 ~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (314)
T cd05099 65 ISEMELMKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQ 142 (314)
T ss_pred HHHHHHHHhccCCCCeeeEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHH
Confidence 5799999999 69999999999877 5679999999998666544321 235889999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||++||+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+ ..++.++||||
T Consensus 143 i~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws 221 (314)
T cd05099 143 VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWS 221 (314)
T ss_pred HHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhH
Confidence 999999999999999999999999999999999999999765432111 1112233567999999876 46899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|+|++ |..||.+.+..+.+..+... ... .....++.++++||.+||
T Consensus 222 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~cl 273 (314)
T cd05099 222 FGILMWEIFTLGGSPYPGIPVEELFKLLREG--HRM--------------------------DKPSNCTHELYMLMRECW 273 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCC--------------------------CCCCCCCHHHHHHHHHHc
Confidence 9999999999 89999888776666655331 100 011356788999999999
Q ss_pred cCCCCCCcCHHHHHh
Q 009654 223 SVEPYKRATASAALA 237 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~ 237 (529)
..||.+|||+.++++
T Consensus 274 ~~~p~~Rps~~~ll~ 288 (314)
T cd05099 274 HAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCcccCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=268.65 Aligned_cols=205 Identities=27% Similarity=0.385 Sum_probs=168.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-CCC-CCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIK-FSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-~~~-l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.++||||+++++++.+ ...+|+||||++++.+..+... ... +++.++..++.||+.||.|||+.||+|
T Consensus 49 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h 126 (258)
T smart00219 49 LREARIMRKLDHPNIVKLLGVCTE--EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIH 126 (258)
T ss_pred HHHHHHHHhcCCCchheEEEEEcC--CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeee
Confidence 579999999999999999999988 4689999999998666544432 223 999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
+||||+||+++.++.++|+|||++...............+++.|+|||.+.+ ..++.++||||+||++|+|++ |.+||
T Consensus 127 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~ 205 (258)
T smart00219 127 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY 205 (258)
T ss_pred cccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997665432111112236788999999854 568999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.+.......+.... .. .....++..+.++|.+||..||.+|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 206 PGMSNEEVLEYLKKGY--RL--------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCHHHHHHHHhcCC--CC--------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 8877777666654311 10 001236888999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=268.22 Aligned_cols=207 Identities=24% Similarity=0.344 Sum_probs=165.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.++++++||||+++++++.+ ....|+||||+.++.+..++ .....+++..+..++.|++.+|.|||++||+|
T Consensus 39 ~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h 116 (251)
T cd05041 39 FLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116 (251)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeh
Confidence 3579999999999999999999887 56899999999886555443 44457899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCc-cccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||||+|||++.++.+||+|||++........... .....+..|+|||.+.+ ..++.++|||||||++|+|++ |.+|
T Consensus 117 ~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p 195 (251)
T cd05041 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTP 195 (251)
T ss_pred hhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCC
Confidence 99999999999999999999999876542211111 11233567999999876 458999999999999999998 8899
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.........+......+ ....++..+.+||.+||..+|.+|||+.++|+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 196 YPGMSNQQTRERIESGYRMP----------------------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CccCCHHHHHHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 98877655555442211000 01246788999999999999999999999986
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
.
T Consensus 248 ~ 248 (251)
T cd05041 248 E 248 (251)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=269.94 Aligned_cols=206 Identities=27% Similarity=0.434 Sum_probs=171.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||+++..+..++.. ...+++..+..++.||+.||.|||+.|+
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i 124 (256)
T cd08530 47 VNEIRILASVNHPNIISYKEAFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI 124 (256)
T ss_pred HHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 479999999999999999999887 5789999999998666544322 4578999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+|+||+|+||+++.++.+||+|||++...... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|++|
T Consensus 125 ~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p 200 (256)
T cd08530 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPP 200 (256)
T ss_pred ccCCCCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999766543 2233567899999999976 4588999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+.. +..+ .....++.+++++|.+||+.+|.+|||+.++|+
T Consensus 201 ~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 201 FEARSMQDLRYKVQR--GKYP--------------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCHHHHHHHHhc--CCCC--------------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 998876655555432 1110 001246788999999999999999999999999
Q ss_pred cccc
Q 009654 238 SEYF 241 (529)
Q Consensus 238 h~~f 241 (529)
||+.
T Consensus 253 ~p~~ 256 (256)
T cd08530 253 SPAV 256 (256)
T ss_pred CCCC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=269.77 Aligned_cols=202 Identities=25% Similarity=0.401 Sum_probs=170.6
Q ss_pred CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEc
Q 009654 12 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVN 90 (529)
Q Consensus 12 ~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvHrDIKp~NILl~ 90 (529)
++|+||+++|+|.. +..++|.||.|....-.++..-.++++|..+.++...++.||.||.. +||+|||+||+|||||
T Consensus 149 dcpyIV~c~GyFi~--n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD 226 (391)
T KOG0983|consen 149 DCPYIVQCFGYFIT--NTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD 226 (391)
T ss_pred CCCeeeeeeeEEee--CchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc
Confidence 68999999999988 56789999999875555555556689999999999999999999995 5899999999999999
Q ss_pred cCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCCCC-CCHHHHH
Q 009654 91 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQL 167 (529)
Q Consensus 91 ~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf~g-~~~~~~~ 167 (529)
..|+|||||||++-..-... ..+...|.+.|||||.+.- ...|+..+||||||+.|+||.||+.||.+ +++.+.+
T Consensus 227 e~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l 304 (391)
T KOG0983|consen 227 ERGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL 304 (391)
T ss_pred cCCCEEeecccccceeeccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH
Confidence 99999999999997665442 3355588999999999842 35699999999999999999999999998 5788999
Q ss_pred HHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 168 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 168 ~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
.+|.+ ..||. | ++. ..+++.+.+|+..||..|+.+||.-.++|+|||+..
T Consensus 305 tkvln--~ePP~-------L----------~~~-------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 305 TKVLN--EEPPL-------L----------PGH-------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHh--cCCCC-------C----------Ccc-------cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 99877 22221 1 111 238999999999999999999999999999999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=271.36 Aligned_cols=211 Identities=22% Similarity=0.285 Sum_probs=162.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
+.+|+.+++.++||||+++++.+.+ ...+|+|||||+++.+..++.. ...+++..+..++.||+.||+|||+.+
T Consensus 42 ~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 119 (268)
T cd05086 42 FLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119 (268)
T ss_pred HHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 3578999999999999999999987 5678999999998666544322 234677888999999999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCC------CCCCCcchhhhhhHHHH
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGA------TDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~------~~y~~~~DIWSlG~il~ 149 (529)
|+||||||+|||++.++.+||+|||++....... .......++++.|+|||++... ..++.++|||||||++|
T Consensus 120 i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (268)
T cd05086 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLW 199 (268)
T ss_pred eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHH
Confidence 9999999999999999999999999985432211 1112345678899999998531 23578999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 150 ELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 150 ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
+|++ |.+||...++.+.+..+....... + +.+. ....+++.+.+||..|| .+|.+
T Consensus 200 el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------~-----~~~~---------~~~~~~~~~~~l~~~c~-~~P~~ 255 (268)
T cd05086 200 ELFENAAQPYSHLSDREVLNHVIKDQQVK---------L-----FKPQ---------LELPYSERWYEVLQFCW-LSPEK 255 (268)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhhcccc---------c-----CCCc---------cCCCCcHHHHHHHHHHh-hCccc
Confidence 9997 578998888877777664421110 0 0000 01246778899999999 78999
Q ss_pred CcCHHHHHh
Q 009654 229 RATASAALA 237 (529)
Q Consensus 229 R~ta~e~L~ 237 (529)
|||+.++++
T Consensus 256 Rp~~~~i~~ 264 (268)
T cd05086 256 RATAEEVHR 264 (268)
T ss_pred CCCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=277.68 Aligned_cols=212 Identities=23% Similarity=0.367 Sum_probs=167.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvH 79 (529)
.+|+.++.++ +||||+++++++.+ ...+|+||||+.+.+...+......+++.++..++.||+.||.|||+ .||+|
T Consensus 61 ~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H 138 (296)
T cd06618 61 LMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIH 138 (296)
T ss_pred HHHHHHHHhccCCCchHhhheeeec--CCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEec
Confidence 3577666666 59999999999987 56899999999886655555445589999999999999999999997 59999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC---CCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||+|+||+++.++.+||+|||++....... ......+++.|+|||.+.+. ..++.++|||||||++|+|++|++
T Consensus 139 ~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 139 RDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred CCCcHHHEEEcCCCCEEECccccchhccCCC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999987654322 22334578899999998653 247889999999999999999999
Q ss_pred CCCCCC-HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 157 ILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 157 pf~g~~-~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
||.... ..+.+..+... ..+. . .....++.++.+||.+||..||.+||++.++
T Consensus 217 p~~~~~~~~~~~~~~~~~--~~~~-----------------~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 270 (296)
T cd06618 217 PYKNCKTEFEVLTKILQE--EPPS-----------------L-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270 (296)
T ss_pred CCCcchhHHHHHHHHhcC--CCCC-----------------C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 997633 23344443221 1000 0 0012467889999999999999999999999
Q ss_pred HhccccCC
Q 009654 236 LASEYFST 243 (529)
Q Consensus 236 L~h~~f~~ 243 (529)
+.|+||..
T Consensus 271 l~~~~~~~ 278 (296)
T cd06618 271 LQHPFIRR 278 (296)
T ss_pred hcChhhhc
Confidence 99999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=307.03 Aligned_cols=101 Identities=33% Similarity=0.462 Sum_probs=92.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.. ...+|||||||.++.+..++.....+++..++.|+.||+.||.|||++||+|||
T Consensus 52 ~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrD 129 (669)
T cd05610 52 QAERDALALSKSPFIVHLYYSLQS--ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129 (669)
T ss_pred HHHHHHHHhcCCCCcCeEEEEEEE--CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCC
Confidence 578999999999999999998877 578999999999876666655556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~ 104 (529)
|||+||||+.++.+||+|||+++
T Consensus 130 LKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 130 LKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred ccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=275.62 Aligned_cols=213 Identities=22% Similarity=0.292 Sum_probs=166.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC------------CCCCHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD------------IKFSEAQIKCYMNQLLHG 68 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~------------~~l~e~~~~~i~~Qll~g 68 (529)
|.+|+++|++++||||+++++++.. ...+|+|||||.++.+..++... ..+++..+..++.||+.|
T Consensus 64 ~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 141 (295)
T cd05097 64 FLKEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141 (295)
T ss_pred HHHHHHHHHhCCCCCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence 3579999999999999999999977 56899999999986665443211 237889999999999999
Q ss_pred HHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHH
Q 009654 69 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 147 (529)
Q Consensus 69 L~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~i 147 (529)
|.|||++||+||||||+|||++.++.+||+|||++......... ......+++.|+|||++.+ ..++.++|||||||+
T Consensus 142 l~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~ 220 (295)
T cd05097 142 MKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVT 220 (295)
T ss_pred HHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHH
Confidence 99999999999999999999999999999999998765432211 1122344678999999876 458999999999999
Q ss_pred HHHHHh--CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 148 FAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 148 l~ellt--G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
+|+|++ |..||...+..+.+..+.......... .+ ....+.+|+.+.+||.+||..|
T Consensus 221 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~----~~~~~~~~~~l~~li~~~l~~~ 279 (295)
T cd05097 221 LWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ-----------------IY----LSQTPLCPSPVFKLMMRCWSRD 279 (295)
T ss_pred HHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccc-----------------cc----CCCCCCCCHHHHHHHHHHcCCC
Confidence 999988 678898877766665554321110000 00 0112346889999999999999
Q ss_pred CCCCcCHHHHHh
Q 009654 226 PYKRATASAALA 237 (529)
Q Consensus 226 P~kR~ta~e~L~ 237 (529)
|.+|||+.++++
T Consensus 280 p~~RPs~~~i~~ 291 (295)
T cd05097 280 IKDRPTFNKIHH 291 (295)
T ss_pred chhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=269.06 Aligned_cols=207 Identities=21% Similarity=0.302 Sum_probs=162.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++... ....|+||||+.++.+..++ .....+++..+..++.||+.||.|||+.||+||
T Consensus 44 ~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 122 (262)
T cd05058 44 LKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122 (262)
T ss_pred HHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 5799999999999999999977643 45689999999986655444 334457788889999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
||||+|||++.++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+
T Consensus 123 dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred ccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999875432211 11122345678999999876 458999999999999999999 578
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||...+..+....+.. +.++. ....+|..+.+||.+||..+|++||++.+++
T Consensus 202 ~~~~~~~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il 253 (262)
T cd05058 202 PYPDVDSFDITVYLLQ--GRRLL--------------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELV 253 (262)
T ss_pred CCCCCCHHHHHHHHhc--CCCCC--------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 8887766655544422 11100 0024678899999999999999999999998
Q ss_pred hc
Q 009654 237 AS 238 (529)
Q Consensus 237 ~h 238 (529)
+.
T Consensus 254 ~~ 255 (262)
T cd05058 254 SR 255 (262)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=268.20 Aligned_cols=201 Identities=23% Similarity=0.354 Sum_probs=165.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~--~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+++.++||||+++++++.+ ....|+||||++++.+..+..... .+++.++..++.||+.||.|||++||+|
T Consensus 48 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H 125 (256)
T cd05039 48 LAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVH 125 (256)
T ss_pred HHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 579999999999999999999887 578999999999755554443332 6899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
+||||+||+++.++.+||+|||++....... .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 126 ~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~ 200 (256)
T cd05039 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 200 (256)
T ss_pred hhcccceEEEeCCCCEEEccccccccccccc----ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999997663321 22344667999999865 458899999999999999997 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
...+..+....+... ... .....+|+.+.+||.+||..+|.+|||+.++++
T Consensus 201 ~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 201 PRIPLKDVVPHVEKG--YRM--------------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCHHHHHHHHhcC--CCC--------------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 887766655544321 000 011356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=277.48 Aligned_cols=206 Identities=23% Similarity=0.343 Sum_probs=164.1
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.+++.+ +||||+++++++.. ...+|+||||+.++.+..++.. ...+++.++..++.|
T Consensus 71 ~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 148 (307)
T cd05098 71 ISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQ 148 (307)
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence 4799999999 89999999999987 5689999999998655544322 135889999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||+|||++||+||||||+|||++.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++||||
T Consensus 149 i~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 227 (307)
T cd05098 149 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWS 227 (307)
T ss_pred HHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHH
Confidence 9999999999999999999999999999999999999987654321111 112234568999999876 45899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|+|++ |.+||.+.+..+....+.. +... .....++.++.+||.+||
T Consensus 228 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l 279 (307)
T cd05098 228 FGVLLWEIFTLGGSPYPGVPVEELFKLLKE--GHRM--------------------------DKPSNCTNELYMMMRDCW 279 (307)
T ss_pred HHHHHHHHHcCCCCCCCcCCHHHHHHHHHc--CCCC--------------------------CCCCcCCHHHHHHHHHHc
Confidence 9999999998 8899988776555544422 1110 111356889999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
..+|.+|||+.+++++
T Consensus 280 ~~~p~~Rps~~evl~~ 295 (307)
T cd05098 280 HAVPSQRPTFKQLVED 295 (307)
T ss_pred ccChhhCcCHHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.40 Aligned_cols=207 Identities=22% Similarity=0.290 Sum_probs=162.7
Q ss_pred CHHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC------------------------------
Q 009654 1 MAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP------------------------------ 49 (529)
Q Consensus 1 ~~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~------------------------------ 49 (529)
+.+|+.+|++|+ |||||++++++.+ ...+|||||||+++.+..++..
T Consensus 87 ~~~Ei~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (400)
T cd05105 87 LMSELKIMTHLGPHLNIVNLLGACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTR 164 (400)
T ss_pred HHHHHHHHHhcCCCCCeeeEEEEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccccc
Confidence 368999999996 9999999999987 5689999999998655432211
Q ss_pred ------------------------------------------------------------------CCCCCHHHHHHHHH
Q 009654 50 ------------------------------------------------------------------DIKFSEAQIKCYMN 63 (529)
Q Consensus 50 ------------------------------------------------------------------~~~l~e~~~~~i~~ 63 (529)
...+++.++..++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~ 244 (400)
T cd05105 165 SYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTY 244 (400)
T ss_pred chhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHH
Confidence 12478889999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhh
Q 009654 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLW 142 (529)
Q Consensus 64 Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIW 142 (529)
||+.||.|||+.||+||||||+|||++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||
T Consensus 245 qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diw 323 (400)
T cd05105 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVW 323 (400)
T ss_pred HHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHH
Confidence 999999999999999999999999999999999999999976543221 11223356788999999876 4589999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 143 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 143 SlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
||||++|+|++ |..||.+......+.........++ ....++..+.+||.+|
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~c 376 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA---------------------------KPDHATQEVYDIMVKC 376 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHH
Confidence 99999999997 9999987654433333222111100 0135788899999999
Q ss_pred ccCCCCCCcCHHHHHh
Q 009654 222 LSVEPYKRATASAALA 237 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~ 237 (529)
|+.||++|||+.++.+
T Consensus 377 l~~dP~~RPt~~~l~~ 392 (400)
T cd05105 377 WNSEPEKRPSFLHLSD 392 (400)
T ss_pred CccCHhHCcCHHHHHH
Confidence 9999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=269.68 Aligned_cols=206 Identities=22% Similarity=0.318 Sum_probs=165.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-------~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
+.+|+.+|+.++||||+++++++.+ ....|+||||++++.+..++. ....+++.++..++.||+.||.|||
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 123 (269)
T cd05044 46 FLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123 (269)
T ss_pred HHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH
Confidence 3579999999999999999999877 567999999999865554332 2235889999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCC-----cEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHH
Q 009654 74 SRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 147 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g-----~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~i 147 (529)
+.+|+|+||||+|||++.++ .++|+|||++........ .......++..|+|||++.+ ..++.++|||||||+
T Consensus 124 ~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i 202 (269)
T cd05044 124 QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVL 202 (269)
T ss_pred hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHH
Confidence 99999999999999999877 899999999875533211 11123345778999999876 458999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCC
Q 009654 148 FAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226 (529)
Q Consensus 148 l~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP 226 (529)
+|+|++ |..||...+..+....+.... .+ .....+|..+.+||.+||..+|
T Consensus 203 l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p 254 (269)
T cd05044 203 MWEILTLGQQPYPALNNQEVLQHVTAGG-RL---------------------------QKPENCPDKIYQLMTNCWAQDP 254 (269)
T ss_pred HHHHHHcCCCCCcccCHHHHHHHHhcCC-cc---------------------------CCcccchHHHHHHHHHHcCCCc
Confidence 999998 999998877766655542210 00 1113568889999999999999
Q ss_pred CCCcCHHHHHh
Q 009654 227 YKRATASAALA 237 (529)
Q Consensus 227 ~kR~ta~e~L~ 237 (529)
.+||++.++++
T Consensus 255 ~~Rp~~~~i~~ 265 (269)
T cd05044 255 SERPTFDRIQE 265 (269)
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=268.27 Aligned_cols=205 Identities=21% Similarity=0.338 Sum_probs=165.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+++.++|+||+++++++.+ ..+|+||||++++.+..++ . ....+++.++..++.||+.||.|||+.|++
T Consensus 48 ~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~ 124 (260)
T cd05073 48 FLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124 (260)
T ss_pred HHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 3579999999999999999999876 4689999999875554443 2 244688899999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|+||||+||+++.++.+||+|||++...............++..|+|||++.. ..++.++|+|||||++|+|++ |.+|
T Consensus 125 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p 203 (260)
T cd05073 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIP 203 (260)
T ss_pred ccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999997664332222223345677999999876 458999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+.......+...... .....++.++.+++.+||..+|.+||++.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 204 YPGMSNPEVIRALERGYRM----------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCCHHHHHHHHhCCCCC----------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9988776666555331100 011357888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=270.02 Aligned_cols=210 Identities=20% Similarity=0.237 Sum_probs=159.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-----~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..++. ....+++..+..++.||+.||+|||+.|
T Consensus 43 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 120 (269)
T cd05087 43 LEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120 (269)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 579999999999999999999877 467899999999866654432 2234677888899999999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCC------CCCCCcchhhhhhHHHH
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGA------TDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~------~~y~~~~DIWSlG~il~ 149 (529)
|+|+||||+||+++.++.+||+|||++......... ......+++.|+|||++.+. ..++.++|||||||++|
T Consensus 121 i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~ 200 (269)
T cd05087 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIW 200 (269)
T ss_pred EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHH
Confidence 999999999999999999999999998654332111 11234567889999998542 13578999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 150 ELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 150 ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
+|++ |.+||...+..+............ . ..+ .....+++.+.+||..|+ .+|.+
T Consensus 201 el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------~-----~~~---------~~~~~~~~~~~~l~~~c~-~~P~~ 256 (269)
T cd05087 201 ELFELGSQPYRHLSDEQVLTYTVREQQLK---------L-----PKP---------RLKLPLSDRWYEVMQFCW-LQPEQ 256 (269)
T ss_pred HHHhCCCCCCCCCChHHHHHHHhhcccCC---------C-----CCC---------ccCCCCChHHHHHHHHHh-cCccc
Confidence 9996 999998766555443322210000 0 000 001246778899999998 68999
Q ss_pred CcCHHHHHh
Q 009654 229 RATASAALA 237 (529)
Q Consensus 229 R~ta~e~L~ 237 (529)
|||+.+++.
T Consensus 257 Rpt~~~l~~ 265 (269)
T cd05087 257 RPSAEEVHL 265 (269)
T ss_pred CCCHHHHHH
Confidence 999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=270.44 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=167.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..+. .....+++.++..++.|++.||.|||++|++|
T Consensus 52 ~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H 129 (269)
T cd05065 52 FLSEASIMGQFDHPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129 (269)
T ss_pred HHHHHHHHHhCCCcCcceEEEEECC--CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 3579999999999999999999876 56789999999987666444 34557999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC-Cccccc---cccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-C
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRV---VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-G 154 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~---gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G 154 (529)
+||||+||+++.++.+||+|||++......... ...... .+..|+|||.+.+ ..++.++||||+||++|||++ |
T Consensus 130 ~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g 208 (269)
T cd05065 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYG 208 (269)
T ss_pred cccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCC
Confidence 999999999999999999999998765432211 111111 2457999999875 458999999999999999886 9
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.+..+....+......+ ....+|..+.+++.+||..+|.+||++.+
T Consensus 209 ~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (269)
T cd05065 209 ERPYWDMSNQDVINAIEQDYRLP----------------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQ 260 (269)
T ss_pred CCCCCCCCHHHHHHHHHcCCcCC----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99998887766666653311111 01356888999999999999999999999
Q ss_pred HHhc
Q 009654 235 ALAS 238 (529)
Q Consensus 235 ~L~h 238 (529)
++..
T Consensus 261 i~~~ 264 (269)
T cd05065 261 IVST 264 (269)
T ss_pred HHHH
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=289.52 Aligned_cols=215 Identities=30% Similarity=0.481 Sum_probs=174.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCC-chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~-ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.|-.||..-+.+=||+||-.|+| .+++|+||||++|| +..+++ +.+-|.|+.++.|+..|.+|+++.|..|+|||
T Consensus 677 KAERDILAEADn~WVVrLyySFQD--kdnLYFVMdYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHkmGFIHR 753 (1034)
T KOG0608|consen 677 KAERDILAEADNEWVVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHKMGFIHR 753 (1034)
T ss_pred hhhhhhHhhcCCcceEEEEEEecc--CCceEEEEeccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHhccceec
Confidence 457789999999999999999998 67999999999984 555555 55689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEecccccccc---------CCCCC--------------------------------CCcccccc
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFS---------NTGHR--------------------------------QPLTSRVV 119 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~---------~~~~~--------------------------------~~~~~~~g 119 (529)
||||+|||||.+|.|||+|||||+=+ ..+.. ......+|
T Consensus 754 DiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvg 833 (1034)
T KOG0608|consen 754 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVG 833 (1034)
T ss_pred ccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcC
Confidence 99999999999999999999998422 11110 01235689
Q ss_pred ccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC
Q 009654 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 199 (529)
Q Consensus 120 t~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~ 199 (529)
|+.|+|||+|.. ..|+..||.||+|||||||+.|++||-+.+..+...+|++ |...- ..+|
T Consensus 834 t~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n---------w~~~l---------~~~~ 894 (1034)
T KOG0608|consen 834 TPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN---------WRNFL---------HIPY 894 (1034)
T ss_pred CCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---------hhhcc---------cccc
Confidence 999999999987 5699999999999999999999999998887776655533 32100 0011
Q ss_pred cchhhhhccCCcHHHHHHHHHhccCCCCCCcC---HHHHHhccccCCCCC
Q 009654 200 DSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 246 (529)
Q Consensus 200 ~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t---a~e~L~h~~f~~~~~ 246 (529)
..+++.++.+||.+| +.++++|+. ++++-.||||+...|
T Consensus 895 -------~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 895 -------QGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred -------ccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccch
Confidence 247899999999985 578999974 778999999997655
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=268.19 Aligned_cols=199 Identities=22% Similarity=0.276 Sum_probs=159.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~-~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++++||||+++++++.. ...|+||||++++.+..++.... .+++..+..++.||+.||.|||++||+|
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 124 (259)
T cd05037 48 FFETASLMSQLSHKHLVKLYGVCVR---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVH 124 (259)
T ss_pred HHHHHHHHHcCCCcchhheeeEEec---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 3579999999999999999998876 35799999999987776654433 7999999999999999999999999999
Q ss_pred cCCCCCcEEEccCC-------cEEEeccccccccCCCCCCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHH
Q 009654 80 RDIKGSNLLVNNEG-------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 80 rDIKp~NILl~~~g-------~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~el 151 (529)
|||||+|||++.++ .+||+|||++...... ....++..|+|||++.+. ..++.++|||||||++|+|
T Consensus 125 ~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l 199 (259)
T cd05037 125 GNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199 (259)
T ss_pred ccCccceEEEecCccccCCceeEEeCCCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHH
Confidence 99999999999887 7999999998765431 234567789999999764 3689999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 lt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++ |.+||...+..+....... ... . + ......+.+||.+||..+|.+||
T Consensus 200 ~~~~~~p~~~~~~~~~~~~~~~--~~~---------~----------~---------~~~~~~~~~li~~~l~~~p~~Rp 249 (259)
T cd05037 200 CSNGEEPLSTLSSSEKERFYQD--QHR---------L----------P---------MPDCAELANLINQCWTYDPTKRP 249 (259)
T ss_pred HhCCCCCcccCCchhHHHHHhc--CCC---------C----------C---------CCCchHHHHHHHHHhccChhhCC
Confidence 99 5788876653332222210 000 0 0 01126789999999999999999
Q ss_pred CHHHHHh
Q 009654 231 TASAALA 237 (529)
Q Consensus 231 ta~e~L~ 237 (529)
|+.++|+
T Consensus 250 t~~~il~ 256 (259)
T cd05037 250 SFRAILR 256 (259)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=271.19 Aligned_cols=204 Identities=18% Similarity=0.249 Sum_probs=163.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.. ...++++||++++.+. .+......+++.++..++.||+.||.|||++||+||
T Consensus 57 ~~e~~~l~~~~~~~i~~~~~~~~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~ 133 (279)
T cd05109 57 LDEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133 (279)
T ss_pred HHHHHHHHhcCCCCCceEEEEEcC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 579999999999999999999865 3578999999975555 443445579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
||||+|||+++++.+||+|||++......... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||
T Consensus 134 dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred ccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999866432211 1122334678999999876 458999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.........+.. ...++ ....++..+.++|.+||..||++||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 213 DGIPAREIPDLLEK-GERLP---------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCCCHHHHHHHHHC-CCcCC---------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 87665554443322 11111 01246788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=271.29 Aligned_cols=204 Identities=18% Similarity=0.258 Sum_probs=162.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
..|+.+++.++||||+++++++.. ..+++|+||+.++.+. .+......+++..+..++.||+.||.|||++|++||
T Consensus 57 ~~~~~~l~~l~h~~iv~~~~~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 133 (279)
T cd05111 57 TDHMLAMGSLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHR 133 (279)
T ss_pred HHHHHHHhcCCCCCcceEEEEECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence 457778899999999999998754 4578999999975555 443445679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
||||+|||++.++.+||+|||+++........ ......++..|+|||++.+ ..|+.++|||||||++|||++ |.+||
T Consensus 134 dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred ccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999865433221 1223456778999999876 458999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+.........+.. +..+. ....++.++.+++.+||..||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 213 AGMRPHEVPDLLEK--GERLA--------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCHHHHHHHHHC--CCcCC--------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 88776554333321 11100 00135667899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=274.77 Aligned_cols=206 Identities=29% Similarity=0.410 Sum_probs=162.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~-~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+++|++++||||+++++++.. ...+++|||||+++.+..++ .. ...+++.++..++.||+.||.|||+++|+
T Consensus 48 ~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~ii 125 (259)
T PF07714_consen 48 FLNEIQILRKLRHPNIVKLYGFCIE--NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNII 125 (259)
T ss_dssp HHHHHHHHHTHSBTTBE-EEEEEES--SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred eeecccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4689999999999999999999985 45699999999986665443 33 46899999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|+||+++|||++.++.+||+|||++........ ...........|+|||++.+. .++.++||||||+++|||++ |..
T Consensus 126 H~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~ 204 (259)
T PF07714_consen 126 HGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKF 204 (259)
T ss_dssp EST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence 999999999999999999999999987632211 112234567889999998763 48999999999999999999 789
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+...++.+..- + .....++..+.+||..||..||.+|||+.+++
T Consensus 205 p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~ 256 (259)
T PF07714_consen 205 PFSDYDNEEIIEKLKQGQR-L---------------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEIL 256 (259)
T ss_dssp TTTTSCHHHHHHHHHTTEE-T---------------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHH
T ss_pred ccccccccccccccccccc-c---------------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9988888777777744211 1 11135788999999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 257 ~ 257 (259)
T PF07714_consen 257 Q 257 (259)
T ss_dssp H
T ss_pred h
Confidence 5
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=278.42 Aligned_cols=212 Identities=28% Similarity=0.406 Sum_probs=184.3
Q ss_pred HHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 4 EILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 4 Ei~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
|-++|... +-|.++.|+.+|+. .+.+|+||||+.|+.|-+.+.+-++|.|..+..|+..|+-||-+||++||++|||
T Consensus 399 EKrvLAL~~kppFL~qlHScFQT--mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDL 476 (683)
T KOG0696|consen 399 EKRVLALPGKPPFLVQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDL 476 (683)
T ss_pred hhhheecCCCCchHHHHHHHhhh--hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeec
Confidence 45566555 56889999999988 5789999999999887777788889999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~ 162 (529)
|.+|||++.+|.|||+|||+++.---+ .....+.||||.|+|||++.- .+|+.++|.||+||+|||||.|+|||+|.+
T Consensus 477 KLDNvmLd~eGHiKi~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred cccceEeccCCceEeeecccccccccC-CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999743222 234456799999999999865 579999999999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHHh
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALA 237 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L~ 237 (529)
+.+.++.|.+..-.+| +.+|.++.+++..+|...|.+|+. -.++-.
T Consensus 555 E~elF~aI~ehnvsyP-----------------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~ 605 (683)
T KOG0696|consen 555 EDELFQAIMEHNVSYP-----------------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIRE 605 (683)
T ss_pred HHHHHHHHHHccCcCc-----------------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhh
Confidence 9999999988443332 578999999999999999999975 368999
Q ss_pred ccccCCCCCCC
Q 009654 238 SEYFSTKPYAC 248 (529)
Q Consensus 238 h~~f~~~~~~~ 248 (529)
||||+...|..
T Consensus 606 H~FFR~iDWek 616 (683)
T KOG0696|consen 606 HPFFRRIDWEK 616 (683)
T ss_pred CcchhhccHHH
Confidence 99999887754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=272.53 Aligned_cols=205 Identities=25% Similarity=0.376 Sum_probs=164.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------------CCCCCHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------------DIKFSEAQIK 59 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------------~~~l~e~~~~ 59 (529)
.+|+.++++++||||+++++++.+ ...+|+||||++++.+..++.. ...+++.++.
T Consensus 56 ~~ei~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 133 (288)
T cd05050 56 QREAALMAEFDHPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133 (288)
T ss_pred HHHHHHHHhcCCCchheEEEEEcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHH
Confidence 579999999999999999999887 5678999999998655543321 1247889999
Q ss_pred HHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCc
Q 009654 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPS 138 (529)
Q Consensus 60 ~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~ 138 (529)
.++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ ........++.|+|||++.+ ..++.+
T Consensus 134 ~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 212 (288)
T cd05050 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTE 212 (288)
T ss_pred HHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCch
Confidence 9999999999999999999999999999999999999999999875432211 11122234667999999876 458999
Q ss_pred chhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHH
Q 009654 139 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 217 (529)
Q Consensus 139 ~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dL 217 (529)
+|||||||++|+|++ |..||.+.+..+....+... ... .....++.++.+|
T Consensus 213 ~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~l 264 (288)
T cd05050 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG--NVL--------------------------SCPDNCPLELYNL 264 (288)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--CCC--------------------------CCCCCCCHHHHHH
Confidence 999999999999997 88899888777766655331 110 0012467889999
Q ss_pred HHHhccCCCCCCcCHHHHHh
Q 009654 218 IETLLSVEPYKRATASAALA 237 (529)
Q Consensus 218 i~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+||+.||.+|||+.|+++
T Consensus 265 i~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 265 MRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=271.56 Aligned_cols=224 Identities=24% Similarity=0.328 Sum_probs=164.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|+.++||||+++++++.+.....+|+||||++++.+..++. ....+++.++..++.||+.||+|||++||+|
T Consensus 53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H 132 (284)
T cd05079 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVH 132 (284)
T ss_pred HHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 357999999999999999999988754567899999999877665543 3346899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|+++..|
T Consensus 133 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~ 211 (284)
T cd05079 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDS 211 (284)
T ss_pred cccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCC
Confidence 999999999999999999999999866432211 1123456778999999876 4588999999999999999998776
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
+..... .+.+..+.......... .. ....... .......++..+.+||.+||+.||.+|||+.++++
T Consensus 212 ~~~~~~-----~~~~~~~~~~~~~~~~~-~~--~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 212 ESSPMT-----LFLKMIGPTHGQMTVTR-LV--RVLEEGK-----RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred Cccccc-----hhhhhcccccccccHHH-HH--HHHHcCc-----cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 532211 11111111110000000 00 0000000 01112457889999999999999999999999986
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
.
T Consensus 279 ~ 279 (284)
T cd05079 279 G 279 (284)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=278.41 Aligned_cols=206 Identities=22% Similarity=0.323 Sum_probs=166.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.+++++ +||||+++++++.. ...+|+||||+.++.+..++.. ...++..++..++.|
T Consensus 65 ~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (334)
T cd05100 65 VSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQ 142 (334)
T ss_pred HHHHHHHHhhcCCCCeeeeeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence 5799999999 89999999999987 5689999999998665544321 234788899999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||++||+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+ ..++.++||||
T Consensus 143 i~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 221 (334)
T cd05100 143 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWS 221 (334)
T ss_pred HHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHH
Confidence 999999999999999999999999999999999999999765432211 1122334567999999976 45889999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|+|++ |.+||.+.+..+.+..+... ... .....++..+.+||.+||
T Consensus 222 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~cl 273 (334)
T cd05100 222 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEG--HRM--------------------------DKPANCTHELYMIMRECW 273 (334)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC--------------------------CCCCCCCHHHHHHHHHHc
Confidence 9999999998 89999988777766655331 100 011356788999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
..+|.+|||+.++|++
T Consensus 274 ~~~p~~Rps~~ell~~ 289 (334)
T cd05100 274 HAVPSQRPTFKQLVED 289 (334)
T ss_pred ccChhhCcCHHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=265.54 Aligned_cols=205 Identities=30% Similarity=0.464 Sum_probs=163.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.++++++|+||+++++++.+ .+.+|+||||++++.+..++ .....+++.++..++.||+.||.|||+.||
T Consensus 50 ~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 127 (267)
T cd08224 50 LKEIDLLKQLDHPNVIKYLASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127 (267)
T ss_pred HHHHHHHHhCCCCCeeeeeeeeec--CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 579999999999999999999988 56899999999986555333 234568999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..|
T Consensus 128 ~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p 205 (267)
T cd08224 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCcChhhEEECCCCcEEEeccceeeeccCCC-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999987654322 12234567899999999876 4588999999999999999999999
Q ss_pred CCCCCH--HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~--~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+... .+....+.. +..+ + .+ ...++..+.++|.+||..+|.+|||+.++
T Consensus 206 ~~~~~~~~~~~~~~~~~--~~~~----------------~-~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~i 258 (267)
T cd08224 206 FYGDKMNLYSLCKKIEK--CDYP----------------P-LP--------ADHYSEELRDLVSRCINPDPEKRPDISYV 258 (267)
T ss_pred cccCCccHHHHHhhhhc--CCCC----------------C-CC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 965431 122222211 1100 0 00 12567789999999999999999999998
Q ss_pred Hh
Q 009654 236 LA 237 (529)
Q Consensus 236 L~ 237 (529)
++
T Consensus 259 l~ 260 (267)
T cd08224 259 LQ 260 (267)
T ss_pred HH
Confidence 85
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=271.60 Aligned_cols=212 Identities=20% Similarity=0.296 Sum_probs=163.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-----------CCCCCHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMNQLLHGLE 70 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-----------~~~l~e~~~~~i~~Qll~gL~ 70 (529)
.+|+.+|+.|+||||+++++++.+ ...+|+||||+.++.+..++.. ...+++.++..++.||+.||+
T Consensus 67 ~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~ 144 (296)
T cd05095 67 LKEIKIMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMK 144 (296)
T ss_pred HHHHHHHHhCCCCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHH
Confidence 579999999999999999999877 5678999999998655543321 124778899999999999999
Q ss_pred HHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCc-cccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 71 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 71 ~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
|||+.||+|+||||+|||++.++.++|+|||++........... ....+++.|++||++.+ ..++.++|||||||++|
T Consensus 145 ~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~ 223 (296)
T cd05095 145 YLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLW 223 (296)
T ss_pred HHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHH
Confidence 99999999999999999999999999999999876543221111 12234678999998766 35899999999999999
Q ss_pred HHHh--CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 150 ELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 150 ellt--G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
+|++ |..||...+..+.+.........- .. ... ......+++.+.+||.+||..||.
T Consensus 224 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~---~~~----------~~~~~~~~~~~~~li~~cl~~~p~ 282 (296)
T cd05095 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQ--------GR---QVY----------LPKPALCPDSLYKLMLSCWRRNAK 282 (296)
T ss_pred HHHHhCCCCCccccChHHHHHHHHHHHhhc--------cc---ccc----------CCCCCCCCHHHHHHHHHHcCCCcc
Confidence 9998 778998777666554432211000 00 000 011134678899999999999999
Q ss_pred CCcCHHHHHh
Q 009654 228 KRATASAALA 237 (529)
Q Consensus 228 kR~ta~e~L~ 237 (529)
+|||+.++++
T Consensus 283 ~Rp~~~~i~~ 292 (296)
T cd05095 283 ERPSFQEIHA 292 (296)
T ss_pred cCCCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=269.58 Aligned_cols=206 Identities=19% Similarity=0.257 Sum_probs=165.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--------DIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--------~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+|+.|+||||+++++++... ....++++||+.++.+..++.. ...+++.++..++.||+.||+|||
T Consensus 56 ~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 134 (280)
T cd05043 56 LQESCLLYGLSHQNILPILHVCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134 (280)
T ss_pred HHHHHHHHhCCCCCCCeEEEEEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 5799999999999999999987664 4678999999997666544321 146899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
++||+|+||||+|||++.++.+||+|||+++.+....... .....++..|+|||++.+ ..++.++|||||||++|+++
T Consensus 135 ~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~ 213 (280)
T cd05043 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELM 213 (280)
T ss_pred HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHh
Confidence 9999999999999999999999999999997654322111 122345678999999876 45899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 153 I-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 153 t-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
+ |.+||.+.+..+....+... ... .....+|+++.++|.+||..||++|||
T Consensus 214 ~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 265 (280)
T cd05043 214 TLGQTPYVEIDPFEMAAYLKDG--YRL--------------------------AQPINCPDELFAVMACCWALDPEERPS 265 (280)
T ss_pred cCCCCCcCcCCHHHHHHHHHcC--CCC--------------------------CCCCcCCHHHHHHHHHHcCCChhhCCC
Confidence 8 99999887766654444321 100 001246788999999999999999999
Q ss_pred HHHHHh
Q 009654 232 ASAALA 237 (529)
Q Consensus 232 a~e~L~ 237 (529)
+.++++
T Consensus 266 ~~~~~~ 271 (280)
T cd05043 266 FSQLVQ 271 (280)
T ss_pred HHHHHH
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=264.98 Aligned_cols=201 Identities=24% Similarity=0.382 Sum_probs=163.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|+.++||||+++++++.. ...|+||||+.++.+..++ . ....+++..+..++.||+.||.|||+.|++
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ 122 (254)
T cd05083 46 FLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122 (254)
T ss_pred HHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3579999999999999999999865 3479999999985555433 2 233589999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+|||++.++.+||+|||++...... ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+|
T Consensus 123 H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p 197 (254)
T cd05083 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAP 197 (254)
T ss_pred ccccCcceEEEcCCCcEEECCCccceecccc----CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998754322 122234567999998865 458899999999999999997 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+... ..+ .....++..+.+||.+||+.+|.+||++.+++.
T Consensus 198 ~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 198 YPKMSLKEVKECVEKG--YRM--------------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CccCCHHHHHHHHhCC--CCC--------------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9988776665555331 100 001357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=268.27 Aligned_cols=225 Identities=22% Similarity=0.300 Sum_probs=161.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++++||||+++++++.......+|+||||++++.+..++ .....+++..+..++.||+.||.|||++||+|
T Consensus 52 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H 131 (284)
T cd05081 52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131 (284)
T ss_pred HHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 35799999999999999999987665456799999999986665444 33456899999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCC--ccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+|||++.++.+||+|||++.......... .....++..|+|||++.+ ..++.++|||||||++|+|++|..+
T Consensus 132 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~ 210 (284)
T cd05081 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDK 210 (284)
T ss_pred ccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCc
Confidence 9999999999999999999999998664332111 111223456999999876 4589999999999999999998876
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
+..... .....+........ ..+.-. ........ ......++..+.+||.+||..+|++|||+.++++
T Consensus 211 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 211 SCSPPA-EFMRMMGNDKQGQM-IVYHLI-----ELLKNNGR-----LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CCCcch-hhhhhccccccccc-chHHHH-----HHHhcCCc-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 643321 11111100000000 000000 00000000 0112457889999999999999999999999986
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
.
T Consensus 279 ~ 279 (284)
T cd05081 279 Q 279 (284)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=274.34 Aligned_cols=214 Identities=27% Similarity=0.434 Sum_probs=173.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--GVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~--gIvH 79 (529)
.||..|-+.|+||.||++|++|.-. .+.+|.|+|||+|+.|++++....-++|.+++.|+.||+.||.||... -|+|
T Consensus 515 cREyrIHKeLDHpRIVKlYDyfslD-tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIH 593 (775)
T KOG1151|consen 515 CREYRIHKELDHPRIVKLYDYFSLD-TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIH 593 (775)
T ss_pred HHHHhhhhccCcceeeeeeeeeeec-cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeee
Confidence 4899999999999999999999765 678999999999999999888888999999999999999999999987 4999
Q ss_pred cCCCCCcEEEccC---CcEEEeccccccccCCCCCC-----Ccc-ccccccccCCccccc-C--CCCCCCcchhhhhhHH
Q 009654 80 RDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQ-----PLT-SRVVTLWYRPPELLL-G--ATDYGPSVDLWSVGCV 147 (529)
Q Consensus 80 rDIKp~NILl~~~---g~vKl~DFGla~~~~~~~~~-----~~~-~~~gt~~Y~APE~l~-~--~~~y~~~~DIWSlG~i 147 (529)
-||||.||||.+. |.|||+|||++++....... .++ ...||.||++||.+. + ....+.++||||+|||
T Consensus 594 YDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI 673 (775)
T KOG1151|consen 594 YDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI 673 (775)
T ss_pred eccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence 9999999998543 78999999999887543221 222 457899999999984 3 2346789999999999
Q ss_pred HHHHHhCCCCCCCCCHH-HHH--HHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 148 FAELLIGKPILQGRTEV-EQL--HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 148 l~elltG~~pf~g~~~~-~~~--~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
||.+|.|+.||..+... +++ ..|++.... .| ..-+-++.+++++|++||.+
T Consensus 674 FyQClYGrKPFGhnqsQQdILqeNTIlkAtEV---------------qF-----------P~KPvVsseAkaFIRRCLaY 727 (775)
T KOG1151|consen 674 FYQCLYGRKPFGHNQSQQDILQENTILKATEV---------------QF-----------PPKPVVSSEAKAFIRRCLAY 727 (775)
T ss_pred hhhhhccCCCCCCchhHHHHHhhhchhcceec---------------cC-----------CCCCccCHHHHHHHHHHHHh
Confidence 99999999999644222 221 222221000 00 00135789999999999999
Q ss_pred CCCCCcCHHHHHhccccC
Q 009654 225 EPYKRATASAALASEYFS 242 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~ 242 (529)
--++|+.+.++-.||||.
T Consensus 728 RKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 728 RKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhhhhhhHHHHccCcccc
Confidence 999999999999999996
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=302.92 Aligned_cols=210 Identities=24% Similarity=0.335 Sum_probs=164.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-----------CCCCCHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMNQLLHGL 69 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-----------~~~l~e~~~~~i~~Qll~gL 69 (529)
+.+|+.++++++||||+++++++.+ .+..|+|||||+|+.+..++.. ...++...+..++.||+.||
T Consensus 49 flrEi~ILs~L~HPNIVkl~~v~~d--~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL 126 (932)
T PRK13184 49 FLREAKIAADLIHPGIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126 (932)
T ss_pred HHHHHHHHHhCCCcCcCeEEEEEee--CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHH
Confidence 3579999999999999999999987 5789999999999766544321 13456778899999999999
Q ss_pred HHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCC-----------------CCCccccccccccCCcccccCC
Q 009654 70 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----------------RQPLTSRVVTLWYRPPELLLGA 132 (529)
Q Consensus 70 ~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-----------------~~~~~~~~gt~~Y~APE~l~~~ 132 (529)
+|||++||+||||||+|||++.+|.+||+|||++....... .......+||+.|+|||++.+
T Consensus 127 ~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g- 205 (932)
T PRK13184 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG- 205 (932)
T ss_pred HHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-
Confidence 99999999999999999999999999999999997652110 001123478999999999876
Q ss_pred CCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcH
Q 009654 133 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 212 (529)
Q Consensus 133 ~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~ 212 (529)
..++.++||||+|||+|+|++|.+||.+......... .....|. . ...+..+|+
T Consensus 206 ~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~-~-----------------------~~p~~~iP~ 259 (932)
T PRK13184 206 VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPI-E-----------------------VAPYREIPP 259 (932)
T ss_pred CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChh-h-----------------------ccccccCCH
Confidence 4589999999999999999999999987554332221 1111110 0 011246888
Q ss_pred HHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 213 TAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 213 ~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.+.+++.+||..||++|++..++|...
T Consensus 260 ~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 260 FLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999887777653
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=265.30 Aligned_cols=204 Identities=20% Similarity=0.300 Sum_probs=164.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++++||||+++++++.. ...++||||++++.+. .+......+++..+..++.||+.||+|||++||+||
T Consensus 57 ~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~ 133 (279)
T cd05057 57 LDEAYVMASVDHPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133 (279)
T ss_pred HHHHHHHHhCCCCCcceEEEEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence 579999999999999999999876 5789999999886555 444445579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCC-ccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
||||+|||++.++.+||+|||++.......... .....++..|+|||.+.. ..++.++|+|||||++|+|++ |.+||
T Consensus 134 di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~ 212 (279)
T cd05057 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred ccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999998665332111 112223567999998865 458899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+....+....+.. +... ......+..+.++|.+||..||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 213 EGIPAVEIPDLLEK--GERL--------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCHHHHHHHHhC--CCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 98876665555533 1110 001235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=275.67 Aligned_cols=208 Identities=22% Similarity=0.314 Sum_probs=160.6
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-------------------------------
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP------------------------------- 49 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~------------------------------- 49 (529)
.+|+.+|.++ +||||+++++++... ...+|+|||||+++.+..++..
T Consensus 58 ~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (343)
T cd05103 58 MSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKR 136 (343)
T ss_pred HHHHHHHHhccCCccHhhhcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhh
Confidence 5799999999 789999999988664 4578999999998666543321
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC
Q 009654 50 ------------------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 93 (529)
Q Consensus 50 ------------------------------------~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g 93 (529)
...+++.++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 216 (343)
T cd05103 137 RLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN 216 (343)
T ss_pred hccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC
Confidence 12478888999999999999999999999999999999999999
Q ss_pred cEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 009654 94 VLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 171 (529)
Q Consensus 94 ~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~ 171 (529)
.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+....
T Consensus 217 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 295 (343)
T cd05103 217 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295 (343)
T ss_pred cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH
Confidence 999999999876532211 11122344677999999876 458999999999999999997 999998754333332222
Q ss_pred HHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 172 ~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.....++ ....+++++.++|..||..||.+|||+.++++|
T Consensus 296 ~~~~~~~---------------------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 296 KEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred hccCCCC---------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1110000 001356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=285.46 Aligned_cols=210 Identities=20% Similarity=0.333 Sum_probs=171.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCch-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll-~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|++||.+|++-+|-||+=+.|++... .+.||+-+|+|..| ..+.....+|...+...|++||+.|+.|||.++|||
T Consensus 435 FKnEVa~lkkTRH~NIlLFMG~~~~p---~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIH 511 (678)
T KOG0193|consen 435 FKNEVAVLKKTRHENILLFMGACMNP---PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIH 511 (678)
T ss_pred HHHHHHHHhhcchhhheeeehhhcCC---ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 57899999999999999999999873 45999999999544 466667788999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCC-CCCCCccccccccccCCccccc--CCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~--~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||..||+|.+++.|||+|||++..... .....+....|...|||||++. ....|++.+||||||||+|||++|..
T Consensus 512 rDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l 591 (678)
T KOG0193|consen 512 RDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL 591 (678)
T ss_pred hhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence 99999999999999999999999975432 1123444556788899999985 34579999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.......++-.+-...+. ..+.....+++.++++|+..||.+++++||+..++|
T Consensus 592 Pysi~~~dqIifmVGrG~l~------------------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il 647 (678)
T KOG0193|consen 592 PYSIQNRDQIIFMVGRGYLM------------------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLL 647 (678)
T ss_pred CcCCCChhheEEEecccccC------------------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHH
Confidence 99854443333222111111 122334467889999999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
.
T Consensus 648 ~ 648 (678)
T KOG0193|consen 648 S 648 (678)
T ss_pred H
Confidence 6
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=269.59 Aligned_cols=205 Identities=21% Similarity=0.288 Sum_probs=162.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.++||||+++++++.. ...++|+||++++.+. .+......+++..+..++.||+.||.|||++||+||
T Consensus 57 ~~e~~~~~~l~h~niv~~~~~~~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~ 133 (303)
T cd05110 57 MDEALIMASMDHPHLVRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133 (303)
T ss_pred HHHHHHHHhCCCCCcccEEEEEcC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 579999999999999999999865 3468999999975544 444444578999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999866432211 1223345778999999876 458999999999999999997 89999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+....+....+.. ...++ ....++..+.++|.+||..+|++||++.++++.
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 213 DGIPTREIPDLLEK-GERLP---------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCHHHHHHHHHC-CCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87665443333321 11110 012356789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=262.94 Aligned_cols=205 Identities=23% Similarity=0.405 Sum_probs=167.3
Q ss_pred HHHHHHHHh-CCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Q 009654 2 AREILILRR-LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHS-R 75 (529)
Q Consensus 2 ~rEi~iL~~-L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~-~ 75 (529)
.+|+.++++ ++||||+++++++.+ ...+|+||||++++.+..++ .....+++..++.++.||+.||.|||+ .
T Consensus 56 ~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 133 (269)
T cd08528 56 VSEVTIIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK 133 (269)
T ss_pred HHHHHHHhhcCCCCCeeeEEeeEcc--CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence 468888875 699999999999987 57899999999986554332 345579999999999999999999996 7
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||+|+||+|+|||++.++.+||+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 134 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~ 210 (269)
T cd08528 134 RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQ 210 (269)
T ss_pred ceeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCC
Confidence 89999999999999999999999999997655432 3345678899999999976 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||...........+......+. ....+++.+.+||.+||..||.+||++.++
T Consensus 211 ~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~ 263 (269)
T cd08528 211 PPFYSTNMLSLATKIVEAVYEPL---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQV 263 (269)
T ss_pred CcccccCHHHHHHHHhhccCCcC---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence 99987766665555543211110 012467889999999999999999999998
Q ss_pred Hhc
Q 009654 236 LAS 238 (529)
Q Consensus 236 L~h 238 (529)
..+
T Consensus 264 ~~~ 266 (269)
T cd08528 264 SAM 266 (269)
T ss_pred HHH
Confidence 754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=278.43 Aligned_cols=208 Identities=22% Similarity=0.284 Sum_probs=164.4
Q ss_pred CHHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC------------------------------
Q 009654 1 MAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP------------------------------ 49 (529)
Q Consensus 1 ~~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~------------------------------ 49 (529)
+.+|+.+|.+|. |||||++++++.. .+.+|||||||.++.|..++..
T Consensus 87 ~~~E~~~l~~l~~H~niv~~~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (401)
T cd05107 87 LMSELKIMSHLGPHLNIVNLLGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164 (401)
T ss_pred HHHHHHHHHhcCCCCCeEEEEEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence 357999999997 9999999999987 4689999999998655433211
Q ss_pred --------------------------------------------------------------------CCCCCHHHHHHH
Q 009654 50 --------------------------------------------------------------------DIKFSEAQIKCY 61 (529)
Q Consensus 50 --------------------------------------------------------------------~~~l~e~~~~~i 61 (529)
...|++..+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 244 (401)
T cd05107 165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF 244 (401)
T ss_pred ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence 124678889999
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcch
Q 009654 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 140 (529)
Q Consensus 62 ~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~D 140 (529)
+.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|
T Consensus 245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 323 (401)
T cd05107 245 SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSD 323 (401)
T ss_pred HHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhH
Confidence 99999999999999999999999999999999999999999976543211 11223456788999999976 45899999
Q ss_pred hhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHH
Q 009654 141 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 219 (529)
Q Consensus 141 IWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~ 219 (529)
||||||++|||++ |..||......+.+...... +..+ .....++.++.+||.
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~~--------------------------~~p~~~~~~l~~li~ 376 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYRM--------------------------AKPAHASDEIYEIMQ 376 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCCC--------------------------CCCCCCCHHHHHHHH
Confidence 9999999999998 89999876655544443221 1100 011346889999999
Q ss_pred HhccCCCCCCcCHHHHHhc
Q 009654 220 TLLSVEPYKRATASAALAS 238 (529)
Q Consensus 220 ~mL~~dP~kR~ta~e~L~h 238 (529)
+||..+|.+||++.++|+.
T Consensus 377 ~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 377 KCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=289.18 Aligned_cols=205 Identities=27% Similarity=0.402 Sum_probs=172.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcC---------C----CCCCCHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSC---------P----DIKFSEAQIKCYMNQLL 66 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~---------~----~~~l~e~~~~~i~~Qll 66 (529)
|.||+++|..|+|||||+|+|++.. .+-+|||||||.+|.|.. +.. . ..+|+..+..+++.||+
T Consensus 536 F~REaeLla~l~H~nIVrLlGVC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIA 613 (774)
T KOG1026|consen 536 FRREAELLAELQHPNIVRLLGVCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIA 613 (774)
T ss_pred HHHHHHHHHhccCCCeEEEEEEEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHH
Confidence 6799999999999999999999988 678999999999865553 321 1 22389999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCcc-ccccccccCCcccccCCCCCCCcchhhhhh
Q 009654 67 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVG 145 (529)
Q Consensus 67 ~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG 145 (529)
.|++||-++.+|||||-..|+||.++-.|||+|||+++.+-..+..... ...-...|||||.++- ..|+.++||||+|
T Consensus 614 aGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~G 692 (774)
T KOG1026|consen 614 AGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFG 692 (774)
T ss_pred HHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-Ccccchhhhhhhh
Confidence 9999999999999999999999999999999999999866543322222 2233678999999976 4699999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 146 CVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 146 ~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
|+|||+++ |+.||.|-+..+.++.|.+. .. -+...++|.++.+||..||+.
T Consensus 693 VvLWEIFsyG~QPy~glSn~EVIe~i~~g--~l--------------------------L~~Pe~CP~~vY~LM~~CW~~ 744 (774)
T KOG1026|consen 693 VVLWEIFSYGKQPYYGLSNQEVIECIRAG--QL--------------------------LSCPENCPTEVYSLMLECWNE 744 (774)
T ss_pred hhhhhhhccccCcccccchHHHHHHHHcC--Cc--------------------------ccCCCCCCHHHHHHHHHHhhc
Confidence 99999998 89999999999999998662 11 122257999999999999999
Q ss_pred CCCCCcCHHHHH
Q 009654 225 EPYKRATASAAL 236 (529)
Q Consensus 225 dP~kR~ta~e~L 236 (529)
+|.+||++.||-
T Consensus 745 ~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 745 NPKRRPSFKEIH 756 (774)
T ss_pred CcccCCCHHHHH
Confidence 999999999873
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=262.54 Aligned_cols=212 Identities=23% Similarity=0.357 Sum_probs=162.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+++.++||||+++++++.......+|+||||++++.+..++ .....+++..+..++.||+.||+|||+.||+|
T Consensus 53 ~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H 132 (284)
T cd05038 53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIH 132 (284)
T ss_pred HHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 35899999999999999999998876567899999999886555444 33346999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+. .++.++|||||||++|+|++|..|
T Consensus 133 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p 211 (284)
T cd05038 133 RDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDP 211 (284)
T ss_pred CCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCC
Confidence 999999999999999999999999876532211 11123445679999998763 588999999999999999999988
Q ss_pred CCCCCHHHH-----------HHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCC
Q 009654 158 LQGRTEVEQ-----------LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226 (529)
Q Consensus 158 f~g~~~~~~-----------~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP 226 (529)
|........ ...+...+... .. ......++.++.+||.+||..+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~-----~~~~~~~~~~~~~li~~cl~~~p 267 (284)
T cd05038 212 SQSPPAEFLRMIGIAQGQMIVTRLLELLKEG-------------------ER-----LPRPPSCPDEVYDLMKLCWEAEP 267 (284)
T ss_pred cccccchhccccccccccccHHHHHHHHHcC-------------------Cc-----CCCCccCCHHHHHHHHHHhccCh
Confidence 865322110 11111110000 00 00012467889999999999999
Q ss_pred CCCcCHHHHHh
Q 009654 227 YKRATASAALA 237 (529)
Q Consensus 227 ~kR~ta~e~L~ 237 (529)
.+|||+.++++
T Consensus 268 ~~Rpt~~ei~~ 278 (284)
T cd05038 268 QDRPSFADLIL 278 (284)
T ss_pred hhCCCHHHHHH
Confidence 99999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=281.37 Aligned_cols=206 Identities=23% Similarity=0.345 Sum_probs=172.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~-~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+++|++|+|||||++||+... ..-+|||||+|.||.|..++...+ .++..+...++.+.+.||+|||+++++|
T Consensus 208 ~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IH 285 (474)
T KOG0194|consen 208 FMKEARVMRQLNHPNVVRFYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIH 285 (474)
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcc
Confidence 5789999999999999999999988 457999999999977765554444 5999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||-..|+|+..++.+||+|||+++....-. ...........|+|||.+... .|++++||||+||++||+++ |..||
T Consensus 286 RDIAARNcL~~~~~~vKISDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 286 RDIAARNCLYSKKGVVKISDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred hhHhHHHheecCCCeEEeCccccccCCccee-eccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCC
Confidence 9999999999999999999999987654211 111122346789999999764 79999999999999999999 88999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.|.+..+...+|.......+ .....|..+..++.+|+..||++|+|+.++.+
T Consensus 364 ~g~~~~~v~~kI~~~~~r~~---------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRMP---------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCHHHHHHHHHhcCccCC---------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 99999999888855222111 01256788899999999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=253.60 Aligned_cols=210 Identities=40% Similarity=0.606 Sum_probs=171.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.++++++|+||+++++++.. ....++||||++++.+..++.....+++..+..++.+++.+|.|||+.||+|+
T Consensus 34 ~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~ 111 (244)
T smart00220 34 ILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHR 111 (244)
T ss_pred HHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecC
Confidence 3589999999999999999999887 46899999999996555554444448999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+ ..++.++||||||+++|+|++|.+||..
T Consensus 112 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 112 DLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765432 3345567889999999875 4578899999999999999999999987
Q ss_pred -CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 161 -RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 161 -~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
......+..+......+. .....++..+.+++.+||..+|.+||++.++++||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~ 242 (244)
T smart00220 189 DDQLLELFKKIGKPKPPFP--------------------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHP 242 (244)
T ss_pred CCcHHHHHHHHhccCCCCc--------------------------cccccCCHHHHHHHHHHccCCchhccCHHHHhhCC
Confidence 333333333322111110 00112778899999999999999999999999999
Q ss_pred cc
Q 009654 240 YF 241 (529)
Q Consensus 240 ~f 241 (529)
||
T Consensus 243 ~~ 244 (244)
T smart00220 243 FF 244 (244)
T ss_pred CC
Confidence 97
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.06 Aligned_cols=208 Identities=21% Similarity=0.298 Sum_probs=162.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC----CeEEEEEeccCCCchhhhc-C-----CCCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLLS-C-----PDIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~----~~~~lV~E~~~g~ll~~~~-~-----~~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+|+.++||||+++++++..... ...++++||+.++.+..+. . ....+++..+..++.||+.||+|
T Consensus 49 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 128 (273)
T cd05074 49 LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEY 128 (273)
T ss_pred HHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 479999999999999999998865322 1347899999876554332 1 12357899999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||+.||+||||||+||+++.++.+||+|||++......... ......+++.|++||.+.+ ..++.++|||||||++|+
T Consensus 129 lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~e 207 (273)
T cd05074 129 LSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred HHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHH
Confidence 99999999999999999999999999999998765432211 1122344678999999866 457889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+.+..+....+... ..+. ....++..+.+|+.+||+.+|.+|
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~l~~~~l~~~p~~R 259 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKG-NRLK---------------------------QPPDCLEDVYELMCQCWSPEPKCR 259 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcC-CcCC---------------------------CCCCCCHHHHHHHHHHcCCChhhC
Confidence 999 89999887766655555331 0000 012467889999999999999999
Q ss_pred cCHHHHHhc
Q 009654 230 ATASAALAS 238 (529)
Q Consensus 230 ~ta~e~L~h 238 (529)
||+.+++..
T Consensus 260 ps~~~~~~~ 268 (273)
T cd05074 260 PSFQHLRDQ 268 (273)
T ss_pred cCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.97 Aligned_cols=184 Identities=31% Similarity=0.482 Sum_probs=144.2
Q ss_pred EEEEEeccCCCchhhhcCCCCCC-CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccC--
Q 009654 31 IYLVFEYMEHDITGLLSCPDIKF-SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-- 107 (529)
Q Consensus 31 ~~lV~E~~~g~ll~~~~~~~~~l-~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~-- 107 (529)
+||=||||+..++..++..+..+ ....++.+++||++||.|+|++|||||||||.||+|+.++.|||+|||+|+...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~ 750 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKEN 750 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhh
Confidence 68999999999999888766554 578899999999999999999999999999999999999999999999998711
Q ss_pred ---------------CCCCCCccccccccccCCcccccCCC--CCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Q 009654 108 ---------------TGHRQPLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170 (529)
Q Consensus 108 ---------------~~~~~~~~~~~gt~~Y~APE~l~~~~--~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I 170 (529)
.......|..+||--|+|||++.+.. .|+.++||||||+||+||+. ||. +.+|....+
T Consensus 751 ~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL 825 (1351)
T KOG1035|consen 751 LESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASIL 825 (1351)
T ss_pred hhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC--chHHHHHHH
Confidence 11122567889999999999998766 69999999999999999995 354 344443333
Q ss_pred HHHc-CCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccC
Q 009654 171 FKLC-GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 242 (529)
Q Consensus 171 ~~~~-g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~ 242 (529)
..+- |..|.. ...+..--+.-..+|.+||+.||.+||||.|+|++.||-
T Consensus 826 ~~LR~g~iP~~-----------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 826 TNLRKGSIPEP-----------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HhcccCCCCCC-----------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 3321 222211 001112223457899999999999999999999999984
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.51 Aligned_cols=219 Identities=26% Similarity=0.321 Sum_probs=160.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCC-CCCHHHHHHHHHHHHHHHHHHHHCC--
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDI-KFSEAQIKCYMNQLLHGLEHCHSRG-- 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~-~l~e~~~~~i~~Qll~gL~~LH~~g-- 76 (529)
|.+||.+|.+++|||+|+|+|||.+... ..+||+|||+.|.|...+. ... .++|.....|+.+++.||+|||...
T Consensus 118 F~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~ 196 (361)
T KOG1187|consen 118 FLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP 196 (361)
T ss_pred HHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence 5689999999999999999999998422 5899999999877765543 333 8999999999999999999999865
Q ss_pred -CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCcccc-ccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 77 -VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 77 -IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
|+|||||++|||||.+...||+|||+|+...... ...... .||.+|+|||.+.. ...+.++|||||||+|.||++|
T Consensus 197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~-~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitg 274 (361)
T KOG1187|consen 197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD-TSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITG 274 (361)
T ss_pred CEecCCCCHHHeeECCCCCEEccCccCcccCCccc-cceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhC
Confidence 9999999999999999999999999996543311 112222 89999999999865 4689999999999999999999
Q ss_pred CCCCCCCC---HHHHHHHHHHHcCCCCchhhhccCCCccccCCCC---CCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 155 KPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 155 ~~pf~g~~---~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~---~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
+++.+... +...............-..+ ..+. ..|... ..-..+..+..+|+..+|.+
T Consensus 275 r~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei----------iD~~l~~~~~~~~------~~~~~~~~~a~~C~~~~~~~ 338 (361)
T KOG1187|consen 275 RKAVDQSRPRGELSLVEWAKPLLEEGKLREI----------VDPRLKEGEYPDE------KEVKKLAELALRCLRPDPKE 338 (361)
T ss_pred CcccCCCCCcccccHHHHHHHHHHCcchhhe----------eCCCccCCCCChH------HHHHHHHHHHHHHcCcCCCc
Confidence 98876432 11122211111111100000 1111 111100 01122678899999999999
Q ss_pred CcCHHHHHhc
Q 009654 229 RATASAALAS 238 (529)
Q Consensus 229 R~ta~e~L~h 238 (529)
||++.++++.
T Consensus 339 RP~m~~Vv~~ 348 (361)
T KOG1187|consen 339 RPTMSQVVKE 348 (361)
T ss_pred CcCHHHHHHH
Confidence 9999998643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=284.92 Aligned_cols=210 Identities=22% Similarity=0.333 Sum_probs=147.6
Q ss_pred CCeEEEEEeccCCCchhhhcCCC-C-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 009654 28 SCSIYLVFEYMEHDITGLLSCPD-I-------------------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 87 (529)
Q Consensus 28 ~~~~~lV~E~~~g~ll~~~~~~~-~-------------------~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NI 87 (529)
...+||||||+.++.+..+.... . ...+..+..++.||+.||.|||++||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 56799999999987665443211 1 122445778999999999999999999999999999
Q ss_pred EEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC---------------------CCCCcchhhhhh
Q 009654 88 LVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---------------------DYGPSVDLWSVG 145 (529)
Q Consensus 88 Ll~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---------------------~y~~~~DIWSlG 145 (529)
||+. ++.+||+|||+++.............++|+.|+|||.+.... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 578999999999866543333345668899999999764321 244567999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 146 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 146 ~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
||||||+++.. ........+..++..++... ..|.....+. ..+. .....+.+...+..+.+||.+||++|
T Consensus 367 viL~el~~~~~--~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~~~---~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 367 LIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDL-VAWRKLVEPR---ASPD---LRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHhCcC--CCchHHHHHHHHHHhcCCcH-HHHHHhhccc---cchh---hhhhhhhccccchHHHHHHHHHccCC
Confidence 99999998654 45555666666666555432 2232211100 0000 00011222334556789999999999
Q ss_pred CCCCcCHHHHHhccccCCCCC
Q 009654 226 PYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 226 P~kR~ta~e~L~h~~f~~~~~ 246 (529)
|.+|||+.++|+||||.....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999987544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=266.11 Aligned_cols=239 Identities=26% Similarity=0.473 Sum_probs=184.9
Q ss_pred HHHHHHHHhC---C--C---CCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcCC-CCCCCHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL---D--H---PNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLE 70 (529)
Q Consensus 2 ~rEi~iL~~L---~--H---pnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~~-~~~l~e~~~~~i~~Qll~gL~ 70 (529)
+.||++|+++ + | ..||+|++.|... +..++|||||++...||.++... -..++...++.|++|||.||.
T Consensus 122 lDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLd 201 (590)
T KOG1290|consen 122 LDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLD 201 (590)
T ss_pred HHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHH
Confidence 4699999999 2 3 4699999998753 35789999999999999987643 346999999999999999999
Q ss_pred HHHHC-CCcccCCCCCcEEEc-----------------------------------------------------------
Q 009654 71 HCHSR-GVLHRDIKGSNLLVN----------------------------------------------------------- 90 (529)
Q Consensus 71 ~LH~~-gIvHrDIKp~NILl~----------------------------------------------------------- 90 (529)
|||.. ||+|-||||+|||+.
T Consensus 202 YLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~ 281 (590)
T KOG1290|consen 202 YLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQA 281 (590)
T ss_pred HHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhh
Confidence 99965 999999999999983
Q ss_pred -------------------------------------------------------cC-----------------------
Q 009654 91 -------------------------------------------------------NE----------------------- 92 (529)
Q Consensus 91 -------------------------------------------------------~~----------------------- 92 (529)
..
T Consensus 282 ~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~ 361 (590)
T KOG1290|consen 282 KKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPS 361 (590)
T ss_pred hhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccc
Confidence 00
Q ss_pred -----------------------------CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 93 -----------------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 93 -----------------------------g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
-.|||+|||-|+.... .+|.-..|..|+||||+.|. .|++.+||||
T Consensus 362 ~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGs-gY~~~ADiWS 436 (590)
T KOG1290|consen 362 DGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGS-GYSTSADIWS 436 (590)
T ss_pred cccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecC-CCCCchhHHH
Confidence 0167777777765543 34566779999999999996 4999999999
Q ss_pred hhHHHHHHHhCCCCCCCC------CHHHHHHHHHHHcCCCCch----------hhhcc-CCCccccCCCCCCCcchhhhh
Q 009654 144 VGCVFAELLIGKPILQGR------TEVEQLHKIFKLCGSPPDD----------YWKKS-KLPHATLFKPQQPYDSSLRET 206 (529)
Q Consensus 144 lG~il~elltG~~pf~g~------~~~~~~~~I~~~~g~p~~~----------~~~~~-~l~~~~~~~~~~~~~~~l~~~ 206 (529)
++||++||+||-.+|.-. .+.+.++.|++++|..|.. ||++. .|.+...+++ .++...|.+.
T Consensus 437 ~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~-WpL~~VL~eK 515 (590)
T KOG1290|consen 437 TACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKP-WPLYEVLIEK 515 (590)
T ss_pred HHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCC-CcHHHHHHHH
Confidence 999999999999988632 3678999999999988854 33332 2333333222 2233334443
Q ss_pred ccCCc----HHHHHHHHHhccCCCCCCcCHHHHHhccccCCCCCC
Q 009654 207 FKDLP----TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 247 (529)
Q Consensus 207 ~~~~s----~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~~ 247 (529)
+ .+| .++.+||.-||+++|++|+||.++|+|||+...+.+
T Consensus 516 Y-~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 516 Y-EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred h-CCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 3 233 347899999999999999999999999999976543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=250.20 Aligned_cols=212 Identities=27% Similarity=0.433 Sum_probs=159.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc---CCCeEEEEEeccCCC-chhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR---LSCSIYLVFEYMEHD-ITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~---~~~~~~lV~E~~~g~-ll~~~~---~~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
++||...++++||||++++++.... .....||++.|...+ +++.+. ..+..++|.++..|+.+|++||++||+
T Consensus 66 ~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~ 145 (302)
T KOG2345|consen 66 LREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE 145 (302)
T ss_pred HHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc
Confidence 5899999999999999998875432 245699999999876 444332 244479999999999999999999999
Q ss_pred CC--CcccCCCCCcEEEccCCcEEEeccccccccCC---CCCC-----CccccccccccCCcccccCCC--CCCCcchhh
Q 009654 75 RG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNT---GHRQ-----PLTSRVVTLWYRPPELLLGAT--DYGPSVDLW 142 (529)
Q Consensus 75 ~g--IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~---~~~~-----~~~~~~gt~~Y~APE~l~~~~--~y~~~~DIW 142 (529)
.. ++||||||.|||+..++.++|+|||.++...- +..+ ....-..|..|+|||++.-.. ..++++|||
T Consensus 146 ~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIW 225 (302)
T KOG2345|consen 146 KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIW 225 (302)
T ss_pred cCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchh
Confidence 99 99999999999999999999999999864321 1111 112234588999999985322 358899999
Q ss_pred hhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 143 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 143 SlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
||||+||.|+.|..||+ .+....|+..- ...+++..++. -..+|+.+.+||+.||
T Consensus 226 SLGCtLYa~mf~~sPfe---------~~~~~GgSlaL-----------Av~n~q~s~P~-----~~~yse~l~~lik~ml 280 (302)
T KOG2345|consen 226 SLGCTLYAMMFGESPFE---------RIYQQGGSLAL-----------AVQNAQISIPN-----SSRYSEALHQLIKSML 280 (302)
T ss_pred hhhHHHHHHHHcCCcch---------HHhhcCCeEEE-----------eeeccccccCC-----CCCccHHHHHHHHHHh
Confidence 99999999999999995 23232222110 00011111110 1237889999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
++||.+||++.++|.+
T Consensus 281 qvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 281 QVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCcccCCCHHHHHHH
Confidence 9999999999999864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=259.44 Aligned_cols=207 Identities=18% Similarity=0.173 Sum_probs=154.6
Q ss_pred HHHHhCCCCCccceeeEEEccCCC--eEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 009654 6 LILRRLDHPNIIKLEGLITSRLSC--SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 83 (529)
Q Consensus 6 ~iL~~L~HpnIvkl~~~~~~~~~~--~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIK 83 (529)
..+..++|+||+++++++...... ..|+++|++...+...+. ....+++..+..++.||+.||.|||+.+|+|||||
T Consensus 75 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiK 153 (294)
T PHA02882 75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIK 153 (294)
T ss_pred HHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 445567999999999876553221 347888888765544332 23356889999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEeccccccccCCCCC------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 84 GSNLLVNNEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 84 p~NILl~~~g~vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|+|||++.++.++|+|||+|+.+..... .......||+.|+|||++.+ ..|+.++||||+||++|+|++|.+|
T Consensus 154 p~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 154 PENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred HHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999986643211 11233468999999999876 4589999999999999999999999
Q ss_pred CCCCCHHH-HHHHHHH-HcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVE-QLHKIFK-LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~-~~~~I~~-~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+..... .+..... ....... + ...+...++.+.+++..||..+|++||+..++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~--------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l 289 (294)
T PHA02882 233 WKGFGHNGNLIHAAKCDFIKRLHE---------------G--------KIKIKNANKFIYDFIECVTKLSYEEKPDYDAL 289 (294)
T ss_pred CCccccchHHHHHhHHHHHHHhhh---------------h--------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHH
Confidence 98774322 2221111 0000000 0 01124568889999999999999999999998
Q ss_pred Hh
Q 009654 236 LA 237 (529)
Q Consensus 236 L~ 237 (529)
++
T Consensus 290 ~~ 291 (294)
T PHA02882 290 IK 291 (294)
T ss_pred HH
Confidence 75
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=290.60 Aligned_cols=206 Identities=24% Similarity=0.393 Sum_probs=173.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCP------DIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~------~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
|.+|..+|+.++|||||+++|++.+ ....+||+|||+| +|+.++... ...++..+...++.||+.|+.||+
T Consensus 742 Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe 819 (1025)
T KOG1095|consen 742 FLKEALLMSKFDHPNIVSLIGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE 819 (1025)
T ss_pred HHHHHHHHhcCCCcceeeEEEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH
Confidence 5789999999999999999999998 5678999999998 566666554 556999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCcccc-ccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
++++|||||-..|+||+....+||+|||+|+.+........... .-...|||||.+.. ..++.++|||||||+|||++
T Consensus 820 ~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 820 SKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred hCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHH
Confidence 99999999999999999999999999999995443322112222 22467999999986 57999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 153 I-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 153 t-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
+ |..||.+.+..+.+.-..+.. ..+ ....+|+.+.+||..||..+|++||+
T Consensus 899 slG~~PY~~~~n~~v~~~~~~gg-RL~---------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~ 950 (1025)
T KOG1095|consen 899 SLGATPYPSRSNFEVLLDVLEGG-RLD---------------------------PPSYCPEKLYQLMLQCWKHDPEDRPS 950 (1025)
T ss_pred hCCCCCCCCcchHHHHHHHHhCC-ccC---------------------------CCCCCChHHHHHHHHHccCChhhCcc
Confidence 8 899999999888887665532 211 11368999999999999999999999
Q ss_pred HHHHHh
Q 009654 232 ASAALA 237 (529)
Q Consensus 232 a~e~L~ 237 (529)
...+++
T Consensus 951 F~~i~~ 956 (1025)
T KOG1095|consen 951 FRTIVE 956 (1025)
T ss_pred HHHHHh
Confidence 999997
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.02 Aligned_cols=157 Identities=32% Similarity=0.482 Sum_probs=136.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~---~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
-+||+||++|+|||||+++++-++.. .....+|||||.||.+..+... ...|+|.++..++..+..||.|||+
T Consensus 59 ~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE 138 (732)
T KOG4250|consen 59 CREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE 138 (732)
T ss_pred HHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999876654 4566899999999877755532 3469999999999999999999999
Q ss_pred CCCcccCCCCCcEEEcc--CC--cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 75 RGVLHRDIKGSNLLVNN--EG--VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~--~g--~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
+||+||||||+||++.. +| ..||+|||.|+....+ ..+++.+||+.|++||++.....|+..+|+||+||++|+
T Consensus 139 n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ 216 (732)
T KOG4250|consen 139 NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYE 216 (732)
T ss_pred cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHH
Confidence 99999999999999843 34 4899999999987665 478899999999999999865689999999999999999
Q ss_pred HHhCCCCCCC
Q 009654 151 LLIGKPILQG 160 (529)
Q Consensus 151 lltG~~pf~g 160 (529)
+.||..||.-
T Consensus 217 caTG~lPF~p 226 (732)
T KOG4250|consen 217 CATGELPFIP 226 (732)
T ss_pred HhccCCCCCc
Confidence 9999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=260.80 Aligned_cols=238 Identities=31% Similarity=0.498 Sum_probs=179.1
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+++|..+ .+.||+++.+++-. ++.+.+||||+++.....+.. .++..+++.|++.++.||.++|.+||||
T Consensus 81 i~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvH 155 (418)
T KOG1167|consen 81 ILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVH 155 (418)
T ss_pred HHHHHHHHHHhccchhhhcchhhhcc--CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccc
Confidence 35799999999 79999999998866 689999999999976665543 5678999999999999999999999999
Q ss_pred cCCCCCcEEEccC-CcEEEeccccccccCC--------C----C-------------------------------CCCcc
Q 009654 80 RDIKGSNLLVNNE-GVLKLADFGLANFSNT--------G----H-------------------------------RQPLT 115 (529)
Q Consensus 80 rDIKp~NILl~~~-g~vKl~DFGla~~~~~--------~----~-------------------------------~~~~~ 115 (529)
|||||+|+|++.. +.-.|+|||+|..... . + ...-.
T Consensus 156 RDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~a 235 (418)
T KOG1167|consen 156 RDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERA 235 (418)
T ss_pred cCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceec
Confidence 9999999999875 6789999999861100 0 0 00112
Q ss_pred ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCC--------ch--hhhc
Q 009654 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPP--------DD--YWKK 184 (529)
Q Consensus 116 ~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf-~g~~~~~~~~~I~~~~g~p~--------~~--~~~~ 184 (529)
.+.||++|+|||+|+....-++++||||+|||+..+++++.|| ...++.+.+..|....|.-. .. .|.+
T Consensus 236 nrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k 315 (418)
T KOG1167|consen 236 NRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK 315 (418)
T ss_pred ccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc
Confidence 3578999999999999888899999999999999999998665 55666666666666555422 22 4553
Q ss_pred cCCCcc------------ccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 185 SKLPHA------------TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 185 ~~l~~~------------~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
+..+-. ....+...+..........++..+.||+.+||..||.+|+||+++|+||||..
T Consensus 316 sn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 316 SNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 332110 11111111001112222345678999999999999999999999999999983
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=281.74 Aligned_cols=210 Identities=28% Similarity=0.432 Sum_probs=161.5
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCH-HHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSE-AQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e-~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.|||..|+.- +|||||++|+.-.+ ....||..|+|...|-+++... +..+.. ......+.|++.||+|||+.+|
T Consensus 550 ~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~i 627 (903)
T KOG1027|consen 550 QREIQLLQESDEHPNVIRYYCSEQD--RQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKI 627 (903)
T ss_pred HHHHHHHHhccCCCceEEEEeeccC--CceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhccc
Confidence 4899999999 69999999776555 6899999999999876666542 111111 4568899999999999999999
Q ss_pred cccCCCCCcEEEcc---CC--cEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 78 LHRDIKGSNLLVNN---EG--VLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 78 vHrDIKp~NILl~~---~g--~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
|||||||.||||.. ++ .++|.|||+++....+.. .......||-+|+|||+|.... -..++||||+|||+|+
T Consensus 628 VHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyY 706 (903)
T KOG1027|consen 628 VHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYY 706 (903)
T ss_pred ccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEE
Confidence 99999999999976 34 589999999998765432 2244567899999999998754 4669999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 lltG-~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
.++| ..||...- +.-.+|.. |... +...-+....++.|||.+||++||..|
T Consensus 707 vltgG~HpFGd~~--~R~~NIl~--~~~~------------------------L~~L~~~~d~eA~dLI~~ml~~dP~~R 758 (903)
T KOG1027|consen 707 VLTGGSHPFGDSL--ERQANILT--GNYT------------------------LVHLEPLPDCEAKDLISRMLNPDPQLR 758 (903)
T ss_pred EecCCccCCCchH--Hhhhhhhc--Cccc------------------------eeeeccCchHHHHHHHHHhcCCCcccC
Confidence 9996 78996432 33344433 2111 011111112279999999999999999
Q ss_pred cCHHHHHhccccC
Q 009654 230 ATASAALASEYFS 242 (529)
Q Consensus 230 ~ta~e~L~h~~f~ 242 (529)
|+|.++|.||+|=
T Consensus 759 Psa~~VL~HPlFW 771 (903)
T KOG1027|consen 759 PSATDVLNHPLFW 771 (903)
T ss_pred CCHHHHhCCCccC
Confidence 9999999999994
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=299.79 Aligned_cols=205 Identities=18% Similarity=0.224 Sum_probs=150.3
Q ss_pred HHhCCC-CCccceeeEEEcc-----CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 8 LRRLDH-PNIIKLEGLITSR-----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 8 L~~L~H-pnIvkl~~~~~~~-----~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
++.++| +||++++++|... ....++++|||++++|...+......+++.+++.+++||+.||.|||++||+|||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 456778 7999999987221 1246788999998887777655556799999999999999999999999999999
Q ss_pred CCCCcEEEccC-------------------CcEEEeccccccccCCCC---------------CCCccccccccccCCcc
Q 009654 82 IKGSNLLVNNE-------------------GVLKLADFGLANFSNTGH---------------RQPLTSRVVTLWYRPPE 127 (529)
Q Consensus 82 IKp~NILl~~~-------------------g~vKl~DFGla~~~~~~~---------------~~~~~~~~gt~~Y~APE 127 (529)
|||+||||+.. +.+||+|||+++...... .......++|++|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999654 445666666654321100 00011246899999999
Q ss_pred cccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc
Q 009654 128 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 128 ~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 207 (529)
++.+. .|+.++||||||||||||++|.+|+.... ..+..+.... .++ . +
T Consensus 186 ~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~--------------------------~ 234 (793)
T PLN00181 186 EDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q--------------------------I 234 (793)
T ss_pred hhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h--------------------------h
Confidence 99874 58999999999999999999999876422 1222221110 010 0 0
Q ss_pred cCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 208 KDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 208 ~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
....+.+.+++.+||..||.+|||+.++|+||||..
T Consensus 235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 011344678999999999999999999999999975
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=267.32 Aligned_cols=204 Identities=24% Similarity=0.348 Sum_probs=170.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|+.|..||+.++|||||+|+|++.+ .-.|||||+++-|.++ ++......|+......|+.||+.+|.|||+...||
T Consensus 438 flqEa~iMrnfdHphIikLIGv~~e---~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVH 514 (974)
T KOG4257|consen 438 FLQEASIMRNFDHPHIIKLIGVCVE---QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVH 514 (974)
T ss_pred HHHHHHHHHhCCCcchhheeeeeec---cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhh
Confidence 5789999999999999999999987 3689999999976665 55556668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||-..|||+.....+||+|||+++.......-..+...-...|||||.+.- +.++.++|||.|||++||+|. |..||
T Consensus 515 RDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf 593 (974)
T KOG4257|consen 515 RDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF 593 (974)
T ss_pred hhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc
Confidence 9999999999999999999999999887654332333334678999999854 568999999999999999886 89999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
.|-...+.+-.|.+.-.. ...+.+|+.+..|+.+||.+||.+||+..++.
T Consensus 594 qgvkNsDVI~~iEnGeRl----------------------------P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 594 QGVKNSDVIGHIENGERL----------------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ccccccceEEEecCCCCC----------------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 987766665555331111 12257999999999999999999999987653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=275.29 Aligned_cols=207 Identities=25% Similarity=0.411 Sum_probs=185.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|+.|+.||-+++|||||+|.|+.+. ..-+.||+|||+.+.|+ .+...++.|+.-++.-+++.|+.|+.||-+.|+||
T Consensus 677 FL~EAsIMGQFdHPNIIrLEGVVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVH 754 (996)
T KOG0196|consen 677 FLSEASIMGQFDHPNIIRLEGVVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVH 754 (996)
T ss_pred hhhhhhhcccCCCCcEEEEEEEEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchh
Confidence 6789999999999999999999987 56799999999998887 55567789999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCcccccc--ccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||-..|||++.+-.+||+|||++++..++....+++..| ...|.|||.+.. +.++.++||||+|+++||.++ |..
T Consensus 755 RDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGER 833 (996)
T KOG0196|consen 755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGER 833 (996)
T ss_pred hhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCC
Confidence 9999999999999999999999999887665444555544 678999999976 569999999999999999886 899
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||...+..+.++.|.+....|++ -++|..+..||..||+.|-..||+..+++
T Consensus 834 PYWdmSNQdVIkaIe~gyRLPpP----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV 885 (996)
T KOG0196|consen 834 PYWDMSNQDVIKAIEQGYRLPPP----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIV 885 (996)
T ss_pred cccccchHHHHHHHHhccCCCCC----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHH
Confidence 99999999999999887766653 37899999999999999999999999998
Q ss_pred hc
Q 009654 237 AS 238 (529)
Q Consensus 237 ~h 238 (529)
.+
T Consensus 886 ~~ 887 (996)
T KOG0196|consen 886 ST 887 (996)
T ss_pred HH
Confidence 64
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=273.24 Aligned_cols=216 Identities=25% Similarity=0.399 Sum_probs=176.5
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.-|++||+.+ +|||++.+|++|.-.. .+.+|||||||.||...++.. .+.++.|+.+++|++.+|.||.|||.+
T Consensus 63 E~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n 142 (953)
T KOG0587|consen 63 ELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN 142 (953)
T ss_pred HHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc
Confidence 3578899988 8999999999986432 568999999999987765542 256799999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC----CCCCcchhhhhhHHHHHH
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~y~~~~DIWSlG~il~el 151 (529)
.++|||||..|||++.+|.|||+|||++....... ..-.+.+|||+|||||++.... .|+..+|+||||++..||
T Consensus 143 kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEl 221 (953)
T KOG0587|consen 143 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEM 221 (953)
T ss_pred ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehh
Confidence 99999999999999999999999999997665432 3345678999999999996543 477899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 152 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 152 ltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
--|.||+-+.-..-.+-.| .-.||+. ...+...+..+.++|..||..|-.+||+
T Consensus 222 adG~PPl~DmHPmraLF~I---pRNPPPk-----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 222 AEGAPPLCDMHPMRALFLI---PRNPPPK-----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred cCCCCCccCcchhhhhccC---CCCCCcc-----------------------ccchhhHHHHHHHHHHHHHhhccccCcc
Confidence 9999999765554433333 2233321 1123456788999999999999999999
Q ss_pred HHHHHhccccCCC
Q 009654 232 ASAALASEYFSTK 244 (529)
Q Consensus 232 a~e~L~h~~f~~~ 244 (529)
..++|+|||++..
T Consensus 276 ~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 276 TEELLKHPFITEQ 288 (953)
T ss_pred hhhhccCCccccc
Confidence 9999999999843
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=244.04 Aligned_cols=212 Identities=23% Similarity=0.399 Sum_probs=171.7
Q ss_pred HHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 4 EILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 4 Ei~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
|-.+..+- +||.+|-|+.+|+. ...+|+|.||+.|+.+-....+..+|+|+.++.|...|+.||.|||++||++|||
T Consensus 300 ek~vfe~asn~pflvglhscfqt--esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdl 377 (593)
T KOG0695|consen 300 EKHVFEQASNNPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDL 377 (593)
T ss_pred hHHHHHhccCCCeEEehhhhhcc--cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeec
Confidence 44555555 79999999999988 5689999999999777666677779999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC--
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-- 160 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g-- 160 (529)
|.+|+||+..|.+||+|+|+++.--.. .....+.||||.|+|||+|.+ ..|+.++|.|+|||+++||+.|+.||+-
T Consensus 378 kldnvlldaeghikltdygmcke~l~~-gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 378 KLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred cccceEEccCCceeecccchhhcCCCC-CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 999999999999999999999754322 233456799999999999988 5699999999999999999999999961
Q ss_pred ------CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc----
Q 009654 161 ------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---- 230 (529)
Q Consensus 161 ------~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~---- 230 (529)
+++.-+++-|.+..-. ....++-.+..+|+..|+.||.+|.
T Consensus 456 m~n~d~ntedylfqvilekqir-----------------------------iprslsvkas~vlkgflnkdp~erlgc~~ 506 (593)
T KOG0695|consen 456 MDNPDMNTEDYLFQVILEKQIR-----------------------------IPRSLSVKASHVLKGFLNKDPKERLGCRP 506 (593)
T ss_pred CCCcccchhHHHHHHHhhhccc-----------------------------ccceeehhhHHHHHHhhcCCcHHhcCCCc
Confidence 1222233333221100 1134566688899999999999996
Q ss_pred --CHHHHHhccccCCCCCCC
Q 009654 231 --TASAALASEYFSTKPYAC 248 (529)
Q Consensus 231 --ta~e~L~h~~f~~~~~~~ 248 (529)
...++-.|+||....|..
T Consensus 507 ~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 507 QTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred ccchhhhhcchhhhhCCHHH
Confidence 378999999999876643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=247.92 Aligned_cols=214 Identities=22% Similarity=0.320 Sum_probs=170.0
Q ss_pred HHHHHHH-hCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh----hcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Q 009654 3 REILILR-RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL----LSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RG 76 (529)
Q Consensus 3 rEi~iL~-~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~----~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~g 76 (529)
.|..... .=+.||||++||.... .+..||.||+|+-.+-.+ +...+..++|..+.++....+.||.||-. ..
T Consensus 111 ~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk 188 (361)
T KOG1006|consen 111 MEHDTVMKSSNCPNIVKFYGALFS--EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK 188 (361)
T ss_pred HHHHHHHhhcCCcHHHHHhhhhhc--CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh
Confidence 4554433 3379999999999877 456799999999743222 23456689999999999999999999995 48
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC-CCCCcchhhhhhHHHHHHHhCC
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~y~~~~DIWSlG~il~elltG~ 155 (529)
|+|||+||+||||+..|.+||||||++-..... ...+.-+|...|||||.+.... .|+.++|+||||++|||+.||.
T Consensus 189 iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 189 IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN 266 (361)
T ss_pred hhhccCChhheEEecCCCEeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence 999999999999999999999999998655433 2345568899999999996544 4999999999999999999999
Q ss_pred CCCCCC-CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 156 PILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 156 ~pf~g~-~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.|+.+= +..+|+..+.. |.||.-... ...-.++..++.+|..||..|-.+||...+
T Consensus 267 fPyr~w~svfeql~~Vv~--gdpp~l~~~---------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 267 FPYRKWDSVFEQLCQVVI--GDPPILLFD---------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred CCcchHHHHHHHHHHHHc--CCCCeecCc---------------------ccccccCHHHHHHHHHHhhcccccCcchhh
Confidence 999863 44566666644 666532111 111257888999999999999999999999
Q ss_pred HHhccccCC
Q 009654 235 ALASEYFST 243 (529)
Q Consensus 235 ~L~h~~f~~ 243 (529)
++++||+..
T Consensus 324 Lk~~~fyr~ 332 (361)
T KOG1006|consen 324 LKKFPFYRM 332 (361)
T ss_pred hhcCchhhh
Confidence 999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=262.91 Aligned_cols=225 Identities=25% Similarity=0.325 Sum_probs=155.4
Q ss_pred HHHHHHHhCCCCCc-----cceeeEEEcc------CCCeEEEEEeccCCCchhhhcCC----------------------
Q 009654 3 REILILRRLDHPNI-----IKLEGLITSR------LSCSIYLVFEYMEHDITGLLSCP---------------------- 49 (529)
Q Consensus 3 rEi~iL~~L~HpnI-----vkl~~~~~~~------~~~~~~lV~E~~~g~ll~~~~~~---------------------- 49 (529)
.|+.++.++.|.++ ++++++|... .....||||||++++.+..++..
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 47788888876654 6677776532 13468999999998666544321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcc
Q 009654 50 --DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 127 (529)
Q Consensus 50 --~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE 127 (529)
...+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++...............+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 123467789999999999999999999999999999999999999999999999765433221122234489999999
Q ss_pred cccCCCC-------------------CC--CcchhhhhhHHHHHHHhCCC-CCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 009654 128 LLLGATD-------------------YG--PSVDLWSVGCVFAELLIGKP-ILQGRTEVEQLHKIFKLCGSPPDDYWKKS 185 (529)
Q Consensus 128 ~l~~~~~-------------------y~--~~~DIWSlG~il~elltG~~-pf~g~~~~~~~~~I~~~~g~p~~~~~~~~ 185 (529)
++..... |+ ..+||||+|||||+|++|.. ||.+...... ..+.+. .....|...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~-~~~~~~r~~ 456 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYD-NDLNRWRMY 456 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhcc-chHHHHHhh
Confidence 9864221 22 24799999999999999874 6654321111 001000 001112211
Q ss_pred CCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCC---CCCcCHHHHHhccccCC
Q 009654 186 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP---YKRATASAALASEYFST 243 (529)
Q Consensus 186 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP---~kR~ta~e~L~h~~f~~ 243 (529)
.. ..+. ...+..+++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 457 ~~---------~~~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 457 KG---------QKYD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cc---------cCCC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0111 12345688999999999999876 68999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=254.62 Aligned_cols=205 Identities=19% Similarity=0.332 Sum_probs=168.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|+.|+.||+.+.|||+|+|+++|+. ..-+|||+|||.. +||+++...+ .-++.-....++.||.+|++||..+++|
T Consensus 310 FLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFI 387 (1157)
T KOG4278|consen 310 FLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFI 387 (1157)
T ss_pred HHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhh
Confidence 5789999999999999999999988 5679999999975 6777766443 3467777888999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||-..|+|+.++..|||+|||++++...+...........+.|.|||-|.- +.++.++|||+|||+|||+.| |..|
T Consensus 388 HRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsP 466 (1157)
T KOG4278|consen 388 HRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSP 466 (1157)
T ss_pred hhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999999887653333333344788999999854 458899999999999999987 8899
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
|+|.+-...+..+.+. .. -+....+|+.+.+||..||+++|.+||+..++-
T Consensus 467 YPGidlSqVY~LLEkg--yR--------------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 467 YPGIDLSQVYGLLEKG--YR--------------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCccHHHHHHHHhcc--cc--------------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 9998766555444331 10 112247999999999999999999999998874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=253.55 Aligned_cols=213 Identities=21% Similarity=0.284 Sum_probs=168.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~--~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+||++|.+|+|||||.|+++|.. .+.+++|+|||+.+.+..++... ..+.-+....++.||++|++||.+.++|
T Consensus 582 F~kEIkiLsqLkhPNIveLvGVC~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfV 659 (807)
T KOG1094|consen 582 FLKEIKILSRLKHPNIVELLGVCVQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFV 659 (807)
T ss_pred HHHHHHHHhccCCCCeeEEEeeeec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchh
Confidence 5689999999999999999999987 56899999999986665443322 2235556677999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCcc-ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH--hCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL--IGK 155 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell--tG~ 155 (529)
||||.+.|+|++.++++||+|||+++-.-.+...... ..+-.+.|||||.++. ..++.++|+|++|+++||++ |..
T Consensus 660 Hrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e 738 (807)
T KOG1094|consen 660 HRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCRE 738 (807)
T ss_pred hccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhh
Confidence 9999999999999999999999999855544332222 2344788999999875 36999999999999999975 578
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.||...++.+...+........+... .-....-+|..+.+||-+||..|-++|||.+++
T Consensus 739 ~Py~~lt~e~vven~~~~~~~~~~~~---------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 739 QPYSQLTDEQVVENAGEFFRDQGRQV---------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred CchhhhhHHHHHHhhhhhcCCCCcce---------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 99988888777766644433222110 011224578899999999999999999999998
Q ss_pred Hh
Q 009654 236 LA 237 (529)
Q Consensus 236 L~ 237 (529)
..
T Consensus 798 h~ 799 (807)
T KOG1094|consen 798 HL 799 (807)
T ss_pred HH
Confidence 54
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=255.99 Aligned_cols=207 Identities=21% Similarity=0.282 Sum_probs=173.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|++|+.+|.+|+|||+|+|||+..+ .-+.||||+++++.|...+ . ....|-......|+.||+.|+.||.+++.|
T Consensus 158 flrEas~M~~L~H~hliRLyGvVl~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlv 234 (1039)
T KOG0199|consen 158 FLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLV 234 (1039)
T ss_pred HHHHHHHHHhccCcceeEEeeeecc---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 6899999999999999999999987 3578999999986554433 3 455688999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCC-Cc-cccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK 155 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~-~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~ 155 (529)
||||-..||||.....|||||||+.+..+.+... .+ ..+.....|+|||.|.. ..++.++|+|++||+||||++ |.
T Consensus 235 HRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGE 313 (1039)
T KOG0199|consen 235 HRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGE 313 (1039)
T ss_pred hhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCC
Confidence 9999999999999999999999999877654321 11 12344677999999976 569999999999999999998 78
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.||.|.....++++|-+.-- -...+.+|+++.+++..||..+|.+|||...+
T Consensus 314 ePW~G~~g~qIL~~iD~~er----------------------------LpRPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 314 EPWVGCRGIQILKNIDAGER----------------------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCCCCCCHHHHHHhcccccc----------------------------CCCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 99999999999998853111 12235789999999999999999999999888
Q ss_pred Hhcc
Q 009654 236 LASE 239 (529)
Q Consensus 236 L~h~ 239 (529)
.+.-
T Consensus 366 r~~~ 369 (1039)
T KOG0199|consen 366 REDL 369 (1039)
T ss_pred HHhH
Confidence 6443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=277.26 Aligned_cols=212 Identities=22% Similarity=0.317 Sum_probs=153.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH---SRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH---~~gIv 78 (529)
..|+.+|++++|||||++++++.+ ....|+|||||+++.+..++. .+++.++..++.||+.||+||| +.+|+
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 805 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVV 805 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 357999999999999999999987 467899999999877776653 4889999999999999999999 66999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+||+++.++..++. ||....... .....+|+.|+|||++.+ ..|+.++||||+||++|||++|+.||
T Consensus 806 H~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~ 878 (968)
T PLN00113 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPA 878 (968)
T ss_pred cCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCC
Confidence 99999999999998887775 665443221 123467899999999876 46999999999999999999999998
Q ss_pred CCCCHH-HHHHHHHHHcC-CCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 159 QGRTEV-EQLHKIFKLCG-SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 159 ~g~~~~-~~~~~I~~~~g-~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
...... ..+......+. ......|....+ .+..... .....++.+|+.+||+.||++|||+.+++
T Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~-------~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSI------RGDVSVN-------QNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred CcccCCCCcHHHHHHHhcCccchhheeCccc------cCCCCcc-------HHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 543211 11111111110 000011100000 0000000 11233578999999999999999999998
Q ss_pred hc
Q 009654 237 AS 238 (529)
Q Consensus 237 ~h 238 (529)
+.
T Consensus 946 ~~ 947 (968)
T PLN00113 946 KT 947 (968)
T ss_pred HH
Confidence 64
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=217.99 Aligned_cols=165 Identities=22% Similarity=0.300 Sum_probs=125.9
Q ss_pred CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccc
Q 009654 41 DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120 (529)
Q Consensus 41 ~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt 120 (529)
++...+......|++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~ 67 (176)
T smart00750 2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVD 67 (176)
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCc
Confidence 333444444557999999999999999999999998 999999999999999 9998766442 22689
Q ss_pred cccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC
Q 009654 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 199 (529)
Q Consensus 121 ~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~-~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~ 199 (529)
+.|+|||++.+ ..|+.++||||+|||+|+|++|.+||...... ..+..+........ . .
T Consensus 68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~----------------~ 127 (176)
T smart00750 68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---P----------------R 127 (176)
T ss_pred ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---c----------------c
Confidence 99999999977 46899999999999999999999999765443 23333332111100 0 0
Q ss_pred cchhhhhccCCcH--HHHHHHHHhccCCCCCCcCHHHHHhccccC
Q 009654 200 DSSLRETFKDLPT--TAVNLIETLLSVEPYKRATASAALASEYFS 242 (529)
Q Consensus 200 ~~~l~~~~~~~s~--~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~ 242 (529)
. ......++. .++++|.+||..||.+|||+.++++|+|+.
T Consensus 128 ~---~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 D---RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred c---cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0 000112333 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=254.00 Aligned_cols=206 Identities=26% Similarity=0.414 Sum_probs=164.8
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCC---------------CCCCHHHHHHHHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPD---------------IKFSEAQIKCYMN 63 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~---------------~~l~e~~~~~i~~ 63 (529)
+..|+++|+.+ .||||+.+.++++. .+.+++|+|||..+.+. ++.... ..++..+...++.
T Consensus 348 ~~~El~~m~~~g~H~niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~ 425 (609)
T KOG0200|consen 348 LMSELNVLKELGKHPNIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAY 425 (609)
T ss_pred HHHHHHHHHHhcCCcchhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHH
Confidence 36899999999 69999999999988 67899999999975444 443332 2389999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccc--cccccCCcccccCCCCCCCcchh
Q 009654 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV--VTLWYRPPELLLGATDYGPSVDL 141 (529)
Q Consensus 64 Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~--gt~~Y~APE~l~~~~~y~~~~DI 141 (529)
||+.|++||++..++||||-..||||..+..+||+|||+|+.............. -...|||||.+.. ..|+.++||
T Consensus 426 QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDV 504 (609)
T KOG0200|consen 426 QIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDV 504 (609)
T ss_pred HHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Ccccccchh
Confidence 9999999999999999999999999999999999999999865443222112122 2345999999987 679999999
Q ss_pred hhhhHHHHHHHh-CCCCCCCCC-HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHH
Q 009654 142 WSVGCVFAELLI-GKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 219 (529)
Q Consensus 142 WSlG~il~ellt-G~~pf~g~~-~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~ 219 (529)
||+|++||||++ |..||++-. ..+.+..+.. |.-. +....++.++.++|.
T Consensus 505 WSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~--G~r~--------------------------~~P~~c~~eiY~iM~ 556 (609)
T KOG0200|consen 505 WSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE--GNRM--------------------------EQPEHCSDEIYDLMK 556 (609)
T ss_pred hHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc--CCCC--------------------------CCCCCCCHHHHHHHH
Confidence 999999999998 889999854 4444444433 2110 111356889999999
Q ss_pred HhccCCCCCCcCHHHHHh
Q 009654 220 TLLSVEPYKRATASAALA 237 (529)
Q Consensus 220 ~mL~~dP~kR~ta~e~L~ 237 (529)
.||+.+|++||+..++.+
T Consensus 557 ~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 557 SCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhCCCcccCCCHHHHHH
Confidence 999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=217.17 Aligned_cols=167 Identities=25% Similarity=0.395 Sum_probs=141.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG---LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-G 76 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~---~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~-g 76 (529)
++|+.+..+. ++|.+|.+||.+.+ ...++|.||.|...+-. ..+..++.++|..+-+++..++.||.|||++ .
T Consensus 92 L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~ 169 (282)
T KOG0984|consen 92 LMDLDIIMRTVDCPFTVHFYGALFR--EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS 169 (282)
T ss_pred HHhhhhhccCCCCCeEEEeehhhhc--cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh
Confidence 4677766666 89999999998877 46899999999975433 3456778899999999999999999999977 8
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC---CCCCCCcchhhhhhHHHHHHHh
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~y~~~~DIWSlG~il~ellt 153 (529)
|+|||+||+||||+.+|.+||||||++-.....- ..+...|.-.|+|||.+.. ...|+.++||||||+.+.||.+
T Consensus 170 vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 170 VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred hhhccCCcceEEEccCCcEEEcccccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 9999999999999999999999999997765432 3344578889999999853 2369999999999999999999
Q ss_pred CCCCCC-CCCHHHHHHHHHH
Q 009654 154 GKPILQ-GRTEVEQLHKIFK 172 (529)
Q Consensus 154 G~~pf~-g~~~~~~~~~I~~ 172 (529)
++.||+ ..++.+++.++.+
T Consensus 248 lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 248 LRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ccccccccCCHHHHHHHHhc
Confidence 999996 5789999998866
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=245.48 Aligned_cols=152 Identities=31% Similarity=0.501 Sum_probs=137.0
Q ss_pred HHHHHHHhCC---CCCccceeeEEEccCCCeEEEEEeccCCC-chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 3 REILILRRLD---HPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 3 rEi~iL~~L~---HpnIvkl~~~~~~~~~~~~~lV~E~~~g~-ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
-||.||..|+ |+||+|++++|++ .+++||+||-...+ .|..++.....++|.+++.|++|+..|+++||++|||
T Consensus 615 ~EIqIla~l~~~sH~NIlKlLdfFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~iv 692 (772)
T KOG1152|consen 615 SEIQILATLNKHSHENILKLLDFFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIV 692 (772)
T ss_pred hhHHHHHHhhhcCccchhhhhheeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCce
Confidence 5999999996 9999999999999 68999999987642 2334455667899999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||||-+|+.++.+|.+||+|||.+.+...+ ++...+||..|.|||+|.|..+.+..-|||+||++||.++....||
T Consensus 693 hrdikdenvivd~~g~~klidfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 693 HRDIKDENVIVDSNGFVKLIDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ecccccccEEEecCCeEEEeeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9999999999999999999999999887765 6677899999999999998777799999999999999999988887
Q ss_pred C
Q 009654 159 Q 159 (529)
Q Consensus 159 ~ 159 (529)
.
T Consensus 770 y 770 (772)
T KOG1152|consen 770 Y 770 (772)
T ss_pred c
Confidence 5
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=248.18 Aligned_cols=215 Identities=29% Similarity=0.381 Sum_probs=178.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+||-+++.++|||||.+++.|.. ...++|+||||.|+.+..+..-.++++|-++....+..+.||+|||++|-+|||
T Consensus 60 qqei~~~~dc~h~nivay~gsylr--~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRd 137 (829)
T KOG0576|consen 60 QQEIGMLRDCRHPNIVAYFGSYLR--RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRD 137 (829)
T ss_pred ccceeeeecCCCcChHHHHhhhhh--hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCccccc
Confidence 579999999999999999999988 467999999999999998888888999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc--CCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||..|||+++.|.+|++|||.+..+...- ....+..||++|||||+-. ....|+..+|||++|+...|+---+||..
T Consensus 138 iKGanilltd~gDvklaDfgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 138 IKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred ccccceeecccCceeecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 99999999999999999999987665432 2335678999999999963 33469999999999999999988888876
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
..-....+...-+-...||. .+.-...++.+-+|++.+|..+|++|||+..+|.||
T Consensus 217 dlhpmr~l~LmTkS~~qpp~------------------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 217 DLHPMRALFLMTKSGFQPPT------------------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred ccchHHHHHHhhccCCCCCc------------------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 65555544444332222210 011123456688999999999999999999999999
Q ss_pred ccCC
Q 009654 240 YFST 243 (529)
Q Consensus 240 ~f~~ 243 (529)
|...
T Consensus 273 fvs~ 276 (829)
T KOG0576|consen 273 FVSQ 276 (829)
T ss_pred eecc
Confidence 9975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-27 Score=260.22 Aligned_cols=220 Identities=28% Similarity=0.398 Sum_probs=171.4
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
.|+-+-..|.||||+....++.+. ..++-+||||++++...+. ..+.++..++.++++||+.||.|||+.||.||||
T Consensus 370 sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~~mE~~~~Dlf~~~~-~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 370 SEFCIGSSLSHPNIIETLDIVQEI--DGILQSMEYCPYDLFSLVM-SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hheeecccccCCchhhhHHHHhhc--ccchhhhhcccHHHHHHHh-cccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 466667788999999888877663 3445559999995555544 4468999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|++|+++...|.+||+|||.+..+..+.. ......+|+..|+|||++.+...-...+||||+|+|++.|++|+.||.
T Consensus 447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 99999999999999999999987754432 345577899999999999886645668999999999999999999997
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
-....+... ....+. .+..........+..+|...+.+|.+||++||.+|+|+++||+.+
T Consensus 527 ~a~~~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 527 VAKKSDNSF--KTNNYS------------------DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred cccccccch--hhhccc------------------cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 543322211 000000 000111122445567899999999999999999999999999999
Q ss_pred ccCCCC
Q 009654 240 YFSTKP 245 (529)
Q Consensus 240 ~f~~~~ 245 (529)
||+...
T Consensus 587 W~~~i~ 592 (601)
T KOG0590|consen 587 WIRSIE 592 (601)
T ss_pred Hhhhcc
Confidence 998643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=205.92 Aligned_cols=176 Identities=40% Similarity=0.626 Sum_probs=149.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+++.+.|++|+++++++.. ....++||||+.+..+..+.... ..+++..+..++.+++.+|.+||+.|++|
T Consensus 38 ~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H 115 (215)
T cd00180 38 LLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIH 115 (215)
T ss_pred HHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3589999999999999999999987 47899999999975555444332 47899999999999999999999999999
Q ss_pred cCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 80 RDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+.....++.+.|+|++|+++++|
T Consensus 116 ~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------- 187 (215)
T cd00180 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------- 187 (215)
T ss_pred cCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------
Confidence 999999999999 89999999999986654321 133456788899999987643688999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
..+.++|.+||+.||.+||++.+++++
T Consensus 188 -----------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 125689999999999999999999987
Q ss_pred c
Q 009654 239 E 239 (529)
Q Consensus 239 ~ 239 (529)
+
T Consensus 215 ~ 215 (215)
T cd00180 215 L 215 (215)
T ss_pred C
Confidence 4
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=203.41 Aligned_cols=169 Identities=38% Similarity=0.583 Sum_probs=140.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~-l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+..++.++|+||+++++++.. ....|+|+||++++.+..++..... +++..+..++.|++.+|.+||+.+++|+
T Consensus 45 ~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~ 122 (225)
T smart00221 45 LREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHR 122 (225)
T ss_pred HHHHHHHHhCCCCChhhheeeeec--CCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 579999999999999999999877 4689999999999555544433334 8999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||+|.||+++.++.++|+|||++...............++..|++||.+.+...++.++|+|+|||++++|++|++||.+
T Consensus 123 di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 123 DLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999999999876543211234456788999999984445678899999999999999999999987
Q ss_pred -CCHH-HHHHHHHH
Q 009654 161 -RTEV-EQLHKIFK 172 (529)
Q Consensus 161 -~~~~-~~~~~I~~ 172 (529)
.... +....|..
T Consensus 203 ~~~~~~~~~~~~~~ 216 (225)
T smart00221 203 EGEFTSLLSDVWSF 216 (225)
T ss_pred cchhHHHHHHHHhc
Confidence 3444 55566544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=218.75 Aligned_cols=221 Identities=24% Similarity=0.302 Sum_probs=151.0
Q ss_pred HHHHHHhCCCCCccceeeEEEccC--CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC------
Q 009654 4 EILILRRLDHPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR------ 75 (529)
Q Consensus 4 Ei~iL~~L~HpnIvkl~~~~~~~~--~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~------ 75 (529)
+|.-+-.|.|+||+++++.-.... ...++||+||.+.+.|..++... .+++.....++..|+.||+|||+.
T Consensus 254 ~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~ 332 (534)
T KOG3653|consen 254 NIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDH 332 (534)
T ss_pred HHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCC
Confidence 344444559999999987643211 23799999999987777665433 789999999999999999999964
Q ss_pred ---CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCC-----CcchhhhhhH
Q 009654 76 ---GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYG-----PSVDLWSVGC 146 (529)
Q Consensus 76 ---gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~-----~~~DIWSlG~ 146 (529)
.|+|||||..||||.+++++-|+|||+|..+.++... .....+||..|||||+|.++.+.. ..+||||+|.
T Consensus 333 ~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL 412 (534)
T KOG3653|consen 333 HKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL 412 (534)
T ss_pred CCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence 4999999999999999999999999999887755332 334579999999999999876665 3689999999
Q ss_pred HHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCCc--hhhhccCCCccccCCCCCCCcchhhhhcc--CCcHHHHHHHHHh
Q 009654 147 VFAELLIGKPILQ-GRTEVEQLHKIFKLCGSPPD--DYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETL 221 (529)
Q Consensus 147 il~elltG~~pf~-g~~~~~~~~~I~~~~g~p~~--~~~~~~~l~~~~~~~~~~~~~~~l~~~~~--~~s~~~~dLi~~m 221 (529)
|||||++.-..++ +..+ +-.--....+|.-|. +.|.- ...+...|+ +...|. .-...+++.|+-|
T Consensus 413 VLWEi~SRC~~~~~~~vp-~Yqlpfe~evG~hPt~e~mq~~------VV~kK~RP~---~p~~W~~h~~~~~l~et~EeC 482 (534)
T KOG3653|consen 413 VLWEIASRCTDADPGPVP-EYQLPFEAEVGNHPTLEEMQEL------VVRKKQRPK---IPDAWRKHAGMAVLCETIEEC 482 (534)
T ss_pred HHHHHHhhcccccCCCCC-cccCchhHHhcCCCCHHHHHHH------HHhhccCCC---ChhhhhcCccHHHHHHHHHHH
Confidence 9999998644332 1110 000000001121110 00000 000001111 111121 2234578999999
Q ss_pred ccCCCCCCcCHHHH
Q 009654 222 LSVEPYKRATASAA 235 (529)
Q Consensus 222 L~~dP~kR~ta~e~ 235 (529)
|.-||+.|+||.=+
T Consensus 483 WDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 483 WDHDAEARLTAGCV 496 (534)
T ss_pred cCCchhhhhhhHHH
Confidence 99999999998644
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=227.83 Aligned_cols=205 Identities=20% Similarity=0.288 Sum_probs=168.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCC-chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~-ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|+.|+.+|.+|+|||+++|++++... .+.||++||++| |++++.....++-......|..||+.|+.|||.+++||
T Consensus 745 ~LdeAl~masldHpnl~RLLgvc~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVH 821 (1177)
T KOG1025|consen 745 LLDEALRMASLDHPNLLRLLGVCMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVH 821 (1177)
T ss_pred HHHHHHHHhcCCCchHHHHhhhcccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhh
Confidence 46899999999999999999999873 488999999985 55566667778999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCcc-ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||-..|+|+.....+||.|||+++........... .....+.|||-|.+.. ..|+.++||||+||.+||++| |..|
T Consensus 822 rdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~P 900 (1177)
T KOG1025|consen 822 RDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKP 900 (1177)
T ss_pred hhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCc
Confidence 999999999999999999999999987765433222 2233677899998865 579999999999999999998 8899
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
+.|....++-..+.+. .. | ...+.++-++.-+|.+||..|+..||++.++..
T Consensus 901 y~gi~~~eI~dlle~g-eR----------L-----------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 901 YDGIPAEEIPDLLEKG-ER----------L-----------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred cCCCCHHHhhHHHhcc-cc----------C-----------------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 9988766554433221 00 0 112457888999999999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=202.34 Aligned_cols=189 Identities=27% Similarity=0.358 Sum_probs=142.0
Q ss_pred CCCCccceeeE-EEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 009654 12 DHPNIIKLEGL-ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 90 (529)
Q Consensus 12 ~HpnIvkl~~~-~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~ 90 (529)
.|.|||.-|++ |+. .+.+++++||++.+.|...... ..+-|.-.+.++.||++||.|+|+.++||||||.+||||-
T Consensus 79 ~H~hIi~tY~vaFqt--~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif 155 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQT--SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIF 155 (378)
T ss_pred cchhhhHHHHHHhhc--CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEe
Confidence 58999998876 444 5688899999997655544333 3678899999999999999999999999999999999985
Q ss_pred cC--CcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHH
Q 009654 91 NE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 164 (529)
Q Consensus 91 ~~--g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~ 164 (529)
.. ..|||||||+.+..+.. ..-.-.+..|.+||++.. .....+..|+|.||+|+|.+|+|.+||+.....
T Consensus 156 ~~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~ 231 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM 231 (378)
T ss_pred cCCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence 43 47999999998765432 122233677999998743 223578899999999999999999999854322
Q ss_pred HH-HHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 165 EQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 165 ~~-~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+. +....+ |.+.+ ...+-..|..+++.+..+.++-|..+|++|
T Consensus 232 d~~Y~~~~~---------w~~rk-------------~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 232 DKPYWEWEQ---------WLKRK-------------NPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred CchHHHHHH---------Hhccc-------------CccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 21 111111 22211 123345667899999999999999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-23 Score=207.55 Aligned_cols=211 Identities=24% Similarity=0.305 Sum_probs=151.6
Q ss_pred HHHHHHHHh--CCCCCccceeeEEEccC--CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Q 009654 2 AREILILRR--LDHPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-- 75 (529)
Q Consensus 2 ~rEi~iL~~--L~HpnIvkl~~~~~~~~--~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~-- 75 (529)
.||.+|.+. |+|+||+.+++.--... -..+|||++|.+.|.|.+++.. ..++.+....++..+++||+|||..
T Consensus 251 frEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~ 329 (513)
T KOG2052|consen 251 FRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIV 329 (513)
T ss_pred hhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHh
Confidence 466666655 59999999987532211 2458999999999888877765 4899999999999999999999953
Q ss_pred ------CCcccCCCCCcEEEccCCcEEEeccccccccCCCC---CCCccccccccccCCcccccCCCCC-----CCcchh
Q 009654 76 ------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDY-----GPSVDL 141 (529)
Q Consensus 76 ------gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~y-----~~~~DI 141 (529)
.|.|||||..|||+..+|.+-|+|+|||....... ..+.+.++||-.|||||+|...-+. -..+||
T Consensus 330 GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADI 409 (513)
T KOG2052|consen 330 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADI 409 (513)
T ss_pred cCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHH
Confidence 39999999999999999999999999997655432 2355788999999999999653221 125899
Q ss_pred hhhhHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc
Q 009654 142 WSVGCVFAELLIG----------KPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 142 WSlG~il~elltG----------~~pf~g~~----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 207 (529)
||||.|+||+... ++||.+-. ..+.+.+++- ...+.|.. ...|
T Consensus 410 YafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVC-----------------v~~~RP~i------pnrW 466 (513)
T KOG2052|consen 410 YAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVC-----------------VQKLRPNI------PNRW 466 (513)
T ss_pred HHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhccee-----------------ecccCCCC------Cccc
Confidence 9999999999752 46775432 2223322211 11111111 1112
Q ss_pred cCCc--HHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 208 KDLP--TTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 208 ~~~s--~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
...+ ..+-.||+.||..||.-|.||--+-
T Consensus 467 ~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 467 KSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred ccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 2222 2356799999999999999986653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=193.55 Aligned_cols=222 Identities=34% Similarity=0.498 Sum_probs=172.7
Q ss_pred CHHHHHHHHhCCCC-CccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 1 MAREILILRRLDHP-NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 1 ~~rEi~iL~~L~Hp-nIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~---~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
+.+|+.++..+.|+ +|+++++.+.. ....+++++|+.++.+..+..... .+++..+..++.|++.++.|+|+.|
T Consensus 44 ~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~ 121 (384)
T COG0515 44 FLREIQILASLNHPPNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121 (384)
T ss_pred HHHHHHHHHHccCCcceeeEEEEEec--CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 36899999999888 79999999966 455899999999977665544443 7999999999999999999999999
Q ss_pred CcccCCCCCcEEEccCC-cEEEeccccccccCCCCCC-----CccccccccccCCcccccCC--CCCCCcchhhhhhHHH
Q 009654 77 VLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ-----PLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVF 148 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g-~vKl~DFGla~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il 148 (529)
++||||||+||+++..+ .++++|||++......... .....++|.+|++||.+.+. ..+....|+||+|+++
T Consensus 122 ~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 99999999999999988 7999999999755443221 34677899999999999874 4689999999999999
Q ss_pred HHHHhCCCCCCCCCH---HHHHHHHHHHcCCC-CchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 149 AELLIGKPILQGRTE---VEQLHKIFKLCGSP-PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 149 ~elltG~~pf~g~~~---~~~~~~I~~~~g~p-~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
+++++|..||..... .............+ ... ..... .. ......+.+++.+++..
T Consensus 202 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~--~~---~~~~~~~~~~~~~~~~~ 261 (384)
T COG0515 202 YELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS---------------PLSPS--NP---ELISKAASDLLKKLLAK 261 (384)
T ss_pred HHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc---------------ccCcc--cc---chhhHHHHHHHHHHHhc
Confidence 999999999887764 33333333322222 000 00000 00 12335788999999999
Q ss_pred CCCCCcCHHHHHhccccCCC
Q 009654 225 EPYKRATASAALASEYFSTK 244 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~ 244 (529)
+|..|.+..+...++|....
T Consensus 262 ~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 262 DPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CchhcCCHHHHhhchHhhCc
Confidence 99999999999998776543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=196.69 Aligned_cols=207 Identities=22% Similarity=0.349 Sum_probs=167.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhc-C----C--CCCCCHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLS-C----P--DIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~-~----~--~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
|+.|-.+|..+.|||++.+.++.... ....++++.++.-+.+. .+. + + ...++-.+...++.||..|++||
T Consensus 334 ~L~es~lly~~sH~nll~V~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl 412 (563)
T KOG1024|consen 334 LLQESMLLYGASHPNLLSVLGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL 412 (563)
T ss_pred HHHHHHHHhcCcCCCccceeEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence 35788888889999999999987654 56788899998864444 333 1 1 12377788999999999999999
Q ss_pred HHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCcccc-ccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 73 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 73 H~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
|++||+|.||-..|++|++.-.+||+|=.+++..-+.....+... --...||+||.+.. ..|+.++|+|||||+||||
T Consensus 413 h~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWEL 491 (563)
T KOG1024|consen 413 HNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWEL 491 (563)
T ss_pred HhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHH
Confidence 999999999999999999999999999999987766544433322 22567999999987 5699999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 lt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++ |+.|+...++.|..+.+.+... -.+| -++|+++..+|.-||..+|++||
T Consensus 492 mtlg~~PyaeIDPfEm~~ylkdGyR-------------------laQP---------~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 492 MTLGKLPYAEIDPFEMEHYLKDGYR-------------------LAQP---------FNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred HhcCCCCccccCHHHHHHHHhccce-------------------ecCC---------CCCcHHHHHHHHHHHhcCcccCC
Confidence 98 8999998888888887766211 0111 36999999999999999999999
Q ss_pred CHHHHHh
Q 009654 231 TASAALA 237 (529)
Q Consensus 231 ta~e~L~ 237 (529)
+.+++..
T Consensus 544 sf~Qlv~ 550 (563)
T KOG1024|consen 544 SFSQLVI 550 (563)
T ss_pred CHHHHHH
Confidence 9999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-22 Score=208.45 Aligned_cols=202 Identities=27% Similarity=0.441 Sum_probs=173.7
Q ss_pred HHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.|-.++..++ ||.+|+++..|+. ...+|++++|..|+.+.........|++...+.+...++.+++++|+.||+|||
T Consensus 45 ~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd 122 (612)
T KOG0603|consen 45 QERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRD 122 (612)
T ss_pred cHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhc
Confidence 4667788886 9999999999988 568999999999977776666777899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
+|++||+++.+|.+++.|||+++..-.... .|||..|||||++.+ ...++|.||+|+++++|++|..||.+
T Consensus 123 ~k~enilld~~Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~- 193 (612)
T KOG0603|consen 123 YKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG- 193 (612)
T ss_pred ccccceeecccCccccCCchhhhHhHhhhh-----cccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch-
Confidence 999999999999999999999987654321 299999999999973 78999999999999999999999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L 236 (529)
+..+.|.+.+-..| ..++..+.+++..|+..+|.+|.- +.+++
T Consensus 194 ---~~~~~Il~~~~~~p-----------------------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 194 ---DTMKRILKAELEMP-----------------------------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred ---HHHHHHhhhccCCc-----------------------------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 77777877332222 246778999999999999999975 57999
Q ss_pred hccccCCCCCC
Q 009654 237 ASEYFSTKPYA 247 (529)
Q Consensus 237 ~h~~f~~~~~~ 247 (529)
+|+||....|-
T Consensus 242 ~h~f~~~i~~~ 252 (612)
T KOG0603|consen 242 QHEFFQSIDWN 252 (612)
T ss_pred ccchheeeeHh
Confidence 99999876553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=185.18 Aligned_cols=198 Identities=24% Similarity=0.368 Sum_probs=143.8
Q ss_pred CCCCccceeeEEEccC-------------------------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHH
Q 009654 12 DHPNIIKLEGLITSRL-------------------------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLL 66 (529)
Q Consensus 12 ~HpnIvkl~~~~~~~~-------------------------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll 66 (529)
.|||||++.+.|.+.- +.++|+||....+.+.+++... ..+.....-++.|+|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHH
Confidence 7999999999886531 3578999999999887776543 456777888999999
Q ss_pred HHHHHHHHCCCcccCCCCCcEEEc--cCC--cEEEeccccccccCC-CCC----CCccccccccccCCcccccCCCCC--
Q 009654 67 HGLEHCHSRGVLHRDIKGSNLLVN--NEG--VLKLADFGLANFSNT-GHR----QPLTSRVVTLWYRPPELLLGATDY-- 135 (529)
Q Consensus 67 ~gL~~LH~~gIvHrDIKp~NILl~--~~g--~vKl~DFGla~~~~~-~~~----~~~~~~~gt~~Y~APE~l~~~~~y-- 135 (529)
+|+.|||.+||.|||+|.+||||. +++ .+.|+|||.|--... +-. .......|.-..||||+.......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999984 444 378999998743221 111 112344567889999998543211
Q ss_pred ---CCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcH
Q 009654 136 ---GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 212 (529)
Q Consensus 136 ---~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~ 212 (529)
-.++|.|++|.+.||++....||.+..+.-.-..- |.++.+| .....+|+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----------Yqe~qLP----------------alp~~vpp 484 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----------YQESQLP----------------ALPSRVPP 484 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----------hhhhhCC----------------CCcccCCh
Confidence 13689999999999999999999875433211111 1111221 12246889
Q ss_pred HHHHHHHHhccCCCCCCcCH---HHHHhc
Q 009654 213 TAVNLIETLLSVEPYKRATA---SAALAS 238 (529)
Q Consensus 213 ~~~dLi~~mL~~dP~kR~ta---~e~L~h 238 (529)
.+++|+-.+|+.||++|+++ +.+|+-
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 99999999999999999984 455553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-20 Score=203.05 Aligned_cols=156 Identities=31% Similarity=0.464 Sum_probs=131.4
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC--------------CccccccccccCCccccc
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--------------PLTSRVVTLWYRPPELLL 130 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--------------~~~~~~gt~~Y~APE~l~ 130 (529)
++.+++|||+-||+|||+||+|+||..-|.+|++|||+.+........ .-...||||.|+|||+++
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 478999999999999999999999999999999999998654321110 113458999999999997
Q ss_pred CCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCC
Q 009654 131 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210 (529)
Q Consensus 131 ~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 210 (529)
. ..|+..+|+|++|+|+|+.+.|..||.|++..+++..++......++.. ..+
T Consensus 232 r-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d--------------------------ea~ 284 (1205)
T KOG0606|consen 232 R-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED--------------------------EAL 284 (1205)
T ss_pred h-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC--------------------------cCC
Confidence 6 5699999999999999999999999999999999988877555444332 357
Q ss_pred cHHHHHHHHHhccCCCCCCc---CHHHHHhccccCCCCCC
Q 009654 211 PTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKPYA 247 (529)
Q Consensus 211 s~~~~dLi~~mL~~dP~kR~---ta~e~L~h~~f~~~~~~ 247 (529)
++++++||..||..+|..|. .+-++-+|+||+...|.
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 89999999999999999995 57788899999887775
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-20 Score=204.18 Aligned_cols=204 Identities=29% Similarity=0.439 Sum_probs=147.5
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
+|++ ...++|||++.+.-+... ....|||-+|+.++|.+.+.- ...+..-+.+-|+.|||.||..||..||+|+||
T Consensus 71 ~~ik-~~l~~~pn~lPfqk~~~t--~kAAylvRqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDI 146 (1431)
T KOG1240|consen 71 EEIK-FALMKAPNCLPFQKVLVT--DKAAYLVRQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDI 146 (1431)
T ss_pred HHHH-HHhhcCCcccchHHHHHh--hHHHHHHHHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 4556 556699999998776554 467899999999998877653 336788899999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccC--CCCCCCcccccc----ccccCCcccccCCC----------CCCCcchhhhhhH
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSN--TGHRQPLTSRVV----TLWYRPPELLLGAT----------DYGPSVDLWSVGC 146 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~--~~~~~~~~~~~g----t~~Y~APE~l~~~~----------~y~~~~DIWSlG~ 146 (529)
|.+||||..=.-+.|+||-.-+..- .++...++...- -.+|+|||.+.... ..+++.||||+||
T Consensus 147 KsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GC 226 (1431)
T KOG1240|consen 147 KSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGC 226 (1431)
T ss_pred ccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhH
Confidence 9999999988889999997654321 222122222222 35799999985421 1567899999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 147 VFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 147 il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
+++||++ |+|||. ..|+-.... |.- .....+-+.+. +..++.||..|++.|
T Consensus 227 ViaELf~Eg~PlF~----LSQL~aYr~--~~~--------------------~~~e~~Le~Ie--d~~~Rnlil~Mi~rd 278 (1431)
T KOG1240|consen 227 VIAELFLEGRPLFT----LSQLLAYRS--GNA--------------------DDPEQLLEKIE--DVSLRNLILSMIQRD 278 (1431)
T ss_pred HHHHHHhcCCCccc----HHHHHhHhc--cCc--------------------cCHHHHHHhCc--CccHHHHHHHHHccC
Confidence 9999988 799995 112211111 100 00111111111 336899999999999
Q ss_pred CCCCcCHHHHHhc
Q 009654 226 PYKRATASAALAS 238 (529)
Q Consensus 226 P~kR~ta~e~L~h 238 (529)
|.+|.+|++.|+-
T Consensus 279 Ps~RlSAedyL~~ 291 (1431)
T KOG1240|consen 279 PSKRLSAEDYLQK 291 (1431)
T ss_pred chhccCHHHHHHh
Confidence 9999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=180.26 Aligned_cols=117 Identities=23% Similarity=0.259 Sum_probs=92.6
Q ss_pred CHHHHHHHHhCCCCCccc-eeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvk-l~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|+||+. +++. ...|||||||+|+.+.... . .. ...++.|++.+|.|||++||+|
T Consensus 68 ~~~E~~iL~~L~h~~iv~~l~~~------~~~~LVmE~~~G~~L~~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiH 134 (365)
T PRK09188 68 AAREIRALKTVRGIGVVPQLLAT------GKDGLVRGWTEGVPLHLAR-P---HG---DPAWFRSAHRALRDLHRAGITH 134 (365)
T ss_pred HHHHHHHHHhccCCCCCcEEEEc------CCcEEEEEccCCCCHHHhC-c---cc---hHHHHHHHHHHHHHHHHCCCee
Confidence 468999999999999995 4331 3479999999997765331 1 11 2568899999999999999999
Q ss_pred cCC-CCCcEEEccCCcEEEeccccccccCCCCC-------CCccccccccccCCccccc
Q 009654 80 RDI-KGSNLLVNNEGVLKLADFGLANFSNTGHR-------QPLTSRVVTLWYRPPELLL 130 (529)
Q Consensus 80 rDI-Kp~NILl~~~g~vKl~DFGla~~~~~~~~-------~~~~~~~gt~~Y~APE~l~ 130 (529)
||| ||+|||++.++.+||+|||+|+.+..... ...+...+++.|+|||.+.
T Consensus 135 rDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 135 NDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999 99999999899999999999987654321 1124557788999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=165.47 Aligned_cols=149 Identities=21% Similarity=0.157 Sum_probs=112.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+++|++| +|++|++++++ ...|++|||+.|..+..... .. ...++.|++.+|.+||++||+||
T Consensus 49 ~rE~~iL~~L~~~~~vP~ll~~------~~~~lvmeyI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHr 115 (218)
T PRK12274 49 RREALALRQLDGLPRTPRLLHW------DGRHLDRSYLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHN 115 (218)
T ss_pred HHHHHHHHhcCCCCCCCEEEEE------cCEEEEEeeecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccC
Confidence 5899999999 56889999885 23699999999976643221 11 24578899999999999999999
Q ss_pred CC-CCCcEEEccCCcEEEeccccccccCCCCCC----C--------ccccccccccCCcccccCCCCCC-CcchhhhhhH
Q 009654 81 DI-KGSNLLVNNEGVLKLADFGLANFSNTGHRQ----P--------LTSRVVTLWYRPPELLLGATDYG-PSVDLWSVGC 146 (529)
Q Consensus 81 DI-Kp~NILl~~~g~vKl~DFGla~~~~~~~~~----~--------~~~~~gt~~Y~APE~l~~~~~y~-~~~DIWSlG~ 146 (529)
|| ||+|||++.+|.++|+|||+|......... . ..-...++.|+.|+.-.-....+ ...+.++.|+
T Consensus 116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK 195 (218)
T ss_pred CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence 99 799999999999999999999865542210 0 01123478888887653322233 5668888999
Q ss_pred HHHHHHhCCCCCCCCCH
Q 009654 147 VFAELLIGKPILQGRTE 163 (529)
Q Consensus 147 il~elltG~~pf~g~~~ 163 (529)
-+|.++|+..++.++++
T Consensus 196 ~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 196 PVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHhccCCccccCC
Confidence 99999999988876543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-17 Score=170.79 Aligned_cols=211 Identities=24% Similarity=0.231 Sum_probs=156.6
Q ss_pred CHHHHHHHHhCCC----CCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 1 MAREILILRRLDH----PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 1 ~~rEi~iL~~L~H----pnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
+..|+.+|..+.. +++..+++... ......||||+.+..+|..+.. .....|+...+..++.|++.+|+++|+.
T Consensus 63 l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~ 141 (322)
T KOG1164|consen 63 LKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK 141 (322)
T ss_pred chhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc
Confidence 3569999999963 68889988874 1256889999999988877663 3357899999999999999999999999
Q ss_pred CCcccCCCCCcEEEccC-----CcEEEecccccc--ccCCCCC----CC---ccccccccccCCcccccCCCCCCCcchh
Q 009654 76 GVLHRDIKGSNLLVNNE-----GVLKLADFGLAN--FSNTGHR----QP---LTSRVVTLWYRPPELLLGATDYGPSVDL 141 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~-----g~vKl~DFGla~--~~~~~~~----~~---~~~~~gt~~Y~APE~l~~~~~y~~~~DI 141 (529)
|++||||||+|+++... ..+.|+|||+++ .+..... .+ .....||..|.++.+..+ ...+...|+
T Consensus 142 G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDl 220 (322)
T KOG1164|consen 142 GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDL 220 (322)
T ss_pred CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhh
Confidence 99999999999999765 359999999998 3221111 11 123459999999999887 458999999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 142 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 142 WSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
||++.++.+|+.|..||.+........++......... .......+.++..++.-+
T Consensus 221 es~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~ 276 (322)
T KOG1164|consen 221 ESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLT------------------------DRFGDLKPEEFAKILEYI 276 (322)
T ss_pred hhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcc------------------------ccccCCChHHHHHHHHHh
Confidence 99999999999999999776644333333322111000 001233556677777777
Q ss_pred ccCCCCCCcCHHHHHh
Q 009654 222 LSVEPYKRATASAALA 237 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~ 237 (529)
-..+...+|....+..
T Consensus 277 ~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 277 DSLDYEDKPDYEKLAE 292 (322)
T ss_pred hccCCcCCCCHHHHHH
Confidence 7788888887766654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-19 Score=185.34 Aligned_cols=175 Identities=28% Similarity=0.475 Sum_probs=133.7
Q ss_pred eEEEEEeccCCCchhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEecccccccc
Q 009654 30 SIYLVFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 30 ~~~lV~E~~~g~ll~~~~~~~---~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
++||.|++|.-+.+.+++... ...+....+.++.|+..|++| +|.+|||+||.||++..++.+||+|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 589999999998777776432 346677889999999999999 99999999999999999999999999998765
Q ss_pred CCCC-----CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCC
Q 009654 107 NTGH-----RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL---HKIFKLCGSPP 178 (529)
Q Consensus 107 ~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~---~~I~~~~g~p~ 178 (529)
.... ....+..+||.+||+||.+.+ ..|+.++||||||+||+||+.- | .+..+.. ..|.. |..|
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f--~T~~er~~t~~d~r~--g~ip 478 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---F--STQFERIATLTDIRD--GIIP 478 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---h--ccHHHHHHhhhhhhc--CCCC
Confidence 4433 235677899999999999987 5699999999999999999972 1 1222222 22211 3333
Q ss_pred chhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 179 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+.+|. +. +.-.+||.+||...|.+||++.+.--|.|.
T Consensus 479 ~~~~~-------------------------d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQ-------------------------DY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhh-------------------------cC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 33321 22 235689999999999999987777666653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-17 Score=172.80 Aligned_cols=205 Identities=28% Similarity=0.391 Sum_probs=155.2
Q ss_pred HHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-cccCCCCC
Q 009654 8 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV-LHRDIKGS 85 (529)
Q Consensus 8 L~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI-vHrDIKp~ 85 (529)
|+.|.|.|+.++++.+.+ ...+++|.+||..+.+.+++ .....++.--...+++.|+.||.|+|.--| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 567899999999999998 47899999999987666554 457789999999999999999999998876 99999999
Q ss_pred cEEEccCCcEEEeccccccccCCC-CCCCccccccccccCCcccccCCCC------CCCcchhhhhhHHHHHHHhCCCCC
Q 009654 86 NLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 86 NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~------y~~~~DIWSlG~il~elltG~~pf 158 (529)
|++++..-.+||+|||+..+.... .........-..-|.|||++.+... .+.+.||||+|+|++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998766321 1111122223456899999976321 356799999999999999999999
Q ss_pred CCCC----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 159 QGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 159 ~g~~----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.... ..+.+..+.+ .+..+ + .+.+... ..+++++..++..||..+|.+||++.+
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~~--------------~------rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSNP--------------F------RPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCCC--------------c------Ccchhhh-hhcchHHHHHHHHhcccChhhCccHHH
Confidence 7532 2344444444 11111 1 1111111 156668999999999999999999988
Q ss_pred HH
Q 009654 235 AL 236 (529)
Q Consensus 235 ~L 236 (529)
+-
T Consensus 217 i~ 218 (484)
T KOG1023|consen 217 IR 218 (484)
T ss_pred HH
Confidence 74
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-18 Score=171.40 Aligned_cols=162 Identities=24% Similarity=0.382 Sum_probs=105.0
Q ss_pred EEEEEeccCCCchhhhc---C-CCCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 31 IYLVFEYMEHDITGLLS---C-PDIK--FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 31 ~~lV~E~~~g~ll~~~~---~-~~~~--l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.+++|.-+.+++...+. . .... +.......+..|++..+++||..||+|+||+|+|+|++.+|.++|+||+...
T Consensus 114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~ 193 (288)
T PF14531_consen 114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV 193 (288)
T ss_dssp EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence 47888888887655432 1 1111 2222334555899999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccccccCCcccccCC-------CCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 009654 105 FSNTGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177 (529)
Q Consensus 105 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p 177 (529)
..+.. ......+..|.+||+.... ..|+.+.|.|+||+++|.|+||..||...+.....
T Consensus 194 r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~---------- 259 (288)
T PF14531_consen 194 RAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP---------- 259 (288)
T ss_dssp ETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS----------
T ss_pred ecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc----------
Confidence 55432 1223446789999987432 24788999999999999999999999754321100
Q ss_pred CchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 178 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+ | . .....++|+.++.||..||..||.+|
T Consensus 260 -~--~-------------------~-f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 260 -E--W-------------------D-FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -G--G-------------------G-GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred -c--c-------------------c-chhcCCcCHHHHHHHHHHccCCcccC
Confidence 0 0 0 11223789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-17 Score=161.07 Aligned_cols=128 Identities=16% Similarity=0.236 Sum_probs=98.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|+..+.+|.||+|..+..++.+.. .+..||||||++|..+..+. .+++ ..+.+|+.+|..||..
T Consensus 83 e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~ 154 (232)
T PRK10359 83 ENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQH 154 (232)
T ss_pred HHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHc
Confidence 58999999999999999999877542 23579999999997665542 2333 2466999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
||+||||||+||+++.+| ++|+|||......... |-+.+.-...|+.++|+|+||+++..+.
T Consensus 155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~--------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK--------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCccCCCChHHEEEeCCC-EEEEECCCcccccchh--------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 999999999999999988 9999999876543221 0111222245788999999999887664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-18 Score=190.58 Aligned_cols=215 Identities=30% Similarity=0.436 Sum_probs=173.9
Q ss_pred HHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCc
Q 009654 3 REILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDI-KFSEAQIKCYMNQLLHGLEHCH-SRGVL 78 (529)
Q Consensus 3 rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~-~l~e~~~~~i~~Qll~gL~~LH-~~gIv 78 (529)
.|+.+-+.+. |+|++.+++...+ ....+++++|..|+.+...+ ..+. ..+...+..++.|+..+|.|+| ..++.
T Consensus 69 ~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~ 146 (601)
T KOG0590|consen 69 TETDIQKKLSKHSNTVHMIEPSSS--PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVT 146 (601)
T ss_pred ccccccccccccccccccCCccCC--CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccc
Confidence 3666667776 9999999998877 67889999999987766665 5665 7888999999999999999999 99999
Q ss_pred ccCCCCCcEEEccCC-cEEEeccccccccCC--CCCCCcccccc-ccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 79 HRDIKGSNLLVNNEG-VLKLADFGLANFSNT--GHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 79 HrDIKp~NILl~~~g-~vKl~DFGla~~~~~--~~~~~~~~~~g-t~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
|+||||+|.+++..+ .+++.|||+|..+.. +........+| ++.|.|||.+.+....++..|+||+|+++.-+++|
T Consensus 147 h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 147 HRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred cCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence 999999999999999 999999999987655 33344556788 99999999998866779999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
..|+.-....... ...|...+ .......|..++..+.+++.++|..+|..|.+..+
T Consensus 227 ~~p~~~~~~~~~~-----------~~~~~~~~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 227 ELPWDFPSRKDGR-----------YSSWKSNK-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred CCCcccccccccc-----------ceeecccc-------------cccccCccccCChhhhhcccccccCCchhcccccc
Confidence 9998643322200 01111111 00012345678899999999999999999999999
Q ss_pred HHhccccCC
Q 009654 235 ALASEYFST 243 (529)
Q Consensus 235 ~L~h~~f~~ 243 (529)
+-.++|+..
T Consensus 283 ~~~d~~~~~ 291 (601)
T KOG0590|consen 283 LKLDNWLSS 291 (601)
T ss_pred ccccccccc
Confidence 999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.2e-16 Score=152.02 Aligned_cols=166 Identities=25% Similarity=0.304 Sum_probs=137.6
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.-|....+.| ..+.|..+|-+-.. ..+-.||+|++.-.|.+++.-.+.+|+...+.-++.||+.-++|+|++.+|+|
T Consensus 71 rdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYR 148 (449)
T KOG1165|consen 71 RDEYRTYKLLGGTEGIPQVYYFGQE--GKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYR 148 (449)
T ss_pred HHHHHHHHHHcCCCCCCceeeeccc--cchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeec
Confidence 4588888888 68999998655444 56778999999988877777778899999999999999999999999999999
Q ss_pred CCCCCcEEEccCC-----cEEEeccccccccCCCCCC------CccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 81 DIKGSNLLVNNEG-----VLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 81 DIKp~NILl~~~g-----~vKl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
||||+|+||...+ .|.|+|||+|+.+...... ...+..||..||+--..+|. .-+...|+=|||.++.
T Consensus 149 DIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFm 227 (449)
T KOG1165|consen 149 DIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFM 227 (449)
T ss_pred ccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhh
Confidence 9999999997543 5999999999877544321 22356789999999888884 4688999999999999
Q ss_pred HHHhCCCCCCCC---CHHHHHHHH
Q 009654 150 ELLIGKPILQGR---TEVEQLHKI 170 (529)
Q Consensus 150 elltG~~pf~g~---~~~~~~~~I 170 (529)
..|-|..||+|. +..+-+++|
T Consensus 228 YFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 228 YFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred hhccCCCccccccCcchHHHHHHh
Confidence 999999999875 455556555
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.8e-16 Score=149.55 Aligned_cols=100 Identities=23% Similarity=0.264 Sum_probs=81.4
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC-HSRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~L-H~~gIvHrD 81 (529)
+|+.+|.+|.+++|.....+... ..||||||++|+.+.........+++.++..++.||+.+|.+| |+.||+|||
T Consensus 68 ~E~~~l~~l~~~~v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrD 143 (190)
T cd05147 68 KEMRNLKRLVTAGIPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHAD 143 (190)
T ss_pred HHHHHHHHHHHCCCCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 49999999998887554443322 2389999999865543323356899999999999999999999 799999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
|||+|||++ ++.++|+|||+|....
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccCC
Confidence 999999998 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.3e-16 Score=151.97 Aligned_cols=199 Identities=17% Similarity=0.217 Sum_probs=151.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRG-- 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~--~~l~e~~~~~i~~Qll~gL~~LH~~g-- 76 (529)
|..|.-.|+.+.||||+.+++.+.. +.++.+|..||+.+.+..+.... ...+..++..++.+|+.|+.|||+..
T Consensus 234 fneefp~lrifshpnilpvlgacns--ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ 311 (448)
T KOG0195|consen 234 FNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM 311 (448)
T ss_pred hhhhCcceeeecCCchhhhhhhccC--CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh
Confidence 3456777888999999999999988 57899999999987666554433 34678899999999999999999874
Q ss_pred CcccCCCCCcEEEccCCcEEE--eccccccccCCCCCCCccccccccccCCcccccCCCCC--CCcchhhhhhHHHHHHH
Q 009654 77 VLHRDIKGSNLLVNNEGVLKL--ADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY--GPSVDLWSVGCVFAELL 152 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl--~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y--~~~~DIWSlG~il~ell 152 (529)
|.---|....++||++-+.+| +|--++. ....+...|.|++||.|...... -.++|+|||+++||||.
T Consensus 312 ipr~~lns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~ 383 (448)
T KOG0195|consen 312 IPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN 383 (448)
T ss_pred hhhhhcccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh
Confidence 444568899999999866554 4433221 11234568899999999765432 34799999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|...||..-...+.-.+|-- -|.. ....+.++..+..||.-|++.||.+||..
T Consensus 384 trevpfadlspmecgmkial-eglr--------------------------v~ippgis~hm~klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 384 TREVPFADLSPMECGMKIAL-EGLR--------------------------VHIPPGISRHMNKLMNICMNEDPGKRPKF 436 (448)
T ss_pred ccccccccCCchhhhhhhhh-cccc--------------------------ccCCCCccHHHHHHHHHHhcCCCCcCCCc
Confidence 99999998887776555422 1110 12235788889999999999999999988
Q ss_pred HHHH
Q 009654 233 SAAL 236 (529)
Q Consensus 233 ~e~L 236 (529)
+.++
T Consensus 437 dmiv 440 (448)
T KOG0195|consen 437 DMIV 440 (448)
T ss_pred ceeh
Confidence 7654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.5e-16 Score=148.28 Aligned_cols=99 Identities=16% Similarity=0.202 Sum_probs=77.5
Q ss_pred HHHHHHHHhC-----CCCCccceeeEEEccCC-CeEE-EEEecc--CCCchhhhcCCCCCCCHHHHHHHHHHHHHHH-HH
Q 009654 2 AREILILRRL-----DHPNIIKLEGLITSRLS-CSIY-LVFEYM--EHDITGLLSCPDIKFSEAQIKCYMNQLLHGL-EH 71 (529)
Q Consensus 2 ~rEi~iL~~L-----~HpnIvkl~~~~~~~~~-~~~~-lV~E~~--~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL-~~ 71 (529)
.+||.+|+.| +||||+++++++++... ..+| +||||+ .++.|..++.. ..+++. ..++.|++.++ +|
T Consensus 44 ~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~y 120 (210)
T PRK10345 44 RRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRY 120 (210)
T ss_pred HHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHH
Confidence 6899999999 67999999999988532 2334 789994 46666655543 357666 46688888888 99
Q ss_pred HHHCCCcccCCCCCcEEEccC----CcEEEeccccc
Q 009654 72 CHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLA 103 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~----g~vKl~DFGla 103 (529)
||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 121 Lh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 121 LLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999999999999999999743 37999995543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.3e-16 Score=145.88 Aligned_cols=102 Identities=20% Similarity=0.273 Sum_probs=83.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvHr 80 (529)
.+|+..+.+|.|++|.....+... ..||||||++|+.+.........+++.++..++.|++.+|.+||+ +||+||
T Consensus 67 ~~E~~~l~~l~~~~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr 142 (190)
T cd05145 67 EKEFRNLKRLYEAGVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG 142 (190)
T ss_pred HHHHHHHHHHHhCCCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 468999999999998666555433 248999999986333222234578899999999999999999999 999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNT 108 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~ 108 (529)
||||+|||++ ++.++|+|||++.....
T Consensus 143 DlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 143 DLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCChhhEEEE-CCCEEEEEcccceecCC
Confidence 9999999998 78999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-15 Score=143.14 Aligned_cols=169 Identities=25% Similarity=0.267 Sum_probs=134.2
Q ss_pred CHHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+..|..+.+.|. -..|..+..++.+ ..+-.||||++.-.+.+++......|+...+.-++-|++.-|+|+|.++.+|
T Consensus 57 L~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiH 134 (341)
T KOG1163|consen 57 LLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIH 134 (341)
T ss_pred hhHHHHHHHHhccCCCCchhhhhccc--cccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcccc
Confidence 357889999995 4677777777766 4577899999998887777667779999999999999999999999999999
Q ss_pred cCCCCCcEEEccC---CcEEEeccccccccCCCCCC------CccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 80 RDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 80 rDIKp~NILl~~~---g~vKl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
|||||+|+|..-. ..+.++|||+|+.+...... .-....||..|.+--...+. .-+...|+=|+|.+|..
T Consensus 135 RDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmY 213 (341)
T KOG1163|consen 135 RDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMY 213 (341)
T ss_pred ccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeee
Confidence 9999999998533 46899999999876543211 22345789999987777663 35778999999999999
Q ss_pred HHhCCCCCCCCCHH---HHHHHHHH
Q 009654 151 LLIGKPILQGRTEV---EQLHKIFK 172 (529)
Q Consensus 151 lltG~~pf~g~~~~---~~~~~I~~ 172 (529)
+..|..||+|.... .-+++|.+
T Consensus 214 fnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 214 FNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred eecCCCcccccchhhHHHHHHHHHH
Confidence 99999999986544 34444544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.9e-14 Score=133.72 Aligned_cols=98 Identities=26% Similarity=0.345 Sum_probs=82.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++..+.|++|+....++.+ ....++||||++|..+..+..... . ....++.+|+.+|.+||+.|++|+|
T Consensus 47 ~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~D 120 (211)
T PRK14879 47 RREARIMSRARKAGVNVPAVYFVD--PENFIIVMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGD 120 (211)
T ss_pred HHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCC
Confidence 479999999999999887777665 456799999999976665543321 2 7889999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
++|.|||++ ++.++|+|||++...
T Consensus 121 l~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 121 LTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcccEEEE-CCCEEEEECCcccCC
Confidence 999999999 789999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.8e-14 Score=137.02 Aligned_cols=101 Identities=21% Similarity=0.256 Sum_probs=79.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-Cccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG-VLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g-IvHr 80 (529)
.+|+.+|++|.+. ++.+..++... ..||||||++|+.+.........+...++..++.||+.+|.+||++| |+||
T Consensus 98 ~~E~~~L~~L~~~-~i~~p~~~~~~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~ 173 (237)
T smart00090 98 EKEFRNLQRLYEA-GVPVPKPIAWR---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHG 173 (237)
T ss_pred HHHHHHHHHHHhc-CCCCCeeeEec---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence 4799999999753 33333333321 34899999999766544334456777788999999999999999999 9999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
||||+||+++ ++.++|+|||.+....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 7899999999986543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.9e-13 Score=132.62 Aligned_cols=99 Identities=21% Similarity=0.253 Sum_probs=76.9
Q ss_pred HHHHHHHHhCCCCCc--cceeeEEEccCCC--eEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRLDHPNI--IKLEGLITSRLSC--SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L~HpnI--vkl~~~~~~~~~~--~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.++.+|.|++| ++.+++....... ..+||||+++| ..+..++.. ..+++.. +.||+.+|.+||++|
T Consensus 88 ~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G 162 (239)
T PRK01723 88 FAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG 162 (239)
T ss_pred HHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC
Confidence 579999999998885 6677664443221 22599999997 455544433 3566543 568999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
|+||||||.|||++.++.++|+|||.+..
T Consensus 163 I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 163 VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999989999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.40 E-value=5e-13 Score=127.36 Aligned_cols=95 Identities=22% Similarity=0.290 Sum_probs=76.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.|.|++|....-++.+ ....+|||||++|..+..+...... .++.||+.+|.+||+.||+|+|
T Consensus 45 ~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~D 115 (199)
T TIGR03724 45 RNEARLLSRARKAGVNTPVVYDVD--PDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGD 115 (199)
T ss_pred HHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCC
Confidence 479999999998876655444444 3457899999999766654432211 7899999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
++|.||+++ ++.++|+|||++...
T Consensus 116 l~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 116 LTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999999 789999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.1e-13 Score=151.94 Aligned_cols=147 Identities=23% Similarity=0.284 Sum_probs=119.2
Q ss_pred HHHHhCC---CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 6 LILRRLD---HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 6 ~iL~~L~---HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
+++.+|+ -|-|+.+..++.. .+.-+||+||.+.|.+-.+.+..+.+++..+..+..|||.-|++||..+|||+||
T Consensus 743 q~~~RLk~~~~~~~~~~~~a~~~--~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDi 820 (974)
T KOG1166|consen 743 QVMERLKPQMLPSIMHISSAHVF--QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDI 820 (974)
T ss_pred HHHHhhchhhhcchHHHHHHHcc--CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccC
Confidence 3455555 3456666555555 3466899999999887777778889999999999999999999999999999999
Q ss_pred CCCcEEEcc-------CCcEEEeccccccccCC-CCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 83 KGSNLLVNN-------EGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 83 Kp~NILl~~-------~g~vKl~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
||+|+||.. .-.++|+|||-+..... .....+...+.|-.+-.+|++.| +.++..+|.|.|+.+++.||.|
T Consensus 821 KPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 821 KPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred CcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHH
Confidence 999999843 23499999999864432 12245667788999999999988 5699999999999999999998
Q ss_pred C
Q 009654 155 K 155 (529)
Q Consensus 155 ~ 155 (529)
+
T Consensus 900 ~ 900 (974)
T KOG1166|consen 900 K 900 (974)
T ss_pred H
Confidence 5
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.7e-13 Score=145.97 Aligned_cols=94 Identities=20% Similarity=0.232 Sum_probs=80.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+|++|+..+.++.+ ....++||||++|+.+..+.. ....++.||+.+|.+||+.||+|||
T Consensus 384 ~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrD 453 (535)
T PRK09605 384 RAEARLLSEARRAGVPTPVIYDVD--PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGD 453 (535)
T ss_pred HHHHHHHHhhcccCCCeeEEEEEe--CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCC
Confidence 579999999999999987766665 345789999999976665432 4577899999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
|||+|||+ .++.++|+|||+++..
T Consensus 454 lkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 454 LTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999 5789999999998653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.5e-13 Score=149.34 Aligned_cols=207 Identities=25% Similarity=0.309 Sum_probs=158.1
Q ss_pred CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC
Q 009654 13 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 92 (529)
Q Consensus 13 HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~ 92 (529)
+|-++...-.+.. ....+||++|+.++.+.-.+...+..+++-++.++..+..+++|||+..+.|+|++|.|+|+..+
T Consensus 863 ~P~v~~~~~s~~~--rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~ 940 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPC--RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD 940 (1205)
T ss_pred CCceecccCCCCC--CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc
Confidence 3444444333223 35689999999875444444445578888899999999999999999999999999999999999
Q ss_pred CcEEEeccccccccCCC---------------------C---------CCCccccccccccCCcccccCCCCCCCcchhh
Q 009654 93 GVLKLADFGLANFSNTG---------------------H---------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 142 (529)
Q Consensus 93 g~vKl~DFGla~~~~~~---------------------~---------~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIW 142 (529)
|..++.|||.....+.- . .......++|+.|.+||.+.+. ..+.++|+|
T Consensus 941 gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~ 1019 (1205)
T KOG0606|consen 941 GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWW 1019 (1205)
T ss_pred CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhh
Confidence 99999999843221100 0 0012334679999999999885 478899999
Q ss_pred hhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 143 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 143 SlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
++|+++++.++|.+||...+....+.+|....-. |. .-....+.++.+++.++|
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~-----~p---------------------~g~~~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIP-----WP---------------------EGPEEGSYEAQDLINRLL 1073 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCC-----CC---------------------CCccccChhhhhhhhhhh
Confidence 9999999999999999999988887777542211 11 111356888999999999
Q ss_pred cCCCCCCcCHH---HHHhccccCCCCCCC
Q 009654 223 SVEPYKRATAS---AALASEYFSTKPYAC 248 (529)
Q Consensus 223 ~~dP~kR~ta~---e~L~h~~f~~~~~~~ 248 (529)
..+|.+|..+. ++-.|+||+...|..
T Consensus 1074 ~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1074 TEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred ccCchhccCcccccccccCCccCCCCccc
Confidence 99999999988 888999999877754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.6e-12 Score=121.79 Aligned_cols=95 Identities=16% Similarity=0.227 Sum_probs=75.6
Q ss_pred HHHHHHHHhCCCCC--ccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~Hpn--Ivkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.++..+.|++ ++.+++ .+..++||||++|..+..+.. ......++.+|+.++.++|+.||+|
T Consensus 81 ~~E~~~l~~l~~~~i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H 148 (198)
T cd05144 81 QKEFAALKALYEEGFPVPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIH 148 (198)
T ss_pred HHHHHHHHHHHHcCCCCCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCc
Confidence 46899999998875 343332 234589999999976654422 1456778899999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNT 108 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~ 108 (529)
|||||+||+|+.++.++|+|||++.....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-12 Score=137.93 Aligned_cols=207 Identities=22% Similarity=0.288 Sum_probs=160.0
Q ss_pred HHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCC
Q 009654 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH----GLEHCHSRGV 77 (529)
Q Consensus 3 rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~----gL~~LH~~gI 77 (529)
+|+.-.+++ .|+|+++.+..+++ .+..|+=+|+|...+..........+++..++.++.+.+. ||.++|+.+|
T Consensus 166 ~~~~s~~~i~~~~~~v~~~~~~e~--~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~ 243 (524)
T KOG0601|consen 166 REFLSHHKIDSHENPVRDSPAWEG--SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNI 243 (524)
T ss_pred chhhcccccCccccccccCccccc--CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcc
Confidence 455556666 59999998888877 6789999999998777777666666899999999999999 9999999999
Q ss_pred cccCCCCCcEEEccC-CcEEEeccccccccCCCCCCCcc----ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 78 LHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLT----SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 78 vHrDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~----~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
+|-|+||.||++..+ ..++++|||+...+..+...... ...+...|++||++.+ -++...||+++|.++.+..
T Consensus 244 ~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~ 321 (524)
T KOG0601|consen 244 VHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAI 321 (524)
T ss_pred cccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhH
Confidence 999999999999998 88999999999888765422111 1145667999999977 5899999999999999998
Q ss_pred hCCCCCCCC--CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 153 IGKPILQGR--TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 153 tG~~pf~g~--~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
+|..++-.. +.-.++..+. .+ .+.+...+.++..++..|+..+|..|+
T Consensus 322 l~~~~~~~g~~~~W~~~r~~~-----ip-------------------------~e~~~~~s~~l~~~~~~~~d~~~~~~~ 371 (524)
T KOG0601|consen 322 LGSHLPSVGKNSSWSQLRQGY-----IP-------------------------LEFCEGGSSSLRSVTSQMLDEDPRLRL 371 (524)
T ss_pred hhcccccCCCCCCcccccccc-----Cc-------------------------hhhhcCcchhhhhHHHHhcCcchhhhh
Confidence 886554322 1101111100 00 122234566667799999999999999
Q ss_pred CHHHHHhccccCC
Q 009654 231 TASAALASEYFST 243 (529)
Q Consensus 231 ta~e~L~h~~f~~ 243 (529)
+++.+++++++..
T Consensus 372 ~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 372 TAQILTALNVIHS 384 (524)
T ss_pred HHHHHhccccccc
Confidence 9999999998874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.5e-12 Score=112.29 Aligned_cols=97 Identities=26% Similarity=0.335 Sum_probs=81.8
Q ss_pred CHHHHHHHHhCCC--CCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q 009654 1 MAREILILRRLDH--PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--- 75 (529)
Q Consensus 1 ~~rEi~iL~~L~H--pnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~--- 75 (529)
+.+|+.+++.|.| +++++++.++.. .+..|++|||+.+..+..+ +......++.+++.+|.++|..
T Consensus 38 ~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~ 108 (155)
T cd05120 38 REREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLL 108 (155)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCce
Confidence 3579999999976 589999887766 4678999999998655433 5567788899999999999985
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
+++|+||+|.|||++..+.++++|||.+...
T Consensus 109 ~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-11 Score=121.95 Aligned_cols=203 Identities=18% Similarity=0.197 Sum_probs=139.2
Q ss_pred HHHhCCCCCccceeeEEEccCC---CeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 009654 7 ILRRLDHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRG--V 77 (529)
Q Consensus 7 iL~~L~HpnIvkl~~~~~~~~~---~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~g--I 77 (529)
-|-+|.|.|||+++.|+.+.+. ..+.+++|||..+.+...+ .....+.....++|+.||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3456689999999999887432 3567899999986655333 34456889999999999999999999885 9
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCC---CCC-ccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~-~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
+|+++..+.|++..+|-|||+----. .....- ... .....+-++|.+||.=.. .+.+-++|||++|+...+|..
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHH
Confidence 99999999999999999998532111 111100 000 112244688999996533 346778999999999999988
Q ss_pred CCCC-CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~p-f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+..- -.+....+.-..|....-.. -...-+++|.+||+..|..||++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~l--------------------------------en~lqr~~i~kcl~~eP~~rp~a 325 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGL--------------------------------ENGLQRGSITKCLEGEPNGRPDA 325 (458)
T ss_pred heeccCCCcceeehhhhhhhheeec--------------------------------cCccccCcCcccccCCCCCCcch
Confidence 7532 22222222222221111000 01112568999999999999999
Q ss_pred HHHHhccccCC
Q 009654 233 SAALASEYFST 243 (529)
Q Consensus 233 ~e~L~h~~f~~ 243 (529)
.++|-||..-+
T Consensus 326 r~llfHpllfe 336 (458)
T KOG1266|consen 326 RLLLFHPLLFE 336 (458)
T ss_pred hhhhcCceeee
Confidence 99999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-10 Score=125.47 Aligned_cols=141 Identities=23% Similarity=0.364 Sum_probs=107.0
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH-~~gIvHrD 81 (529)
+=++-|+.|+||||+++++.++. .+++|||+|-+.- +..... .+....+.--+.||+.||.+|| ..+++|++
T Consensus 58 ~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~P--l~~~lk---~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgN 130 (690)
T KOG1243|consen 58 RAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRP--LETVLK---ELGKEEVCLGLFQILAALSFLNDDCNLVHGN 130 (690)
T ss_pred HHHHHhhhccCchhhhhhhhhcc--cCceEEEeecccc--HHHHHH---HhHHHHHHHHHHHHHHHHHHHhccCCeeecc
Confidence 44678899999999999999887 5699999998864 111111 2337778888999999999998 66899999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
|.-+.|+|+..|..||++|.++........ +......--.|..|+.+.. -+...|.|-|||++++++.|
T Consensus 131 v~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 131 VCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred EeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 999999999999999999998864432211 1122222334677775532 22568999999999999999
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-10 Score=109.69 Aligned_cols=97 Identities=23% Similarity=0.281 Sum_probs=69.3
Q ss_pred HHHHHHHhCCCCC--ccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Q 009654 3 REILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 79 (529)
Q Consensus 3 rEi~iL~~L~Hpn--Ivkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvH 79 (529)
.|..++..+.+.. +.+++++ ...++||||++++.+........... .++..++.+++.++.++|. .||+|
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCc
Confidence 4566666664432 4444432 13589999999843221110111111 6788999999999999999 99999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
+||||+||+++ ++.++|+|||.+....
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999 8999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.4e-10 Score=108.89 Aligned_cols=99 Identities=18% Similarity=0.248 Sum_probs=76.2
Q ss_pred HHHHHHHHhCC--CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCc
Q 009654 2 AREILILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC-HSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~--HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~L-H~~gIv 78 (529)
.+|+..|++|. --++.+++.+ . .-+|||||++++.+......+..+++.++..++.|++.+|..| |..||+
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 37999999994 3566677654 2 2489999998753322112233566777888899999999999 899999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
|+||++.|||+. ++.+.|+|||.+....
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999997 4789999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.5e-10 Score=125.18 Aligned_cols=154 Identities=25% Similarity=0.362 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHC-CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccc--------cccccccCCcccccCCCC
Q 009654 64 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--------RVVTLWYRPPELLLGATD 134 (529)
Q Consensus 64 Qll~gL~~LH~~-gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~--------~~gt~~Y~APE~l~~~~~ 134 (529)
++..|+.|+|.. ++||++|.|++|.++..|..||+.|+++.....+..-+... ..-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 566899999965 89999999999999999999999999886544321111111 122567999999987 56
Q ss_pred CCCcchhhhhhHHHHHHH-hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHH
Q 009654 135 YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 213 (529)
Q Consensus 135 y~~~~DIWSlG~il~ell-tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~ 213 (529)
.+.++|++|+||++|.++ .|++.+.+.........-....+.. . ...-..+|.+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~------------------~-------~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG------------------A-------FGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc------------------c-------ccccccCcHH
Confidence 899999999999999999 6777776654333222221111110 0 1111578999
Q ss_pred HHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 214 AVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 214 ~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
+++=|.++|..++..||++..++..+||..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 999999999999999999999999999975
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.2e-09 Score=98.11 Aligned_cols=90 Identities=21% Similarity=0.166 Sum_probs=67.8
Q ss_pred HHHHHHHHhCCCCCcc-ceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC---
Q 009654 2 AREILILRRLDHPNII-KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV--- 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIv-kl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI--- 77 (529)
.+|+.+|+.+.+.+++ +++.+.. ...++||||++|..+... ......++.+++.+|..||+.++
T Consensus 40 ~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~ 107 (170)
T cd05151 40 ENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDL 107 (170)
T ss_pred HHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCc
Confidence 5799999999655544 4554432 234899999999654322 11123457799999999999986
Q ss_pred --cccCCCCCcEEEccCCcEEEecccccc
Q 009654 78 --LHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 78 --vHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
+|+|++|.||+++ ++.++|+|||.+.
T Consensus 108 ~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 108 VPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred eeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999999999998 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5e-09 Score=97.39 Aligned_cols=94 Identities=20% Similarity=0.272 Sum_probs=71.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|.++.--.|..-.-++.+ .....|+|||++|.++...+... ...+++.+=.-+.-||..||+|+|
T Consensus 47 ~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGD 117 (204)
T COG3642 47 RREARILAKAREAGVPVPIVYDVD--PDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGD 117 (204)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCC
Confidence 579999999854444333334444 45678999999998888554333 256777788888899999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~ 105 (529)
|.++||++... .+.++|||++.+
T Consensus 118 LTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 118 LTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred CccceEEEeCC-cEEEEECCcccc
Confidence 99999999765 499999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=8.2e-10 Score=117.92 Aligned_cols=202 Identities=21% Similarity=0.215 Sum_probs=148.1
Q ss_pred HHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.|+.+...| .|.+++.++..+.. ....||=.|||++....+.+.-...+++...+.++.|++.++.++|+..++|+|
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d 391 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQ--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLD 391 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccc--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhccc
Confidence 577777777 68888887766554 356789999999876665554445688999999999999999999999999999
Q ss_pred CCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccC-CcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYR-PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~-APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+||++.++ +..+++|||.++...-. ......+-++. .+|++.....+..++|++|||.-+.+.++|.+.-.
T Consensus 392 ~~psni~i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 392 VKPSNILISNDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ccccceeeccchhhhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 99999999886 77899999988642211 11122244455 36667666778999999999999999999876543
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
..+ +...|+. | .....+.....+..+.+.|+..++..|+.+.++..|.
T Consensus 468 ~~~---~~~~i~~--~---------------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 468 SGV---QSLTIRS--G---------------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ccc---cceeeec--c---------------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 211 1111111 0 0111233446778899999999999999999998876
Q ss_pred ccC
Q 009654 240 YFS 242 (529)
Q Consensus 240 ~f~ 242 (529)
-|.
T Consensus 516 ~~~ 518 (524)
T KOG0601|consen 516 EFY 518 (524)
T ss_pred hhh
Confidence 553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.2e-08 Score=101.98 Aligned_cols=179 Identities=19% Similarity=0.278 Sum_probs=129.7
Q ss_pred HHHHHhCCCCCccceeeEEEccC--CCeEEEEEeccCC--CchhhhcC--------------CCCCCCHHHHHHHHHHHH
Q 009654 5 ILILRRLDHPNIIKLEGLITSRL--SCSIYLVFEYMEH--DITGLLSC--------------PDIKFSEAQIKCYMNQLL 66 (529)
Q Consensus 5 i~iL~~L~HpnIvkl~~~~~~~~--~~~~~lV~E~~~g--~ll~~~~~--------------~~~~l~e~~~~~i~~Qll 66 (529)
+++++++.|+|||++.++|.... ...+++|++|.++ .|+..+.. .+.+.+|..+++|+.||.
T Consensus 324 ve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLt 403 (655)
T KOG3741|consen 324 VEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLT 403 (655)
T ss_pred HHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHH
Confidence 78899999999999999987422 4578999999997 34443322 223578899999999999
Q ss_pred HHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhH
Q 009654 67 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 146 (529)
Q Consensus 67 ~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~ 146 (529)
.||.++|+.|..-+-|.|.+||++.+..++|..-|+......+.. |.+.+ -..-|.=.||.
T Consensus 404 aaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------~~le~----~Qq~D~~~lG~ 464 (655)
T KOG3741|consen 404 AALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------EPLES----QQQNDLRDLGL 464 (655)
T ss_pred HHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------cchhH----HhhhhHHHHHH
Confidence 999999999999999999999999887888877666554443310 11211 23568999999
Q ss_pred HHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 147 VFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 147 il~elltG~~p-f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
+++.|.||..- +......+. .+......++.+++++|.-+...+
T Consensus 465 ll~aLAt~~~ns~~~d~~~~s-----------------------------------~~~~I~~~yS~D~rn~v~yl~s~~ 509 (655)
T KOG3741|consen 465 LLLALATGTENSNRTDSTQSS-----------------------------------HLTRITTTYSTDLRNVVEYLESLN 509 (655)
T ss_pred HHHHHhhcccccccccchHHH-----------------------------------HHHHhhhhhhHHHHHHHHHHHhcC
Confidence 99999999532 111111111 012222467888999999999999
Q ss_pred CCCCcCHHHHHhc
Q 009654 226 PYKRATASAALAS 238 (529)
Q Consensus 226 P~kR~ta~e~L~h 238 (529)
+.+ -++.++|.+
T Consensus 510 ~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 510 FRE-KSIQDLLPM 521 (655)
T ss_pred ccc-ccHHHHHHH
Confidence 987 677787754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-08 Score=108.80 Aligned_cols=102 Identities=18% Similarity=0.246 Sum_probs=68.6
Q ss_pred HHHHHHHHhC----CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHH-HHHHHHHC
Q 009654 2 AREILILRRL----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLH-GLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L----~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~-gL~~LH~~ 75 (529)
.+|+..+.++ .|.+-|.+-.+|.+. ....+|||||++|..+..+.. ....++ ...++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4677777766 233333333333322 234699999999966554321 111122 3345555555 47889999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccC
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
|++|+|++|.||+++.+|.++|+|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.1e-08 Score=95.09 Aligned_cols=97 Identities=26% Similarity=0.323 Sum_probs=66.5
Q ss_pred HHHHHHHHhCCCC--CccceeeEEEccCCCeEEEEEeccC--CCchhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHHCC
Q 009654 2 AREILILRRLDHP--NIIKLEGLITSRLSCSIYLVFEYME--HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH-CHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L~Hp--nIvkl~~~~~~~~~~~~~lV~E~~~--g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~-LH~~g 76 (529)
.+|+++|.+|..- ++.+++.+. + .+|||||++ |..+..+... .++.+....++.+++..+.. +|..|
T Consensus 56 ~~E~~~L~~l~~~Gv~vP~p~~~~--~----~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g 127 (188)
T PF01163_consen 56 KKEFRNLKRLYEAGVPVPKPYDYN--R----NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG 127 (188)
T ss_dssp HHHHHHHHHCCCTT-SS--EEEEE--T----TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHCCccCCcEEEEe--C----CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC
Confidence 5799999999655 567776542 1 279999999 6544444322 22355677888888886555 57999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccC
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
|+|+||.+.|||++.+ .+.|+|||.+....
T Consensus 128 ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 128 IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999999876 99999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.1e-08 Score=98.38 Aligned_cols=103 Identities=14% Similarity=0.117 Sum_probs=76.0
Q ss_pred HHHHHHHHhCCCCCcc--ceeeEEEccC---CCeEEEEEeccCCC-chhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNII--KLEGLITSRL---SCSIYLVFEYMEHD-ITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIv--kl~~~~~~~~---~~~~~lV~E~~~g~-ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+..+.+|..-+|. .+..+++... ...-|||||++++. .+..+.. .....++.....++.+|...+.-||
T Consensus 76 ~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH 155 (268)
T PRK15123 76 DREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH 155 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4788888888433333 3344544321 12468999999984 4444432 1335667788899999999999999
Q ss_pred HCCCcccCCCCCcEEEcc-------CCcEEEecccccc
Q 009654 74 SRGVLHRDIKGSNLLVNN-------EGVLKLADFGLAN 104 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~-------~g~vKl~DFGla~ 104 (529)
..||+|+|+++.||||+. ++.+.|+||+.+.
T Consensus 156 ~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 156 AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999999999999999975 3579999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.2e-08 Score=91.01 Aligned_cols=102 Identities=18% Similarity=0.283 Sum_probs=75.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCC--CchhhhcCCCCCCCHHH-HHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH--DITGLLSCPDIKFSEAQ-IKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g--~ll~~~~~~~~~l~e~~-~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+++|.++.--.|.--.-+|.| ...-.|+|||++| .+...++.....-.+.+ ...++++|=+.|.-||..+|+
T Consensus 58 ~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndii 135 (229)
T KOG3087|consen 58 KQEARLLAKCRALGIPAPRLIFID--TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDII 135 (229)
T ss_pred HHHHHHHHHHHHhCCCCceEEEEe--cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCee
Confidence 579999999854444443335555 3445899999999 45455543332323333 378999999999999999999
Q ss_pred ccCCCCCcEEEccCCc---EEEeccccccc
Q 009654 79 HRDIKGSNLLVNNEGV---LKLADFGLANF 105 (529)
Q Consensus 79 HrDIKp~NILl~~~g~---vKl~DFGla~~ 105 (529)
|+||..+||+|..+|. +.++|||++..
T Consensus 136 HGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 136 HGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cccccccceEEecCCCcCceEEEeecchhc
Confidence 9999999999987753 58999999753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.8e-08 Score=92.36 Aligned_cols=104 Identities=22% Similarity=0.218 Sum_probs=78.6
Q ss_pred HHHHHHHHhCCC--CCccceeeEEEccCC--CeEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRLDH--PNIIKLEGLITSRLS--CSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L~H--pnIvkl~~~~~~~~~--~~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|...+..|.. =.+.+.+.+.+.+.. ...|||+|++++ ..+..+......++......++.++...+.-||.+|
T Consensus 59 ~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g 138 (206)
T PF06293_consen 59 KREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAG 138 (206)
T ss_pred HHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCc
Confidence 468887777733 234455555554322 245899999998 345554443333777888999999999999999999
Q ss_pred CcccCCCCCcEEEccCC---cEEEeccccccc
Q 009654 77 VLHRDIKGSNLLVNNEG---VLKLADFGLANF 105 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g---~vKl~DFGla~~ 105 (529)
|+|+|+++.|||++.++ .+.|+||+.+..
T Consensus 139 i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 139 IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.57 E-value=6.7e-08 Score=105.38 Aligned_cols=99 Identities=17% Similarity=0.255 Sum_probs=67.1
Q ss_pred HHHHHHHHhC----CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCC----CCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDI----KFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L----~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~----~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+..+.++ .+.+.+.+-.+|.+- ....+||||||+|.-+..+. ...+ .+.+..+..++.||+
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 3455555555 244444444444332 33568999999996554321 1121 355666777777776
Q ss_pred HHHCCCcccCCCCCcEEEccCC----cEEEeccccccccCC
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 108 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g----~vKl~DFGla~~~~~ 108 (529)
..|++|+|+||.||+++.+| .++++|||++.....
T Consensus 278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 48999999999999999888 899999999876644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.6e-07 Score=88.86 Aligned_cols=103 Identities=23% Similarity=0.277 Sum_probs=78.3
Q ss_pred HHHHHHHHhCCC--CCccceeeEEEccC-CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH----
Q 009654 2 AREILILRRLDH--PNIIKLEGLITSRL-SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS---- 74 (529)
Q Consensus 2 ~rEi~iL~~L~H--pnIvkl~~~~~~~~-~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~---- 74 (529)
.+|+.+++.|.+ .++.+++.+..... .+..|+||||++|..+...... ..+++.+...++.+++..|..||+
T Consensus 43 ~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 121 (223)
T cd05154 43 AREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPA 121 (223)
T ss_pred HHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChh
Confidence 579999999965 45677776654421 1256899999999766554321 357888888888899999988884
Q ss_pred ----------------------------------------------------CCCcccCCCCCcEEEcc--CCcEEEecc
Q 009654 75 ----------------------------------------------------RGVLHRDIKGSNLLVNN--EGVLKLADF 100 (529)
Q Consensus 75 ----------------------------------------------------~gIvHrDIKp~NILl~~--~g~vKl~DF 100 (529)
..++|+|+.|.|||++. ++.+.|+||
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~ 201 (223)
T cd05154 122 AVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDW 201 (223)
T ss_pred hcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEec
Confidence 23589999999999998 567899999
Q ss_pred ccccc
Q 009654 101 GLANF 105 (529)
Q Consensus 101 Gla~~ 105 (529)
+.+..
T Consensus 202 e~~~~ 206 (223)
T cd05154 202 ELATL 206 (223)
T ss_pred ccccc
Confidence 98754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=5e-06 Score=85.93 Aligned_cols=189 Identities=16% Similarity=0.179 Sum_probs=122.9
Q ss_pred eEEEEEeccCCC-chhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEecccc
Q 009654 30 SIYLVFEYMEHD-ITGLLSCPD------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 102 (529)
Q Consensus 30 ~~~lV~E~~~g~-ll~~~~~~~------~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGl 102 (529)
.+-++|..+.|- -...+..+. ..+.+.-+....+.|+.+.+.||..|.+-+|+.++|+|+.+++.+.|+|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 366778877762 112222211 2367888999999999999999999999999999999999999999987554
Q ss_pred ccccCCCCCCCccccccccccCCccccc-C---CCCCCCcchhhhhhHHHHHHHhC-CCCCCCCCHHH----HH-HHHHH
Q 009654 103 ANFSNTGHRQPLTSRVVTLWYRPPELLL-G---ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVE----QL-HKIFK 172 (529)
Q Consensus 103 a~~~~~~~~~~~~~~~gt~~Y~APE~l~-~---~~~y~~~~DIWSlG~il~elltG-~~pf~g~~~~~----~~-~~I~~ 172 (529)
-.+... .......+|...|.+||+-. + .-.-+...|.|.||+++++||.| +.||.|..... -+ ..|-.
T Consensus 164 fqi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 164 FQINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 332222 23455678999999999763 1 11246788999999999999987 89998742100 00 01111
Q ss_pred HcCCCCchhhhccCCCccccCCCCCCCcc-hhhhhccCCcHHHHHHHHHhccC--CCCCCcCHHH
Q 009654 173 LCGSPPDDYWKKSKLPHATLFKPQQPYDS-SLRETFKDLPTTAVNLIETLLSV--EPYKRATASA 234 (529)
Q Consensus 173 ~~g~p~~~~~~~~~l~~~~~~~~~~~~~~-~l~~~~~~~s~~~~dLi~~mL~~--dP~kR~ta~e 234 (529)
|.+.+ -+ +....+.. -...-|..+++++..|..+|+.. ++.-|||++.
T Consensus 242 --g~f~y--a~----------~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 --GRFAY--AS----------DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred --ceeee--ch----------hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11000 00 00001110 11223456889999999999964 3567999753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1e-06 Score=95.09 Aligned_cols=207 Identities=17% Similarity=0.193 Sum_probs=140.2
Q ss_pred HHHHHHhCCCCC-ccceeeEEEccCCCeEEEEEeccCCC--chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 4 EILILRRLDHPN-IIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 4 Ei~iL~~L~Hpn-Ivkl~~~~~~~~~~~~~lV~E~~~g~--ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
++++|.+++||| .+..++-++. ....++++++|.++ ...........|.+-+...+.+.-+.+|+++|+.--+|+
T Consensus 283 ~~eLLdK~n~P~~~v~~~~d~~~--E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~ 360 (829)
T KOG0576|consen 283 AIELLDKVNNPNPVVRYLEDYDG--EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHR 360 (829)
T ss_pred HHHHHHHccCCCCcccccccCCc--ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCc
Confidence 789999999999 5544444333 57889999999986 222222333456666777777888889999999888899
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
| ||+..+ +..|.+||+....+.... ......+|+.++|||+... ..+....|.|++|+-..+|--|.+|-..
T Consensus 361 d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 361 D----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC
Confidence 8 777654 789999999886655432 2345678999999999876 4588999999999887778777777532
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
|+.....-..-+...... . ...|.... -.++...|+...|..|+++..++-|.+
T Consensus 433 ----------------P~~~~~~~g~~p~s~~L~-----~---~~aw~~~~--~~~~~~~~~~g~P~~pkv~mgacfsKv 486 (829)
T KOG0576|consen 433 ----------------PPAVLPMIGNGPNSPMLT-----D---KSAWSPVF--HRDFPAPCLNGLPPTPKVHMGACFSKV 486 (829)
T ss_pred ----------------CccccCCCCCCCCccccc-----h---hhhcCccc--ccCCcccccCCCCCCCcchhhHHHHHH
Confidence 111000000000000000 0 01111111 115778899999999999999999999
Q ss_pred cCCCCC
Q 009654 241 FSTKPY 246 (529)
Q Consensus 241 f~~~~~ 246 (529)
|...|.
T Consensus 487 fngCpl 492 (829)
T KOG0576|consen 487 FNGCPL 492 (829)
T ss_pred hccCcc
Confidence 987544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.5e-06 Score=78.27 Aligned_cols=104 Identities=16% Similarity=0.195 Sum_probs=75.8
Q ss_pred CHHHHHHHHhCCC--CCccceeeEEEc-c--CCCeEEEEEeccCC--CchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDH--PNIIKLEGLITS-R--LSCSIYLVFEYMEH--DITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 1 ~~rEi~iL~~L~H--pnIvkl~~~~~~-~--~~~~~~lV~E~~~g--~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
|.+|+..|.+|.. -.+.++. ++.. . ..-.-+||+|-++| ++...+.. ...+.++.+...++.++...|.-|
T Consensus 66 f~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~L 144 (216)
T PRK09902 66 IVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKM 144 (216)
T ss_pred HHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHH
Confidence 4689999999942 2245544 2221 1 11235899998886 44333322 123567888889999999999999
Q ss_pred HHCCCcccCCCCCcEEEccCCc--EEEeccccccc
Q 009654 73 HSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANF 105 (529)
Q Consensus 73 H~~gIvHrDIKp~NILl~~~g~--vKl~DFGla~~ 105 (529)
|+.|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 145 H~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 145 HSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999999999999999987777 99999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.6e-06 Score=82.21 Aligned_cols=95 Identities=23% Similarity=0.296 Sum_probs=75.2
Q ss_pred HHHHHHHHhCCCC--CccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHP--NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~Hp--nIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|.++|.+|.-. .|.+.+++ +...+||||++|-.+..+ +++.+.+..++..|++-+..+-..||||
T Consensus 157 ~rEf~~L~~L~~~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 157 EREFEALQRLYPEGVKVPKPIAW------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred HHHHHHHHHhhhcCCCCCCcccc------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 4899999999654 77777664 345899999999544333 2356667777888888888888999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
+|+.+-|||++++|.+.|+||=.+....
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccCC
Confidence 9999999999999999999997665443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.1e-06 Score=95.12 Aligned_cols=200 Identities=19% Similarity=0.163 Sum_probs=136.7
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCe--EEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCS--IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~--~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
-|+..+.++.|+|++.++.+-..+.... ..+..|+|....+..+...-+..+...++.+..++++||.|+|+....|.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v 310 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHV 310 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcccee
Confidence 3667778889999999998876654333 23455788775555555566688999999999999999999999966665
Q ss_pred CCCCC---cEEEccCCcEEEe--ccccccccCCCCCCCccccccccccCCcccccCCCCCCCc--chhhhhhHHHHHHHh
Q 009654 81 DIKGS---NLLVNNEGVLKLA--DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS--VDLWSVGCVFAELLI 153 (529)
Q Consensus 81 DIKp~---NILl~~~g~vKl~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~--~DIWSlG~il~ellt 153 (529)
-+..+ +-..+..+.+.+. ||+......... .......+..|.+||.+... .+..+ .|+|.+|..+.-+..
T Consensus 311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred EEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCccccccccccccc-cchhhhhhHHHHHHHHHhhhhh
Confidence 55444 3334455666766 888876654432 11222335567788877542 34443 699999999999988
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccC-CcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~-~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|..+-.- ...+ ...... ...+..+++.+|+.-++++|+.+
T Consensus 388 ~~~i~~~------~~~~---------------------------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 388 GEDISEK------SAVP---------------------------------VSLLDVLSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred cCccccc------ccch---------------------------------hhhhccccchhhhhhhhhhcchhhhhccch
Confidence 7644210 0000 000111 11267889999999999999999
Q ss_pred HHHHhccccCCC
Q 009654 233 SAALASEYFSTK 244 (529)
Q Consensus 233 ~e~L~h~~f~~~ 244 (529)
.++|.|+|.+..
T Consensus 429 ~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 429 LELLTHPFLRFP 440 (1351)
T ss_pred hhhhhchhcccc
Confidence 999999998753
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.6e-05 Score=76.80 Aligned_cols=67 Identities=22% Similarity=0.348 Sum_probs=50.6
Q ss_pred CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 29 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 29 ~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
...+|||||++|-.+..+. .+++ .+...|..++.-+|+.|++|+|+.|.|+++.++ .++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 3456899999995444332 1233 244567788999999999999999999999865 59999998643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.85 E-value=8.7e-05 Score=72.61 Aligned_cols=99 Identities=17% Similarity=0.208 Sum_probs=74.6
Q ss_pred HHHHHHHHhCC--CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCc
Q 009654 2 AREILILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~--HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIv 78 (529)
.+|+.-|+++. +=.+.+-+.+.. ..|||||+..+....-.-.+..+...++..+..+++..+.-|-. .|+|
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LV 189 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLV 189 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence 36888888883 445556655542 38999999876222222233445555788899999999999887 8999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~ 107 (529)
|+||+.-|||+. ++.+.|+|||.|....
T Consensus 190 HgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 190 HGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999998 8899999999886554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.82 E-value=7.1e-05 Score=71.13 Aligned_cols=98 Identities=27% Similarity=0.243 Sum_probs=78.1
Q ss_pred HHHHHHHhCCC-CCccceeeEEEccCCCeEEEEEeccCCC-chhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 009654 3 REILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLL--SCPDIKFSEAQIKCYMNQLLHGLEHCHS---R 75 (529)
Q Consensus 3 rEi~iL~~L~H-pnIvkl~~~~~~~~~~~~~lV~E~~~g~-ll~~~--~~~~~~l~e~~~~~i~~Qll~gL~~LH~---~ 75 (529)
.|.-+|+.|.+ +++++++|+|-. ++|+||...+ +.+.. +..-...++..+..++.+++..+++++. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58899999965 799999998733 7899999964 32110 1111245799999999999999999998 4
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
.+...|++++|+-|+++|.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5777999999999999999999999887554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0002 Score=70.48 Aligned_cols=29 Identities=24% Similarity=0.249 Sum_probs=25.9
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00037 Score=68.21 Aligned_cols=28 Identities=29% Similarity=0.396 Sum_probs=25.2
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00054 Score=79.52 Aligned_cols=107 Identities=25% Similarity=0.453 Sum_probs=65.5
Q ss_pred CHHHHHHHHhCC-CCCc--cceeeEEEccC-CCeEEEEEeccCCCchhh------------------------hcCCCC-
Q 009654 1 MAREILILRRLD-HPNI--IKLEGLITSRL-SCSIYLVFEYMEHDITGL------------------------LSCPDI- 51 (529)
Q Consensus 1 ~~rEi~iL~~L~-HpnI--vkl~~~~~~~~-~~~~~lV~E~~~g~ll~~------------------------~~~~~~- 51 (529)
+.+|+.+|+.|. |++| .+++.++.+.. .+..|+||||++|..+.. +..-+.
T Consensus 85 ~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~ 164 (822)
T PLN02876 85 VEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVD 164 (822)
T ss_pred HHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCch
Confidence 358999999995 7765 77777776531 145789999999853211 000000
Q ss_pred -----------CCCHHHHHHHHHH---------------HHHHHHHHHH-----------CCCcccCCCCCcEEEccC--
Q 009654 52 -----------KFSEAQIKCYMNQ---------------LLHGLEHCHS-----------RGVLHRDIKGSNLLVNNE-- 92 (529)
Q Consensus 52 -----------~l~e~~~~~i~~Q---------------ll~gL~~LH~-----------~gIvHrDIKp~NILl~~~-- 92 (529)
.+...++..+..| +...+.+|.. ..+||+|+++.|||++.+
T Consensus 165 ~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~ 244 (822)
T PLN02876 165 AIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTED 244 (822)
T ss_pred hcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCC
Confidence 0112233332222 2223455532 249999999999999853
Q ss_pred CcEEEeccccccccC
Q 009654 93 GVLKLADFGLANFSN 107 (529)
Q Consensus 93 g~vKl~DFGla~~~~ 107 (529)
..+-|+||+++..-.
T Consensus 245 ~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 245 RVIGILDWELSTLGN 259 (822)
T ss_pred eEEEEEeeeccccCC
Confidence 346799999987544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=2.9e-05 Score=90.82 Aligned_cols=209 Identities=15% Similarity=0.025 Sum_probs=143.4
Q ss_pred HHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Q 009654 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRG--- 76 (529)
Q Consensus 4 Ei~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~---~~~~l~e~~~~~i~~Qll~gL~~LH~~g--- 76 (529)
|...++...|+++...+.=.....+...|++++||.++-+. .++. +...+.+.-+.+.+++.+.+..-||+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 44556667899998877766666667789999999985554 4433 2234666677777777788888888653
Q ss_pred --CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 77 --VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 77 --IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
.+|++||+-|.+|..+..+|++++|+.++..+. .......++++.|+.|++... -.++.+.|+|..||-+|++.-|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcc
Confidence 889999999999999999999999999844432 223345567889999997755 4577889999999999999998
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.++|- ..+..+.+ |...+. +.+ ..-.-.|.++-.+...+|-+.-..||.-..
T Consensus 1437 n~~fi-----~flq~~Lk--giidn~----------tf~-----------sIe~l~pgdaNve~~~~Ll~K~~~rp~q~i 1488 (2724)
T KOG1826|consen 1437 NAYFI-----FFLQPALK--GIIDNH----------TFF-----------SIEKLKPGDANVEALHRLLWKYMERPGQYI 1488 (2724)
T ss_pred cHHHH-----HHHHHHHc--Cccccc----------ccc-----------cccccCCCcccHHHHHHHHHHhhhcchhhh
Confidence 88773 33333332 111110 000 111122344444555556666777888888
Q ss_pred HHhccccC
Q 009654 235 ALASEYFS 242 (529)
Q Consensus 235 ~L~h~~f~ 242 (529)
.+.-+.|.
T Consensus 1489 sls~d~~a 1496 (2724)
T KOG1826|consen 1489 SLSRDHFA 1496 (2724)
T ss_pred hccccccc
Confidence 88777664
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0011 Score=70.75 Aligned_cols=167 Identities=22% Similarity=0.352 Sum_probs=109.3
Q ss_pred HHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 009654 5 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKG 84 (529)
Q Consensus 5 i~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp 84 (529)
..+|+.+.|+|...++.+.... .....+|+|+++-++.+...... +-.. +++ .+|+.|-
T Consensus 33 ~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~~---- 91 (725)
T KOG1093|consen 33 FQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLHL---- 91 (725)
T ss_pred hHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cchh-------hhc-------cccccee----
Confidence 5678888999999988876654 34588999999987766554222 1111 111 2222222
Q ss_pred CcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHH
Q 009654 85 SNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 164 (529)
Q Consensus 85 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~ 164 (529)
+.++++|- ++ +. | | ...++++|||++|.|+.++..|...+...+..
T Consensus 92 --------~~~~~td~-~~-----------t~------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s 137 (725)
T KOG1093|consen 92 --------NIIYITDH-FL-----------TK------Y--P------SPIGPKSDVWSLGFIILELYLGISLEAELTES 137 (725)
T ss_pred --------hhhhcccc-cc-----------cc------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence 23344440 00 00 0 1 11235999999999999999999999988888
Q ss_pred HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 165 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 165 ~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
+++..|.+....+....- -..-......++....+++.+|+-..|..||...++.+++-|..
T Consensus 138 ~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 138 EYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 988888775433321100 00001222456778899999999999999999999999988874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0015 Score=62.82 Aligned_cols=30 Identities=30% Similarity=0.557 Sum_probs=20.8
Q ss_pred CCCcccCCCCCcEEEc-cCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVN-NEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~-~~g~vKl~DFGla~ 104 (529)
..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3599999999999999 55667899998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0017 Score=70.85 Aligned_cols=103 Identities=18% Similarity=0.285 Sum_probs=62.2
Q ss_pred HHHHHHHHhC-----CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRL-----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L-----~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|..-+.++ +.|+|. +=.+|.+- ...-.|+|||++|--+..+. .....++...+...+.++ .+..+=..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~-VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~d 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVY-VPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeE-eceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhc
Confidence 4677666666 334432 22233221 23458999999993333221 122344533332222111 12333348
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCC
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 108 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~ 108 (529)
|++|.|.+|.||+++.+|.+-+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0013 Score=64.44 Aligned_cols=29 Identities=31% Similarity=0.456 Sum_probs=25.2
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
+++|+|+.+.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876667899999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0047 Score=61.26 Aligned_cols=29 Identities=41% Similarity=0.594 Sum_probs=25.4
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
.++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999997743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0096 Score=57.04 Aligned_cols=94 Identities=20% Similarity=0.266 Sum_probs=65.3
Q ss_pred HHHHHHHHhCC------CCCccceeeEEEccCCCeEEEEEeccCC---C---chhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD------HPNIIKLEGLITSRLSCSIYLVFEYMEH---D---ITGLLSCPDIKFSEAQIKCYMNQLLHGL 69 (529)
Q Consensus 2 ~rEi~iL~~L~------HpnIvkl~~~~~~~~~~~~~lV~E~~~g---~---ll~~~~~~~~~l~e~~~~~i~~Qll~gL 69 (529)
.+|+.-...+. +..|.+++|+.++ +...-+|+|.+.. . ++..+. ....+++ .+...|-.-.
T Consensus 59 ~~E~~~y~~l~~~~~~~~~~i~r~~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~----~~~~~L~~f~ 131 (199)
T PF10707_consen 59 RRELRYYKQLSLRRGVDWSHIPRFYGFVET--NLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE----ELRQALDEFK 131 (199)
T ss_pred HHHHHHHHHHhhccCCcccccccEeEEEec--CCceEEEEEEEECCCCCcCccHHHHH-HcCCccH----HHHHHHHHHH
Confidence 35666555555 8899999999988 5677889998754 1 223333 2334555 3334455666
Q ss_pred HHHHHCCCcccCCCCCcEEEccC--C--cEEEec-ccc
Q 009654 70 EHCHSRGVLHRDIKGSNLLVNNE--G--VLKLAD-FGL 102 (529)
Q Consensus 70 ~~LH~~gIvHrDIKp~NILl~~~--g--~vKl~D-FGl 102 (529)
.||-+++|+.+||+|.||++... + .+.|+| ||.
T Consensus 132 ~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 132 RYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred HHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 78899999999999999999653 2 477887 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0038 Score=68.11 Aligned_cols=85 Identities=20% Similarity=0.205 Sum_probs=54.3
Q ss_pred ccceeeEEEccCCCeEEEEEeccCCCc---hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-
Q 009654 16 IIKLEGLITSRLSCSIYLVFEYMEHDI---TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN- 91 (529)
Q Consensus 16 Ivkl~~~~~~~~~~~~~lV~E~~~g~l---l~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~- 91 (529)
|.++|-.++ ..-.|+||||+|.- +..+.. ..++...+...+.+... +-+=..|.+|+|-+|.||++..
T Consensus 266 VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~ 337 (538)
T KOG1235|consen 266 VPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPN 337 (538)
T ss_pred CCeehhhcC----cceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecC
Confidence 555544333 35689999999933 233322 24555544433333222 2233568999999999999984
Q ss_pred ---CCcEEEeccccccccCC
Q 009654 92 ---EGVLKLADFGLANFSNT 108 (529)
Q Consensus 92 ---~g~vKl~DFGla~~~~~ 108 (529)
++.+.+.|||+...+..
T Consensus 338 ~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 338 PEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCCCccEEEEcccccccccH
Confidence 56799999999876554
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.012 Score=60.44 Aligned_cols=33 Identities=21% Similarity=0.400 Sum_probs=29.1
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCC
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 108 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~ 108 (529)
.++|+|+.+.||+|++.+.+-|+||+++.+-.+
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 388999999999999998899999999876543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.029 Score=56.68 Aligned_cols=30 Identities=33% Similarity=0.564 Sum_probs=26.7
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988778999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.016 Score=58.97 Aligned_cols=91 Identities=14% Similarity=0.212 Sum_probs=64.2
Q ss_pred HHHHHHHHhC-CCC-CccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRL-DHP-NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L-~Hp-nIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+..|+.| +|- -|.+.+++ +..++|||++.|--+..+.. ...+..+...|+.-+--|-.+|+||
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIH 225 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIH 225 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCcee
Confidence 4788888888 332 23344442 34589999999843332211 1223445556777778889999999
Q ss_pred cCCCCCcEEEccCCcEEEecccccc
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
+|+.-=||+|.+++.++++||-.+.
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999996543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.11 Score=52.84 Aligned_cols=41 Identities=17% Similarity=0.150 Sum_probs=30.5
Q ss_pred CHHHHHHHHhCC-C--CCccceeeEEEccC-CCeEEEEEeccCCC
Q 009654 1 MAREILILRRLD-H--PNIIKLEGLITSRL-SCSIYLVFEYMEHD 41 (529)
Q Consensus 1 ~~rEi~iL~~L~-H--pnIvkl~~~~~~~~-~~~~~lV~E~~~g~ 41 (529)
+.+|...|+.|. + -.|.++++++.+.. .+..|||||+++|.
T Consensus 54 ~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~ 98 (297)
T PRK10593 54 AQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGV 98 (297)
T ss_pred HHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCE
Confidence 468999999994 3 46788888776521 34579999999984
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.033 Score=53.55 Aligned_cols=29 Identities=38% Similarity=0.647 Sum_probs=20.5
Q ss_pred CCcccCCCCCcEEE-ccCCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLV-NNEGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl-~~~g~vKl~DFGla~ 104 (529)
.++|.||.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48899999999999 778999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.099 Score=54.22 Aligned_cols=72 Identities=21% Similarity=0.324 Sum_probs=56.0
Q ss_pred CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 28 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 28 ~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~-gIvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
.-+.|++|++-.+.+.. +. .-..+++..++.+-+.-+.-+... ..-|||+.-.||||+ +|+|-|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is~-ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPISI-IK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceeee-ee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 45678888876654432 21 224688889999888887777755 688999999999999 89999999999984
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.098 Score=54.34 Aligned_cols=99 Identities=21% Similarity=0.260 Sum_probs=73.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH-~~gIvHr 80 (529)
..|+.-|++|....|.--.-+..- ...|||+|+..+-...-.-.+..++...+..+-.|++.-+.-|- ..++||.
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHA 289 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHA 289 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceecc
Confidence 368899999977765544434333 35899999987433332334567888888888888888877765 5689999
Q ss_pred CCCCCcEEEccCCcEEEeccccccc
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
||.--|+|+. +|.+.|+|.+.+..
T Consensus 290 DLSEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 290 DLSEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred chhhhhheEE-CCEEEEEEcccccc
Confidence 9999999985 58999999887643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.075 Score=53.59 Aligned_cols=31 Identities=19% Similarity=0.394 Sum_probs=25.7
Q ss_pred CCcccCCCCCcEEEccCCc-EEEecccccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGV-LKLADFGLANFS 106 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~-vKl~DFGla~~~ 106 (529)
.++|+|+.|.|||++.++. +-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997554 579999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.16 Score=52.66 Aligned_cols=28 Identities=36% Similarity=0.624 Sum_probs=24.5
Q ss_pred CcccCCCCCcEEEcc-CCcEEEecccccc
Q 009654 77 VLHRDIKGSNLLVNN-EGVLKLADFGLAN 104 (529)
Q Consensus 77 IvHrDIKp~NILl~~-~g~vKl~DFGla~ 104 (529)
.+|.|+.+.|||+++ ++.++++||+.|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 4789999999763
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.091 Score=53.61 Aligned_cols=30 Identities=37% Similarity=0.588 Sum_probs=27.0
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988877899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.25 Score=52.23 Aligned_cols=28 Identities=29% Similarity=0.254 Sum_probs=23.4
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLA 103 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla 103 (529)
...+|.|+-+.|||+++ +.+.++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence 45799999999999754 56999999865
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.13 Score=52.57 Aligned_cols=30 Identities=33% Similarity=0.550 Sum_probs=26.0
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.|++|+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999876666899999764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.29 Score=47.02 Aligned_cols=84 Identities=24% Similarity=0.282 Sum_probs=58.5
Q ss_pred HHHHHHHHhC---CCCCc--cceeeEEEcc----------------CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHH
Q 009654 2 AREILILRRL---DHPNI--IKLEGLITSR----------------LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60 (529)
Q Consensus 2 ~rEi~iL~~L---~HpnI--vkl~~~~~~~----------------~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~ 60 (529)
..|.+..-+| .+.++ |+++|++.-. .....-||.||+.... .++..
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~---- 168 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR---- 168 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----
Confidence 4566665555 45566 8999987322 1123467888877643 22333
Q ss_pred HHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccc
Q 009654 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103 (529)
Q Consensus 61 i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla 103 (529)
-+.+|++-|..+|..||+-+|+++.|.. .=||+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 3457888899999999999999999986 3489999865
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.14 Score=52.08 Aligned_cols=29 Identities=28% Similarity=0.509 Sum_probs=25.3
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.1 Score=50.79 Aligned_cols=29 Identities=24% Similarity=0.454 Sum_probs=25.9
Q ss_pred CCcccCCCCCcEEEcc-CCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNN-EGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~-~g~vKl~DFGla~ 104 (529)
+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5999999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.05 E-value=0.22 Score=50.44 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=25.8
Q ss_pred CCcccCCCCCcEEEccC----CcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNNE----GVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~----g~vKl~DFGla~ 104 (529)
+++|+|+.+.|||++.+ +.+.|+||+.|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999874 889999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.54 E-value=0.57 Score=44.05 Aligned_cols=94 Identities=17% Similarity=0.217 Sum_probs=60.1
Q ss_pred CHHHHHHHHhCCCCCccc-eeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvk-l~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|..|+++|..+.--++-. +|.+-. .++.|||+.|-.+..+.... + +.-+..+++.---|-..||-|
T Consensus 62 l~kEakiLeil~g~~~~p~vy~yg~------~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H 128 (201)
T COG2112 62 LEKEAKILEILAGEGVTPEVYFYGE------DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEH 128 (201)
T ss_pred HHHHHHHHHHhhhcCCCceEEEech------hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccch
Confidence 467999999887655543 433322 36679999995444432211 1 222334555545566789999
Q ss_pred cCCC-CCcEEEccCCcEEEeccccccccC
Q 009654 80 RDIK-GSNLLVNNEGVLKLADFGLANFSN 107 (529)
Q Consensus 80 rDIK-p~NILl~~~g~vKl~DFGla~~~~ 107 (529)
..|. |.-++|.+++.+.|+||..|++..
T Consensus 129 ~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 129 GELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 9986 455555566699999999987443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.07 E-value=0.17 Score=48.01 Aligned_cols=28 Identities=36% Similarity=0.554 Sum_probs=24.7
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
.+|+|+.|.||++.++| ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998777 89999998743
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=90.66 E-value=0.33 Score=48.81 Aligned_cols=47 Identities=28% Similarity=0.408 Sum_probs=35.4
Q ss_pred HHHHHHHHHHHHHHHHHC--CCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 58 IKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 58 ~~~i~~Qll~gL~~LH~~--gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
....+..+-..+.-.+.. -++|.|+.|+|+|+++.|.++|+||.-|.
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 344444455555555544 58999999999999998999999998764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.64 E-value=0.41 Score=45.60 Aligned_cols=31 Identities=23% Similarity=0.365 Sum_probs=25.6
Q ss_pred HCCCcccCCCCCcEEEccCC-----cEEEecccccc
Q 009654 74 SRGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN 104 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g-----~vKl~DFGla~ 104 (529)
...++|||+.+.||++..++ .+.|+||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 34699999999999997543 58999999764
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=90.01 E-value=0.4 Score=49.00 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=27.5
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
+++|+|+.+.|||++.++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.78 E-value=0.37 Score=49.86 Aligned_cols=28 Identities=25% Similarity=0.469 Sum_probs=25.1
Q ss_pred CcccCCCCCcEEEccCCc-EEEecccccc
Q 009654 77 VLHRDIKGSNLLVNNEGV-LKLADFGLAN 104 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~-vKl~DFGla~ 104 (529)
|||+|+.|.|||++.+.. +.++||+-|.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 8999999763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=89.77 E-value=0.32 Score=50.69 Aligned_cols=29 Identities=21% Similarity=0.560 Sum_probs=25.5
Q ss_pred CCcccCCCCCcEEEcc-CCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNN-EGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~-~g~vKl~DFGla~ 104 (529)
.++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4689999998774
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=89.34 E-value=1.6 Score=46.48 Aligned_cols=27 Identities=19% Similarity=0.418 Sum_probs=22.9
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLA 103 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla 103 (529)
..+|+||.+.|||++.++ ++++|..++
T Consensus 231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 231 ALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred ceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 589999999999998765 888887655
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.64 E-value=2 Score=46.46 Aligned_cols=27 Identities=30% Similarity=0.560 Sum_probs=22.9
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLA 103 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla 103 (529)
.++|.|+-+.|||++.+ .++|+||..|
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeeccc
Confidence 47999999999987654 4999999865
|
|
| >PF13202 EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ_B 1UHI_A 1UHH_B 1EJ3_B 1UHK_A 2ZFD_A 1UHN_A | Back alignment and domain information |
|---|
Probab=87.08 E-value=0.27 Score=30.47 Aligned_cols=20 Identities=5% Similarity=0.027 Sum_probs=17.9
Q ss_pred HHHHHHhcCCCCCccccccc
Q 009654 307 TQFAKKINGHSLHILKDDEL 326 (529)
Q Consensus 307 ~~~~~~~d~~~~g~~~~ee~ 326 (529)
.+.|+.+|.|+||.++.+|+
T Consensus 2 ~~~F~~~D~d~DG~is~~E~ 21 (25)
T PF13202_consen 2 KDAFQQFDTDGDGKISFEEF 21 (25)
T ss_dssp HHHHHHHTTTSSSEEEHHHH
T ss_pred HHHHHHHcCCCCCcCCHHHH
Confidence 56899999999999999886
|
... |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=86.89 E-value=2.2 Score=43.95 Aligned_cols=91 Identities=18% Similarity=0.266 Sum_probs=69.0
Q ss_pred HHHHHHHhC-----CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCC
Q 009654 3 REILILRRL-----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRG 76 (529)
Q Consensus 3 rEi~iL~~L-----~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH-~~g 76 (529)
+|+.-|.++ .+|-+|.+. ...|||-|+..+-+..-.-+...|+..+.++.-.|++..+.-|- ..-
T Consensus 334 kEmhNL~RMq~~GlpcP~vV~lk---------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~ 404 (531)
T KOG2269|consen 334 KEMHNLSRMQKHGLPCPQVVKLK---------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECL 404 (531)
T ss_pred HHHHHHHHHHhcCCCCCceeeee---------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhh
Confidence 577667666 456666662 24789999987544433335567999999999999999887764 667
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccc
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLA 103 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla 103 (529)
+||-||.--|||+.. |.+-++|...+
T Consensus 405 LVHADlSEyN~Lw~~-gKvw~IDVsQs 430 (531)
T KOG2269|consen 405 LVHADLSEYNLLWTP-GKVWVIDVSQS 430 (531)
T ss_pred eeecchhhhhheecC-CceEEEechhc
Confidence 999999999999976 58889987654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.77 E-value=1.1 Score=46.30 Aligned_cols=28 Identities=25% Similarity=0.204 Sum_probs=23.5
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999763
|
|
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=84.38 E-value=0.47 Score=30.52 Aligned_cols=21 Identities=5% Similarity=0.025 Sum_probs=19.0
Q ss_pred HHHHHHHhcCCCCCccccccc
Q 009654 306 RTQFAKKINGHSLHILKDDEL 326 (529)
Q Consensus 306 ~~~~~~~~d~~~~g~~~~ee~ 326 (529)
+.+.|+.+|.|++|.|+.+|+
T Consensus 2 ~~~~F~~~D~d~dG~I~~~Ef 22 (29)
T PF00036_consen 2 LKEAFREFDKDGDGKIDFEEF 22 (29)
T ss_dssp HHHHHHHHSTTSSSEEEHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHH
Confidence 567899999999999999886
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=84.15 E-value=0.82 Score=47.25 Aligned_cols=52 Identities=23% Similarity=0.275 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHHHHH---HHH-HCCCcccCCCCCcEEEccCC------------------cEEEeccccccccC
Q 009654 56 AQIKCYMNQLLHGLE---HCH-SRGVLHRDIKGSNLLVNNEG------------------VLKLADFGLANFSN 107 (529)
Q Consensus 56 ~~~~~i~~Qll~gL~---~LH-~~gIvHrDIKp~NILl~~~g------------------~vKl~DFGla~~~~ 107 (529)
+-++.++.||+.-.- .|- ..+.+|-||||+||||-+.. .++|.||.++...+
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 446667777654431 122 34699999999999985432 25677887776543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 529 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-51 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-50 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-50 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-50 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-46 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-46 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-46 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-46 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-46 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-45 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-44 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-44 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-44 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-44 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-44 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-44 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-44 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-44 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-44 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-44 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-44 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-44 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-44 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-44 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-44 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-43 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-43 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-43 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-43 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-43 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-43 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-43 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-43 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-43 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-43 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-43 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-43 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-43 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-43 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-43 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-43 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-43 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-43 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-43 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-43 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-43 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-43 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-42 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-41 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-41 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-40 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-40 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-39 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-39 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-39 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-39 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-39 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-38 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-38 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-37 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-37 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-36 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-36 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-36 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-36 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-36 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-36 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-36 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-36 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-36 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-35 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-35 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-35 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-35 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-35 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-35 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-35 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-35 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-35 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-35 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-35 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-35 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-35 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-35 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-35 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-35 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-35 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-35 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-35 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-35 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-35 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-35 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-35 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-35 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-35 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-35 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-35 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-35 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-35 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-35 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-35 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-35 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-35 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-35 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-35 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-35 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-35 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-35 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-35 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-35 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-35 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-35 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-35 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-35 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-35 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-35 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-35 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-35 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-35 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-35 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-35 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-35 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-35 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-35 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-35 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-35 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-35 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-35 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-35 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-35 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-35 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-35 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-35 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-35 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-35 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-34 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-34 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-34 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-34 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-34 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-34 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-34 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-34 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-34 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-34 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-34 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-34 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-34 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-34 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-34 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-34 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-34 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-34 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-34 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-34 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-34 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-34 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-34 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-34 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-34 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-34 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-34 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-34 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-34 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-34 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-34 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-33 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-33 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-33 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-33 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-33 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-32 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-32 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-31 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-31 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-31 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-31 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-31 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-30 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-30 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-30 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-30 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-30 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-30 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-30 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-30 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-30 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-30 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-30 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-30 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-30 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-30 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-30 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-30 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-30 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-30 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-30 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-29 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-29 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-29 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-29 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-29 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-29 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-29 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-29 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-29 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-28 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-28 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-26 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-26 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-25 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-25 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-25 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-25 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-25 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-25 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-25 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-25 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-25 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-25 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-25 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-24 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-24 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-24 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-23 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-17 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-17 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-17 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 3e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 3e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-04 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 430 bits (1108), Expect = e-149
Identities = 109/284 (38%), Positives = 156/284 (54%), Gaps = 14/284 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLS------CSIYLVFEYMEHDITGLLSCPDIKFSEA 56
REI IL+ L H N++ L + ++ S SIYLVF++ EHD+ GLLS +KF+ +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQP 113
+IK M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
T+RVVTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 174 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRA 230
CGS + W + + +++ K A++LI+ LL ++P +R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 231 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 274
+ AL ++F + P DL + + + RRK
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP--PRRKH 346
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-136
Identities = 108/288 (37%), Positives = 153/288 (53%), Gaps = 9/288 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L HPNII L + +I LVF++ME D+ ++ + + + IK YM
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
L GLE+ H +LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT W
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRW 177
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
YR PELL GA YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++ W
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237
Query: 183 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
LP FK L F ++LI+ L P R TA+ AL +YF
Sbjct: 238 PDMCSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
Query: 242 STKPYACDLSSLPIYPPSKEIDAKHRE---DARRKKVGGRVRGAETRK 286
S +P LP E + +RK+ +G +K
Sbjct: 296 SNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-116
Identities = 97/276 (35%), Positives = 142/276 (51%), Gaps = 11/276 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE+ +L+ L H NI+ L +I + S+ LVFEY++ D+ L + +K ++
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTE--KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
QLL GL +CH + VLHRD+K NLL+N G LKLADFGLA S + + VVTL
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTL 164
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYRPP++LLG+TDY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224
Query: 182 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
W + + +L L + +L+ LL E R +A A+ +
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 241 FSTKPYACDLSSLPIYP---PSKEIDAKHREDARRK 273
F + LP KEI + R
Sbjct: 285 FLSLGERIH--KLPDTTSIFALKEIQLQKEASLRSA 318
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-113
Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 17/271 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-----FSEAQ 57
REI +++ L H NI++L +I + + LVFE+M++D+ + +
Sbjct: 52 REISLMKELKHENIVRLYDVIHTE--NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL 109
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTS 116
+K + QLL GL CH +LHRD+K NLL+N G LKL DFGLA F +S
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSS 167
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
VVTLWYR P++L+G+ Y S+D+WS GC+ AE++ GKP+ G + EQL IF + G+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 177 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKD-----LPTTAVNLIETLLSVEPYKRA 230
P + W +KLP Q+P LR+ + L ++ + LL + P R
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPP-RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 231 TASAALASEYFSTKPYACDLSSLPIYPPSKE 261
+A AL +F+ + + +
Sbjct: 287 SAKQALHHPWFAEYYHHASMGGSRSHHHHHH 317
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 341 bits (875), Expect = e-113
Identities = 96/338 (28%), Positives = 161/338 (47%), Gaps = 39/338 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFS 54
REI +LR L HPN+I L+ + S ++L+F+Y EHD+ ++ + ++
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGH 110
+K + Q+L G+ + H+ VLHRD+K +N+LV G +K+AD G A N+
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 111 RQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---- 164
+ L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246
Query: 165 -----EQLHKIFKLCGSPPDDYWKK-SKLPHATLFKP---QQPYDSS-----LRETFKDL 210
+QL +IF + G P D W+ K+P + + Y + + +
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 211 PTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP---IYPPSKEIDAKHR 267
+ A +L++ LL+++P KR T+ A+ YF P YP + + +
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEP 366
Query: 268 EDA----RRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 301
+D +++ G T + ++ P++
Sbjct: 367 DDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-113
Identities = 98/245 (40%), Positives = 139/245 (56%), Gaps = 6/245 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L HPNI+ L +I S + LVFE+ME D+ +L ++QIK Y+
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
QLL G+ HCH +LHRD+K NLL+N++G LKLADFGLA F + T VVTL
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTL 183
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR P++L+G+ Y SVD+WS+GC+FAE++ GKP+ G T+ +QL KIF + G+P
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 182 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
W + +LP Q ++L+ +L +P KR +A A+ Y
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
Query: 241 FSTKP 245
F
Sbjct: 304 FKDLD 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-113
Identities = 93/252 (36%), Positives = 138/252 (54%), Gaps = 16/252 (6%)
Query: 3 REILILRRL---DHPNIIKLEGLITSR---LSCSIYLVFEYMEHDITGLL-SCPDIKFSE 55
RE+ +LRRL +HPN+++L + + + LVFE+++ D+ L P
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 119
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 114
IK M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA + ++ L
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMAL 176
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T VVTLWYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L
Sbjct: 177 TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 175 GSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
G PP+D W + LP P + ++ ++ + L+ +L+ P+KR +A
Sbjct: 236 GLPPEDDWPRDVSLPRGAF--PPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 234 AALASEYFSTKP 245
AL Y
Sbjct: 293 RALQHSYLHKDE 304
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-113
Identities = 93/242 (38%), Positives = 141/242 (58%), Gaps = 7/242 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI IL+ L H NI+KL +I ++ + LVFE+++ D+ LL + K ++
Sbjct: 49 REISILKELKHSNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
QLL+G+ +CH R VLHRD+K NLL+N EG LK+ADFGLA F + T +VTL
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTL 164
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR P++L+G+ Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 182 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
W ++LP K L + ++L+ +L ++P +R TA AL Y
Sbjct: 225 WPNVTELPKYDPNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 241 FS 242
F
Sbjct: 284 FK 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-112
Identities = 99/246 (40%), Positives = 140/246 (56%), Gaps = 8/246 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L H NI++L ++ S + LVFE+ + D+ + +K ++
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
QLL GL CHSR VLHRD+K NLL+N G LKLA+FGLA F + ++ VVTL
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTL 165
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 180
WYRPP++L GA Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 181 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
W +KLP + P P +SL L T +L++ LL P +R +A AL
Sbjct: 226 QWPSMTKLPDYKPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 240 YFSTKP 245
YFS
Sbjct: 285 YFSDFC 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-112
Identities = 99/273 (36%), Positives = 148/273 (54%), Gaps = 18/273 (6%)
Query: 3 REILILRRL---DHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLL-SCPDIKFSE 55
RE+ +LR L +HPN+++L + T + + LVFE+++ D+T L P+
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 114
IK M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + + L
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMAL 176
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
TS VVTLWYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI +
Sbjct: 177 TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 175 GSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
G P ++ W + LP + + D+ +L+ L+ P KR +A
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSA---QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292
Query: 234 AALASEYFSTKPYACD--LSSLPIYPPSKEIDA 264
+AL+ YF + S LP + E++
Sbjct: 293 SALSHPYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-109
Identities = 87/262 (33%), Positives = 129/262 (49%), Gaps = 7/262 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L++L HPN++ L + + ++LVFEY +H + L E +K
Sbjct: 51 REIRMLKQLKHPNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
Q L + CH +HRD+K N+L+ V+KL DFG A + G V T
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATR 166
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR PELL+G T YGP VD+W++GCVFAELL G P+ G+++V+QL+ I K G +
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 182 WKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
+ S + + K P L F ++ A+ L++ L ++P +R T L
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 240 YFSTKPYACDLSSLPIYPPSKE 261
YF DL+ P
Sbjct: 287 YFENIREIEDLAKEHDKPAENL 308
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-108
Identities = 95/252 (37%), Positives = 144/252 (57%), Gaps = 14/252 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCY 61
RE+ +L+ L H NII+L+ +I ++L+FEY E+D+ + PD S IK +
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHN--HRLHLIFEYAENDLKKYMDKNPD--VSMRVIKSF 137
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLA-NFSNTGHRQPLT 115
+ QL++G+ CHSR LHRD+K NLL++ VLK+ DFGLA F + T
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFT 195
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
++TLWYRPPE+LLG+ Y SVD+WS+ C++AE+L+ P+ G +E++QL KIF++ G
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255
Query: 176 SPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234
P D W + LP P+ + R L ++L+ +L ++P KR +A
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 235 ALASEYFSTKPY 246
AL YFS +
Sbjct: 316 ALEHPYFSHNDF 327
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-108
Identities = 82/271 (30%), Positives = 141/271 (52%), Gaps = 15/271 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L++L H N++ L + + YLVFE+++H I L ++ Y+
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL 130
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 121
Q+++G+ CHS ++HRDIK N+LV+ GV+KL DFG A + G + V T
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATR 188
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR PELL+G YG +VD+W++GC+ E+ +G+P+ G ++++QL+ I G+ +
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 182 WKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
+ +K P + P+ L + L ++L + L ++P KR + L +
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308
Query: 240 YFSTKPYACDLSSLPIYPPSKEIDAKHREDA 270
+F +A S+E+ K ++DA
Sbjct: 309 FFQMDGFAER--------FSQELQLKVQKDA 331
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 4e-88
Identities = 92/249 (36%), Positives = 129/249 (51%), Gaps = 12/249 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLL---SCPDIKFSE 55
RE+ I+R+LDH NI++L S + LV +Y+ + + S
Sbjct: 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPL 114
+K YM QL L + HS G+ HRDIK NLL++ + VLKL DFG A G +P
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPN 213
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
S + + +YR PEL+ GATDY S+D+WS GCV AELL+G+PI G + V+QL +I K+
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273
Query: 175 GSPPDDYWKKSKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
G+P + ++ P+ T FK PQ + P A+ L LL P R T
Sbjct: 274 GTPTREQIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 234 AALASEYFS 242
A A +F
Sbjct: 333 EACAHSFFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 2e-84
Identities = 89/249 (35%), Positives = 128/249 (51%), Gaps = 12/249 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLL---SCPDIKFSE 55
RE+ I+R + HPN++ L+ S + LV EY+ + +
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPL 114
IK YM QLL L + HS G+ HRDIK NLL++ GVLKL DFG A G +P
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPN 198
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
S + + +YR PEL+ GAT+Y ++D+WS GCV AEL+ G+P+ G + ++QL +I K+
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATAS 233
G+P + K+ P+ K Q + F P A++LI LL P R TA
Sbjct: 259 GTPSREQI-KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 234 AALASEYFS 242
AL +F
Sbjct: 318 EALCHPFFD 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-77
Identities = 76/254 (29%), Positives = 118/254 (46%), Gaps = 16/254 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS-----IYLVFEYME---HDITGLLSCPDIKFS 54
+ + L L HPNI++L+ + + +V EY+ H +
Sbjct: 68 QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP 127
Query: 55 EAQIKCYMNQLLHGLE--HCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHR 111
IK ++ QL+ + H S V HRDIK N+LVN G LKL DFG A +
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-- 185
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+P + + + +YR PEL+ G Y +VD+WSVGC+FAE+++G+PI +G QLH+I
Sbjct: 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
++ G P + +K H + P+ + + A +L+ LL P +
Sbjct: 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305
Query: 229 RATASAALASEYFS 242
R AL YF
Sbjct: 306 RMKPYEALCHPYFD 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 5e-76
Identities = 87/282 (30%), Positives = 130/282 (46%), Gaps = 46/282 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS-------------------------------- 30
RE+ I++ LDH NIIKL +
Sbjct: 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 31 ----IYLVFEYME---HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 83
+ ++ EY+ H + I Y+ QL + HS G+ HRDIK
Sbjct: 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168
Query: 84 GSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 142
NLLVN + LKL DFG A +P + + + +YR PEL+LGAT+Y PS+DLW
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLW 226
Query: 143 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-PQQPYDS 201
S+GCVF EL++GKP+ G T ++QL +I ++ G+P + + PH T + P
Sbjct: 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLK-AK 284
Query: 202 SLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 242
R+ + P+ A++L+E +L EP R A+A +F
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 5e-76
Identities = 81/253 (32%), Positives = 127/253 (50%), Gaps = 18/253 (7%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKC 60
REI IL L PNII L ++ +S + LVFE+ D L ++ I+
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRF 134
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVV 119
YM ++L L++CHS G++HRD+K N+++++E L+L D+GLA F + G Q RV
Sbjct: 135 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVA 192
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 178
+ +++ PELL+ Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 179 -DDYWKKSKLPHATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRA 230
DY K + F S R E + A++ ++ LL + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 231 TASAALASEYFST 243
TA A+ YF T
Sbjct: 313 TAREAMEHPYFYT 325
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 7e-76
Identities = 72/246 (29%), Positives = 110/246 (44%), Gaps = 8/246 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI +L HPNI+ L + + +YLV E M D+ ++ I S I+
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
+M +L GL H GV+HRD+ N+L+ + + + DF LA T V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVT 195
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
WYR PEL++ + VD+WS GCV AE+ K + +G T QL+KI ++ G+P
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 180 DYWKKSKLPHATLF-KPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ P A + + + A++LI +L P +R + AL
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 237 ASEYFS 242
YF
Sbjct: 316 RHPYFE 321
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 7e-75
Identities = 88/247 (35%), Positives = 131/247 (53%), Gaps = 9/247 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI IL R H NII + +I + +Y+V + ME D+ LL + S I
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL--SNDHIC 131
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLTSR 117
++ Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA + H LT
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
V T WYR PE++L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 178 PDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
+ A + P+ + F + + A++L++ +L+ P+KR A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 236 LASEYFS 242
LA Y
Sbjct: 312 LAHPYLE 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 4e-74
Identities = 87/246 (35%), Positives = 136/246 (55%), Gaps = 13/246 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+L+L+ + H N+I L + T S YLV +M+ D+ ++ FSE +I
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKI 128
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL++ HS GV+HRD+K NL VN + LK+ DFGLA ++ +T V
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYV 184
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT WYR PE++L Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244
Query: 179 DDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
++ +K A + P + F A +L+E +L ++ KR TA+ AL
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304
Query: 237 ASEYFS 242
+F
Sbjct: 305 THPFFE 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 8e-74
Identities = 84/246 (34%), Positives = 135/246 (54%), Gaps = 12/246 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + T + YLV +M D+ L+ K E +I
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRI 130
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL + H+ G++HRD+K NL VN + LK+ DFGLA +++ +T V
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYV 186
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT WYR PE++L Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246
Query: 179 DDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
++ ++ + A + P + AVNL+E +L ++ +R TA AL
Sbjct: 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 237 ASEYFS 242
A YF
Sbjct: 307 AHPYFE 312
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 2e-73
Identities = 91/257 (35%), Positives = 137/257 (53%), Gaps = 20/257 (7%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS------------IYLVFEYMEHDITGLLSCPD 50
REI I+RRLDH NI+K+ ++ S +Y+V EYME D+ +L
Sbjct: 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116
Query: 51 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA--NFSN 107
+ E + +M QLL GL++ HS VLHRD+K +NL +N E VLK+ DFGLA +
Sbjct: 117 L--LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 167
H+ L+ +VT WYR P LLL +Y ++D+W+ GC+FAE+L GK + G E+EQ+
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 168 HKIFKLCGSPPDDYWKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225
I + ++ ++ S +P +P L + + AV+ +E +L+
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFS 293
Query: 226 PYKRATASAALASEYFS 242
P R TA AL+ Y S
Sbjct: 294 PMDRLTAEEALSHPYMS 310
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 3e-73
Identities = 88/262 (33%), Positives = 136/262 (51%), Gaps = 15/262 (5%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + T S +YLV M D+ ++ C + ++ +
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHV 134
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA + +T V
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYV 190
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T WYR PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 179 DDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ KK A + + F AV+L+E +L ++ KR TA+ AL
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 237 ASEYFSTKPYACDLSSLPIYPP 258
A YF+ Y D P+ P
Sbjct: 311 AHAYFA--QYH-DPDDEPVADP 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 6e-73
Identities = 82/255 (32%), Positives = 129/255 (50%), Gaps = 17/255 (6%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI IL+ H NII + + + +Y++ E M+ D+ ++S + S+ I+
Sbjct: 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML--SDDHIQ 115
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------NFSNTGH 110
++ Q L ++ H V+HRD+K SNLL+N+ LK+ DFGLA N TG
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ + V T WYR PE++L + Y ++D+WS GC+ AEL + +PI GR QL I
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 171 FKLCGSPPDDYWKKS-KLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPY 227
F + G+P D + + P A + P L + F + ++L++ +L +P
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 228 KRATASAALASEYFS 242
KR TA AL Y
Sbjct: 296 KRITAKEALEHPYLQ 310
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 1e-71
Identities = 88/329 (26%), Positives = 140/329 (42%), Gaps = 74/329 (22%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI IL RL+H +++K+ ++ + +Y+V E + D L P + +E IK
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIK 159
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------- 103
+ LL G+++ HS G+LHRD+K +N LVN + +K+ DFGLA
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 104 ----------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL- 152
++ LT VVT WYR PEL+L +Y ++D+WS+GC+FAELL
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 153 ----------IGKPILQG--------------------RTEVEQLHKIFKLCGSPPDDYW 182
P+ G R +QL+ IF + G+P ++
Sbjct: 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI 339
Query: 183 KKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
+ + A + P L E F A++L++ +L P KR T + LA +
Sbjct: 340 EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHRED 269
F + E +A +
Sbjct: 400 FK-----------EVRIAEVETNATEKVR 417
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-69
Identities = 82/279 (29%), Positives = 135/279 (48%), Gaps = 41/279 (14%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
REI+IL L H NI+ L ++ + +YLVF+YME D+ ++ + +
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL--EPVHKQYV 114
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------------------ 103
+ QL+ +++ HS G+LHRD+K SN+L+N E +K+ADFGL+
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 104 --NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161
+ + LT V T WYR PE+LLG+T Y +D+WS+GC+ E+L GKPI G
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 162 TEVEQLHKIFKLCGSPPDDYW----------------KKSKLPHATLFKPQQPYDSSLRE 205
+ + QL +I + P ++ +K ++ + + + L +
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294
Query: 206 TFKDLPTT--AVNLIETLLSVEPYKRATASAALASEYFS 242
A++L++ LL P KR +A+ AL + S
Sbjct: 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 3e-68
Identities = 77/282 (27%), Positives = 138/282 (48%), Gaps = 34/282 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+++++ ++H NII L + T + S +Y+V E M+ ++ ++ ++
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERM 129
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T V
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 187
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT +YR PE++LG Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P
Sbjct: 188 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 179 DDYWKK---------SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETL 221
++ KK P ++ + E K + A +L+ +
Sbjct: 247 PEFMKKLQPTVRTYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 302
Query: 222 LSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID 263
L ++ KR + AL Y + + D S PP
Sbjct: 303 LVIDASKRISVDEALQHPYIN--VWY-DPSEAEAPPPKIPDK 341
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-67
Identities = 91/321 (28%), Positives = 135/321 (42%), Gaps = 66/321 (20%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI IL RL II+L LI +Y+V E + D+ L P I +E IK
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIK 132
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------- 103
+ LL G H G++HRD+K +N L+N + +K+ DFGLA
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 104 -----NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG---- 154
N ++ LTS VVT WYR PEL+L +Y S+D+WS GC+FAELL
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 155 -------KPILQG-----------------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 190
P+ G ++ +QL+ IF + G+P +D K P
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312
Query: 191 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 248
+ P+ +L++ + + +NL+E++L P KR T AL Y
Sbjct: 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK------ 366
Query: 249 DLSSLPIYPPSKEIDAKHRED 269
+ E + +
Sbjct: 367 -----DVRKKKLENFSTKKII 382
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-67
Identities = 78/279 (27%), Positives = 140/279 (50%), Gaps = 34/279 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+++++ ++H NII L + T + + +YLV E M+ ++ ++ ++
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERM 166
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T V
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 224
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT +YR PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P
Sbjct: 225 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 179 DDYWKK---------SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETL 221
++ KK P + + E K + A +L+ +
Sbjct: 284 PEFMKKLQPTVRNYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 339
Query: 222 LSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSK 260
L ++P KR + AL Y + + D + + PP
Sbjct: 340 LVIDPAKRISVDDALQHPYIN--VWY-DPAEVEAPPPQI 375
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-48
Identities = 56/267 (20%), Positives = 105/267 (39%), Gaps = 52/267 (19%)
Query: 3 REILILRRLDHPNIIKL-----------EGLITSRLSCSIYLVFEYME-HDITGLLSCPD 50
E+++L L+H +++ + + + ++++ EY E + L+ +
Sbjct: 51 SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110
Query: 51 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------- 103
+ + Q+L L + HS+G++HRD+K N+ ++ +K+ DFGLA
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 104 ------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157
+ + G LTS + T Y E+L G Y +D++S+G +F E++ P
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPF 228
Query: 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 217
G V L K+ + P D+ + +
Sbjct: 229 STGMERVNILKKLRSVSIEFPPDFD-------------------------DNKMKVEKKI 263
Query: 218 IETLLSVEPYKRATASAALASEYFSTK 244
I L+ +P KR A L S + K
Sbjct: 264 IRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 57/255 (22%), Positives = 97/255 (38%), Gaps = 24/255 (9%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCP--DIKFSEAQ 57
RE +L++L+H NI+KL + + L+ E+ + +L P E++
Sbjct: 54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQP 113
+ ++ G+ H G++HR+IK N++ + + V KL DFG A +
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQ 171
Query: 114 LTSRVVTLWYRPPELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQGRT 162
S T Y P++ A YG +VDLWS+G F G R
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222
E ++KI S +K++ + P SL + L ++ +L
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANIL 287
Query: 223 SVEPYKRATASAALA 237
+ K A
Sbjct: 288 EADQEKCWGFDQFFA 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 45/257 (17%)
Query: 3 REILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
EI L +L + II+L + IY+V E D+ L + K
Sbjct: 75 NEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKS 131
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV 119
Y +L + H G++H D+K +N L+ + G+LKL DFG+AN S+V
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 120 TLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLH 168
T+ Y PPE + + P D+WS+GC+ + GK Q + +LH
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250
Query: 169 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
I + ++ ++++ L +P +
Sbjct: 251 AIID--PNHEIEFP-------------------------DIPEKDLQDVLKCCLKRDPKQ 283
Query: 229 RATASAALASEYFSTKP 245
R + LA Y +
Sbjct: 284 RISIPELLAHPYVQIQT 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 61/308 (19%), Positives = 108/308 (35%), Gaps = 45/308 (14%)
Query: 3 REILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
EI L +L + II+L + IY+V E D+ L + K
Sbjct: 56 NEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKS 112
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV 119
Y +L + H G++H D+K +N L+ + G+LKL DFG+AN S+V
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 120 TLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLH 168
T+ Y PPE + + P D+WS+GC+ + GK Q + +LH
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231
Query: 169 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
I + ++ ++++ L +P +
Sbjct: 232 AIID--PNHEIEFPDI-------------------------PEKDLQDVLKCCLKRDPKQ 264
Query: 229 RATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTT 288
R + LA Y + + + + K + + + + +
Sbjct: 265 RISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSG 324
Query: 289 RKSHGMSK 296
+SH S
Sbjct: 325 GESHNSSS 332
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 32/277 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME--------HDITGLLSCPDIKFS 54
E+ I+ + + + EG+IT+ +Y+++EYME L
Sbjct: 92 NELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 55 EAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
IKC + +L+ + H+ + + HRD+K SN+L++ G +KL+DFG + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--- 206
Query: 114 LTSRVVTLWYRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KIF 171
+ T + PPE + Y G VD+WS+G + + + +L I
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ + P + + L ++ ++ L P +R T
Sbjct: 267 T------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 232 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 268
+ AL E+ + + SKE+ K ++
Sbjct: 317 SEDALKHEWLADTNIE------DLREFSKELYKKRKK 347
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 55/257 (21%), Positives = 95/257 (36%), Gaps = 28/257 (10%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSE 55
RE +L++L+H NI+KL + + L+ E+ + + E
Sbjct: 54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY--GLPE 111
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 111
++ + ++ G+ H G++HR+IK N++ + + V KL DFG A
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-- 169
Query: 112 QPLTSRVVTLWYRPPELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQG 160
+ S T Y P++ A YG +VDLWS+G F G
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 220
R E ++KI S +K++ + P SL + L ++
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLAN 285
Query: 221 LLSVEPYKRATASAALA 237
+L + K A
Sbjct: 286 ILEADQEKCWGFDQFFA 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 61/308 (19%), Positives = 105/308 (34%), Gaps = 45/308 (14%)
Query: 3 REILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
EI L +L + II+L + IY+V E D+ L + K
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKS 159
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV 119
Y +L + H G++H D+K +N L+ + G+LKL DFG+AN S+V
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 120 TLWYRPPELLLGATD----------YGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLH 168
+ Y PPE + + P D+WS+GC+ + GK Q + +LH
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 169 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
I P ++++ L +P +
Sbjct: 279 AIIDPNHEIE--------FP-------------------DIPEKDLQDVLKCCLKRDPKQ 311
Query: 229 RATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTT 288
R + LA Y + + + + K + + + + +
Sbjct: 312 RISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSG 371
Query: 289 RKSHGMSK 296
+SH S
Sbjct: 372 GESHNSSS 379
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 56/288 (19%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----DI---- 51
M+ EI I R L H +++ G +++V E C ++
Sbjct: 88 MSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLEL----------CRRRSLLELHKRR 135
Query: 52 -KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 110
+E + + Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA
Sbjct: 136 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 194
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ T Y PE+L + VD+WS+GC+ LL+GKP + E +I
Sbjct: 195 GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
Query: 171 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
K +Y +P K + A +LI+ +L +P R
Sbjct: 254 KKN------EY----SIP-------------------KHINPVAASLIQKMLQTDPTARP 284
Query: 231 TASAALASEYFST--KPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 276
T + L E+F++ P ++ L I PP I + + RK +
Sbjct: 285 TINELLNDEFFTSGYIPARLPITCLTI-PPRFSIAPSSLDPSNRKPLT 331
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-43
Identities = 68/271 (25%), Positives = 112/271 (41%), Gaps = 57/271 (21%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----DI---- 51
M+ EI I R L H +++ G +++V E C ++
Sbjct: 62 MSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLEL----------CRRRSLLELHKRR 109
Query: 52 -KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-G 109
+E + + Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA G
Sbjct: 110 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
R T Y PE+L + VD+WS+GC+ LL+GKP + E +
Sbjct: 170 ER--KKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226
Query: 170 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
I K +Y +P K + A +LI+ +L +P R
Sbjct: 227 IKKN------EY----SIP-------------------KHINPVAASLIQKMLQTDPTAR 257
Query: 230 ATASAALASEYFST--KPYACDLSSLPIYPP 258
T + L E+F++ P ++ L I P
Sbjct: 258 PTINELLNDEFFTSGYIPARLPITCLTIPPR 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 52/250 (20%), Positives = 89/250 (35%), Gaps = 39/250 (15%)
Query: 3 REILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
RE+ +LR D HPN+I+ R Y+ E + + D +
Sbjct: 66 REVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITL 123
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHR--QPL 114
+ Q GL H HS ++HRD+K N+L++ ++DFGL G
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 115 TSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIF 171
+ T + PE+L +VD++S GCVF ++ G + + +
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ + A LIE +++++P KR +
Sbjct: 244 ACSLDCLHPEKHEDVI--------------------------ARELIEKMIAMDPQKRPS 277
Query: 232 ASAALASEYF 241
A L +F
Sbjct: 278 AKHVLKHPFF 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 65/248 (26%), Positives = 104/248 (41%), Gaps = 39/248 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL---SCPDIKFSEAQI 58
E+ +LR L HPNI++ I R + ++Y+V EY E D+ ++ + E +
Sbjct: 54 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 59 KCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
M QL L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF- 172
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ V T +Y PE + Y D+WS+GC+ EL P ++ E KI +
Sbjct: 173 AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE- 230
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
G ++P Y L +I +L+++ Y R +
Sbjct: 231 -GKFR-------RIP--------YRYSDELN-----------EIITRMLNLKDYHRPSVE 263
Query: 234 AALASEYF 241
L +
Sbjct: 264 EILENPLI 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-42
Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 34/242 (14%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+ E+ I +L HP+I++L S +YLV E + ++ L FSE + +
Sbjct: 58 VQNEVKIHCQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
+M+Q++ G+ + HS G+LHRD+ SNLL+ +K+ADFGLA H + T
Sbjct: 116 HFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CG 174
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T Y PE+ + +G D+WS+GC+F LLIG+P T L+K+
Sbjct: 175 TPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------ 227
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
DY ++P L A +LI LL P R + S+ L
Sbjct: 228 DY----EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 240 YF 241
+
Sbjct: 265 FM 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 57/259 (22%), Positives = 98/259 (37%), Gaps = 54/259 (20%)
Query: 3 REILILRRLDHPNIIKL--------------EGLITSRLSCSIYLVFEYMEH-DITGLLS 47
RE+ L +LDH NI+ + + +++ E+ + + +
Sbjct: 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 48 -CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NF 105
K + Q+ G+++ HS+ +++RD+K SN+ + + +K+ DFGL +
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 106 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 165
N G R T TL Y PE + DYG VDL+++G + AELL T E
Sbjct: 173 KNDGKR---TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHV-----CDTAFE 223
Query: 166 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225
L + + +D + L++ LLS +
Sbjct: 224 TSKFFTDL---------RDGIIS--------DIFDKKEK-----------TLLQKLLSKK 255
Query: 226 PYKRATASAALASEYFSTK 244
P R S L + K
Sbjct: 256 PEDRPNTSEILRTLTVWKK 274
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 9e-42
Identities = 57/251 (22%), Positives = 94/251 (37%), Gaps = 18/251 (7%)
Query: 3 REILILRRLDHPNIIKL----EGLITSRLSCSIYLVFEYMEH-DITGLLSCPD--IKFSE 55
EI I+++L+HPN++ +GL + L EY E D+ L+ + E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ 112
I+ ++ + L + H ++HRD+K N+++ + K+ D G A + G +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
T V TL Y PELL Y +VD WS G + E + G + Q H +
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 173 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
+ L A F P + L ++ +L +R T
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK---LERWLQCMLMWHQRQRGTD 292
Query: 233 SAALASEYFST 243
F
Sbjct: 293 PQNPNVGCFQA 303
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 41/245 (16%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSE 55
+ EI +L+ LDHPNIIK+ + + +Y+V E E I + SE
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGK-ALSE 123
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 112
+ M Q+++ L + HS+ V+H+D+K N+L + +K+ DFGLA + +
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--E 181
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
T+ T Y PE+ D D+WS G V LL G G + E K
Sbjct: 182 HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-- 237
Query: 173 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
+ + + L AV+L++ +L+ +P +R +A
Sbjct: 238 ----------TYKEP--------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273
Query: 233 SAALA 237
+ L
Sbjct: 274 AQVLH 278
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 74/266 (27%), Positives = 110/266 (41%), Gaps = 46/266 (17%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFS 54
+ EI +L+ LDHPNIIKL + + YLV E+ G L I KF
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFY----EGGELFE--QIINRHKFD 144
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 111
E M Q+L G+ + H ++HRDIK N+L+ N +K+ DFGL++F +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-- 202
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
L R+ T +Y PE+L Y D+WS G + LL G P G+ + + + K+
Sbjct: 203 YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
K + WK + A LI+ +L+ + KR T
Sbjct: 261 KGKYYFDFNDWKN-------------------------ISDEAKELIKLMLTYDYNKRCT 295
Query: 232 ASAALASEYFSTKPYACDLSSLPIYP 257
A AL S + + S
Sbjct: 296 AEEALNSRWIKKYANNINKSDQKTLC 321
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 71/264 (26%), Positives = 113/264 (42%), Gaps = 46/264 (17%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFS 54
+ RE+ +L++LDHPNI+KL + YLV E G L +I +FS
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGY--FYLVGEVYT----GGELFD--EIISRKRFS 124
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 111
E + Q+L G+ + H ++HRD+K NLL+ + + +++ DFGL+
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-- 182
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+ + ++ T +Y PE+L G Y D+WS G + LL G P G E + L K+
Sbjct: 183 KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
K + WKK + +A +LI +L+ P R +
Sbjct: 241 KGKYTFELPQWKK-------------------------VSESAKDLIRKMLTYVPSMRIS 275
Query: 232 ASAALASEYFSTKPYACDLSSLPI 255
A AL E+ T +P
Sbjct: 276 ARDALDHEWIQTYTKEQISVDVPS 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 71/248 (28%), Positives = 104/248 (41%), Gaps = 53/248 (21%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSE 55
RE I R+L HPNI++L I YLVF+ + DI +SE
Sbjct: 54 REARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVARE-------FYSE 104
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 112
A + Q+L + +CHS G++HR++K NLL+ ++ +KLADFGLA N +
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--E 162
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
T Y PE+L Y VD+W+ G + LL+G P + +I
Sbjct: 163 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-- 219
Query: 173 LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
G+ P W + A +LI+++L+V P KR
Sbjct: 220 KAGAYDYPSPEWDTVTP--------------------------EAKSLIDSMLTVNPKKR 253
Query: 230 ATASAALA 237
TA AL
Sbjct: 254 ITADQALK 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-41
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 46/245 (18%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFS 54
+ E+ +L+ LDHPNI+KL + + YLV E G L +I KF+
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRN--YYLVMECY----KGGELFD--EIIHRMKFN 134
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 111
E + Q+L G+ + H ++HRD+K NLL+ + + ++K+ DFGL+
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+ + R+ T +Y PE+L Y D+WS+G + LL G P G+T+ E L K+
Sbjct: 193 KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
K + WK + A +LI+ +L + +R +
Sbjct: 251 KGKYTFDSPEWKN-------------------------VSEGAKDLIKQMLQFDSQRRIS 285
Query: 232 ASAAL 236
A AL
Sbjct: 286 AQQAL 290
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 64/263 (24%), Positives = 111/263 (42%), Gaps = 46/263 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
EI IL++L+HP IIK++ + Y+V E ME + G + + EA
Sbjct: 64 TEIEILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVG-----NKRLKEAT 115
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPL 114
K Y Q+L +++ H G++HRD+K N+L++++ ++K+ DFG + +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLM 173
Query: 115 TSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIF 171
+ T Y PE+L+ Y +VD WS+G + L G P + RT+V +I
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ + W ++ A++L++ LL V+P R T
Sbjct: 234 SGKYNFIPEVW-------------------------AEVSEKALDLVKKLLVVDPKARFT 268
Query: 232 ASAALASEYFSTKPYACDLSSLP 254
AL + + L
Sbjct: 269 TEEALRHPWLQDEDMKRKFQDLL 291
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 72/240 (30%), Positives = 108/240 (45%), Gaps = 37/240 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE+ I L HPNI++L G + +YL+ EY + L KF E + Y
Sbjct: 58 REVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATY 114
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ +L + L +CHS+ V+HRDIK NLL+ + G LK+ADFG + + + R L TL
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TL 171
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
Y PPE++ G + VDLWS+G + E L+GKP + T E +I ++ ++
Sbjct: 172 DYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF 224
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
P + A +LI LL P +R L +
Sbjct: 225 ----TFP-------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 58/245 (23%), Positives = 93/245 (37%), Gaps = 40/245 (16%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
E+ ++ HP ++LE +YL E + EAQ+ Y
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGY 162
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 120
+ L L H HS+G++H D+K +N+ + G KL DFGL G + +
Sbjct: 163 LRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE---VQEGD 219
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
Y PELL G YG + D++S+G E+ + E ++ + G P +
Sbjct: 220 PRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQ--GYLPPE 272
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
+ S LR +++ +L +P RATA A LA
Sbjct: 273 FTAG--------------LSSELR-----------SVLVMMLEPDPKLRATAEALLALPV 307
Query: 241 FSTKP 245
+P
Sbjct: 308 L-RQP 311
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 68/308 (22%), Positives = 120/308 (38%), Gaps = 37/308 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIKFSEAQIKC 60
RE+ +L + HPNI++ S+Y+V +Y E D+ ++ + F E QI
Sbjct: 72 REVAVLANMKHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ Q+ L+H H R +LHRDIK N+ + +G ++L DFG+A N+ + + T
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGT 188
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
+Y PE+ Y D+W++GCV EL K + + + KI GS P
Sbjct: 189 PYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFP-- 243
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
+ Y LR +L+ L P R + ++ L +
Sbjct: 244 -----PVS--------LHYSYDLR-----------SLVSQLFKRNPRDRPSVNSILEKGF 279
Query: 241 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 300
+ + L + +K K R + + + ++K A
Sbjct: 280 IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAK---RPASGQNSISVMPAQKITKPAAK 336
Query: 301 EDVAVRTQ 308
+ + +
Sbjct: 337 YGIPLAYK 344
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 76/266 (28%), Positives = 107/266 (40%), Gaps = 54/266 (20%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKF 53
+EI I++ LDHPNII+L IYLV E + F
Sbjct: 53 FKQEIEIMKSLDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKR-------VF 103
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGH 110
E+ M +L + +CH V HRD+K N L + LKL DFGLA G
Sbjct: 104 RESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ + ++V T +Y P++L G YGP D WS G + LL G P T+ E + KI
Sbjct: 163 -KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219
Query: 171 FKLCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
G+ P+ W S A +LI LL+ P
Sbjct: 220 --REGTFTFPEKDWLNVSP--------------------------QAESLIRRLLTKSPK 251
Query: 228 KRATASAALASEYFSTKPYACDLSSL 253
+R T+ AL E+F + + + L
Sbjct: 252 QRITSLQALEHEWFEKQLSSSPRNLL 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-41
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 46/245 (18%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFS 54
+ RE+ +L++LDHPNI+KL ++ S Y+V E TG L +I +FS
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSS--FYIVGELY----TGGELFD--EIIKRKRFS 119
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 111
E + Q+ G+ + H ++HRD+K N+L+ + + +K+ DFGL+
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-- 177
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+ R+ T +Y PE+L G Y D+WS G + LL G P G+ E + L ++
Sbjct: 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ W+ + A +LI +L+ P R T
Sbjct: 236 TGKYAFDLPQWRT-------------------------ISDDAKDLIRKMLTFHPSLRIT 270
Query: 232 ASAAL 236
A+ L
Sbjct: 271 ATQCL 275
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-41
Identities = 64/250 (25%), Positives = 104/250 (41%), Gaps = 54/250 (21%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKF 53
+ RE+ +L++LDHPNI+KL ++ S Y+V E +I +F
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRK-------RF 118
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGH 110
SE + Q+ G+ + H ++HRD+K N+L+ ++ +K+ DFGL+
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ R+ T +Y PE+L G Y D+WS G + LL G P G+ E + L ++
Sbjct: 178 -TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
Query: 171 FKLCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
G W+ S A +LI +L+ P
Sbjct: 235 --ETGKYAFDLPQWRTISD--------------------------DAKDLIRKMLTFHPS 266
Query: 228 KRATASAALA 237
R TA+ L
Sbjct: 267 LRITATQCLE 276
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 64/249 (25%), Positives = 109/249 (43%), Gaps = 50/249 (20%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFS 54
+ EI IL++L+HP IIK++ + Y+V E M G L + +
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAE---DYYIVLELM----EGGELFD--KVVGNKRLK 237
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR 111
EA K Y Q+L +++ H G++HRD+K N+L++++ ++K+ DFG +
Sbjct: 238 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-- 295
Query: 112 QPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLH 168
+ + T Y PE+L+ Y +VD WS+G + L G P + RT+V
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 169 KIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
+I + + W + S+ A++L++ LL V+P
Sbjct: 356 QITSGKYNFIPEVWAEVSE--------------------------KALDLVKKLLVVDPK 389
Query: 228 KRATASAAL 236
R T AL
Sbjct: 390 ARFTTEEAL 398
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 68/252 (26%), Positives = 107/252 (42%), Gaps = 53/252 (21%)
Query: 1 MAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIK 52
+E+ ILR++ HPNII+L+ + +LVF+ M+ +T
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKV-------T 120
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 112
SE + + M LL + H ++HRD+K N+L++++ +KL DFG + + G +
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--E 178
Query: 113 PLTSRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 167
L T Y PE++ + + YG VD+WS G + LL G P R ++ L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 168 HKIFKLCGSP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225
I + G+ W +T KD L+ L V+
Sbjct: 239 RMI--MSGNYQFGSPEWD------------------DYSDTVKD-------LVSRFLVVQ 271
Query: 226 PYKRATASAALA 237
P KR TA ALA
Sbjct: 272 PQKRYTAEEALA 283
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 65/272 (23%), Positives = 102/272 (37%), Gaps = 56/272 (20%)
Query: 3 REILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME---HDI---TGLLSCPDIKFSE 55
EI +L D HPN+I+ T+ +Y+ E D+ + E
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-------------LKLADFGL 102
+ Q+ G+ H HS ++HRD+K N+LV+ + ++DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 103 ANFSNTGH---RQPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELL- 152
++G R L + T +R PELL + + S+D++S+GCVF +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 212
GK + E I + L + +D SL D
Sbjct: 235 KGKHPFGDKYSRES--NIIR----------GIFSLDE-----MKCLHDRSLIAEATD--- 274
Query: 213 TAVNLIETLLSVEPYKRATASAALASEYFSTK 244
LI ++ +P KR TA L F K
Sbjct: 275 ----LISQMIDHDPLKRPTAMKVLRHPLFWPK 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 39/243 (16%), Positives = 66/243 (27%), Gaps = 33/243 (13%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI------KFSEAQIKC 60
+ P +L + L+ D+ L S D +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
QL+ + S+G++H NL + +G L L D T + V
Sbjct: 199 LTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVP 254
Query: 121 LWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP- 178
+ Y P E L + +++ W +G + C P
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRV---------------------WCLFLPF 293
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
K DS + LP LI L+ + +R A+ +
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
Query: 239 EYF 241
F
Sbjct: 354 PEF 356
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 71/262 (27%), Positives = 109/262 (41%), Gaps = 45/262 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI I L HPNI+++ R IYL+ E+ ++ L +F E + +
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATF 119
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
M +L L +CH R V+HRDIK NLL+ +G LK+ADFG + + + R+ + TL
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TL 176
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
Y PPE++ G + VDLW G + E L+G P + E +I + D
Sbjct: 177 DYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL 229
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
K P L + +LI LL P +R + +
Sbjct: 230 ----KFP-------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
Query: 242 --STKPYACDLSSLPIYPPSKE 261
+++ LP S +
Sbjct: 267 KANSRRV------LPPVYQSTQ 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-40
Identities = 71/248 (28%), Positives = 104/248 (41%), Gaps = 53/248 (21%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSE 55
RE I R+L HPNI++L I YLVF+ + DI +SE
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVARE-------FYSE 127
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 112
A + Q+L + +CHS G++HR++K NLL+ ++ +KLADFGLA N +
Sbjct: 128 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--E 185
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
T Y PE+L Y VD+W+ G + LL+G P + +I
Sbjct: 186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-- 242
Query: 173 LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
G+ P W + A +LI+++L+V P KR
Sbjct: 243 KAGAYDYPSPEWDTVTP--------------------------EAKSLIDSMLTVNPKKR 276
Query: 230 ATASAALA 237
TA AL
Sbjct: 277 ITADQALK 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 54/248 (21%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSE 55
EI +L+++ H NI+ LE + S YLV + + I G ++E
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERG-------VYTE 105
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 112
+ Q+L +++ H G++HRD+K NLL + + DFGL+ G
Sbjct: 106 KDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
+++ T Y PE+L Y +VD WS+G + LL G P TE + KI +
Sbjct: 163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221
Query: 173 LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
G +W S+ +A + I LL +P +R
Sbjct: 222 --GYYEFESPFWDDISE--------------------------SAKDFICHLLEKDPNER 253
Query: 230 ATASAALA 237
T AL+
Sbjct: 254 YTCEKALS 261
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 39/235 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----DITGLLSCPDIKFSEAQI 58
+EI IL++LDHPN++KL ++ +Y+VFE + ++ SE Q
Sbjct: 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQA 139
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Y L+ G+E+ H + ++HRDIK SNLLV +G +K+ADFG++N L++ V
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTV 198
Query: 119 VTLWYRPPELLLGAT-DY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
T + PE L + G ++D+W++G + G+ + KI
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS---- 254
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ P D+ +LI +L P R
Sbjct: 255 --QAL----EFPD-----------------QPDIAEDLKDLITRMLDKNPESRIV 286
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 62/284 (21%), Positives = 97/284 (34%), Gaps = 77/284 (27%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME--------------------- 39
+ E+ ++++L HPNI +L + I LV E
Sbjct: 75 IKTEVRLMKKLHHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 40 -------------------HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80
I G D E I M Q+ L + H++G+ HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 81 DIKGSNLLV--NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGATD- 134
DIK N L N +KL DFGL+ N G +T++ T ++ PE+L +
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 135 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWKKSKLPHATL 192
YGP D WS G + LL+G G + + + ++ + +
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNY---------- 300
Query: 193 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
L A +L+ LL+ +R A AL
Sbjct: 301 ---------------NVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 56/241 (23%), Positives = 89/241 (36%), Gaps = 44/241 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQ 57
E++ L P I+ L G + +I++ E +E G S + E +
Sbjct: 99 EELVACAGLSSPRIVPLYGAVREGPWVNIFM--ELLE---GG--SLGQLIKQMGCLPEDR 151
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL-KLADFG----LANFSNTGHRQ 112
Y+ Q L GLE+ H+R +LH D+K N+L++++G L DFG L
Sbjct: 152 ALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
T + PE+++G VD+WS C+ +L G T+ + K
Sbjct: 212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLK 267
Query: 173 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
+ PP P + S I+ L EP RA+A
Sbjct: 268 IASEPP----------------PIREIPPSCAPLTAQ-------AIQEGLRKEPVHRASA 304
Query: 233 S 233
Sbjct: 305 M 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 46/245 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
RE+ ILR + HPNII L + ++ + L+ E + + +E +
Sbjct: 57 REVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLA-----EKESLTEDE 109
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQP 113
++ Q+L G+ + HS+ + H D+K N+++ ++ V +KL DFG+A+ G
Sbjct: 110 ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NE 167
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ T + PE++ G D+WS+G + LL G G T+ E L I +
Sbjct: 168 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226
Query: 174 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
++Y+ S+L A + I LL +P +R T
Sbjct: 227 NYDFDEEYFSNTSEL--------------------------AKDFIRRLLVKDPKRRMTI 260
Query: 233 SAALA 237
+ +L
Sbjct: 261 AQSLE 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 63/241 (26%), Positives = 94/241 (39%), Gaps = 39/241 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQI 58
+EI +L++L+HPN+IK + +V E + + E +
Sbjct: 81 KEIDLLKQLNHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSR 117
Y QL LEH HSR V+HRDIK +N+ + GV+KL D GL FS+ S
Sbjct: 139 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSL 196
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQL-HKIFKLCG 175
V T +Y PE + Y D+WS+GC+ E+ + G + L KI +
Sbjct: 197 VGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--C 253
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
P P Y LR L+ ++ +P KR +
Sbjct: 254 DYPP--------------LPSDHYSEELR-----------QLVNMCINPDPEKRPDVTYV 288
Query: 236 L 236
Sbjct: 289 Y 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 70/250 (28%), Positives = 101/250 (40%), Gaps = 53/250 (21%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFS 54
RE ILR++ HP+II L S ++LVF+ M +T S
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKV-------ALS 198
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E + + M LL + H+ ++HRD+K N+L+++ ++L+DFG + G + L
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKL 256
Query: 115 TSRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
T Y PE+L + D YG VDLW+ G + LL G P R ++ L
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
Query: 170 IFKLCGSP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
I + G W T KD LI LL V+P
Sbjct: 317 I--MEGQYQFSSPEW------------------DDRSSTVKD-------LISRLLQVDPE 349
Query: 228 KRATASAALA 237
R TA AL
Sbjct: 350 ARLTAEQALQ 359
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 69/269 (25%), Positives = 113/269 (42%), Gaps = 33/269 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCY 61
+EI +LRRL H N+I+L ++ + +Y+V EY + +L S P+ +F Q Y
Sbjct: 55 KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY 114
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVT 120
QL+ GLE+ HS+G++H+DIK NLL+ G LK++ G+A + + +
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 121 LWYRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
++PPE+ G + G VD+WS G + G +G + I K
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------G 228
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
Y +P D +L++ +L EP KR +
Sbjct: 229 SY----AIP-------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265
Query: 240 YFSTKPYACDLSSLPIYPPSKEIDAKHRE 268
+F K + + +PI P D
Sbjct: 266 WF-RKKHPPAEAPVPIPPSPDTKDRWRSM 293
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 73/246 (29%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
RE I R L HPNI++L I+ YL+F+ + DI +SEA
Sbjct: 59 REARICRLLKHPNIVRLHDSISEEGH--HYLIFDLVTGGELFEDI-----VAREYYSEAD 111
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPL 114
+ Q+L + HCH GV+HR++K NLL+ ++ +KLADFGLA G +Q
Sbjct: 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAW 170
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
T Y PE+L YG VDLW+ G + LL+G P + +I
Sbjct: 171 FGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KA 227
Query: 175 GSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
G+ P W + A +LI +L++ P KR T
Sbjct: 228 GAYDFPSPEWDTVTP--------------------------EAKDLINKMLTINPSKRIT 261
Query: 232 ASAALA 237
A+ AL
Sbjct: 262 AAEALK 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 56/244 (22%), Positives = 100/244 (40%), Gaps = 46/244 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
RE+ IL+ + HPN+I L + ++ + L+ E + + +E +
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLA-----EKESLTEEE 115
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQP 113
++ Q+L+G+ + HS + H D+K N+++ + +K+ DFGLA+ + G
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NE 173
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ T + PE++ G D+WS+G + LL G G T+ E L + +
Sbjct: 174 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 174 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
D+Y+ S L A + I LL +P KR T
Sbjct: 233 NYEFEDEYFSNTSAL--------------------------AKDFIRRLLVKDPKKRMTI 266
Query: 233 SAAL 236
+L
Sbjct: 267 QDSL 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 46/244 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
RE+ ILR++ H N+I L + +R + L+ E + + SE +
Sbjct: 64 REVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLA-----QKESLSEEE 116
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQP 113
++ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+ G
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VE 174
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ T + PE++ G D+WS+G + LL G G T+ E L I +
Sbjct: 175 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233
Query: 174 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
++++ S+L A + I LL E KR T
Sbjct: 234 SYDFDEEFFSHTSEL--------------------------AKDFIRKLLVKETRKRLTI 267
Query: 233 SAAL 236
AL
Sbjct: 268 QEAL 271
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 58/251 (23%), Positives = 93/251 (37%), Gaps = 49/251 (19%)
Query: 3 REILILRRL-DHPNIIKLEGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFS 54
+E+ + P+I+ + + + ++ E ME I D F+
Sbjct: 70 QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI---QERGDQAFT 126
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR 111
E + M + ++ HS + HRD+K NLL ++ VLKL DFG A +
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-- 184
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
L + T +Y PE +LG Y S D+WS+G + LL G P T +
Sbjct: 185 -ALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 172 K--LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
+ G P+ W + S+ A LI LL +P
Sbjct: 243 RRIRLGQYGFPNPEWSEVSE--------------------------DAKQLIRLLLKTDP 276
Query: 227 YKRATASAALA 237
+R T + +
Sbjct: 277 TERLTITQFMN 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 52/247 (21%), Positives = 95/247 (38%), Gaps = 42/247 (17%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEA 56
RE + R +HPNI++L L +L+ + + + L +E
Sbjct: 75 READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----- 111
QI + + GLE H++G HRD+K +N+L+ +EG L D G N +
Sbjct: 135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 112 ---QPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 166
Q ++ T+ YR PEL D+WS+GCV ++ G+ +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 167 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
+ + + +P + S+L L+ ++++V+P
Sbjct: 255 SVAL-AVQN--------QLSIP------QSPRHSSALW-----------QLLNSMMTVDP 288
Query: 227 YKRATAS 233
++R
Sbjct: 289 HQRPHIP 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 55/265 (20%), Positives = 97/265 (36%), Gaps = 55/265 (20%)
Query: 1 MAREILILRRLDHPNIIK----------LEGLITSRLSCSIYLVFEYMEH-DITGLLS-- 47
+ RE+ L +L+HP I++ E L S +Y+ + ++ ++
Sbjct: 50 VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109
Query: 48 CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---- 103
C + + Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL
Sbjct: 110 CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 104 -------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
+ T +V T Y PE + G Y VD++S+G + ELL P
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--P 226
Query: 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216
V L + P + +K
Sbjct: 227 FSTQMERVRTLTDVRN--LKFPPLFTQKYP--------------------------CEYV 258
Query: 217 LIETLLSVEPYKRATASAALASEYF 241
+++ +LS P +R A + + F
Sbjct: 259 MVQDMLSPSPMERPEAINIIENAVF 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 60/312 (19%), Positives = 105/312 (33%), Gaps = 54/312 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
+EI IL H NI+ L S + ++FE++ I + +E +
Sbjct: 50 KEISILNIARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTS----AFELNERE 103
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLT 115
I Y++Q+ L+ HS + H DI+ N++ +K+ +FG A G
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFR 161
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
Y PE+ + D+WS+G + LL G T + + I
Sbjct: 162 LLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
+ ++ + K++ A++ ++ LL E R TAS A
Sbjct: 221 TFDEEAF-------------------------KEISIEAMDFVDRLLVKERKSRMTASEA 255
Query: 236 LASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR-------GAETRKTT 288
L + K + + + + KK V G R
Sbjct: 256 LQHPWLKQKIERVSTKVI------RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQK 309
Query: 289 RKSHGMSKLAPV 300
S K+A +
Sbjct: 310 GVSVAKVKVASI 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 43/243 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
EI I+ +L HP +I L + + L+ E+ ++G ++ D K SEA+
Sbjct: 97 NEISIMNQLHHPKLINLHDAFEDKYE--MVLILEF----LSGGELFDRIAAEDYKMSEAE 150
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLT 115
+ YM Q GL+H H ++H DIK N++ +K+ DFGLA N + +
Sbjct: 151 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVK 208
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
T + PE++ G D+W++G + LL G G ++E L + +
Sbjct: 209 VTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267
Query: 176 SPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234
+D + S A + I+ LL EP KR T
Sbjct: 268 EFDEDAFSSVSPE--------------------------AKDFIKNLLQKEPRKRLTVHD 301
Query: 235 ALA 237
AL
Sbjct: 302 ALE 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 68/243 (27%), Positives = 103/243 (42%), Gaps = 48/243 (19%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLL--SCPDIKFSEAQIK 59
EI + + L H NI++ G + I++ E + ++ LL +K +E I
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRV 118
Y Q+L GL++ H ++HRDIKG N+L+N GVLK++DFG + G +
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFT 184
Query: 119 VTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
TL Y PE++ YG + D+WS+GC E+ GKP P
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--------------------P 224
Query: 178 PDDYWKKSKLPHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
+ + P A +FK P+ P S K I +P KRA
Sbjct: 225 ----FYELGEPQAAMFKVGMFKVHPEIPESMS--AEAKA-------FILKCFEPDPDKRA 271
Query: 231 TAS 233
A+
Sbjct: 272 CAN 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 66/317 (20%), Positives = 117/317 (36%), Gaps = 57/317 (17%)
Query: 3 REILILRRL-DHPNIIKLEGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFS 54
RE+ + R P+I+++ + + +V E ++ I D F+
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFT 159
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR 111
E + M + +++ HS + HRD+K NLL ++ +LKL DFG A + +
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 217
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
LT+ T +Y PE +LG Y S D+WS+G + LL G P + +
Sbjct: 218 NSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
Query: 172 K--LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
G P+ W + S+ LI LL EP
Sbjct: 277 TRIRMGQYEFPNPEWSEVSE--------------------------EVKMLIRNLLKTEP 310
Query: 227 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRK 286
+R T + + + P++ + K R + ++++ +
Sbjct: 311 TQRMTITEFMNHPWIMQSTKV---PQTPLHTSRVLKEDKERWEDVKEEMTSALA------ 361
Query: 287 TTRKSHGMSKLAPVEDV 303
T R + K+ +ED
Sbjct: 362 TMRVDYEQIKIKKIEDA 378
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 46/244 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
RE+ ILR++ HPNII L + +R + L+ E + + SE +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLA-----QKESLSEEE 116
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQP 113
++ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+ G
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VE 174
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ T + PE++ G D+WS+G + LL G G T+ E L I +
Sbjct: 175 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
Query: 174 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
++++ + S+L A + I LL E KR T
Sbjct: 234 SYDFDEEFFSQTSEL--------------------------AKDFIRKLLVKETRKRLTI 267
Query: 233 SAAL 236
AL
Sbjct: 268 QEAL 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 74/253 (29%), Positives = 103/253 (40%), Gaps = 54/253 (21%)
Query: 3 REILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSE 55
+EI L+ + HPNI+KL + +L +LV E + G L I FSE
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLH--TFLVMELL----NGGELFE--RIKKKKHFSE 105
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 112
+ M +L+ + H H GV+HRD+K NLL +E +K+ DFG A Q
Sbjct: 106 TEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQ 164
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHK 169
PL + TL Y PE LL Y S DLWS+G + +L G+ Q +
Sbjct: 165 PLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 170 IFK--LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224
I K G + WK S+ A +LI+ LL+V
Sbjct: 224 IMKKIKKGDFSFEGEAWKNVSQ--------------------------EAKDLIQGLLTV 257
Query: 225 EPYKRATASAALA 237
+P KR S
Sbjct: 258 DPNKRLKMSGLRY 270
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 51/248 (20%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQ 57
RE I L HP+I++L +S +Y+VFE+M+ +I +SEA
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRAD-AGFVYSEAV 131
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLA-NFSNTGHRQP 113
YM Q+L L +CH ++HRD+K +L+ N +KL FG+A +G
Sbjct: 132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LV 189
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK- 172
RV T + PE++ YG VD+W G + LL G G E ++F+
Sbjct: 190 AGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEG 243
Query: 173 -LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
+ G W S+ +A +L+ +L ++P +
Sbjct: 244 IIKGKYKMNPRQWSHISE--------------------------SAKDLVRRMLMLDPAE 277
Query: 229 RATASAAL 236
R T AL
Sbjct: 278 RITVYEAL 285
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 43/260 (16%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSE 55
+ EI ++ +LDH N+I+L S+ I LV EY++ I +E
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRII----DESYNLTE 186
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQP 113
+M Q+ G+ H H +LH D+K N+L N +K+ DFGLA +
Sbjct: 187 LDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EK 244
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
L T + PE++ D+WSVG + LL G G + E L+ I
Sbjct: 245 LKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303
Query: 174 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
D+ ++ S+ A I LL E R +A
Sbjct: 304 RWDLEDEEFQDISEE--------------------------AKEFISKLLIKEKSWRISA 337
Query: 233 SAALASEYFSTKPYACDLSS 252
S AL + S LS+
Sbjct: 338 SEALKHPWLSDHKLHSRLSA 357
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 59/282 (20%), Positives = 94/282 (33%), Gaps = 48/282 (17%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSE 55
+ +EI + L HP ++ L + +++E+M + K SE
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVAD----EHNKMSE 254
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQP 113
+ YM Q+ GL H H +H D+K N++ LKL DFGL + Q
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 312
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ T + PE+ G G D+WSVG + LL G G + E L +
Sbjct: 313 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 371
Query: 174 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
+ D + S+ + I LL +P R T
Sbjct: 372 DWNMDDSAFSGISED--------------------------GKDFIRKLLLADPNTRMTI 405
Query: 233 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 274
AL + + + K R+ + K
Sbjct: 406 HQALEHPWLTP-----GNAPGRDSQIPSSRYTKIRDSIKTKY 442
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 5e-36
Identities = 36/272 (13%), Positives = 78/272 (28%), Gaps = 55/272 (20%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL------SCPDIKFS 54
+++ +I++ S + ++ M+ ++ S
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
Q++ L H G++H ++ +++++ G + L F
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----R 259
Query: 115 TSRVVTLWYRPPELL----------LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 164
V+ + PPEL T S D W++G V + + +
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319
Query: 165 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224
IF+ C K++P L+E L
Sbjct: 320 GGSEWIFRSC---------------------------------KNIPQPVRALLEGFLRY 346
Query: 225 EPYKRATASAALASEYFSTKPYACDLSSLPIY 256
R A+ + + + ++LP+Y
Sbjct: 347 PKEDRLLPLQAMETPEY-EQLRTELSAALPLY 377
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 67/286 (23%), Positives = 119/286 (41%), Gaps = 56/286 (19%)
Query: 4 EILILRRL------DHPNIIKLEGLITSRLSCSIY-----LVFEYMEHDITGLLSCPDIK 52
EI IL L + N+I + L + + FE + ++ L+ +
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHM-------LENFTFRNHICMTFELLSMNLYELIKKNKFQ 195
Query: 53 -FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTG 109
FS ++ + + +L L+ H ++H D+K N+L+ +G +K+ DFG + + +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-- 253
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
Q + + + + +YR PE++LGA YG +D+WS+GC+ AELL G P+L G E +QL
Sbjct: 254 --QRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 170 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYD----------------SSLRETFKDLPTT 213
+ +L G P SK + P S R + P +
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 214 A--------------VNLIETLLSVEPYKRATASAALASEYFSTKP 245
++ ++ L +P R T AL + +
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 37/234 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIK 59
+EI I + L+H N++K G YL EY G L PDI E +
Sbjct: 54 KEICINKMLNHENVVKFYGHRREG--NIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQ 108
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
+ +QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA +R+ L +++
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 120 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP 177
TL Y PELL + VD+WS G V +L G+ P Q ++ +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----- 223
Query: 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ +K + + + L+ +L P R T
Sbjct: 224 ------------KKTYLNP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 59/271 (21%), Positives = 97/271 (35%), Gaps = 63/271 (23%)
Query: 3 REILILRRLD----HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI------- 51
E+ +L ++ HP +I+L ++ LV E D+
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEG--FMLVLERPL-------PAQDLFDYITEK 133
Query: 52 -KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTG 109
E +C+ Q++ ++HCHSRGV+HRDIK N+L++ G KL DFG
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--- 190
Query: 110 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 169
H +P T T Y PPE + + +WS+G + L+
Sbjct: 191 HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGIL-------------------LYD 231
Query: 170 IFKLCGSPP-DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
+ +CG P + ++ A L P + LI L+ +P
Sbjct: 232 M--VCGDIPFERD---QEILEAELHFPAH------------VSPDCCALIRRCLAPKPSS 274
Query: 229 RATASAALASEYFSTKPYACDLSSLPIYPPS 259
R + L + P + P+
Sbjct: 275 RPSLEEILLDPWM-QTPAEDVPLNPSKGGPA 304
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 71/249 (28%), Positives = 100/249 (40%), Gaps = 54/249 (21%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEA 56
EI +L RL HPNIIKL+ + + I LV E + TG L I +SE
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELV----TGGELFD--RIVEKGYYSER 148
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQP 113
+ Q+L + + H G++HRD+K NLL LK+ADFGL+
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VL 206
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK- 172
+ + T Y PE+L G YGP VD+WSVG + LL G +F+
Sbjct: 207 MKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRR 262
Query: 173 -LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228
L +W + S A +L+ L+ ++P K
Sbjct: 263 ILNCEYYFISPWWDEVSL--------------------------NAKDLVRKLIVLDPKK 296
Query: 229 RATASAALA 237
R T AL
Sbjct: 297 RLTTFQALQ 305
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 80/315 (25%), Positives = 117/315 (37%), Gaps = 68/315 (21%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSE 55
EI IL R HPNII L+ + +Y+V E M G LL I FSE
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKY--VYVVTELM----KGGELLD--KILRQKFFSE 115
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 111
+ + + +E+ H++GV+HRD+K SN+L N +++ DFG A
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLH 168
L + T + PE+L Y + D+WS+G + +L G T E L
Sbjct: 175 GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 169 KIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227
+I S YW S TA +L+ +L V+P+
Sbjct: 234 RIGSGKFSLSGGYWNSVSD--------------------------TAKDLVSKMLHVDPH 267
Query: 228 KRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKT 287
+R TA+ L P+ LP Y +R+DA G
Sbjct: 268 QRLTAALVLRH------PWIVHWDQLPQYQL-------NRQDAPHLVKGAMAATYSALNR 314
Query: 288 TRKSH----GMSKLA 298
+ G S LA
Sbjct: 315 NQSPVLEPVGRSTLA 329
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 65/266 (24%), Positives = 100/266 (37%), Gaps = 38/266 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIK 59
+EI I + L+H N++K G YL EY G L PDI E +
Sbjct: 54 KEICINKMLNHENVVKFYGHRREG--NIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQ 108
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRV 118
+ +QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA +R + L
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP 177
TL Y PELL + VD+WS G V +L G+ P Q ++ +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----- 223
Query: 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
+ +K + + + L+ +L P R T
Sbjct: 224 ------------KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKK 261
Query: 238 SEYFSTKPYACDLSSLPIYPPSKEID 263
++ KP +
Sbjct: 262 DRWY-NKPLKKGAKRPRVTSGGVSES 286
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 54/246 (21%), Positives = 92/246 (37%), Gaps = 46/246 (18%)
Query: 3 REILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITG------LLSCPDIKFSE 55
EI +L P +I L + + I L+ EY G L SE
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSE--IILILEYA----AGGEIFSLCLPELAEMVSE 130
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQ 112
+ + Q+L G+ + H ++H D+K N+L+++ G +K+ DFG++
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--C 188
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
L + T Y PE+L + D+W++G + LL G E I +
Sbjct: 189 ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 173 LCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ ++ + S+L A + I++LL P KR T
Sbjct: 248 VNVDYSEETFSSVSQL--------------------------ATDFIQSLLVKNPEKRPT 281
Query: 232 ASAALA 237
A L+
Sbjct: 282 AEICLS 287
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-35
Identities = 59/269 (21%), Positives = 97/269 (36%), Gaps = 62/269 (23%)
Query: 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KF 53
+ RE+ +L + H N+++L YLVFE M G +LS I F
Sbjct: 57 VFREVEMLYQCQGHRNVLELIEFFEEEDR--FYLVFEKM----RGGSILS--HIHKRRHF 108
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGH 110
+E + + + L+ H++G+ HRD+K N+L + +K+ DF L +
Sbjct: 109 NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 111 R------QPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQG 160
L + + Y PE++ A+ Y DLWS+G + IL
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-------IL-- 219
Query: 161 RTEVEQLHKIFKLCGSPP----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT---- 212
L G PP A ++S + + P
Sbjct: 220 ------------LSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWA 266
Query: 213 ----TAVNLIETLLSVEPYKRATASAALA 237
A +LI LL + +R +A+ L
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 47/241 (19%), Positives = 86/241 (35%), Gaps = 46/241 (19%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSE 55
E +L+ L HPNI++ T + I LV E M +G +
Sbjct: 74 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT---SG--TLKTYLKRFKVMKI 128
Query: 56 AQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQ 112
++ + Q+L GL+ H+R ++HRD+K N+ + G +K+ D GLA +
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188
Query: 113 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 172
+ + T + PE + Y SVD+++ G E+ + Q+++
Sbjct: 189 ---AVIGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-- 241
Query: 173 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
T +D K+ +IE + +R +
Sbjct: 242 -----------------VTSGVKPASFDKVAIPEVKE-------IIEGCIRQNKDERYSI 277
Query: 233 S 233
Sbjct: 278 K 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 56/277 (20%)
Query: 3 REILILRRLDHPNIIKL-EGLITSRLSCSIYLVFEY----------MEHDITGLLSCPDI 51
RE+ I++ L+HPNI+KL E + T + ++YL+ EY + H
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEK---TLYLIMEYASGGEVFDYLVAHG---------- 109
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
+ E + + Q++ +++CH + ++HRD+K NLL++ + +K+ADFG +N G
Sbjct: 110 RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
L + Y PEL G GP VD+WS+G + L+ G G+ E ++
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ G ++ + T NL++ L + P KR T
Sbjct: 228 R--GKYRIPFY---------------------------MSTDCENLLKRFLVLNPIKRGT 258
Query: 232 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 268
+ + + D + P D K +
Sbjct: 259 LEQIMKDRWI-NAGHEEDELKPFVEPELDISDQKRID 294
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 59/274 (21%), Positives = 99/274 (36%), Gaps = 64/274 (23%)
Query: 3 REILILRRLDH--PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------K 52
E+++L+++ +I+L S L+ E E D+
Sbjct: 95 MEVVLLKKVSSGFSGVIRLLDWFERPDS--FVLILERPE-------PVQDLFDFITERGA 145
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHR 111
E + + Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV- 204
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
T T Y PPE + +G S +WS+G + ++
Sbjct: 205 --YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM-------------------- 242
Query: 172 KLCGSPP-DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
+CG P + ++ +F Q+ + + +LI L++ P R
Sbjct: 243 -VCGDIPFEH---DEEIIRGQVFFRQR------------VSSECQHLIRWCLALRPSDRP 286
Query: 231 TASAALASEYF---STKPYACDLSSLPIYP-PSK 260
T + ++ + P PSK
Sbjct: 287 TFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 43/262 (16%), Positives = 88/262 (33%), Gaps = 62/262 (23%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK---FSEAQ 57
RE+ L H ++++ + + EY + +S F EA+
Sbjct: 59 REVYAHAVLGQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL-------------------KLA 98
+K + Q+ GL + HS ++H DIK SN+ ++ + K+
Sbjct: 117 LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 99 DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158
D G + E+L + P D++++ +P+
Sbjct: 177 DLGHV-----TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231
Query: 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 218
+ +Q H+I + G P +P L + F + L+
Sbjct: 232 R---NGDQWHEIRQ--GRLPR-------IP------------QVLSQEFTE-------LL 260
Query: 219 ETLLSVEPYKRATASAALASEY 240
+ ++ +P +R +A A +
Sbjct: 261 KVMIHPDPERRPSAMALVKHSV 282
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 56/271 (20%), Positives = 102/271 (37%), Gaps = 57/271 (21%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFS 54
EI IL R++H NIIK+ + ++ LV ME +GL D+ +
Sbjct: 78 LEIAILSRVEHANIIKVLDIFENQGF--FQLV---MEKHGSGL----DLFAFIDRHPRLD 128
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E QL+ + + + ++HRDIK N+++ + +KL DFG A + G
Sbjct: 129 EPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LF 186
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
+ T+ Y PE+L+G GP +++WS+G L +
Sbjct: 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL---------------------VF 225
Query: 175 GSPP-DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
P + + + A + P + ++L+ LL P +R T
Sbjct: 226 EENPFCELEETVE---AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLE 270
Query: 234 AALASEYFSTKPYACDLSSLPIYPPSKEIDA 264
+ + T+P + + ++
Sbjct: 271 KLVTDPWV-TQPVNLADYTWEEVFRVNKPES 300
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 64/322 (19%), Positives = 110/322 (34%), Gaps = 57/322 (17%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI-------KF 53
E+ + + +HPNI+ + + L ++V +M + G S D+
Sbjct: 75 GELHVSKLFNHPNIVPYRATFIADNEL----WVVTSFMAY---G--SAKDLICTHFMDGM 125
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQ 112
+E I + +L L++ H G +HR +K S++L++ +G + L+ + + G RQ
Sbjct: 126 NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185
Query: 113 -----PLTSRVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKP---------- 156
V L + PE+L Y D++SVG EL G
Sbjct: 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
Query: 157 ---ILQGRT-----------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 202
L G E + + S D S + P PY +
Sbjct: 246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
Query: 203 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLPIYPPSKE 261
F +E L P R +AS L +F K A + + P +
Sbjct: 306 FSPHFHH-------FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPI 358
Query: 262 IDAKHREDARRKKVGGRVRGAE 283
+ + + + G V E
Sbjct: 359 TNFEGSQSQDHSGIFGLVTNLE 380
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 69/313 (22%), Positives = 122/313 (38%), Gaps = 47/313 (15%)
Query: 4 EILILRRL-----------DHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSC-P 49
EI +L+R+ +I+KL + +VFE + ++ L+
Sbjct: 65 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 124
Query: 50 DIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNE------GVLKLADFGL 102
+K QLL GL++ H R G++H DIK N+L+ +K+AD G
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 103 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
A + + + T+ + T YR PE+LLGA +G D+WS C+ EL+ G + +
Sbjct: 185 ACWYD----EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDE 239
Query: 163 ------EVEQLHKIFKLCGSPP----------DDYWKKSKLPHATLFKPQQPYDSSLRET 206
+ + + +I +L G P ++ L P + L E
Sbjct: 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 299
Query: 207 FKDLPTTA---VNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS--SLPIYPPSKE 261
+K A + + +L ++P KRA A + + ++ +Y +
Sbjct: 300 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSD 359
Query: 262 IDAKHREDARRKK 274
I E K+
Sbjct: 360 IPGWFEEVRDHKR 372
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 51/250 (20%), Positives = 84/250 (33%), Gaps = 69/250 (27%)
Query: 3 REILILRRL-DHPNIIKLEGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFS 54
RE+ + R P+I+++ + + +V E ++ I D F+
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFT 115
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR 111
E + M + +++ HS + HRD+K NLL ++ +LKL DFG A
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------- 167
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
E Y S D+WS+G + LL G P + +
Sbjct: 168 --------------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
Query: 172 K--LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
G P+ W + S+ LI LL EP
Sbjct: 212 TRIRMGQYEFPNPEWSEVSE--------------------------EVKMLIRNLLKTEP 245
Query: 227 YKRATASAAL 236
+R T + +
Sbjct: 246 TQRMTITEFM 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-33
Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 70/294 (23%)
Query: 4 EILILRRL------DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLS 47
EI +L L +++ ++ L S Y +++ E+
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY---DFIKENGFLP--- 114
Query: 48 CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------ 94
F I+ Q+ + HS + H D+K N L V ++
Sbjct: 115 -----FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 95 ------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 148
+K+ DFG A + + + ++ V T YR PE++L + D+WS+GC+
Sbjct: 170 TLINPDIKVVDFGSATYDD----EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCIL 224
Query: 149 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRE 205
E +G + E L + ++ G P +K++ F + SS
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGR 282
Query: 206 TF----KDLPT----------TAVNLIETLLSVEPYKRATASAALASEYFSTKP 245
K L +LI+ +L +P KR T AL +F
Sbjct: 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 73/295 (24%)
Query: 4 EILILRRL-----DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLSC 48
E IL+++ ++ NI+K G LI L S+Y E + ++ G
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNG---- 133
Query: 49 PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------- 94
F IK Y ++L L + + H D+K N LL +
Sbjct: 134 ----FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189
Query: 95 -----------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143
+KL DFG A F + S + T YR PE++L + S D+WS
Sbjct: 190 KIQIYRTKSTGIKLIDFGCATFKS----DYHGSIINTRQYRAPEVILNL-GWDVSSDMWS 244
Query: 144 VGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF------KPQQ 197
GCV AEL G + + +E L + + P + ++ + + + K
Sbjct: 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAW 304
Query: 198 PYDSSLRETFKDLPTTA-----------VNLIETLLSVEPYKRATASAALASEYF 241
P ++S + K + + + ++L ++P R + + L ++
Sbjct: 305 PENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/293 (19%), Positives = 109/293 (37%), Gaps = 68/293 (23%)
Query: 4 EILILRRL------DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLS 47
EI +L+++ + + + + L + + E++ E++
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF---EFLKENNFQP--- 119
Query: 48 CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------ 94
+ ++ QL H L H + H D+K N L VN+E
Sbjct: 120 -----YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 95 ------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 148
+++ADFG A F + + T+ V T YRPPE++L + D+WS+GC+
Sbjct: 175 SVKNTSIRVADFGSATFDH----EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCIL 229
Query: 149 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH----------------ATL 192
E G + Q E L + K+ G P +++ +
Sbjct: 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYV 289
Query: 193 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 245
+ +P S + + + +L+ +L +P +R T + AL +F+
Sbjct: 290 KENCKPLKSYMLQDSLEHVQL-FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 63/290 (21%)
Query: 4 EILILRRL------DHPNIIKLEGLITSRLSCSIY-----LVFEYMEHDITGLLSCPDIK 52
E+ +L + I+ L ++ LVFE + +++ LL + +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHL-------KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFR 152
Query: 53 -FSEAQIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEG--VLKLADFGLANFSN 107
S + + Q+ L + ++H D+K N+L+ N +K+ DFG +
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
Query: 108 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 167
Q + + + +YR PE+LLG Y ++D+WS+GC+ E+ G+P+ G EV+Q+
Sbjct: 213 ----QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
Query: 168 HKIFKLCGSPPDDYWKKS---------------------------------KLPHATLFK 194
+KI ++ G PP ++ KL + +
Sbjct: 268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVE 327
Query: 195 PQQPYDSSLRETFKDLPTTA--VNLIETLLSVEPYKRATASAALASEYFS 242
P E+ + +LI +L +P R AL +F
Sbjct: 328 TGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 50/255 (19%), Positives = 93/255 (36%), Gaps = 47/255 (18%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQ 57
+ +I + N + L S +Y+ + ++ ++ C
Sbjct: 108 PSVKIRRMDPFSTKNTVG--QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------NFS 106
Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL +
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 107 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 166
T +V T Y PE + G +Y VD++S+G + ELL T++E+
Sbjct: 226 PMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFS-----TQMER 279
Query: 167 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
+ I + + K P F +++ +LS P
Sbjct: 280 VRIITDV---------RNLKFP----------------LLFTQKYPQEHMMVQDMLSPSP 314
Query: 227 YKRATASAALASEYF 241
+R A+ + + F
Sbjct: 315 TERPEATDIIENAIF 329
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIK 59
REI L+ HP+IIKL +I++ ++V EY+ G L C + E + +
Sbjct: 60 REIQNLKLFRHPHIIKLYQVISTP--TDFFMVMEYVSG---GELFDYICKHGRVEEMEAR 114
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Q+L +++CH V+HRD+K N+L++ K+ADFGL+N + G L +
Sbjct: 115 RLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCG 172
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
+ Y PE++ G GP VD+WS G + LL G KI
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------G 226
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
+ +P + L + L+ +L V+P KRAT
Sbjct: 227 VF----YIP-------------------EYLNRSVATLLMHMLQVDPLKRAT 255
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 68/277 (24%), Positives = 105/277 (37%), Gaps = 46/277 (16%)
Query: 3 REILILRRLDHPNIIKL-EGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQI 58
REI+ R L HPNI++ E ++T + ++ EY G L C +FSE +
Sbjct: 65 REIINHRSLRHPNIVRFKEVILTPT---HLAIIMEYASG---GELYERICNAGRFSEDEA 118
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTS 116
+ + QLL G+ +CHS + HRD+K N L+ + LK+ DFG + S + S
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKS 176
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LC 174
V T Y PE+LL G D+WS G +L+G + E K + L
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236
Query: 175 G--SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232
S PDD + +LI + +P R +
Sbjct: 237 VKYSIPDDIR---------------------------ISPECCHLISRIFVADPATRISI 269
Query: 233 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 269
+F K DL + + + +
Sbjct: 270 PEIKTHSWF-LKNLPADLMNESNTGSQFQEPEQPMQS 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 27/251 (10%), Positives = 65/251 (25%), Gaps = 43/251 (17%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS------CPDIKFS 54
+++ +I++ S + ++ M+ ++
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
Q++ L H G++H ++ +++++ G + L F P+
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPI 269
Query: 115 TSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+L T + D W++G + + I
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329
Query: 171 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
F+ C K++P L+E L R
Sbjct: 330 FRSC---------------------------------KNIPQPVRALLEGFLRYPKEDRL 356
Query: 231 TASAALASEYF 241
A+ + +
Sbjct: 357 LPLQAMETPEY 367
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 52/238 (21%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY---------MEHDITGLLSCPDIKF 53
REI L+ L HP+IIKL +IT+ I +V EY +E +
Sbjct: 58 REISYLKLLRHPHIIKLYDVITTP--TDIVMVIEYAGGELFDYIVEKK----------RM 105
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
+E + + + Q++ +E+CH ++HRD+K NLL+++ +K+ADFGL+N G+
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--F 163
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
L + + Y PE++ G GP VD+WS G V +L+G+ K+
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS- 222
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
Y +P L A +LI ++ +P +R T
Sbjct: 223 -----CVY----VMP-------------------DFLSPGAQSLIRRMIVADPMQRIT 252
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 51/257 (19%), Positives = 95/257 (36%), Gaps = 55/257 (21%)
Query: 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEY---MEHDITGLLSC-----PDI 51
+ +E+ +++L HPNI++ + S E+ E L+
Sbjct: 72 IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 109
S + Q ++H H + ++HRD+K NLL++N+G +KL DFG A +
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 110 HRQPLTS-----------RVVTLWYRPPEL--LLGATDYGPSVDLWSVGCVFAELLIGKP 156
++ R T YR PE+ L G D+W++GC+ L +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216
+ ++ ++ + + PP D + +
Sbjct: 252 PFEDGAKLRIVNGKYSI---PPHD-----------------TQYTVFH-----------S 280
Query: 217 LIETLLSVEPYKRATAS 233
LI +L V P +R + +
Sbjct: 281 LIRAMLQVNPEERLSIA 297
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 62/267 (23%), Positives = 106/267 (39%), Gaps = 44/267 (16%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYME----HDI----TGLLSCPDIK 52
+EI + + HPNI+ ++ L +LV + + DI
Sbjct: 62 KEIQAMSQCHHPNIVSYYTSFVVKDEL----WLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHR 111
E+ I + ++L GLE+ H G +HRD+K N+L+ +G +++ADFG++ F + G
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 112 QPLTSR---VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 168
R V T + PE++ Y D+WS G EL G ++ L
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
Query: 169 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR--ETFKDLPTTAVNLIETLLSVEP 226
+ PP +L Q + + ++F+ +I L +P
Sbjct: 238 LTLQ--NDPP------------SLETGVQDKEMLKKYGKSFRK-------MISLCLQKDP 276
Query: 227 YKRATASAALASEYFSTKPYACDLSSL 253
KR TA+ L ++F A + L
Sbjct: 277 EKRPTAAELLRHKFFQK---AKNKEFL 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 48/258 (18%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEA 56
EIL++R +PNI+ L+ L ++V EY+ G S D+ E
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLA---GG--SLTDVVTETCMDEG 116
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLT 115
QI + L LE HS V+HRDIK N+L+ +G +KL DFG A + ++ +
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S 174
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
+ V T ++ PE++ YGP VD+WS+G + E++ G+P L ++ +
Sbjct: 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIAT 230
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
+ P L P++ L F+D + L ++ KR +A
Sbjct: 231 NGT---------P--ELQNPEK-----LSAIFRD-------FLNRCLEMDVEKRGSAKEL 267
Query: 236 LASEYFSTKPYACDLSSL 253
L ++ A LSSL
Sbjct: 268 LQHQFLKI---AKPLSSL 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 39/276 (14%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+EI I+++ D P+++K G + L ++V EY ++ ++ + +E +I
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDL----WIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
+ L GLE+ H +HRDIK N+L+N EG KLADFG+A T + +
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIG 187
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T ++ PE++ Y D+WS+G E+ GKP ++ + IF + +PP
Sbjct: 188 TPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNPP- 242
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
P T KP+ + F D ++ L P +RATA+ L
Sbjct: 243 --------P--TFRKPEL-----WSDNFTD-------FVKQCLVKSPEQRATATQLLQHP 280
Query: 240 YFSTKPYACDLSSL-PIYPPSKEIDAKHREDARRKK 274
+ + A +S L + + ++ K +E +R++
Sbjct: 281 FVRS---AKGVSILRDLINEAMDVKLKRQESQQREE 313
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+E+ L++L HPN I+ G L +LV EY + LL E +I
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ L GL + HS ++HRD+K N+L++ G++KL DFG A P S V T
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGT 213
Query: 121 LWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
++ PE++L + Y VD+WS+G EL KP L + + ++ + +
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNES 270
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
P L E F++ +++ L P R T+ L
Sbjct: 271 ---------P--ALQSGH------WSEYFRN-------FVDSCLQKIPQDRPTSEVLLKH 306
Query: 239 EYFSTKPYACDLSSL-PIYPPSKEIDAKHREDARRKK 274
+ + + + +K+ + RK
Sbjct: 307 RFVLR---ERPPTVIMDLIQRTKDAVRELDNLQYRKM 340
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 63/258 (24%), Positives = 115/258 (44%), Gaps = 48/258 (18%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEA 56
E++I+R H N++++ L+ L +++ E+++ G + DI + +E
Sbjct: 91 NEVVIMRDYQHFNVVEMYKSYLVGEEL----WVLMEFLQ---GG--ALTDIVSQVRLNEE 141
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLT 115
QI +L L + H++GV+HRDIK ++L+ +G +KL+DFG A S ++
Sbjct: 142 QIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--K 199
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
S V T ++ PE++ + Y VD+WS+G + E++ G+P + + +L
Sbjct: 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRD 255
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
SPP P L + + +D +E +L +P +RATA
Sbjct: 256 SPP---------P--KLKNSHK-----VSPVLRDF-------LERMLVRDPQERATAQEL 292
Query: 236 LASEYFSTKPYACDLSSL 253
L + L
Sbjct: 293 LDHPFLLQ---TGLPECL 307
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 72/264 (27%), Positives = 113/264 (42%), Gaps = 40/264 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIK 59
REI L+ HP+IIKL +I++ I++V EY+ G L C + + E + +
Sbjct: 65 REIQNLKLFRHPHIIKLYQVISTP--SDIFMVMEYVSG---GELFDYICKNGRLDEKESR 119
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Q+L G+++CH V+HRD+K N+L++ K+ADFGL+N + G L +
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCG 177
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
+ Y PE++ G GP VD+WS G + LL G KI
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD------G 231
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
+ P + L + ++L++ +L V+P KRAT E
Sbjct: 232 IF----YTP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268
Query: 240 YFSTKPYACDLSSLPIYPPSKEID 263
+F + L S ID
Sbjct: 269 WF-KQDLPKYLFPEDPSYSSTMID 291
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 38/241 (15%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
EI IL DHP I+KL G +L +++ E+ + ++ D +E QI+
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKL----WIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Q+L L HS+ ++HRD+K N+L+ EG ++LADFG++ N Q S +
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIG 179
Query: 120 TLWYRPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
T ++ PE+++ T Y D+WS+G E+ +P E+ + + K+
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAK 236
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
S P P TL P S F+D ++ L P R +A+
Sbjct: 237 SDP---------P--TLLTP-----SKWSVEFRD-------FLKIALDKNPETRPSAAQL 273
Query: 236 L 236
L
Sbjct: 274 L 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 39/232 (16%), Positives = 77/232 (33%), Gaps = 28/232 (12%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-----ITGLLSCPDIKFSE 55
+ + L+ +K + LV E + I + P+ +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----------EGVLKLADFGLAN 104
+ + ++L+ +E H ++H DIK N ++ N L L D G +
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 105 FSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRT 162
T++ T ++ E+L + +D + V +L G + ++
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLP 211
+ +F+ P D W + H L P P LR+ K +
Sbjct: 291 GECKPEGLFR--RLPHLDMWN--EFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE ++ RLDHP +KL T + +Y Y ++ ++ + F E + Y
Sbjct: 79 RERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 135
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 120
+++ LE+ H +G++HRD+K N+L+N + +++ DFG A + +Q + V T
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
Y PELL S DLW++GC+ +L+ G P + E KI K
Sbjct: 196 AQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------- 246
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
+ P + A +L+E LL ++ KR
Sbjct: 247 --LEYDFP-------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 50/275 (18%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEA 56
+EI +L + D P + K G L ++L +++ EY+ G S D+ E
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYLKDTKL----WIIMEYLG---GG--SALDLLEPGPLDET 119
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLT 115
QI + ++L GL++ HS +HRDIK +N+L++ G +KLADFG+ ++T ++
Sbjct: 120 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--N 177
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
+ V T ++ PE++ + Y D+WS+G EL G+P +E+ + +F +
Sbjct: 178 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPK 233
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
+ P P TL + + + K+ +E L+ EP R TA
Sbjct: 234 NNP---------P--TL-------EGNYSKPLKE-------FVEACLNKEPSFRPTAKEL 268
Query: 236 LASEYFSTKPYACDLSSL-PIYPPSKEIDAKHRED 269
L ++ A S L + K A+ D
Sbjct: 269 LKHKFI--LRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 36/163 (22%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITG----LLSCPDIKFSE 55
E+ +LR+ H NI+ G + + +V ++ E L + KF
Sbjct: 69 NEVGVLRKTRHVNILLFMG------YSTAPQLAIVTQWCEG---SSLYHHLHASETKFEM 119
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPL 114
++ Q G+++ H++ ++HRD+K +N+ ++ + +K+ DFGLA S
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 115 TSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGK 155
++ + PE++ Y D+++ G V EL+ G+
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 40/166 (24%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+E+ ++R L+HPN++K G++ + + EY++ + G++ D ++ +Q
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV 111
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFS 106
+ + G+ + HS ++HRD+ N LV + +ADFGLA
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 107 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
R+ + V ++ PE++ G Y VD++S G V E++
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 56/236 (23%), Positives = 85/236 (36%), Gaps = 46/236 (19%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
+L D I +L + +YLV EY D+ LLS + +
Sbjct: 114 VLVNGDRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR 165
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
Y+ +++ ++ H G +HRDIK N+L++ G ++LADFG V
Sbjct: 166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 120 TLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
T Y PE+L YGP D W++G E+ G+ + E KI
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH- 284
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
K L P + +P A + I+ LL P R
Sbjct: 285 ---------YKEHLSL-----PLVD---------EGVPEEARDFIQRLLC-PPETR 316
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 21/221 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQ 57
RE+ +L + P I+ G S I + E+M+ G S + + E
Sbjct: 80 RELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMD---GG--SLDQVLKKAGRIPEQI 132
Query: 58 IKCYMNQLLHGLEHCHSRG-VLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLT 115
+ ++ GL + + ++HRD+K SN+LVN+ G +KL DFG++ ++
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---- 188
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
S V T Y PE L G T Y D+WS+G E+ +G+ + E
Sbjct: 189 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216
+ + + P L + DS +L VN
Sbjct: 248 GDAAETPPRPRTPGRPL--NKFGMDSRPPMAIFELLDYIVN 286
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 85/286 (29%)
Query: 33 LVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVN 90
+VFE + H + + +K + Q+L GL++ H++ ++H DIK N+L++
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181
Query: 91 NE-------------------------------------------------GVLKLADFG 101
+K+AD G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241
Query: 102 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161
A + + + + +R YR E+L+G+ Y D+WS C+ EL G + +
Sbjct: 242 NACWVHKHFTEDIQTRQ----YRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 162 T------EVEQLHKIFKLCGSPPDDYWKKSK-----------LPHATLFKPQ-------Q 197
+ + + + I +L G P K L H T KP +
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 198 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243
Y+ S E + + +L + P KRATA+ L + ++
Sbjct: 357 KYEWSQEEAAGFT-----DFLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 3 REILILRRL-DHPNIIKLEG----LITSRLSCSIYLVFEYME----HDITGLLSCPDIKF 53
+EI +L++ H NI G + ++LV E+ D+ + +
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTL 126
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQ 112
E I ++L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 113 PLTSRVVTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKP 156
+ + T ++ PE++ + Y DLWS+G E+ G P
Sbjct: 187 --NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 51/239 (21%), Positives = 85/239 (35%), Gaps = 39/239 (16%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
++ ++ + D P I++ G + I E M L E +
Sbjct: 72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLKKRMQGPIPERILGKM 129
Query: 62 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV 119
++ L + GV+HRD+K SN+L++ G +KL DFG+ + +
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAG 186
Query: 120 TLWYRPPE----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLC 174
Y PE DY D+WS+G EL G+ P +T+ E L K+ +
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-- 244
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
PP LP F F+ ++ L+ + KR +
Sbjct: 245 EEPP-------LLPGHMGFSGD----------FQS-------FVKDCLTKDHRKRPKYN 279
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 11/171 (6%)
Query: 7 ILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN 63
+L D I L + L YLV +Y D+ LLS + + E + Y+
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNL----YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA 182
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 123
+++ ++ H +HRDIK N+L++ G ++LADFG + V T Y
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 124 RPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
PE+L YGP D WS+G E+L G+ + VE KI
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 48/234 (20%), Positives = 92/234 (39%), Gaps = 50/234 (21%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEYME------HDITGLLSCPDIKFSE 55
IL +++ ++ L ++ LV M H + F E
Sbjct: 237 ILEKVNSRFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPE 285
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
A+ Y ++ GLE H +++RD+K N+L+++ G ++++D GLA + Q +
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK 343
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
RV T+ Y PE++ Y S D W++GC+ E++ G+ Q R + + ++
Sbjct: 344 GRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---- 398
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
+ + + A +L LL +P +R
Sbjct: 399 --------RLVKEVPEEYSER-------------FSPQARSLCSQLLCKDPAER 431
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 49/235 (20%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEYME------HDITGLLSCPDIKFSE 55
IL ++ I+ L + LV M H I + F E
Sbjct: 238 ILAKVHSRFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQE 288
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
+ Y Q++ GLEH H R +++RD+K N+L++++G ++++D GLA G +
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
T + PELLLG +Y SVD +++G E++ + + R E + ++ +
Sbjct: 349 -YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--- 403
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKR 229
L + T+ + + E LL +P KR
Sbjct: 404 --------------RVLEQA---------VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKC 60
RE+ I+ L+HPNI+KL GL+ + +V E++ D+ L +
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLR 126
Query: 61 YMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHRQP 113
M + G+E+ ++ ++HRD++ N+ + + K+ADFGL+ S
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---- 182
Query: 114 LTSRVVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGK 155
++ + + PE + + Y D +S + +L G+
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSC-PDIKFSEAQ 57
E+ L R++HPNI+KL G + + LV EY E +++ L P ++ A
Sbjct: 50 VELRQLSRVNHPNIVKLYGACLNPV----CLVMEYAEGGSLYNV--LHGAEPLPYYTAAH 103
Query: 58 IKCYMNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQP 113
+ Q G+ + HS ++HRD+K NLL+ G VLK+ DFG A T
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
+T+ + + PE+ G ++Y D++S G + E++ +
Sbjct: 160 MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRR 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 63/229 (27%), Positives = 91/229 (39%), Gaps = 38/229 (16%)
Query: 7 ILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMN 63
I+ + P +++L L Y+V EYM D+ L+S + E + Y
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYL----YMVMEYMPGGDLVNLMS--NYDVPEKWARFYTA 175
Query: 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 123
+++ L+ HS G +HRD+K N+L++ G LKLADFG N + V T Y
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 124 RPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
PE+L G YG D WSVG E+L+G + V KI
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN-------- 287
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
K+ L P D+ A NLI L+ + R
Sbjct: 288 --HKNSLTF-----PDDN----------DISKEAKNLICAFLT-DREVR 318
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 53/242 (21%), Positives = 93/242 (38%), Gaps = 40/242 (16%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM----EHDITGLLSCPDIKFSEAQ 57
++ ++ R D P I++ G + C I E M + + S D E
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWI--CMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 58 IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLT 115
+ + L H ++HRDIK SN+L++ G +KL DFG+ ++ + T
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---T 183
Query: 116 SRVVTLWYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIF 171
Y PE + + Y D+WS+G EL G+ P + + +QL ++
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
K G PP +L + ++ + S F + + L+ + KR
Sbjct: 244 K--GDPP-------QLSN----SEEREFSPS----FIN-------FVNLCLTKDESKRPK 279
Query: 232 AS 233
Sbjct: 280 YK 281
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 24/161 (14%), Positives = 59/161 (36%), Gaps = 16/161 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQI 58
E LR HPN++ + G S + L+ +M +++ L + ++Q
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQA 113
Query: 59 KCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 116
+ + G+ H+ + + +++++ + +++ + +
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PG 167
Query: 117 RVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGK 155
R+ + PE L S D+WS + EL+ +
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 49/240 (20%), Positives = 94/240 (39%), Gaps = 54/240 (22%)
Query: 3 REILILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEYME------HDITGLLSCPDIKFS 54
+E+ I++ L+HP ++ L + ++V + + H L ++ F
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEEDM----FMVVDLLLGGDLRYH-----LQ-QNVHFK 113
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E +K ++ +L+ L++ ++ ++HRD+K N+L++ G + + DF +A + +
Sbjct: 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--AMLPRETQI 171
Query: 115 TSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHK 169
T+ T Y PE+ Y +VD WS+G ELL G+ I + E +H
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 170 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
P V+L++ LL P +R
Sbjct: 232 FET----------TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 31/166 (18%), Positives = 71/166 (42%), Gaps = 16/166 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE++ R+ H N++ G S +I + + + ++ I + +
Sbjct: 78 REVMAYRQTRHENVVLFMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQI 135
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSR 117
+++ G+ + H++G+LH+D+K N+ +N G + + DFGL L +
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 118 VVTLWYRPPELLLGATD--------YGPSVDLWSVGCVFAELLIGK 155
L + PE++ + + D++++G ++ EL +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 57/235 (24%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSCS------IYLVFEY------MEHDITGLLSCPDIKFS 54
IL ++HP I+KL + +YL+ ++ LS ++ F+
Sbjct: 79 ILVEVNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR-----LS-KEVMFT 124
Query: 55 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
E +K Y+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ + H +
Sbjct: 125 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKA 183
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
S T+ Y PE++ + S D WS G + E+L G QG+ E + I K
Sbjct: 184 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-- 240
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
K +P + L A +L+ L P R
Sbjct: 241 --------AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 8e-22
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 55/234 (23%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 55
IL + HP I+ L +YL+ EY L + F E
Sbjct: 74 ILEEVKHPFIVDLI-------YAFQTGGKLYLILEYLSGGELFMQ-----LE-REGIFME 120
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
Y+ ++ L H H +G+++RD+K N+++N++G +KL DFGL +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTH 179
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
+ T+ Y PE+L+ + + +VD WS+G + ++L G P G + + KI K
Sbjct: 180 TFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--- 235
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
K LP L A +L++ LL R
Sbjct: 236 -------CKLNLP-------------------PYLTQEARDLLKKLLKRNAASR 263
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 20/196 (10%)
Query: 3 REILI-LRRLDHPNIIKLEGLITSRLSCSIYLVFEYME---HDITGLLSCPDIKFSEAQI 58
++ I +R +D P + G + I E M+ + E +
Sbjct: 54 MDLDISMRTVDCPFTVTFYGALFREGDVWI--CMELMDTSLDKFYKQVIDKGQTIPEDIL 111
Query: 59 KCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTS 116
++ LEH HS V+HRD+K SN+L+N G +K+ DFG+ + +
Sbjct: 112 GKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DI 168
Query: 117 RVVTLWYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFK 172
Y PE + + Y D+WS+G EL I + P T +QL ++
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-- 226
Query: 173 LCGSPP---DDYWKKS 185
+ P D +
Sbjct: 227 VEEPSPQLPADKFSAE 242
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK--FSEAQI 58
RE+ I++RL HPNI+ G +T + SI V EY+ + LL + E +
Sbjct: 82 LREVAIMKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 59 KCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 116
+ G+ + H+R ++HR++K NLLV+ + +K+ DFGL+ + S
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKS 198
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
T + PE+L D++S G + EL +
Sbjct: 199 AAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 36/168 (21%), Positives = 68/168 (40%), Gaps = 23/168 (13%)
Query: 3 REILILRRLDHPNIIKL------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSE 55
E L + HP+I+++ + Y+V EY+ +
Sbjct: 128 AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG---YIVMEYVGGQSLKRSKGQK---LPV 181
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
A+ Y+ ++L L + HS G+++ D+K N+++ E + KL D G R
Sbjct: 182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAV------SRINSF 234
Query: 116 SRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
+ T ++ PE++ + D+++VG A L + P GR
Sbjct: 235 GYLYGTPGFQAPEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 1/102 (0%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+EI ILR L H NI+K +G+ T I L+ E++ + L K + Q Y
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+++ SR +HRD+ N+LV +E +K+ DFGL
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 41/169 (24%), Positives = 60/169 (35%), Gaps = 21/169 (12%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
E+ L H NI+ + + S ++L+ Y E + L +
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI 110
Query: 60 CYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNT 108
+ GL H H + HRD+K N+LV G +AD GLA + S
Sbjct: 111 VL--SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 109 GHRQPLTSRVVTLWYRPPELLLGATDYGPS-----VDLWSVGCVFAELL 152
RV T Y PE+L VD+W+ G V E+
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 21/169 (12%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
EI + H NI+ + + +YL+ +Y E+ + L +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL 139
Query: 60 CYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
Y + GL H H+ + HRD+K N+LV G +AD GLA +
Sbjct: 140 AY--SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 112 Q---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELL 152
+ P +RV T Y PPE+L + D++S G + E+
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 46/231 (19%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYM 62
E IL+ ++ P ++KLE + + + ++Y+V EY+ ++ L +FSE + Y
Sbjct: 91 EKRILQAVNFPFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYA 147
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL- 121
Q++ E+ HS +++RD+K NLL++ +G +++ DFG A + + R TL
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--------KRVKGRTWTLC 199
Query: 122 ---WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
PE++L Y +VD W++G + E+ G P ++ KI
Sbjct: 200 GTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------ 252
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
K + P + +L+ LL V+ KR
Sbjct: 253 ----GKVRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 54/235 (22%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQI 58
E L+L + HP II++ G T + + I+++ +Y+E G LL +F
Sbjct: 56 ERLMLSIVTHPFIIRMWG--TFQDAQQIFMIMDYIE----GGELFSLLRK-SQRFPNPVA 108
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
K Y ++ LE+ HS+ +++RD+K N+L++ G +K+ DFG A +
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VT 160
Query: 119 VTLW----YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
TL Y PE++ Y S+D WS G + E+L G ++ KI
Sbjct: 161 YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-- 217
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
+ + P +L+ L++ + +R
Sbjct: 218 --------AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 1/102 (0%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI IL+ L H NI+K +G+ S ++ L+ EY+ + + L + ++ Y
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+Q+ G+E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E + L HPNII L G+ ++ LV E+ + +LS I + +
Sbjct: 55 QEAKLFAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPD--ILVNW 110
Query: 62 MNQLLHGLEHCHSRG---VLHRDIKGSNLLVNNEG--------VLKLADFGLANFSNTGH 110
Q+ G+ + H ++HRD+K SN+L+ + +LK+ DFGLA H
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---H 167
Query: 111 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155
R S + PE++ + + D+WS G + ELL G+
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 1/102 (0%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI IL+ L H NI+K +G+ S ++ L+ EY+ + + L + ++ Y
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+Q+ G+E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 57/243 (23%), Positives = 93/243 (38%), Gaps = 73/243 (30%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 55
+L+ HP + L+ + V EY H LS + F+E
Sbjct: 58 VLQNTRHPFLTALK-------YAFQTHDRLCFVMEYANGGELFFH-----LS-RERVFTE 104
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 108
+ + Y +++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL T
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 109 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 166
G T Y PE+L DYG +VD W +G V E++ G+ +
Sbjct: 165 FCG----------TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 167 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226
I ++ + P + L A +L+ LL +P
Sbjct: 214 FELILM----------EEIRFP-------------------RTLSPEAKSLLAGLLKKDP 244
Query: 227 YKR 229
+R
Sbjct: 245 KQR 247
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 1e-20
Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 3 REIL-ILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQI 58
R +L ++ D P I+ + +L + + M D+ LS FSEA +
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHG-VFSEADM 294
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Y +++ GLEH H+R V++RD+K +N+L++ G ++++D GLA + + V
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 351
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T Y PE+L Y S D +S+GC+ +LL G + ++ H+I +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR------ 404
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
+ P +L+E LL + +R
Sbjct: 405 -------MTLTMAVELPDS------------FSPELRSLLEGLLQRDVNRR 436
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 41/169 (24%), Positives = 63/169 (37%), Gaps = 21/169 (12%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
EI L H NI+ + ++LV +Y EH + L+ +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL 144
Query: 60 CYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
GL H H + HRD+K N+LV G +AD GLA ++
Sbjct: 145 AL--STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 112 Q---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELL 152
RV T Y PE+L + + D++++G VF E+
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 56/235 (23%)
Query: 7 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 55
+L+ HP + L+ + V EY H LS + FSE
Sbjct: 201 VLQNSRHPFLTALK-------YSFQTHDRLCFVMEYANGGELFFH-----LS-RERVFSE 247
Query: 56 AQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 114
+ + Y +++ L++ HS + V++RD+K NL+++ +G +K+ DFGL +
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATM 306
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
+ T Y PE+L DYG +VD W +G V E++ G+ + + I
Sbjct: 307 KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-- 363
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
++ + P + L A +L+ LL +P +R
Sbjct: 364 --------EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 56/238 (23%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDI 51
R +L L+ + HP ++ L +Y V +Y H L +
Sbjct: 89 RNVL-LKNVKHPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH-----LQ-RER 134
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
F E + + Y ++ L + HS +++RD+K N+L++++G + L DFGL N H
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHN 193
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
++ T Y PE+L Y +VD W +G V E+L G P R E I
Sbjct: 194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
K +L ++ +A +L+E LL + KR
Sbjct: 253 N----------KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 13/159 (8%)
Query: 3 REILILRRLDHPNIIKL--EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIK 59
RE RL P+++ + G I +L Y+ + D+ +L + +
Sbjct: 83 REARTAGRLQEPHVVPIHDFGEIDGQL----YVDMRLINGVDLAAMLR-RQGPLAPPRAV 137
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRV 118
+ Q+ L+ H+ G HRD+K N+LV+ + L DFG+A+ ++ Q
Sbjct: 138 AIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNT 195
Query: 119 V-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
V TL+Y PE + D++++ CV E L G P
Sbjct: 196 VGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSP 233
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 22/184 (11%)
Query: 3 REILILRRLDHPNIIKLEG--LITSRLSCSIYLVFEYMEH------------DITGLLSC 48
E+ L + H NI++ G + + ++L+ + E L
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH- 125
Query: 49 PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 108
I + A+ Y+++ + GL+ H + HRDIK N+L+ N +ADFGLA
Sbjct: 126 --IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 109 GHRQPLTSRVV-TLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTE 163
G T V T Y PE+L GA D +D++++G V EL G +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 164 VEQL 167
L
Sbjct: 244 EYML 247
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 41/159 (25%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 3 REILILRRLDHPNIIKL--EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIK 59
RE L+HP I+ + G + Y+V EY++ + ++ + + +
Sbjct: 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAI 119
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRV 118
+ L H G++HRD+K +N++++ +K+ DFG+A +++G+ T+ V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 119 V-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
+ T Y PE G + D++S+GCV E+L G+P
Sbjct: 180 IGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC-PDIKFSEAQIKC 60
+EI ILR L H +IIK +G + S+ LV EY+ G L P AQ+
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL---GSLRDYLPRHSIGLAQLLL 138
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ Q+ G+ + H++ +HRD+ N+L++N+ ++K+ DFGLA
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 1/102 (0%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
REI IL+ L I+K G+ S+ LV EY+ + L + +++ Y
Sbjct: 73 REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+Q+ G+E+ SR +HRD+ N+LV +E +K+ADFGLA
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 28/180 (15%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
+F+E +++ Y+ +++ LEH H G+++RDIK N+L+++ G + L DFGL+
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 112 QPLTSRVVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 170
+ T+ Y P+++ G + +VD WS+G + ELL G E +I
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
Query: 171 F-KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
++ S P P +++ A +LI+ LL +P KR
Sbjct: 275 SRRILKSEP-------PYP-------------------QEMSALAKDLIQRLLMKDPKKR 308
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 49/187 (26%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------N 104
+F EA+ + Y +++ L H +G+++RD+K N+L+++EG KLADFG+
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
Query: 105 FSNT--GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
+ T G T Y PE+L YGP+VD W++G + E+L G +
Sbjct: 180 TTATFCG----------TPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
Query: 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222
E + I + P L A ++++ +
Sbjct: 229 EDDLFEAILN----------DEVVYP-------------------TWLHEDATGILKSFM 259
Query: 223 SVEPYKR 229
+ P R
Sbjct: 260 TKNPTMR 266
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 21/163 (12%)
Query: 3 REILILRRLDHPNIIKL------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSE 55
RE+ +L H NI+ + + YLV EY+E ++ + S
Sbjct: 60 REVHNSSQLSHQNIVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIE-SHGPLSV 110
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPL 114
+ NQ+L G++H H ++HRDIK N+L+++ LK+ DFG+A S T Q
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-- 168
Query: 115 TSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156
T+ V+ T+ Y PE G D++S+G V E+L+G+P
Sbjct: 169 TNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 46/187 (24%), Positives = 76/187 (40%), Gaps = 49/187 (26%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------N 104
+F E Y ++ GL S+G+++RD+K N+++++EG +K+ADFG+
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
Query: 105 FSNT--GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
+ T G T Y PE++ YG SVD W+ G + E+L G+ +G
Sbjct: 177 TTKTFCG----------TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
Query: 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222
E E I + P K + AV + + L+
Sbjct: 226 EDELFQSIME----------HNVAYP-------------------KSMSKEAVAICKGLM 256
Query: 223 SVEPYKR 229
+ P KR
Sbjct: 257 TKHPGKR 263
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 56/238 (23%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDI 51
+ +L +HP + + +++ V EY M H +
Sbjct: 68 KRVL-SLAWEHPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYH-----IQSCH- 113
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 111
KF ++ Y +++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ N
Sbjct: 114 KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGD 172
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+ T Y PE+LLG Y SVD WS G + E+LIG+ G+ E E H I
Sbjct: 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
P + L A +L+ L EP KR
Sbjct: 232 M----------DNPFYP-------------------RWLEKEAKDLLVKLFVREPEKR 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 3e-19
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 46/233 (19%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEYMEH-DITGLLSCPDIKFSEA 56
+ +L L P + +L SC +Y V EY+ D+ + +F E
Sbjct: 392 KRVLALPG-KPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEP 442
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 116
Y ++ GL S+G+++RD+K N+++++EG +K+ADFG+ N +
Sbjct: 443 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKT 501
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
T Y PE++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 502 FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---- 556
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
P K + AV + + L++ P KR
Sbjct: 557 ------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 39/179 (21%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 3 REILILRRLDHPNIIKLEG---LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQI 58
+ I + ++H NI + +T+ LV EY + + LS + +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR 115
Query: 59 KCYMNQLLHGLEHCHS---------RGVLHRDIKGSNLLVNNEGVLKLADFGLA------ 103
+ + GL + H+ + HRD+ N+LV N+G ++DFGL+
Sbjct: 116 LAH--SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 104 -NFSNTGHRQPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGK 155
S V T+ Y PE+L GA + VD++++G ++ E+ +
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 62/198 (31%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------N 104
K E + Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ +
Sbjct: 106 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
Query: 105 FSNT--GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
++T G T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 166 TTSTFCG----------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------ 208
Query: 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLP 211
P + P ++ F + L
Sbjct: 209 -------------------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 212 TTAVNLIETLLSVEPYKR 229
A +++++ L+ +P +R
Sbjct: 244 VKAASVLKSFLNKDPKER 261
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 26/102 (25%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE I+ +LD+P I++L G+ + ++ LV E + L + + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
++Q+ G+++ + +HRD+ N+L+ N K++DFGL+
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 25/105 (23%), Positives = 49/105 (46%), Gaps = 10/105 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQI 58
E ++ +D+P++ +L G+ + ++ L+ + M G LL +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPF---GCLLDYVREHKDNIGSQYL 119
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 2/102 (1%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E +I++ HPN++ L G+ R S +V YM+H D+ + + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 3/102 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E I+ + DHPNII+LEG++T +V EYME+ + L D +F+ Q+
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + G+ + G +HRD+ N+LV++ V K++DFGL+
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 10/105 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQI 58
RE+ + LDH N+I+L G++ + + +V E G LL F +
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPL---GSLLDRLRKHQGHFLLGTL 123
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Y Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E ++ +L HP +++L G+ I LV E+MEH ++ L F+ +
Sbjct: 52 EEAEVMMKLSHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM 109
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ G+ + V+HRD+ N LV V+K++DFG+
Sbjct: 110 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 62/198 (31%)
Query: 52 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------N 104
K E + Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ +
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
Query: 105 FSNT--GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162
++T G T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 209 TTSTFCG----------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------ 251
Query: 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLP 211
P + P ++ F + L
Sbjct: 252 -------------------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 212 TTAVNLIETLLSVEPYKR 229
A +++++ L+ +P +R
Sbjct: 287 VKAASVLKSFLNKDPKER 304
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 36/102 (35%), Positives = 60/102 (58%), Gaps = 3/102 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E I+ + DHPNII+LEG++T S + +V EYME+ + L D +F+ Q+
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + G+++ G +HRD+ N+L+N+ V K++DFGL
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 33/102 (32%), Positives = 58/102 (56%), Gaps = 3/102 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E I+ + H NII+LEG+I+ + ++ EYME+ + L D +FS Q+
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + G+++ + +HRD+ N+LVN+ V K++DFGL+
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 34/156 (21%), Positives = 68/156 (43%), Gaps = 13/156 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
+E +++ + HPN+++L G+ T Y++ E+M + G L C + S
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTY---GNLLDYLRECNRQEVSAVV 319
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTS 116
+ Q+ +E+ + +HR++ N LV ++K+ADFGL+ + +
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P L + D+W+ G + E+
Sbjct: 380 KFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIA 413
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 28/106 (26%), Positives = 53/106 (50%), Gaps = 10/106 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
+E +++ + HPN+++L G+ T Y++ E+M + G L C + S
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCT--REPPFYIITEFMTY---GNLLDYLRECNRQEVSAVV 112
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ Q+ +E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 2/102 (1%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E +I++ HPN++ L G+ R S +V YM+H D+ + + + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 22/102 (21%), Positives = 48/102 (47%), Gaps = 4/102 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E ++ +D+P++ +L G+ + ++ L+ + M + + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E L +R+ DHP+I+KL G+IT ++++ E ++ L A + Y
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 28/106 (26%), Positives = 49/106 (46%), Gaps = 9/106 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
E ++ +L H N+++L G+I +Y+V EYM G L S
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAK---GSLVDYLRSRGRSVLGGDC 118
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 119 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 24/102 (23%), Positives = 50/102 (49%), Gaps = 4/102 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+L + LDH +I++L GL S+ LV +Y+ + + + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+ + G++HR++ N+L+ + +++ADFG+A
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 3/102 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E ++ L H +++L G+ T I+++ EYM + + L +F Q+
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ +E+ S+ LHRD+ N LVN++GV+K++DFGL+
Sbjct: 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 3/102 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E IL++ HPNI++L G+ T + IY+V E ++ D L + +
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQM 218
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ G+E+ S+ +HRD+ N LV + VLK++DFG++
Sbjct: 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 4/102 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E +I++ LDHP+I+KL G+I +++ E + ++ L + Y
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ + + S +HRDI N+LV + +KL DFGL+
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 25/102 (24%), Positives = 48/102 (47%), Gaps = 3/102 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E + +L HP ++K G+ + IY+V EY+ + + L +Q+
Sbjct: 52 QEAQTMMKLSHPKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ G+ S +HRD+ N LV+ + +K++DFG+
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 25/102 (24%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E ++++LD+P I+++ G+ + S LV E E + L + I
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIEL 122
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
++Q+ G+++ +HRD+ N+L+ + K++DFGL+
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 25/102 (24%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE I+ +LD+P I++L G+ + ++ LV E + L + + +
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
++Q+ G+++ + +HR++ N+L+ N K++DFGL+
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 14/156 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
+E ++++L H +++L +++ IY+V EYM G L Q
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSK---GSLLDFLKGETGKYLRLPQ 281
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 117
+ Q+ G+ + +HRD++ +N+LV V K+ADFGLA
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 118 VVTL-WYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P L G + D+WS G + EL
Sbjct: 342 KFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 375
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E L +R+ DHP+I+KL G+IT ++++ E ++ L A + Y
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
E ++++L H +++L ++T IY++ EYME+ G L + IK + +
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQE---PIYIITEYMEN---GSLVDFLKTPSGIKLTINK 110
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ Q+ G+ R +HRD++ +N+LV++ K+ADFGLA
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 14/156 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
+E ++++L H +++L +++ IY+V EYM G L Q
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSK---GSLLDFLKGETGKYLRLPQ 364
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 117
+ Q+ G+ + +HRD++ +N+LV V K+ADFGLA
Sbjct: 365 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424
Query: 118 VVTL-WYRPPELLLGATDYGPSVDLWSVGCVFAELL 152
+ W P L G + D+WS G + EL
Sbjct: 425 KFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 458
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 28/106 (26%), Positives = 49/106 (46%), Gaps = 9/106 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
E ++ +L H N+++L G+I +Y+V EYM G L S
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAK---GSLVDYLRSRGRSVLGGDC 290
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 291 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 29/102 (28%), Positives = 55/102 (53%), Gaps = 2/102 (1%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE L++R L+HPN++ L G++ +++ YM H D+ + P + + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
Q+ G+E+ + +HRD+ N +++ +K+ADFGLA
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 18/111 (16%), Positives = 50/111 (45%), Gaps = 12/111 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--SCPDIKFSEAQIK 59
E +++ + ++++L G+++ ++ E M D+ L P + +
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 60 CYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+++++ G+ + ++ +HRD+ N +V + +K+ DFG+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 27/117 (23%), Positives = 49/117 (41%), Gaps = 18/117 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLL 46
E ++ RL HPN++ L G++T + ++F Y H T
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 47 SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ Q+ G+E+ S V+H+D+ N+LV ++ +K++D GL
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 25/110 (22%), Positives = 51/110 (46%), Gaps = 9/110 (8%)
Query: 3 REILILRRLDHPNIIKLEGLIT---SRLSCSIYLVFEYMEH-DITGLL-----SCPDIKF 53
E ++ HPN+I+L G+ S+ ++ +M++ D+ L
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ +M + G+E+ +R LHRD+ N ++ ++ + +ADFGL+
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
E +++ L H ++KL ++T IY++ E+M G L S K +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKE---PIYIITEFMAK---GSLLDFLKSDEGSKQPLPK 285
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + Q+ G+ R +HRD++ +N+LV+ V K+ADFGLA
Sbjct: 286 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 29/180 (16%), Positives = 60/180 (33%), Gaps = 21/180 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
++ +L H +++ G+ LV E+++ + L +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--------VLKLADFGLANF--SNTGHR 111
QL + ++H ++ N+L+ E +KL+D G++ +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 170
+ + W PPE + + + D WS G E+ G L +L
Sbjct: 179 ERIP------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 27/114 (23%), Positives = 50/114 (43%), Gaps = 16/114 (14%)
Query: 3 REILILRRLDHPNIIKLEGLIT----SRLSCSIYLVFEYMEHDITG-----LLSC----P 49
RE ++ DHP++ KL G+ ++ +M+H G LL+
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH---GDLHAFLLASRIGEN 130
Query: 50 DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ +M + G+E+ SR +HRD+ N ++ + + +ADFGL+
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 27/179 (15%), Positives = 50/179 (27%), Gaps = 35/179 (19%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIK 59
L L R+D P + ++ ++ +R +V E++ + + +
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGG--LVVAEWIRGGSLQEVADTSPSPVGAIRA- 134
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
M L + H GV S + V+ +G + LA
Sbjct: 135 --MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
P P D+ +G LL+ + L L + P
Sbjct: 175 ---TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.4 bits (179), Expect = 2e-14
Identities = 28/155 (18%), Positives = 53/155 (34%), Gaps = 19/155 (12%)
Query: 31 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLV 89
+++V E+ L S A K ++QL L + HRD+ N+L+
Sbjct: 137 LFIVLEFEFGG-IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 90 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149
+ KL S P V++ DY S VF
Sbjct: 196 KKTSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFC 240
Query: 150 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 184
++ + + + G + + I++L ++ W +
Sbjct: 241 DVSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGE 273
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 30/118 (25%), Positives = 48/118 (40%), Gaps = 21/118 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----------DITGLLSCPDIK 52
RE +L L H +I++ G+ T + +VFEYM H L
Sbjct: 92 REAELLTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 53 FSEAQIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + + QLL G+ + +HRD+ N LV V+K+ DFG++
Sbjct: 150 VAPGPLG--LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 18/117 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKF 53
RE +L L H +I+K G+ + +VFEYM+H D+ L D +
Sbjct: 66 REAELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 54 SEAQIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+A+ + ++Q+LH G+ + S+ +HRD+ N LV ++K+ DFG++
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 47/173 (27%), Positives = 71/173 (41%), Gaps = 40/173 (23%)
Query: 4 EILILRRLDHPNIIKL-----EGLITSRLSCSIYLVFEYME--------HDITGLLSCP- 49
EI ++ + H N+++L +G LV+ YM + G
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDG--DDLC-----LVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 50 ----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 105
I A G+ H +HRDIK +N+L++ K++DFGLA
Sbjct: 133 HMRCKIAQGAAN----------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 106 SNTGHRQPLTSRVV-TLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKP 156
S + +TSR+V T Y PE L G T D++S G V E++ G P
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEALRGEITP---KSDIYSFGVVLLEIITGLP 232
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 19/118 (16%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ +L +L HPNII L G +YL EY H +
Sbjct: 74 GELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 46 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ S Q+ + + G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 33/125 (26%), Positives = 50/125 (40%), Gaps = 26/125 (20%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-----------------DITGL 45
RE ++ D+PNI+KL G+ + + L+FEYM +
Sbjct: 99 REAALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 46 LSCPDIKFSEAQIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 98
LS S + L G+ + R +HRD+ N LV V+K+A
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 99 DFGLA 103
DFGL+
Sbjct: 217 DFGLS 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 22/116 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
E LI+ + +H NI++ G+ S +++ E M G L +
Sbjct: 82 MEALIISKFNHQNIVRCIGVSL--QSLPRFILMELMAG---GDLKSFLRETRPRPSQPSS 136
Query: 58 IKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA 103
+ M LLH G ++ +HRDI N L+ G V K+ DFG+A
Sbjct: 137 LA--MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 25/125 (20%), Positives = 55/125 (44%), Gaps = 26/125 (20%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH---------------------- 40
E +L++++HP++IKL G + + L+ EY ++
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 41 --DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 98
+ + L + + + + Q+ G+++ ++HRD+ N+LV +K++
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 99 DFGLA 103
DFGL+
Sbjct: 193 DFGLS 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 22/116 (18%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQ 57
E LI+ + +H NI++ G+ S +++ E M G L +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAG---GDLKSFLRETRPRPSQPSS 177
Query: 58 IKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA 103
+ M LLH G ++ +HRDI N L+ G V K+ DFG+A
Sbjct: 178 LA--MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 18/118 (15%)
Query: 3 REILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ IL + H N++ L G T + + ++ E+ +
Sbjct: 79 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 46 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 46/189 (24%), Positives = 76/189 (40%), Gaps = 46/189 (24%)
Query: 4 EILILRRLDHPNIIKLEGLITSRLSCSIY--------LVFEYMEHDITGLLSCPDIKFSE 55
EI L HP+++ L G + L+++YME+ G L +
Sbjct: 85 EIETLSFCRHPHLVSLIG----------FCDERNEMILIYKYMEN---GNLK--RHLYGS 129
Query: 56 AQIKCYM--NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 106
M Q L GL + H+R ++HRD+K N+L++ V K+ DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 107 NTGHRQPLTSRVV-TLWYRPPELLLGATDYGPS------VDLWSVGCVFAELLIGKPILQ 159
+ L++ V TL Y PE Y D++S G V E+L + +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 160 GRTEVEQLH 168
E ++
Sbjct: 243 QSLPREMVN 251
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 24/139 (17%)
Query: 32 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-- 89
++V E + D+ + + F ++ + ++L LE+ H +H DIK +NLL+
Sbjct: 128 FMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186
Query: 90 NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV--------- 139
N + LAD+GL+ + G+ + P + G ++ S+
Sbjct: 187 KNPDQVYLADYGLSYRYCPNGNHKQYQ-------ENPRKGHNGTIEF-TSLDAHKGVALS 238
Query: 140 ---DLWSVGCVFAELLIGK 155
D+ +G L GK
Sbjct: 239 RRSDVEILGYCMLRWLCGK 257
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 19/118 (16%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ +++ + H NII L G T +Y++ EY +
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 46 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
P+ + + + QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 19/118 (16%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ +++ + H NII L G T +Y++ EY +
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 46 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
P+ + + + QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 41/186 (22%)
Query: 4 EILILRRLDHPNIIKLEGL-ITS--RLSCSIYLVFEYME--------HDITGLLSCPD-- 50
E+ ++ H N+++L G +T RL LV+ YM + D
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 51 ----IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 106
I A+ Y LH +HC + ++HRD+K +N+L++ E + DFGLA
Sbjct: 132 KRQRIALGSARGLAY----LH--DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 107 NTG--HRQPLTSRVV-TLWYRPPE-LLLG-ATDYGPSVDLWSVGCVFAELLIG-KPILQG 160
+ H +T+ V T+ + PE L G +++ D++ G + EL+ G +
Sbjct: 185 DYKDTH---VTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLA 238
Query: 161 RTEVEQ 166
R +
Sbjct: 239 RLANDD 244
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 21/120 (17%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-----------DITGLLSCPD 50
E+ +L L +H NI+ L G T ++ EY + D
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 51 IKFSEAQIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ ++ + LL G+ S+ +HRD+ N+L+ + + K+ DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 25/120 (20%)
Query: 3 REILILRRLD-HPNIIKLEGLITSRLSCS----IYLVFEYMEH--------------DIT 43
E+ I+ L H NI+ L G C+ + ++ EY + +
Sbjct: 98 SELKIMSHLGQHENIVNLLGA------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 44 GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
+ + S + + +Q+ G+ S+ +HRD+ N+L+ N V K+ DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 19/118 (16%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ +++ + H NII L G T +Y++ EY
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 46 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
P+ + S + Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 35/156 (22%), Positives = 58/156 (37%), Gaps = 24/156 (15%)
Query: 32 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN- 90
+++ + D+ + +FS + ++L LE+ H +H DIK SNLL+N
Sbjct: 128 FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187
Query: 91 -NEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDY---------GPS- 138
N + L D+GLA + G + P G ++ PS
Sbjct: 188 KNPDQVYLVDYGLAYRYCPEGVHKAYA-------ADPKRCHDGTIEFTSIDAHNGVAPSR 240
Query: 139 -VDLWSVGCVFAELLIGK-P--ILQGRTEVEQLHKI 170
DL +G + L G P + + KI
Sbjct: 241 RGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKI 276
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 27/140 (19%), Positives = 47/140 (33%), Gaps = 24/140 (17%)
Query: 32 YLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV- 89
+LV + + L P SE + +LL LE H +H ++ N+ V
Sbjct: 134 FLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193
Query: 90 -NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV-------- 139
++ + LA +G A + +G G ++ S+
Sbjct: 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYV-------EGSRSPHEGDLEFI-SMDLHKGCGP 245
Query: 140 ----DLWSVGCVFAELLIGK 155
DL S+G + L G
Sbjct: 246 SRRSDLQSLGYCMLKWLYGF 265
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 41/184 (22%)
Query: 32 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-- 89
+V E + + L + KFS + +Q++ +E+ HS+ +HRD+K N L+
Sbjct: 81 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140
Query: 90 -NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV------ 139
++ + DFGLA + T P YR + L G Y S+
Sbjct: 141 GKKGNLVYIIDFGLAKKYRDARTHQHIP---------YRENKNLTGTARY-ASINTHLGI 190
Query: 140 ------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 190
DL S+G V +G L+ T+ ++ +I + KK P
Sbjct: 191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----------KKMSTPIE 240
Query: 191 TLFK 194
L K
Sbjct: 241 VLCK 244
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 26/125 (20%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ ++ +L H NI+ L G T IYL+FEY + D
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 46 LSCPDIKFSEAQIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 98
+ ++ E LL G+E + +HRD+ N+LV + V+K+
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 99 DFGLA 103
DFGLA
Sbjct: 215 DFGLA 219
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 43/186 (23%), Positives = 67/186 (36%), Gaps = 43/186 (23%)
Query: 32 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-- 89
+V E + + L D FS + QL+ +E+ HS+ +++RD+K N L+
Sbjct: 81 AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR 140
Query: 90 ---NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV---- 139
+ V+ + DF LA T P YR + L G Y S+
Sbjct: 141 PGNKTQQVIHIIDFALAKEYIDPETKKHIP---------YREHKSLTGTARYM-SINTHL 190
Query: 140 --------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 188
DL ++G +F L G L+ T E+ KI K P
Sbjct: 191 GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD----------TKRATP 240
Query: 189 HATLFK 194
L +
Sbjct: 241 IEVLCE 246
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 43/186 (23%), Positives = 68/186 (36%), Gaps = 43/186 (23%)
Query: 32 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-- 89
LV + + + LL KFS + Q+L ++ H + +++RDIK N L+
Sbjct: 82 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 141
Query: 90 ---NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV---- 139
N ++ + DFG+ F T P YR + L G Y S+
Sbjct: 142 PNSKNANMIYVVDFGMVKFYRDPVTKQHIP---------YREKKNLSGTARYM-SINTHL 191
Query: 140 --------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 188
DL ++G VF L G L+ T ++ +I + KK P
Sbjct: 192 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE----------KKQSTP 241
Query: 189 HATLFK 194
L
Sbjct: 242 LRELCA 247
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 45/184 (24%), Positives = 69/184 (37%), Gaps = 41/184 (22%)
Query: 32 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-- 89
LV + + + L + K S + +Q+++ +E HS+ LHRDIK N L+
Sbjct: 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138
Query: 90 -NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV------ 139
+ + DFGLA ++T P YR + L G Y SV
Sbjct: 139 GRRANQVYIIDFGLAKKYRDTSTHQHIP---------YRENKNLTGTARY-ASVNTHLGI 188
Query: 140 ------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 190
DL S+G V L G L+ T+ ++ KI + KK
Sbjct: 189 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----------KKVATSIE 238
Query: 191 TLFK 194
L +
Sbjct: 239 ALCR 242
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 19/44 (43%), Positives = 29/44 (65%)
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 68/510 (13%), Positives = 130/510 (25%), Gaps = 177/510 (34%)
Query: 155 KPILQGRTEVEQLHKIF-KLCGSPP------------DDY-WKKSKLPHATLFKPQQP-- 198
I+ + V ++F L +Y + S + + +QP
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT----EQRQPSM 107
Query: 199 ----YDSSLRETFKDLPTTA----------VNLIETLLSVEPY------------KRATA 232
Y + D A + L + LL + P K A
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 233 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 292
S K I+ + + + + + + + + T+R H
Sbjct: 168 LDVCLSYKVQCKM------DFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 293 GMSKLAPVEDV--AVRTQFAKKINGHSLHILKD--------------------------D 324
+ + + +R K + L +L + D
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 325 ELSGREVQKPLVDNREEA----------SHVKNASHGDIPFS----GPLQVS-----TSS 365
LS +D+ + D+P P ++S
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD 339
Query: 366 GFA-WAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNY----------------- 407
G A W + + + +S +N LEP+ R +
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESS----LNVLEPA---EYRKMFDRLSVFPPSAHIPTILL 392
Query: 408 -----DSRKHENGDIINGSRTDS-----------RGHDSLEAVKIAMLNQWSQLER---- 447
D K + ++N S +K+ + N+ L R
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE-YALHRSIVD 451
Query: 448 ----PDSFDASD--------------GYHSQELSLALYQREEMATKRN---NLGFQDQGE 486
P +FD+ D G+H + + E M R + F +Q
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP----ERMTLFRMVFLDFRFLEQ-- 505
Query: 487 KVEFSGPLLSQSHRIDELL---ERHERQIR 513
K+ + S I L + ++ I
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 7e-04
Identities = 53/366 (14%), Positives = 102/366 (27%), Gaps = 118/366 (32%)
Query: 3 REILILRRLDHPNIIK-LEG----LITSR-------LSCSIYLVFEYMEHDITG------ 44
+L+L + + L+T+R LS + ++H
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS-LDHHSMTLTPDEV 303
Query: 45 ---LLSCPDIKFSE--AQIKCYMNQLLHGL-------EHCHSRGVLHRDIKGSNLLVNNE 92
LL D + + ++ N + H VN +
Sbjct: 304 KSLLLKYLDCRPQDLPREV-LTTNPRRLSIIAESIRDGLATWDNWKH---------VNCD 353
Query: 93 GVLKLADFGLANFSNTGHRQ------------PLTSRV-VTLW----YRPPELLLGATDY 135
+ + + L +R+ + + + +W +++ +
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV-NKLH 412
Query: 136 GPS-VDLWSVGCVFAELLIGKPILQGRTEVE-----QLHKIF--------KLCG---SPP 178
S V+ E I P + +V+ LH+ PP
Sbjct: 413 KYSLVEKQP-----KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467
Query: 179 --DDYWKKSKLP-HATLFKPQQP-YDSSLRETFKDL---------PTTAVN----LIETL 221
D Y+ S + H L + P + R F D +TA N ++ TL
Sbjct: 468 YLDQYF-YSHIGHH--LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 222 LSVEPYKR-----ATASAALASEY--FSTK--------PYACDLSSLPIYPPSKEI-DAK 265
++ YK L + F K Y DL + + + I +
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKY-TDLLRIALMAEDEAIFEEA 583
Query: 266 HREDAR 271
H++ R
Sbjct: 584 HKQVQR 589
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 529 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.69 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.48 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.75 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.69 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.09 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.94 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.66 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.14 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.42 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 90.74 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 89.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 87.71 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 85.41 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=434.67 Aligned_cols=214 Identities=26% Similarity=0.470 Sum_probs=188.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+||.||++|+|||||+++++|.+ .+.+|||||||+|+.|..++.. .+|++.+++.|+.||+.||+|||++||+||
T Consensus 118 ~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 194 (346)
T 4fih_A 118 LFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHR 194 (346)
T ss_dssp GHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 4689999999999999999999998 5789999999999877766543 479999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+|+.+.... ...++.+||++|+|||++.+ ..|+.++||||||||||||++|.+||.+
T Consensus 195 DlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCHHHEEECCCCCEEEecCcCceecCCCC-CcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999998775432 34567899999999999876 5699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+..|..... +. ...+..+|+++++||.+||+.||++|||+.|+|+|||
T Consensus 273 ~~~~~~~~~i~~~~~-~~-------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 273 EPPLKAMKMIRDNLP-PR-------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp SCHHHHHHHHHHSSC-CC-------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred cCHHHHHHHHHcCCC-CC-------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 999999988866221 11 0123468999999999999999999999999999999
Q ss_pred cCCCC
Q 009654 241 FSTKP 245 (529)
Q Consensus 241 f~~~~ 245 (529)
|++..
T Consensus 327 ~~~~~ 331 (346)
T 4fih_A 327 LAKAG 331 (346)
T ss_dssp GGGCC
T ss_pred hcCCC
Confidence 98643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=441.89 Aligned_cols=244 Identities=32% Similarity=0.569 Sum_probs=204.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc----CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~----~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+||.+|+.|+|||||++++++... ..+.+|||||||+|++...+. ..+.|++.+++.|++||+.||.|||++||
T Consensus 101 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~i 179 (398)
T 4b99_A 101 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQV 179 (398)
T ss_dssp HHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 5899999999999999999998653 236899999999988766654 45689999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCC---CCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||||||+||||+.+|.+||+|||+|+.+... .....++.+||++|+|||++.+...|+.++||||+|||||||++|
T Consensus 180 iHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G 259 (398)
T 4b99_A 180 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 259 (398)
T ss_dssp BCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred cCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHC
Confidence 99999999999999999999999999876432 223456789999999999998877889999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccc----cCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT----LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~----~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++||.|.+..+++..|+...|.|+...|......... .+.+ .....+...++.++++++|||.+||.+||.+||
T Consensus 260 ~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPP--RQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCC--CCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCC--cCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 9999999999999999999999998777543221111 0111 112235566788999999999999999999999
Q ss_pred CHHHHHhccccCCCCCCC
Q 009654 231 TASAALASEYFSTKPYAC 248 (529)
Q Consensus 231 ta~e~L~h~~f~~~~~~~ 248 (529)
||.|+|+||||+....+.
T Consensus 338 ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 338 SAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp CHHHHTTSGGGTTTCCGG
T ss_pred CHHHHhcCHhhCcCCCCc
Confidence 999999999999765443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=428.27 Aligned_cols=215 Identities=28% Similarity=0.417 Sum_probs=189.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.||++|+|||||+++++|++ .+.+|||||||+|+.|..++...+.|+|.+++.|+.||+.||+|||++||+||
T Consensus 79 ~~~E~~il~~l~HpnIv~l~~~~~~--~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHR 156 (311)
T 4aw0_A 79 VTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHR 156 (311)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 3689999999999999999999998 57999999999997776666666789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||+||||+.+|.+||+|||+|+.+.... .....+.+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.
T Consensus 157 DlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999875432 234567799999999999987 469999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH-----
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA----- 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e----- 234 (529)
+.+..+.+.+|.+.-..+ ...+++++++||.+||+.||++|+|+.|
T Consensus 236 ~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~ 286 (311)
T 4aw0_A 236 AGNEGLIFAKIIKLEYDF-----------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 286 (311)
T ss_dssp CSSHHHHHHHHHHTCCCC-----------------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH
T ss_pred CCCHHHHHHHHHcCCCCC-----------------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCH
Confidence 999999999997732111 1357899999999999999999999987
Q ss_pred -HHhccccCCCCCC
Q 009654 235 -ALASEYFSTKPYA 247 (529)
Q Consensus 235 -~L~h~~f~~~~~~ 247 (529)
+++||||+...|.
T Consensus 287 ~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 287 PLKAHPFFESVTWE 300 (311)
T ss_dssp HHHTSGGGTTCCCT
T ss_pred HHHCCCCcCCCCHH
Confidence 5889999877664
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=418.25 Aligned_cols=209 Identities=31% Similarity=0.495 Sum_probs=175.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|||||||+|+++..+.. .++|++.+++.++.||+.||+|||++||+||
T Consensus 60 ~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHR 136 (275)
T 3hyh_A 60 IEREISYLRLLRHPHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHR 136 (275)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 3689999999999999999999988 578999999998887776654 4589999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+|+..... ....+.+||+.|+|||++.+...++.++||||||||||+|++|++||.+
T Consensus 137 DiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 137 DLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp CCCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCChHHeEECCCCCEEEeecCCCeecCCC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999876543 2345679999999999998866668999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+.+|... .++ ....+|+++++||.+||+.||++|||+.|+|+|||
T Consensus 215 ~~~~~~~~~i~~~--~~~---------------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 215 ESIPVLFKNISNG--VYT---------------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp SSHHHHHHHHHHT--CCC---------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred CCHHHHHHHHHcC--CCC---------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 9998888888662 211 01357899999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|+.
T Consensus 266 ~k~ 268 (275)
T 3hyh_A 266 FKV 268 (275)
T ss_dssp HHT
T ss_pred ccc
Confidence 975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=436.22 Aligned_cols=213 Identities=26% Similarity=0.477 Sum_probs=187.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+||.||++|+|||||+++++|.+ .+.+|||||||+|+.|..++. ..+|++.+++.|+.||+.||+|||++||+||
T Consensus 195 ~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iVmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHR 271 (423)
T 4fie_A 195 LFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 271 (423)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEEEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 3689999999999999999999998 578999999999987776654 3479999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+|+.+.... ...++.+||++|||||++.+ ..|+.++||||||||||||++|++||.+
T Consensus 272 DiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCHHHEEEcCCCCEEEecCccceECCCCC-ccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999998765432 34567899999999999976 5699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+..|..... +. ...+..+|+++++||.+||..||.+|||+.|+|+|||
T Consensus 350 ~~~~~~~~~i~~~~~-~~-------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 350 EPPLKAMKMIRDNLP-PR-------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp SCHHHHHHHHHHSCC-CC-------------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred cCHHHHHHHHHcCCC-CC-------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence 999999988866311 11 0122468999999999999999999999999999999
Q ss_pred cCCC
Q 009654 241 FSTK 244 (529)
Q Consensus 241 f~~~ 244 (529)
|+..
T Consensus 404 ~~~~ 407 (423)
T 4fie_A 404 LAKA 407 (423)
T ss_dssp GGGC
T ss_pred hcCC
Confidence 9864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=413.58 Aligned_cols=212 Identities=23% Similarity=0.326 Sum_probs=178.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG-- 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g-- 76 (529)
|.+|+.+|++|+|||||+++++|.+. ....+|||||||+|+.|..++.....+++.+++.|+.||+.||+|||++|
T Consensus 72 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~ 151 (290)
T 3fpq_A 72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151 (290)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46899999999999999999998752 23578999999999888777666678999999999999999999999999
Q ss_pred CcccCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 77 VLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 77 IvHrDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|+||||||+||||+. +|.+||+|||+|+.... ....+.+||+.|||||++.+ .|+.++||||||||||||++|+
T Consensus 152 IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~---~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~ 226 (290)
T 3fpq_A 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp CCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEecccChhheeEECCCCCEEEEeCcCCEeCCC---CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999985 79999999999986543 23456799999999999875 5999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+....+...... +.++.. ....+++++++||.+||..||.+|||+.++
T Consensus 227 ~Pf~~~~~~~~~~~~i~~-~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~ 280 (290)
T 3fpq_A 227 YPYSECQNAAQIYRRVTS-GVKPAS-------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280 (290)
T ss_dssp CTTTTCSSHHHHHHHHTT-TCCCGG-------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCcHHHHHHHHHc-CCCCCC-------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999876655544333221 222111 124578899999999999999999999999
Q ss_pred HhccccCC
Q 009654 236 LASEYFST 243 (529)
Q Consensus 236 L~h~~f~~ 243 (529)
|+||||++
T Consensus 281 l~Hp~~~~ 288 (290)
T 3fpq_A 281 LNHAFFQE 288 (290)
T ss_dssp HTSGGGC-
T ss_pred hcCccccC
Confidence 99999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=420.25 Aligned_cols=213 Identities=29% Similarity=0.423 Sum_probs=182.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||+++++|++ .+.+|||||||+|+.|..++...+.|++.+++.|+.||+.||+|||++||+||
T Consensus 73 ~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 150 (304)
T 3ubd_A 73 TKMERDILVEVNHPFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150 (304)
T ss_dssp -----CCCCCCCCTTEECEEEEEEE--TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 4579999999999999999999998 57899999999997777666666789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.+|.+||+|||+|+...... ....+.+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+
T Consensus 151 DlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 151 DLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp SCCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHeEEcCCCCEEecccccceeccCCC-ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998654332 34456799999999999977 5699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~ 235 (529)
.+..+.+.+|.+....+ ...+|+++++||.+||+.||++||| ++|+
T Consensus 229 ~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~ei 279 (304)
T 3ubd_A 229 KDRKETMTMILKAKLGM-----------------------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279 (304)
T ss_dssp SSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHH
T ss_pred cCHHHHHHHHHcCCCCC-----------------------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHH
Confidence 99999999987632111 1357899999999999999999998 5899
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
|+||||+...|
T Consensus 280 l~Hp~f~~idw 290 (304)
T 3ubd_A 280 KRHSFFSTIDW 290 (304)
T ss_dssp HTSGGGTTCCH
T ss_pred HcCccccCCCH
Confidence 99999997654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=426.33 Aligned_cols=211 Identities=27% Similarity=0.455 Sum_probs=184.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++|+|||||+++++|++ .+.+|||||||+|+.|..++ .....+++.+++.|+.||+.||+|||++||+
T Consensus 70 ~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~Ii 147 (350)
T 4b9d_A 70 SRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKIL 147 (350)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred HHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3689999999999999999999998 67899999999986665444 3445689999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+||||+.+|.+||+|||+|+...... ...+..+||+.|+|||++.+ ..|+.++||||||||||||++|++||
T Consensus 148 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF 225 (350)
T 4b9d_A 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF 225 (350)
T ss_dssp ETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eccCCHHHEEECCCCCEEEcccccceeecCCc-ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999998765321 12345689999999999987 56999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+.+|... .++. ....+|+++++||.+||+.||.+|||+.|+|+|
T Consensus 226 ~~~~~~~~~~~i~~~--~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 226 EAGSMKNLVLKIISG--SFPP--------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCSSHHHHHHHHHHT--CCCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCcCHHHHHHHHHcC--CCCC--------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999998763 2210 113588999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
|||+.
T Consensus 278 p~~~~ 282 (350)
T 4b9d_A 278 GFIAK 282 (350)
T ss_dssp HHHHT
T ss_pred HHhhc
Confidence 99975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=417.64 Aligned_cols=238 Identities=26% Similarity=0.433 Sum_probs=186.7
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.+ +|||||+++++|.+ .+++|||||||+|+.+..++ ..|++.+++.|++||+.||+|||++||+||
T Consensus 67 ~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHR 141 (361)
T 4f9c_A 67 AAELQCLTVAGGQDNVMGVKYCFRK--NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHR 141 (361)
T ss_dssp HHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhcCCCCCceEEEEEEE--CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 5899999999 79999999999988 67999999999986665554 269999999999999999999999999999
Q ss_pred CCCCCcEEEccC-CcEEEeccccccccCCCC---------------------------CCCccccccccccCCcccccCC
Q 009654 81 DIKGSNLLVNNE-GVLKLADFGLANFSNTGH---------------------------RQPLTSRVVTLWYRPPELLLGA 132 (529)
Q Consensus 81 DIKp~NILl~~~-g~vKl~DFGla~~~~~~~---------------------------~~~~~~~~gt~~Y~APE~l~~~ 132 (529)
||||+||||+.+ +.+||+|||+|+...... ....++.+||++|+|||++.+.
T Consensus 142 DiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 142 DVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred cCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 999999999877 899999999997654321 1234567899999999999887
Q ss_pred CCCCCcchhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCchhhhcc---------CCCccc-----------
Q 009654 133 TDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPPDDYWKKS---------KLPHAT----------- 191 (529)
Q Consensus 133 ~~y~~~~DIWSlG~il~elltG~~pf-~g~~~~~~~~~I~~~~g~p~~~~~~~~---------~l~~~~----------- 191 (529)
..|+.++||||+|||+|+|++|++|| .+.++.+++..|+..+|.++...|... ..+...
T Consensus 222 ~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 301 (361)
T 4f9c_A 222 PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGM 301 (361)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--
T ss_pred CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccc
Confidence 78999999999999999999999887 567889999999999987543322210 000000
Q ss_pred -c----CCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 192 -L----FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 192 -~----~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
. +...........+.+..+|++++|||.+||++||.+|+||.|||+||||+..
T Consensus 302 ~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 302 DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 0000000011123467899999999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=412.90 Aligned_cols=213 Identities=27% Similarity=0.339 Sum_probs=181.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||+++++|.+ .+.+|||||||+|+.|..++...+.|++.+++.|+.||+.||+|||++||+|||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 175 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 489999999999999999999988 578999999999977776666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCC-cEEEeccccccccCCCCCC----CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 82 IKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ----PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 82 IKp~NILl~~~g-~vKl~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||+||||+.+| .+||+|||+|+........ .....+||+.|||||++.+ ..|+.++||||||||||||++|++
T Consensus 176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcC
Confidence 999999999988 5999999999877543211 1234589999999999987 569999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH-
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA- 235 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~- 235 (529)
||.+.+..+.+.+|.. +.++ +.+..+.+|+++.+||.+||+.||.+|||+.|+
T Consensus 255 Pf~~~~~~~~~~~i~~--~~~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~ 308 (336)
T 4g3f_A 255 PWTQYFRGPLCLKIAS--EPPP------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELR 308 (336)
T ss_dssp SSTTTCCSCCHHHHHH--SCCG------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHc--CCCC------------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 9999888777777765 2221 112335789999999999999999999999997
Q ss_pred ------------HhccccCC
Q 009654 236 ------------LASEYFST 243 (529)
Q Consensus 236 ------------L~h~~f~~ 243 (529)
|+|||+..
T Consensus 309 ~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 309 RKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHHhhhhhccCCCcCC
Confidence 56888875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=421.75 Aligned_cols=218 Identities=26% Similarity=0.399 Sum_probs=192.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCch-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll-~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.|+|||||+|+++|.+ .+.+|||||||+|+.| ..+......|++.+++.|+.||+.||+|||++||+||
T Consensus 202 ~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHR 279 (573)
T 3uto_A 202 RKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279 (573)
T ss_dssp HHHHHHHHHTCCTTBCCEEEEEEC--SSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 589999999999999999999998 6799999999998555 4555566789999999999999999999999999999
Q ss_pred CCCCCcEEEccC--CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~--g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+||||+.+ |.+||+|||+|+.+... ......+||++|+|||++.+ ..|+.++||||||||||+|++|.+||
T Consensus 280 DlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf 356 (573)
T 3uto_A 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF 356 (573)
T ss_dssp CCCGGGEEESSSSCCCEEECCCSSCEECCTT--SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred cCChhhccccCCCCCCEEEeeccceeEccCC--CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999864 89999999999987654 34566799999999999987 56999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+.+|......++.. .+..+|+++++||.+||..||.+|||+.|+|+|
T Consensus 357 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 357 GGENDDETLRNVKSCDWNMDDS-------------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCSSHHHHHHHHHTTCCCCCSG-------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999997754444322 235789999999999999999999999999999
Q ss_pred cccCCCCCCCC
Q 009654 239 EYFSTKPYACD 249 (529)
Q Consensus 239 ~~f~~~~~~~~ 249 (529)
|||+...++..
T Consensus 412 pw~~~~~~~~~ 422 (573)
T 3uto_A 412 PWLTPGNAPGR 422 (573)
T ss_dssp TTTSCCCCTTT
T ss_pred cCcCCCCCCCc
Confidence 99997666543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=387.89 Aligned_cols=215 Identities=22% Similarity=0.368 Sum_probs=162.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCC----------CeEEEEEeccCCCchhhhcCCCCC---CCHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLS----------CSIYLVFEYMEHDITGLLSCPDIK---FSEAQIKCYMNQLLH 67 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~----------~~~~lV~E~~~g~ll~~~~~~~~~---l~e~~~~~i~~Qll~ 67 (529)
+.+|+.+|++|+|||||+++++|.+... ..+|||||||+++.+..++..... .++..++.|+.||+.
T Consensus 50 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~ 129 (299)
T 4g31_A 50 VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129 (299)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHH
Confidence 3689999999999999999999876432 247999999999777766544433 455678999999999
Q ss_pred HHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-----------CCccccccccccCCcccccCCCCCC
Q 009654 68 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-----------QPLTSRVVTLWYRPPELLLGATDYG 136 (529)
Q Consensus 68 gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~y~ 136 (529)
||+|||++||+||||||+||||+.+|.+||+|||+|+....... ...++.+||+.|||||++.+ ..|+
T Consensus 130 al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~ 208 (299)
T 4g31_A 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYS 208 (299)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT-CCCC
T ss_pred HHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCC
Confidence 99999999999999999999999999999999999987654321 12345689999999999987 5699
Q ss_pred CcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHH
Q 009654 137 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216 (529)
Q Consensus 137 ~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~d 216 (529)
.++||||||||||||++ ||.+. .+....+........+ ..+...++.+.+
T Consensus 209 ~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~p-------------------------~~~~~~~~~~~~ 258 (299)
T 4g31_A 209 HKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKFP-------------------------PLFTQKYPCEYV 258 (299)
T ss_dssp THHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCCC-------------------------HHHHHHCHHHHH
T ss_pred CHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCCC-------------------------CCCcccCHHHHH
Confidence 99999999999999996 67543 2333333332211110 112345677899
Q ss_pred HHHHhccCCCCCCcCHHHHHhccccCCCCC
Q 009654 217 LIETLLSVEPYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 217 Li~~mL~~dP~kR~ta~e~L~h~~f~~~~~ 246 (529)
||.+||+.||.+|||+.++|+||||+...+
T Consensus 259 li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 259 MVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 999999999999999999999999987544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=383.94 Aligned_cols=213 Identities=22% Similarity=0.340 Sum_probs=172.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.. +.+|||||||+++.|..+ .....++++.++..|+.||+.||+|||++||+|
T Consensus 79 f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiH 155 (307)
T 3omv_A 79 FRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155 (307)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 4689999999999999999998754 468999999998766644 455678999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCC--CCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||||+||||+.++.+||+|||+|+...... ....+..+||+.|||||++.+. ..|+.++||||||||||||++|++
T Consensus 156 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~ 235 (307)
T 3omv_A 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235 (307)
T ss_dssp SCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999998765322 2334567899999999999653 358999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+....+..+......+|. +......+|+++.+||.+||+.||++|||+.+++
T Consensus 236 Pf~~~~~~~~~~~~~~~~~~~p~-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 236 PYSHINNRDQIIFMVGRGYASPD-----------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp TTTTCCCHHHHHHHHHTTCCCCC-----------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred CCCCCChHHHHHHHHhcCCCCCC-----------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 99988776666555442222110 1122357899999999999999999999999887
Q ss_pred hcc
Q 009654 237 ASE 239 (529)
Q Consensus 237 ~h~ 239 (529)
++-
T Consensus 293 ~~L 295 (307)
T 3omv_A 293 SSI 295 (307)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=411.28 Aligned_cols=210 Identities=24% Similarity=0.364 Sum_probs=179.9
Q ss_pred HHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 009654 4 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 83 (529)
Q Consensus 4 Ei~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIK 83 (529)
++.+++.++|||||+++++|++ ...+|||||||+||.|..++...+.|++..++.|+.||+.||+|||++||||||||
T Consensus 242 ~l~ll~~~~HP~IV~l~~~f~~--~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 242 MLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp HHHHHSSSCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred HHHHHhhCCCCCEeEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 4667778899999999999998 67999999999997777666666789999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCH
Q 009654 84 GSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 163 (529)
Q Consensus 84 p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~ 163 (529)
|+||||+.+|.+||+|||+|+.+... ...+.+||+.|+|||++.+...|+.++||||||||||||++|.+||.+.+.
T Consensus 320 PeNILld~~G~vKL~DFGlA~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 320 PANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred hHHeEEeCCCCEEecccceeeecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999877543 345679999999999997656799999999999999999999999987532
Q ss_pred ---HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHH
Q 009654 164 ---VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAA 235 (529)
Q Consensus 164 ---~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~ 235 (529)
.+....+... .+ ..+..+|+++++||.+||+.||.+|++ +.++
T Consensus 397 ~~~~~i~~~i~~~--~~---------------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei 447 (689)
T 3v5w_A 397 KDKHEIDRMTLTM--AV---------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447 (689)
T ss_dssp CCHHHHHHHHHHC--CC---------------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH
T ss_pred HHHHHHHHhhcCC--CC---------------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH
Confidence 3334444331 11 011368999999999999999999998 8999
Q ss_pred HhccccCCCCCC
Q 009654 236 LASEYFSTKPYA 247 (529)
Q Consensus 236 L~h~~f~~~~~~ 247 (529)
++||||+...|.
T Consensus 448 ~~HpfF~~idW~ 459 (689)
T 3v5w_A 448 KESPFFRSLDWQ 459 (689)
T ss_dssp TTSGGGTTCCHH
T ss_pred hcCccccCCCHH
Confidence 999999987664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=376.93 Aligned_cols=209 Identities=23% Similarity=0.365 Sum_probs=177.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-------------CCCCCCHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-------------PDIKFSEAQIKCYMNQLLH 67 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-------------~~~~l~e~~~~~i~~Qll~ 67 (529)
|.+|+.+|++|+|||||++++++.+ .+.+|||||||+++.|..++. ....|++.++..|+.||+.
T Consensus 62 f~~E~~il~~l~HpnIV~l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 139 (299)
T 4asz_A 62 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139 (299)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCccEEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHH
Confidence 4689999999999999999999987 568999999999877665442 2357999999999999999
Q ss_pred HHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhH
Q 009654 68 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 146 (529)
Q Consensus 68 gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~ 146 (529)
||.|||+++|+||||||+||||+.++.+||+|||+|+........ .....+||+.|+|||++.+ ..|+.++|||||||
T Consensus 140 gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gv 218 (299)
T 4asz_A 140 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGV 218 (299)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHH
T ss_pred HHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHH
Confidence 999999999999999999999999999999999999866443221 2234568999999999976 46999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 147 VFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 147 il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
+||||+| |++||.+.+..+.+..|.. |..++ ....+|+++.+||.+||+.|
T Consensus 219 vl~Ellt~G~~Pf~~~~~~~~~~~i~~--~~~~~--------------------------~p~~~~~~~~~li~~cl~~d 270 (299)
T 4asz_A 219 VLWEIFTYGKQPWYQLSNNEVIECITQ--GRVLQ--------------------------RPRTCPQEVYELMLGCWQRE 270 (299)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHH--TCCCC--------------------------CCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHc--CCCCC--------------------------CCccchHHHHHHHHHHcCCC
Confidence 9999998 8999999999988888866 22110 11358899999999999999
Q ss_pred CCCCcCHHHHHhccccC
Q 009654 226 PYKRATASAALASEYFS 242 (529)
Q Consensus 226 P~kR~ta~e~L~h~~f~ 242 (529)
|++|||+.+++ +|+.
T Consensus 271 P~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 271 PHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp GGGSCCHHHHH--HHHH
T ss_pred hhHCcCHHHHH--HHHH
Confidence 99999999994 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=377.71 Aligned_cols=207 Identities=23% Similarity=0.335 Sum_probs=169.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC---------------CCCCCHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP---------------DIKFSEAQIKCYMNQL 65 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~---------------~~~l~e~~~~~i~~Ql 65 (529)
|.+|+.+|++|+|||||+++++|.+ ...+|||||||+++.|..++.. ..+|++.++..|+.||
T Consensus 90 f~~E~~il~~l~HpnIV~l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 167 (329)
T 4aoj_A 90 FQREAELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167 (329)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHH
Confidence 4689999999999999999999987 5689999999999777654422 2469999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 66 l~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
+.||+|||+++|+||||||+||||+.++.+||+|||+++....... ...+..+||+.|+|||++.+ ..|+.++|||||
T Consensus 168 a~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~ 246 (329)
T 4aoj_A 168 AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSF 246 (329)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHH
T ss_pred HHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccch
Confidence 9999999999999999999999999999999999999987654322 22345679999999999977 569999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
|||||||+| |++||.+.+..+.+..|... ..++ ....+|+++.+||.+||+
T Consensus 247 Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g--~~~~--------------------------~p~~~~~~~~~li~~cl~ 298 (329)
T 4aoj_A 247 GVVLWEIFTYGKQPWYQLSNTEAIDCITQG--RELE--------------------------RPRACPPEVYAIMRGCWQ 298 (329)
T ss_dssp HHHHHHHHTTSCCTTCSSCHHHHHHHHHHT--CCCC--------------------------CCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CCCC--------------------------CcccccHHHHHHHHHHcC
Confidence 999999998 89999999998888888652 2110 113578999999999999
Q ss_pred CCCCCCcCHHHHHhc
Q 009654 224 VEPYKRATASAALAS 238 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h 238 (529)
.||++|||+.+++++
T Consensus 299 ~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 299 REPQQRHSIKDVHAR 313 (329)
T ss_dssp SSTTTSCCHHHHHHH
T ss_pred cChhHCcCHHHHHHH
Confidence 999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=397.43 Aligned_cols=282 Identities=30% Similarity=0.393 Sum_probs=229.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||+++++|.+ ...+|||||||+++.+...+.....+++..+..++.||+.||.|||++||+|||
T Consensus 94 ~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~D 171 (504)
T 3q5i_A 94 YNEISLLKSLDHPNIIKLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRD 171 (504)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 579999999999999999999988 678999999999866655444456899999999999999999999999999999
Q ss_pred CCCCcEEEccCC---cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g---~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.++ .+||+|||++...... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||
T Consensus 172 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp CSGGGEEESSTTCCSSEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CcHHHEEEecCCCCccEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC
Confidence 999999998876 6999999999877543 24456789999999999875 5999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..|......++ ...|..+|+++++||.+||..||.+|||+.++|+|
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 248 GGQNDQDIIKKVEKGKYYFD-------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCSSHHHHHHHHHHCCCCCC-------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCCC-------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999988877433222 23346789999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCChhHHhhhhHHHHhhhhcCcccccccccccccccCCCCCCChHHHHHHHHHHHHhcCCCC
Q 009654 239 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSL 318 (529)
Q Consensus 239 ~~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~d~~~~ 318 (529)
|||+...... . ..+.+.......+.. ++...++.++.....+..++.+.+++..+.+.|..+|.|++
T Consensus 303 ~~~~~~~~~~--------~---~~~~~~~~~~~~~~~--~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~d 369 (504)
T 3q5i_A 303 RWIKKYANNI--------N---KSDQKTLCGALSNMR--KFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGD 369 (504)
T ss_dssp HHHHHTCCCC--------C---GGGHHHHHHHHHHHH--HCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCS
T ss_pred Hhhhhchhcc--------c---ccchhhHHHHHHHHH--HHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCC
Confidence 9998642210 0 111111111111111 34445556666666666677799999999999999999999
Q ss_pred CcccccccC
Q 009654 319 HILKDDELS 327 (529)
Q Consensus 319 g~~~~ee~~ 327 (529)
|.++.+|+.
T Consensus 370 G~I~~~El~ 378 (504)
T 3q5i_A 370 GQLDKKELI 378 (504)
T ss_dssp SEECHHHHH
T ss_pred CeEcHHHHH
Confidence 999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=395.88 Aligned_cols=280 Identities=26% Similarity=0.417 Sum_probs=223.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||++++++.+ ...+|+|||||.++.+...+.....+++.++..++.||+.||.|||++||+|||
T Consensus 69 ~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 146 (486)
T 3mwu_A 69 LREVELLKKLDHPNIMKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146 (486)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 589999999999999999999988 678999999999876655444456899999999999999999999999999999
Q ss_pred CCCCcEEEcc---CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~---~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+. ++.+||+|||++...... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||
T Consensus 147 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CchHHEEEecCCCCCCEEEEECCcCeECCCC--CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999954 567999999999876543 23456789999999999986 5999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......++. ..+..+|+++++||.+||+.||.+|||+.++|+|
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 223 YGKNEYDILKRVETGKYAFDL-------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCSSHHHHHHHHHHTCCCSCS-------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCHHHHHHHHHhCCCCCCC-------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999998888764333221 2345689999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCChhHHh--hhhHHHHhhhhcCcccccccccccccccCCCCCCChHHHHHHHHHHHHhcCC
Q 009654 239 EYFSTKPYACDLSSLPIYPPSKEIDA--KHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGH 316 (529)
Q Consensus 239 ~~f~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~d~~ 316 (529)
|||+...... | ....... ......+ .+....+.++.....++.++.+.+++..+.+.|..+|.|
T Consensus 278 p~~~~~~~~~-----~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~~~D~d 343 (486)
T 3mwu_A 278 PWIQKYSSET-----P---TISDLPSLESAMTNIR------QFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTN 343 (486)
T ss_dssp HHHHHTCCCC-----C---CGGGHHHHHHHHHHHH------HHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTT
T ss_pred HhhccCcccC-----c---cccccccHHHHHHHHH------HHHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCC
Confidence 9998643211 1 1111111 1111111 122233445555566666667899999999999999999
Q ss_pred CCCccccccc
Q 009654 317 SLHILKDDEL 326 (529)
Q Consensus 317 ~~g~~~~ee~ 326 (529)
++|.++.+|+
T Consensus 344 ~dG~I~~~El 353 (486)
T 3mwu_A 344 NDGMLDRDEL 353 (486)
T ss_dssp CSSSBCHHHH
T ss_pred CCceeeHHHH
Confidence 9999999997
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=369.52 Aligned_cols=240 Identities=40% Similarity=0.710 Sum_probs=202.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|||||||+++++..+......+++.+++.++.||+.||.|||++||+|||
T Consensus 67 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~D 144 (311)
T 3niz_A 67 IREISLLKELHHPNIVSLIDVIHS--ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRD 144 (311)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECC--SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHHcCCCCEeeeeeEEcc--CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 589999999999999999999987 578999999999988888877777899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.
T Consensus 145 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 145 LKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEETTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CchHhEEECCCCCEEEccCcCceecCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765332 23455688999999999987677999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccC-CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+.+..+...++.+....|........... .........+....+.+++++++||.+||+.||.+|||+.++|+|||
T Consensus 224 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 224 TDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp STTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred ChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 99999999999999988777765322111000 00011112234556778999999999999999999999999999999
Q ss_pred cCCC
Q 009654 241 FSTK 244 (529)
Q Consensus 241 f~~~ 244 (529)
|+..
T Consensus 304 f~~~ 307 (311)
T 3niz_A 304 FKDL 307 (311)
T ss_dssp GTTS
T ss_pred cccC
Confidence 9864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=362.97 Aligned_cols=240 Identities=39% Similarity=0.693 Sum_probs=203.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.+ ...+|||||||+++++..+......+++.+++.++.||+.||.|||++||+|||
T Consensus 49 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~d 126 (292)
T 3o0g_A 49 LREICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126 (292)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 589999999999999999999988 578999999999998888877777899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC-CCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~-~pf~g 160 (529)
|||+|||++.++.+||+|||++....... ......++|+.|+|||++.+...|+.++|||||||++|+|++|. |+|.+
T Consensus 127 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 127 LKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred CCHHHEEEcCCCCEEEeecccceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 99999999999999999999998765332 23455688999999999988667899999999999999999765 55788
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+..++...+.++...|............+..+....+....+.+++++++||.+||+.||.+|||+.++|+|||
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 89999999999999999888776533211111111112223334455678999999999999999999999999999999
Q ss_pred cCCC
Q 009654 241 FSTK 244 (529)
Q Consensus 241 f~~~ 244 (529)
|+..
T Consensus 286 f~~~ 289 (292)
T 3o0g_A 286 FSDF 289 (292)
T ss_dssp GTTC
T ss_pred cccC
Confidence 9863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=372.88 Aligned_cols=207 Identities=21% Similarity=0.327 Sum_probs=176.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
|.+|+.+|++|+|||||++++++.+ ...+|||||||+++.|..++.. ...|++.++..|+.|
T Consensus 76 f~~E~~il~~l~HpNIV~l~g~~~~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 153 (308)
T 4gt4_A 76 FRHEAMLRARLQHPNVVCLLGVVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153 (308)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCcceEEEE--CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHH
Confidence 4689999999999999999999987 5678999999998766644321 246999999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||+|||+++|+||||||+||||++++.+||+|||+++...... ....+..+||+.|+|||++.+ ..|+.++||||
T Consensus 154 ia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwS 232 (308)
T 4gt4_A 154 IAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWS 232 (308)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhh
Confidence 9999999999999999999999999999999999999998664322 223456689999999999976 46999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
||||||||+| |.+||.+.+..+.+..|......+ ....+|+++.+||.+||
T Consensus 233 fGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~ 284 (308)
T 4gt4_A 233 YGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP----------------------------CPDDCPAWVYALMIECW 284 (308)
T ss_dssp HHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CcccchHHHHHHHHHHc
Confidence 9999999998 899999999988888775521111 11368899999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
+.||.+|||+.+++++
T Consensus 285 ~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 285 NEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=396.71 Aligned_cols=281 Identities=27% Similarity=0.372 Sum_probs=223.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||+++++|.+ ...+|+|||||.++.+...+.....+++.++..++.||+.||.|||++||+|||
T Consensus 74 ~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~D 151 (484)
T 3nyv_A 74 LREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151 (484)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 589999999999999999999988 678999999999877665555566899999999999999999999999999999
Q ss_pred CCCCcEEE---ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+|||| +.++.+||+|||++..+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||
T Consensus 152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 152 LKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp CCGGGEEESSSSTTCCEEECCTTHHHHBCCC--CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCcEEEEeeeeeEEcccc--cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 99999999 45688999999999877554 23456789999999999977 5999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......++. ..+..+++.+++||.+||+.||.+|||+.++|+|
T Consensus 228 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 228 NGANEYDILKKVEKGKYTFEL-------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCSSHHHHHHHHHHCCCCCCS-------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCCCC-------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 999999999888774333221 2335689999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCChhHHhhhhHHHHhhhhcCcccccccccccccccCCCCCCChHHHHHHHHHHHHhcCCCC
Q 009654 239 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSL 318 (529)
Q Consensus 239 ~~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~d~~~~ 318 (529)
|||+......... ..+.....-...+ .+...+..++.....+...+.+.+++..+.+.|..+|.|++
T Consensus 283 ~~~~~~~~~~~~~---~~~~~~~~~~~~~----------~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~~D~d~d 349 (484)
T 3nyv_A 283 EWIQTYTKEQISV---DVPSLDNAILNIR----------QFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGD 349 (484)
T ss_dssp HHHHHHTC--------CCCBCHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCS
T ss_pred hhhcccccccccc---cccchHHHHHHHH----------HHhhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHHhCcCCC
Confidence 9997543211111 1111111111111 11122233333444444445578889999999999999999
Q ss_pred Cccccccc
Q 009654 319 HILKDDEL 326 (529)
Q Consensus 319 g~~~~ee~ 326 (529)
|.++.+|+
T Consensus 350 G~I~~~El 357 (484)
T 3nyv_A 350 GQLDRAEL 357 (484)
T ss_dssp SEEEHHHH
T ss_pred ceEeHHHH
Confidence 99999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=395.44 Aligned_cols=285 Identities=26% Similarity=0.386 Sum_probs=226.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+|||||+++++|.+ ...+|||||||+++.+...+.....+++.+++.++.||+.||.|||++||+|||
T Consensus 84 ~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~D 161 (494)
T 3lij_A 84 LEEVAVLKLLDHPNIMKLYDFFED--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161 (494)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 589999999999999999999988 578999999999876655444456899999999999999999999999999999
Q ss_pred CCCCcEEEccC---CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.. +.+||+|||++...... ......+||++|+|||++.+ .|+.++||||||||+|+|++|.+||
T Consensus 162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECBTT--BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CChhhEEEeCCCCCCcEEEEECCCCeECCCC--ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCC
Confidence 99999999764 45999999999877643 24456789999999999864 6999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......++. ..|..+++.+++||.+||+.||.+|||+.++|+|
T Consensus 238 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 238 GGQTDQEILRKVEKGKYTFDS-------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSSHHHHHHHHHHTCCCCCS-------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCHHHHHHHHHhCCCCCCc-------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 999999999888774443332 2345789999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCChhHHhhhhHHHHhhhhcCcccccccccccccccCCCCCCChHHHHHHHHHHHHhcCCCC
Q 009654 239 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSL 318 (529)
Q Consensus 239 ~~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~d~~~~ 318 (529)
|||+........ ....+.... ..+..+ .+...+..++.....++..+.+.+++..+.+.|+.+|.|++
T Consensus 293 p~~~~~~~~~~~--~~~~~~~~~----~~~~~~------~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~d 360 (494)
T 3lij_A 293 PWIKEMCSKKES--GIELPSLAN----AIENMR------KFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGD 360 (494)
T ss_dssp HHHHHHHHHHHC-----CCCCSS----HHHHHH------TTTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCS
T ss_pred cccccCcccccc--cccccccHH----HHHHHH------HHHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCC
Confidence 999753111000 001111111 011111 23334445555555555666789999999999999999999
Q ss_pred CcccccccCCc
Q 009654 319 HILKDDELSGR 329 (529)
Q Consensus 319 g~~~~ee~~~~ 329 (529)
|.++.+|+...
T Consensus 361 G~I~~~El~~~ 371 (494)
T 3lij_A 361 GQLDRQELIDG 371 (494)
T ss_dssp SEECHHHHHHT
T ss_pred CeEcHHHHHHH
Confidence 99999997433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=360.61 Aligned_cols=237 Identities=38% Similarity=0.724 Sum_probs=196.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+||||+++++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 48 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 125 (288)
T 1ob3_A 48 IREISILKELKHSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125 (288)
T ss_dssp HHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 589999999999999999999987 568999999999987777766667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 126 LKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHEEEcCCCCEEEeECccccccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765321 23345678999999999987667999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC--CcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~--~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+..+.+..+....+.++...|....... .+.+... ....+......+++++++||.+||+.||.+|||+.++|+||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 205 SEADQLMRIFRILGTPNSKNWPNVTELP--KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHHHHHHHCCCChhhchhhhccc--ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 9999999999999998877765422110 0000000 01122344567899999999999999999999999999999
Q ss_pred ccCC
Q 009654 240 YFST 243 (529)
Q Consensus 240 ~f~~ 243 (529)
||+.
T Consensus 283 ~f~~ 286 (288)
T 1ob3_A 283 YFKE 286 (288)
T ss_dssp GGGC
T ss_pred chhh
Confidence 9975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=383.61 Aligned_cols=246 Identities=34% Similarity=0.603 Sum_probs=195.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+.|+|||||++++++.... ...+||||||+++++...+. ....|++..++.++.||+.||.|||++||+
T Consensus 100 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ii 178 (458)
T 3rp9_A 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGIL 178 (458)
T ss_dssp HHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcC
Confidence 58999999999999999999985432 35799999999987766664 445799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC--------------------------CCccccccccccCCcccccCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------------------------QPLTSRVVTLWYRPPELLLGA 132 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--------------------------~~~~~~~gt~~Y~APE~l~~~ 132 (529)
||||||+||||+.++.+||+|||+++....... ...+..+||++|+|||++...
T Consensus 179 HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 258 (458)
T 3rp9_A 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258 (458)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC
T ss_pred CCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC
Confidence 999999999999999999999999987643211 134567889999999988766
Q ss_pred CCCCCcchhhhhhHHHHHHHh-----------CCCCCCCCC--------------------HHHHHHHHHHHcCCCCchh
Q 009654 133 TDYGPSVDLWSVGCVFAELLI-----------GKPILQGRT--------------------EVEQLHKIFKLCGSPPDDY 181 (529)
Q Consensus 133 ~~y~~~~DIWSlG~il~ellt-----------G~~pf~g~~--------------------~~~~~~~I~~~~g~p~~~~ 181 (529)
..|+.++||||||||||||++ |.++|.|.+ ..+++..|++.+|.|+.+.
T Consensus 259 ~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~ 338 (458)
T 3rp9_A 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED 338 (458)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHH
T ss_pred CCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHH
Confidence 779999999999999999998 889998865 3688999999999999877
Q ss_pred hhccCCCccccCC--CCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCCCCCC
Q 009654 182 WKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 248 (529)
Q Consensus 182 ~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~~~ 248 (529)
|..........+. ........+...++.+++++++||.+||.+||.+|||+.|+|+||||+...++.
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 339 IEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 6543321111000 001112234566788899999999999999999999999999999999866543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=363.72 Aligned_cols=242 Identities=36% Similarity=0.679 Sum_probs=199.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-----~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.+|++|+||||+++++++.+ .+.+|||||||++++...+.. ....+++..+..++.||+.||.|||++|
T Consensus 51 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 128 (317)
T 2pmi_A 51 IREISLMKELKHENIVRLYDVIHT--ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128 (317)
T ss_dssp HHHHHHHTTCCBTTBCCEEEEECC--TTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhcCCCCcceEEEEEEE--CCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 589999999999999999999987 578999999999877665532 2246999999999999999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|+||||||+|||++.+|.+||+|||++....... ......++|+.|+|||++.+...|+.++|||||||++|+|++|.+
T Consensus 129 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (317)
T 2pmi_A 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207 (317)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeeCCCChHHeEEcCCCCEEECcCccceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998765332 234456889999999999876679999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CccccC---CCCCCCcchhh-hhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLF---KPQQPYDSSLR-ETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~---~~~~~~~~~l~-~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
||.+.+..+++..|++.+|.++...|..... +..... .+...+...+. .....++.++++||.+||+.||.+|||
T Consensus 208 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 287 (317)
T 2pmi_A 208 LFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287 (317)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC
Confidence 9999999999999999999998888865321 111000 00011111111 122368999999999999999999999
Q ss_pred HHHHHhccccCCCCC
Q 009654 232 ASAALASEYFSTKPY 246 (529)
Q Consensus 232 a~e~L~h~~f~~~~~ 246 (529)
+.++|+||||+....
T Consensus 288 ~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 288 AKQALHHPWFAEYYH 302 (317)
T ss_dssp HHHHTTSGGGGGGCC
T ss_pred HHHHhCChhhhcccc
Confidence 999999999986433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=376.36 Aligned_cols=242 Identities=36% Similarity=0.592 Sum_probs=198.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~---~~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+.|+||||++++++|.... ...+|||||||+++++..+. .....+++..++.++.||+.||.|||+
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37999999999999999999986532 23488999999998766443 235689999999999999999999999
Q ss_pred CCCcccCCCCCcEEEc-cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 75 RGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
+||+||||||+||||+ .++.+||+|||+++...... .....++|++|+|||++.+...|+.++||||||||+|+|++
T Consensus 160 ~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 237 (394)
T 4e7w_A 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237 (394)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999 78999999999998765432 34566889999999999887779999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc-cCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|++||.+.+..+++..|.+.+|.|+...|............+... ...+...+ ..+++++++||.+||+.||.+|||+
T Consensus 238 g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (394)
T 4e7w_A 238 GQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIR-PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316 (394)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCC-CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhcccccc-CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence 999999999999999999999999877654422111000011111 11122223 3589999999999999999999999
Q ss_pred HHHHhccccCCCCC
Q 009654 233 SAALASEYFSTKPY 246 (529)
Q Consensus 233 ~e~L~h~~f~~~~~ 246 (529)
.++|+||||+...+
T Consensus 317 ~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 317 IEALCHPFFDELRT 330 (394)
T ss_dssp HHHHTSGGGSTTTS
T ss_pred HHHhcChhhhhhcc
Confidence 99999999987544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.76 Aligned_cols=247 Identities=41% Similarity=0.705 Sum_probs=209.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||++++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 60 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 137 (346)
T 1ua2_A 60 LREIKLLQELSHPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137 (346)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHhhCCCCCCCeEEEEEee--CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCC
Confidence 579999999999999999999987 568999999999987777766667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.+|.+||+|||++....... ......++|++|+|||++.+...|+.++||||||||+|+|++|.+||.+.
T Consensus 138 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 138 LKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCCEEEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999998765432 23456688999999999987667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+.+..|+..++.++...|.... ++....+.... ...+...+..++.++++||.+||..||.+|||+.++|+|||
T Consensus 217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 217 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 9999999999999999888776532 22211111111 11234556788999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCC
Q 009654 241 FSTKPYACDLSSL 253 (529)
Q Consensus 241 f~~~~~~~~~~~~ 253 (529)
|+..+.+......
T Consensus 295 f~~~~~~~~~~~~ 307 (346)
T 1ua2_A 295 FSNRPGPTPGCQL 307 (346)
T ss_dssp GTSSSCCCCSSSS
T ss_pred hhcCCCCCCcccC
Confidence 9987776544333
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=372.82 Aligned_cols=241 Identities=35% Similarity=0.598 Sum_probs=194.5
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.+. ||||+++++++.......+|||||||++++...+.. ..+++..+..++.||+.||+|||++||+||
T Consensus 56 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHr 133 (388)
T 3oz6_A 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHR 133 (388)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeC
Confidence 58999999996 999999999998765568999999999877666543 479999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCC--------------------CCCCccccccccccCCcccccCCCCCCCcch
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTG--------------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVD 140 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~--------------------~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~D 140 (529)
||||+||||+.++.+||+|||+++.+... .....+..+||++|+|||++.+...|+.++|
T Consensus 134 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 213 (388)
T 3oz6_A 134 DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213 (388)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHH
T ss_pred CCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhh
Confidence 99999999999999999999999865321 1123456789999999999988778999999
Q ss_pred hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCC---------CCCCCc---chhh----
Q 009654 141 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK---------PQQPYD---SSLR---- 204 (529)
Q Consensus 141 IWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~---------~~~~~~---~~l~---- 204 (529)
|||||||+|+|++|++||.+.+..+++..|...++.|+.+.+.....+....+. ....+. ..+.
T Consensus 214 iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (388)
T 3oz6_A 214 MWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL 293 (388)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcc
Confidence 999999999999999999999999999999999999987766543222110000 000000 0000
Q ss_pred --hhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 205 --ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 205 --~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
.....+++++++||.+||..||.+|||+.++|+||||+..
T Consensus 294 ~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred cccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 0112689999999999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=364.52 Aligned_cols=241 Identities=37% Similarity=0.682 Sum_probs=198.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|||||||++++...+......+++.+++.++.||+.||.|||++||+|||
T Consensus 48 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 125 (324)
T 3mtl_A 48 IREVSLLKDLKHANIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125 (324)
T ss_dssp CCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred HHHHHHHHhcCCCCCCeeeeEEee--CCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence 469999999999999999999987 578999999999988887776667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......++|++|+|||++.+...|+.++||||||||+|+|++|.+||.+.
T Consensus 126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 126 LKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp CCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998655332 23445678999999999988777999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
+..+++..+...++.|+...|........ ..+.........+......+++++.+||.+||+.||.+|||+.++|+|||
T Consensus 205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 205 TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred CHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 99999999999999998887764211100 00011111122334556788999999999999999999999999999999
Q ss_pred cCCCC
Q 009654 241 FSTKP 245 (529)
Q Consensus 241 f~~~~ 245 (529)
|....
T Consensus 285 f~~~~ 289 (324)
T 3mtl_A 285 FLSLG 289 (324)
T ss_dssp GGGGC
T ss_pred hhhcc
Confidence 98643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=382.41 Aligned_cols=237 Identities=31% Similarity=0.595 Sum_probs=188.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+|||||+++++|.... ...+|||||||+++++..+.. .+++.+++.++.||+.||+|||++||
T Consensus 109 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~i 185 (464)
T 3ttj_A 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGI 185 (464)
T ss_dssp HHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 58999999999999999999997642 257899999999988776643 59999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.++.+||+|||+++..... ...+..+||++|+|||++.+. .|+.++||||||||||+|++|++|
T Consensus 186 iHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~p 262 (464)
T 3ttj_A 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 262 (464)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCCCC-----C--CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543 245667899999999999874 699999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCc-chhhhhcc------------CCcHHHHHHHHHhccC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-SSLRETFK------------DLPTTAVNLIETLLSV 224 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~-~~l~~~~~------------~~s~~~~dLi~~mL~~ 224 (529)
|.+.+..+++.+|.+.+|.|...+|................+. ..+...++ ..++++++||.+||.+
T Consensus 263 F~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 342 (464)
T 3ttj_A 263 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342 (464)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC
Confidence 9999999999999999999988877543210000000000000 00111111 1267899999999999
Q ss_pred CCCCCcCHHHHHhccccCCC
Q 009654 225 EPYKRATASAALASEYFSTK 244 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~ 244 (529)
||.+|||+.|+|+||||+..
T Consensus 343 dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 343 DPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp STTTSCCHHHHHTSTTTGGG
T ss_pred ChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999853
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=372.01 Aligned_cols=209 Identities=22% Similarity=0.315 Sum_probs=171.8
Q ss_pred CHHHHHHHHhCCC-CCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHH
Q 009654 1 MAREILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMN 63 (529)
Q Consensus 1 ~~rEi~iL~~L~H-pnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~ 63 (529)
|.+|+.+|++|+| ||||+++++|... ...+|||||||+++.|..++.. ...|++.++..|+.
T Consensus 114 ~~~E~~il~~l~hhpnIV~l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 192 (353)
T 4ase_A 114 LMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 192 (353)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCcEEEEEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHH
Confidence 4689999999965 9999999998764 4568999999999766654421 34589999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhh
Q 009654 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLW 142 (529)
Q Consensus 64 Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIW 142 (529)
||+.||+|||+++||||||||+||||+.++.+||+|||+|+....... ...+..+||+.|||||++.+ ..|+.++|||
T Consensus 193 qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVw 271 (353)
T 4ase_A 193 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVW 271 (353)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHH
T ss_pred HHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEe
Confidence 999999999999999999999999999999999999999987654322 22345678999999999987 4699999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 143 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 143 SlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
||||+||||++ |.+||.+.+..+.+.++......++ ....+|+++.+||.+|
T Consensus 272 S~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c 324 (353)
T 4ase_A 272 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDC 324 (353)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHH
Confidence 99999999998 9999998765554444433211111 0135789999999999
Q ss_pred ccCCCCCCcCHHHHHhc
Q 009654 222 LSVEPYKRATASAALAS 238 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~h 238 (529)
|+.||.+|||+.++++|
T Consensus 325 ~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 325 WHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCcChhHCcCHHHHHHH
Confidence 99999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=361.43 Aligned_cols=247 Identities=41% Similarity=0.716 Sum_probs=201.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|+.+|+.|+||||+++++++.+.. ...+|||||||+++++..+......+++.+++.++.||+.||.|||++
T Consensus 64 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 143 (351)
T 3mi9_A 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143 (351)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 58999999999999999999998743 346899999999988888877777899999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCC---CCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
||+||||||+||||+.++.+||+|||++...... ........++|+.|+|||++.+...|+.++||||||||+|+|+
T Consensus 144 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 223 (351)
T 3mi9_A 144 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223 (351)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH
Confidence 9999999999999999999999999999876532 1223456688999999999987677999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCcchhhhhc--cCCcHHHHHHHHHhccCCCCCC
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~--~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+|.+||.+.+..+++..+...++.++...|........ ............+...+ ...++.+++||.+||+.||.+|
T Consensus 224 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 303 (351)
T 3mi9_A 224 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303 (351)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGS
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhC
Confidence 99999999999999999999999998877765321110 00000000011111111 1247889999999999999999
Q ss_pred cCHHHHHhccccCCCCCCC
Q 009654 230 ATASAALASEYFSTKPYAC 248 (529)
Q Consensus 230 ~ta~e~L~h~~f~~~~~~~ 248 (529)
||+.++|+||||+..+.+.
T Consensus 304 ~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 304 IDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp CCHHHHHTSGGGGSSSCCC
T ss_pred CCHHHHhCCCCcCCCCCcc
Confidence 9999999999999766543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=360.90 Aligned_cols=211 Identities=28% Similarity=0.481 Sum_probs=185.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ...+|+|||||+++.+..++.....+++.++..++.||+.||.|||++||+|||
T Consensus 62 ~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrD 139 (328)
T 3fe3_A 62 FREVRIMKILNHPNIVKLFEVIET--EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139 (328)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccC
Confidence 589999999999999999999987 578999999999876665554556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++...... ......+||++|+|||++.+...++.++||||||||+|+|++|.+||.+.
T Consensus 140 lkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 140 LKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp CCGGGEEECTTSCEEECSTTCCGGGSSS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCCEEEeeccCceecCCC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543 24566789999999999988665568999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+....+.......| ..+++++.+||.+||..||.+|||+.++|+||||
T Consensus 218 ~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 218 NLKELRERVLRGKYRIP-----------------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp SHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CHHHHHHHHHhCCCCCC-----------------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 98888888866221111 2468899999999999999999999999999999
Q ss_pred CCCC
Q 009654 242 STKP 245 (529)
Q Consensus 242 ~~~~ 245 (529)
+...
T Consensus 269 ~~~~ 272 (328)
T 3fe3_A 269 NAGH 272 (328)
T ss_dssp TTTC
T ss_pred cCCC
Confidence 8643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=366.13 Aligned_cols=212 Identities=27% Similarity=0.411 Sum_probs=188.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||++++++|.+ ...+|||||||+|+.+..++.....+++.++..++.||+.||.|||++||+|||
T Consensus 63 ~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrD 140 (361)
T 2yab_A 63 EREVSILRQVLHPNIITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140 (361)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCcCCCcEEEEEEe--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 589999999999999999999988 578999999999877776666677899999999999999999999999999999
Q ss_pred CCCCcEEEccCC----cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 82 IKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 82 IKp~NILl~~~g----~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+|
T Consensus 141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCSSCEECCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCHHHEEEeCCCCCccCEEEEecCCceEcCCC--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999998876 7999999999876553 23456789999999999976 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..|......++.. .+..+++.+++||.+||..||.+|||+.++|+
T Consensus 218 f~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 218 FLGDTKQETLANITAVSYDFDEE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHhcCCCCCch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999998887754444333 33578999999999999999999999999999
Q ss_pred ccccCC
Q 009654 238 SEYFST 243 (529)
Q Consensus 238 h~~f~~ 243 (529)
||||+.
T Consensus 273 hp~~~~ 278 (361)
T 2yab_A 273 HPWITP 278 (361)
T ss_dssp STTTSC
T ss_pred CcCcCC
Confidence 999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=375.55 Aligned_cols=245 Identities=36% Similarity=0.611 Sum_probs=197.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC---CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~---~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+.|+||||+++++++..... ..+|||||||++++...+. ....+++..++.++.||+.||.|||++||+
T Consensus 73 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~giv 151 (432)
T 3n9x_A 73 LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGII 151 (432)
T ss_dssp HHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 589999999999999999999876421 5799999999987666554 455799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC---------------------CCccccccccccCCcccccCCCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---------------------QPLTSRVVTLWYRPPELLLGATDYGP 137 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~---------------------~~~~~~~gt~~Y~APE~l~~~~~y~~ 137 (529)
||||||+||||+.++.+||+|||+++....... ...+..+||++|+|||++.....|+.
T Consensus 152 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 231 (432)
T 3n9x_A 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231 (432)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCT
T ss_pred CCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCc
Confidence 999999999999999999999999987654321 13467799999999999876677999
Q ss_pred cchhhhhhHHHHHHHh-----------CCCCCCCCC-----------------HHHHHHHHHHHcCCCCchhhhccCCCc
Q 009654 138 SVDLWSVGCVFAELLI-----------GKPILQGRT-----------------EVEQLHKIFKLCGSPPDDYWKKSKLPH 189 (529)
Q Consensus 138 ~~DIWSlG~il~ellt-----------G~~pf~g~~-----------------~~~~~~~I~~~~g~p~~~~~~~~~l~~ 189 (529)
++||||||||||||++ |.|+|.|.+ ..+++..|++.+|.|+.+.|.......
T Consensus 232 ~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~ 311 (432)
T 3n9x_A 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE 311 (432)
T ss_dssp HHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHH
Confidence 9999999999999997 677777765 478999999999999987765433211
Q ss_pred cccCC--CCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCCCCC
Q 009654 190 ATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 247 (529)
Q Consensus 190 ~~~~~--~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~~ 247 (529)
...+. ........+...++.+++++++||.+||.+||.+|||+.++|+||||+...+.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 312 VIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 11000 00111223456677899999999999999999999999999999999976554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=358.69 Aligned_cols=241 Identities=37% Similarity=0.705 Sum_probs=191.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+||||+++++++.+ ...+|||||||++++...+. ....+++.+++.++.||+.||.|||++||+||
T Consensus 80 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~ 156 (329)
T 3gbz_A 80 AIREVSLLKELQHRNIIELKSVIHH--NHRLHLIFEYAENDLKKYMD-KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHR 156 (329)
T ss_dssp CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHcCCCCcceEEEEEec--CCEEEEEEecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECC
Confidence 4689999999999999999999988 57899999999987666554 34479999999999999999999999999999
Q ss_pred CCCCCcEEEc-----cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVN-----NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~-----~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||+||||+ ..+.+||+|||++....... ......++|+.|+|||++.+...|+.++||||||||+|+|++|.
T Consensus 157 Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 235 (329)
T 3gbz_A 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235 (329)
T ss_dssp CCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEEecCCCCccceEEECcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999994 44569999999998765332 23455678999999999988677999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCcchhhh-hccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRE-TFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~-~~~~~~~~~~~~l~~-~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
+||.+.+..+.+..++...+.++...|........ ....+... ...+.. ....+++++++||.+||..||.+|||+.
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 314 (329)
T 3gbz_A 236 PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR-GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314 (329)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC-CCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhc-cccHhhhcccccCHHHHHHHHHHccCChhhCCCHH
Confidence 99999999999999999999998877754321111 00001111 111122 2234789999999999999999999999
Q ss_pred HHHhccccCCCCC
Q 009654 234 AALASEYFSTKPY 246 (529)
Q Consensus 234 e~L~h~~f~~~~~ 246 (529)
++|+||||+...|
T Consensus 315 e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 315 NALEHPYFSHNDF 327 (329)
T ss_dssp HHHTSGGGSSSCS
T ss_pred HHhCCcccCCCCC
Confidence 9999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=366.40 Aligned_cols=239 Identities=35% Similarity=0.651 Sum_probs=198.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC----CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~----~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+||||+++++++..... ..+|||||||.+++...+.. ..+++..+..++.||+.||.|||++||
T Consensus 72 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~i 149 (367)
T 1cm8_A 72 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGI 149 (367)
T ss_dssp HHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 589999999999999999999976421 45799999996555444433 479999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.++.+||+|||+++.... ..+..++|++|+|||++.+...|+.++||||||||+|+|++|++|
T Consensus 150 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 225 (367)
T 1cm8_A 150 IHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225 (367)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccCcCHHHEEEcCCCCEEEEeeeccccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987643 245678899999999998866799999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccC---CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~---~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
|.+.+..+++..|.+..|.|+.+++..........+ .+. .....+...+..+++.+++||.+||..||.+|||+.+
T Consensus 226 f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE-LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304 (367)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCC-CCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCC-CCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence 999999999999999999999877654321110000 000 0012234556788999999999999999999999999
Q ss_pred HHhccccCCCCCC
Q 009654 235 ALASEYFSTKPYA 247 (529)
Q Consensus 235 ~L~h~~f~~~~~~ 247 (529)
+|+||||+....+
T Consensus 305 ~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 305 ALAHPYFESLHDT 317 (367)
T ss_dssp HHHSGGGTTTC--
T ss_pred HhcChHHHhhcCC
Confidence 9999999875443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=373.22 Aligned_cols=213 Identities=32% Similarity=0.476 Sum_probs=186.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||++++++.+ ...+|||||||+|+.+...+.....+++.++..++.||+.||.|||++||+|||
T Consensus 58 ~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrD 135 (444)
T 3soa_A 58 EREARICRLLKHPNIVRLHDSISE--EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRN 135 (444)
T ss_dssp HHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 589999999999999999999987 678999999999876665555556899999999999999999999999999999
Q ss_pred CCCCcEEEcc---CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~---~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+|||++. ++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||
T Consensus 136 lKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp CSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCHHHEEEeccCCCCcEEEccCceeEEecCCC-ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCC
Confidence 9999999984 5789999999998765432 33456789999999999976 46999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..|......++.. .+..+++++++||.+||+.||.+|||+.++|+|
T Consensus 214 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 214 WDEDQHRLYQQIKAGAYDFPSP-------------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCSSHHHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCccHHHHHHHHHhCCCCCCcc-------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999999998887744433322 235789999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
|||+.
T Consensus 269 p~~~~ 273 (444)
T 3soa_A 269 PWISH 273 (444)
T ss_dssp CTTHH
T ss_pred ccccC
Confidence 99974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=369.90 Aligned_cols=247 Identities=36% Similarity=0.709 Sum_probs=190.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--------~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+|++|+|||||+++++|.+.....+|||||||+++++..+.. ....+++..++.++.||+.||.|||
T Consensus 66 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 145 (405)
T 3rgf_A 66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145 (405)
T ss_dssp HHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999997766789999999999987776531 2235999999999999999999999
Q ss_pred HCCCcccCCCCCcEEE----ccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHH
Q 009654 74 SRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 147 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl----~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~i 147 (529)
++||+||||||+|||| +.++.+||+|||+++....... ......+||++|+|||++.+...|+.++||||||||
T Consensus 146 ~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i 225 (405)
T 3rgf_A 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 225 (405)
T ss_dssp HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHH
T ss_pred hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHH
Confidence 9999999999999999 6678999999999987653211 233456889999999999887779999999999999
Q ss_pred HHHHHhCCCCCCCCCH---------HHHHHHHHHHcCCCCchhhhccC-CCcccc----CC----CCCCCcchhhhhccC
Q 009654 148 FAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSK-LPHATL----FK----PQQPYDSSLRETFKD 209 (529)
Q Consensus 148 l~elltG~~pf~g~~~---------~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~----~~----~~~~~~~~l~~~~~~ 209 (529)
||+|++|.+||.+.+. .+++..|+..+|.|+...|.... ++.... +. ........+......
T Consensus 226 l~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (405)
T 3rgf_A 226 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305 (405)
T ss_dssp HHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCC
T ss_pred HHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCC
Confidence 9999999999987765 48899999999999988876532 111000 00 000000111111223
Q ss_pred CcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCCCCCC
Q 009654 210 LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 248 (529)
Q Consensus 210 ~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~~~ 248 (529)
.++.+++||.+||.+||.+|||+.++|+||||+..+++.
T Consensus 306 ~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp TTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 478899999999999999999999999999999877654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=350.46 Aligned_cols=238 Identities=38% Similarity=0.692 Sum_probs=198.2
Q ss_pred HHHHHHHHhCC---CCCccceeeEEEccCCC---eEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD---HPNIIKLEGLITSRLSC---SIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~---HpnIvkl~~~~~~~~~~---~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+++.|. ||||+++++++...... .+|+||||+++++...+.... ..+++.+++.++.||+.||+|||+
T Consensus 59 ~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 138 (308)
T 3g33_A 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 138 (308)
T ss_dssp HHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888888874 99999999999874322 589999999987776665433 349999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||+||||||+||||+.++.+||+|||++...... ......++|+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus 139 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g 215 (308)
T 3g33_A 139 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRR 215 (308)
T ss_dssp TTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTS
T ss_pred CCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC--cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999876543 23456788999999999977 4589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.+..+.+.++....+.++...|..........+.+.. ...+....+.+++.+.+||.+||+.||.+|||+.+
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 293 (308)
T 3g33_A 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG--PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293 (308)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCC--CCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCC--CCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999999999999999998888654332222222221 22345566789999999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|+||||+..
T Consensus 294 ~l~h~~~~~~ 303 (308)
T 3g33_A 294 ALQHSYLHKD 303 (308)
T ss_dssp HHTSTTC---
T ss_pred HhcCccccCC
Confidence 9999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.05 Aligned_cols=241 Identities=37% Similarity=0.593 Sum_probs=195.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~---~~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+.|+|||||+++++|.... ...++||||||++++...+. .....+++..++.++.||+.||.|||+
T Consensus 95 ~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 174 (420)
T 1j1b_A 95 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174 (420)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999986421 23478999999997665443 345689999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 75 RGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
+||+||||||+||||+.+ +.+||+|||+++...... .....++|++|+|||++.+...|+.++||||||||||||++
T Consensus 175 ~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999965 578999999998765432 34566889999999999876679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc-cCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|++||.+.+..+++..|++.+|.|..+.|............+... ...+...+ ..+++++++||.+||.+||.+|||+
T Consensus 253 G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~ 331 (420)
T 1j1b_A 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK-AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331 (420)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccC-CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence 999999999999999999999999877765432111110001110 11122222 4678999999999999999999999
Q ss_pred HHHHhccccCCCC
Q 009654 233 SAALASEYFSTKP 245 (529)
Q Consensus 233 ~e~L~h~~f~~~~ 245 (529)
.++|+||||....
T Consensus 332 ~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 332 LEACAHSFFDELR 344 (420)
T ss_dssp HHHHTSGGGGGGG
T ss_pred HHHhCCHhhcccc
Confidence 9999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=362.80 Aligned_cols=240 Identities=36% Similarity=0.634 Sum_probs=187.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+||||+++++++.... ...+|+||||+.+++...+.. ..+++..+..++.||+.||.|||++||
T Consensus 76 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~gi 153 (367)
T 2fst_X 76 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADI 153 (367)
T ss_dssp HHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 58999999999999999999987531 256899999997665554432 579999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.++.+||+|||+++.... ..+..++|++|+|||++.+...|+.++||||||||+|+|++|++|
T Consensus 154 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 229 (367)
T 2fst_X 154 IHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 229 (367)
T ss_dssp CCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred eeCCCCHhhEEECCCCCEEEeeccccccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986543 245678999999999998767799999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccC---CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~---~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
|.+.+..+++..|.+.+|.|+.+.|....-.....+ .+..+ ...+...+..+++.+++||.+||..||.+|||+.+
T Consensus 230 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e 308 (367)
T 2fst_X 230 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308 (367)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCC-CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCC-CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence 999999999999999999998877654321110000 00000 12334566788999999999999999999999999
Q ss_pred HHhccccCCCCCCC
Q 009654 235 ALASEYFSTKPYAC 248 (529)
Q Consensus 235 ~L~h~~f~~~~~~~ 248 (529)
+|+||||.....+.
T Consensus 309 ~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 309 ALAHAYFAQYHDPD 322 (367)
T ss_dssp HHTSGGGTTTCCGG
T ss_pred HhcChhhhhccCCC
Confidence 99999998755443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.65 Aligned_cols=214 Identities=25% Similarity=0.356 Sum_probs=186.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.|+||||+++++++.+ ...+|||||||+++.+...+ .....+++.++..++.||+.||.|||++||+||
T Consensus 49 ~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~ 126 (321)
T 1tki_A 49 KKEISILNIARHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126 (321)
T ss_dssp HHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhCCCCCCCeEeEEEec--CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcC
Confidence 589999999999999999999988 57899999999986555444 444579999999999999999999999999999
Q ss_pred CCCCCcEEEcc--CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~--~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+|||++. ++.+||+|||++....... .....++|+.|+|||++.+ ..++.++||||||||+|+|++|.+||
T Consensus 127 Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf 203 (321)
T 1tki_A 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999987 7899999999998775432 3455688999999999976 45899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......++ ...+..+|.++++||.+||..||.+|||+.++|+|
T Consensus 204 ~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 204 LAETNQQIIENIMNAEYTFD-------------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCSSHHHHHHHHHHTCCCCC-------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHcCCCCCC-------------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 99999998888877443333 23346789999999999999999999999999999
Q ss_pred cccCCCC
Q 009654 239 EYFSTKP 245 (529)
Q Consensus 239 ~~f~~~~ 245 (529)
|||+...
T Consensus 259 p~~~~~~ 265 (321)
T 1tki_A 259 PWLKQKI 265 (321)
T ss_dssp HHHHSCG
T ss_pred hhhccCc
Confidence 9998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=358.59 Aligned_cols=212 Identities=32% Similarity=0.477 Sum_probs=185.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||++++++.+ ...+|||||||+++.+...+.....+++.++..++.||+.||.|||++||+|||
T Consensus 76 ~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~D 153 (362)
T 2bdw_A 76 EREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153 (362)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 589999999999999999999988 578999999999977665555667899999999999999999999999999999
Q ss_pred CCCCcEEEccC---CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.+ +.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||
T Consensus 154 lkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf 230 (362)
T 2bdw_A 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPF 230 (362)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCBCCTTC--CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CchHHEEEecCCCCCCEEEeecCcceEecCC--cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999865 45999999999876543 23456789999999999976 46999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..|......++. ..+..+++++++||.+||..||.+|||+.++|+|
T Consensus 231 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 231 WDEDQHRLYAQIKAGAYDYPS-------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCSSHHHHHHHHHHTCCCCCT-------------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999998888888764333322 2235689999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
|||..
T Consensus 286 p~~~~ 290 (362)
T 2bdw_A 286 PWICN 290 (362)
T ss_dssp HHHHT
T ss_pred cccCC
Confidence 99975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=347.01 Aligned_cols=242 Identities=33% Similarity=0.575 Sum_probs=194.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++++..+......+++..+..++.||+.||.|||++||+|||
T Consensus 50 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~d 127 (311)
T 4agu_A 50 LREIRMLKQLKHPNLVNLLEVFRR--KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRD 127 (311)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCccchhheeec--CCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 579999999999999999999988 578999999999998887776677899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......++|++|+|||++.+...|+.++|||||||++|+|++|.+||.+.
T Consensus 128 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 128 VKPENILITKHSVIKLCDFGFARLLTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CChhhEEEcCCCCEEEeeCCCchhccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765332 23345688999999999987677999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCc--cccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPH--ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~--~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+..+.+..+.+..+......+....... .....+.......+...++.++..+.+||.+||..||.+|||+.++|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 9999999998888876543221100000 00001111112234455678999999999999999999999999999999
Q ss_pred ccCCCCC
Q 009654 240 YFSTKPY 246 (529)
Q Consensus 240 ~f~~~~~ 246 (529)
||+....
T Consensus 287 ~f~~~~~ 293 (311)
T 4agu_A 287 YFENIRE 293 (311)
T ss_dssp GGTTCC-
T ss_pred HHHhccC
Confidence 9997543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=359.30 Aligned_cols=239 Identities=35% Similarity=0.621 Sum_probs=196.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc------------------------------------CCCeEEEEEeccCCCchhh
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR------------------------------------LSCSIYLVFEYMEHDITGL 45 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~------------------------------------~~~~~~lV~E~~~g~ll~~ 45 (529)
.+|+.+|+.|+|||||+++++|... ....+|||||||++++...
T Consensus 48 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~ 127 (383)
T 3eb0_A 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127 (383)
T ss_dssp CHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHH
T ss_pred HHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHH
Confidence 4799999999999999999998552 2345899999999875544
Q ss_pred h---cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-cCCcEEEeccccccccCCCCCCCcccccccc
Q 009654 46 L---SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121 (529)
Q Consensus 46 ~---~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~ 121 (529)
+ ......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... .....++|+
T Consensus 128 l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~ 205 (383)
T 3eb0_A 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSR 205 (383)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCS
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCC
Confidence 3 34567899999999999999999999999999999999999998 57899999999998765432 345668899
Q ss_pred ccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcc
Q 009654 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 201 (529)
Q Consensus 122 ~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~ 201 (529)
.|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|.+.+|.|+.+.|............+... ..
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~ 284 (383)
T 3eb0_A 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AK 284 (383)
T ss_dssp SCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC-CC
T ss_pred CccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC-cc
Confidence 99999999887779999999999999999999999999999999999999999999877665432211111111111 11
Q ss_pred hhhhhc-cCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 202 SLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 202 ~l~~~~-~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
.+...+ ..+++++++||.+||..||.+|||+.++|+||||+.
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 222222 458999999999999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=350.92 Aligned_cols=213 Identities=26% Similarity=0.408 Sum_probs=187.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..++.....+++.++..++.||+.||.|||++||+|||
T Consensus 62 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 139 (326)
T 2y0a_A 62 EREVSILKEIQHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFD 139 (326)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCC
Confidence 589999999999999999999987 578999999999877776666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCC----cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 82 IKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 82 IKp~NILl~~~g----~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+|
T Consensus 140 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp CCGGGEEESCSSSSSCCEEECCCTTCEECCTT--SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCHHHEEEecCCCCCCCEEEEECCCCeECCCC--CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999998887 7999999999876543 23456689999999999976 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+......++. ..+..++..+.+||.+||..||.+|||+.++|+
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 217 FLGDTKQETLANVSAVNYEFED-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCcCc-------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999998888888764333322 234578999999999999999999999999999
Q ss_pred ccccCCC
Q 009654 238 SEYFSTK 244 (529)
Q Consensus 238 h~~f~~~ 244 (529)
||||+..
T Consensus 272 hp~~~~~ 278 (326)
T 2y0a_A 272 HPWIKPK 278 (326)
T ss_dssp STTTSCC
T ss_pred CCCccCC
Confidence 9999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=352.25 Aligned_cols=212 Identities=25% Similarity=0.393 Sum_probs=184.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||++++++|.+ ...+|||||||+|+.+..++.....+++.+++.++.||+.||+|||++||+|||
T Consensus 53 ~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 130 (337)
T 1o6l_A 53 VTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130 (337)
T ss_dssp HHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHHHHHHHhCCCCcCcceEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCc
Confidence 579999999999999999999988 578999999999977766655566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.
T Consensus 131 lkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 131 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 99999999999999999999997643321 23456789999999999976 46899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+..+....|....... ...+++++++||.+||..||.+|| ++.+++
T Consensus 209 ~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~ 259 (337)
T 1o6l_A 209 DHERLFELILMEEIRF-----------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259 (337)
T ss_dssp SHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred CHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHH
Confidence 8888888776521111 125789999999999999999999 999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||....|
T Consensus 260 ~h~~f~~~~~ 269 (337)
T 1o6l_A 260 EHRFFLSINW 269 (337)
T ss_dssp TSGGGTTCCH
T ss_pred cCCCcCCCCH
Confidence 9999987554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=358.30 Aligned_cols=212 Identities=25% Similarity=0.407 Sum_probs=180.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.+ +||||++++++|.+ ...+|||||||+|+.+..++.....+++.+++.|+.||+.||+|||++||+||
T Consensus 71 ~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHr 148 (353)
T 3txo_A 71 MTEKRILSLARNHPFLTQLFCCFQT--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148 (353)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHhccCCCceeeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 4799999998 79999999999988 57899999999997776666556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+
T Consensus 149 Dlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEECCCCCEEEccccceeecccCC-ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 999999999999999999999997543322 23456789999999999976 4589999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH------HH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SA 234 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta------~e 234 (529)
.+..+.+.+|.......+ ..+++++.+||.+||..||.+|+++ .+
T Consensus 227 ~~~~~~~~~i~~~~~~~p-----------------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~ 277 (353)
T 3txo_A 227 ENEDDLFEAILNDEVVYP-----------------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHA 277 (353)
T ss_dssp SSHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHH
T ss_pred CCHHHHHHHHHcCCCCCC-----------------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHH
Confidence 999999999876321111 2478899999999999999999998 99
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
+++||||+...|
T Consensus 278 il~hp~f~~~~w 289 (353)
T 3txo_A 278 ILRHPFFKEIDW 289 (353)
T ss_dssp HHTSGGGTTCCH
T ss_pred HhhCCcccCCCH
Confidence 999999997655
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=343.44 Aligned_cols=212 Identities=28% Similarity=0.438 Sum_probs=180.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+.....+|||||||+++.+..+.. ...+++.++..++.||+.||.|||++||+|||
T Consensus 84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 162 (298)
T 2zv2_A 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRD 162 (298)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 57999999999999999999998765678999999999877766543 45799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCC--CCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+||||+.++.+||+|||++....... ......+||+.|+|||++.+... ++.++|||||||++|+|++|.+||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999998765432 22345689999999999976432 4778999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+.......+.......+ ....+++.+.+||.+||+.||.+|||+.++|+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 242 DERIMCLHSKIKSQALEFP---------------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp CSSHHHHHHHHHHCCCCCC---------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred CccHHHHHHHHhcccCCCC---------------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 8887777666654211111 1146889999999999999999999999999999
Q ss_pred ccC
Q 009654 240 YFS 242 (529)
Q Consensus 240 ~f~ 242 (529)
||+
T Consensus 295 ~~~ 297 (298)
T 2zv2_A 295 WVT 297 (298)
T ss_dssp HHH
T ss_pred ccc
Confidence 996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=366.25 Aligned_cols=221 Identities=24% Similarity=0.335 Sum_probs=188.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|..++||||++++++|.+ ...+|||||||+|+.+..++ .....+++..++.|+.||+.||.|||++||+||
T Consensus 122 ~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHr 199 (437)
T 4aw2_A 122 REERDVLVNGDSKWITTLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199 (437)
T ss_dssp HHHHHHHHHSCTTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhCCCCCEEEEEEEEee--CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence 579999999999999999999988 57899999999886665544 335789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc----CCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+||||+.+|.+||+|||+++.............+||++|+|||++. +...|+.++||||||||+|||++|++
T Consensus 200 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence 99999999999999999999999876554333344578999999999996 23568999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e 234 (529)
||.+.+..+.+.+|......+. + ...+..+++++++||.+||+.+|++ |+++.+
T Consensus 280 Pf~~~~~~~~~~~i~~~~~~~~--------~----------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e 335 (437)
T 4aw2_A 280 PFYAESLVETYGKIMNHKERFQ--------F----------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIED 335 (437)
T ss_dssp TTCCSSHHHHHHHHHTHHHHCC--------C----------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred CCCCCChhHHHHhhhhcccccc--------C----------------CcccccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence 9999999999988875322110 0 0112458999999999999999988 999999
Q ss_pred HHhccccCCCCCCC
Q 009654 235 ALASEYFSTKPYAC 248 (529)
Q Consensus 235 ~L~h~~f~~~~~~~ 248 (529)
+++||||+...|..
T Consensus 336 il~Hpff~~i~w~~ 349 (437)
T 4aw2_A 336 FKKHPFFSGIDWDN 349 (437)
T ss_dssp HHTSGGGTTCCTTT
T ss_pred HhCCCccCCCCHHH
Confidence 99999999877653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.42 Aligned_cols=212 Identities=26% Similarity=0.426 Sum_probs=182.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||++++++|.+ ...+|+|||||+++.+..+... ..+++.++..++.||+.||.|||++||+|||
T Consensus 65 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~D 141 (297)
T 3fxz_A 65 INEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141 (297)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHhcCCCCCCCeEeEEEEE--CCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Confidence 589999999999999999999988 5789999999998777765543 3699999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.
T Consensus 142 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEECCCCCEEEeeCCCceecCCcc-cccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765432 23445689999999999977 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+....+..+........ .....+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 220 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 220 NPLRALYLIATNGTPEL--------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp CHHHHHHHHHHHCSCCC--------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred CHHHHHHHHHhCCCCCC--------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 88877776655321110 0113578899999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
+..
T Consensus 274 ~~~ 276 (297)
T 3fxz_A 274 KIA 276 (297)
T ss_dssp GGC
T ss_pred ccc
Confidence 853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.67 Aligned_cols=209 Identities=24% Similarity=0.391 Sum_probs=184.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+|+|||||+|+.+..++.....+++..++.++.||+.||.|||++||+|||
T Consensus 54 ~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 131 (318)
T 1fot_A 54 NDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 131 (318)
T ss_dssp HHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HHHHHHHhhCCCCCCceEeEEEEe--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 479999999999999999999988 578999999999977766665566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.
T Consensus 132 lkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 132 LKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CChheEEEcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999865432 345689999999999976 46899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+..+.+.+|.......+ ..+++++++||.+||..||.+|+ ++.+++
T Consensus 207 ~~~~~~~~i~~~~~~~p-----------------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 207 NTMKTYEKILNAELRFP-----------------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp SHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CHHHHHHHHHhCCCCCC-----------------------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 99888888876321111 25788999999999999999999 999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 258 ~hp~f~~~~~ 267 (318)
T 1fot_A 258 NHPWFKEVVW 267 (318)
T ss_dssp TSGGGSSCCH
T ss_pred cCccccCCCH
Confidence 9999987655
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=356.42 Aligned_cols=215 Identities=27% Similarity=0.415 Sum_probs=163.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.|+||||+++++++.+ ...+|||||||+++.+..++.....+++..++.++.||+.||.|||++||+|||
T Consensus 64 ~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~D 141 (361)
T 3uc3_A 64 QREIINHRSLRHPNIVRFKEVILT--PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRD 141 (361)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEee--CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 589999999999999999999988 578999999999877665555556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCc--EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGV--LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+||||+.++. +||+|||+++..... ......+||++|+|||++.+...++.++||||||||+|+|++|++||.
T Consensus 142 lkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp CCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCHHHEEEcCCCCceEEEeecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 9999999987765 999999999754332 233456899999999999875544556999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+......+..+......... .. .....+++.+++||.+||..||.+|||+.++|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~------~~-----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 220 DPEEPRDYRKTIQRILSVKY------SI-----------------PDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp ----CCCHHHHHHHHHTTCC------CC-----------------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCccHHHHHHHHHHHhcCCC------CC-----------------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 76543333222221111100 00 01125789999999999999999999999999999
Q ss_pred ccCC
Q 009654 240 YFST 243 (529)
Q Consensus 240 ~f~~ 243 (529)
||..
T Consensus 277 ~f~~ 280 (361)
T 3uc3_A 277 WFLK 280 (361)
T ss_dssp HHHT
T ss_pred chhc
Confidence 9965
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.38 Aligned_cols=238 Identities=31% Similarity=0.607 Sum_probs=193.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+||||||++++++..+......+++..+..++.||+.||.|||++||+|||
T Consensus 72 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d 149 (331)
T 4aaa_A 72 MREIKLLKQLRHENLVNLLEVCKK--KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRD 149 (331)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHhhCCCCCEeeEEEEeec--CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccC
Confidence 579999999999999999999987 578999999999998887766667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.++.+||+|||++....... ......++|++|+|||++.+...++.++||||||||+|+|++|.+||.+.
T Consensus 150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 150 IKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp CCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cChheEEEcCCCcEEEEeCCCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997665432 23345678999999999987667899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhh---ccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWK---KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~---~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+..+.+..+....+.+.+..+. ....... ...+...........++.+++.+.+||.+||..||.+|||+.++|+|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT-CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CcHHHHHHHHHHhCCCChhhhhHhhhcccccc-ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 9999999999888877654321 1111000 01111112223445567899999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
|||+.
T Consensus 308 p~f~~ 312 (331)
T 4aaa_A 308 DFFQM 312 (331)
T ss_dssp HHHHG
T ss_pred chhcc
Confidence 99985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=361.81 Aligned_cols=218 Identities=28% Similarity=0.360 Sum_probs=186.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++|||||+++++|.+ ...+|||||||+|+.+..++.. ..+++..++.++.||+.||+|||++||+|||
T Consensus 117 ~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrD 193 (410)
T 3v8s_A 117 WEERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193 (410)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 579999999999999999999988 6789999999988766655433 4799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC---CCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.+|.+||+|||++..............+||+.|+|||++.+.. .|+.++||||||||+|+|++|.+||
T Consensus 194 LKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 9999999999999999999999876554333345678999999999997643 2789999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC--CcCHHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAAL 236 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k--R~ta~e~L 236 (529)
.+.+..+.+.+|......+. ......+++++++||.+||..+|.+ |+++.+++
T Consensus 274 ~~~~~~~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 274 YADSLVGTYSKIMNHKNSLT-------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp CCSSHHHHHHHHHTHHHHCC-------------------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred CCCChhhHHHHHHhcccccc-------------------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 99999999998876321110 0011368999999999999999988 99999999
Q ss_pred hccccCCCCCC
Q 009654 237 ASEYFSTKPYA 247 (529)
Q Consensus 237 ~h~~f~~~~~~ 247 (529)
+||||+...|.
T Consensus 329 ~Hp~f~~~~w~ 339 (410)
T 3v8s_A 329 RHLFFKNDQWA 339 (410)
T ss_dssp TSGGGCCSSCC
T ss_pred cCccccCCCHH
Confidence 99999987664
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=357.51 Aligned_cols=239 Identities=31% Similarity=0.591 Sum_probs=181.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+||||+++++++.... ...+|||||||++++...+. ..+++..+..++.||+.||.|||++||
T Consensus 72 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~i 148 (371)
T 2xrw_A 72 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGI 148 (371)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 58999999999999999999997642 13789999999998777664 358999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.++.+||+|||++...... ......++|+.|+|||++.+ ..|+.++||||||||+|+|++|.+|
T Consensus 149 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p 225 (371)
T 2xrw_A 149 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVL 225 (371)
T ss_dssp CCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ecccCCHHHEEEcCCCCEEEEEeecccccccc--cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999866543 23455689999999999987 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCc-chhhhhc------------cCCcHHHHHHHHHhccC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-SSLRETF------------KDLPTTAVNLIETLLSV 224 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~-~~l~~~~------------~~~s~~~~dLi~~mL~~ 224 (529)
|.+.+..+++..+.+.+|.+...+|................+. ..+...+ ...+..+++||.+||..
T Consensus 226 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 305 (371)
T 2xrw_A 226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305 (371)
T ss_dssp SCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcC
Confidence 9999999999999999999887766442100000000000000 0011111 12367899999999999
Q ss_pred CCCCCcCHHHHHhccccCCCCC
Q 009654 225 EPYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~~~ 246 (529)
||.+|||+.++|+||||+....
T Consensus 306 dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 306 DASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp SGGGSCCHHHHHHSHHHHTTCC
T ss_pred ChhhCCCHHHHhCCcchhhhcC
Confidence 9999999999999999986433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.73 Aligned_cols=241 Identities=36% Similarity=0.607 Sum_probs=198.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+||||+++++++.... ...+|+||||+++++...+.. ..+++.++..++.||+.||.|||++||+
T Consensus 73 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iv 150 (364)
T 3qyz_A 73 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVL 150 (364)
T ss_dssp HHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 58999999999999999999997632 247899999999977666643 4699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||||+||||+.++.+||+|||++........ ......+||++|+|||++.+...|+.++||||||||+|+|++|.+
T Consensus 151 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999987653321 123556899999999998776779999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcccc--CCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~--~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
||.+.+..+.+..|...+|.++.+.|.......... ..........+...+..+++++.+||.+||+.||.+|||+.+
T Consensus 231 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 310 (364)
T 3qyz_A 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310 (364)
T ss_dssp SSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 999999999999999999999877664321100000 000001112234556788999999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|+||||+..
T Consensus 311 ~l~hp~~~~~ 320 (364)
T 3qyz_A 311 ALAHPYLEQY 320 (364)
T ss_dssp HHTSGGGTTT
T ss_pred HhcCcchhhc
Confidence 9999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.36 Aligned_cols=241 Identities=30% Similarity=0.513 Sum_probs=192.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc---CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR---LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~---~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+||||+++++++... ....+|||||||+++++..+......+++..+..++.||+.||.|||++||+
T Consensus 77 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 156 (362)
T 3pg1_A 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVV 156 (362)
T ss_dssp HHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCE
Confidence 5899999999999999999998652 2357899999999998888877777899999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+||||+.++.+||+|||++...... ......++|++|+|||++.+...++.++||||||||+|+|++|.+||
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecCCChHHEEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999755433 23345688999999999987667999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccC---CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~---~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.+.+..+.+..+....+.+....+.....+....+ .........+......+++.+.+||.+||+.||.+|||+.++
T Consensus 235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 314 (362)
T 3pg1_A 235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314 (362)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 99999999999999999887654332111100000 000011123345556789999999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|+||||+..
T Consensus 315 l~hp~f~~~ 323 (362)
T 3pg1_A 315 LRHPYFESL 323 (362)
T ss_dssp HTSGGGTTT
T ss_pred HcCchhhhc
Confidence 999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.13 Aligned_cols=209 Identities=25% Similarity=0.366 Sum_probs=184.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+|||||||+|+.+..++.....+++.+++.++.||+.||+|||++||+|||
T Consensus 89 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 166 (350)
T 1rdq_E 89 LNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166 (350)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 579999999999999999999988 578999999999876665555556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++...... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.
T Consensus 167 lkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 167 LKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 9999999999999999999999876542 345689999999999976 46899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L 236 (529)
+..+.+.+|....... ...+++++.+||.+||+.||.+||+ +.+++
T Consensus 242 ~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~ 292 (350)
T 1rdq_E 242 QPIQIYEKIVSGKVRF-----------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp SHHHHHHHHHHCCCCC-----------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred CHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence 9988888887621111 1257899999999999999999998 99999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||....|
T Consensus 293 ~h~~f~~~~w 302 (350)
T 1rdq_E 293 NHKWFATTDW 302 (350)
T ss_dssp TSGGGTTCCH
T ss_pred hCcCcCCCCH
Confidence 9999987655
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.93 Aligned_cols=214 Identities=28% Similarity=0.396 Sum_probs=179.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.|+||||+++++++.+ ...+|||||||+++.+..++.....+++.++..++.||+.||.|||++||+|||
T Consensus 53 ~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~D 130 (323)
T 3tki_A 53 KKEICINKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130 (323)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 589999999999999999999987 678999999999977777777777899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||+||||+.++.+||+|||++..+.... .......+||+.|+|||++.+...++.++||||||||+|+|++|.+||.+
T Consensus 131 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998664322 22344668999999999998765568899999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+............... ...+..+++.+.+||.+||..||.+|||+.++|+|||
T Consensus 211 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 211 PSDSCQEYSDWKEKKTY--------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp SCTTSHHHHHHHTTCTT--------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CchHHHHHHHHhccccc--------------------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 66543222221211110 1123468899999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|+.
T Consensus 265 ~~~ 267 (323)
T 3tki_A 265 YNK 267 (323)
T ss_dssp TTC
T ss_pred hcc
Confidence 985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=344.87 Aligned_cols=212 Identities=27% Similarity=0.435 Sum_probs=178.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ...+|||||||+++.+..++.....+++..+..++.||+.||.|||++||+|||
T Consensus 69 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~D 146 (327)
T 3a62_A 69 KAERNILEEVKHPFIVDLIYAFQT--GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRD 146 (327)
T ss_dssp --HHHHHHHCCCTTBCCEEEEEEC--SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHhCCCCCccceeEEEEc--CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEccc
Confidence 579999999999999999999988 578999999999876665555556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.
T Consensus 147 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 147 LKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp CCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999987543321 23345689999999999976 45899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+..+.+..|.......+ ..++.++.+||.+||..||.+|| ++.++|
T Consensus 225 ~~~~~~~~i~~~~~~~p-----------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 225 NRKKTIDKILKCKLNLP-----------------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp SHHHHHHHHHHTCCCCC-----------------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred CHHHHHHHHHhCCCCCC-----------------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 99888888876321111 24788999999999999999999 899999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 276 ~hp~f~~~~~ 285 (327)
T 3a62_A 276 AHPFFRHINW 285 (327)
T ss_dssp HSGGGSSCCH
T ss_pred cCCcccCCCH
Confidence 9999987544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=344.09 Aligned_cols=245 Identities=31% Similarity=0.535 Sum_probs=197.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC-----CCeEEEEEeccCCCchhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL-----SCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~-----~~~~~lV~E~~~g~ll~~~~---~~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+..|+.++||||++++++|.... ...+|||||||+++++..+. .....+++..+..++.||+.||.|||
T Consensus 67 ~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 146 (360)
T 3e3p_A 67 LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146 (360)
T ss_dssp HHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 35777788889999999999987632 22489999999998765433 46668999999999999999999999
Q ss_pred --HCCCcccCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 74 --SRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 74 --~~gIvHrDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
++||+||||||+||||+. ++.+||+|||++....... .....++|+.|+|||++.+...|+.++||||||||+|+
T Consensus 147 ~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~e 224 (360)
T 3e3p_A 147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224 (360)
T ss_dssp STTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred CCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999997 8999999999998765432 33456789999999999876679999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcccc---CCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 151 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL---FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 151 lltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~---~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
|++|.+||.+.+..+.+..+.+..+.++...|.......... .....++...+......+++++++||.+||+.||.
T Consensus 225 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcc
Confidence 999999999999999999999999999887776533211110 11111122122222234788999999999999999
Q ss_pred CCcCHHHHHhccccCCCCCCC
Q 009654 228 KRATASAALASEYFSTKPYAC 248 (529)
Q Consensus 228 kR~ta~e~L~h~~f~~~~~~~ 248 (529)
+|||+.++|+||||+....+.
T Consensus 305 ~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 305 ERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp GSCCHHHHTTSGGGGGGGCTT
T ss_pred ccCCHHHHhcCccccccCCcc
Confidence 999999999999998765443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.66 Aligned_cols=212 Identities=29% Similarity=0.446 Sum_probs=183.9
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|..+ +||||++++++|.+ ...+|||||||+|+.+..++.....+++.++..++.||+.||+|||++||+||
T Consensus 65 ~~E~~il~~~~~hp~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 142 (345)
T 1xjd_A 65 MVEKRVLSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142 (345)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 4688999887 99999999999988 57899999999987776665555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+
T Consensus 143 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 143 DLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChhhEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999997643322 23456789999999999977 4589999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH-HHHhcc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASE 239 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~-e~L~h~ 239 (529)
.+..+.+.+|... .+. + ...+++++++||.+||..||.+||++. ++++||
T Consensus 221 ~~~~~~~~~i~~~--~~~--------------------~-------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 221 QDEEELFHSIRMD--NPF--------------------Y-------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp SSHHHHHHHHHHC--CCC--------------------C-------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred CCHHHHHHHHHhC--CCC--------------------C-------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 9998888888652 110 0 024789999999999999999999998 999999
Q ss_pred ccCCCCC
Q 009654 240 YFSTKPY 246 (529)
Q Consensus 240 ~f~~~~~ 246 (529)
||+...|
T Consensus 272 ~f~~~~w 278 (345)
T 1xjd_A 272 LFREINW 278 (345)
T ss_dssp GGTTCCH
T ss_pred cccCCCH
Confidence 9997655
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=347.35 Aligned_cols=213 Identities=28% Similarity=0.438 Sum_probs=178.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~---~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+||||+++++++.+ ...+|||||||+++.+. .+. .....+++..+..++.||+.||.|||++||
T Consensus 74 ~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 151 (351)
T 3c0i_A 74 KREASICHMLKHPHIVELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151 (351)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 589999999999999999999988 57899999999986554 332 233469999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCc---EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 78 LHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~---vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||||||+||||+.++. +||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|
T Consensus 152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g 229 (351)
T 3c0i_A 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSG 229 (351)
T ss_dssp ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeccCChHHeEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHC
Confidence 99999999999987654 9999999998765432 22445689999999999976 4589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.. .+.+..+.......+ ...+..+++++++||.+||..||.+|||+.+
T Consensus 230 ~~pf~~~~-~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 283 (351)
T 3c0i_A 230 CLPFYGTK-ERLFEGIIKGKYKMN-------------------------PRQWSHISESAKDLVRRMLMLDPAERITVYE 283 (351)
T ss_dssp SCSSCSSH-HHHHHHHHHTCCCCC-------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCcH-HHHHHHHHcCCCCCC-------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 99998753 455555655322221 2234578999999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|+||||+..
T Consensus 284 ~l~hp~~~~~ 293 (351)
T 3c0i_A 284 ALNHPWLKER 293 (351)
T ss_dssp HHTSHHHHTH
T ss_pred HhcChhhcCC
Confidence 9999999853
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.77 Aligned_cols=230 Identities=25% Similarity=0.343 Sum_probs=188.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|..++||||++++++|.+ ...+|||||||+|+.+..++. ....+++..++.|+.||+.||+|||++||+||
T Consensus 109 ~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHr 186 (412)
T 2vd5_A 109 REERDVLVNGDRRWITQLHFAFQD--ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186 (412)
T ss_dssp HHHHHHHHHSCTTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhcCCCCeeeEEEEEee--CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 579999999999999999999988 578999999998866654443 34579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC------CCCCCCcchhhhhhHHHHHHHhC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~y~~~~DIWSlG~il~elltG 154 (529)
||||+||||+.+|.+||+|||++..............+||+.|+|||++.+ ...|+.++||||||||+|||++|
T Consensus 187 DLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred ccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence 999999999999999999999998765543223345689999999999972 34689999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC---cC
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---AT 231 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR---~t 231 (529)
++||.+.+..+.+.+|........ + ......+|+++++||.+||+ +|.+| ++
T Consensus 267 ~~Pf~~~~~~~~~~~i~~~~~~~~--------~----------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~ 321 (412)
T 2vd5_A 267 QTPFYADSTAETYGKIVHYKEHLS--------L----------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGG 321 (412)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCC--------C----------------C----CCCHHHHHHHHTTSS-CGGGCTTTTT
T ss_pred CCCCCCCCHHHHHHHHHhcccCcC--------C----------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence 999999999998888865321110 0 00113689999999999999 99998 59
Q ss_pred HHHHHhccccCCCCCCCCCCCCCCCCC
Q 009654 232 ASAALASEYFSTKPYACDLSSLPIYPP 258 (529)
Q Consensus 232 a~e~L~h~~f~~~~~~~~~~~~p~~~~ 258 (529)
+.++++||||+...|..-....|.+.|
T Consensus 322 ~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 322 AGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp HHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred HHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 999999999998877654433344433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.19 Aligned_cols=213 Identities=30% Similarity=0.414 Sum_probs=184.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCch-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll-~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+|||||++++++.+ ...+|||||||+++.+ ..+......+++.++..++.||+.||.|||++||+|
T Consensus 133 ~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 210 (373)
T 2x4f_A 133 VKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILH 210 (373)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3689999999999999999999988 5789999999998555 445445557999999999999999999999999999
Q ss_pred cCCCCCcEEE--ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl--~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+|||| +.++.+||+|||++....... .....+||+.|+|||++.+ ..++.++||||||||+|+|++|.+|
T Consensus 211 ~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 287 (373)
T 2x4f_A 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSP 287 (373)
T ss_dssp CCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999 456789999999998775542 3445679999999999876 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..|......++. ..+..+++++++||.+||..||.+|||+.++|+
T Consensus 288 f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 288 FLGDNDAETLNNILACRWDLED-------------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TCCSSHHHHHHHHHHTCCCSCS-------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhccCCCCh-------------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999988775433321 223578999999999999999999999999999
Q ss_pred ccccCC
Q 009654 238 SEYFST 243 (529)
Q Consensus 238 h~~f~~ 243 (529)
||||+.
T Consensus 343 hp~~~~ 348 (373)
T 2x4f_A 343 HPWLSD 348 (373)
T ss_dssp SHHHHC
T ss_pred CcCcCC
Confidence 999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=355.64 Aligned_cols=209 Identities=29% Similarity=0.498 Sum_probs=175.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ...+||||||+.|+++..+.. ...+++.+++.++.||+.||.|||++||+|||
T Consensus 57 ~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~D 133 (336)
T 3h4j_B 57 EREISYLKLLRHPHIIKLYDVITT--PTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRD 133 (336)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 589999999999999999999988 578999999998777776653 45799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...+++++||||||||+|+|++|.+||.+.
T Consensus 134 lkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 134 LKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp CSTTTEEECTTCCEEECCSSCTBTTTTS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred CchhhEEEcCCCCEEEEEeccceeccCC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999876543 23456689999999999987554588999999999999999999999765
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
...+....+.. ........+++++.+||.+||..||.+|||+.++|+||||
T Consensus 212 ~~~~~~~~i~~-----------------------------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 212 FIPNLFKKVNS-----------------------------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp SSTTCBCCCCS-----------------------------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred cHHHHHHHHHc-----------------------------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 42221111100 0001123578999999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
+..
T Consensus 263 ~~~ 265 (336)
T 3h4j_B 263 NVN 265 (336)
T ss_dssp HTT
T ss_pred ccC
Confidence 853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=360.81 Aligned_cols=210 Identities=31% Similarity=0.502 Sum_probs=185.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ...+|||||||+++.+..++...+.+++.++..++.||+.||.|||++||+|||
T Consensus 64 ~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrD 141 (476)
T 2y94_A 64 RREIQNLKLFRHPHIIKLYQVIST--PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRD 141 (476)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCccc
Confidence 589999999999999999999988 578999999999877776666677899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||||||||+|+|++|.+||.+.
T Consensus 142 Lkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 142 LKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccHHHEEEecCCCeEEEeccchhhcccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999999876543 23456789999999999988655688999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+....+.+|....... ...+++++.+||.+||..||.+|||+.++|+||||
T Consensus 220 ~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 220 HVPTLFKKICDGIFYT-----------------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp SSHHHHHHHHTTCCCC-----------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred CHHHHHHHHhcCCcCC-----------------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 8888888876532111 12478899999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
+..
T Consensus 271 ~~~ 273 (476)
T 2y94_A 271 KQD 273 (476)
T ss_dssp HTT
T ss_pred hhc
Confidence 864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=348.58 Aligned_cols=237 Identities=37% Similarity=0.661 Sum_probs=192.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCC----eEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~----~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+||||+++++++...... .+|+||||+.+++...+ ...+++.++..++.||+.||.|||++||
T Consensus 89 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~i 165 (371)
T 4exu_A 89 YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGV 165 (371)
T ss_dssp HHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 5899999999999999999999874321 34999999998766555 3359999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.++.+||+|||++..... .....++|++|+|||++.+...|+.++|||||||++|+|++|.+|
T Consensus 166 vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 241 (371)
T 4exu_A 166 VHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL 241 (371)
T ss_dssp CCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCHHHeEECCCCCEEEEecCccccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986543 234567899999999998767799999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccC--CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~--~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+..+.+..+....+.++..++..........+ .........+...+..+++.+.+||.+||+.||.+|||+.++
T Consensus 242 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 321 (371)
T 4exu_A 242 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 321 (371)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence 999999999999999999998776654221100000 000111223345567889999999999999999999999999
Q ss_pred HhccccCCCC
Q 009654 236 LASEYFSTKP 245 (529)
Q Consensus 236 L~h~~f~~~~ 245 (529)
|+||||+...
T Consensus 322 l~hp~f~~~~ 331 (371)
T 4exu_A 322 LTHPFFEPFR 331 (371)
T ss_dssp HTSGGGTTTC
T ss_pred hcCcccccCC
Confidence 9999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=353.70 Aligned_cols=213 Identities=23% Similarity=0.405 Sum_probs=178.1
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|.++ +|||||+++++|.+ ...+|||||||+++.+..++.....|++..++.|+.||+.||+|||++||+||
T Consensus 100 ~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHr 177 (396)
T 4dc2_A 100 QTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177 (396)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHhcCCCCCcCeeEEEEEE--CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence 5799999887 89999999999988 57899999999997776666556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+++..... .......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+
T Consensus 178 DLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cCCHHHEEECCCCCEEEeecceeeecccC-CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999999999753322 123456789999999999987 4699999999999999999999999964
Q ss_pred CC---------HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 161 RT---------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 161 ~~---------~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
.. .......|....-. ....+++++++||.+||+.||.+|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~i~~~~~~-----------------------------~p~~~s~~~~~li~~lL~~dP~~R~~ 306 (396)
T 4dc2_A 256 VGSSDNPDQNTEDYLFQVILEKQIR-----------------------------IPRSLSVKAASVLKSFLNKDPKERLG 306 (396)
T ss_dssp TTC------CCHHHHHHHHHHCCCC-----------------------------CCTTSCHHHHHHHHHHTCSCTTTSTT
T ss_pred cccccccchhhHHHHHHHHhccccC-----------------------------CCCcCCHHHHHHHHHHhcCCHhHcCC
Confidence 32 22233444331100 11357899999999999999999998
Q ss_pred H------HHHHhccccCCCCCC
Q 009654 232 A------SAALASEYFSTKPYA 247 (529)
Q Consensus 232 a------~e~L~h~~f~~~~~~ 247 (529)
+ .++++||||+...|.
T Consensus 307 ~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 307 CHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp CSTTTHHHHHHHSTTTTTCCHH
T ss_pred CCCCCCHHHHhcCccccCCCHH
Confidence 5 899999999976553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.15 Aligned_cols=212 Identities=23% Similarity=0.375 Sum_probs=181.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+|||||+++++|.+ ...+|+|||||.|+.+..++.....+++..++.|+.||+.||.|||++||+|||
T Consensus 63 ~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 140 (384)
T 4fr4_A 63 FKELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140 (384)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 579999999999999999999988 578999999999988877776777899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC--CCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+||||+.+|.+||+|||++...... ......+||+.|+|||++.+. ..|+.++||||||||+|+|++|.+||.
T Consensus 141 lkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 141 MKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcHHHeEECCCCCEEEeccceeeeccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876543 345667899999999999642 358999999999999999999999998
Q ss_pred CCC---HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-HHHH
Q 009654 160 GRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAA 235 (529)
Q Consensus 160 g~~---~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-a~e~ 235 (529)
+.. ..+.+..+....... ...+++.+.+||.+||+.||.+||+ +.++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~-----------------------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 219 IRSSTSSKEIVHTFETTVVTY-----------------------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp CCTTSCHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred CCCCccHHHHHHHHhhcccCC-----------------------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 543 333334433311111 1357889999999999999999998 9999
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
++||||....|
T Consensus 270 ~~hp~f~~~~w 280 (384)
T 4fr4_A 270 QNFPYMNDINW 280 (384)
T ss_dssp HTSGGGTTCCH
T ss_pred HcChhhhcCCH
Confidence 99999987655
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.16 Aligned_cols=212 Identities=24% Similarity=0.419 Sum_probs=177.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+++ +||||++++++|.+ ...+|||||||+++.+..++.....+++..++.++.||+.||+|||++||+||
T Consensus 57 ~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 134 (345)
T 3a8x_A 57 QTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134 (345)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHhcCCCCccCeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 5799999998 89999999999988 57899999999987776655555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+
T Consensus 135 Dlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 999999999999999999999997643221 23456789999999999977 4689999999999999999999999975
Q ss_pred C---------CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 161 R---------TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 161 ~---------~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
. +.......|... .+ .+ ...++.++++||.+||+.||.+||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~--~~--------------------~~-------p~~~s~~~~~li~~lL~~dP~~R~~ 263 (345)
T 3a8x_A 213 VGSSDNPDQNTEDYLFQVILEK--QI--------------------RI-------PRSLSVKAASVLKSFLNKDPKERLG 263 (345)
T ss_dssp TTC-------CHHHHHHHHHHC--CC--------------------CC-------CTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred cccccccccccHHHHHHHHHcC--CC--------------------CC-------CCCCCHHHHHHHHHHhcCCHhHCCC
Confidence 2 223334444331 11 00 1357889999999999999999999
Q ss_pred H------HHHHhccccCCCCC
Q 009654 232 A------SAALASEYFSTKPY 246 (529)
Q Consensus 232 a------~e~L~h~~f~~~~~ 246 (529)
+ .++++||||+...|
T Consensus 264 ~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 264 CHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp CCTTTHHHHHHTSGGGTTCCH
T ss_pred CCCcCCHHHHhcCCccCCCCH
Confidence 5 89999999987655
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=347.30 Aligned_cols=212 Identities=25% Similarity=0.359 Sum_probs=184.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|..+ +||||++++++|.+ ...+|||||||+|+.+..++.....+++.+++.++.||+.||+|||++||+||
T Consensus 68 ~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHr 145 (353)
T 2i0e_A 68 MVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145 (353)
T ss_dssp HHHHHHHTCTTCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHhcCCCCEEeeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence 4789999988 89999999999988 57899999999987776665555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+
T Consensus 146 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCHHHEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 999999999999999999999997643221 23456789999999999976 4689999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~ 235 (529)
.+..+.+.+|....... ...+++++++||.+||..||.+|| ++.++
T Consensus 224 ~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i 274 (353)
T 2i0e_A 224 EDEDELFQSIMEHNVAY-----------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 274 (353)
T ss_dssp SSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHH
T ss_pred CCHHHHHHHHHhCCCCC-----------------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence 99999888887621111 135789999999999999999999 47999
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
++||||+...|
T Consensus 275 ~~h~~f~~~~w 285 (353)
T 2i0e_A 275 KEHAFFRYIDW 285 (353)
T ss_dssp HTSGGGTTCCH
T ss_pred hcCccccCCCH
Confidence 99999987655
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.50 Aligned_cols=213 Identities=28% Similarity=0.445 Sum_probs=183.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+|||||++++++.+ ...+|||||||+++.+..++ .....+++.++..++.||+.||.|||++||+||
T Consensus 96 ~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr 173 (387)
T 1kob_A 96 KNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 173 (387)
T ss_dssp HHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhCCCcCCCeEEEEEEe--CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 589999999999999999999988 57899999999986665444 444579999999999999999999999999999
Q ss_pred CCCCCcEEEcc--CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~--~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+|||++. .+.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||
T Consensus 174 Dlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf 250 (387)
T 1kob_A 174 DIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF 250 (387)
T ss_dssp CCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ccchHHeEEecCCCCceEEEecccceecCCC--cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCC
Confidence 99999999974 467999999999876543 23345689999999999976 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......++. ..+..+++++++||.+||..||.+|||+.++|+|
T Consensus 251 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 251 AGEDDLETLQNVKRCDWEFDE-------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSHHHHHHHHHHCCCCCCS-------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHhCCCCCCc-------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 999998888888663222211 1234689999999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||+..
T Consensus 306 p~~~~~ 311 (387)
T 1kob_A 306 PWLKGD 311 (387)
T ss_dssp TTTSSC
T ss_pred ccccCC
Confidence 999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=332.40 Aligned_cols=211 Identities=34% Similarity=0.514 Sum_probs=184.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..+......+++.++..++.||+.||.|||++||+|||
T Consensus 54 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d 131 (277)
T 3f3z_A 54 KQEIEIMKSLDHPNIIRLYETFED--NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRD 131 (277)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEec--CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence 589999999999999999999987 578999999999876665554556799999999999999999999999999999
Q ss_pred CCCCcEEE---ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+|||+ +.++.+||+|||++....... ......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||
T Consensus 132 lkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~ 207 (277)
T 3f3z_A 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPF 207 (277)
T ss_dssp CSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCC
Confidence 99999999 778899999999998765432 3455678999999999876 4899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+......++. ..+..+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 208 SAPTDSEVMLKIREGTFTFPE-------------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCSSHHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCHHHHHHHHHhCCCCCCc-------------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999998888888774433332 2234689999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
|||+.
T Consensus 263 ~~~~~ 267 (277)
T 3f3z_A 263 EWFEK 267 (277)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.88 Aligned_cols=214 Identities=30% Similarity=0.427 Sum_probs=168.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 95 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~ 172 (349)
T 2w4o_A 95 VRTEIGVLLRLSHPNIIKLKEIFET--PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172 (349)
T ss_dssp ----CHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHhCCCCCCcceeeeEec--CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 3579999999999999999999987 57899999999987776666666789999999999999999999999999999
Q ss_pred CCCCCcEEEcc---CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 81 DIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 81 DIKp~NILl~~---~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
||||+||||+. ++.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|..|
T Consensus 173 Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p 249 (349)
T 2w4o_A 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEP 249 (349)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCcccEEEecCCCCCCEEEccCccccccCcc--cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCC
Confidence 99999999975 789999999999866543 23345688999999999976 4589999999999999999999999
Q ss_pred CCCCCHHH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 158 LQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 158 f~g~~~~~-~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
|.+....+ .+..+......++ ...+..++.++.+||.+||..||.+|||+.++|
T Consensus 250 f~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 250 FYDERGDQFMFRRILNCEYYFI-------------------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp TCCTTCHHHHHHHHHTTCCCCC-------------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCcccHHHHHHHHhCCCccC-------------------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 98765544 5555544222111 122356899999999999999999999999999
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
+||||...
T Consensus 305 ~hp~~~~~ 312 (349)
T 2w4o_A 305 QHPWVTGK 312 (349)
T ss_dssp HSTTTTST
T ss_pred cCcccCCC
Confidence 99999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.62 Aligned_cols=213 Identities=27% Similarity=0.392 Sum_probs=186.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..++.....+++..+..++.||+.||.|||++||+|||
T Consensus 63 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~d 140 (321)
T 2a2a_A 63 EREVSILRQVLHHNVITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140 (321)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCcceEEEEEec--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 589999999999999999999987 578999999999877766666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCC----cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 82 IKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 82 IKp~NILl~~~g----~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||+|||++.++ .+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 141 ikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CChHHEEEecCCCCcCCEEEccCccceecCccc--cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCC
Confidence 999999999887 79999999998765432 3355678999999999976 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+.......+. ..+..+++.+.+||.+||..||.+|||+.++|+
T Consensus 218 f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 218 FLGDTKQETLANITSVSYDFDE-------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCH-------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcccccCh-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999988888887664333222 233578899999999999999999999999999
Q ss_pred ccccCCC
Q 009654 238 SEYFSTK 244 (529)
Q Consensus 238 h~~f~~~ 244 (529)
||||+..
T Consensus 273 hp~~~~~ 279 (321)
T 2a2a_A 273 HPWITPV 279 (321)
T ss_dssp STTTSCS
T ss_pred CccccCC
Confidence 9999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=346.18 Aligned_cols=214 Identities=29% Similarity=0.393 Sum_probs=178.6
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|.++ +||||++++++|.+ ...+|||||||+|+.+...+.....+++.++..++.||+.||.|||++||+||
T Consensus 63 ~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHr 140 (342)
T 2qr7_A 63 TEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR 140 (342)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence 5799999998 89999999999988 67899999999986666555556689999999999999999999999999999
Q ss_pred CCCCCcEEEccC----CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~----g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+|||+..+ +.+||+|||++....... ......++|+.|+|||++.+ ..|+.++||||||||+|+|++|.+
T Consensus 141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~ 218 (342)
T 2qr7_A 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYT 218 (342)
T ss_dssp CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCC
Confidence 999999998543 359999999998765432 23456688999999999976 348899999999999999999999
Q ss_pred CCCC---CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 157 ILQG---RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 157 pf~g---~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
||.+ .+..+.+..|......++. ..+..+++++++||.+||..||.+|||+.
T Consensus 219 Pf~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 273 (342)
T 2qr7_A 219 PFANGPDDTPEEILARIGSGKFSLSG-------------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273 (342)
T ss_dssp SSCSSTTSCHHHHHHHHHHCCCCCCS-------------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCcCCHHHHHHHHccCCcccCc-------------------------cccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 9986 3555666666552222211 12356899999999999999999999999
Q ss_pred HHHhccccCCC
Q 009654 234 AALASEYFSTK 244 (529)
Q Consensus 234 e~L~h~~f~~~ 244 (529)
++|+||||...
T Consensus 274 ~il~hp~~~~~ 284 (342)
T 2qr7_A 274 LVLRHPWIVHW 284 (342)
T ss_dssp HHTTSHHHHTG
T ss_pred HHhcCCeecCc
Confidence 99999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.12 Aligned_cols=214 Identities=23% Similarity=0.251 Sum_probs=158.1
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCC--CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR----- 75 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~--~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~----- 75 (529)
+||.++.+|+|||||++++++.+... ..+|||||||+++.|..++.. ..++++++..++.|++.||+|||++
T Consensus 46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~ 124 (303)
T 3hmm_A 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence 46667778999999999999987532 368999999998777766543 4799999999999999999999987
Q ss_pred ---CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC---CccccccccccCCcccccCCC-----CCCCcchhhhh
Q 009654 76 ---GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSV 144 (529)
Q Consensus 76 ---gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~-----~y~~~~DIWSl 144 (529)
+|+||||||+||||+.++.+||+|||+|+........ .....+||++|+|||++.+.. .|+.++|||||
T Consensus 125 ~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred CCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 9999999999999999999999999999876543211 223468999999999997642 36779999999
Q ss_pred hHHHHHHHhCCCCCCCCCH--------------HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCC
Q 009654 145 GCVFAELLIGKPILQGRTE--------------VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210 (529)
Q Consensus 145 G~il~elltG~~pf~g~~~--------------~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 210 (529)
|||||||++|.+||..... .+.+.+.....+ ..|..+ .. ......
T Consensus 205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------------~rp~~p--~~--~~~~~~ 263 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-----------------LRPNIP--NR--WQSCEA 263 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----------------CCCCCC--GG--GGSSHH
T ss_pred HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhccc-----------------CCCCCC--cc--ccchHH
Confidence 9999999999887643221 111111111000 001000 00 000123
Q ss_pred cHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 211 PTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 211 s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+..+.+||.+||+.||++|||+.++++.
T Consensus 264 ~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 264 LRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 4578899999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.73 Aligned_cols=234 Identities=24% Similarity=0.394 Sum_probs=186.8
Q ss_pred HHHHHHHHhCC-----CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLD-----HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~-----HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|+.+|+.+. ||||+++++++.. ...+|||||||.+++...+... ...+++.++..++.||+.||.|||++
T Consensus 79 ~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 156 (360)
T 3llt_A 79 KIEADILKKIQNDDINNNNIVKYHGKFMY--YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156 (360)
T ss_dssp HHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcccCCCCCCeecccceeeE--CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46999999996 9999999999988 5789999999966666655433 34699999999999999999999999
Q ss_pred CCcccCCCCCcEEEcc-------------------------CCcEEEeccccccccCCCCCCCccccccccccCCccccc
Q 009654 76 GVLHRDIKGSNLLVNN-------------------------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 130 (529)
Q Consensus 76 gIvHrDIKp~NILl~~-------------------------~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 130 (529)
||+||||||+||||+. ++.+||+|||++...... ....+||+.|+|||++.
T Consensus 157 ~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVIL 232 (360)
T ss_dssp TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHT
T ss_pred CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHc
Confidence 9999999999999975 788999999999865432 34568899999999998
Q ss_pred CCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCC---------CCCC-Cc
Q 009654 131 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK---------PQQP-YD 200 (529)
Q Consensus 131 ~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~---------~~~~-~~ 200 (529)
+. .|+.++||||||||+|+|++|.+||.+.+..+.+..+....+.++...+..........+. +... ..
T Consensus 233 ~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 311 (360)
T 3llt_A 233 NL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSI 311 (360)
T ss_dssp TC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCH
T ss_pred CC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccch
Confidence 74 5999999999999999999999999999999999999999888886654432211100000 0000 00
Q ss_pred chhh-------hhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccC
Q 009654 201 SSLR-------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 242 (529)
Q Consensus 201 ~~l~-------~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~ 242 (529)
.... ......++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 312 NSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0000 01112357788999999999999999999999999995
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=343.26 Aligned_cols=214 Identities=34% Similarity=0.516 Sum_probs=160.5
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.+. ||||+++++++.+ ...+|||||||+++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 53 ~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~ 130 (325)
T 3kn6_A 53 QKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130 (325)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Confidence 57999999996 9999999999988 57899999999997766655556789999999999999999999999999999
Q ss_pred CCCCCcEEEccCC---cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 81 DIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 81 DIKp~NILl~~~g---~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
||||+|||++.++ .+||+|||++....... ......++|+.|+|||++.+ ..|+.++||||||||+|+|++|.+|
T Consensus 131 Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p 208 (325)
T 3kn6_A 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVP 208 (325)
T ss_dssp CCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCC
Confidence 9999999998765 79999999998665432 34456688999999999976 4689999999999999999999999
Q ss_pred CCCCCH-------HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 158 LQGRTE-------VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 158 f~g~~~-------~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
|.+.+. .+.+..|......++ ...+..+++++++||.+||..||.+||
T Consensus 209 f~~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rp 263 (325)
T 3kn6_A 209 FQSHDRSLTCTSAVEIMKKIKKGDFSFE-------------------------GEAWKNVSQEAKDLIQGLLTVDPNKRL 263 (325)
T ss_dssp TC-------CCCHHHHHHHHTTTCCCCC-------------------------SHHHHTSCHHHHHHHHHHHCCCTTTCC
T ss_pred CCCCccccccccHHHHHHHHHcCCCCCC-------------------------cccccCCCHHHHHHHHHHCCCChhHCC
Confidence 987543 344555533222221 233457899999999999999999999
Q ss_pred CHHHHHhccccCCC
Q 009654 231 TASAALASEYFSTK 244 (529)
Q Consensus 231 ta~e~L~h~~f~~~ 244 (529)
|+.++|+||||+..
T Consensus 264 t~~ell~h~w~~~~ 277 (325)
T 3kn6_A 264 KMSGLRYNEWLQDG 277 (325)
T ss_dssp CTTTSTTCGGGCTT
T ss_pred CHHHHhcChhhccC
Confidence 99999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=356.82 Aligned_cols=212 Identities=25% Similarity=0.376 Sum_probs=179.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvHr 80 (529)
.+|+.+|+.++||||++++++|.+ ...+|||||||+++.+..++.....+++..+..++.||+.||+|||+ +||+||
T Consensus 196 ~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr 273 (446)
T 4ejn_A 196 LTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273 (446)
T ss_dssp -----CCCCCSCTTSCCEEEEEEE--TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred HHHHHHHHhCCCCeEeeEEEEEee--CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC
Confidence 578999999999999999999988 57899999999997777666556689999999999999999999998 999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.++.+||+|||++...... .......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+
T Consensus 274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 274 DLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEECCCCCEEEccCCCceeccCC-CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 99999999999999999999999764332 233456789999999999976 4699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~ 235 (529)
.+..+.+..|....... ...+++++.+||.+||..||.+|| |+.++
T Consensus 352 ~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~el 402 (446)
T 4ejn_A 352 QDHEKLFELILMEEIRF-----------------------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI 402 (446)
T ss_dssp SSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH
T ss_pred CCHHHHHHHHHhCCCCC-----------------------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHH
Confidence 99888888876522111 135789999999999999999999 99999
Q ss_pred HhccccCCCCC
Q 009654 236 LASEYFSTKPY 246 (529)
Q Consensus 236 L~h~~f~~~~~ 246 (529)
|+||||+...|
T Consensus 403 l~hp~f~~~~~ 413 (446)
T 4ejn_A 403 MQHRFFAGIVW 413 (446)
T ss_dssp HTSGGGTTCCH
T ss_pred HhCccccCCCH
Confidence 99999987544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=332.73 Aligned_cols=240 Identities=39% Similarity=0.677 Sum_probs=197.6
Q ss_pred HHHHHHHHhC---CCCCccceeeEEEc---cCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL---DHPNIIKLEGLITS---RLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L---~HpnIvkl~~~~~~---~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+++.| +||||+++++++.. .....+|+||||+++++...+.. ....+++.++..++.||+.||.|||+
T Consensus 59 ~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 138 (326)
T 1blx_A 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138 (326)
T ss_dssp HHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4788888877 89999999999872 12467999999999877666543 33459999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 ~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g 215 (326)
T 1blx_A 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRR 215 (326)
T ss_dssp TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCceeccCCHHHeEEcCCCCEEEecCcccccccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999999766432 23445678999999999976 4589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.+..+.+..+....+.++...|..........+.... ...+......++..+++||.+||..||.+|||+.+
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 293 (326)
T 1blx_A 216 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293 (326)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccC--cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999999999999999999999888777653221111111111 11234455789999999999999999999999999
Q ss_pred HHhccccCCCCC
Q 009654 235 ALASEYFSTKPY 246 (529)
Q Consensus 235 ~L~h~~f~~~~~ 246 (529)
+|+||||+....
T Consensus 294 ~l~hp~~~~~~~ 305 (326)
T 1blx_A 294 ALSHPYFQDLER 305 (326)
T ss_dssp HHTSGGGTTCCC
T ss_pred HhcCccccccch
Confidence 999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.90 Aligned_cols=236 Identities=28% Similarity=0.498 Sum_probs=191.6
Q ss_pred HHHHHHHHhC------CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL------DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L------~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+.| +||||+++++++.. ...+|||||||.+++...+.... ..+++..++.++.||+.||.|||+
T Consensus 141 ~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 218 (429)
T 3kvw_A 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218 (429)
T ss_dssp HHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhccccCCcCEEEEEeeccc--CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4688888888 67899999999988 57899999999998877665433 459999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCc--EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 75 RGVLHRDIKGSNLLVNNEGV--LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
+||+||||||+||||+.++. +||+|||++..... .....++|+.|+|||++.+. .|+.++||||||||||+|+
T Consensus 219 ~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell 293 (429)
T 3kvw_A 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELL 293 (429)
T ss_dssp HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHH
T ss_pred CCeecCCCCHHHeEEccCCCcceEEeecccceecCC----cccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHH
Confidence 99999999999999999887 99999999976543 23456889999999999874 5899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCC-----------------------------CCCCCcchh
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-----------------------------PQQPYDSSL 203 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~-----------------------------~~~~~~~~l 203 (529)
+|.+||.+.+..+++..|.+.+|.|+...+............ ...+....+
T Consensus 294 tG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (429)
T 3kvw_A 294 TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW 373 (429)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCH
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhh
Confidence 999999999999999999999999987765543211000000 000111112
Q ss_pred hhhc-cCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 204 RETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 204 ~~~~-~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
...+ ...++.+++||.+||++||.+|||+.|+|+||||+..
T Consensus 374 ~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 374 GNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp HHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred HhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 2222 2458889999999999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.18 Aligned_cols=244 Identities=33% Similarity=0.563 Sum_probs=193.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+||||+++++++.... ...+|+||||+.+++...+.. ..+++.++..++.||+.||.|||++||+
T Consensus 57 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~iv 134 (353)
T 2b9h_A 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVI 134 (353)
T ss_dssp HHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 58999999999999999999876531 367899999999876665543 4799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCC---------CccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
||||||+|||++.++.+||+|||++......... .....+||+.|+|||++.+...++.++|||||||++|
T Consensus 135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 214 (353)
T 2b9h_A 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214 (353)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHH
T ss_pred cCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHH
Confidence 9999999999999999999999999876532111 1234578999999999876667999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC-CCcccc---CCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 150 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATL---FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 150 elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~-l~~~~~---~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
+|++|.+||.+.+..+++..++...|.+......... .+.... ..+. .....+...+..+++++.+||.+||..|
T Consensus 215 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPM-YPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccC-CCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 9999999999999999999999998887633211100 000000 0000 0012234556789999999999999999
Q ss_pred CCCCcCHHHHHhccccCCCCCCC
Q 009654 226 PYKRATASAALASEYFSTKPYAC 248 (529)
Q Consensus 226 P~kR~ta~e~L~h~~f~~~~~~~ 248 (529)
|.+|||+.++|+||||+....+.
T Consensus 294 P~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 294 PAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp GGGSCCHHHHHTSGGGTTTCCTT
T ss_pred cccCCCHHHHhcCccccccCCcc
Confidence 99999999999999999765543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.26 Aligned_cols=243 Identities=20% Similarity=0.289 Sum_probs=175.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++|+|||||+++++|.+ ...+|||||||+++.+..++.. ...+++..++.++.||+.||.|||++||+|
T Consensus 74 ~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 151 (389)
T 3gni_B 74 QGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVH 151 (389)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHhCCCCCCCcEeEEEEE--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 579999999999999999999988 5789999999998777655432 367999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCC------CCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHH
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~ell 152 (529)
|||||+||||+.++.+||+|||++....... .......+||+.|+|||++.+. ..|+.++||||||||+|+|+
T Consensus 152 rDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp CCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence 9999999999999999999999986442211 1112334789999999999764 46899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCC--------CCchhhhcc-------CCCccccCC-CCC-CCcchhhhhccCCcHHHH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGS--------PPDDYWKKS-------KLPHATLFK-PQQ-PYDSSLRETFKDLPTTAV 215 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~--------p~~~~~~~~-------~l~~~~~~~-~~~-~~~~~l~~~~~~~s~~~~ 215 (529)
+|.+||.+.+..+.+..+....-. +....+... .+....... +.. ............+++.++
T Consensus 232 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 311 (389)
T 3gni_B 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311 (389)
T ss_dssp HSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHHH
T ss_pred HCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHH
Confidence 999999987766655444331100 000000000 000000000 000 000001123456899999
Q ss_pred HHHHHhccCCCCCCcCHHHHHhccccCCCCC
Q 009654 216 NLIETLLSVEPYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 216 dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~ 246 (529)
+||.+||+.||.+|||+.++|+||||+...+
T Consensus 312 ~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred HHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 9999999999999999999999999986543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=329.67 Aligned_cols=215 Identities=31% Similarity=0.468 Sum_probs=184.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++|+||||+++++++.+ ....|+||||++++.+.........+++.++..++.||+.||.|||++||+|||
T Consensus 53 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 130 (284)
T 3kk8_A 53 EREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130 (284)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHcCCCCcCeEEEEEEc--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCC
Confidence 579999999999999999999987 578999999999866654444456799999999999999999999999999999
Q ss_pred CCCCcEEEccCCc---EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~g~---vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+|||++.++. +||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 131 ikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf 207 (284)
T 3kk8_A 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPF 207 (284)
T ss_dssp CCGGGEEESSSSTTCCEEECCCTTCEECCSS--CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCcEEEeeceeeEEcccC--ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCC
Confidence 9999999986654 999999999776543 23345688999999999976 45899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+.......+. ..+..+++++.+||.+||+.||.+|||+.++|+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 208 WDEDQHRLYAQIKAGAYDYPS-------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCSSHHHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCchhHHHHHHHhccccCCc-------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 999988888887664333221 1234688999999999999999999999999999
Q ss_pred cccCCCCC
Q 009654 239 EYFSTKPY 246 (529)
Q Consensus 239 ~~f~~~~~ 246 (529)
|||+....
T Consensus 263 ~~~~~~~~ 270 (284)
T 3kk8_A 263 PWICNRER 270 (284)
T ss_dssp HHHHSCCC
T ss_pred ccccCChh
Confidence 99986533
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=335.23 Aligned_cols=212 Identities=24% Similarity=0.458 Sum_probs=182.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++++||||+++++++.. ...+||||||++++.+..+... ..+++.++..++.||+.||.|||++||+|||
T Consensus 90 ~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 166 (321)
T 2c30_A 90 FNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166 (321)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 589999999999999999999988 5789999999999887776643 4799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.
T Consensus 167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 167 IKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765432 22345689999999999976 46899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+..+... .++. ......+++.+.+||.+||..||.+|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~--~~~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 245 SPVQAMKRLRDS--PPPK------------------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp CHHHHHHHHHHS--SCCC------------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHhcC--CCCC------------------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 888877776542 1110 00113578899999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
...
T Consensus 299 ~~~ 301 (321)
T 2c30_A 299 LQT 301 (321)
T ss_dssp GGC
T ss_pred ccC
Confidence 864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=340.04 Aligned_cols=218 Identities=27% Similarity=0.380 Sum_probs=178.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--------------------------------
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-------------------------------- 49 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-------------------------------- 49 (529)
.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..++..
T Consensus 76 ~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (345)
T 3hko_A 76 KTEVRLMKKLHHPNIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153 (345)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSC
T ss_pred HHHHHHHHhCCCCCcceeehhhcc--CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccc
Confidence 579999999999999999999988 5789999999998766554420
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC--cEEEeccccccccCCC---CCCCccc
Q 009654 50 --------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTG---HRQPLTS 116 (529)
Q Consensus 50 --------~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g--~vKl~DFGla~~~~~~---~~~~~~~ 116 (529)
...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 233 (345)
T 3hko_A 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233 (345)
T ss_dssp C--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------
T ss_pred cccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccc
Confidence 22346888999999999999999999999999999999998776 8999999999865432 1123456
Q ss_pred cccccccCCcccccCC-CCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCC
Q 009654 117 RVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 195 (529)
Q Consensus 117 ~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~ 195 (529)
..+|+.|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......++.
T Consensus 234 ~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 297 (345)
T 3hko_A 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------- 297 (345)
T ss_dssp -CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS----------------
T ss_pred cCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC----------------
Confidence 6889999999999653 56899999999999999999999999999998888888763322221
Q ss_pred CCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCCCC
Q 009654 196 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 196 ~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~~ 246 (529)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+...+
T Consensus 298 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 298 ---------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp ---------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred ---------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 223457899999999999999999999999999999986543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.16 Aligned_cols=209 Identities=29% Similarity=0.458 Sum_probs=181.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|||||||.|++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 102 ~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 179 (348)
T 1u5q_A 102 IKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179 (348)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEE--CCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 589999999999999999999988 578999999999988777665566899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||+||||+.++.+||+|||++...... ...+||+.|+|||++.+ ...|+.++||||||||+|+|++|.+||.
T Consensus 180 lkp~NIll~~~~~~kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 180 VKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp CSGGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCHHHEEECCCCCEEEeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999766432 35678999999999853 3568999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+..+.+..+.... .+. .....+++.+.+||.+||+.||.+|||+.++|+||
T Consensus 255 ~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 255 NMNAMSALYHIAQNE-SPA--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp TSCHHHHHHHHHHSC-CCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCChHHHHHHHHhcC-CCC--------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 988887777665521 110 00135688899999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
||...
T Consensus 308 ~~~~~ 312 (348)
T 1u5q_A 308 FVLRE 312 (348)
T ss_dssp HHHSC
T ss_pred hhhcc
Confidence 99753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=340.82 Aligned_cols=237 Identities=37% Similarity=0.665 Sum_probs=190.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC----CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS----CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~----~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|+.|+||||+++++++..... ..+|+||||+.+++...+. ..+++.++..++.||+.||.|||++||
T Consensus 71 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~i 147 (353)
T 3coi_A 71 YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGV 147 (353)
T ss_dssp HHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 579999999999999999999987422 2469999999986655442 359999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||++...... ....++|+.|+|||++.+...++.++||||||||+|+|++|.+|
T Consensus 148 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 223 (353)
T 3coi_A 148 VHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL 223 (353)
T ss_dssp CCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999765432 34567899999999998766799999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccC--CCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~--~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+..+.+..+.+..|.++..++....-.....+ .........+...+..+++.+.+||.+||+.||.+|||+.++
T Consensus 224 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 303 (353)
T 3coi_A 224 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303 (353)
T ss_dssp SBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999999999999999999988776654221000000 000000111233456789999999999999999999999999
Q ss_pred HhccccCCCC
Q 009654 236 LASEYFSTKP 245 (529)
Q Consensus 236 L~h~~f~~~~ 245 (529)
|+||||+...
T Consensus 304 l~hp~f~~~~ 313 (353)
T 3coi_A 304 LTHPFFEPFR 313 (353)
T ss_dssp HTSGGGTTTC
T ss_pred hcCcchhhcc
Confidence 9999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.70 Aligned_cols=212 Identities=25% Similarity=0.375 Sum_probs=179.3
Q ss_pred HHHHHH-HHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILI-LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~i-L~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|..+ ++.++|||||+++++|.+ ...+|||||||+|+.+..++.....+++..++.++.||+.||+|||++||+||
T Consensus 86 ~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHr 163 (373)
T 2r5t_A 86 MSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163 (373)
T ss_dssp -----CCBCCCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHhCCCCCCCCEEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 345555 567899999999999988 57999999999997776665556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+
T Consensus 164 Dlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 164 DLKPENILLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp CCCGGGEEECTTSCEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCHHHEEECCCCCEEEeeCccccccccCC-CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998643321 23456789999999999976 4699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH----HHHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAAL 236 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta----~e~L 236 (529)
.+..+.+.+|....-.. ...++.++++||.+||+.||.+|+++ .+++
T Consensus 242 ~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 242 RNTAEMYDNILNKPLQL-----------------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp SBHHHHHHHHHHSCCCC-----------------------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCHHHHHHHHHhcccCC-----------------------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 99999888887621111 13578999999999999999999986 6999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 293 ~h~~f~~~~w 302 (373)
T 2r5t_A 293 SHVFFSLINW 302 (373)
T ss_dssp TSGGGTTCCH
T ss_pred CCccccCCCH
Confidence 9999987655
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.74 Aligned_cols=216 Identities=25% Similarity=0.375 Sum_probs=182.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+.+ +||||+++++++.+ ...+|+|||||+++.+..+.. ....+++.++..++.||+.||+|||++||+
T Consensus 76 ~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~giv 153 (327)
T 3lm5_A 76 LHEIAVLELAKSCPRVINLHEVYEN--TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153 (327)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhccCCCCEEEEEEEEEe--CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 5799999999 57999999999987 578999999999966665543 246799999999999999999999999999
Q ss_pred ccCCCCCcEEEcc---CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 79 HRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 79 HrDIKp~NILl~~---~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||||+||||+. ++.+||+|||++....... .....++|+.|+|||++.+ ..|+.++||||||||+|+|++|.
T Consensus 154 H~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~ 230 (327)
T 3lm5_A 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHT 230 (327)
T ss_dssp CSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCcCChHHEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999987 7899999999998765432 3345689999999999976 46899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+..+.+..+......++. ..+..+++.+.+||.+||..||.+|||+.++
T Consensus 231 ~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l 285 (327)
T 3lm5_A 231 SPFVGEDNQETYLNISQVNVDYSE-------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285 (327)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCchHHHHHHHhcccccCc-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999998888888775443322 2234688999999999999999999999999
Q ss_pred HhccccCCCCCC
Q 009654 236 LASEYFSTKPYA 247 (529)
Q Consensus 236 L~h~~f~~~~~~ 247 (529)
|+||||+...+.
T Consensus 286 l~h~~~~~~~~~ 297 (327)
T 3lm5_A 286 LSHSWLQQWDFE 297 (327)
T ss_dssp TTCGGGCCCCTT
T ss_pred hCCHhhcccccc
Confidence 999999986654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.60 Aligned_cols=243 Identities=36% Similarity=0.612 Sum_probs=190.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc------------CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR------------LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 69 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~------------~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL 69 (529)
.+|+.+|++|+||||+++++++... ....+|+||||+++++...+. ...+++..+..++.||+.||
T Consensus 56 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l 133 (320)
T 2i6l_A 56 LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGL 133 (320)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHH
Confidence 5899999999999999999988432 246889999999986655553 35799999999999999999
Q ss_pred HHHHHCCCcccCCCCCcEEEc-cCCcEEEeccccccccCCCC--CCCccccccccccCCcccccCCCCCCCcchhhhhhH
Q 009654 70 EHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 146 (529)
Q Consensus 70 ~~LH~~gIvHrDIKp~NILl~-~~g~vKl~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~ 146 (529)
.|||++||+||||||+|||++ .++.+||+|||++....... ........+|++|+|||++.+...++.++|||||||
T Consensus 134 ~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 213 (320)
T 2i6l_A 134 KYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213 (320)
T ss_dssp HHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHH
T ss_pred HHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHH
Confidence 999999999999999999997 45789999999998764321 122345577999999999977667999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC--CccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 147 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL--PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 147 il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l--~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
++|+|++|.+||.+.+..+.+..+......+....+..... +..... ........+...+..++.++.+||.+||+.
T Consensus 214 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (320)
T 2i6l_A 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN-DMTEPHKPLTQLLPGISREAVDFLEQILTF 292 (320)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHH-HTTSCCCCHHHHSTTCCHHHHHHHHTTSCS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccc-cccCCCCChhHhcchhhHHHHHHHHHHcCC
Confidence 99999999999999999999999988776665444332100 000000 000001123445567999999999999999
Q ss_pred CCCCCcCHHHHHhccccCCCCCC
Q 009654 225 EPYKRATASAALASEYFSTKPYA 247 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~~~~ 247 (529)
||.+|||+.++|+||||+...++
T Consensus 293 dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 293 SPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp SGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CccccCCHHHHhCCcccccccCc
Confidence 99999999999999999976654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=328.91 Aligned_cols=210 Identities=30% Similarity=0.418 Sum_probs=171.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+...+ .....+++..+..++.||+.||.|||++||
T Consensus 68 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 145 (285)
T 3is5_A 68 EAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145 (285)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhCCCchHHhHHHheec--CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 589999999999999999999987 57899999999985554332 234679999999999999999999999999
Q ss_pred cccCCCCCcEEEc---cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 78 LHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 78 vHrDIKp~NILl~---~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||||||+||||+ .++.+||+|||++....... .....++|+.|+|||++.+ .++.++||||||||+|+|++|
T Consensus 146 vH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp CCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhC
Confidence 9999999999994 45789999999998665432 3345678999999999864 589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
..||.+.+..+....+........ .....+++.+.+||.+||+.||.+|||+.+
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 275 (285)
T 3is5_A 222 CLPFTGTSLEEVQQKATYKEPNYA--------------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQ 275 (285)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCC--------------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred CCCCCCCCHHHHHhhhccCCcccc--------------------------cccCcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999887777666544211110 111347889999999999999999999999
Q ss_pred HHhccccCC
Q 009654 235 ALASEYFST 243 (529)
Q Consensus 235 ~L~h~~f~~ 243 (529)
+|+||||++
T Consensus 276 ~l~hp~f~~ 284 (285)
T 3is5_A 276 VLHHEWFKQ 284 (285)
T ss_dssp HHTSGGGGC
T ss_pred HhcCHHhhc
Confidence 999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.51 Aligned_cols=216 Identities=25% Similarity=0.359 Sum_probs=170.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+++ +||||+++++++.+ ...+|||||||+++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 58 ~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 135 (316)
T 2ac3_A 58 FREVEMLYQCQGHRNVLELIEFFEE--EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135 (316)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Confidence 5899999995 89999999999988 57899999999986666555455689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCc---EEEeccccccccCCCC------CCCccccccccccCCcccccCC----CCCCCcchhhhhhHH
Q 009654 81 DIKGSNLLVNNEGV---LKLADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCV 147 (529)
Q Consensus 81 DIKp~NILl~~~g~---vKl~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~----~~y~~~~DIWSlG~i 147 (529)
||||+|||++.++. +||+|||++....... .......+||+.|+|||++.+. ..|+.++||||||||
T Consensus 136 dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 215 (316)
T 2ac3_A 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215 (316)
T ss_dssp CCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred CCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence 99999999988765 9999999987654221 1122345789999999998641 347899999999999
Q ss_pred HHHHHhCCCCCCCCCH---------------HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcH
Q 009654 148 FAELLIGKPILQGRTE---------------VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 212 (529)
Q Consensus 148 l~elltG~~pf~g~~~---------------~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~ 212 (529)
+|+|++|.+||.+... ...+..+......++ ...+..+++
T Consensus 216 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~ 270 (316)
T 2ac3_A 216 LYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP-------------------------DKDWAHISC 270 (316)
T ss_dssp HHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-------------------------HHHHTTSCH
T ss_pred HHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC-------------------------chhcccCCH
Confidence 9999999999987642 223344433211111 123356899
Q ss_pred HHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 213 TAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 213 ~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
.+++||.+||+.||.+|||+.++|+||||+..
T Consensus 271 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 271 AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 99999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=341.21 Aligned_cols=212 Identities=32% Similarity=0.494 Sum_probs=184.2
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+++ +||||+++++++.. ...+|||||||+++.+..+......+++..+..++.||+.||.|||+.||+||
T Consensus 147 ~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~ 224 (365)
T 2y7j_A 147 RRETHILRQVAGHPHIITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHR 224 (365)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEEB--SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhcCCCCEeEEEEEEee--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 5799999999 89999999999987 57899999999997766655555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC-----CCCCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||+||||+.+|.+||+|||++....... .....+||+.|+|||++.+ ...|+.++||||||||+|+|++|.
T Consensus 225 Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 999999999999999999999998765432 3456789999999999863 235889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+....+..+......++ ...+..++..+.+||.+||..||.+|||+.++
T Consensus 303 ~pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 357 (365)
T 2y7j_A 303 PPFWHRRQILMLRMIMEGQYQFS-------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357 (365)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCC-------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCC-------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999888888887766333222 22345788999999999999999999999999
Q ss_pred HhccccC
Q 009654 236 LASEYFS 242 (529)
Q Consensus 236 L~h~~f~ 242 (529)
|+||||+
T Consensus 358 l~hp~f~ 364 (365)
T 2y7j_A 358 LQHPFFE 364 (365)
T ss_dssp HHSGGGC
T ss_pred hcCcccC
Confidence 9999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=328.80 Aligned_cols=208 Identities=34% Similarity=0.524 Sum_probs=178.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++++||||+++++++.+ ...+|+||||++++.+.........+++..+..++.||+.||.|||++||+|||
T Consensus 57 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~d 134 (279)
T 3fdn_A 57 RREVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRD 134 (279)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECC
T ss_pred HHHHHHHHcCCCCCCcchhheEec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence 579999999999999999999987 578999999999876665555556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.++.+||+|||++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 135 lkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 135 IKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp CCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CChHhEEEcCCCCEEEEeccccccCCcc---cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999998655432 2345678999999999976 46899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+....+.......+ ..+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 211 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 211 TYQETYKRISRVEFTFP-----------------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp SHHHHHHHHHHTCCCCC-----------------------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred cHHHHHHHHHhCCCCCC-----------------------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence 98888887765322211 2478889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
+..
T Consensus 262 ~~~ 264 (279)
T 3fdn_A 262 TAN 264 (279)
T ss_dssp HHH
T ss_pred cCC
Confidence 864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=348.04 Aligned_cols=212 Identities=28% Similarity=0.452 Sum_probs=169.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.. ..+|||||||+++.+.........+++.++..++.||+.||.|||++||+|||
T Consensus 188 ~~E~~~l~~l~hpniv~l~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrD 264 (419)
T 3i6u_A 188 ETEIEILKKLNHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 264 (419)
T ss_dssp HHHHHHHHHCCCTTBCCCCEEEES---SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEec---CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 589999999999999999999865 46899999999977766666677899999999999999999999999999999
Q ss_pred CCCCcEEEccCC---cEEEeccccccccCCCCCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 82 IKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 82 IKp~NILl~~~g---~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||+||||+.++ .+||+|||++...... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+
T Consensus 265 lkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 265 LKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp CCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred CChHhEEEecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999997654 5999999999876543 23456789999999999863 3568889999999999999999999
Q ss_pred CCCCCCHHH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 157 ILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 157 pf~g~~~~~-~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
||.+..... ....+......+ ....+..+++.+.+||.+||+.||.+|||+.++
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 397 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNF-------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCC-------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCcchHHHHHHHhcCCCCC-------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 998754332 223332211111 123446789999999999999999999999999
Q ss_pred HhccccCC
Q 009654 236 LASEYFST 243 (529)
Q Consensus 236 L~h~~f~~ 243 (529)
|+||||+.
T Consensus 398 l~hp~~~~ 405 (419)
T 3i6u_A 398 LRHPWLQD 405 (419)
T ss_dssp HHSGGGCC
T ss_pred hCCcccCC
Confidence 99999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=333.72 Aligned_cols=238 Identities=31% Similarity=0.531 Sum_probs=186.3
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|. ||||+++++++.+.....+|+||||++++.+..+.. .+++.++..++.||+.||.|||++||+||
T Consensus 78 ~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 154 (330)
T 3nsz_A 78 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHR 154 (330)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence 58999999996 999999999998866678999999999877766553 58999999999999999999999999999
Q ss_pred CCCCCcEEEccCC-cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC-
Q 009654 81 DIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL- 158 (529)
Q Consensus 81 DIKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf- 158 (529)
||||+||||+.++ .+||+|||++....... .....++|+.|+|||++.+...|+.++||||||||+|+|++|..||
T Consensus 155 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999999777 89999999998765442 3456688999999999987677999999999999999999999888
Q ss_pred CCCCHHHHHHHHHHHcCCCCchh-hhccCCCcccc------CCCCCCCcchh-hhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDY-WKKSKLPHATL------FKPQQPYDSSL-RETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~-~~~~~l~~~~~------~~~~~~~~~~l-~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
.+....+.+..+...++.+.... +.......... ......+.... ......+++++++||.+||+.||.+||
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 312 (330)
T 3nsz_A 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312 (330)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC
Confidence 56677777777777666433211 11111000000 00000000000 111234799999999999999999999
Q ss_pred CHHHHHhccccCCC
Q 009654 231 TASAALASEYFSTK 244 (529)
Q Consensus 231 ta~e~L~h~~f~~~ 244 (529)
|+.++|+||||+..
T Consensus 313 ta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 313 TAREAMEHPYFYTV 326 (330)
T ss_dssp CHHHHHTSGGGTTC
T ss_pred CHHHHhcCccHhhh
Confidence 99999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=330.61 Aligned_cols=212 Identities=27% Similarity=0.427 Sum_probs=182.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..+......+++.++..++.||+.||.|||++||+|||
T Consensus 54 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 131 (304)
T 2jam_A 54 ENEIAVLKKIKHENIVTLEDIYES--TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131 (304)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCS
T ss_pred HHHHHHHHhCCCCCeeehhhhccc--CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 589999999999999999999987 578999999999866655444455799999999999999999999999999999
Q ss_pred CCCCcEEE---ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+|||+ +.++.+||+|||++...... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||
T Consensus 132 ikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999 67789999999998765432 2345578999999999976 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......++. ..+..+++.+.+||.+||..||.+|||+.++|+|
T Consensus 208 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 208 YEETESKLFEKIKEGYYEFES-------------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTSCHHHHHHHHHHCCCCCCT-------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCCCc-------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 999988888888763322211 1224688999999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||...
T Consensus 263 ~~~~~~ 268 (304)
T 2jam_A 263 PWIDGN 268 (304)
T ss_dssp HHHHSS
T ss_pred ccccCC
Confidence 999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.72 Aligned_cols=215 Identities=25% Similarity=0.375 Sum_probs=166.6
Q ss_pred HHHHHHHHh-CCCCCccceeeEEEc--cCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRR-LDHPNIIKLEGLITS--RLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~-L~HpnIvkl~~~~~~--~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.++.+ ++||||++++++|.. .....+|||||||+|+.+..++.. ...|++.+++.++.||+.||.|||++|
T Consensus 102 ~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 181 (400)
T 1nxk_A 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181 (400)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 579998855 489999999999865 224578999999998655544433 346999999999999999999999999
Q ss_pred CcccCCCCCcEEEcc---CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 77 VLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 77 IvHrDIKp~NILl~~---~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
|+||||||+||||+. ++.+||+|||+++..... ......+||+.|+|||++.+ ..|+.++||||||||||+|++
T Consensus 182 ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~ 258 (400)
T 1nxk_A 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_dssp EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHH
T ss_pred ccccCcCcceEEEecCCCCccEEEEecccccccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHh
Confidence 999999999999997 788999999999866533 23456789999999999866 569999999999999999999
Q ss_pred CCCCCCCCCHHH----HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 154 GKPILQGRTEVE----QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 154 G~~pf~g~~~~~----~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|.+||.+.+... ....|.......+ ...+..+++++++||.+||..||.+|
T Consensus 259 g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R 313 (400)
T 1nxk_A 259 GYPPFYSNHGLAISPGMKTRIRMGQYEFP-------------------------NPEWSEVSEEVKMLIRNLLKTEPTQR 313 (400)
T ss_dssp SSCSCCCCTTCSSCCSHHHHHHHTCCCCC-------------------------TTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred CCCCCCCCccccccHHHHHHHHcCcccCC-------------------------CcccccCCHHHHHHHHHHCCCChhHC
Confidence 999998765432 2333332111111 11235689999999999999999999
Q ss_pred cCHHHHHhccccCCC
Q 009654 230 ATASAALASEYFSTK 244 (529)
Q Consensus 230 ~ta~e~L~h~~f~~~ 244 (529)
||+.++|+||||...
T Consensus 314 pt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 314 MTITEFMNHPWIMQS 328 (400)
T ss_dssp CCHHHHHHSHHHHTT
T ss_pred cCHHHHhcCccccCC
Confidence 999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=324.77 Aligned_cols=211 Identities=23% Similarity=0.322 Sum_probs=175.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--V 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g--I 77 (529)
.+|+.+|++|+||||+++++++.+. ....+|+|||||+++.+..++.....+++..+..++.||+.||.|||++| |
T Consensus 73 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i 152 (290)
T 1t4h_A 73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152 (290)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCE
Confidence 5799999999999999999998753 24578999999999777766655568999999999999999999999999 9
Q ss_pred cccCCCCCcEEEc-cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 78 LHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 78 vHrDIKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~ 227 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCccccccc---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999997 7899999999999765443 3345678999999999875 58999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+......+...... +..+ .......++++.+||.+||..||.+|||+.++|
T Consensus 228 pf~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 228 PYSECQNAAQIYRRVTS-GVKP-------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp TTTTCSSHHHHHHHHTT-TCCC-------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCcCcHHHHHHHHhc-cCCc-------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 99886555444333221 1111 111235678899999999999999999999999
Q ss_pred hccccCC
Q 009654 237 ASEYFST 243 (529)
Q Consensus 237 ~h~~f~~ 243 (529)
+||||+.
T Consensus 282 ~h~~f~~ 288 (290)
T 1t4h_A 282 NHAFFQE 288 (290)
T ss_dssp TSGGGC-
T ss_pred hCccccc
Confidence 9999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.04 Aligned_cols=214 Identities=27% Similarity=0.392 Sum_probs=178.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..+......+++.++..++.||+.||.|||++||+|||
T Consensus 53 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 130 (276)
T 2yex_A 53 KKEICINKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130 (276)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhcCCCCceeeeeEEEc--CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 589999999999999999999987 578999999999877776666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
|||+|||++.++.+||+|||++....... .......++|+.|+|||++.+...++.++|||||||++|+|++|..||.+
T Consensus 131 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 210 (276)
T 2yex_A 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (276)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred CChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999997654322 12234567899999999998755457899999999999999999999987
Q ss_pred CCHHH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 161 RTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 161 ~~~~~-~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
..... .+..+...... ...+..+++.+.+||.+||+.||.+|||+.++|+||
T Consensus 211 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 211 PSDSCQEYSDWKEKKTY---------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp SCTTSHHHHHHHTTCTT---------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CchHHHHHHHhhhcccc---------------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 65432 22222221000 011346789999999999999999999999999999
Q ss_pred ccCCC
Q 009654 240 YFSTK 244 (529)
Q Consensus 240 ~f~~~ 244 (529)
||+..
T Consensus 264 ~~~~~ 268 (276)
T 2yex_A 264 WYNKP 268 (276)
T ss_dssp TTTCC
T ss_pred cccCh
Confidence 99853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.64 Aligned_cols=208 Identities=30% Similarity=0.455 Sum_probs=179.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.++++|+||||+++++++.+ ...+|+||||++++.+..+......+++..+..++.||+.||.|||++||+|||
T Consensus 62 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 139 (284)
T 2vgo_A 62 RREIEIQSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139 (284)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HHHHHHHhcCCCCCEeeEEEEEEc--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 579999999999999999999987 578999999999866655544455799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 140 l~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 140 IKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECSSS---CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCHHHEEEcCCCCEEEecccccccCccc---ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999998765432 2345678999999999976 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+....+....... ...++..+++||.+||..||.+|||+.++|+||||
T Consensus 216 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 216 SHTETHRRIVNVDLKF-----------------------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp SHHHHHHHHHTTCCCC-----------------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred CHhHHHHHHhccccCC-----------------------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 8887777765421110 13578899999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
+..
T Consensus 267 ~~~ 269 (284)
T 2vgo_A 267 KAN 269 (284)
T ss_dssp HHH
T ss_pred Hhh
Confidence 853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.97 Aligned_cols=212 Identities=26% Similarity=0.427 Sum_probs=179.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+||||++++.+..++.....+++.++..++.||+.||.|||++||+|||
T Consensus 56 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 133 (283)
T 3bhy_A 56 EREVNILREIRHPNIITLHDIFEN--KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFD 133 (283)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCCCCCeeehhheecC--CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 589999999999999999999987 578999999999876666555556899999999999999999999999999999
Q ss_pred CCCCcEEEccCC----cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 82 IKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 82 IKp~NILl~~~g----~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||+|||++.++ .+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 134 l~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p 210 (283)
T 3bhy_A 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 210 (283)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CChHHEEEecCCCCCCceEEEecccceeccCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCC
Confidence 999999998877 79999999998765432 3345678999999999976 4589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+.......+ ...+..+++.+.+||.+||..||.+|||+.++|+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 211 FLGETKQETLTNISAVNYDFD-------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcchHHHHHHhHhcccCCc-------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 999988888877755322222 2334578899999999999999999999999999
Q ss_pred ccccCC
Q 009654 238 SEYFST 243 (529)
Q Consensus 238 h~~f~~ 243 (529)
||||+.
T Consensus 266 h~~~~~ 271 (283)
T 3bhy_A 266 HSWIKA 271 (283)
T ss_dssp CHHHHH
T ss_pred CHHHHH
Confidence 999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=342.56 Aligned_cols=236 Identities=24% Similarity=0.425 Sum_probs=187.7
Q ss_pred HHHHHHHHhCC--------CCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD--------HPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLE 70 (529)
Q Consensus 2 ~rEi~iL~~L~--------HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~ 70 (529)
.+|+.+|+.|. ||||++++++|... ....+|||||||.++++..+.... ..+++.+++.++.||+.||.
T Consensus 81 ~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 160 (397)
T 1wak_A 81 LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160 (397)
T ss_dssp HHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence 58999999995 88899999998732 246899999999998888776443 57999999999999999999
Q ss_pred HHHHC-CCcccCCCCCcEEEccCC-------------------------------------------------cEEEecc
Q 009654 71 HCHSR-GVLHRDIKGSNLLVNNEG-------------------------------------------------VLKLADF 100 (529)
Q Consensus 71 ~LH~~-gIvHrDIKp~NILl~~~g-------------------------------------------------~vKl~DF 100 (529)
|||++ ||+||||||+||||+.++ .+||+||
T Consensus 161 ~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 240 (397)
T 1wak_A 161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240 (397)
T ss_dssp HHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCG
T ss_pred HHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccc
Confidence 99999 999999999999998775 7999999
Q ss_pred ccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHHHc
Q 009654 101 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLC 174 (529)
Q Consensus 101 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~------~~~~~~~I~~~~ 174 (529)
|++...... ....++|+.|+|||++.+. .|+.++||||||||||+|++|.+||.+.+ ..+.+..+...+
T Consensus 241 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 315 (397)
T 1wak_A 241 GNACWVHKH----FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315 (397)
T ss_dssp GGCEETTBC----SCSCCSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH
T ss_pred ccccccccc----CccCCCCCcccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc
Confidence 999876532 3556889999999999874 58999999999999999999999998765 677888999999
Q ss_pred CCCCchhhhccCCCcccc--------CCCCCCCc--chhhhh---ccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 175 GSPPDDYWKKSKLPHATL--------FKPQQPYD--SSLRET---FKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 175 g~p~~~~~~~~~l~~~~~--------~~~~~~~~--~~l~~~---~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
|.++...|.......... .....++. ..+... ...++..+++||.+||+.||.+|||+.++|+||||
T Consensus 316 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred CCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 998876554333211000 00000000 001111 12345678999999999999999999999999999
Q ss_pred C
Q 009654 242 S 242 (529)
Q Consensus 242 ~ 242 (529)
+
T Consensus 396 ~ 396 (397)
T 1wak_A 396 N 396 (397)
T ss_dssp G
T ss_pred c
Confidence 6
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.58 Aligned_cols=212 Identities=25% Similarity=0.440 Sum_probs=178.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|+.++|||||+++++|.+ ...+|||||||+|+.+..++.. ...+++..++.|+.||+.||+|||++||+|
T Consensus 232 ~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvH 309 (576)
T 2acx_A 232 LNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309 (576)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHcCCCCEeeEEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 579999999999999999999988 5789999999998766654433 235999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||||+.+|.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.
T Consensus 310 rDLKPeNILld~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~ 386 (576)
T 2acx_A 310 RDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQ 386 (576)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECCTT--CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred cCCchheEEEeCCCCeEEEecccceecccC--ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999999876543 23456689999999999976 458999999999999999999999998
Q ss_pred CCCH----HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----
Q 009654 160 GRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----- 230 (529)
Q Consensus 160 g~~~----~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~----- 230 (529)
+.+. .+....+... +.. + ...+++++++||.+||+.||.+||
T Consensus 387 ~~~~~~~~~~i~~~i~~~----~~~------------------~-------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~ 437 (576)
T 2acx_A 387 QRKKKIKREEVERLVKEV----PEE------------------Y-------SERFSPQARSLCSQLLCKDPAERLGCRGG 437 (576)
T ss_dssp CSSSCCCHHHHHHHHHHC----CCC------------------C-------CTTSCHHHHHHHHHHTCSSGGGSTTCSSS
T ss_pred ccccchhHHHHHHHhhcc----ccc------------------C-------CccCCHHHHHHHHHhccCCHHHcCCCCCC
Confidence 7642 3333333321 100 0 135789999999999999999999
Q ss_pred CHHHHHhccccCCCCCC
Q 009654 231 TASAALASEYFSTKPYA 247 (529)
Q Consensus 231 ta~e~L~h~~f~~~~~~ 247 (529)
++.++++||||+...|.
T Consensus 438 sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 438 SAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHHHHHTSGGGTTCCHH
T ss_pred CHHHHHhChhhccCCHH
Confidence 89999999999976553
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=324.81 Aligned_cols=214 Identities=30% Similarity=0.475 Sum_probs=183.9
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+++. ||||+++++++.+ ...+|+||||++++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 71 ~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 148 (298)
T 1phk_A 71 LKEVDILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR 148 (298)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhcCCCCEeeeeeeecc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 57999999995 9999999999987 57899999999986666555555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc-----CCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||+|||++.++.+||+|||++....... ......+|+.|+|||++. ....++.++|||||||++|+|++|.
T Consensus 149 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCcceEEEcCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 999999999999999999999998765432 345567899999999985 2346889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+..+....+......++. ..+..++..+.+||.+||+.||.+|||+.++
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 227 PPFWHRKQMLMLRMIMSGNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCcCccHHHHHHHHhcCCcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 999999888888777663322211 1234688999999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|+||||+..
T Consensus 282 l~h~~~~~~ 290 (298)
T 1phk_A 282 LAHPFFQQY 290 (298)
T ss_dssp TTSGGGCTT
T ss_pred HhChHhhhc
Confidence 999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=324.96 Aligned_cols=217 Identities=29% Similarity=0.449 Sum_probs=180.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+.....+|||||||++++...+. .....+++.++..++.||+.||.|||++||+|
T Consensus 53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H 132 (305)
T 2wtk_C 53 VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132 (305)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 35899999999999999999998765567899999999998666544 24567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCC-CCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~-~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+|||++.++.+||+|||++....... ........+|+.|+|||++.+.. .++.++|||||||++|+|++|..|
T Consensus 133 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (305)
T 2wtk_C 133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212 (305)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765321 12234557899999999997633 347799999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+...... ....+++.+.+||.+||..||.+|||+.++|+
T Consensus 213 ~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 213 FEGDNIYKLFENIGKGSYA-----------------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCCSSHHHHHHHHHHCCCC-----------------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCchHHHHHHHHhcCCCC-----------------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9998888877777552111 01357889999999999999999999999999
Q ss_pred ccccCCCCC
Q 009654 238 SEYFSTKPY 246 (529)
Q Consensus 238 h~~f~~~~~ 246 (529)
||||+....
T Consensus 264 ~~~~~~~~~ 272 (305)
T 2wtk_C 264 HSWFRKKHP 272 (305)
T ss_dssp SHHHHSCCC
T ss_pred CcccccCCC
Confidence 999987544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.39 Aligned_cols=205 Identities=27% Similarity=0.378 Sum_probs=169.1
Q ss_pred HHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
+|+..+.++ +||||+++++++.+ ...+|||||||.+++...+......+++..+..++.||+.||.|||++||+|||
T Consensus 105 ~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (311)
T 3p1a_A 105 AEVGSHEKVGQHPCCVRLEQAWEE--GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182 (311)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhcCCCcEEEEEEEEEe--CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence 455555555 99999999999987 678999999998888777766666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.++.+||+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.
T Consensus 183 ikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 183 VKPANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp CSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred CCHHHEEECCCCCEEEccceeeeecccCC--CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999998765432 3345678999999999986 5899999999999999999998777654
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
... ..+.. +..+ ......+++++.+||.+||+.||.+|||+.++|+||||
T Consensus 259 ~~~---~~~~~--~~~~-------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 259 EGW---QQLRQ--GYLP-------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp HHH---HHHTT--TCCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred cHH---HHHhc--cCCC-------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 322 22211 1111 12235689999999999999999999999999999999
Q ss_pred CC
Q 009654 242 ST 243 (529)
Q Consensus 242 ~~ 243 (529)
++
T Consensus 309 ~~ 310 (311)
T 3p1a_A 309 RQ 310 (311)
T ss_dssp SC
T ss_pred cC
Confidence 75
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=322.26 Aligned_cols=210 Identities=30% Similarity=0.463 Sum_probs=172.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++||||+++++++.+ ...+|+||||++++.+..++.....+++.++..++.||+.||.|||++||+|+|
T Consensus 59 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 136 (276)
T 2h6d_A 59 KREIQNLKLFRHPHIIKLYQVIST--PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRD 136 (276)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCC
T ss_pred HHHHHHHhcCCCCCEeEEEEEEec--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 579999999999999999999987 578999999999866665554556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.
T Consensus 137 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 137 LKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChhhEEECCCCCEEEeecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765432 2345578999999999987554578999999999999999999999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+..+....... ...++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 215 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 215 HVPTLFKKIRGGVFYI-----------------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp SHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred cHHHHHHHhhcCcccC-----------------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 8877777765421111 12467889999999999999999999999999999
Q ss_pred CCC
Q 009654 242 STK 244 (529)
Q Consensus 242 ~~~ 244 (529)
+..
T Consensus 266 ~~~ 268 (276)
T 2h6d_A 266 KQD 268 (276)
T ss_dssp HTT
T ss_pred ccC
Confidence 753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.36 Aligned_cols=203 Identities=24% Similarity=0.364 Sum_probs=172.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCC-chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~-ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+||||++++++|.+ ...+|+||||+.++ .+..+......+++..+..++.||+.||.|||++||+||
T Consensus 77 ~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~ 154 (335)
T 3dls_A 77 TLEIAILSRVEHANIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR 154 (335)
T ss_dssp EHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHhCCCCCEeeEEEEEee--CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEe
Confidence 479999999999999999999987 57899999999764 556555566689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.++.+||+|||++....... .....+||+.|+|||++.+...++.++||||||||+|+|++|.+||.+
T Consensus 155 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 155 DIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccCHHHEEEcCCCcEEEeecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 999999999999999999999998765432 344568999999999998765558899999999999999999999965
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
... +.. .. ......+++++.+||.+||..||.+|||+.++|+|||
T Consensus 233 ~~~------~~~---~~--------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 233 LEE------TVE---AA--------------------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp GGG------GTT---TC--------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred HHH------HHh---hc--------------------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 221 000 00 0001247899999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|+.
T Consensus 278 ~~~ 280 (335)
T 3dls_A 278 VTQ 280 (335)
T ss_dssp TTC
T ss_pred ccC
Confidence 985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=363.74 Aligned_cols=213 Identities=25% Similarity=0.376 Sum_probs=186.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|..+ +||||++++++|.+ ...+|||||||+|+.|..++.....|++.+++.|+.||+.||+|||++||+||
T Consensus 389 ~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHr 466 (674)
T 3pfq_A 389 MVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466 (674)
T ss_dssp HHHHHHHTCTTCCTTBCCEEEECBC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECC
T ss_pred HHHHHHHHhccCCCeEEEEEEEEEe--CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence 4789999988 79999999999987 57899999999997777666555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+
T Consensus 467 DLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp CCCSTTEEECSSSCEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCChhhEEEcCCCcEEEeecceeeccccCC-cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998643322 23456789999999999976 4699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH-----HHH
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAA 235 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta-----~e~ 235 (529)
.+..+.+..|......++ ..+++++++||.+||..||.+|+++ .++
T Consensus 545 ~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei 595 (674)
T 3pfq_A 545 EDEDELFQSIMEHNVAYP-----------------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595 (674)
T ss_dssp SSHHHHHHHHHSSCCCCC-----------------------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHH
T ss_pred CCHHHHHHHHHhCCCCCC-----------------------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHH
Confidence 999999998866221111 3578999999999999999999997 999
Q ss_pred HhccccCCCCCC
Q 009654 236 LASEYFSTKPYA 247 (529)
Q Consensus 236 L~h~~f~~~~~~ 247 (529)
++||||+...|.
T Consensus 596 ~~h~ff~~i~w~ 607 (674)
T 3pfq_A 596 KEHAFFRYIDWE 607 (674)
T ss_dssp HSSGGGSSCCHH
T ss_pred hcCccccCCCHH
Confidence 999999976653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.63 Aligned_cols=236 Identities=25% Similarity=0.463 Sum_probs=186.0
Q ss_pred HHHHHHHHhCC-CCC-----ccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHH-
Q 009654 2 AREILILRRLD-HPN-----IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCH- 73 (529)
Q Consensus 2 ~rEi~iL~~L~-Hpn-----Ivkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH- 73 (529)
.+|+.+|+.+. |+| |+++++++.. ...+|||||||++++...+.... ..+++..++.++.||+.||.|||
T Consensus 98 ~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 175 (382)
T 2vx3_A 98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175 (382)
T ss_dssp HHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHhcccccceeEEEeeeeecc--CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc
Confidence 46889999884 554 9999999988 57899999999998777665433 56999999999999999999999
Q ss_pred -HCCCcccCCCCCcEEEc--cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 74 -SRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 74 -~~gIvHrDIKp~NILl~--~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
+.||+||||||+||||+ .++.+||+|||++..... .....++|+.|+|||++.+. .|+.++||||||||+|+
T Consensus 176 ~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~e 250 (382)
T 2vx3_A 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVE 250 (382)
T ss_dssp TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHH
T ss_pred CCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc----ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHH
Confidence 57999999999999995 467899999999987654 23456889999999999874 59999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC--------Ccccc-----CCC----CCCCcchhhhhcc-----
Q 009654 151 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL--------PHATL-----FKP----QQPYDSSLRETFK----- 208 (529)
Q Consensus 151 lltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l--------~~~~~-----~~~----~~~~~~~l~~~~~----- 208 (529)
|++|.+||.+.+..+++..|...++.++...+..... +.... ... ..+....+...+.
T Consensus 251 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 330 (382)
T 2vx3_A 251 MHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330 (382)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccC
Confidence 9999999999999999999999999988766543210 00000 000 0000111111110
Q ss_pred -------------CCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 209 -------------DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 209 -------------~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
..++++++||.+||++||.+|||+.++|+||||+..
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp GGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 011478999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=324.18 Aligned_cols=212 Identities=28% Similarity=0.421 Sum_probs=182.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.++||||+++++++.+ ...+|+|||||+++.+..+......+++.++..++.||+.||.|||++||+|||
T Consensus 63 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 140 (294)
T 2rku_A 63 SMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 140 (294)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCEeeeeeeecc--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 579999999999999999999987 578999999999877766655556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 141 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CChHhEEEcCCCCEEEEeccCceecccCc-cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765322 23345678999999999976 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+..+....... ...+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 219 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 219 CLKETYLRIKKNEYSI-----------------------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp SHHHHHHHHHTTCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred CHHHHHHHHhhccCCC-----------------------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 8877776664421110 13578889999999999999999999999999999
Q ss_pred CCCCC
Q 009654 242 STKPY 246 (529)
Q Consensus 242 ~~~~~ 246 (529)
+....
T Consensus 270 ~~~~~ 274 (294)
T 2rku_A 270 TSGYI 274 (294)
T ss_dssp HTSCC
T ss_pred ecCCc
Confidence 87654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.59 Aligned_cols=213 Identities=24% Similarity=0.382 Sum_probs=179.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|++++||||++++++|.+ ...+|||||||+|+.+..++.. ...+++..+..|+.||+.||.|||++||
T Consensus 233 ~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gI 310 (543)
T 3c4z_A 233 MVEKKILAKVHSRFIVSLAYAFET--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310 (543)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHhcCCCCEeeEEEEEee--CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCC
Confidence 579999999999999999999988 5789999999998766644422 3469999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+|
T Consensus 311 vHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~P 388 (543)
T 3c4z_A 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP 388 (543)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCChHHEEEeCCCCEEEeecceeeeccCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCC
Confidence 999999999999999999999999998765432 22344689999999999987 5699999999999999999999999
Q ss_pred CCCCC----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC--
Q 009654 158 LQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-- 231 (529)
Q Consensus 158 f~g~~----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-- 231 (529)
|.+.+ ..+....|....... ...+++++++||.+||+.||.+||+
T Consensus 389 F~~~~~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 389 FRARGEKVENKELKQRVLEQAVTY-----------------------------PDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp SCCTTCCCCHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred CCCCccchhHHHHHHHHhhcccCC-----------------------------CcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 98763 344555554421111 1357899999999999999999995
Q ss_pred ---HHHHHhccccCCCCCC
Q 009654 232 ---ASAALASEYFSTKPYA 247 (529)
Q Consensus 232 ---a~e~L~h~~f~~~~~~ 247 (529)
+.++++||||+...|.
T Consensus 440 ~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 440 DGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp TTBSHHHHTSGGGTTCCHH
T ss_pred ccCHHHHHcCccccCCCHH
Confidence 5899999999986653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.69 Aligned_cols=214 Identities=26% Similarity=0.440 Sum_probs=175.8
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.| +||||+++++++.. ...+|||||||+++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 106 ~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 183 (355)
T 1vzo_A 106 RTERQVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183 (355)
T ss_dssp CCHHHHHHHHHTCTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHccCCCceeEEEEEEee--CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 4699999999 79999999999988 57899999999987776655555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||+||||+.++.+||+|||+++.+...........+||+.|+|||++.+. ..++.++||||||||||+|++|.+||.
T Consensus 184 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 9999999999999999999999987654333334456899999999999763 457899999999999999999999997
Q ss_pred CCCH----HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----
Q 009654 160 GRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----- 230 (529)
Q Consensus 160 g~~~----~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~----- 230 (529)
.... ......+.. ..++ ....++..+.+||.+||..||.+||
T Consensus 264 ~~~~~~~~~~~~~~~~~--~~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~ 314 (355)
T 1vzo_A 264 VDGEKNSQAEISRRILK--SEPP---------------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPR 314 (355)
T ss_dssp CTTSCCCHHHHHHHHHH--CCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred cCCccchHHHHHHHHhc--cCCC---------------------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCC
Confidence 5432 233333322 1110 1135788999999999999999999
Q ss_pred CHHHHHhccccCCCCC
Q 009654 231 TASAALASEYFSTKPY 246 (529)
Q Consensus 231 ta~e~L~h~~f~~~~~ 246 (529)
|+.++|+||||....|
T Consensus 315 s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 315 DADEIKEHLFFQKINW 330 (355)
T ss_dssp THHHHHTSGGGTTCCH
T ss_pred CHHHHHcCcchhcCCh
Confidence 9999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.53 Aligned_cols=211 Identities=28% Similarity=0.424 Sum_probs=182.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+||||+++++++.+ ...+|||||||+++.+..+......+++.++..++.||+.||.|||++||+|||
T Consensus 89 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~d 166 (335)
T 2owb_A 89 SMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166 (335)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Confidence 579999999999999999999988 578999999999877766655556899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++....... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 167 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCchhEEEcCCCCEEEeeccCceecccCc-ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 99999999999999999999998765322 23345678999999999976 45899999999999999999999999998
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
...+.+..+....... ...+++.+.+||.+||..||.+|||+.++|+|+||
T Consensus 245 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 245 CLKETYLRIKKNEYSI-----------------------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp SHHHHHHHHHHTCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred CHHHHHHHHhcCCCCC-----------------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 8877777665521111 12578889999999999999999999999999999
Q ss_pred CCCC
Q 009654 242 STKP 245 (529)
Q Consensus 242 ~~~~ 245 (529)
+...
T Consensus 296 ~~~~ 299 (335)
T 2owb_A 296 TSGY 299 (335)
T ss_dssp HTSC
T ss_pred cCCC
Confidence 8754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.92 Aligned_cols=212 Identities=28% Similarity=0.464 Sum_probs=174.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++... .+|+|||||+++.+..+......+++.++..++.||+.||.|||++||+|||
T Consensus 63 ~~E~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 139 (322)
T 2ycf_A 63 ETEIEILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139 (322)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCCCCCCceEeeEEcCC---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 5799999999999999999998763 4899999999866665555667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCc---EEEeccccccccCCCCCCCccccccccccCCccccc--CCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 82 IKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 82 IKp~NILl~~~g~---vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||+||||+.++. +||+|||++...... ......++|+.|+|||++. +...|+.++||||||||+|+|++|.+
T Consensus 140 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 140 LKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp CSGGGEEESSSSSSCCEEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEEecCCCCCeEEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999987654 999999999876542 1233457899999999984 34568999999999999999999999
Q ss_pred CCCCCCHH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 157 ILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 157 pf~g~~~~-~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
||.+.... .....+......+ ....+..+++.+.+||.+||..||.+|||+.++
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~ 272 (322)
T 2ycf_A 218 PFSEHRTQVSLKDQITSGKYNF-------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272 (322)
T ss_dssp SSCSTTCSSCHHHHHHHTCCCC-------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCcccchHHHHHHHHHhCcccc-------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 99865433 2223332211111 123345789999999999999999999999999
Q ss_pred HhccccCC
Q 009654 236 LASEYFST 243 (529)
Q Consensus 236 L~h~~f~~ 243 (529)
|+||||+.
T Consensus 273 l~h~~~~~ 280 (322)
T 2ycf_A 273 LRHPWLQD 280 (322)
T ss_dssp HTSGGGCC
T ss_pred hhCcCcCC
Confidence 99999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.65 Aligned_cols=210 Identities=33% Similarity=0.497 Sum_probs=152.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++++++||||+++++++.+ ...+|+|||||+++.+..+ ......+++.++..++.||+.||.|||++||+||
T Consensus 59 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 136 (278)
T 3cok_A 59 QNEVKIHCQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136 (278)
T ss_dssp HHHHHHHTTBCCTTBCCEEEEEEC--SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHhCCCCCeEeEEEEEcc--CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 579999999999999999999988 5789999999998666544 4444679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 137 dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPH-EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp SCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEEcCCCCEEEEeecceeeccCCC-CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765332 12234578999999999876 4589999999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+..+.. .. + .....++.++.+||.+||..||.+|||+.++|+|||
T Consensus 215 ~~~~~~~~~~~~----------------------~~--~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 215 DTVKNTLNKVVL----------------------AD--Y-----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp CSCC-----CCS----------------------SC--C-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred hhHHHHHHHHhh----------------------cc--c-----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 654333322210 00 0 011347889999999999999999999999999999
Q ss_pred cCCC
Q 009654 241 FSTK 244 (529)
Q Consensus 241 f~~~ 244 (529)
|...
T Consensus 266 ~~~~ 269 (278)
T 3cok_A 266 MSRN 269 (278)
T ss_dssp TC--
T ss_pred ccCC
Confidence 9853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=327.98 Aligned_cols=228 Identities=24% Similarity=0.412 Sum_probs=181.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh------cCC--CCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL------SCP--DIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~------~~~--~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..+ ... ...+++..+..++.||+.||.|||
T Consensus 91 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 168 (348)
T 2pml_X 91 KNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH 168 (348)
T ss_dssp HHHHHHHTTCCCTTBCCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 589999999999999999999988 5789999999999666554 433 568999999999999999999999
Q ss_pred H-CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCC-cchhhhhhHHHHHH
Q 009654 74 S-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP-SVDLWSVGCVFAEL 151 (529)
Q Consensus 74 ~-~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~-~~DIWSlG~il~el 151 (529)
+ +||+||||||+|||++.++.+||+|||++...... ......+|+.|+|||++.+...++. ++||||||||+|+|
T Consensus 169 ~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 245 (348)
T 2pml_X 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245 (348)
T ss_dssp HTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred ccCCEeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence 9 99999999999999999999999999999876543 3445678999999999987545666 99999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 ltG~~pf~g~~~-~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++|.+||.+.+. .+.+..+.......+... .....+.. ..........++.++.+||.+||+.||.+||
T Consensus 246 ~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 315 (348)
T 2pml_X 246 FYNVVPFSLKISLVELFNNIRTKNIEYPLDR--------NHFLYPLT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315 (348)
T ss_dssp HHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS--------SSSTTTTC--C--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred HhCCCCCCCCCcHHHHHHHHhccCcCCccch--------hhhhcccc--ccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence 999999998877 666666644221111100 00000000 0011222357899999999999999999999
Q ss_pred CHHHHHhccccCCC
Q 009654 231 TASAALASEYFSTK 244 (529)
Q Consensus 231 ta~e~L~h~~f~~~ 244 (529)
|+.++|+||||+..
T Consensus 316 s~~e~l~hp~f~~~ 329 (348)
T 2pml_X 316 TSEDALKHEWLADT 329 (348)
T ss_dssp CHHHHHTSGGGTTC
T ss_pred CHHHHhcCccccCC
Confidence 99999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.02 Aligned_cols=235 Identities=23% Similarity=0.428 Sum_probs=188.9
Q ss_pred HHHHHHHHhCCCCC------ccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPN------IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~Hpn------Ivkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|++|.|+| |+.+++++.. ...+|||||||.++++..+.... ..+++.++..++.||+.||.|||+
T Consensus 64 ~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~ 141 (355)
T 2eu9_A 64 RLEINVLKKIKEKDKENKFLCVLMSDWFNF--HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141 (355)
T ss_dssp HHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhcCCCCceeEEEeeeeeee--CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57999999998776 8999999887 57899999999888888765443 579999999999999999999999
Q ss_pred CCCcccCCCCCcEEE-------------------ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCC
Q 009654 75 RGVLHRDIKGSNLLV-------------------NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 135 (529)
Q Consensus 75 ~gIvHrDIKp~NILl-------------------~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y 135 (529)
+||+||||||+|||| +.++.+||+|||++...... ....+||+.|+|||++.+ ..|
T Consensus 142 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~ 216 (355)
T 2eu9_A 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGW 216 (355)
T ss_dssp TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-CCC
T ss_pred CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-CCC
Confidence 999999999999999 56788999999999865432 345688999999999976 468
Q ss_pred CCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcc------hhhh----
Q 009654 136 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS------SLRE---- 205 (529)
Q Consensus 136 ~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~------~l~~---- 205 (529)
+.++||||||||+|+|++|.+||.+.+..+.+..+.+.++.++...+........ .+.....+.. .+..
T Consensus 217 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 295 (355)
T 2eu9_A 217 AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKY-FYKGGLVWDENSSDGRYVKENCKP 295 (355)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGG-EETTEECCCTTSHHHHHHHHHCCC
T ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhh-hcccccccccccchhccccccCCc
Confidence 9999999999999999999999999999999999999999888766544321100 0000000000 0000
Q ss_pred ------hccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 206 ------TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 206 ------~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
.....+..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 296 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred ccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 001235678999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=321.67 Aligned_cols=215 Identities=27% Similarity=0.397 Sum_probs=174.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.++++|+||||+++++++.+ ...+|+|||||+++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 58 ~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 135 (294)
T 4eqm_A 58 FEREVHNSSQLSHQNIVSMIDVDEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHR 135 (294)
T ss_dssp HHHHHHHHTTCCBTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhcCCCCCCceEEEeeee--CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 3589999999999999999999987 57899999999997777666555689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 136 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp CCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765543333445679999999999987 4589999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+...++... ..+. ........+|+.+.++|.+||..||.+||+..+.|.+.|
T Consensus 215 ~~~~~~~~~~~~~--~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 215 ETAVSIAIKHIQD--SVPN----------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp SCHHHHHHHHHSS--CCCC----------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CChHHHHHHHhhc--cCCC----------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 8887766554331 1110 112233578999999999999999999997777777777
Q ss_pred cC
Q 009654 241 FS 242 (529)
Q Consensus 241 f~ 242 (529)
..
T Consensus 271 ~~ 272 (294)
T 4eqm_A 271 SS 272 (294)
T ss_dssp HT
T ss_pred HH
Confidence 65
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.18 Aligned_cols=216 Identities=21% Similarity=0.354 Sum_probs=175.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCC--eEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSC--SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~--~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.++++|+||||+++++++...... .+|||||||+++.+..++.....+++.++..++.||+.||.|||++||+|
T Consensus 60 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 139 (311)
T 3ork_A 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIH 139 (311)
T ss_dssp HHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCc
Confidence 5899999999999999999998764322 45999999998777766655568999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+||||+.++.+||+|||++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 140 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p 218 (311)
T 3ork_A 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPP 218 (311)
T ss_dssp CCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999986654321 12234578999999999987 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+......++ ......++.++.+||.+||+.||.+||++.++|.
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 219 FTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCSSHHHHHHHHHHCCCCCH-------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCChHHHHHHHhcCCCCCc-------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 999988887776655322221 2223568999999999999999999999999999
Q ss_pred ccccCC
Q 009654 238 SEYFST 243 (529)
Q Consensus 238 h~~f~~ 243 (529)
|+|+..
T Consensus 274 ~~l~~~ 279 (311)
T 3ork_A 274 ADLVRV 279 (311)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.26 Aligned_cols=223 Identities=25% Similarity=0.405 Sum_probs=168.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--------~~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
+.+|+.+|++|+||||+++++++.. ...+|+||||++++.+..++. ....+++..+..++.||+.||.||
T Consensus 60 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 137 (303)
T 2vwi_A 60 LLKEIQAMSQCHHPNIVSYYTSFVV--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137 (303)
T ss_dssp ------CCCCCCCTTBCCEEEEEES--SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCCEeeEEEEEee--cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3579999999999999999999988 568999999998866654432 345699999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC----CCccccccccccCCcccccCCCCCCCcchhhhhhHHH
Q 009654 73 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 148 (529)
Q Consensus 73 H~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il 148 (529)
|++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+...++.++|||||||++
T Consensus 138 H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 217 (303)
T 2vwi_A 138 HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217 (303)
T ss_dssp HHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHH
T ss_pred HhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHH
Confidence 999999999999999999999999999999976643211 1223457899999999987544689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 149 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 149 ~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
|+|++|.+||.+......+..... +.++.. ............++.++.+||.+||+.||.+
T Consensus 218 ~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 278 (303)
T 2vwi_A 218 IELATGAAPYHKYPPMKVLMLTLQ--NDPPSL-----------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 278 (303)
T ss_dssp HHHHHSSCTTTTSCGGGHHHHHHT--SSCCCT-----------------TC-----CCCCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCccCchhhHHHHHhc--cCCCcc-----------------ccccccchhhhhhhHHHHHHHHHHccCChhh
Confidence 999999999998776655544332 111100 0000011233578899999999999999999
Q ss_pred CcCHHHHHhccccCCC
Q 009654 229 RATASAALASEYFSTK 244 (529)
Q Consensus 229 R~ta~e~L~h~~f~~~ 244 (529)
|||+.++|+||||+..
T Consensus 279 Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 279 RPTAAELLRHKFFQKA 294 (303)
T ss_dssp SCCHHHHHTSTTC---
T ss_pred CcCHHHHhhChhhhcC
Confidence 9999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.76 Aligned_cols=234 Identities=23% Similarity=0.412 Sum_probs=187.0
Q ss_pred HHHHHHHHhCCCCC------ccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPN------IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~Hpn------Ivkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+.|.|+| |+++++++.+ ...+|||||||.+++...+.... ..+++.++..++.||+.||+|||+
T Consensus 59 ~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 136 (339)
T 1z57_A 59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136 (339)
T ss_dssp HHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhcCCCCceeeEeeeccccc--CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 57999999997665 9999999988 57999999999777777665432 469999999999999999999999
Q ss_pred CCCcccCCCCCcEEEcc-------------------CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCC
Q 009654 75 RGVLHRDIKGSNLLVNN-------------------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 135 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~-------------------~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y 135 (529)
+||+||||||+||||+. ++.+||+|||++...... ....++|+.|+|||++.+ ..|
T Consensus 137 ~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~ 211 (339)
T 1z57_A 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGW 211 (339)
T ss_dssp TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCC
T ss_pred CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCC
Confidence 99999999999999987 667999999999865432 345688999999999976 458
Q ss_pred CCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcc------hh------
Q 009654 136 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS------SL------ 203 (529)
Q Consensus 136 ~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~------~l------ 203 (529)
+.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...+........ .......+.. .+
T Consensus 212 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 290 (339)
T 1z57_A 212 SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY-FHHDRLDWDEHSSAGRYVSRACKP 290 (339)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGG-EETTEECCCTTSHHHHHHHHHCCC
T ss_pred CcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhH-HhhccccccccccccchhhhcCcc
Confidence 9999999999999999999999999999999999999999888766554321100 0000000000 00
Q ss_pred ----hhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 204 ----RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 204 ----~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
.......++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 0001123677899999999999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=320.72 Aligned_cols=210 Identities=22% Similarity=0.360 Sum_probs=162.5
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCc
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVL 78 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~---~~~~~l~e~~~~~i~~Qll~gL~~LH~~-gIv 78 (529)
+|..+++.++||||+++++++.+ ...+|+|||||++++...+. .....+++..+..++.||+.||.|||++ ||+
T Consensus 55 ~~~~~~~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~ 132 (290)
T 3fme_A 55 DLDISMRTVDCPFTVTFYGALFR--EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132 (290)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEC--SSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCC
T ss_pred HHHHHHHhCCCCeEEEEeeeeec--cCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Confidence 34455788899999999999987 56899999999987654432 3566899999999999999999999998 999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccc---cCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL---LGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l---~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||||+|||++.++.+||+|||++....... ......+|+.|+|||++ .....++.++|||||||++|+|++|.
T Consensus 133 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 210 (290)
T 3fme_A 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210 (290)
T ss_dssp CCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTS
T ss_pred cCCCCHHHEEECCCCCEEEeecCCcccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999998765432 23345789999999997 34456899999999999999999999
Q ss_pred CCCCC-CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 156 PILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 156 ~pf~g-~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
+||.+ ......+..+....... .....+++++.+||.+||..||.+|||+.+
T Consensus 211 ~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 263 (290)
T 3fme_A 211 FPYDSWGTPFQQLKQVVEEPSPQ---------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPE 263 (290)
T ss_dssp CSSCCCSCHHHHHHHHHHSCCCC---------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCccccCchHHHHHHHhccCCCC---------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence 99986 44445555444321110 001357889999999999999999999999
Q ss_pred HHhccccCC
Q 009654 235 ALASEYFST 243 (529)
Q Consensus 235 ~L~h~~f~~ 243 (529)
+|+||||+.
T Consensus 264 ~l~hp~f~~ 272 (290)
T 3fme_A 264 LMQHPFFTL 272 (290)
T ss_dssp HTTSHHHHH
T ss_pred HHhCccccc
Confidence 999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=335.12 Aligned_cols=213 Identities=26% Similarity=0.442 Sum_probs=167.9
Q ss_pred CHHHHHHHHhCC--CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~--HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++|. |||||++++++.. ...+|||||++.+++...+. ....+++.++..++.||+.||.|||++||+
T Consensus 101 ~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~E~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~iv 177 (390)
T 2zmd_A 101 YRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177 (390)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred HHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 358999999996 5999999999987 56899999965555555544 445899999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCC----------CCCCCcchhhhhhHH
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCV 147 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~----------~~y~~~~DIWSlG~i 147 (529)
||||||+||||+ ++.+||+|||++......... .....+||+.|+|||++.+. ..|+.++||||||||
T Consensus 178 HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi 256 (390)
T 2zmd_A 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256 (390)
T ss_dssp CCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred ecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence 999999999995 589999999999876543221 23456899999999999652 358999999999999
Q ss_pred HHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCC
Q 009654 148 FAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226 (529)
Q Consensus 148 l~elltG~~pf~g~~~-~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP 226 (529)
||+|++|.+||.+... ...+..+....... .+ ....+.++.+||.+||..||
T Consensus 257 l~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~--------------------~~-------~~~~~~~~~~li~~~L~~dP 309 (390)
T 2zmd_A 257 LYYMTYGKTPFQQIINQISKLHAIIDPNHEI--------------------EF-------PDIPEKDLQDVLKCCLKRDP 309 (390)
T ss_dssp HHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--------------------CC-------CCCSCHHHHHHHHHHTCSST
T ss_pred HHHHHHCCCcchhhhHHHHHHHHHhCccccC--------------------CC-------CccchHHHHHHHHHHcccCh
Confidence 9999999999987543 34444443211100 00 12347789999999999999
Q ss_pred CCCcCHHHHHhccccCCC
Q 009654 227 YKRATASAALASEYFSTK 244 (529)
Q Consensus 227 ~kR~ta~e~L~h~~f~~~ 244 (529)
.+|||+.++|+||||+..
T Consensus 310 ~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 310 KQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TTSCCHHHHHTSHHHHSC
T ss_pred hhCCCHHHHhhCcCcccc
Confidence 999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.49 Aligned_cols=211 Identities=29% Similarity=0.482 Sum_probs=179.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+||||++++.+.........+++.++..++.||+.||.|||++||+|||
T Consensus 69 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d 146 (287)
T 2wei_A 69 LREVELLKKLDHPNIMKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146 (287)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhccCCCccEEEEEEeC--CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 589999999999999999999987 578999999999866654443445799999999999999999999999999999
Q ss_pred CCCCcEEEccC---CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+|||++.+ +.+||+|||++...... .......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||
T Consensus 147 l~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~ 222 (287)
T 2wei_A 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF 222 (287)
T ss_dssp CCGGGEEESCSSTTCCEEECSTTGGGTBCCC--SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CChhhEEEecCCCcccEEEeccCcceeecCC--CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCC
Confidence 99999999764 46999999999876543 23345578999999999976 4899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......++ ...+..+++++.+||.+||..||.+|||+.++|+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 223 YGKNEYDILKRVETGKYAFD-------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCSSHHHHHHHHHHCCCCCC-------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHcCCCCCC-------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 99988888777765322111 12235689999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
|||+.
T Consensus 278 p~~~~ 282 (287)
T 2wei_A 278 PWIQK 282 (287)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=328.85 Aligned_cols=212 Identities=27% Similarity=0.446 Sum_probs=165.9
Q ss_pred HHHHHHHHhCCC--CCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDH--PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~H--pnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++|.| |||+++++++.+ ...+|||||++.+++...+. ....+++.++..++.||+.||.|||++||+|
T Consensus 55 ~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~iiH 131 (343)
T 3dbq_A 55 RNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 131 (343)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhhhhcCCceEEEeeeEee--CCEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 579999999976 999999999987 57899999976666655554 4568999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccC----------CCCCCCcchhhhhhHHH
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVF 148 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~----------~~~y~~~~DIWSlG~il 148 (529)
|||||+||||+ ++.+||+|||++......... .....+||+.|+|||++.+ ...|+.++||||||||+
T Consensus 132 rDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il 210 (343)
T 3dbq_A 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210 (343)
T ss_dssp CCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred CCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence 99999999996 688999999999876543221 2345689999999999853 24688999999999999
Q ss_pred HHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 149 AELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 149 ~elltG~~pf~g~~~-~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
|+|++|.+||.+... ...+..+....... ......+..+.+||.+||..||.
T Consensus 211 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~L~~dp~ 263 (343)
T 3dbq_A 211 YYMTYGKTPFQQIINQISKLHAIIDPNHEI---------------------------EFPDIPEKDLQDVLKCCLKRDPK 263 (343)
T ss_dssp HHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---------------------------CCCCCSCHHHHHHHHHHTCSSTT
T ss_pred HHHHhCCCcchhhhhHHHHHHHHhcCCccc---------------------------CCcccCCHHHHHHHHHHcCCChh
Confidence 999999999987533 33333332211100 00123567899999999999999
Q ss_pred CCcCHHHHHhccccCCC
Q 009654 228 KRATASAALASEYFSTK 244 (529)
Q Consensus 228 kR~ta~e~L~h~~f~~~ 244 (529)
+|||+.++|+||||+..
T Consensus 264 ~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 264 QRISIPELLAHPYVQIQ 280 (343)
T ss_dssp TSCCHHHHHTSHHHHSC
T ss_pred HCCCHHHHHhCcccccc
Confidence 99999999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.23 Aligned_cols=212 Identities=23% Similarity=0.363 Sum_probs=166.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCC----------------------------------------------------
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLS---------------------------------------------------- 28 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~---------------------------------------------------- 28 (529)
+.+|+.+|++|+|||||+++++|.+...
T Consensus 51 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (332)
T 3qd2_B 51 VMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130 (332)
T ss_dssp HHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------------
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCC
Confidence 3589999999999999999999865321
Q ss_pred ---CeEEEEEeccCCCchhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEecccc
Q 009654 29 ---CSIYLVFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 102 (529)
Q Consensus 29 ---~~~~lV~E~~~g~ll~~~~~~~~---~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGl 102 (529)
..+|+|||||+++.+..+..... ..++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 131 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 210 (332)
T 3qd2_B 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 210 (332)
T ss_dssp -CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCc
Confidence 24899999999977665554332 356677999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-----------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 009654 103 ANFSNTGHR-----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171 (529)
Q Consensus 103 a~~~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~ 171 (529)
+........ ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..|+.. .......+.
T Consensus 211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~ 287 (332)
T 3qd2_B 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR 287 (332)
T ss_dssp CEECSCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH
T ss_pred ccccccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh
Confidence 987654321 12345679999999999987 4689999999999999999998776521 111222221
Q ss_pred HHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 172 ~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
. +..+ ..+...++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 288 ~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 288 N--LKFP--------------------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp T--TCCC--------------------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred c--cCCC--------------------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 1 1111 112345677899999999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=319.16 Aligned_cols=204 Identities=19% Similarity=0.258 Sum_probs=166.8
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.++..+ +||||+++++++.+ ...+|||||||+++.+..++.. ...+++.++..++.||+.||.|||++|
T Consensus 58 ~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 135 (289)
T 1x8b_A 58 LREVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135 (289)
T ss_dssp HHHHHHHHHSCSCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5799999999 99999999999987 5789999999998666544432 257999999999999999999999999
Q ss_pred CcccCCCCCcEEEccC-------------------CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCC
Q 009654 77 VLHRDIKGSNLLVNNE-------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 137 (529)
Q Consensus 77 IvHrDIKp~NILl~~~-------------------g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~ 137 (529)
|+||||||+|||++.+ ..+||+|||++...... ....+|+.|+|||++.+...++.
T Consensus 136 ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 210 (289)
T 1x8b_A 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLP 210 (289)
T ss_dssp EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHH
T ss_pred EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCc
Confidence 9999999999999844 47999999999876543 23468999999999987656778
Q ss_pred cchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHH
Q 009654 138 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 217 (529)
Q Consensus 138 ~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dL 217 (529)
++|||||||++|+|++|.+++..... ...+.. +..+ .....+++.+.+|
T Consensus 211 ~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~--~~~~--------------------------~~~~~~~~~~~~l 259 (289)
T 1x8b_A 211 KADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQ--GRLP--------------------------RIPQVLSQEFTEL 259 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHT--TCCC--------------------------CCSSCCCHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHc--CCCC--------------------------CCCcccCHHHHHH
Confidence 99999999999999999988765432 222322 1110 0113578999999
Q ss_pred HHHhccCCCCCCcCHHHHHhccccCC
Q 009654 218 IETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 218 i~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
|.+||..||.+|||+.++|+||||..
T Consensus 260 i~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 260 LKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHHHhCCCcccCCCHHHHhhChHhhh
Confidence 99999999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.30 Aligned_cols=214 Identities=26% Similarity=0.421 Sum_probs=179.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+||||+++++++.. ...+|+|||||+++.+..+. .....+++.++..++.||+.||.|||++||+|+
T Consensus 72 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~ 149 (314)
T 3com_A 72 IKEISIMQQCDSPHVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149 (314)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 589999999999999999999987 57899999999986666544 345689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 150 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcCHHHEEECCCCCEEEeecccchhhhhhc-cccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999997665432 22345578999999999976 4589999999999999999999999998
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.........+... .++. + .....++..+.+||.+||..||.+|||+.++|+|||
T Consensus 228 ~~~~~~~~~~~~~--~~~~-------------------~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 228 IHPMRAIFMIPTN--PPPT-------------------F-----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp SCHHHHHHHHHHS--CCCC-------------------C-----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CChHHHHHHHhcC--CCcc-------------------c-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 8776665554331 1100 0 011346889999999999999999999999999999
Q ss_pred cCCCC
Q 009654 241 FSTKP 245 (529)
Q Consensus 241 f~~~~ 245 (529)
|+...
T Consensus 282 ~~~~~ 286 (314)
T 3com_A 282 VRSAK 286 (314)
T ss_dssp HHTCC
T ss_pred HhcCC
Confidence 98643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.48 Aligned_cols=214 Identities=28% Similarity=0.415 Sum_probs=175.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.++||||+++++++.+ ...+|+|||||+++.+..+. .....+++.++..++.||+.||.|||++||+||
T Consensus 64 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 141 (302)
T 2j7t_A 64 IVEIEILATCDHPYIVKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141 (302)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC--C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHhcCCCCCEeeeeeeeee--CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 579999999999999999999987 56899999999997776543 335579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc----CCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+|||++.++.+||+|||++....... .......+|+.|+|||++. ....++.++|||||||++|+|++|.+
T Consensus 142 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 220 (302)
T 2j7t_A 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220 (302)
T ss_dssp CCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEECCCCCEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999875432110 1123457899999999984 34568999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+....+..+... .++.. .....++..+.+||.+||..||.+|||+.++|
T Consensus 221 p~~~~~~~~~~~~~~~~--~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 221 PHHELNPMRVLLKIAKS--DPPTL------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp TTTTSCHHHHHHHHHHS--CCCCC------------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred CCccCCHHHHHHHHhcc--CCccc------------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 99998887777666552 11100 01135688899999999999999999999999
Q ss_pred hccccCCC
Q 009654 237 ASEYFSTK 244 (529)
Q Consensus 237 ~h~~f~~~ 244 (529)
+||||+..
T Consensus 275 ~h~~~~~~ 282 (302)
T 2j7t_A 275 EHPFVSSI 282 (302)
T ss_dssp TSTTTTTC
T ss_pred cChHHhhh
Confidence 99999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.19 Aligned_cols=231 Identities=22% Similarity=0.330 Sum_probs=174.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~---~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+||||+++++++.+.....+|||||||+++.+..++... ..+++.++..++.||+.||.|||++||+
T Consensus 55 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 134 (319)
T 4euu_A 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134 (319)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 5899999999999999999999886566899999999986666544322 2399999999999999999999999999
Q ss_pred ccCCCCCcEEE----ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC-------CCCCCCcchhhhhhHH
Q 009654 79 HRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-------ATDYGPSVDLWSVGCV 147 (529)
Q Consensus 79 HrDIKp~NILl----~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-------~~~y~~~~DIWSlG~i 147 (529)
||||||+|||| +.++.+||+|||++....... .....++|+.|+|||++.. ...|+.++||||||||
T Consensus 135 H~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp CSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred cCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 99999999999 777889999999998765542 3345679999999999852 3568999999999999
Q ss_pred HHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCCchhhhccCCCcccc--CCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 148 FAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 148 l~elltG~~pf~g~~----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~--~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
+|+|++|.+||.+.. ..+.+.++.. +.| ...|.......... +....+.. ......++..+.+||.+|
T Consensus 213 l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~p-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ll~~~ 286 (319)
T 4euu_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKP-SGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANI 286 (319)
T ss_dssp HHHHHHSSCSEECTTCGGGCHHHHHHHHH--HCC-TTCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHhc--CCC-cccchhhhcccCCccccCccCCcc---cccchhHHHHhHHHHHHh
Confidence 999999999997533 3444555544 222 22221110000000 00000110 011134567889999999
Q ss_pred ccCCCCCCcCHHHHHhccc
Q 009654 222 LSVEPYKRATASAALASEY 240 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~h~~ 240 (529)
|+.||++|||+.++|+||-
T Consensus 287 L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 287 LEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp SCCCTTTSCCHHHHHHHHH
T ss_pred ccCChhhhccHHHhhhccH
Confidence 9999999999999999963
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=321.38 Aligned_cols=212 Identities=24% Similarity=0.357 Sum_probs=168.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK---FSEAQIKCYMNQLLHGLEHCHSRG- 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~---l~e~~~~~i~~Qll~gL~~LH~~g- 76 (529)
+.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..++..... +++..+..++.||+.||.|||++|
T Consensus 81 ~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~ 158 (309)
T 3p86_A 81 FLREVAIMKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158 (309)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEE--CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3589999999999999999999987 5678999999999766655544333 999999999999999999999999
Q ss_pred -CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 77 -VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 77 -IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|+||||||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 159 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~ 236 (309)
T 3p86_A 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQ 236 (309)
T ss_dssp CCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCC
T ss_pred CEECCCCChhhEEEeCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999997654321 22345688999999999977 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.||.+.+..+....+......+ .....+++.+.+||.+||..||.+|||+.++
T Consensus 237 ~Pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 289 (309)
T 3p86_A 237 QPWGNLNPAQVVAAVGFKCKRL---------------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATI 289 (309)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999988887776664422211 1113678999999999999999999999999
Q ss_pred Hh--ccccCC
Q 009654 236 LA--SEYFST 243 (529)
Q Consensus 236 L~--h~~f~~ 243 (529)
++ .++++.
T Consensus 290 l~~L~~~~~~ 299 (309)
T 3p86_A 290 MDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHC-
T ss_pred HHHHHHHHHh
Confidence 98 566654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=330.90 Aligned_cols=237 Identities=22% Similarity=0.294 Sum_probs=174.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~-gIvHr 80 (529)
.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..++.....+++..+..++.||+.||.|||+. ||+||
T Consensus 79 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~ 156 (360)
T 3eqc_A 79 IRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156 (360)
T ss_dssp HHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCS
T ss_pred HHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcC
Confidence 589999999999999999999988 578999999999977776665556899999999999999999999996 99999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.++.+||+|||++...... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+
T Consensus 157 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CccHHHEEECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998755322 2345678999999999977 4689999999999999999999999998
Q ss_pred CCHHHHHHHHHHHc-CCCCchhhhccCC--Cccc-cCCCCCCC--cchhh---------hhccCCcHHHHHHHHHhccCC
Q 009654 161 RTEVEQLHKIFKLC-GSPPDDYWKKSKL--PHAT-LFKPQQPY--DSSLR---------ETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 161 ~~~~~~~~~I~~~~-g~p~~~~~~~~~l--~~~~-~~~~~~~~--~~~l~---------~~~~~~s~~~~dLi~~mL~~d 225 (529)
.+..+....+.... +.+....+..... +... ........ ...+. .....++.++.+||.+||..|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS
T ss_pred CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC
Confidence 77665443332111 1111100000000 0000 00000000 00000 001247889999999999999
Q ss_pred CCCCcCHHHHHhccccCCC
Q 009654 226 PYKRATASAALASEYFSTK 244 (529)
Q Consensus 226 P~kR~ta~e~L~h~~f~~~ 244 (529)
|.+|||+.++|+||||+..
T Consensus 313 P~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 313 PAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp TTTSCCHHHHHTSHHHHHH
T ss_pred hhhCCCHHHHhhChHhhcc
Confidence 9999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.20 Aligned_cols=216 Identities=25% Similarity=0.378 Sum_probs=171.7
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+++ +||||+++++++.... ...+|||||||+++.+..++. ....+++..+..++.||+.||.|||+
T Consensus 68 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 147 (326)
T 2x7f_A 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 147 (326)
T ss_dssp HHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 5899999999 8999999999998743 468999999999866554442 23579999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHH
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~e 150 (529)
+||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ...++.++||||||||+|+
T Consensus 148 ~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp TTCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 999999999999999999999999999997664321 12345578999999999863 2458999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 151 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 151 lltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
|++|.+||.+.+....+..+.... .+. .....++..+.+||.+||..||.+||
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~--~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rp 279 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRALFLIPRNP--APR-------------------------LKSKKWSKKFQSFIESCLVKNHSQRP 279 (326)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSC--CCC-------------------------CSCSCSCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCc--ccc-------------------------CCccccCHHHHHHHHHHhccChhhCC
Confidence 999999999888777666554411 100 01135788999999999999999999
Q ss_pred CHHHHHhccccCCCC
Q 009654 231 TASAALASEYFSTKP 245 (529)
Q Consensus 231 ta~e~L~h~~f~~~~ 245 (529)
|+.++|+||||+..+
T Consensus 280 s~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 280 ATEQLMKHPFIRDQP 294 (326)
T ss_dssp CHHHHHTSHHHHCCT
T ss_pred CHHHHhhChHHhhCc
Confidence 999999999998643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=312.86 Aligned_cols=207 Identities=23% Similarity=0.354 Sum_probs=176.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..+. .....+++..+..++.||+.||.|||++||+|
T Consensus 52 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 129 (269)
T 4hcu_A 52 FIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 129 (269)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEec--CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3589999999999999999999987 56799999999987666444 55567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 130 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~ 208 (269)
T 4hcu_A 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY 208 (269)
T ss_dssp SCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999998765433233345567889999999976 458999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+........ ...+++.+.+||.+||..||.+|||+.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 209 ENRSNSEVVEDISTGFRLYK----------------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TTCCHHHHHHHHHTTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHhcCccCCC----------------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99998888877755211110 12468889999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=316.17 Aligned_cols=214 Identities=25% Similarity=0.419 Sum_probs=165.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC-----------CCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL-----------SCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGL 69 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~-----------~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL 69 (529)
.+|+.+|++|+||||+++++++.+.. ...+|+|||||+++.+..+ ......+++.++..++.||+.||
T Consensus 50 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l 129 (303)
T 1zy4_A 50 LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129 (303)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHH
Confidence 57999999999999999999886531 3578999999998555544 33555789999999999999999
Q ss_pred HHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCC-------------CCCccccccccccCCcccccCCCCCC
Q 009654 70 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------------RQPLTSRVVTLWYRPPELLLGATDYG 136 (529)
Q Consensus 70 ~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~y~ 136 (529)
.|||++||+||||||+|||++.++.+||+|||++....... ........+|+.|+|||++.+...++
T Consensus 130 ~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 209 (303)
T 1zy4_A 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209 (303)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCC
T ss_pred HHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCc
Confidence 99999999999999999999999999999999997654221 12234567899999999998766799
Q ss_pred CcchhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHH
Q 009654 137 PSVDLWSVGCVFAELLIGKPILQ-GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 215 (529)
Q Consensus 137 ~~~DIWSlG~il~elltG~~pf~-g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~ 215 (529)
.++|||||||++|+|++ ||. +.+..+.+..+.......+. .....++..+.
T Consensus 210 ~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~ 261 (303)
T 1zy4_A 210 EKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPP-------------------------DFDDNKMKVEK 261 (303)
T ss_dssp THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCT-------------------------TCCTTTSHHHH
T ss_pred chhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCc-------------------------cccccchHHHH
Confidence 99999999999999998 443 33333444444332111111 01135678899
Q ss_pred HHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 216 NLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 216 dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
+||.+||+.||.+|||+.++|+||||+.
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 262 KIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 9999999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=314.96 Aligned_cols=210 Identities=29% Similarity=0.441 Sum_probs=180.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|+.++||||+++++++.+ ...+|+||||++++.+..+... ..+++.++..++.||+.||.|||++||+||
T Consensus 67 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 143 (303)
T 3a7i_A 67 IQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHR 143 (303)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 3589999999999999999999987 5789999999999777666543 579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 144 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCChheEEECCCCCEEEeecccceecCccc-cccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 999999999999999999999997765432 22345678999999999976 4589999999999999999999999998
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
....+....+... .++ .....++..+.+||.+||..||.+|||+.++|+|||
T Consensus 222 ~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 222 LHPMKVLFLIPKN--NPP--------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp SCHHHHHHHHHHS--CCC--------------------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cCHHHHHHHhhcC--CCC--------------------------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 8877766665441 111 011357889999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|..
T Consensus 274 ~~~ 276 (303)
T 3a7i_A 274 ILR 276 (303)
T ss_dssp HHH
T ss_pred hhc
Confidence 975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=326.78 Aligned_cols=238 Identities=28% Similarity=0.482 Sum_probs=182.5
Q ss_pred HHHHHHHHhCC-----------CCCccceeeEEEccC--CCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD-----------HPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLH 67 (529)
Q Consensus 2 ~rEi~iL~~L~-----------HpnIvkl~~~~~~~~--~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~ 67 (529)
.+|+.+|+++. ||||+++++++.... ...+|+||||+.+++...+.. ....+++..+..++.||+.
T Consensus 63 ~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~ 142 (373)
T 1q8y_A 63 EDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142 (373)
T ss_dssp HHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHH
Confidence 57999999886 899999999988642 237899999996666665543 3456999999999999999
Q ss_pred HHHHHHHC-CCcccCCCCCcEEEcc------CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcch
Q 009654 68 GLEHCHSR-GVLHRDIKGSNLLVNN------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 140 (529)
Q Consensus 68 gL~~LH~~-gIvHrDIKp~NILl~~------~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~D 140 (529)
||.|||++ ||+||||||+||||+. .+.+||+|||++...... ....++|+.|+|||++.+. .|+.++|
T Consensus 143 aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~D 217 (373)
T 1q8y_A 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGA-PWGCGAD 217 (373)
T ss_dssp HHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTC-CCCTHHH
T ss_pred HHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCC-CCCchHh
Confidence 99999998 9999999999999953 347999999999876532 3456889999999999874 5899999
Q ss_pred hhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCCchhhhccCCCcc-----ccCCCCC-----CCcchhh
Q 009654 141 LWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHA-----TLFKPQQ-----PYDSSLR 204 (529)
Q Consensus 141 IWSlG~il~elltG~~pf~g~~------~~~~~~~I~~~~g~p~~~~~~~~~l~~~-----~~~~~~~-----~~~~~l~ 204 (529)
|||||||+|+|++|.+||.+.+ ..+.+..+...+|.++...|........ ....... +....+.
T Consensus 218 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (373)
T 1q8y_A 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297 (373)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh
Confidence 9999999999999999998764 5678888999999988765544322100 0000000 0000111
Q ss_pred hh---ccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCC
Q 009654 205 ET---FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 244 (529)
Q Consensus 205 ~~---~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~ 244 (529)
.. ...++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 298 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 11 12356788999999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.41 Aligned_cols=215 Identities=25% Similarity=0.374 Sum_probs=166.2
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|+.+ +|||||++++++.+ ...+|||||||++++...+......+.+.++..++.||+.||.|||++||+|
T Consensus 64 ~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 141 (432)
T 3p23_A 64 ADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141 (432)
T ss_dssp CHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEe
Confidence 36899999999 89999999999987 5789999999999887777766666777788899999999999999999999
Q ss_pred cCCCCCcEEEcc---CC--cEEEeccccccccCCCCC--CCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHH
Q 009654 80 RDIKGSNLLVNN---EG--VLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 80 rDIKp~NILl~~---~g--~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~e 150 (529)
|||||+||||+. ++ .+||+|||++........ ......+||++|+|||++.+ ...++.++||||||||+|+
T Consensus 142 rDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~e 221 (432)
T 3p23_A 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221 (432)
T ss_dssp CCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHH
Confidence 999999999953 23 588999999987654321 23345689999999999975 3457889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+...... ..+ .+......+ ......+..+.+||.+||+.||.+|
T Consensus 222 llt~g~~pf~~~~~~~~-~~~---~~~~~~~~~----------------------~~~~~~~~~~~~li~~~L~~dP~~R 275 (432)
T 3p23_A 222 VISEGSHPFGKSLQRQA-NIL---LGACSLDCL----------------------HPEKHEDVIARELIEKMIAMDPQKR 275 (432)
T ss_dssp HHTTSCBTTBSTTTHHH-HHH---TTCCCCTTS----------------------CTTCHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHcCCCCCcchhhHHHH-HHH---hccCCcccc----------------------CccccccHHHHHHHHHHHhCCHhhC
Confidence 999 8999965544332 222 121110000 0001245668999999999999999
Q ss_pred cCHHHHHhccccCC
Q 009654 230 ATASAALASEYFST 243 (529)
Q Consensus 230 ~ta~e~L~h~~f~~ 243 (529)
||+.++|+||||..
T Consensus 276 ps~~evl~hp~f~~ 289 (432)
T 3p23_A 276 PSAKHVLKHPFFWS 289 (432)
T ss_dssp CCHHHHHTSTTTCC
T ss_pred CCHHHHHhCccccC
Confidence 99999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=315.23 Aligned_cols=212 Identities=28% Similarity=0.434 Sum_probs=176.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRG- 76 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~g- 76 (529)
.+|+.+|++|+||||+++++++.+.....+|+|||||+++.+..++. ....+++.++..++.||+.||.|||++|
T Consensus 53 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 132 (279)
T 2w5a_A 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132 (279)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccC
Confidence 57999999999999999999987655678999999999855554432 2345999999999999999999999999
Q ss_pred ----CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 77 ----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 77 ----IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
|+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 133 ~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~ 210 (279)
T 2w5a_A 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELC 210 (279)
T ss_dssp -----CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHH
T ss_pred CCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc-ccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999998765431 112345789999999999774 5899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+|.+||.+.+..+....+... ..+ .....++.++.+||.+||..||.+|||+
T Consensus 211 ~g~~p~~~~~~~~~~~~i~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~ 262 (279)
T 2w5a_A 211 ALMPPFTAFSQKELAGKIREG--KFR--------------------------RIPYRYSDELNEIITRMLNLKDYHRPSV 262 (279)
T ss_dssp HSSCSSCCSSHHHHHHHHHHT--CCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCcccCHHHHHHHHhhc--ccc--------------------------cCCcccCHHHHHHHHHHcCCCcccCCCH
Confidence 999999998887777776552 111 0013578899999999999999999999
Q ss_pred HHHHhccccCC
Q 009654 233 SAALASEYFST 243 (529)
Q Consensus 233 ~e~L~h~~f~~ 243 (529)
.++|+|+|+..
T Consensus 263 ~~ll~~~~~~~ 273 (279)
T 2w5a_A 263 EEILENPLILE 273 (279)
T ss_dssp HHHHTSTTCCG
T ss_pred HHHHhChhhhh
Confidence 99999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=312.56 Aligned_cols=207 Identities=22% Similarity=0.336 Sum_probs=175.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..+. .....+++.++..++.||+.||.|||++||+|
T Consensus 66 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 143 (283)
T 3gen_A 66 FIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143 (283)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhcCCCCCEeeEEEEEec--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 3589999999999999999999977 56899999999886655444 33567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+||+|||++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||
T Consensus 144 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~ 222 (283)
T 3gen_A 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPY 222 (283)
T ss_dssp SSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999987654322233445668899999999763 58999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+........ ...+++.+.+||.+||+.||.+|||+.++|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 223 ERFTNSETAEHIAQGLRLYR----------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTSCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccChhHHHHHHhcccCCCC----------------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99988888777755321111 12467889999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=313.23 Aligned_cols=213 Identities=30% Similarity=0.463 Sum_probs=170.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-C--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-P--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+++.|+||||+++++++.+ ...+|+||||++++.+..+.. . ...+++..+..++.||+.||.|||++||+
T Consensus 67 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 144 (295)
T 2clq_A 67 HEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144 (295)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 579999999999999999999987 578999999999866665442 2 23577999999999999999999999999
Q ss_pred ccCCCCCcEEEcc-CCcEEEeccccccccCCCCCCCccccccccccCCcccccCC-CCCCCcchhhhhhHHHHHHHhCCC
Q 009654 79 HRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 79 HrDIKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||||+|||++. ++.+||+|||++....... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|.+
T Consensus 145 H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (295)
T 2clq_A 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223 (295)
T ss_dssp CCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSC
T ss_pred ccCCChhhEEEECCCCCEEEeecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999987 8999999999998765322 123455789999999999653 247899999999999999999999
Q ss_pred CCCCCCHHHH-HHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 157 ILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 157 pf~g~~~~~~-~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
||.+...... ...... ....+ .....+++++.+||.+||+.||.+|||+.++
T Consensus 224 pf~~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 276 (295)
T 2clq_A 224 PFYELGEPQAAMFKVGM-FKVHP--------------------------EIPESMSAEAKAFILKCFEPDPDKRACANDL 276 (295)
T ss_dssp TTGGGSSHHHHHHHHHH-HCCCC--------------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred CccCCCchhHHHHhhcc-ccccc--------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9976443322 222111 11110 0113578899999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|+||||+..
T Consensus 277 l~~~~~~~~ 285 (295)
T 2clq_A 277 LVDEFLKVS 285 (295)
T ss_dssp HTSGGGCC-
T ss_pred hcChhhhhc
Confidence 999999853
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=310.28 Aligned_cols=206 Identities=21% Similarity=0.295 Sum_probs=174.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..++ .....+++.++..++.||+.||.|||++||+||
T Consensus 51 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 128 (268)
T 3sxs_A 51 FQEAQTMMKLSHPKLVKFYGVCSK--EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128 (268)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred HHHHHHHHhCCCCCEeeEEEEEcc--CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 589999999999999999999977 56899999999987555443 334469999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~ 159 (529)
||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.
T Consensus 129 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp SCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999998766543333344556788999999976 458999999999999999999 999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+.+..+....+......+. ...+++.+.+||.+||+.||.+|||+.++|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 208 LYTNSEVVLKVSQGHRLYR----------------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TSCHHHHHHHHHTTCCCCC----------------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccChHHHHHHHHcCCCCCC----------------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9888887777654211110 12467889999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=325.15 Aligned_cols=207 Identities=23% Similarity=0.337 Sum_probs=172.0
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMN 63 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~ 63 (529)
+.+|+.+|++| +|||||++++++.+ ...+|||||||+++.+..++.. ...+++.++..++.
T Consensus 133 ~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 210 (370)
T 2psq_A 133 LVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210 (370)
T ss_dssp HHHHHHHHHHSCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCEeeEEEEEcc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHH
Confidence 35899999999 89999999999987 5679999999998666544321 23589999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhh
Q 009654 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLW 142 (529)
Q Consensus 64 Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIW 142 (529)
||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|||
T Consensus 211 qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvw 289 (370)
T 2psq_A 211 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVW 289 (370)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHH
T ss_pred HHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHH
Confidence 999999999999999999999999999999999999999986654322 22334567899999999977 4599999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 143 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 143 SlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
|||||+|+|++ |.+||.+....+.+..+... ..+ .....++.++.+||.+|
T Consensus 290 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~ 341 (370)
T 2psq_A 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG--HRM--------------------------DKPANCTNELYMMMRDC 341 (370)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--CCC--------------------------CCCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC--------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999999 99999988777666655431 110 01135788999999999
Q ss_pred ccCCCCCCcCHHHHHhc
Q 009654 222 LSVEPYKRATASAALAS 238 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~h 238 (529)
|..||.+|||+.+++++
T Consensus 342 l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 342 WHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.36 Aligned_cols=203 Identities=18% Similarity=0.246 Sum_probs=159.3
Q ss_pred HHHH---HHHHhCCCCCcccee-------eEEEccCC----------C-----eEEEEEeccCCCchhhhcCCCCCCC--
Q 009654 2 AREI---LILRRLDHPNIIKLE-------GLITSRLS----------C-----SIYLVFEYMEHDITGLLSCPDIKFS-- 54 (529)
Q Consensus 2 ~rEi---~iL~~L~HpnIvkl~-------~~~~~~~~----------~-----~~~lV~E~~~g~ll~~~~~~~~~l~-- 54 (529)
.+|+ .+|++++|||||+++ +++.+... . ..|||||||.|++...+.. ...++
T Consensus 121 ~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~-~~~~~~~ 199 (377)
T 3byv_A 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV-LLSHSST 199 (377)
T ss_dssp HHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHH-HHHTTTT
T ss_pred HHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHh-ccccccc
Confidence 5899 455555899999998 67665311 0 3899999997766555432 22344
Q ss_pred -----HHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccc
Q 009654 55 -----EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 129 (529)
Q Consensus 55 -----e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 129 (529)
+..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..... .....+| +.|+|||++
T Consensus 200 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~ 274 (377)
T 3byv_A 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELE 274 (377)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHH
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhh
Confidence 488889999999999999999999999999999999999999999999986433 3345677 999999999
Q ss_pred cCC----------CCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC
Q 009654 130 LGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 199 (529)
Q Consensus 130 ~~~----------~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~ 199 (529)
.+. ..|+.++||||||||||+|++|++||.+.+..+.+..+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------------------- 325 (377)
T 3byv_A 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------------------- 325 (377)
T ss_dssp HHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG-----------------------------
T ss_pred cccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh-----------------------------
Confidence 764 25899999999999999999999999765432211111
Q ss_pred cchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 200 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 200 ~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
...+..+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 326 ----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 326 ----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp ----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred ----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 1122578999999999999999999999999999999973
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=312.17 Aligned_cols=206 Identities=24% Similarity=0.395 Sum_probs=160.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ +.+|+||||++++.+..+ ......+++.++..++.||+.||.|||++||+|
T Consensus 63 ~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 139 (281)
T 1mp8_A 63 FLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 139 (281)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCccceEEEEEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3589999999999999999999854 468999999998655544 344557999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||
T Consensus 140 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf 218 (281)
T 1mp8_A 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF 218 (281)
T ss_dssp SCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999998765443223344566889999999975 458999999999999999996 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......+ ....+|+.+.+||.+||..||.+|||+.+++++
T Consensus 219 ~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 219 QGVKNNDVIGRIENGERLP----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9988777777664421110 113678999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=318.96 Aligned_cols=206 Identities=25% Similarity=0.371 Sum_probs=172.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 97 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 174 (325)
T 3kul_A 97 FLSEASIMGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174 (325)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECG--GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEe--CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 3589999999999999999999987 56789999999986665444 45568999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCC--ccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+||||+.++.+||+|||++.......... .....+|+.|+|||++.+ ..|+.++||||||||+|+|++ |.+
T Consensus 175 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999998765432221 223355788999999976 458999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+....+......+ ....+++.+.+||.+||..||.+|||+.+++
T Consensus 254 p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil 305 (325)
T 3kul_A 254 PYWNMTNRDVISSVEEGYRLP----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305 (325)
T ss_dssp TTTTSCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcccCCHHHHHHHHHcCCCCC----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999888887775532111 1135789999999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 306 ~ 306 (325)
T 3kul_A 306 S 306 (325)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.20 Aligned_cols=218 Identities=18% Similarity=0.216 Sum_probs=153.7
Q ss_pred HHHHHHHHhC--CCCCcccee-------eEEEccCC---------------CeEEEEEeccCCCchhhhcCCCCCCCHHH
Q 009654 2 AREILILRRL--DHPNIIKLE-------GLITSRLS---------------CSIYLVFEYMEHDITGLLSCPDIKFSEAQ 57 (529)
Q Consensus 2 ~rEi~iL~~L--~HpnIvkl~-------~~~~~~~~---------------~~~~lV~E~~~g~ll~~~~~~~~~l~e~~ 57 (529)
.+|+.+++.| +||||++++ +++..... ..+|||||||++++...+......+.+..
T Consensus 110 ~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~ 189 (371)
T 3q60_A 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189 (371)
T ss_dssp HHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCH
T ss_pred HHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhh
Confidence 4675544444 699988755 45544322 45899999999777666654333455555
Q ss_pred H------HHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC
Q 009654 58 I------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 131 (529)
Q Consensus 58 ~------~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 131 (529)
+ ..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++...... .....+|+.|+|||++.+
T Consensus 190 ~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTC
T ss_pred hhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccC
Confidence 5 677799999999999999999999999999999999999999999876532 224567799999999965
Q ss_pred C-CCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCC
Q 009654 132 A-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210 (529)
Q Consensus 132 ~-~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 210 (529)
. ..|+.++|||||||+||+|++|++||.+.+... ...|........ . ...+ ....+..+
T Consensus 266 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~~~~~~--~--~~~~---~~~~~~~~ 325 (371)
T 3q60_A 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------KGSWKRPSLRVP--G--TDSL---AFGSCTPL 325 (371)
T ss_dssp SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------TTCCCBCCTTSC--C--CCSC---CCTTSSCC
T ss_pred CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------ccchhhhhhhhc--c--cccc---chhhccCC
Confidence 2 468999999999999999999999998754210 001111000000 0 0000 01223578
Q ss_pred cHHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 211 PTTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 211 s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus 326 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 326 PDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 999999999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=317.70 Aligned_cols=215 Identities=19% Similarity=0.282 Sum_probs=163.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCC----eEEEEEeccCCCchhhhcC------CCCCCCHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSC------PDIKFSEAQIKCYMNQLLHGLE 70 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~----~~~lV~E~~~g~ll~~~~~------~~~~l~e~~~~~i~~Qll~gL~ 70 (529)
+.+|+.+|++|+||||+++++++.+.... ..|+|||||+++.+..+.. ....+++.++..++.||+.||.
T Consensus 72 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 151 (323)
T 3qup_A 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151 (323)
T ss_dssp HHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH
Confidence 35899999999999999999999874221 2499999999966654432 2226999999999999999999
Q ss_pred HHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 71 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 71 ~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|||||||++|
T Consensus 152 ~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ 230 (323)
T 3qup_A 152 YLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMW 230 (323)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred HHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHH
Confidence 99999999999999999999999999999999987654321 12234456889999999976 45899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 150 ELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 150 ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
+|++ |.+||.+.+..+....+......+ ....+++++.+||.+||+.||.+
T Consensus 231 ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~ 282 (323)
T 3qup_A 231 EIMTRGQTPYAGIENAEIYNYLIGGNRLK----------------------------QPPECMEEVYDLMYQCWSADPKQ 282 (323)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHTTCSSGGG
T ss_pred HHHhCCCCCccccChHHHHHHHhcCCCCC----------------------------CCCccCHHHHHHHHHHccCChhh
Confidence 9999 999999988887777765421110 11357889999999999999999
Q ss_pred CcC-------HHHHHhccccCCC
Q 009654 229 RAT-------ASAALASEYFSTK 244 (529)
Q Consensus 229 R~t-------a~e~L~h~~f~~~ 244 (529)
||| +.+++.|+|+...
T Consensus 283 Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 283 RPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp SCCHHHHHHHHHHHHHC------
T ss_pred CcCHHHHHHHHHHHHHHhhhcCC
Confidence 999 7888999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.27 Aligned_cols=209 Identities=22% Similarity=0.315 Sum_probs=170.0
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC----------------------------
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI---------------------------- 51 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~---------------------------- 51 (529)
+.+|+.+|++| +|||||++++++.+. ...+|+|||||+++.+..++....
T Consensus 72 ~~~E~~~l~~l~~hpniv~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (359)
T 3vhe_A 72 LMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK 150 (359)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------
T ss_pred HHHHHHHHHhhcCCcceeeeeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhh
Confidence 35899999999 899999999998774 345899999999866654443221
Q ss_pred --------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC
Q 009654 52 --------------------------------------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 93 (529)
Q Consensus 52 --------------------------------------~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g 93 (529)
.+++..+..++.||+.||.|||++||+||||||+||||+.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~ 230 (359)
T 3vhe_A 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 230 (359)
T ss_dssp ---------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC
Confidence 289999999999999999999999999999999999999999
Q ss_pred cEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 009654 94 VLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 171 (529)
Q Consensus 94 ~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~ 171 (529)
.+||+|||++....... ........+|+.|+|||++.+ ..|+.++||||||||+|+|++ |.+||.+....+.+....
T Consensus 231 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 309 (359)
T 3vhe_A 231 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309 (359)
T ss_dssp CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred cEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH
Confidence 99999999998664322 123345677999999999976 458999999999999999998 999999877555554444
Q ss_pred HHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 172 ~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.....+. ....+++++.+||.+||..||.+|||+.++++|
T Consensus 310 ~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 310 KEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCC---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 4222111 013478899999999999999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=325.90 Aligned_cols=211 Identities=19% Similarity=0.279 Sum_probs=174.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-------~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|++|+|||||++++++.+ ....|||||||+++.+..++. ....+++.++..++.||+.||.|||+
T Consensus 122 ~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 199 (367)
T 3l9p_A 122 LMEALIISKFNHQNIVRCIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199 (367)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCeEEEEEec--CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh
Confidence 589999999999999999999987 567899999998855554432 12469999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCC---cEEEeccccccccCCC-CCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 75 RGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g---~vKl~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
+||+||||||+||||+.+| .+||+|||+++..... .........+|+.|+|||++.+ ..|+.++||||||||+|+
T Consensus 200 ~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~e 278 (367)
T 3l9p_A 200 NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWE 278 (367)
T ss_dssp TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHH
T ss_pred CCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHH
Confidence 9999999999999999655 5999999999754321 1122345577999999999976 458999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+.+..+.+..+....... ....++..+.+||.+||+.||.+|
T Consensus 279 llt~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~R 330 (367)
T 3l9p_A 279 IFSLGYMPYPSKSNQEVLEFVTSGGRMD----------------------------PPKNCPGPVYRIMTQCWQHQPEDR 330 (367)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCCHhHC
Confidence 998 999999999888877775522111 013578899999999999999999
Q ss_pred cCHHHHHhccccCC
Q 009654 230 ATASAALASEYFST 243 (529)
Q Consensus 230 ~ta~e~L~h~~f~~ 243 (529)
||+.++|++.++..
T Consensus 331 ps~~eil~~l~~~~ 344 (367)
T 3l9p_A 331 PNFAIILERIEYCT 344 (367)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHh
Confidence 99999999988753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=313.17 Aligned_cols=209 Identities=21% Similarity=0.231 Sum_probs=169.9
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++| +||||+++++++.+ ...+|||||||.+++...+......+++.++..++.||+.||+|||++||+|
T Consensus 51 ~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH 128 (330)
T 2izr_A 51 LHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIY 128 (330)
T ss_dssp HHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 35899999999 99999999999988 5789999999955555555544568999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCc-----EEEeccccccccCCCCCC------CccccccccccCCcccccCCCCCCCcchhhhhhHHH
Q 009654 80 RDIKGSNLLVNNEGV-----LKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 148 (529)
Q Consensus 80 rDIKp~NILl~~~g~-----vKl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il 148 (529)
|||||+||||+.++. +||+|||++..+...... .....+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 129 rDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il 207 (330)
T 2izr_A 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMF 207 (330)
T ss_dssp CCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHH
T ss_pred cCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHH
Confidence 999999999998887 999999999876543211 1245689999999999987 4589999999999999
Q ss_pred HHHHhCCCCCCCC---CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCC
Q 009654 149 AELLIGKPILQGR---TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225 (529)
Q Consensus 149 ~elltG~~pf~g~---~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~d 225 (529)
|+|++|.+||.+. +..+.+..|.......+. ......+| ++.+||..||+.|
T Consensus 208 ~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~p-~~~~li~~~l~~~ 262 (330)
T 2izr_A 208 MYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI------------------------EVLCENFP-EMATYLRYVRRLD 262 (330)
T ss_dssp HHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH------------------------HHHTTTCH-HHHHHHHHHHHCC
T ss_pred HHHhcCCCCccccccccHHHHHHHHHhhhccCCH------------------------HHHhccCh-HHHHHHHHHHhCC
Confidence 9999999999884 344445555332111110 11223456 8999999999999
Q ss_pred CCCCcCHHHHHh
Q 009654 226 PYKRATASAALA 237 (529)
Q Consensus 226 P~kR~ta~e~L~ 237 (529)
|.+||++.++++
T Consensus 263 p~~RP~~~~l~~ 274 (330)
T 2izr_A 263 FFEKPDYDYLRK 274 (330)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999998875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=320.13 Aligned_cols=206 Identities=22% Similarity=0.331 Sum_probs=173.6
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.+|++| +|||||++++++.+ ...+|||||||+++.+..++.. ...+++.++..++.|
T Consensus 122 ~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 199 (382)
T 3tt0_A 122 ISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199 (382)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCchhhhheeeecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHH
Confidence 5899999999 99999999999987 5678999999998666544322 245999999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++||||
T Consensus 200 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Diws 278 (382)
T 3tt0_A 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWS 278 (382)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHH
T ss_pred HHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHH
Confidence 99999999999999999999999999999999999999987654322 22344567899999999987 46899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
||||+|+|++ |.+||.+.+..+....+....... ....+++++.+||.+||
T Consensus 279 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l 330 (382)
T 3tt0_A 279 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD----------------------------KPSNCTNELYMMMRDCW 330 (382)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCSSCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHc
Confidence 9999999999 999999988877776664421110 11357889999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
+.||.+|||+.+++++
T Consensus 331 ~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 331 HAVPSQRPTFKQLVED 346 (382)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.55 Aligned_cols=206 Identities=19% Similarity=0.243 Sum_probs=168.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.++++++||||+++++++.+ ..+|+|||||.++.+. .+......+++..+..++.||+.||.|||++||+|
T Consensus 62 ~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 138 (325)
T 3kex_A 62 VTDHMLAIGSLDHAHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH 138 (325)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhcCCCCCcCeEEEEEcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 3579999999999999999999864 4689999999975554 44444568999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||||+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+|
T Consensus 139 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp SCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 999999999999999999999999877544322 2345567889999999976 358999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+......+ ....++.++.+||.+||..||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 218 YAGLRLAEVPDLLEKGERLA----------------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp TTTSCTTHHHHHHHTTCBCC----------------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred ccccCHHHHHHHHHcCCCCC----------------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99887766666654421110 01235667889999999999999999999998
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
+
T Consensus 270 ~ 270 (325)
T 3kex_A 270 E 270 (325)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.13 Aligned_cols=203 Identities=22% Similarity=0.372 Sum_probs=165.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 54 ~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 131 (310)
T 3s95_A 54 FLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131 (310)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 3589999999999999999999988 57899999999996666544 44668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCC-------------ccccccccccCCcccccCCCCCCCcchhhhhhH
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-------------LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 146 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-------------~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~ 146 (529)
|||||+||||+.++.+||+|||++.......... ....+||+.|+|||++.+ ..|+.++|||||||
T Consensus 132 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~ 210 (310)
T 3s95_A 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGI 210 (310)
T ss_dssp SCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHH
T ss_pred CCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHH
Confidence 9999999999999999999999998765432111 125578999999999977 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 147 VFAELLIGKPILQGRTEVE-----QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 147 il~elltG~~pf~g~~~~~-----~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
++|+|++|.+||....... ....... ......+|+.+.+||.+|
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~ 259 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-------------------------------RYCPPNCPPSFFPITVRC 259 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-------------------------------HTCCTTCCTTHHHHHHHH
T ss_pred HHHHHhcCCCCCcchhhhHHHHhhhhhcccc-------------------------------ccCCCCCCHHHHHHHHHH
Confidence 9999999999986432100 0000000 011246788999999999
Q ss_pred ccCCCCCCcCHHHHHh
Q 009654 222 LSVEPYKRATASAALA 237 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~ 237 (529)
|+.||.+|||+.++++
T Consensus 260 l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 260 CDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=303.38 Aligned_cols=203 Identities=23% Similarity=0.355 Sum_probs=164.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG---VL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g---Iv 78 (529)
.+|+.+++.++||||+++++++.+ ...+|+||||++++.+..+.. ...+++.++..++.||+.||.|||++| |+
T Consensus 54 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~ 130 (271)
T 3dtc_A 54 RQEAKLFAMLKHPNIIALRGVCLK--EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPII 130 (271)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECC--C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCC
T ss_pred HHHHHHHHhcCCCCEeeEEEEEec--CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Confidence 579999999999999999999987 567899999999987776664 458999999999999999999999999 89
Q ss_pred ccCCCCCcEEEcc--------CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 79 HRDIKGSNLLVNN--------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 79 HrDIKp~NILl~~--------~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||||||+|||++. ++.+||+|||++....... .....+|+.|+|||++.+ ..++.++|||||||++|+
T Consensus 131 H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ 206 (271)
T 3dtc_A 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWE 206 (271)
T ss_dssp CSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHH
T ss_pred ecCCchHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHH
Confidence 9999999999986 6789999999998665432 235578999999999976 458999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 151 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 151 lltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
|++|.+||.+.+.......+......+ .....+++.+.+||.+||+.||.+||
T Consensus 207 l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 259 (271)
T 3dtc_A 207 LLTGEVPFRGIDGLAVAYGVAMNKLAL---------------------------PIPSTCPEPFAKLMEDCWNPDPHSRP 259 (271)
T ss_dssp HHHCCCTTTTSCHHHHHHHHHTSCCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCHHHHHHhhhcCCCCC---------------------------CCCcccCHHHHHHHHHHhcCCcccCc
Confidence 999999999988777666554321111 01135788999999999999999999
Q ss_pred CHHHHHhc
Q 009654 231 TASAALAS 238 (529)
Q Consensus 231 ta~e~L~h 238 (529)
|+.+++++
T Consensus 260 s~~e~l~~ 267 (271)
T 3dtc_A 260 SFTNILDQ 267 (271)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=310.14 Aligned_cols=211 Identities=22% Similarity=0.349 Sum_probs=162.7
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRD 81 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~-gIvHrD 81 (529)
.+..+++.++||||+++++++.+ ...+||||||+.+.+..........+++..+..++.||+.||.|||++ ||+|||
T Consensus 73 ~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~d 150 (318)
T 2dyl_A 73 DLDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150 (318)
T ss_dssp HHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred HHHHHHHhcCCCceeeEEEEEec--CCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCC
Confidence 34457888899999999999988 578999999995433333333356899999999999999999999995 999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc----CCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||+|||++.++.+||+|||++....... ......+|+.|+|||++. ....++.++||||||||+|+|++|..|
T Consensus 151 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (318)
T 2dyl_A 151 VKPSNILLDERGQIKLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCHHHEEECCCCCEEEEECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCC
Confidence 99999999999999999999997664432 234557899999999995 234688999999999999999999999
Q ss_pred CCC-CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 158 LQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 158 f~g-~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
|.+ .+..+.+..+... .++. ......+++++.+||.+||..||.+|||+.++|
T Consensus 229 f~~~~~~~~~~~~~~~~--~~~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (318)
T 2dyl_A 229 YKNCKTDFEVLTKVLQE--EPPL------------------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282 (318)
T ss_dssp TTTCCSHHHHHHHHHHS--CCCC------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCccHHHHHHHhcc--CCCC------------------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 987 4555666666542 1110 001135789999999999999999999999999
Q ss_pred hccccCC
Q 009654 237 ASEYFST 243 (529)
Q Consensus 237 ~h~~f~~ 243 (529)
+||||+.
T Consensus 283 ~h~~~~~ 289 (318)
T 2dyl_A 283 EHSFIKR 289 (318)
T ss_dssp TSHHHHH
T ss_pred hCHHHHh
Confidence 9999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.03 Aligned_cols=206 Identities=19% Similarity=0.283 Sum_probs=170.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC------------------------CCCCHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD------------------------IKFSEAQ 57 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~------------------------~~l~e~~ 57 (529)
.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..++... ..+++.+
T Consensus 74 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (314)
T 2ivs_A 74 LSEFNVLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151 (314)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHH
T ss_pred HHHHHHHhhCCCCceeeEEEEEec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHH
Confidence 579999999999999999999987 56799999999986665444322 2489999
Q ss_pred HHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCC
Q 009654 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYG 136 (529)
Q Consensus 58 ~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~ 136 (529)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++
T Consensus 152 ~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 230 (314)
T 2ivs_A 152 LISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYT 230 (314)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEEC
T ss_pred HHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcC
Confidence 999999999999999999999999999999999999999999999986654321 12234466889999999976 4589
Q ss_pred CcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHH
Q 009654 137 PSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 215 (529)
Q Consensus 137 ~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~ 215 (529)
.++||||||||+|+|++ |.+||.+.+..+....+.... .+ .....+++.+.
T Consensus 231 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~ 282 (314)
T 2ivs_A 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH--RM--------------------------ERPDNCSEEMY 282 (314)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--CC--------------------------CCCTTCCHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC--cC--------------------------CCCccCCHHHH
Confidence 99999999999999999 999999888766665553311 10 01135789999
Q ss_pred HHHHHhccCCCCCCcCHHHHHhc
Q 009654 216 NLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 216 dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+||.+||+.||.+|||+.+++++
T Consensus 283 ~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 283 RLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.14 Aligned_cols=201 Identities=17% Similarity=0.179 Sum_probs=163.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ ....|||||||+++.+..++ .....+++..+..++.||+.||.|||++||+|
T Consensus 59 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 136 (289)
T 4fvq_A 59 FFEAASMMSKLSHKHLVLNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIH 136 (289)
T ss_dssp HHHHHHHHHTSCCTTBCCEEEEECC--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEEe--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeEC
Confidence 3589999999999999999999987 56789999999976655444 34445999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCc--------EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 80 RDIKGSNLLVNNEGV--------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 80 rDIKp~NILl~~~g~--------vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
|||||+||||+.++. +||+|||++...... ....+|+.|+|||++.+...++.++|||||||++|+|
T Consensus 137 ~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 211 (289)
T 4fvq_A 137 GNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211 (289)
T ss_dssp CCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHH
T ss_pred CCcCcceEEEecCCcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHH
Confidence 999999999998887 999999998655332 3456799999999998756789999999999999999
Q ss_pred HhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 ltG-~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++| .+||.+.......... ...... ...+++++.+||.+||+.||.+||
T Consensus 212 ~~g~~~~~~~~~~~~~~~~~-~~~~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rp 261 (289)
T 4fvq_A 212 CSGGDKPLSALDSQRKLQFY-EDRHQL-----------------------------PAPKAAELANLINNCMDYEPDHRP 261 (289)
T ss_dssp HTTTCCTTTTSCHHHHHHHH-HTTCCC-----------------------------CCCSSCTTHHHHHHHSCSSGGGSC
T ss_pred HcCCCCCccccchHHHHHHh-hccCCC-----------------------------CCCCCHHHHHHHHHHcCCChhHCc
Confidence 995 5666555544433332 211110 123467789999999999999999
Q ss_pred CHHHHHhc
Q 009654 231 TASAALAS 238 (529)
Q Consensus 231 ta~e~L~h 238 (529)
|+.+++++
T Consensus 262 s~~~ll~~ 269 (289)
T 4fvq_A 262 SFRAIIRD 269 (289)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=329.68 Aligned_cols=216 Identities=28% Similarity=0.411 Sum_probs=160.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCC------CCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK------FSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~------l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+++ +|||||++++++.+ ...+|||||||++++...+...... .++..+..++.||+.||+|||+
T Consensus 56 ~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 133 (434)
T 2rio_A 56 LMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133 (434)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH
Confidence 5799999987 89999999999987 5789999999988665555432211 1333567899999999999999
Q ss_pred CCCcccCCCCCcEEEccC-------------CcEEEeccccccccCCCCCC---CccccccccccCCcccccC------C
Q 009654 75 RGVLHRDIKGSNLLVNNE-------------GVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLG------A 132 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~-------------g~vKl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~------~ 132 (529)
+||+||||||+||||+.+ +.+||+|||++......... .....+||+.|+|||++.+ .
T Consensus 134 ~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 213 (434)
T 2rio_A 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213 (434)
T ss_dssp TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCC
T ss_pred CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccc
Confidence 999999999999999754 47999999999877543211 2335689999999999965 2
Q ss_pred CCCCCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCc
Q 009654 133 TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 211 (529)
Q Consensus 133 ~~y~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s 211 (529)
..++.++||||||||+|+|++ |.+||.+....+ ..+.......+.. .. .....++
T Consensus 214 ~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~----------------~~------~~~~~~~ 269 (434)
T 2rio_A 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM----------------KC------LHDRSLI 269 (434)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC----------------TT------CCCHHHH
T ss_pred cCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc----------------cc------cccccch
Confidence 468999999999999999999 999997765443 2333311111100 00 0012356
Q ss_pred HHHHHHHHHhccCCCCCCcCHHHHHhccccCC
Q 009654 212 TTAVNLIETLLSVEPYKRATASAALASEYFST 243 (529)
Q Consensus 212 ~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~ 243 (529)
+++.+||.+||+.||.+|||+.++|+||||..
T Consensus 270 ~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 88999999999999999999999999999963
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=310.37 Aligned_cols=207 Identities=22% Similarity=0.300 Sum_probs=160.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++++++.+ ...+|+||||++++.+..++.....+++.++..++.||+.||.|||++||+|||
T Consensus 82 ~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 159 (309)
T 2h34_A 82 QREARTAGRLQEPHVVPIHDFGEI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRD 159 (309)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHhhcCCCCeeEEEEEEee--CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCC
Confidence 579999999999999999999988 578999999999866666555556799999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 160 VKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp CCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred CChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999998765543334456688999999999976 46899999999999999999999999887
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-CHHHHHh
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-TASAALA 237 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-ta~e~L~ 237 (529)
+.......+ ...... .......+|+.+.+||.+||+.||.+|| |+.++++
T Consensus 239 ~~~~~~~~~-~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 239 QLSVMGAHI-NQAIPR-------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHH-HSCCCC-------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hHHHHHHHh-ccCCCC-------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 655333333 211111 0122356889999999999999999999 7777764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.37 Aligned_cols=207 Identities=25% Similarity=0.353 Sum_probs=171.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC------------------------CCCCCHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP------------------------DIKFSEA 56 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~------------------------~~~l~e~ 56 (529)
+.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..++.. ...+++.
T Consensus 97 ~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 174 (343)
T 1luf_A 97 FQREAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174 (343)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHH
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEcc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHH
Confidence 3589999999999999999999987 5689999999998666544322 1579999
Q ss_pred HHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCC
Q 009654 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDY 135 (529)
Q Consensus 57 ~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y 135 (529)
++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..|
T Consensus 175 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~ 253 (343)
T 1luf_A 175 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRY 253 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCc
Confidence 9999999999999999999999999999999999999999999999976543211 22234567999999999876 358
Q ss_pred CCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHH
Q 009654 136 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 214 (529)
Q Consensus 136 ~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~ 214 (529)
+.++|||||||++|+|++ |..||.+.+..+....+... ..+ .....+++.+
T Consensus 254 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l 305 (343)
T 1luf_A 254 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG--NIL--------------------------ACPENCPLEL 305 (343)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CCC--------------------------CCCTTCCHHH
T ss_pred CcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC--CcC--------------------------CCCCCCCHHH
Confidence 999999999999999999 99999998888777766542 110 0113578899
Q ss_pred HHHHHHhccCCCCCCcCHHHHHhc
Q 009654 215 VNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 215 ~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+||.+||+.||.+|||+.+++++
T Consensus 306 ~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 306 YNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCcccCCCHHHHHHH
Confidence 999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=306.75 Aligned_cols=212 Identities=22% Similarity=0.358 Sum_probs=161.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++++||||+++++++.. ..+|+|||||+++.+. .+......+++.++..++.||+.||.|||++||+|
T Consensus 67 ~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 143 (289)
T 3og7_A 67 FKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143 (289)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCcEEEEEeeccC---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3589999999999999999996543 4689999999986655 44455667999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCC-CCCCccccccccccCCcccccC--CCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~--~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||||+||||+.++.+||+|||++...... .........||+.|+|||++.. ...++.++|||||||++|+|++|..
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 223 (289)
T 3og7_A 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223 (289)
T ss_dssp SCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCC
Confidence 999999999999999999999999765432 1223345678999999999862 3457889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+..+......++. +......+|+.+.+||.+||..||.+|||+.++|
T Consensus 224 p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 280 (289)
T 3og7_A 224 PYSNINNRDQIIEMVGRGSLSPD-----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280 (289)
T ss_dssp TTSSCCCHHHHHHHHHHTSCCCC-----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CccccchHHHHHHHhcccccCcc-----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 99987766665555443221110 1122246889999999999999999999999998
Q ss_pred hc
Q 009654 237 AS 238 (529)
Q Consensus 237 ~h 238 (529)
+.
T Consensus 281 ~~ 282 (289)
T 3og7_A 281 AE 282 (289)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.13 Aligned_cols=209 Identities=21% Similarity=0.232 Sum_probs=171.7
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+++.| +||||+++++++.+ ...+|+||||+.+++...+......+++.++..++.||+.||.|||++||+||
T Consensus 53 ~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 130 (298)
T 1csn_A 53 RDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 130 (298)
T ss_dssp HHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred HHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 5899999999 89999999999887 67899999999555555555455579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCc-----EEEeccccccccCCCCC------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 81 DIKGSNLLVNNEGV-----LKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 81 DIKp~NILl~~~g~-----vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
||||+||||+.++. +||+|||++........ ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 131 Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ 209 (298)
T 1csn_A 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFM 209 (298)
T ss_dssp CCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHH
T ss_pred CCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHH
Confidence 99999999987765 99999999987654322 12345678999999999976 45899999999999999
Q ss_pred HHHhCCCCCCCC---CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCC
Q 009654 150 ELLIGKPILQGR---TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226 (529)
Q Consensus 150 elltG~~pf~g~---~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP 226 (529)
+|++|.+||.+. +..+.+..+......++ .......+|+++.+||.+||+.||
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dp 265 (298)
T 1csn_A 210 YFLRGSLPWQGLKAATNKQKYERIGEKKQSTP------------------------LRELCAGFPEEFYKYMHYARNLAF 265 (298)
T ss_dssp HHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC------------------------HHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred HHHcCCCCcchhhccccHHHHHHHHhhccCcc------------------------HHHHHhhCcHHHHHHHHHHhcCCc
Confidence 999999999874 34445555443221111 123335789999999999999999
Q ss_pred CCCcCHHHHHh
Q 009654 227 YKRATASAALA 237 (529)
Q Consensus 227 ~kR~ta~e~L~ 237 (529)
.+|||+.++++
T Consensus 266 ~~RP~~~~l~~ 276 (298)
T 1csn_A 266 DATPDYDYLQG 276 (298)
T ss_dssp TCCCCHHHHHH
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=306.04 Aligned_cols=206 Identities=21% Similarity=0.305 Sum_probs=167.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ ...|+||||++++.+..++ .....+++..+..++.||+.||.|||++||+|
T Consensus 60 ~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 136 (281)
T 3cc6_A 60 FMSEAVIMKNLDHPHIVKLIGIIEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVH 136 (281)
T ss_dssp HHHHHHHHHHHCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCcceEEEEEcC---CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3579999999999999999999865 3568999999986665444 34456999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 137 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~ 215 (281)
T 3cc6_A 137 RDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPF 215 (281)
T ss_dssp CCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999998765543333344567889999999975 458999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+......+ ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 216 FWLENKDVIGVLEKGDRLP----------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTSCGGGHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCChHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 8877766666554421111 013478899999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=302.65 Aligned_cols=207 Identities=23% Similarity=0.349 Sum_probs=173.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ ...+|+||||++++.+.. +......+++..+..++.||+.||.|||++||+|
T Consensus 50 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 127 (267)
T 3t9t_A 50 FIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127 (267)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3589999999999999999999987 567899999999865554 4444567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus 128 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp SSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCC
Confidence 9999999999999999999999998664432223344567889999999975 458999999999999999999 89999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+....+....... ....++..+.+||.+||+.||.+|||+.+++++
T Consensus 207 ~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 207 ENRSNSEVVEDISTGFRLY----------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCcCC----------------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9988888777765421110 012468889999999999999999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.53 Aligned_cols=206 Identities=18% Similarity=0.271 Sum_probs=169.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+. ..++|+||+.++.+. .+......+++..+..++.||+.||.|||++||+|
T Consensus 64 ~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 140 (327)
T 3poz_A 64 ILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140 (327)
T ss_dssp HHHHHHHHHHCCBTTBCCEEEEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeC
Confidence 35799999999999999999999873 478999999886555 44445668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||||+||||+.++.+||+|||+++........ ......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+|
T Consensus 141 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp SCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 999999999999999999999999876543222 2234456889999999976 468999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+......+ ....++..+.+||.+||..||.+|||+.++|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 220 YDGIPASEISSILEKGERLP----------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TTTCCGGGHHHHHHTTCCCC----------------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99887766655554321111 01346788999999999999999999999997
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
+
T Consensus 272 ~ 272 (327)
T 3poz_A 272 E 272 (327)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=314.98 Aligned_cols=209 Identities=22% Similarity=0.285 Sum_probs=170.2
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCC----------------------CCCCHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPD----------------------IKFSEA 56 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~----------------------~~l~e~ 56 (529)
+.+|+.+|++| +||||+++++++.+ ...+|||||||+++.+..++ ... ..+++.
T Consensus 95 ~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 172 (344)
T 1rjb_A 95 LMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172 (344)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHH
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHH
Confidence 35899999999 99999999999987 56799999999986555443 222 238999
Q ss_pred HHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCC
Q 009654 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDY 135 (529)
Q Consensus 57 ~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y 135 (529)
.+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..|
T Consensus 173 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~ 251 (344)
T 1rjb_A 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIY 251 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCC
Confidence 99999999999999999999999999999999999999999999999866543221 2234466889999999876 458
Q ss_pred CCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHH
Q 009654 136 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 214 (529)
Q Consensus 136 ~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~ 214 (529)
+.++||||||||+|+|++ |.+||.+......+..+......++ ....+++++
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l 304 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD---------------------------QPFYATEEI 304 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC---------------------------CCTTCCHHH
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC---------------------------CCCCCCHHH
Confidence 999999999999999998 9999998776555555544211110 013578899
Q ss_pred HHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 215 VNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 215 ~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
.+||.+||..||.+|||+.+++++-
T Consensus 305 ~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 305 YIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=306.09 Aligned_cols=206 Identities=19% Similarity=0.310 Sum_probs=172.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++|+||||+++++++.+ ...+|+|||||+++.+..+.. ....+++..+..++.||+.||.|||++||+
T Consensus 56 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 133 (288)
T 3kfa_A 56 FLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133 (288)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcc--CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCcc
Confidence 3589999999999999999999977 567999999999755554432 345699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 134 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p 212 (288)
T 3kfa_A 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP 212 (288)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998776543333445567889999999976 358999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+.......+...... .....+|+.+.+||.+||..||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 213 YPGIDLSQVYELLEKDYRM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp STTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHhccCCC----------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9988776666655432111 011357899999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.62 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=170.1
Q ss_pred HHHHHHHHhCC--CCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~--HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|+++. ||||+++++++.+ ...+|+|||++.+ +.+..++.....+++..+..++.||+.||.|||++||+
T Consensus 94 ~~E~~~l~~l~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv 171 (320)
T 3a99_A 94 PMEVVLLKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 171 (320)
T ss_dssp EHHHHHHHHHCSSSCSBCCEEEEEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhhccCCCCceEEEEEEec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 47999999995 5999999999987 5789999999985 44554444456899999999999999999999999999
Q ss_pred ccCCCCCcEEEc-cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 79 HRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
||||||+||||+ +++.+||+|||++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|..|
T Consensus 172 H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred eCCCCHHHEEEeCCCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 999999999999 6789999999999876543 334567899999999997755567899999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+... +.. +.. .....+++++.+||.+||..||.+|||+.++|+
T Consensus 249 f~~~~~------~~~--~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 249 FEHDEE------IIR--GQV---------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCSHHH------HHH--CCC---------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCChhh------hhc--ccc---------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 975321 111 110 001357899999999999999999999999999
Q ss_pred ccccCCC
Q 009654 238 SEYFSTK 244 (529)
Q Consensus 238 h~~f~~~ 244 (529)
||||+..
T Consensus 294 hp~~~~~ 300 (320)
T 3a99_A 294 HPWMQDV 300 (320)
T ss_dssp SGGGSSC
T ss_pred CHhhcCc
Confidence 9999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=308.51 Aligned_cols=208 Identities=21% Similarity=0.301 Sum_probs=170.4
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CC-----------------CCCCHHHHHHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PD-----------------IKFSEAQIKCY 61 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~-----------------~~l~e~~~~~i 61 (529)
+.+|+.+|++| +||||+++++++.+ ...+|+|||||+++.+..++. .. ..+++.++..+
T Consensus 73 ~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (313)
T 1t46_A 73 LMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (313)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred HHHHHHHHhhcccCCCeeeEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHH
Confidence 35899999999 99999999999987 567899999999855554432 21 24899999999
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcch
Q 009654 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 140 (529)
Q Consensus 62 ~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~D 140 (529)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|
T Consensus 151 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 229 (313)
T 1t46_A 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESD 229 (313)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHH
Confidence 999999999999999999999999999999999999999999876544221 1234466889999999876 45899999
Q ss_pred hhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHH
Q 009654 141 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 219 (529)
Q Consensus 141 IWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~ 219 (529)
||||||++|+|++ |.+||.+......+..+......+. ....++..+.+||.
T Consensus 230 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 282 (313)
T 1t46_A 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMK 282 (313)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC---------------------------CcccCCHHHHHHHH
Confidence 9999999999998 9999998776555555444221110 01357889999999
Q ss_pred HhccCCCCCCcCHHHHHhc
Q 009654 220 TLLSVEPYKRATASAALAS 238 (529)
Q Consensus 220 ~mL~~dP~kR~ta~e~L~h 238 (529)
+||..||.+|||+.+++++
T Consensus 283 ~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 283 TCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCchhCcCHHHHHHH
Confidence 9999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.51 Aligned_cols=204 Identities=15% Similarity=0.190 Sum_probs=170.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRG-- 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~--~l~e~~~~~i~~Qll~gL~~LH~~g-- 76 (529)
+.+|+.+|++|+||||+++++++.+.....+|+|||||+++.+..++.... .+++.++..++.||+.||.|||++|
T Consensus 54 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ 133 (271)
T 3kmu_A 54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133 (271)
T ss_dssp HHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSC
T ss_pred HHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCc
Confidence 358999999999999999999998865578999999999866655443333 5999999999999999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC--CCCCcchhhhhhHHHHHHHhC
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~y~~~~DIWSlG~il~elltG 154 (529)
|+||||||+|||++.++.++|+|||++..... ....+|+.|+|||++.+.. .++.++|||||||++|+|++|
T Consensus 134 i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 207 (271)
T 3kmu_A 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207 (271)
T ss_dssp CTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHC
T ss_pred eecCCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999998754322 3457899999999997632 223379999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.+..+....+......+. ....+++.+.+||.+||+.||.+|||+.+
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (271)
T 3kmu_A 208 EVPFADLSNMEIGMKVALEGLRPT---------------------------IPPGISPHVSKLMKICMNEDPAKRPKFDM 260 (271)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCccccChHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999888877766654221111 11357899999999999999999999999
Q ss_pred HHh
Q 009654 235 ALA 237 (529)
Q Consensus 235 ~L~ 237 (529)
+++
T Consensus 261 il~ 263 (271)
T 3kmu_A 261 IVP 263 (271)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.49 Aligned_cols=213 Identities=17% Similarity=0.137 Sum_probs=169.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+++.++||||+++++++.+. ....+||||||| ++.+..++.....+++.++..++.||+.||.|||++||+|
T Consensus 96 ~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 174 (345)
T 2v62_A 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVH 174 (345)
T ss_dssp HHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 4788899999999999999998773 246899999999 6555655555558999999999999999999999999999
Q ss_pred cCCCCCcEEEccCC--cEEEeccccccccCCCC------CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 80 RDIKGSNLLVNNEG--VLKLADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 80 rDIKp~NILl~~~g--~vKl~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
|||||+||||+.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 175 ~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el 253 (345)
T 2v62_A 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRW 253 (345)
T ss_dssp SCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHH
Confidence 99999999999877 99999999997664321 112245678999999999987 4589999999999999999
Q ss_pred HhCCCCCCCC--CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhcc--CCcHHHHHHHHHhccCCCC
Q 009654 152 LIGKPILQGR--TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 152 ltG~~pf~g~--~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~--~~s~~~~dLi~~mL~~dP~ 227 (529)
++|.+||.+. +...............+.. +..... .+|+++.+||.+||..||.
T Consensus 254 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~ 311 (345)
T 2v62_A 254 LCGKLPWEQNLKDPVAVQTAKTNLLDELPQS----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYD 311 (345)
T ss_dssp HHSSCTTGGGTTCHHHHHHHHHHHHHTTTHH----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTT
T ss_pred HhCCCCccccccccHHHHHHHHhhcccccHH----------------------HHhhccccccHHHHHHHHHHHhhcCcc
Confidence 9999999653 3333333222222222211 112222 6899999999999999999
Q ss_pred CCcCHHHHHhc
Q 009654 228 KRATASAALAS 238 (529)
Q Consensus 228 kR~ta~e~L~h 238 (529)
+|||+.++++.
T Consensus 312 ~Rps~~~l~~~ 322 (345)
T 2v62_A 312 EKPNYQALKKI 322 (345)
T ss_dssp CCCCHHHHHHH
T ss_pred cCCCHHHHHHH
Confidence 99999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.13 Aligned_cols=203 Identities=26% Similarity=0.442 Sum_probs=166.4
Q ss_pred HHHHHHHHhC----CCCCccceeeEEEccCCCeEEEEEec-cCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRL----DHPNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L----~HpnIvkl~~~~~~~~~~~~~lV~E~-~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.+++++ +||||+++++++.+ ...+|+|||| +.++.+..++.....+++.++..++.||+.||.|||++|
T Consensus 82 ~~e~~~l~~l~~~~~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 159 (312)
T 2iwi_A 82 PLEVALLWKVGAGGGHPGVIRLLDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG 159 (312)
T ss_dssp CHHHHHHHHHHSSCCCSSBCCEEEEC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhhcccCCCCCeeeEEEEEec--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4799999999 89999999999887 4678999999 677666655545567999999999999999999999999
Q ss_pred CcccCCCCCcEEEc-cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 77 VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 77 IvHrDIKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+...++.++||||||||+|+|++|+
T Consensus 160 i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred eeecCCChhhEEEeCCCCeEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence 99999999999999 7899999999999876543 3455678999999999976554566899999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
.||.+... +... .. .....++..+.+||.+||..||.+|||+.++
T Consensus 237 ~pf~~~~~------~~~~--~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 237 IPFERDQE------ILEA--EL---------------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp CSCCSHHH------HHHT--CC---------------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCChHH------Hhhh--cc---------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99975321 2111 00 0013578899999999999999999999999
Q ss_pred HhccccCCC
Q 009654 236 LASEYFSTK 244 (529)
Q Consensus 236 L~h~~f~~~ 244 (529)
|+||||+..
T Consensus 282 l~~~~~~~~ 290 (312)
T 2iwi_A 282 LLDPWMQTP 290 (312)
T ss_dssp HHSTTTCC-
T ss_pred hcChhhcCc
Confidence 999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=315.36 Aligned_cols=214 Identities=24% Similarity=0.348 Sum_probs=144.7
Q ss_pred HHHHhCCCCCccceeeEEEccC--CCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 6 LILRRLDHPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 6 ~iL~~L~HpnIvkl~~~~~~~~--~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
..++.+.||||+++++++.... ...+|||||||+++.+..++.. ...+++.+++.++.||+.||.|||++||+|||
T Consensus 74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~d 153 (336)
T 3fhr_A 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 153 (336)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 3466679999999999987622 3458999999998655544432 24699999999999999999999999999999
Q ss_pred CCCCcEEEccC---CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 82 IKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 82 IKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
|||+||||+.+ +.+||+|||++...... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||
T Consensus 154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCHHHEEEEecCCCceEEEeccccceecccc---ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999764 55999999999866532 2345678999999999865 45889999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+.......+........ ..+. ...+..+++++.+||.+||..||.+|||+.++|+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~------------------~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQ------------------YGFP---NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---------------------------------------CCC---TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccchhhhhhHHHhhhccc------------------cccC---chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 87665443222111100000 0000 12235689999999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||+..
T Consensus 289 p~~~~~ 294 (336)
T 3fhr_A 289 PWINQS 294 (336)
T ss_dssp HHHHTG
T ss_pred cccccc
Confidence 999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.48 Aligned_cols=206 Identities=25% Similarity=0.411 Sum_probs=161.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 93 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (373)
T 2qol_A 93 FLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170 (373)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEee--CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 3689999999999999999999987 56889999999886666444 44557999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCcc--ccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT--SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+||||+.++.+||+|||++............ ...+|+.|+|||++.+ ..|+.++||||||||+|+|++ |.+
T Consensus 171 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred CCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876543222222 2345788999999976 458999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+....+......+. ...++..+.+||.+||+.||.+|||+.+++
T Consensus 250 P~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~ 301 (373)
T 2qol_A 250 PYWEMSNQDVIKAVDEGYRLPP----------------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301 (373)
T ss_dssp TTTTCCHHHHHHHHHTTEECCC----------------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCC----------------------------CccccHHHHHHHHHHhCcChhhCcCHHHHH
Confidence 9999888777776644221110 125788999999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 302 ~ 302 (373)
T 2qol_A 302 S 302 (373)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.69 Aligned_cols=207 Identities=20% Similarity=0.257 Sum_probs=173.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.. ..+|+||||++++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 57 ~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 133 (287)
T 1u59_A 57 MMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133 (287)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCEeEEEEEecC---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 3589999999999999999999954 4689999999986666544 45567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+
T Consensus 134 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999987654321 12233456899999999975 458999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+....+... ..+ .....+|+.+.+||.+||..||.+|||+.+++
T Consensus 213 p~~~~~~~~~~~~i~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 264 (287)
T 1u59_A 213 PYKKMKGPEVMAFIEQG--KRM--------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVE 264 (287)
T ss_dssp TTTTCCTHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CcccCCHHHHHHHHhcC--CcC--------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99998887777666441 110 01136789999999999999999999999999
Q ss_pred hcc
Q 009654 237 ASE 239 (529)
Q Consensus 237 ~h~ 239 (529)
++.
T Consensus 265 ~~l 267 (287)
T 1u59_A 265 QRM 267 (287)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=311.11 Aligned_cols=204 Identities=26% Similarity=0.344 Sum_probs=168.7
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC----------------CCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~----------------~~l~e~~~~~i~~Q 64 (529)
.+|+.+|++| +||||+++++++.+ ...+|||||||+++.+..++... ..+++.++..++.|
T Consensus 73 ~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 150 (327)
T 1fvr_A 73 AGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150 (327)
T ss_dssp HHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCchhhhceeeee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHH
Confidence 5799999999 99999999999988 57899999999886555444332 37999999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
|+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||
T Consensus 151 i~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 227 (327)
T 1fvr_A 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSY 227 (327)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHH
T ss_pred HHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHH
Confidence 999999999999999999999999999999999999998744322 12234466889999999976 458999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
|||+|+|++ |.+||.+.+..+....+...... .....+++.+.+||.+||.
T Consensus 228 G~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~ 279 (327)
T 1fvr_A 228 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL----------------------------EKPLNCDDEVYDLMRQCWR 279 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC----------------------------CCCTTBCHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC----------------------------CCCCCCCHHHHHHHHHHcc
Confidence 999999998 99999998887776665331100 0113578899999999999
Q ss_pred CCCCCCcCHHHHHhc
Q 009654 224 VEPYKRATASAALAS 238 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h 238 (529)
.||.+|||+.++|++
T Consensus 280 ~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 280 EKPYERPSFAQILVS 294 (327)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.01 Aligned_cols=205 Identities=22% Similarity=0.354 Sum_probs=172.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~--~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++|+||||+++++++.+ ..+|+||||++++.+..++... ..+++.++..++.||+.||.|||++||+
T Consensus 55 ~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 131 (279)
T 1qpc_A 55 FLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131 (279)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhCCCcCcceEEEEEcC---CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3589999999999999999999865 3589999999987666655432 2699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 132 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p 210 (279)
T 1qpc_A 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIP 210 (279)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998776543333344566889999999975 358899999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+....... ....+++.+.+||.+||..||.+|||+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 211 YPGMTNPEVIQNLERGYRMV----------------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp STTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccCHHHHHHHHhcccCCC----------------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99988887777664421100 01357889999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=310.03 Aligned_cols=206 Identities=16% Similarity=0.256 Sum_probs=171.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------CCCCCHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEH 71 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------~~~l~e~~~~~i~~Qll~gL~~ 71 (529)
.+|+.+|+.|+||||+++++++.+ ...+|+|||||+++.+..++.. ...+++.++..++.||+.||.|
T Consensus 76 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 153 (322)
T 1p4o_A 76 LNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153 (322)
T ss_dssp HHHHHHGGGCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCEeeeEEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHH
Confidence 589999999999999999999977 5678999999998655544321 2467999999999999999999
Q ss_pred HHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 72 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 72 LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+
T Consensus 154 lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e 232 (322)
T 1p4o_A 154 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWE 232 (322)
T ss_dssp HHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHH
T ss_pred HHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999999999976543211 12234466899999999876 458999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 151 LLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 151 llt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
|++ |.+||.+.+..+....+... ... .....++..+.+||.+||..||.+|
T Consensus 233 l~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~R 284 (322)
T 1p4o_A 233 IATLAEQPYQGLSNEQVLRFVMEG--GLL--------------------------DKPDNCPDMLFELMRMCWQYNPKMR 284 (322)
T ss_dssp HHHTSCCTTTTSCHHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhcCCCccccCCHHHHHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHHHHcCCCcccC
Confidence 999 89999998887777666442 110 0113578899999999999999999
Q ss_pred cCHHHHHhc
Q 009654 230 ATASAALAS 238 (529)
Q Consensus 230 ~ta~e~L~h 238 (529)
||+.+++++
T Consensus 285 ps~~e~l~~ 293 (322)
T 1p4o_A 285 PSFLEIISS 293 (322)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.51 Aligned_cols=206 Identities=19% Similarity=0.263 Sum_probs=168.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+||||+++++++... ....|+|||||+++.+.. +......+++.++..++.||+.||.|||++||+||
T Consensus 74 ~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 152 (298)
T 3f66_A 74 LTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152 (298)
T ss_dssp HHHHHHHHTCCCTTBCCCCEEECCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHhCCCCCEeeeeeEEEcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 5899999999999999999987654 467899999999965554 44456679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+
T Consensus 153 dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp CCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999986643221 12334567889999999976 458999999999999999999 778
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+....+......+. ...++..+.+||.+||..||.+|||+.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell 283 (298)
T 3f66_A 232 PYPDVNTFDITVYLLQGRRLLQ----------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 283 (298)
T ss_dssp SSTTSCTTTHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCccCCHHHHHHHHhcCCCCCC----------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 8888777666666544211110 134688899999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 284 ~ 284 (298)
T 3f66_A 284 S 284 (298)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.36 Aligned_cols=213 Identities=27% Similarity=0.441 Sum_probs=164.5
Q ss_pred HHHHHHHHhCC--CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 2 AREILILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 2 ~rEi~iL~~L~--HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
.+|+.+|++|. ||||+++++++.+ ...+|||||++.+++...+. ....+++.++..++.||+.||.|||++||+|
T Consensus 74 ~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 150 (313)
T 3cek_A 74 RNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 150 (313)
T ss_dssp HHHHHHHHHHGGGCTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhccccCCceEEEEEEeec--CCEEEEEEecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 58999999996 5999999999987 56899999966655555544 4458999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCC----------CCCCCcchhhhhhHHH
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVF 148 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~----------~~y~~~~DIWSlG~il 148 (529)
|||||+|||++ ++.+||+|||++......... .....++|+.|+|||++.+. ..++.++|||||||++
T Consensus 151 ~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il 229 (313)
T 3cek_A 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229 (313)
T ss_dssp CCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHH
T ss_pred cCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHH
Confidence 99999999996 489999999999876543211 22345789999999998652 3588899999999999
Q ss_pred HHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 149 AELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 149 ~elltG~~pf~g~~~-~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
|+|++|..||.+... ...+..+....... ......+..+.+||.+||..||.
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~ 282 (313)
T 3cek_A 230 YYMTYGKTPFQQIINQISKLHAIIDPNHEI---------------------------EFPDIPEKDLQDVLKCCLKRDPK 282 (313)
T ss_dssp HHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---------------------------CCCCCSCHHHHHHHHHHTCSSTT
T ss_pred HHHHhCCCchhhHHHHHHHHHHHHhccccc---------------------------CCcccchHHHHHHHHHHccCCcc
Confidence 999999999987543 33333332211000 00124578899999999999999
Q ss_pred CCcCHHHHHhccccCCCC
Q 009654 228 KRATASAALASEYFSTKP 245 (529)
Q Consensus 228 kR~ta~e~L~h~~f~~~~ 245 (529)
+|||+.++|+||||+...
T Consensus 283 ~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 283 QRISIPELLAHPYVQIQT 300 (313)
T ss_dssp TSCCHHHHHTSHHHHCC-
T ss_pred cCcCHHHHhcCccccCCC
Confidence 999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.49 Aligned_cols=206 Identities=18% Similarity=0.270 Sum_probs=164.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+. ..++|+||+.++.+. .+......+++..+..++.||+.||.|||++||+|
T Consensus 64 ~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 140 (327)
T 3lzb_A 64 ILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140 (327)
T ss_dssp HHHHHHHHTTCCBTTBCCCCEEEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCeeEEEEEEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcC
Confidence 35799999999999999999999873 488999999885554 44445668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+|
T Consensus 141 ~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p 219 (327)
T 3lzb_A 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp SCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987654321 12234456889999999986 458999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+......+ ....++.++.+||.+||..||.+|||+.++|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 220 YDGIPASEISSILEKGERLP----------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TTTCCGGGHHHHHHTTCCCC----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99888777666554421111 01347888999999999999999999999996
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
.
T Consensus 272 ~ 272 (327)
T 3lzb_A 272 E 272 (327)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=319.47 Aligned_cols=206 Identities=25% Similarity=0.365 Sum_probs=169.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ ...+|||||||+++.+. .+......+++.++..++.||+.||+|||++||+|
T Consensus 159 ~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 236 (377)
T 3cbl_A 159 FLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236 (377)
T ss_dssp TTHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEec--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCC
Confidence 4689999999999999999999977 46789999999875554 44434456999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCc-cccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||||+||||+.++.+||+|||++........... ....+++.|+|||++.+ ..|+.++|||||||++|||++ |.+|
T Consensus 237 rDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p 315 (377)
T 3cbl_A 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASP 315 (377)
T ss_dssp SCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986543211111 12345788999999975 358999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+.... .++ ....+|+.+.+||.+||+.||.+|||+.++++
T Consensus 316 ~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 316 YPNLSNQQTREFVEKGG-RLP---------------------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp STTSCHHHHHHHHHTTC-CCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC-CCC---------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99988777666554321 110 01347889999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=304.61 Aligned_cols=208 Identities=19% Similarity=0.260 Sum_probs=164.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCC---eEEEEEeccCCCchhhhc------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSC---SIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~---~~~lV~E~~~g~ll~~~~------~~~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
.+|+.+|++|+||||+++++++.+.... ..|+||||++++.+..++ .....+++.++..++.||+.||.||
T Consensus 84 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 163 (313)
T 3brb_A 84 LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163 (313)
T ss_dssp HHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH
Confidence 5799999999999999999999874322 469999999986665443 3445799999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 73 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 73 H~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
|++||+||||||+||||+.++.+||+|||++........ .......+++.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 164 H~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el 242 (313)
T 3brb_A 164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEI 242 (313)
T ss_dssp HTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHH
T ss_pred HhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHH
Confidence 999999999999999999999999999999986644321 12234456889999999976 4689999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 152 LI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 152 lt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
++ |.+||.+.+..+....+...... .....+++.+.+||.+||..||.+||
T Consensus 243 ~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rp 294 (313)
T 3brb_A 243 ATRGMTPYPGVQNHEMYDYLLHGHRL----------------------------KQPEDCLDELYEIMYSCWRTDPLDRP 294 (313)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCC----------------------------CCBTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred HhcCCCCCccCCHHHHHHHHHcCCCC----------------------------CCCccccHHHHHHHHHHcCCChhhCc
Confidence 99 99999988877776666442111 01136788999999999999999999
Q ss_pred CHHHHHhc
Q 009654 231 TASAALAS 238 (529)
Q Consensus 231 ta~e~L~h 238 (529)
|+.+++++
T Consensus 295 s~~~l~~~ 302 (313)
T 3brb_A 295 TFSVLRLQ 302 (313)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=306.66 Aligned_cols=224 Identities=21% Similarity=0.309 Sum_probs=162.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.......+|||||||+++.+..++ .....+++.++..++.||+.||.|||++||+|
T Consensus 58 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (295)
T 3ugc_A 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137 (295)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 35899999999999999999998765456789999999886555443 44456999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++|..|
T Consensus 138 ~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEK 216 (295)
T ss_dssp SCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred CCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999987654321 12234456888999999976 4589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|...... . ....+..+...+....+... ...... ......+|+++.+||.+||..||.+|||+.++++
T Consensus 217 ~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 217 SKSPPAE--F---MRMIGNDKQGQMIVFHLIEL--LKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TCSHHHH--H---HHHHCTTCCTHHHHHHHHHH--HHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCChHH--H---HhhhcCccccchhHHHHHHH--HhccCc-----CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8643211 1 11111111100000000000 000000 0112467899999999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=300.60 Aligned_cols=206 Identities=22% Similarity=0.323 Sum_probs=168.6
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+||||+++++++.+. ....|+||||+.++.+. .+......+++.++..++.||+.||.|||++||+||
T Consensus 70 ~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~ 148 (298)
T 3pls_A 70 LREGLLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148 (298)
T ss_dssp HHHHHHHHTCCCTTBCCCCEEECCS-SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHhCCCCCeeeEEEEEecC-CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 5899999999999999999999774 34458999999875554 454556789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCC---CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
||||+|||++.++.+||+|||++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+
T Consensus 149 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~ 227 (298)
T 3pls_A 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAP 227 (298)
T ss_dssp CCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred CCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCC
Confidence 999999999999999999999997654321 122334567899999999976 458999999999999999999 567
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+....+......+ ....+++.+.+||.+||+.||.+|||+.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 279 (298)
T 3pls_A 228 PYRHIDPFDLTHFLAQGRRLP----------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279 (298)
T ss_dssp TTTTSCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCccCCHHHHHHHhhcCCCCC----------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHH
Confidence 777776666665554422111 0135788999999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 280 ~ 280 (298)
T 3pls_A 280 G 280 (298)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.29 Aligned_cols=208 Identities=22% Similarity=0.314 Sum_probs=168.7
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC----------------CCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI----------------KFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~----------------~l~e~~~~~i~~Q 64 (529)
.+|+.+|+++ +||||+++++++... ...+|+|||||+++.+..++.... .+++.++..++.|
T Consensus 78 ~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 156 (316)
T 2xir_A 78 MSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156 (316)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCeeeEEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHH
Confidence 5899999999 799999999998764 456899999999866655443322 2899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++||||
T Consensus 157 i~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~s 235 (316)
T 2xir_A 157 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWS 235 (316)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHH
T ss_pred HHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHH
Confidence 99999999999999999999999999999999999999986654321 12234567899999999976 45899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|+|++ |.+||.+.+..+.+.........+. ....+++.+.+||.+||
T Consensus 236 lG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l 288 (316)
T 2xir_A 236 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCW 288 (316)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC---------------------------CCCCCCHHHHHHHHHHc
Confidence 9999999998 9999988765444433333211110 01347889999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
..||.+|||+.++++|
T Consensus 289 ~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 289 HGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.77 Aligned_cols=214 Identities=19% Similarity=0.190 Sum_probs=164.5
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCC--CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~--~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+|+.+++.++||||+++++++..... ..+|||||||.+++...+......+++.++..++.||+.||.|||++||+||
T Consensus 97 ~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHr 176 (364)
T 3op5_A 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHG 176 (364)
T ss_dssp HHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEe
Confidence 56677788889999999999876422 5689999999444544554555789999999999999999999999999999
Q ss_pred CCCCCcEEEc--cCCcEEEeccccccccCCCCC------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 81 DIKGSNLLVN--NEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 81 DIKp~NILl~--~~g~vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
||||+||||+ .++.+||+|||+++.+..... ......+||+.|+|||++.+. .|+.++||||||||||+|+
T Consensus 177 Dlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHH
T ss_pred cCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHH
Confidence 9999999999 789999999999976643211 122345699999999999774 5899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc--cCCcHHHHHHHHHhccCCCCCCc
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~--~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
+|.+||.+......+.........+.. ...+...+ ..+|+++.+||..||..||.+||
T Consensus 256 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 256 TGHLPWEDNLKDPKYVRDSKIRYRENI--------------------ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHHHCH--------------------HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCC
T ss_pred hCCCCccccccCHHHHHHHHHHhhhhH--------------------HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCC
Confidence 999999864333322222111100000 00011111 46799999999999999999999
Q ss_pred CHHHHHh
Q 009654 231 TASAALA 237 (529)
Q Consensus 231 ta~e~L~ 237 (529)
++.++++
T Consensus 316 ~~~~l~~ 322 (364)
T 3op5_A 316 LYENLRD 322 (364)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=312.99 Aligned_cols=221 Identities=21% Similarity=0.266 Sum_probs=167.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD----IKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~----~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
+.+|+.+|+.|+||||+++++++.+ ...+|+|||||+++.+..++... ..+++.++..++.||+.||.|||++|
T Consensus 82 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 159 (321)
T 2qkw_B 82 FETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159 (321)
T ss_dssp HHHHHHGGGSCCCTTBCCEEEECCC--TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC
Confidence 3589999999999999999999877 56889999999986666554322 35999999999999999999999999
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|+||||||+|||++.++.+||+|||++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 160 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~ 238 (321)
T 2qkw_B 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCAR 238 (321)
T ss_dssp EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCC
T ss_pred eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCC
Confidence 9999999999999999999999999998654322 122344568999999999876 35899999999999999999999
Q ss_pred CCCCCCCHHHHHHHH---HHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 156 PILQGRTEVEQLHKI---FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I---~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
+||.+....+....+ ....... .+.. ...+. .. ......++..+.+||.+||..||++|||+
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~--~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (321)
T 2qkw_B 239 SAIVQSLPREMVNLAEWAVESHNNG--------QLEQ--IVDPN--LA---DKIRPESLRKFGDTAVKCLALSSEDRPSM 303 (321)
T ss_dssp TTCSCSSSSSCCCHHHHTHHHHTTT--------CCCS--SSSSS--CT---TCSCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred CcccccCcHHHHHHHHHhhhccccc--------cHHH--hcChh--hc---cccCHHHHHHHHHHHHHHcCCCcccCcCH
Confidence 999765432211111 0000000 0000 00000 00 01112456789999999999999999999
Q ss_pred HHHHhcc
Q 009654 233 SAALASE 239 (529)
Q Consensus 233 ~e~L~h~ 239 (529)
.++|++-
T Consensus 304 ~ell~~L 310 (321)
T 2qkw_B 304 GDVLWKL 310 (321)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.87 Aligned_cols=228 Identities=22% Similarity=0.250 Sum_probs=166.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC--CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR---- 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~--~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~---- 75 (529)
.+|+.+|++|+|||||++++++.+.. ...+|||||||+++.+..++.. ..+++.++..++.||+.||.|||+.
T Consensus 66 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l 144 (322)
T 3soc_A 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGL 144 (322)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 46899999999999999999998753 2358999999999666655533 3699999999999999999999999
Q ss_pred ------CCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCC----CCCCCcchhhhh
Q 009654 76 ------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSV 144 (529)
Q Consensus 76 ------gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~----~~y~~~~DIWSl 144 (529)
||+||||||+||||+.++.+||+|||++........ ......+||+.|+|||++.+. ..++.++|||||
T Consensus 145 ~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp TTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred ccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 999999999999999999999999999977654322 223456889999999999763 235568899999
Q ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc--cCCcHHHHHHHHHhc
Q 009654 145 GCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLL 222 (529)
Q Consensus 145 G~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~--~~~s~~~~dLi~~mL 222 (529)
|||+|+|++|.+||.+................+....+....... ...+ . +...+ ...++++.+||.+||
T Consensus 225 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~----~~~~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK--KKRP--V----LRDYWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp HHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS--CCCC--C----CCGGGGSSHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc--cCCC--C----ccccccccchHHHHHHHHHHHc
Confidence 999999999999998754322111111111122111111000000 0000 0 01111 123566999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
+.||.+|||+.++++.
T Consensus 297 ~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 297 DHDAEARLSAGCVGER 312 (322)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.40 Aligned_cols=205 Identities=21% Similarity=0.346 Sum_probs=171.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||++++++.. ..+|||||||+++.+..++.. ...+++.++..++.||+.||+|||++||+
T Consensus 230 ~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 306 (454)
T 1qcf_A 230 FLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306 (454)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEeC---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4689999999999999999999864 468999999998666554432 23689999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||||+.++.+||+|||+++..............+|+.|+|||++.. ..|+.++|||||||+||||++ |.+|
T Consensus 307 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P 385 (454)
T 1qcf_A 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIP 385 (454)
T ss_dssp CSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765432222234456789999999975 458999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+......+. ...+|+++.+||.+||..||.+|||+.++++
T Consensus 386 ~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 386 YPGMSNPEVIRALERGYRMPR----------------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp STTCCHHHHHHHHHHTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCC----------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999998888877765321110 1357899999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=311.40 Aligned_cols=213 Identities=23% Similarity=0.382 Sum_probs=150.6
Q ss_pred HHHH-HHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 009654 3 REIL-ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSR-G 76 (529)
Q Consensus 3 rEi~-iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~----~~~~~l~e~~~~~i~~Qll~gL~~LH~~-g 76 (529)
+|+. +++.++||||+++++++.+ ...+|||||||++++...+. .....+++..+..++.||+.||.|||++ |
T Consensus 69 ~e~~~~~~~~~h~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 146 (327)
T 3aln_A 69 MDLDVVMRSSDCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146 (327)
T ss_dssp HHHHHHHSSCCCTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCcEeeeeeEEEe--CCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence 4555 7777899999999999988 57899999999997655443 2356899999999999999999999999 9
Q ss_pred CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc---CCCCCCCcchhhhhhHHHHHHHh
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~y~~~~DIWSlG~il~ellt 153 (529)
|+||||||+||||+.++.+||+|||++....... ......||+.|+|||++. ....|+.++||||||||+|+|++
T Consensus 147 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~ 224 (327)
T 3aln_A 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224 (327)
T ss_dssp CCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHH
T ss_pred EeECCCCHHHEEEcCCCCEEEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999999999997665432 233457899999999984 23458999999999999999999
Q ss_pred CCCCCCCCCHH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCH
Q 009654 154 GKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 232 (529)
Q Consensus 154 G~~pf~g~~~~-~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta 232 (529)
|..||.+.... +.+..+.. +.++ .+. ......+++.+.+||.+||..||.+|||+
T Consensus 225 g~~pf~~~~~~~~~~~~~~~--~~~~-------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 280 (327)
T 3aln_A 225 GRFPYPKWNSVFDQLTQVVK--GDPP-------------------QLS---NSEEREFSPSFINFVNLCLTKDESKRPKY 280 (327)
T ss_dssp SCCCSSCC-------CCCCC--SCCC-------------------CCC---CCSSCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCcchHHHHHHHHhc--CCCC-------------------CCC---CcccccCCHHHHHHHHHHhhCChhhCcCH
Confidence 99999864322 11111100 0000 000 11124688999999999999999999999
Q ss_pred HHHHhccccCC
Q 009654 233 SAALASEYFST 243 (529)
Q Consensus 233 ~e~L~h~~f~~ 243 (529)
.++|+||||..
T Consensus 281 ~ell~hp~~~~ 291 (327)
T 3aln_A 281 KELLKHPFILM 291 (327)
T ss_dssp HHHTTSHHHHH
T ss_pred HHHHhChHHHH
Confidence 99999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=307.16 Aligned_cols=207 Identities=24% Similarity=0.362 Sum_probs=166.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..+ ......+++.++..++.||+.||.|||++||+|
T Consensus 93 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (333)
T 1mqb_A 93 FLGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170 (333)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEec--CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 3589999999999999999999977 5689999999998666544 445568999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCC--ccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+||||+.++.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||||+|+|++ |..
T Consensus 171 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999998765432111 123345789999999976 458999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+..+......+ ....++..+.+||.+||+.||.+|||+.+++
T Consensus 250 pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 301 (333)
T 1mqb_A 250 PYWELSNHEVMKAINDGFRLP----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIV 301 (333)
T ss_dssp TTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CcccCCHHHHHHHHHCCCcCC----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999988877777765421111 0135788999999999999999999999998
Q ss_pred hc
Q 009654 237 AS 238 (529)
Q Consensus 237 ~h 238 (529)
++
T Consensus 302 ~~ 303 (333)
T 1mqb_A 302 SI 303 (333)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=302.11 Aligned_cols=205 Identities=20% Similarity=0.262 Sum_probs=170.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|+.|+||||+++++++.. ..+|+||||++++.+..++.....+++.++..++.||+.||.|||++||+||
T Consensus 65 ~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~ 141 (291)
T 1xbb_A 65 LLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141 (291)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhCCCCCEEEEEEEECC---CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcC
Confidence 3579999999999999999999843 5789999999987777665556679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 142 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p 220 (291)
T 1xbb_A 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKP 220 (291)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999876543221 1223456789999999976 358899999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+... ..+ .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 221 YRGMKGSEVTAMLEKG--ERM--------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp STTCCHHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcC--CCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9998887776666441 110 011357899999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.49 Aligned_cols=212 Identities=19% Similarity=0.271 Sum_probs=172.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-------IKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-------~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
+.+|+.+|++|+||||+++++++.+ ...+|||||||+++.+..++... ..+++.++..++.||+.||.|||
T Consensus 80 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH 157 (327)
T 2yfx_A 80 FLMEALIISKFNHQNIVRCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157 (327)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhCCCCCCCeEEEEEcC--CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 3579999999999999999999987 56789999999886555443221 45999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEccC---CcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 74 SRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~---g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
++||+||||||+||||+.+ ..+||+|||++....... ........+|+.|+|||++.+ ..++.++||||||||+|
T Consensus 158 ~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ 236 (327)
T 2yfx_A 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLW 236 (327)
T ss_dssp HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHH
Confidence 9999999999999999854 469999999997553322 122234567999999999976 45899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 150 ELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 150 ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
+|++ |.+||.+.+..+.+..+....... ....++..+.+||.+||+.||.+
T Consensus 237 ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~ 288 (327)
T 2yfx_A 237 EIFSLGYMPYPSKSNQEVLEFVTSGGRMD----------------------------PPKNCPGPVYRIMTQCWQHQPED 288 (327)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHcCCCCCCCCcCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHhcCChhh
Confidence 9998 999999988877776664421110 11357889999999999999999
Q ss_pred CcCHHHHHhccccCC
Q 009654 229 RATASAALASEYFST 243 (529)
Q Consensus 229 R~ta~e~L~h~~f~~ 243 (529)
|||+.+++++.|+..
T Consensus 289 Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 289 RPNFAIILERIEYCT 303 (327)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHh
Confidence 999999999988753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.69 Aligned_cols=222 Identities=24% Similarity=0.325 Sum_probs=165.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|+.|+||||+++++++.+.....+|+|||||+++.+..+. .....+++.++..++.||+.||.|||++||+||
T Consensus 71 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 150 (302)
T 4e5w_A 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR 150 (302)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccC
Confidence 5899999999999999999999886557899999999986665444 455679999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|+
T Consensus 151 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999987654322 22335577899999999976 45889999999999999999999886
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.... ..+....+......... .+......... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 230 ~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 230 SSPM-----ALFLKMIGPTHGQMTVT-RLVNTLKEGKR-------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GSHH-----HHHHHHHCSCCGGGHHH-HHHHHHHTTCC-------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cchh-----hHHhhccCCcccccCHH-HHHHHHhccCC-------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 4221 11111111111100000 00000000000 0112467899999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.43 Aligned_cols=206 Identities=23% Similarity=0.323 Sum_probs=171.8
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC----------------CCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~----------------~~l~e~~~~~i~~Q 64 (529)
.+|+.+|++| +||||+++++++.+ ...+|||||||+++.+..++... ..+++.++..++.|
T Consensus 88 ~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 165 (334)
T 2pvf_A 88 VSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165 (334)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCEeeEEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHH
Confidence 5899999999 99999999999987 56889999999986665444322 24899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++||||
T Consensus 166 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 244 (334)
T 2pvf_A 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWS 244 (334)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHH
Confidence 99999999999999999999999999999999999999987654321 12234466889999999976 45899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|+|++ |.+||.+.+..+....+......+ ....++..+.+||.+||
T Consensus 245 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l 296 (334)
T 2pvf_A 245 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD----------------------------KPANCTNELYMMMRDCW 296 (334)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHc
Confidence 9999999999 999999988877777665521110 11357889999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
..||.+|||+.+++++
T Consensus 297 ~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 297 HAVPSQRPTFKQLVED 312 (334)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=298.10 Aligned_cols=202 Identities=24% Similarity=0.356 Sum_probs=164.8
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCC-chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--Cc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~-ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g--Iv 78 (529)
.+|+.+|++|+||||+++++++.+. . ++||||++++ +...+......+++..+..++.||+.||.|||++| |+
T Consensus 71 ~~E~~~l~~l~h~~i~~~~~~~~~~--~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~iv 146 (287)
T 4f0f_A 71 QREVFIMSNLNHPNIVKLYGLMHNP--P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIV 146 (287)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEETTT--T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred HHHHHHHHhCCCCCchhhheeecCC--C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCee
Confidence 5799999999999999999998663 2 7999999964 44566666678999999999999999999999999 99
Q ss_pred ccCCCCCcEEEccCCc-----EEEeccccccccCCCCCCCccccccccccCCcccccC-CCCCCCcchhhhhhHHHHHHH
Q 009654 79 HRDIKGSNLLVNNEGV-----LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 79 HrDIKp~NILl~~~g~-----vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~y~~~~DIWSlG~il~ell 152 (529)
||||||+|||++.++. +||+|||++..... ......+|+.|+|||++.+ ...|+.++|||||||++|+|+
T Consensus 147 H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred cCCCCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 9999999999988776 99999999975433 3345678999999999843 345788999999999999999
Q ss_pred hCCCCCCCCCHHHH--HHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 153 IGKPILQGRTEVEQ--LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 153 tG~~pf~g~~~~~~--~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
+|.+||.+.+.... ...+.. .+..+ .....+++.+.+||.+||+.||.+||
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rp 275 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIRE-EGLRP--------------------------TIPEDCPPRLRNVIELCWSGDPKKRP 275 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHH-SCCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCCCCccccccHHHHHHHHhc-cCCCC--------------------------CCCcccCHHHHHHHHHHhcCChhhCc
Confidence 99999987653332 333322 11111 01136789999999999999999999
Q ss_pred CHHHHHhc
Q 009654 231 TASAALAS 238 (529)
Q Consensus 231 ta~e~L~h 238 (529)
|+.++++.
T Consensus 276 s~~~ll~~ 283 (287)
T 4f0f_A 276 HFSYIVKE 283 (287)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=310.42 Aligned_cols=222 Identities=19% Similarity=0.223 Sum_probs=168.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC--
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSR-- 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----~~~l~e~~~~~i~~Qll~gL~~LH~~-- 75 (529)
.+|+.+|+.++||||+++++++.+ ....|+|||||+++.+..++.. ...+++..+..++.||+.||.|||++
T Consensus 75 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 152 (326)
T 3uim_A 75 QTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152 (326)
T ss_dssp HHHHHGGGTCCCTTBCCCCEEECC--SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHhccCCCccceEEEEec--CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 589999999999999999999987 5678999999999666654432 23499999999999999999999999
Q ss_pred -CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 76 -GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 76 -gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
||+||||||+|||++.++.+||+|||++...............||+.|+|||++.+ ..++.++||||||||+|+|++|
T Consensus 153 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp SCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHC
T ss_pred CCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhC
Confidence 99999999999999999999999999998776544344455679999999999976 3589999999999999999999
Q ss_pred CCCCCCC-----CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 155 KPILQGR-----TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 155 ~~pf~g~-----~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
.+||... ........+....... .+... .... .. .......+..+.+||.+||+.||.+|
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~--~~---~~~~~~~~~~l~~li~~cl~~dP~~R 296 (326)
T 3uim_A 232 QRAFDLARLANDDDVMLLDWVKGLLKEK--------KLEAL--VDVD--LQ---GNYKDEEVEQLIQVALLCTQSSPMER 296 (326)
T ss_dssp CCSBCHHHHTTTSCSBHHHHHTTTTSSC--------CSTTS--SCTT--CT---TSCCHHHHHHHHHHHHHHTCSCGGGS
T ss_pred CCcccccccccccchhHHHHHHHHhhch--------hhhhh--cChh--hc---cccCHHHHHHHHHHHHHHhCcCCccC
Confidence 9999621 1111111110000000 00000 0000 00 01112345779999999999999999
Q ss_pred cCHHHHHhcccc
Q 009654 230 ATASAALASEYF 241 (529)
Q Consensus 230 ~ta~e~L~h~~f 241 (529)
||+.++|++-.-
T Consensus 297 ps~~ell~~L~~ 308 (326)
T 3uim_A 297 PKMSEVVRMLEG 308 (326)
T ss_dssp CCHHHHHHHHHT
T ss_pred CCHHHHHHHhcC
Confidence 999999998653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.47 Aligned_cols=206 Identities=19% Similarity=0.306 Sum_probs=171.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||++++++.+ ...+|||||||+++.+..++. ....+++..+..++.||+.||+|||++||+
T Consensus 263 ~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 340 (495)
T 1opk_A 263 FLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340 (495)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEec--CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4689999999999999999999987 467899999999765554432 345699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||||+.++.+||+|||+++..............+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+|
T Consensus 341 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p 419 (495)
T 1opk_A 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP 419 (495)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765433233334456789999999976 458999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+...... .....+|+.+.+||.+||..||.+|||+.++++
T Consensus 420 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 420 YPGIDLSQVYELLEKDYRM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp STTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9988776666555331110 011357899999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=298.15 Aligned_cols=210 Identities=20% Similarity=0.218 Sum_probs=167.9
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.+.|+|++..+..+... ....||||||+.+++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 52 ~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D 130 (296)
T 4hgt_A 52 HIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 130 (296)
T ss_dssp HHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHhcCCCCCCeeeeecCC-CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 5799999999998888877776543 578899999995566555554566899999999999999999999999999999
Q ss_pred CCCCcEEE---ccCCcEEEeccccccccCCCCC------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 82 IKGSNLLV---NNEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 82 IKp~NILl---~~~g~vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
|||+|||| +.++.+||+|||++........ .......+|+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 131 lkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~ 209 (296)
T 4hgt_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHh
Confidence 99999999 7889999999999987654322 122356789999999999874 5899999999999999999
Q ss_pred hCCCCCCCCCHH---HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 153 IGKPILQGRTEV---EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 153 tG~~pf~g~~~~---~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+|.+||.+.+.. ..+..+.......+ .......+|+++.+||.+||+.||.+|
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R 265 (296)
T 4hgt_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTP------------------------IEVLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSC------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred cCCCCCcccchhhhhhhhhhhhcccccch------------------------hhhhhccCCHHHHHHHHHHHhcCCCCC
Confidence 999999875332 22222222111111 122235689999999999999999999
Q ss_pred cCHHHHHh
Q 009654 230 ATASAALA 237 (529)
Q Consensus 230 ~ta~e~L~ 237 (529)
||+.++++
T Consensus 266 pt~~~l~~ 273 (296)
T 4hgt_A 266 PDYSYLRQ 273 (296)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.49 Aligned_cols=208 Identities=22% Similarity=0.289 Sum_probs=169.4
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--------------CCCCCCHHHHHHHHHHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--------------PDIKFSEAQIKCYMNQL 65 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--------------~~~~l~e~~~~~i~~Ql 65 (529)
+.+|+.+|++| +||||+++++++.+ ...+|||||||+++.+..++. ....+++..+..++.||
T Consensus 96 ~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 173 (333)
T 2i1m_A 96 LMSELKIMSHLGQHENIVNLLGACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173 (333)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHH
Confidence 35899999999 89999999999987 567999999999855554332 13468999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 66 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 66 l~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
+.||.|||++||+||||||+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||
T Consensus 174 ~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 252 (333)
T 2i1m_A 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSY 252 (333)
T ss_dssp HHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHH
T ss_pred HHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHH
Confidence 99999999999999999999999999999999999999866433211 2234466889999999876 458999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 145 GCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 145 G~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
|||+|+|++ |.+||.+......+..+......+. ....+++.+.+||.+||+
T Consensus 253 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~ 305 (333)
T 2i1m_A 253 GILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---------------------------QPAFAPKNIYSIMQACWA 305 (333)
T ss_dssp HHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHhc
Confidence 999999998 9999998776655555544321111 012468889999999999
Q ss_pred CCCCCCcCHHHHHhc
Q 009654 224 VEPYKRATASAALAS 238 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h 238 (529)
.||.+|||+.+++++
T Consensus 306 ~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 306 LEPTHRPTFQQICSF 320 (333)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred cChhhCcCHHHHHHH
Confidence 999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=298.23 Aligned_cols=210 Identities=20% Similarity=0.217 Sum_probs=167.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+++.|.|++++..+..+... ...+|+||||+.+++...+......+++.++..++.||+.||.|||++||+|||
T Consensus 52 ~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 130 (296)
T 3uzp_A 52 HIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 130 (296)
T ss_dssp HHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHhhcCCCCCccccccCC-CCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 5899999999999888777766543 578899999995566555554566899999999999999999999999999999
Q ss_pred CCCCcEEE---ccCCcEEEeccccccccCCCCCC------CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 82 IKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 82 IKp~NILl---~~~g~vKl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
|||+|||| +.++.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 131 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~ 209 (296)
T 3uzp_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHH
T ss_pred CCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHH
Confidence 99999999 47889999999999876543221 2345678999999999987 45899999999999999999
Q ss_pred hCCCCCCCCC---HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCC
Q 009654 153 IGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 153 tG~~pf~g~~---~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+|++||.+.. ..+.+..+......++ .......+|+++.+||.+||+.||.+|
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R 265 (296)
T 3uzp_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTP------------------------IEVLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSC------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred hCCCCCCCcCchhhhhhhhhhcccccCCc------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcC
Confidence 9999998743 2233333333211111 112235689999999999999999999
Q ss_pred cCHHHHHh
Q 009654 230 ATASAALA 237 (529)
Q Consensus 230 ~ta~e~L~ 237 (529)
||+.++++
T Consensus 266 ps~~~l~~ 273 (296)
T 3uzp_A 266 PDYSYLRQ 273 (296)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.52 Aligned_cols=210 Identities=24% Similarity=0.367 Sum_probs=168.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+||||+++++++.+ ..+|||||||+++.+..++. ....+++.++..++.||+.||+|||++||+
T Consensus 226 ~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 302 (452)
T 1fmk_A 226 FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302 (452)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4689999999999999999999865 46899999999866665543 234699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||||+.++.+||+|||+++..............+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+|
T Consensus 303 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P 381 (452)
T 1fmk_A 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP 381 (452)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765433223334456889999999976 358999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+......+ ....+|+.+.+||.+||..||.+|||+.++++
T Consensus 382 ~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 382 YPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp STTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99998888777775421111 01357889999999999999999999999987
Q ss_pred --ccccC
Q 009654 238 --SEYFS 242 (529)
Q Consensus 238 --h~~f~ 242 (529)
..+|.
T Consensus 434 ~L~~~~~ 440 (452)
T 1fmk_A 434 FLEDYFT 440 (452)
T ss_dssp HHHTTTS
T ss_pred HHHHHhc
Confidence 35554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=301.72 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=156.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHH---
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHS--- 74 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~---~l~e~~~~~i~~Qll~gL~~LH~--- 74 (529)
+.+|+.+|++|+||||+++++++.+ .+|||||||+++.+..++.... .+++..+..++.||+.||.|||+
T Consensus 48 ~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~ 123 (307)
T 2eva_A 48 FIVELRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123 (307)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEBCTT----TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHHhcCCCCCcCeEEEEEcC----CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3589999999999999999998764 3799999999866665544332 47899999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCc-EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 75 RGVLHRDIKGSNLLVNNEGV-LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~-vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
+||+||||||+||||+.++. +||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 124 ~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~ 198 (307)
T 2eva_A 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVIT 198 (307)
T ss_dssp SCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHH
T ss_pred CCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHH
Confidence 89999999999999998886 799999999765432 244578999999999976 468999999999999999999
Q ss_pred CCCCCCCCCH--HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 154 GKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 154 G~~pf~g~~~--~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
|+.||.+... ......+.. +..+ .....+|+.+.+||.+||+.||.+|||
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps 250 (307)
T 2eva_A 199 RRKPFDEIGGPAFRIMWAVHN--GTRP--------------------------PLIKNLPKPIESLMTRCWSKDPSQRPS 250 (307)
T ss_dssp TCCTTTTTCSSHHHHHHHHHT--TCCC--------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCchhhCccHHHHHHHHhc--CCCC--------------------------CcccccCHHHHHHHHHHhcCChhhCcC
Confidence 9999975432 222222211 1111 112467899999999999999999999
Q ss_pred HHHHHh
Q 009654 232 ASAALA 237 (529)
Q Consensus 232 a~e~L~ 237 (529)
+.++++
T Consensus 251 ~~ell~ 256 (307)
T 2eva_A 251 MEEIVK 256 (307)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=333.73 Aligned_cols=205 Identities=20% Similarity=0.262 Sum_probs=170.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
|.+|+.+|++|+|||||++++++.+ ..+|||||||+++.+..++.....+++.++..++.||+.||+|||++||+||
T Consensus 417 ~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr 493 (635)
T 4fl3_A 417 LLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493 (635)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCC
Confidence 3689999999999999999999865 3589999999997777666666789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||+||||+.++.+||+|||+++.+..... ...+...+|+.|+|||++.+ ..|+.++||||||||||||++ |.+|
T Consensus 494 DLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~P 572 (635)
T 4fl3_A 494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKP 572 (635)
T ss_dssp CCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999987654321 22334456889999999976 458999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+......+ ....+|+++.+||.+||..||.+|||+.++++
T Consensus 573 f~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 573 YRGMKGSEVTAMLEKGERMG----------------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp STTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999888777775521110 11357899999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=302.98 Aligned_cols=208 Identities=16% Similarity=0.251 Sum_probs=167.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++++||||+++++++.+ ...+|+|||||+++.+..++. ....+++.++..++.||+.||.|||++||+|
T Consensus 76 ~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H 153 (319)
T 2y4i_B 76 FKREVMAYRQTRHENVVLFMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153 (319)
T ss_dssp CCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhcCCCCCEeEEEEEEec--CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3579999999999999999999987 567999999999866665544 3447999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCC----CCCCccccccccccCCcccccC--------CCCCCCcchhhhhhHH
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTG----HRQPLTSRVVTLWYRPPELLLG--------ATDYGPSVDLWSVGCV 147 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~----~~~~~~~~~gt~~Y~APE~l~~--------~~~y~~~~DIWSlG~i 147 (529)
|||||+|||++ ++.+||+|||++...... .........||+.|+|||++.+ ...|+.++|||||||+
T Consensus 154 ~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp CCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred cCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 99999999998 689999999998755321 1123344568999999999975 2357889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 148 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 148 l~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
+|+|++|..||.+.+.......+........ ....++.++.+||.+||..||.
T Consensus 233 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~ 285 (319)
T 2y4i_B 233 WYELHAREWPFKTQPAEAIIWQMGTGMKPNL---------------------------SQIGMGKEISDILLFCWAFEQE 285 (319)
T ss_dssp HHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC---------------------------CCSSCCTTHHHHHHHHHCSSTT
T ss_pred HHHHHhCCCCCCCCCHHHHHHHhccCCCCCC---------------------------CcCCCCHHHHHHHHHHhcCChh
Confidence 9999999999999888777766644211100 0124778899999999999999
Q ss_pred CCcCHHHHHhc
Q 009654 228 KRATASAALAS 238 (529)
Q Consensus 228 kR~ta~e~L~h 238 (529)
+|||+.++++.
T Consensus 286 ~Rpt~~~l~~~ 296 (319)
T 2y4i_B 286 ERPTFTKLMDM 296 (319)
T ss_dssp TSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999963
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=298.28 Aligned_cols=207 Identities=25% Similarity=0.354 Sum_probs=168.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEc--------------cCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITS--------------RLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQ 64 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~--------------~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Q 64 (529)
+.+|+.+|++|+||||+++++++.. .....+|+|||||+++.+..++. ....+++..+..++.|
T Consensus 51 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 130 (284)
T 2a19_B 51 AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130 (284)
T ss_dssp GHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHH
Confidence 3689999999999999999998864 11346899999999966655442 3357999999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 144 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSl 144 (529)
|+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||
T Consensus 131 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 207 (284)
T 2a19_B 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYAL 207 (284)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHH
T ss_pred HHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHH
Confidence 9999999999999999999999999999999999999998765432 2345578999999999976 458999999999
Q ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccC
Q 009654 145 GCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 145 G~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
||++|+|++|..||... ......+.. +. ....++..+.+||.+||..
T Consensus 208 G~il~~l~~~~~~~~~~--~~~~~~~~~--~~-----------------------------~~~~~~~~~~~li~~~l~~ 254 (284)
T 2a19_B 208 GLILAELLHVCDTAFET--SKFFTDLRD--GI-----------------------------ISDIFDKKEKTLLQKLLSK 254 (284)
T ss_dssp HHHHHHHHSCCSSHHHH--HHHHHHHHT--TC-----------------------------CCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHHhcCCcchhH--HHHHHHhhc--cc-----------------------------ccccCCHHHHHHHHHHccC
Confidence 99999999999887431 111222211 00 0124688899999999999
Q ss_pred CCCCCcCHHHHHhccccCC
Q 009654 225 EPYKRATASAALASEYFST 243 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~ 243 (529)
||.+|||+.+++++.|.-.
T Consensus 255 dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 255 KPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp SGGGSCCHHHHHHHHHHHT
T ss_pred ChhhCcCHHHHHHHHHHHh
Confidence 9999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.78 Aligned_cols=218 Identities=22% Similarity=0.292 Sum_probs=168.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~---~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
+.+|+.+|++|+||||+++++++.+ ...+|+||||++++.+..++. ....+++..+..++.||+.||.|||++||
T Consensus 77 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 154 (307)
T 2nru_A 77 FDQEIKVMAKCQHENLVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154 (307)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHhcCCCCeEEEEEEEec--CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 3589999999999999999999987 568899999998866554432 23469999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCC
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999866543221 1234578999999999876 48999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCc--hhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPD--DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~--~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
||.+......+..+......... ..|-... +.......+..+.+||.+||..||.+|||+.+
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 296 (307)
T 2nru_A 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK----------------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296 (307)
T ss_dssp SBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS----------------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CcccCcchHHHHHHHHHhhhhhhhhhhhcccc----------------ccccchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 99876544333333322111110 0010000 00111234677899999999999999999999
Q ss_pred HHhc
Q 009654 235 ALAS 238 (529)
Q Consensus 235 ~L~h 238 (529)
++++
T Consensus 297 l~~~ 300 (307)
T 2nru_A 297 VQQL 300 (307)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=319.48 Aligned_cols=203 Identities=19% Similarity=0.309 Sum_probs=167.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-C-CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-P-DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~-~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||++++++... ...+|||||||+++.+..++. . ...+++..+..++.||+.||+|||++||+
T Consensus 233 ~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 311 (450)
T 1k9a_A 233 FLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311 (450)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46899999999999999999998764 347999999999865554433 2 23479999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+|
T Consensus 312 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P 386 (450)
T 1k9a_A 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 386 (450)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCCCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999855432 123366889999999976 458999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+...... .....+|+.+.+||.+||..||.+|||+.++++
T Consensus 387 ~~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 387 YPRIPLKDVVPRVEKGYKM----------------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp STTSCTTTHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9988777766666442110 011357899999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.96 Aligned_cols=222 Identities=23% Similarity=0.278 Sum_probs=167.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.......+|||||||+++.+..++. ....+++.++..++.||+.||.|||++||+|
T Consensus 71 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 150 (327)
T 3lxl_A 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 150 (327)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 368999999999999999999998765778999999998866665443 3456999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 151 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDK 229 (327)
T ss_dssp SCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654321 12234567899999999976 4589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCc--hhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPD--DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~--~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+........ . ......+. ....... ... . ......+++.+.+||.+||..||.+|||+.++
T Consensus 230 ~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~----~~~--~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 294 (327)
T 3lxl_A 230 SCSPSAEFLRM-M-GCERDVPALSRLLELLE----EGQ--R-------LPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294 (327)
T ss_dssp GGSHHHHHHHH-C-C----CCHHHHHHHHHH----TTC--C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred Cccccchhhhh-c-ccccccccHHHHHHHhh----ccc--C-------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 87543221100 0 00000000 0000000 000 0 01124678999999999999999999999999
Q ss_pred Hhc
Q 009654 236 LAS 238 (529)
Q Consensus 236 L~h 238 (529)
+++
T Consensus 295 l~~ 297 (327)
T 3lxl_A 295 GPQ 297 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.94 Aligned_cols=208 Identities=20% Similarity=0.292 Sum_probs=160.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+||||+++++++... ....|+|||||+++.+. .+......+++.++..++.||+.||.|||++||+|
T Consensus 137 ~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 215 (373)
T 3c1x_A 137 FLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215 (373)
T ss_dssp HHHHHTTSTTCCCTTBCCCCEEECCC-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEcC-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 35899999999999999999987653 45789999999985555 44445567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK 155 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~ 155 (529)
|||||+||||+.++.+||+|||+++....... .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.
T Consensus 216 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~ 294 (373)
T 3c1x_A 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGA 294 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcC
Confidence 99999999999999999999999986543221 11234466889999999976 468999999999999999999 78
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+..+....+.. +... .....+|..+.+||.+||..||.+|||+.++
T Consensus 295 ~p~~~~~~~~~~~~~~~--~~~~--------------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 295 PPYPDVNTFDITVYLLQ--GRRL--------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp CSCTTSCSSCHHHHHHT--TCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHc--CCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 99988766655555533 1110 0013578899999999999999999999999
Q ss_pred Hhc
Q 009654 236 LAS 238 (529)
Q Consensus 236 L~h 238 (529)
+++
T Consensus 347 l~~ 349 (373)
T 3c1x_A 347 VSR 349 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=322.13 Aligned_cols=229 Identities=23% Similarity=0.351 Sum_probs=171.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~---~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+||||+++++++.+.....+|||||||+++.+..++... ..+++.++..++.||+.||.|||++||+
T Consensus 55 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 134 (396)
T 4eut_A 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134 (396)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 5899999999999999999999886566899999999986666554432 2399999999999999999999999999
Q ss_pred ccCCCCCcEEE----ccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC-------CCCCCcchhhhhhHH
Q 009654 79 HRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCV 147 (529)
Q Consensus 79 HrDIKp~NILl----~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~y~~~~DIWSlG~i 147 (529)
||||||+|||| +.++.+||+|||++...... ......+||+.|+|||++.+. ..|+.++|||||||+
T Consensus 135 H~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp CCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred ECCcCHHHEEEeecCCCceeEEEecCCCceEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 99999999999 67778999999999876543 233456799999999998641 347889999999999
Q ss_pred HHHHHhCCCCCCC----CCHHHHHHHHHHHcCCCCchhhhccCCCccc--cCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 148 FAELLIGKPILQG----RTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT--LFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 148 l~elltG~~pf~g----~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~--~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
+|+|++|.+||.+ ....+.+.++.. +.|+ ..|......... .+....+.. ......++..+.+||.+|
T Consensus 213 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~p~-~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~l~~ll~~~ 286 (396)
T 4eut_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS-GAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANI 286 (396)
T ss_dssp HHHHHHSSCSEECTTCTTTCHHHHHHHHH--SCCT-TCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCcccchHHHHHHHhc--CCCc-ccchhheeccCCCcccCccCCcc---cccchHHHhhchHHHHHh
Confidence 9999999999974 233455555544 3332 222111000000 000000111 011134567789999999
Q ss_pred ccCCCCCCcCHHHHHhc
Q 009654 222 LSVEPYKRATASAALAS 238 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~h 238 (529)
|..||++|+|+.+++++
T Consensus 287 L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 287 LEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCCTTTSCCHHHHHHH
T ss_pred hccChhhhccHHHHHHH
Confidence 99999999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=300.32 Aligned_cols=206 Identities=25% Similarity=0.340 Sum_probs=169.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+||||+++++++.+. ..++||||++++.+. .+......+++.++..++.||+.||.|||++||+||
T Consensus 69 ~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 145 (291)
T 1u46_A 69 IREVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 145 (291)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHhCCCCCcccEEEEEccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 5899999999999999999998773 389999999975554 444444579999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 146 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p 224 (291)
T 1u46_A 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEP 224 (291)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999876543211 1234467889999999976 458899999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+......++ ....++..+.+||.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 225 WIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHccCCCCC---------------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999988887777754221111 11357899999999999999999999999996
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
+
T Consensus 278 ~ 278 (291)
T 1u46_A 278 F 278 (291)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.26 Aligned_cols=215 Identities=16% Similarity=0.176 Sum_probs=166.7
Q ss_pred CHHHHHHHHhCCCCCccc---------------eeeEEEccCCCeEEEEEeccCCCchhhhcCC-CCCCCHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIK---------------LEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvk---------------l~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~-~~~l~e~~~~~i~~Q 64 (529)
+.+|+.+|++|+||||++ +++++... ...+|||||||.++|...+... ...+++.++..++.|
T Consensus 89 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~q 167 (352)
T 2jii_A 89 LFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167 (352)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHH
Confidence 358999999999999998 56666553 5789999999944444444322 368999999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCC--cEEEeccccccccCCCCC------CCccccccccccCCcccccCCCCCC
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYG 136 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g--~vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~y~ 136 (529)
|+.||.|||++||+||||||+||||+.++ .+||+|||++........ .......||+.|+|||++.+ ..|+
T Consensus 168 i~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 246 (352)
T 2jii_A 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPS 246 (352)
T ss_dssp HHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCC
T ss_pred HHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCC
Confidence 99999999999999999999999999988 899999999976643211 12234588999999999977 4589
Q ss_pred CcchhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHH
Q 009654 137 PSVDLWSVGCVFAELLIGKPILQGRT--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 214 (529)
Q Consensus 137 ~~~DIWSlG~il~elltG~~pf~g~~--~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~ 214 (529)
.++||||||||||+|++|..||.+.. .......+......+..- . .....+..+++.+
T Consensus 247 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-------------------~~~~~~~~~~~~l 306 (352)
T 2jii_A 247 RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF-V-------------------GPCGHWIRPSETL 306 (352)
T ss_dssp HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCE-E-------------------CTTSCEECCCHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhh-h-------------------hhccccCCCcHHH
Confidence 99999999999999999999998763 333333333222222110 0 0011234679999
Q ss_pred HHHHHHhccCCCCCCcCHHHHHh
Q 009654 215 VNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 215 ~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+||.+||..||.+|||+.++++
T Consensus 307 ~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 307 QKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhCChhhCCCHHHHHH
Confidence 99999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=303.37 Aligned_cols=211 Identities=25% Similarity=0.336 Sum_probs=167.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+||||+++++++.+.....+|||||||+++.+..++... .+++.++..++.||+.||.|||++||+||
T Consensus 80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~ 158 (318)
T 3lxp_A 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHR 158 (318)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 35899999999999999999999886667899999999987666655433 59999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 159 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 9999999999999999999999987754321 12234567889999999976 35889999999999999999999999
Q ss_pred CCCCHHH-----------HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 159 QGRTEVE-----------QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 159 ~g~~~~~-----------~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
....... ....+....... . . ......+++++.+||.+||..||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---------~-------~~~~~~~~~~l~~li~~~l~~dP~ 293 (318)
T 3lxp_A 238 QSPPTKFLELIGIAQGQMTVLRLTELLERG--------E---------R-------LPRPDKCPAEVYHLMKNCWETEAS 293 (318)
T ss_dssp GSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--------C---------C-------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cccchhhhhhhcccccchhHHHHHHHHhcc--------c---------C-------CCCCccccHHHHHHHHHHcCCCcc
Confidence 7542211 000111100000 0 0 011246789999999999999999
Q ss_pred CCcCHHHHHh
Q 009654 228 KRATASAALA 237 (529)
Q Consensus 228 kR~ta~e~L~ 237 (529)
+|||+.++++
T Consensus 294 ~Rps~~ell~ 303 (318)
T 3lxp_A 294 FRPTFENLIP 303 (318)
T ss_dssp GSCCHHHHHH
T ss_pred cCcCHHHHHH
Confidence 9999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.15 Aligned_cols=208 Identities=23% Similarity=0.360 Sum_probs=148.8
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEc------cCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD-HPNIIKLEGLITS------RLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHC 72 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~------~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~L 72 (529)
.+|+.+|+++. ||||+++++++.. .....+|+|||||.|++...+.. ....+++.++..++.||+.||.||
T Consensus 73 ~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (337)
T 3ll6_A 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152 (337)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 58999999995 9999999999852 22456899999999887776542 455799999999999999999999
Q ss_pred HHCC--CcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-----------CccccccccccCCccccc--CCCCCCC
Q 009654 73 HSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-----------PLTSRVVTLWYRPPELLL--GATDYGP 137 (529)
Q Consensus 73 H~~g--IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~l~--~~~~y~~ 137 (529)
|++| |+||||||+||||+.++.+||+|||++......... .....++|+.|+|||++. ....++.
T Consensus 153 H~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 232 (337)
T 3ll6_A 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE 232 (337)
T ss_dssp HTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSH
T ss_pred HhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCCh
Confidence 9999 999999999999999999999999999876543211 112456899999999984 2345788
Q ss_pred cchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHH
Q 009654 138 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 217 (529)
Q Consensus 138 ~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dL 217 (529)
++||||||||+|+|++|.+||.+......+... ... .....++..+.+|
T Consensus 233 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~---------------------------~~~~~~~~~~~~l 281 (337)
T 3ll6_A 233 KQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK----YSI---------------------------PPHDTQYTVFHSL 281 (337)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC----------------CCC---------------------------CTTCCSSGGGHHH
T ss_pred HHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc----ccC---------------------------CcccccchHHHHH
Confidence 999999999999999999999765443322211 000 0113456778999
Q ss_pred HHHhccCCCCCCcCHHHHHhccc
Q 009654 218 IETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 218 i~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
|.+||+.||.+|||+.++|++-+
T Consensus 282 i~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 282 IRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999998743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=296.38 Aligned_cols=206 Identities=29% Similarity=0.455 Sum_probs=157.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|++|+||||+++++++.+ ...+|+||||++++.+..++. ....+++..+..++.||+.||.|||++||
T Consensus 80 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 157 (310)
T 2wqm_A 80 IKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157 (310)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEc--CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 589999999999999999999988 578999999999966654432 35679999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+||||+.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 158 ~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p 235 (310)
T 2wqm_A 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSP 235 (310)
T ss_dssp CCCCCCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999997665432 22334578999999999976 4589999999999999999999999
Q ss_pred CCCCC--HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRT--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~--~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.. .......+.. +..++ .....+++++.+||.+||..||.+|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 236 FYGDKMNLYSLCKKIEQ-CDYPP--------------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp TC---CCHHHHHHHHHT-TCSCC--------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CcccchhHHHHHHHhhc-ccCCC--------------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 97653 2233333322 11111 0013578899999999999999999999999
Q ss_pred Hhc
Q 009654 236 LAS 238 (529)
Q Consensus 236 L~h 238 (529)
+++
T Consensus 289 l~~ 291 (310)
T 2wqm_A 289 YDV 291 (310)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=298.14 Aligned_cols=203 Identities=18% Similarity=0.297 Sum_probs=160.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~--~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
+.+|+.+|++|+||||+++++++... ...+|+||||++++.+..+..... .+++..+..++.||+.||.|||++||+
T Consensus 61 ~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 139 (278)
T 1byg_A 61 FLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139 (278)
T ss_dssp HHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 35799999999999999999987653 357899999999855554443222 389999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+|
T Consensus 140 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p 214 (278)
T 1byg_A 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 214 (278)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccCCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998765432 223467889999999976 458999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+... ..+ .....+++.+.+||.+||..||.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 215 YPRIPLKDVVPRVEKG--YKM--------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CTTSCGGGHHHHHTTT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHhcC--CCC--------------------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9887766665555321 000 011357899999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.46 Aligned_cols=210 Identities=20% Similarity=0.272 Sum_probs=170.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ ..+|||||||+++.+..+ ......+++.++..++.||+.||+|||++||+|
T Consensus 383 ~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 459 (613)
T 2ozo_A 383 MMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459 (613)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEc
Confidence 4689999999999999999999976 358999999999766644 445567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+||||+.++.+||+|||+++........ ......+|+.|+|||++.+ ..|+.++||||||||||||++ |.+
T Consensus 460 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp SCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999876543211 1123345689999999975 468999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+..|... ... .....+|+++.+||.+||..||.+|||+.+++
T Consensus 539 Pf~~~~~~~~~~~i~~~--~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 539 PYKKMKGPEVMAFIEQG--KRM--------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp TTTTCCSHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcC--CCC--------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999888877777542 110 01135889999999999999999999999974
Q ss_pred ---hccccC
Q 009654 237 ---ASEYFS 242 (529)
Q Consensus 237 ---~h~~f~ 242 (529)
++.|+.
T Consensus 591 ~~L~~~~~~ 599 (613)
T 2ozo_A 591 QRMRACYYS 599 (613)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 444443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=325.18 Aligned_cols=210 Identities=24% Similarity=0.362 Sum_probs=173.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||++++++.+ ..+|||||||+++.|..++. ....+++.++..++.||+.||.|||++||+
T Consensus 309 ~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv 385 (535)
T 2h8h_A 309 FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385 (535)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEee---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4689999999999999999999865 46899999999866654443 234699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||||+.++.+||+|||+++..............+|+.|+|||++.+ ..|+.++||||||||||||++ |..|
T Consensus 386 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P 464 (535)
T 2h8h_A 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP 464 (535)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred CCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765322122234456789999999976 358999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+......+ ....++..+.+||.+||..||++|||+.++++
T Consensus 465 ~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 465 YPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp STTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99998888877775421110 11357889999999999999999999999986
Q ss_pred c--cccC
Q 009654 238 S--EYFS 242 (529)
Q Consensus 238 h--~~f~ 242 (529)
. .+|.
T Consensus 517 ~L~~~~~ 523 (535)
T 2h8h_A 517 FLEDYFT 523 (535)
T ss_dssp HHHTSSC
T ss_pred HHHHHhh
Confidence 4 4554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=293.92 Aligned_cols=215 Identities=25% Similarity=0.288 Sum_probs=162.8
Q ss_pred HHHHHHHHh--CCCCCccceeeEEEccC--CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----
Q 009654 2 AREILILRR--LDHPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH---- 73 (529)
Q Consensus 2 ~rEi~iL~~--L~HpnIvkl~~~~~~~~--~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH---- 73 (529)
.+|.+++.. ++||||+++++++.+.. ...+|+|||||+++.+..++. ...+++..+..++.||+.||.|||
T Consensus 48 ~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 126 (301)
T 3q4u_A 48 FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIF 126 (301)
T ss_dssp HHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBC
T ss_pred HHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhh
Confidence 357777776 79999999999876532 356899999999876666553 447999999999999999999999
Q ss_pred ----HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC---CccccccccccCCcccccCCCC-----CCCcchh
Q 009654 74 ----SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATD-----YGPSVDL 141 (529)
Q Consensus 74 ----~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~-----y~~~~DI 141 (529)
+.||+||||||+||||+.++.+||+|||++......... .....+||+.|+|||++.+... ++.++||
T Consensus 127 ~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv 206 (301)
T 3q4u_A 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206 (301)
T ss_dssp STTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred hccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence 999999999999999999999999999999765443211 1234588999999999977432 3468999
Q ss_pred hhhhHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc
Q 009654 142 WSVGCVFAELLIG----------KPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 142 WSlG~il~elltG----------~~pf~g~~----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 207 (529)
|||||++|+|++| .+||.+.. ....+..+....+..+. ... ....
T Consensus 207 wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~--~~~~ 265 (301)
T 3q4u_A 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN-------------------IPN--RWFS 265 (301)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC-------------------CCG--GGGG
T ss_pred HHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCC-------------------CCh--hhcc
Confidence 9999999999999 88886532 22333333221111110 000 0011
Q ss_pred cCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 208 KDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 208 ~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 266 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 266 DPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2356789999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=325.56 Aligned_cols=206 Identities=24% Similarity=0.394 Sum_probs=169.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.+ +.+|||||||+++.+..++ .....+++..+..++.||+.||.|||++||+|
T Consensus 438 ~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 514 (656)
T 2j0j_A 438 FLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514 (656)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3589999999999999999999854 4689999999986665443 44557999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||
T Consensus 515 rDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp SCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999998765443333344566889999999976 468999999999999999997 99999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......+ ....+|+.+.+||.+||..||.+|||+.++++.
T Consensus 594 ~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 594 QGVKNNDVIGRIENGERLP----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp TTCCHHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCC----------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999888887776521111 113578999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.42 Aligned_cols=210 Identities=23% Similarity=0.333 Sum_probs=163.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|+.+++.|+||||+++++++... ....+|+|||||+++.+..++. ....+++.++..++.||+.||.|||++
T Consensus 74 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 153 (317)
T 2buj_A 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153 (317)
T ss_dssp HHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5899999999999999999998742 2357899999999965554332 456799999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC--------CccccccccccCCcccccCCC--CCCCcchhhhhh
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--------PLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVG 145 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~--~y~~~~DIWSlG 145 (529)
||+||||||+||||+.++.+||+|||++......... ......+|+.|+|||++.+.. .++.++||||||
T Consensus 154 ~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 233 (317)
T 2buj_A 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233 (317)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHH
T ss_pred CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHH
Confidence 9999999999999999999999999998755321100 012345699999999987533 268999999999
Q ss_pred HHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhcc
Q 009654 146 CVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 223 (529)
Q Consensus 146 ~il~elltG~~pf~g~~~~--~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~ 223 (529)
||+|+|++|..||.+.... .....+.. .... .....++..+.+||.+||+
T Consensus 234 ~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~l~~li~~~l~ 285 (317)
T 2buj_A 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSI---------------------------PQSPRHSSALWQLLNSMMT 285 (317)
T ss_dssp HHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C--C---------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCChhhhhcccchhhHHhhc-cCCC---------------------------CccccCCHHHHHHHHHHhh
Confidence 9999999999999531100 01111111 0000 0113578899999999999
Q ss_pred CCCCCCcCHHHHHhcc
Q 009654 224 VEPYKRATASAALASE 239 (529)
Q Consensus 224 ~dP~kR~ta~e~L~h~ 239 (529)
.||.+|||+.+++++-
T Consensus 286 ~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 286 VDPHQRPHIPLLLSQL 301 (317)
T ss_dssp SSGGGSCCHHHHHHHH
T ss_pred cChhhCCCHHHHHHHh
Confidence 9999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=296.23 Aligned_cols=198 Identities=23% Similarity=0.354 Sum_probs=152.3
Q ss_pred HHHHHHH-HhCCCCCccceeeEEEc--cCCCeEEEEEeccCCCchhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILIL-RRLDHPNIIKLEGLITS--RLSCSIYLVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL-~~L~HpnIvkl~~~~~~--~~~~~~~lV~E~~~g~ll~~~~-~-~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.++ +.++||||+++++++.+ .....+|||||||+++.+..++ . ....+++.++..++.||+.||.|||++|
T Consensus 58 ~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (299)
T 3m2w_A 58 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137 (299)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5799988 55699999999999875 2245789999999985555443 2 2347999999999999999999999999
Q ss_pred CcccCCCCCcEEEcc---CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 77 VLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 77 IvHrDIKp~NILl~~---~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
|+||||||+||||+. ++.+||+|||++..... ..|+.++|||||||++|+|++
T Consensus 138 i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~t 193 (299)
T 3m2w_A 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLC 193 (299)
T ss_dssp EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHH
T ss_pred cccCCCCHHHEEEecCCCCCcEEEecccccccccc------------------------ccCCchhhHHHHHHHHHHHHH
Confidence 999999999999998 78899999999864321 247889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
|.+||.+.........+... .......+ ....+..+++++.+||.+||+.||.+|||+.
T Consensus 194 g~~pf~~~~~~~~~~~~~~~------------------~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ 252 (299)
T 3m2w_A 194 GYPPFYSNHGLAISPGMKTR------------------IRMGQYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252 (299)
T ss_dssp SSCSCCC-------CCSCCS------------------SCTTCCSS---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCcchhhhHHHHHH------------------HhhccccC---CchhcccCCHHHHHHHHHHcccChhhCCCHH
Confidence 99999876543321111000 00000011 1233467899999999999999999999999
Q ss_pred HHHhccccCCC
Q 009654 234 AALASEYFSTK 244 (529)
Q Consensus 234 e~L~h~~f~~~ 244 (529)
++|+||||+..
T Consensus 253 e~l~hp~~~~~ 263 (299)
T 3m2w_A 253 EFMNHPWIMQS 263 (299)
T ss_dssp HHHTSHHHHTG
T ss_pred HHhcChhhccc
Confidence 99999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.30 Aligned_cols=234 Identities=23% Similarity=0.269 Sum_probs=171.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEc----cCCCeEEEEEeccCCCchhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITS----RLSCSIYLVFEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~----~~~~~~~lV~E~~~g~ll~~~~~~---~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|++|+||||+++++++.. .....+|||||||+++.+..+... ...+++..+..++.||+.||.|||+
T Consensus 60 ~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs 139 (676)
T 3qa8_A 60 CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139 (676)
T ss_dssp HHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 579999999999999999998755 124678999999988666654433 2369999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCc---EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 75 RGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~---vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
+||+||||||+|||++.++. +||+|||++....... .....++|+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 140 ~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeL 216 (676)
T 3qa8_A 140 NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFEC 216 (676)
T ss_dssp TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHH
T ss_pred CCCccCCCCHHHeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHH
Confidence 99999999999999997764 9999999998765442 3355688999999999976 4689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 152 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 152 ltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
++|..||.+......+.......+......+ ..+.....+....+.. ......+++.+.+||.+||..||.+|||
T Consensus 217 ltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~--~~l~g~~~~~~~lp~p---~~l~~~ls~~L~dLI~~mL~~DP~kRPT 291 (676)
T 3qa8_A 217 ITGFRPFLPNWQPVQWHGKVREKSNEHIVVY--DDLTGAVKFSSVLPTP---NHLSGILAGKLERWLQCMLMWHQRQRGT 291 (676)
T ss_dssp HSSCSSCCSSCHHHHSSTTCC------CCSC--CCCSSSCCCCSSSCCS---CCCCGGGHHHHHHHHHHHSCSSCC---C
T ss_pred HHCCCCCCcccchhhhhhhhhcccchhhhhh--hhhccccccccccCCc---hhhchhhhHHHHHHHHHHccCCHhhCcC
Confidence 9999999876544332211110000000000 0000000111111111 1122457889999999999999999999
Q ss_pred HHHHHhccccCC
Q 009654 232 ASAALASEYFST 243 (529)
Q Consensus 232 a~e~L~h~~f~~ 243 (529)
+.++|+||||+.
T Consensus 292 a~elL~hp~F~~ 303 (676)
T 3qa8_A 292 DPQNPNVGCFQA 303 (676)
T ss_dssp CTTCCCCTTHHH
T ss_pred HHHHhcCHHHHH
Confidence 999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.64 Aligned_cols=202 Identities=15% Similarity=0.149 Sum_probs=160.9
Q ss_pred HHHHHHHHhCC---CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD---HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCH 73 (529)
Q Consensus 2 ~rEi~iL~~L~---HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~-----~~~~l~e~~~~~i~~Qll~gL~~LH 73 (529)
.+|+.+++.|. ||||+++++++.. .+..|||||||+++.+..++. ....+++.++..++.||+.||+|||
T Consensus 112 ~~e~~~~~~l~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH 189 (365)
T 3e7e_A 112 YIGTQLMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189 (365)
T ss_dssp HHHHHHHHHSCGGGGGGBCCEEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhhhhhhhhhheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 57889999996 9999999999988 568899999999866665543 4567999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcc-----------CCcEEEeccccccccCC-CCCCCccccccccccCCcccccCCCCCCCcchh
Q 009654 74 SRGVLHRDIKGSNLLVNN-----------EGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 141 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~-----------~g~vKl~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DI 141 (529)
++||+||||||+||||+. ++.+||+|||++..... ......+..+||+.|+|||++.+. .|+.++||
T Consensus 190 ~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di 268 (365)
T 3e7e_A 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDY 268 (365)
T ss_dssp TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHH
T ss_pred hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccH
Confidence 999999999999999998 89999999999975431 222344567899999999999874 49999999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHh
Q 009654 142 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221 (529)
Q Consensus 142 WSlG~il~elltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~m 221 (529)
||||||+|+|++|++||...... .|... ..+. . ...++.+.+++..|
T Consensus 269 wslG~il~elltg~~pf~~~~~~----------------~~~~~-----------~~~~----~--~~~~~~~~~~~~~~ 315 (365)
T 3e7e_A 269 FGVAATVYCMLFGTYMKVKNEGG----------------ECKPE-----------GLFR----R--LPHLDMWNEFFHVM 315 (365)
T ss_dssp HHHHHHHHHHHHSSCCCEEEETT----------------EEEEC-----------SCCT----T--CSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCccccCCCC----------------ceeec-----------hhcc----c--cCcHHHHHHHHHHH
Confidence 99999999999999998643210 01000 0000 0 02366788999999
Q ss_pred ccCCCCCCcCHHHHHhcc
Q 009654 222 LSVEPYKRATASAALASE 239 (529)
Q Consensus 222 L~~dP~kR~ta~e~L~h~ 239 (529)
|+.+|.+|++..+.|.+.
T Consensus 316 l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 316 LNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp HCCCCTTCCCCHHHHHHH
T ss_pred cCCCCCCcchHHHHHHHH
Confidence 999999997766655543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.83 Aligned_cols=224 Identities=22% Similarity=0.324 Sum_probs=163.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+||||+++++++.......+|+||||++++.+.. +......+++.++..++.||+.||.|||++||+|
T Consensus 89 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 168 (326)
T 2w1i_A 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 168 (326)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 358999999999999999999987754567899999999855554 4444457999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 169 ~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred cCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999876543211 1233456888999999976 3588999999999999999999998
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|..... .+....+......+....+.. ....... ......+++++.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 248 SKSPPA-----EFMRMIGNDKQGQMIVFHLIE--LLKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp GGSHHH-----HHHHHHCTTCCTHHHHHHHHH--HHHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHH-----HHHHhhccccchhhhHHHHHH--HhhcCCC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 864211 111111111110000000000 0000000 0011367899999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=291.49 Aligned_cols=213 Identities=23% Similarity=0.296 Sum_probs=158.0
Q ss_pred HHHHHHHhC--CCCCccceeeEEEccCC--CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q 009654 3 REILILRRL--DHPNIIKLEGLITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--- 75 (529)
Q Consensus 3 rEi~iL~~L--~HpnIvkl~~~~~~~~~--~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~--- 75 (529)
+|.+++..+ +||||+++++++.+... ..+|||||||+++.+..++.. ..+++.++..++.||+.||.|||++
T Consensus 78 ~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 156 (337)
T 3mdy_A 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFS 156 (337)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred hHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 466666655 99999999999887422 689999999998666655433 3799999999999999999999999
Q ss_pred -----CCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC---CccccccccccCCcccccCCCCCCCc------chh
Q 009654 76 -----GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATDYGPS------VDL 141 (529)
Q Consensus 76 -----gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~y~~~------~DI 141 (529)
||+||||||+||||+.++.+||+|||++......... .....+||+.|+|||++.+.. +... +||
T Consensus 157 ~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~Di 235 (337)
T 3mdy_A 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADM 235 (337)
T ss_dssp TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHH
T ss_pred hccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccch
Confidence 9999999999999999999999999999766433211 123568999999999997643 4443 899
Q ss_pred hhhhHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc
Q 009654 142 WSVGCVFAELLIG----------KPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 142 WSlG~il~elltG----------~~pf~g~~----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 207 (529)
||||||+|+|++| ..||.+.. ....+..+.......+ .+.. ....
T Consensus 236 wslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~--~~~~ 294 (337)
T 3mdy_A 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP-------------------SFPN--RWSS 294 (337)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC-------------------CCCG--GGGG
T ss_pred HHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCc-------------------cccc--cchh
Confidence 9999999999999 66665421 1222222221111100 0000 0011
Q ss_pred cCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 208 KDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 208 ~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 295 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 295 DECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2467789999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.10 Aligned_cols=210 Identities=22% Similarity=0.223 Sum_probs=166.2
Q ss_pred CHHHHHHHHhCCCCCccc-eeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIK-LEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvk-l~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|+.|.|++++. +..++.. ....|||||||.+++..++......|++.++..|+.||+.||.|||++||+|
T Consensus 49 ~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 126 (483)
T 3sv0_A 49 LLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126 (483)
T ss_dssp HHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 358999999998755544 4444444 5789999999966666666555668999999999999999999999999999
Q ss_pred cCCCCCcEEE---ccCCcEEEeccccccccCCCCCC------CccccccccccCCcccccCCCCCCCcchhhhhhHHHHH
Q 009654 80 RDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 150 (529)
Q Consensus 80 rDIKp~NILl---~~~g~vKl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~e 150 (529)
|||||+|||| +.++.+||+|||+++.+...... .....+||+.|+|||++.+ ..|+.++||||||||||+
T Consensus 127 rDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~e 205 (483)
T 3sv0_A 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMY 205 (483)
T ss_dssp CCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHH
T ss_pred cccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHH
Confidence 9999999999 57899999999999876543221 1235688999999999987 458999999999999999
Q ss_pred HHhCCCCCCCCCH---HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCC
Q 009654 151 LLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 227 (529)
Q Consensus 151 lltG~~pf~g~~~---~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~ 227 (529)
|++|..||.+... .+.+.++...... ..+......++.++.+||..||..||.
T Consensus 206 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~------------------------~~~~~l~~~~p~~l~~li~~cl~~dP~ 261 (483)
T 3sv0_A 206 FLRGSLPWQGLKAGTKKQKYEKISEKKVA------------------------TSIEALCRGYPTEFASYFHYCRSLRFD 261 (483)
T ss_dssp HHHSSCTTSSCCCSSHHHHHHHHHHHHHH------------------------SCHHHHHTTSCHHHHHHHHHHHTCCTT
T ss_pred HHhCCCCCccccchhHHHHHHHHhhcccc------------------------ccHHHHhcCCcHHHHHHHHHHhcCChh
Confidence 9999999987543 3444444332110 111233467899999999999999999
Q ss_pred CCcCHHHHHh
Q 009654 228 KRATASAALA 237 (529)
Q Consensus 228 kR~ta~e~L~ 237 (529)
+||++.++++
T Consensus 262 ~RPs~~el~~ 271 (483)
T 3sv0_A 262 DKPDYSYLKR 271 (483)
T ss_dssp CCCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999998765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.71 Aligned_cols=204 Identities=18% Similarity=0.164 Sum_probs=156.5
Q ss_pred HHHHHHHHhCC---------CCCccceeeEEE-----------------cc-----------CCCeEEEEEeccCCC-ch
Q 009654 2 AREILILRRLD---------HPNIIKLEGLIT-----------------SR-----------LSCSIYLVFEYMEHD-IT 43 (529)
Q Consensus 2 ~rEi~iL~~L~---------HpnIvkl~~~~~-----------------~~-----------~~~~~~lV~E~~~g~-ll 43 (529)
.+|+.+|+.|+ |||||++++++. +. ....+|||||||+++ ++
T Consensus 71 ~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll 150 (336)
T 2vuw_A 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDL 150 (336)
T ss_dssp HHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEET
T ss_pred HHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccH
Confidence 58999999996 666666665543 20 146899999999886 56
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEccCC--------------------cEEEecccc
Q 009654 44 GLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG--------------------VLKLADFGL 102 (529)
Q Consensus 44 ~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH-~~gIvHrDIKp~NILl~~~g--------------------~vKl~DFGl 102 (529)
..+.. ..+++.+++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+
T Consensus 151 ~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~ 228 (336)
T 2vuw_A 151 EQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228 (336)
T ss_dssp GGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTT
T ss_pred HHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccc
Confidence 65543 57899999999999999999999 99999999999999999887 899999999
Q ss_pred ccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHH-HHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCch
Q 009654 103 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV-FAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDD 180 (529)
Q Consensus 103 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~i-l~elltG~~pf~g~~~-~~~~~~I~~~~g~p~~~ 180 (529)
|+..... ..+||+.|+|||++.+.. +.++||||||++ .++++.|..||.+... ......+........
T Consensus 229 a~~~~~~------~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 298 (336)
T 2vuw_A 229 SRLERDG------IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT-- 298 (336)
T ss_dssp CBEEETT------EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS--
T ss_pred cEecCCC------cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc--
Confidence 9876542 458999999999998743 889999998776 7888999999954221 112223332111100
Q ss_pred hhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH-hccccC
Q 009654 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL-ASEYFS 242 (529)
Q Consensus 181 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L-~h~~f~ 242 (529)
......+..+++++++||.+||+.| ||.++| +||||+
T Consensus 299 --------------------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 --------------------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp --------------------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred --------------------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0001233567899999999999987 999999 999995
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.69 Aligned_cols=234 Identities=20% Similarity=0.218 Sum_probs=156.8
Q ss_pred HHHHHHhCCCCCccceeeEEEc---cCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----
Q 009654 4 EILILRRLDHPNIIKLEGLITS---RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR----- 75 (529)
Q Consensus 4 Ei~iL~~L~HpnIvkl~~~~~~---~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~----- 75 (529)
|+..+..++||||+++++.+.. .....+|||||||+++.+..++.. ..+++..+..++.||+.||.|||+.
T Consensus 57 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~ 135 (336)
T 3g2f_A 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGD 135 (336)
T ss_dssp HHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGG
T ss_pred HHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhcccc
Confidence 3444556899999999986543 223468999999988666655433 3568999999999999999999999
Q ss_pred ----CCcccCCCCCcEEEccCCcEEEeccccccccCCCC-------CCCccccccccccCCcccccCC------CCCCCc
Q 009654 76 ----GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------RQPLTSRVVTLWYRPPELLLGA------TDYGPS 138 (529)
Q Consensus 76 ----gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~------~~y~~~ 138 (529)
||+||||||+||||+.++.+||+|||++....... .......+||+.|+|||++.+. ..++.+
T Consensus 136 ~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 215 (336)
T 3g2f_A 136 HYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215 (336)
T ss_dssp GCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred ccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence 99999999999999999999999999998664321 1223355799999999999763 235678
Q ss_pred chhhhhhHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCCc-hhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHH
Q 009654 139 VDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPD-DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216 (529)
Q Consensus 139 ~DIWSlG~il~elltG~~p-f~g~~~~~~~~~I~~~~g~p~~-~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~d 216 (529)
+||||||||+|+|++|..| |.+....+....+....+..+. ..+..... .....+ .+... ......+++.+.+
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~-~~~~~~~~~~l~~ 290 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS--REKQRP--KFPEA-WKENSLAVRSLKE 290 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHT--TSCCCC--CCCTT-CCCCSHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhc--ccccCC--CCCcc-cccccchHHHHHH
Confidence 9999999999999999644 4443321111111111111111 00000000 000000 00000 0011225668999
Q ss_pred HHHHhccCCCCCCcCHHHHH------hccccCC
Q 009654 217 LIETLLSVEPYKRATASAAL------ASEYFST 243 (529)
Q Consensus 217 Li~~mL~~dP~kR~ta~e~L------~h~~f~~ 243 (529)
||.+||..||.+|||+.+++ .++|-++
T Consensus 291 li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 99999999999999999994 4566554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=290.84 Aligned_cols=215 Identities=22% Similarity=0.238 Sum_probs=162.9
Q ss_pred HHHHHHHHh--CCCCCccceeeEEEccCC--CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----
Q 009654 2 AREILILRR--LDHPNIIKLEGLITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH---- 73 (529)
Q Consensus 2 ~rEi~iL~~--L~HpnIvkl~~~~~~~~~--~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH---- 73 (529)
.+|+++++. ++||||+++++++..... ..+|+||||++++.+..++.. ..+++.++..++.||+.||.|||
T Consensus 82 ~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ 160 (342)
T 1b6c_B 82 FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 160 (342)
T ss_dssp HHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred HHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHh
Confidence 578899988 799999999999987432 279999999999666655433 37999999999999999999999
Q ss_pred ----HCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC---CccccccccccCCcccccCCCC-----CCCcchh
Q 009654 74 ----SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATD-----YGPSVDL 141 (529)
Q Consensus 74 ----~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~-----y~~~~DI 141 (529)
+.||+||||||+||||+.++.+||+|||++......... .....++|+.|+|||++.+... ++.++||
T Consensus 161 ~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di 240 (342)
T 1b6c_B 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240 (342)
T ss_dssp STTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHH
T ss_pred hhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccH
Confidence 899999999999999999999999999999776543211 2345578999999999976432 2368999
Q ss_pred hhhhHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhc
Q 009654 142 WSVGCVFAELLIG----------KPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 207 (529)
Q Consensus 142 WSlG~il~elltG----------~~pf~g~~----~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~ 207 (529)
||||||+|+|++| ..||.+.. ..+.+..........+ ...... .-
T Consensus 241 ~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~--~~ 299 (342)
T 1b6c_B 241 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP-------------------NIPNRW--QS 299 (342)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC-------------------CCCGGG--GT
T ss_pred HHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCC-------------------CCcccc--cc
Confidence 9999999999999 67886542 1222222211101000 000000 01
Q ss_pred cCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 208 KDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 208 ~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
..++..+.+||.+||+.||.+|||+.+++++
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 300 CEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2345678999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.53 Aligned_cols=176 Identities=15% Similarity=0.198 Sum_probs=145.5
Q ss_pred CeEEEEEeccCCCchhhh------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEecccc
Q 009654 29 CSIYLVFEYMEHDITGLL------SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 102 (529)
Q Consensus 29 ~~~~lV~E~~~g~ll~~~------~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGl 102 (529)
..+|++|+++.+++...+ ......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~ 257 (413)
T 3dzo_A 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257 (413)
T ss_dssp CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence 457899999888776655 23345688889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccCCccccc---------CCCCCCCcchhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 009654 103 ANFSNTGHRQPLTSRVVTLWYRPPELLL---------GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173 (529)
Q Consensus 103 a~~~~~~~~~~~~~~~gt~~Y~APE~l~---------~~~~y~~~~DIWSlG~il~elltG~~pf~g~~~~~~~~~I~~~ 173 (529)
++..... ....+| +.|+|||++. ....|+.++||||||||+|+|++|+.||.+.+..+....+
T Consensus 258 a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~--- 329 (413)
T 3dzo_A 258 LVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--- 329 (413)
T ss_dssp CEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG---
T ss_pred eeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH---
Confidence 8865532 345677 9999999993 3345888999999999999999999999875432211111
Q ss_pred cCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccC
Q 009654 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 242 (529)
Q Consensus 174 ~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~ 242 (529)
......+|+.+.+||.+||..||.+|||+.++|+||||+
T Consensus 330 ------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 330 ------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp ------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred ------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 112246889999999999999999999999999999997
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-34 Score=319.61 Aligned_cols=196 Identities=23% Similarity=0.323 Sum_probs=160.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCC---CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~---~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+|||||++++++..... ..+|||||||+|+.+..+... .+++.++..++.||+.||.|||++||+
T Consensus 127 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~gii 204 (681)
T 2pzi_A 127 MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLV 204 (681)
T ss_dssp HHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCe
Confidence 589999999999999999999987432 127999999999777665433 799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+||||+.+ .+||+|||++...... ...+||+.|+|||++.+ .++.++||||||||||+|++|.+||
T Consensus 205 HrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~ 276 (681)
T 2pzi_A 205 YNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTR 276 (681)
T ss_dssp CCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEE
T ss_pred ecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCC
Confidence 99999999999875 8999999999876542 45679999999999976 3588999999999999999999998
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.... +.+. . .....+++.+.+||.+||..||.+||+..++|.|
T Consensus 277 ~~~~~~----------~~~~---------------------~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 277 NGRYVD----------GLPE---------------------D----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp TTEECS----------SCCT---------------------T----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cccccc----------cccc---------------------c----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 652100 0000 0 0011246789999999999999999999999999
Q ss_pred cccC
Q 009654 239 EYFS 242 (529)
Q Consensus 239 ~~f~ 242 (529)
+|+.
T Consensus 322 ~l~~ 325 (681)
T 2pzi_A 322 QLTG 325 (681)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9884
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=273.43 Aligned_cols=182 Identities=18% Similarity=0.157 Sum_probs=144.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.++++++||||+++++++.+ .+.+|||||||+|+.+..++.. .....++..++.||+.||.|||++||+||
T Consensus 78 ~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~ 153 (286)
T 3uqc_A 78 TLSRTLRLSRIDKPGVARVLDVVHT--RAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALS 153 (286)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhcCCCCCcceeeEEEEE--CCcEEEEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 3689999999999999999999988 5789999999998777766543 24667889999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+++| |++ .++.++|||||||++|+|++|++||.+
T Consensus 154 Dikp~NIll~~~g~~kl~~~~---------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 154 IDHPSRVRVSIDGDVVLAYPA---------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp CCSGGGEEEETTSCEEECSCC---------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred CCCcccEEEcCCCCEEEEecc---------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999999999999999998543 332 378999999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+..+.+..... ...............+|+++.+||.+||+.||.+| |+.++++.
T Consensus 205 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 205 AGVRSGLAPAER----------------------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CSBCCCSEECCB----------------------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCcchhhHHHHH----------------------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 543221100000 00000111234446799999999999999999999 99999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=297.87 Aligned_cols=149 Identities=17% Similarity=0.096 Sum_probs=115.1
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+||++|+++ .|+||+++++++++ ...+|||||||+|+.|..++...+++++. .|+.||+.||+|||++||||
T Consensus 288 ~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIH 362 (569)
T 4azs_A 288 LHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWH 362 (569)
T ss_dssp HHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEE
T ss_pred HHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCcee
Confidence 46899999999 79999999999998 67999999999998888877777888875 47899999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+||||+.+|.+||+|||+|+...... ...++.+||+.|+|||++.+ .+..++|+||+||++++|+++..+
T Consensus 363 RDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 363 DDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 9999999999999999999999998765432 34456789999999999987 467889999999999988776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.5e-23 Score=225.89 Aligned_cols=145 Identities=17% Similarity=0.152 Sum_probs=117.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+||||+++..++.+ ....|||||||+++.+..++.. +..++.||+.||.|||++||+|||
T Consensus 387 ~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrD 456 (540)
T 3en9_A 387 AREARYLALVKDFGIPAPYIFDVD--LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHND 456 (540)
T ss_dssp HHHHHHHHHGGGGTCCCCCEEEEE--TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTT
T ss_pred HHHHHHHHhcCCCCcCceEEEEEe--CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCC
Confidence 689999999999999955545444 3456999999998666655543 668999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCC------ccccccccccCCcccccC-CCCCCCcchhhhhhHHHHHHHhC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQP------LTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~------~~~~~gt~~Y~APE~l~~-~~~y~~~~DIWSlG~il~elltG 154 (529)
|||+|||++. .+||+|||+++......... ....+||++|+|||++.. ...|+..+|+|+..+-..+.+.+
T Consensus 457 iKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~ 534 (540)
T 3en9_A 457 LTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVER 534 (540)
T ss_dssp CCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHT
T ss_pred CCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence 9999999998 99999999998775432111 135688999999999964 13478889999999888888877
Q ss_pred CCCC
Q 009654 155 KPIL 158 (529)
Q Consensus 155 ~~pf 158 (529)
+.+|
T Consensus 535 r~rY 538 (540)
T 3en9_A 535 RARY 538 (540)
T ss_dssp CSCC
T ss_pred cccc
Confidence 7665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=5.3e-18 Score=169.85 Aligned_cols=101 Identities=17% Similarity=0.170 Sum_probs=82.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+ | +++.+++.. +..|+|||||+|+.+..+. + .++..++.||+.||.|||++||+|||
T Consensus 152 ~~E~~~l~~l~--~-~~v~~~~~~---~~~~lvmE~~~g~~L~~l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrD 218 (282)
T 1zar_A 152 RNEFRALQKLQ--G-LAVPKVYAW---EGNAVLMELIDAKELYRVR-----V--ENPDEVLDMILEEVAKFYHRGIVHGD 218 (282)
T ss_dssp HHHHHHHHHTT--T-SSSCCEEEE---ETTEEEEECCCCEEGGGCC-----C--SCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhcc--C-CCcCeEEec---cceEEEEEecCCCcHHHcc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCC
Confidence 58999999999 5 666666654 3469999999986655531 1 33557999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCccccc
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 130 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 130 (529)
|||+||||+ +|.+||+|||+|.. +..|.|||++.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999999999 99999999999853 33478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=8.1e-15 Score=144.51 Aligned_cols=94 Identities=15% Similarity=0.226 Sum_probs=73.2
Q ss_pred HHHHHHHHhCCCCCc--cceeeEEEccCCCeEEEEEeccCC-C----chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-
Q 009654 2 AREILILRRLDHPNI--IKLEGLITSRLSCSIYLVFEYMEH-D----ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH- 73 (529)
Q Consensus 2 ~rEi~iL~~L~HpnI--vkl~~~~~~~~~~~~~lV~E~~~g-~----ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH- 73 (529)
.+|+.+|++|.|++| ..++.+ . ..|||||||++ + .+..+.. .+++..+..++.||+.+|.|||
T Consensus 118 ~~E~~~l~~l~~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 118 EKEFRNLERAKEAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHHHHTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHH
Confidence 579999999988865 333332 2 35899999953 2 3332221 1345678899999999999999
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEecccccccc
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
+.||+||||||+|||++. .++|+|||+|...
T Consensus 189 ~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3e-11 Score=125.54 Aligned_cols=93 Identities=15% Similarity=0.166 Sum_probs=67.6
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
+|+..|.+|.+++|.-..-+... ..+|||||++|..+..+.. .+.+..++.||+.+|.+||++|||||||
T Consensus 162 kE~~nL~rL~~~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 162 KEFAFMKALYEEGFPVPEPIAQS----RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHHTTCSCCCEEEEE----TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHHhcCCCCCeeeecc----CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 46777777754444322222222 1279999999966654432 2345678899999999999999999999
Q ss_pred CCCcEEEccCC----------cEEEeccccccc
Q 009654 83 KGSNLLVNNEG----------VLKLADFGLANF 105 (529)
Q Consensus 83 Kp~NILl~~~g----------~vKl~DFGla~~ 105 (529)
||.||||+.+| .+.|+||+.+..
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999998876 388999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=2.5e-09 Score=104.50 Aligned_cols=97 Identities=16% Similarity=0.119 Sum_probs=77.9
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-----
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS----- 74 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~----- 74 (529)
+.+|+.+|+.| .+.++.++++++.+ .+..|+||||++|..+..... +......++.++..+|..||+
T Consensus 56 ~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~ 128 (263)
T 3tm0_A 56 VEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISD 128 (263)
T ss_dssp HHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCccc
Confidence 35899999999 57888899998876 568899999999976655421 223345788899999999998
Q ss_pred ------------------------------------------------------CCCcccCCCCCcEEEccCCcEEEecc
Q 009654 75 ------------------------------------------------------RGVLHRDIKGSNLLVNNEGVLKLADF 100 (529)
Q Consensus 75 ------------------------------------------------------~gIvHrDIKp~NILl~~~g~vKl~DF 100 (529)
..++|+|++|.|||+++.+.+.|+||
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDw 208 (263)
T 3tm0_A 129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp CSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCC
T ss_pred CCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEc
Confidence 45899999999999987656789999
Q ss_pred cccc
Q 009654 101 GLAN 104 (529)
Q Consensus 101 Gla~ 104 (529)
+.+.
T Consensus 209 e~a~ 212 (263)
T 3tm0_A 209 GRSG 212 (263)
T ss_dssp TTCE
T ss_pred hhcc
Confidence 9764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.8e-08 Score=103.35 Aligned_cols=103 Identities=17% Similarity=0.248 Sum_probs=82.2
Q ss_pred HHHHHHHHhCC--CCCccceeeEEEccCC-CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH----
Q 009654 2 AREILILRRLD--HPNIIKLEGLITSRLS-CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS---- 74 (529)
Q Consensus 2 ~rEi~iL~~L~--HpnIvkl~~~~~~~~~-~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~---- 74 (529)
.+|+.+|+.|. +..+.+++.++.+... +..|+||||++|..+.... ...+++.+...++.++...|..||+
T Consensus 84 ~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~ 161 (359)
T 3dxp_A 84 EREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQ 161 (359)
T ss_dssp HHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTT
T ss_pred HHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCch
Confidence 57999999996 4668888888766321 4579999999996553211 2247889999999999999999997
Q ss_pred ------------------------------------------------------CCCcccCCCCCcEEEccCCc--EEEe
Q 009654 75 ------------------------------------------------------RGVLHRDIKGSNLLVNNEGV--LKLA 98 (529)
Q Consensus 75 ------------------------------------------------------~gIvHrDIKp~NILl~~~g~--vKl~ 98 (529)
.+++|+|+++.|||++.++. +.|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~vi 241 (359)
T 3dxp_A 162 AIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVL 241 (359)
T ss_dssp TTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEEC
T ss_pred hccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEE
Confidence 36899999999999997753 6999
Q ss_pred cccccccc
Q 009654 99 DFGLANFS 106 (529)
Q Consensus 99 DFGla~~~ 106 (529)
||+.+...
T Consensus 242 Dwe~a~~g 249 (359)
T 3dxp_A 242 DWELSTLG 249 (359)
T ss_dssp CCTTCEEE
T ss_pred CccccccC
Confidence 99988643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.69 E-value=2.4e-08 Score=96.60 Aligned_cols=93 Identities=16% Similarity=0.130 Sum_probs=70.9
Q ss_pred HHHHHHHHhCCCCC--ccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Q 009654 2 AREILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--- 76 (529)
Q Consensus 2 ~rEi~iL~~L~Hpn--Ivkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g--- 76 (529)
.+|+.+|+.|.+.+ |.+++.+..+ .+..|+||||++|..+. .. ..+ ...++.++...|..||+..
T Consensus 61 ~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~ 130 (264)
T 1nd4_A 61 QDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPAT 130 (264)
T ss_dssp HHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGG
T ss_pred hHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCC
Confidence 58999999995434 5668887766 45789999999996664 21 122 2356778888888888754
Q ss_pred -------------------------------------------------------CcccCCCCCcEEEccCCcEEEeccc
Q 009654 77 -------------------------------------------------------VLHRDIKGSNLLVNNEGVLKLADFG 101 (529)
Q Consensus 77 -------------------------------------------------------IvHrDIKp~NILl~~~g~vKl~DFG 101 (529)
++|+|++|.|||++.++.+.|+|||
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~ 210 (264)
T 1nd4_A 131 CPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCG 210 (264)
T ss_dssp CCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCT
T ss_pred CCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcch
Confidence 9999999999999877667899999
Q ss_pred ccc
Q 009654 102 LAN 104 (529)
Q Consensus 102 la~ 104 (529)
.+.
T Consensus 211 ~a~ 213 (264)
T 1nd4_A 211 RLG 213 (264)
T ss_dssp TCE
T ss_pred hcc
Confidence 864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.64 E-value=2e-08 Score=100.62 Aligned_cols=151 Identities=16% Similarity=0.124 Sum_probs=97.6
Q ss_pred HHHHHHHHhC-CCCC--ccceeeEEEccC-CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---
Q 009654 2 AREILILRRL-DHPN--IIKLEGLITSRL-SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS--- 74 (529)
Q Consensus 2 ~rEi~iL~~L-~Hpn--Ivkl~~~~~~~~-~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~--- 74 (529)
.+|+.+|+.| .+.. +.+++....+.. ....|+|||+++|..+..... ..++.++...++.|+...|..||+
T Consensus 58 ~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~ 135 (304)
T 3sg8_A 58 FNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINI 135 (304)
T ss_dssp HHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence 5899999988 4433 334433322211 123489999999966543211 257888888999999999999996
Q ss_pred -------------------------------------------------------CCCcccCCCCCcEEEcc--CCcEEE
Q 009654 75 -------------------------------------------------------RGVLHRDIKGSNLLVNN--EGVLKL 97 (529)
Q Consensus 75 -------------------------------------------------------~gIvHrDIKp~NILl~~--~g~vKl 97 (529)
..++|+|++|.|||++. .+.+.|
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~ 215 (304)
T 3sg8_A 136 SGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGI 215 (304)
T ss_dssp TTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEE
T ss_pred CCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEE
Confidence 13699999999999998 456899
Q ss_pred eccccccccCCCCCCCcccccccccc---CCcccccC-CCCCCC------------cchhhhhhHHHHHHHhCCCCCC
Q 009654 98 ADFGLANFSNTGHRQPLTSRVVTLWY---RPPELLLG-ATDYGP------------SVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 98 ~DFGla~~~~~~~~~~~~~~~gt~~Y---~APE~l~~-~~~y~~------------~~DIWSlG~il~elltG~~pf~ 159 (529)
+||+.+....+. ........+ ..|+.+.. ...|+. -.++|+++.++|.+.+|.++|.
T Consensus 216 iD~~~~~~~~~~-----~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 216 IDFGDAAISDPD-----NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CCCTTCEEECTT-----HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred EeCCCCccCChH-----HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 999998654321 111111111 22322110 001211 2589999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.7e-05 Score=78.02 Aligned_cols=102 Identities=19% Similarity=0.174 Sum_probs=72.1
Q ss_pred HHHHHHHHhCCCC---CccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q 009654 2 AREILILRRLDHP---NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--- 75 (529)
Q Consensus 2 ~rEi~iL~~L~Hp---nIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~--- 75 (529)
.+|+.+|+.|.+. .|.+++.+.... .+..|+||||++|..+..... ..++..+...++.||...|..||+.
T Consensus 57 ~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~ 133 (306)
T 3tdw_A 57 NKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVE 133 (306)
T ss_dssp HHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHH
T ss_pred HHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 5899999999642 355666665432 456789999999966553211 1346666667777777777777653
Q ss_pred ---------------------------------------------------------CCcccCCCCCcEEEcc---CCc-
Q 009654 76 ---------------------------------------------------------GVLHRDIKGSNLLVNN---EGV- 94 (529)
Q Consensus 76 ---------------------------------------------------------gIvHrDIKp~NILl~~---~g~- 94 (529)
.++|+|++|.|||++. ++.
T Consensus 134 ~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~ 213 (306)
T 3tdw_A 134 TAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPL 213 (306)
T ss_dssp HHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCE
T ss_pred cccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCce
Confidence 2489999999999987 355
Q ss_pred EEEecccccccc
Q 009654 95 LKLADFGLANFS 106 (529)
Q Consensus 95 vKl~DFGla~~~ 106 (529)
+.|+||+.+...
T Consensus 214 ~~~iD~~~a~~g 225 (306)
T 3tdw_A 214 TGIIDFGDAAIS 225 (306)
T ss_dssp EEECCCTTCEEE
T ss_pred EEEEehhhcCCC
Confidence 589999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=1.3e-05 Score=78.17 Aligned_cols=97 Identities=16% Similarity=0.142 Sum_probs=69.6
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR----- 75 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~----- 75 (529)
.+|+.+|+.|. +--|.+++.++.+ .+..|+|||+++|..+...... .......+..++...|..||..
T Consensus 67 ~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~ 140 (272)
T 4gkh_A 67 TDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNC 140 (272)
T ss_dssp HHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGC
T ss_pred HHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccC
Confidence 57999999993 4346778888777 4688999999999655433211 1223344556666666666641
Q ss_pred -----------------------------------------------------CCcccCCCCCcEEEccCCcEEEecccc
Q 009654 76 -----------------------------------------------------GVLHRDIKGSNLLVNNEGVLKLADFGL 102 (529)
Q Consensus 76 -----------------------------------------------------gIvHrDIKp~NILl~~~g~vKl~DFGl 102 (529)
.++|+|+.+.|||++..+.+-|+||+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~ 220 (272)
T 4gkh_A 141 PFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGR 220 (272)
T ss_dssp CBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTT
T ss_pred CcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcc
Confidence 168999999999999877778999997
Q ss_pred cc
Q 009654 103 AN 104 (529)
Q Consensus 103 a~ 104 (529)
+.
T Consensus 221 a~ 222 (272)
T 4gkh_A 221 VG 222 (272)
T ss_dssp CE
T ss_pred cc
Confidence 74
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=5.2e-05 Score=77.15 Aligned_cols=31 Identities=16% Similarity=0.237 Sum_probs=26.1
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
..++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999999644579999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0024 Score=60.46 Aligned_cols=96 Identities=17% Similarity=0.076 Sum_probs=62.7
Q ss_pred chhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccc
Q 009654 42 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120 (529)
Q Consensus 42 ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt 120 (529)
|...+...+.+|+|++++.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|-+.+ +.+. ...
T Consensus 35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~ 100 (229)
T 2yle_A 35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGE 100 (229)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccc
Confidence 445566677899999999999999999877622 2222333457899999999887764 2110 012
Q ss_pred cccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 121 ~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
..+.|||.+. ...+.+.=|||||+++|.-+-
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 2356888763 235677889999999999984
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0056 Score=63.05 Aligned_cols=30 Identities=17% Similarity=0.310 Sum_probs=25.2
Q ss_pred HCCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 74 SRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 74 ~~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
...++|+|+.+.|||++.+ .++|+||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3579999999999999865 48999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0083 Score=59.31 Aligned_cols=29 Identities=17% Similarity=0.264 Sum_probs=24.5
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
.++|+|+.+.||| ..++.+.|+||+.+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3799999999999 5567789999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0089 Score=61.65 Aligned_cols=97 Identities=20% Similarity=0.213 Sum_probs=61.8
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhh--h----------------cCC----CCCC--CHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL--L----------------SCP----DIKF--SEA 56 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~--~----------------~~~----~~~l--~e~ 56 (529)
.+|+.+|+.| .+.-..++++++.+ .+||||++|..+.. + ..- .... -..
T Consensus 101 ~rE~~vl~~L~~~gv~P~ll~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~ 174 (379)
T 3feg_A 101 VLESVMFAILAERSLGPQLYGVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFG 174 (379)
T ss_dssp HHHHHHHHHHHHTTSSCCEEEEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHH
T ss_pred HHHHHHHHHHHhcCCCCeEEEEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHH
Confidence 4799999988 34334667665532 28999999843321 0 011 1112 245
Q ss_pred HHHHHHHHHHH-------------------HHHHHH----H----CCCcccCCCCCcEEEccC----CcEEEecccccc
Q 009654 57 QIKCYMNQLLH-------------------GLEHCH----S----RGVLHRDIKGSNLLVNNE----GVLKLADFGLAN 104 (529)
Q Consensus 57 ~~~~i~~Qll~-------------------gL~~LH----~----~gIvHrDIKp~NILl~~~----g~vKl~DFGla~ 104 (529)
++..++.|+.. .+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 175 ~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 175 TMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 66667665532 123332 2 249999999999999876 789999999774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.011 Score=59.20 Aligned_cols=32 Identities=31% Similarity=0.376 Sum_probs=27.4
Q ss_pred CCCcccCCCCCcEEEccC----CcEEEecccccccc
Q 009654 75 RGVLHRDIKGSNLLVNNE----GVLKLADFGLANFS 106 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~----g~vKl~DFGla~~~ 106 (529)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 67999999987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.012 Score=58.48 Aligned_cols=30 Identities=17% Similarity=0.274 Sum_probs=27.1
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.031 Score=55.93 Aligned_cols=38 Identities=21% Similarity=0.195 Sum_probs=30.4
Q ss_pred HHHHHHHHhCC---CCCccceeeEEEccCCCeEEEEEeccCCC
Q 009654 2 AREILILRRLD---HPNIIKLEGLITSRLSCSIYLVFEYMEHD 41 (529)
Q Consensus 2 ~rEi~iL~~L~---HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ 41 (529)
.+|+.+|+.|. ...+.+++.+... .+..|+||||++|.
T Consensus 76 ~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 76 RAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEALNKS 116 (312)
T ss_dssp HHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECCCCC
T ss_pred HHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEeccCC
Confidence 57999999983 3668888887765 46789999999985
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.33 E-value=0.023 Score=57.80 Aligned_cols=28 Identities=29% Similarity=0.521 Sum_probs=23.8
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
+++|+|+.+.|||++.++ +.|+||+.+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999997654 8999998774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.13 E-value=0.019 Score=60.17 Aligned_cols=33 Identities=24% Similarity=0.227 Sum_probs=22.9
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCC
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEH 40 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g 40 (529)
.+|+.+|+.|. +.-..++++.+.+ .+|+||++|
T Consensus 123 i~E~~~l~~L~~~g~~P~l~~~~~~------g~v~e~l~G 156 (429)
T 1nw1_A 123 VAESVIFTLLSERHLGPKLYGIFSG------GRLEEYIPS 156 (429)
T ss_dssp HHHHHHHHHHHHTTSSSCEEEEETT------EEEECCCCE
T ss_pred HHHHHHHHHHHhCCCCCcEEEEeCC------CEEEEEeCC
Confidence 46899999884 3333667665532 389999997
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.097 Score=55.23 Aligned_cols=34 Identities=29% Similarity=0.170 Sum_probs=24.2
Q ss_pred HHHHHHHHhCCCCCc-cceeeEEEccCCCeEEEEEeccCCC
Q 009654 2 AREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEYMEHD 41 (529)
Q Consensus 2 ~rEi~iL~~L~HpnI-vkl~~~~~~~~~~~~~lV~E~~~g~ 41 (529)
.+|+.+|+.|...+| .++++++. + .+||||++|.
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~----~--G~v~e~I~G~ 186 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT----N--GRIEEFMDGY 186 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET----T--EEEEECCCSE
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC----C--eEEEEeeCCc
Confidence 479999999964444 56776652 2 2599999983
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.13 E-value=0.027 Score=58.46 Aligned_cols=33 Identities=12% Similarity=0.412 Sum_probs=28.6
Q ss_pred HHCCCcccCCCCCcEEEccCCcEEEecccccccc
Q 009654 73 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 106 (529)
Q Consensus 73 H~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~ 106 (529)
+...++|+|++|.|||++.++ +.|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456899999999999998776 999999988643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.71 E-value=0.068 Score=55.82 Aligned_cols=29 Identities=21% Similarity=0.486 Sum_probs=25.4
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
.++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7778999999998753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.05 E-value=0.27 Score=50.65 Aligned_cols=28 Identities=29% Similarity=0.443 Sum_probs=23.9
Q ss_pred CcccCCCCCcEEEc------cCCcEEEecccccc
Q 009654 77 VLHRDIKGSNLLVN------NEGVLKLADFGLAN 104 (529)
Q Consensus 77 IvHrDIKp~NILl~------~~g~vKl~DFGla~ 104 (529)
++|+|+.+.|||+. .++.+.|+||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 67999999999993 45679999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.25 E-value=0.071 Score=52.70 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=25.7
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999877666899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.74 E-value=0.16 Score=50.26 Aligned_cols=28 Identities=25% Similarity=0.208 Sum_probs=24.4
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999998 4 89999998764
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=89.44 E-value=0.049 Score=54.67 Aligned_cols=115 Identities=15% Similarity=0.114 Sum_probs=65.2
Q ss_pred hccCCcHHHHHHHHHhc---cCCCCCCcCHHHHHhc------cccCCCCCCCCCCCCCCCCCChhHHhhhhHHHHhhhhc
Q 009654 206 TFKDLPTTAVNLIETLL---SVEPYKRATASAALAS------EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 276 (529)
Q Consensus 206 ~~~~~s~~~~dLi~~mL---~~dP~kR~ta~e~L~h------~~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (529)
.++.+.+++.+|.++++ ..+|.+|.+..+.+.+ +|....+... ..+.+++.|....+....
T Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~r~~~~~~~a~ 82 (323)
T 1ij5_A 13 NVKKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKV----------QNEFDARERAEREREAAR 82 (323)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHH----------HHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH----------cChhhhhHHHHHHHHhhc
Confidence 34567888999999999 8999999999999988 7765321100 112334444443333222
Q ss_pred Cccccccc--------cc-----ccccccCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccCCccc
Q 009654 277 GRVRGAET--------RK-----TTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELSGREV 331 (529)
Q Consensus 277 ~~~~~~~~--------~~-----~~~~~~~~~~~~~~~e~~~~~~~~~~~d~~~~g~~~~ee~~~~~~ 331 (529)
|....... .+ ......+. ...+.+++..+...|..+|.|++|.|+.+|+.....
T Consensus 83 g~~~~e~q~~~~vl~~l~~~f~~~~~lkk~~-~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~ 149 (323)
T 1ij5_A 83 GDAAAEKQRLASLLKDLEDDASGYNRLRPSK-PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLA 149 (323)
T ss_dssp SCHHHHHHHHHHHHHHC-------------C-CCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHH
T ss_pred CCCCCcchhhHHHHHHHHHHHHHhhhHHHHH-HhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHH
Confidence 21111000 00 00111112 235889999999999999999999999999744443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=87.71 E-value=0.26 Score=49.48 Aligned_cols=31 Identities=29% Similarity=0.416 Sum_probs=27.4
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANF 105 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~ 105 (529)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987754
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=85.41 E-value=0.17 Score=46.12 Aligned_cols=46 Identities=7% Similarity=-0.096 Sum_probs=34.8
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccCCcc
Q 009654 284 TRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELSGRE 330 (529)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~d~~~~g~~~~ee~~~~~ 330 (529)
..++.....+...+ +.+++..+.+.|..+|.+++|.++.+|+....
T Consensus 33 ~l~~~~l~~~~~~l-~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l 78 (191)
T 3k21_A 33 KFQKLAMTIIAQQS-NDYDVEKLKSTFLVLDEDGKGYITKEQLKKGL 78 (191)
T ss_dssp HHHHHHHHHHHHHC-CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHHHC-CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 34444444444444 88899999999999999999999999974433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 529 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-64 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-63 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-58 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-57 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-56 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-55 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-53 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-48 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-47 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-64
Identities = 103/254 (40%), Positives = 143/254 (56%), Gaps = 6/254 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L HPNII L + +I LVF++ME D+ ++ + + + IK YM
Sbjct: 49 REIKLLQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
L GLE+ H +LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT W
Sbjct: 107 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRW 165
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
YR PELL GA YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++ W
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225
Query: 183 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
LP FK L F ++LI+ L P R TA+ AL +YF
Sbjct: 226 PDMCSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
Query: 242 STKPYACDLSSLPI 255
S +P LP
Sbjct: 284 SNRPGPTPGCQLPR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-63
Identities = 108/260 (41%), Positives = 148/260 (56%), Gaps = 12/260 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLS------CSIYLVFEYMEHDITGLLSCPDIKFSEA 56
REI IL+ L H N++ L + ++ S SIYLVF++ EHD+ GLLS +KF+ +
Sbjct: 58 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 117
Query: 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQP 113
+IK M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA +
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
T+RVVTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +L
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 174 CGSPPDDYW---KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
CGS + W +L Q R A++LI+ LL ++P +R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 231 TASAALASEYFSTKPYACDL 250
+ AL ++F + P DL
Sbjct: 298 DSDDALNHDFFWSDPMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-58
Identities = 95/278 (34%), Positives = 138/278 (49%), Gaps = 12/278 (4%)
Query: 3 REILILRRLDHPNIIKLEGLI---TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIK 59
REI IL R H NII + +I T +YLV M D+ LL S I
Sbjct: 55 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHIC 112
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSR 117
++ Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA + H LT
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
V T WYR PE++L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 178 PDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
+ A + P+ + F + + A++L++ +L+ P+KR A
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
Query: 236 LASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 273
LA Y D S PI + D + + + K
Sbjct: 293 LAHPYLEQYY---DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-57
Identities = 90/268 (33%), Positives = 130/268 (48%), Gaps = 12/268 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITS----RLSCSIYLVFEYMEHDITGLL---SCPDIKFSE 55
RE+ I+R+LDH NI++L S + + LV +Y+ + + S
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPL 114
+K YM QL L + HS G+ HRDIK NLL++ + VLKL DFG A G +P
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPN 179
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
S + + +YR PEL+ GATDY S+D+WS GCV AELL+G+PI G + V+QL +I K+
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234
G+P + ++ + PQ + P A+ L LL P R T
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299
Query: 235 ALASEYFSTKPYACDLSSLPIYPPSKEI 262
A A +F LP + +
Sbjct: 300 ACAHSFF--DELRDPNVKLPNGRDTPAL 325
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-56
Identities = 88/277 (31%), Positives = 144/277 (51%), Gaps = 12/277 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSR----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + T YLV +M D+ L+ K E +I
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRI 123
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL + H+ G++HRD+K NL VN + LK+ DFGLA ++ +T V
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYV 179
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT WYR PE++L Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 179 DDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
++ ++ + A + P + AVNL+E +L ++ +R TA AL
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 237 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 273
A YF + D + Y S + + ++ +R
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 186 bits (472), Expect = 1e-55
Identities = 90/239 (37%), Positives = 136/239 (56%), Gaps = 3/239 (1%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI IL+ L H NI+KL +I ++ + LVFE+++ D+ LL + K ++
Sbjct: 49 REISILKELKHSNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QLL+G+ +CH R VLHRD+K NLL+N EG LK+ADFGLA R+ +VTLW
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLW 165
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
YR P++L+G+ Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P W
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 183 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
K L + ++L+ +L ++P +R TA AL YF
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-54
Identities = 90/276 (32%), Positives = 140/276 (50%), Gaps = 12/276 (4%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+ +L+ + H N+I L + T S +YLV M D+ ++ C K ++ +
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV 123
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ + Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA ++ T V
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYV 179
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T WYR PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 179 DDYWKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ KK S+ + Q + F AV+L+E +L ++ KR TA+ AL
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 237 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARR 272
A YF+ D Y S E ++ +
Sbjct: 300 AHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 7e-54
Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 30/245 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+EI I + L+H N++K G R YL EY PDI E + +
Sbjct: 52 KEICINKMLNHENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 109
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TL 121
+QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA +R+ L +++ TL
Sbjct: 110 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
Y PELL + VD+WS G V +L G+ ++ Q + +K + +
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP- 228
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
+K + + + L+ +L P R T ++
Sbjct: 229 -------------------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
Query: 242 STKPY 246
KP
Sbjct: 264 -NKPL 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-53
Identities = 97/246 (39%), Positives = 137/246 (55%), Gaps = 6/246 (2%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCY 61
REI +L+ L+HPNI+KL +I + +YLVFE++ D+ + + IK Y
Sbjct: 50 REISLLKELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY 107
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ QLL GL CHS VLHRD+K NLL+N EG +KLADFGLA R T VVTL
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTL 166
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
WYR PE+LLG Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
W + + L +L+ +L +P KR +A AALA +F
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 242 S--TKP 245
TKP
Sbjct: 287 QDVTKP 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-52
Identities = 95/241 (39%), Positives = 132/241 (54%), Gaps = 4/241 (1%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
REI +L+ L H NI++L ++ S + LVFE+ + D+ + +K ++
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
QLL GL CHSR VLHRD+K NLL+N G LKLA+FGLA R ++ VVTLW
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLW 166
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDY 181
YRPP++L GA Y S+D+WS GC+FAEL P+ G +QL +IF+L G+P ++
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
W P P +SL L T +L++ LL P +R +A AL YF
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
Query: 242 S 242
S
Sbjct: 287 S 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-51
Identities = 71/242 (29%), Positives = 108/242 (44%), Gaps = 35/242 (14%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+ RE+ I L HPNI++L G + +YL+ EY KF E +
Sbjct: 53 LRREVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 110
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y+ +L + L +CHS+ V+HRDIK NLL+ + G LK+ADFG + + + R + T
Sbjct: 111 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGT 167
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
L Y PPE++ G + VDLWS+G + E L+GKP + T E +I ++ + PD
Sbjct: 168 LDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD- 225
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
+ A +LI LL P +R L +
Sbjct: 226 ----------------------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257
Query: 241 FS 242
+
Sbjct: 258 IT 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (447), Expect = 3e-51
Identities = 60/292 (20%), Positives = 102/292 (34%), Gaps = 33/292 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+EI + L HP ++ L + +++E+M ++ ++ K SE + Y
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 129
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVV 119
M Q+ GL H H +H D+K N++ + LKL DFGL + +
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTG 187
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T + PE+ G G D+WSVG + LL G G + E L + + D
Sbjct: 188 TAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
+ + + I LL +P R T AL
Sbjct: 247 SAF-------------------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281
Query: 240 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 291
+ + S +P +K D+ + + + + RK
Sbjct: 282 WLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 6e-51
Identities = 54/255 (21%), Positives = 96/255 (37%), Gaps = 22/255 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE+ +L + P I+ G S I + E+M+ + + E +
Sbjct: 53 RELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 110
Query: 63 NQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
++ GL + + ++HRD+K SN+LVN+ G +KL DFG++ S V T
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTR 167
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDD 180
Y PE L G T Y D+WS+G E+ +G+ + E +L ++ G +
Sbjct: 168 SYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 181 YWK-----KSKLPHATLFKPQQPYDSSLRETFKDLPTT---------AVNLIETLLSVEP 226
+ + + +P L + P + + L P
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286
Query: 227 YKRATASAALASEYF 241
+RA + +
Sbjct: 287 AERADLKQLMVHAFI 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (442), Expect = 2e-50
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 38/275 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
EI I+ +L HP +I L + + L+ E++ ++ ++ D K SEA++ Y
Sbjct: 75 NEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINY 132
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVV 119
M Q GL+H H ++H DIK N++ +K+ DFGLA N +
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTA 190
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
T + PE++ G D+W++G + LL G G ++E L + + +
Sbjct: 191 TAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
D + + A + I+ LL EP KR T AL
Sbjct: 250 DAFSS-------------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284
Query: 240 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 274
+ D S+L PS + ++ +
Sbjct: 285 WLKG-----DHSNLTSRIPSSRYNKIRQKIKEKYA 314
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 1e-49
Identities = 64/274 (23%), Positives = 105/274 (38%), Gaps = 38/274 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+E+ L++L HPN I+ G + +LV EY + LL E +I
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
+ L GL + HS ++HRD+K N+L++ G++KL DFG A+ P S V T +
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTPY 176
Query: 123 YRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
+ PE++L + Y VD+WS+G EL KP L + L+ I + P
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPAL 234
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240
N +++ L P R T+ L +
Sbjct: 235 QS-------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269
Query: 241 FSTKPYACDLSSLP--IYPPSKEIDAKHREDARR 272
+ + L +E+D ++
Sbjct: 270 VLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-49
Identities = 68/264 (25%), Positives = 111/264 (42%), Gaps = 39/264 (14%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQI 58
+ EIL++R +PNI+ +++V EY+ G L+ + E QI
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAG---GSLTDVVTETCMDEGQI 118
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ L LE HS V+HRDIK N+L+ +G +KL DFG + ++ V
Sbjct: 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV 177
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T ++ PE++ YGP VD+WS+G + E++ G+P + L+ I G+P
Sbjct: 178 GTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE 235
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
+K L + + L ++ KR +A L
Sbjct: 236 LQNPEK-------------------------LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270
Query: 239 EYFSTKPYACDLSSL-PIYPPSKE 261
++ A LSSL P+ +KE
Sbjct: 271 QFLKI---AKPLSSLTPLIAAAKE 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-49
Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 34/245 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
EI IL DHPNI+KL +++++ E+ + ++ + +E+QI+
Sbjct: 58 VEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
Q L L + H ++HRD+K N+L +G +KLADFG++ NT Q S + T
Sbjct: 116 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTP 174
Query: 122 WYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
++ PE+++ T Y D+WS+G E+ +P + L KI K P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPP 233
Query: 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
+ + + ++ L R T S L
Sbjct: 234 TLAQPSR-------------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
Query: 238 SEYFS 242
+ +
Sbjct: 269 HPFVT 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 171 bits (433), Expect = 2e-49
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 16/252 (6%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
REI IL L PNII L ++ +S + LVFE++ + ++ I+ Y
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFY 134
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVT 120
M ++L L++CHS G++HRD+K N+++++E L+L D+GLA F + G RV +
Sbjct: 135 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVAS 192
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP-P 178
+++ PELL+ Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRAT 231
DY K + F S R E + A++ ++ LL + R T
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
Query: 232 ASAALASEYFST 243
A A+ YF T
Sbjct: 313 AREAMEHPYFYT 324
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-49
Identities = 93/246 (37%), Positives = 138/246 (56%), Gaps = 12/246 (4%)
Query: 3 REILILRRL---DHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSC-PDIKFSE 55
RE+ +LR L +HPN+++L + T + + LVFE+++ D+T L P+
Sbjct: 56 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 115
Query: 56 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 115
IK M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + T
Sbjct: 116 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 173
Query: 116 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 175
S VVTLWYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G
Sbjct: 174 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 176 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235
P ++ W + F + + + D+ +L+ L+ P KR +A +A
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
Query: 236 LASEYF 241
L+ YF
Sbjct: 291 LSHPYF 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-48
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 33/245 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE ++ RLDHP +KL +Y Y ++ F E + Y
Sbjct: 57 RERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 114
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TL 121
+++ LE+ H +G++HRD+K N+L+N + +++ DFG A + +Q + V T
Sbjct: 115 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 181
Y PELL + S DLW++GC+ +L+ G P + E KI KL P+ +
Sbjct: 175 QYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 233
Query: 182 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241
+ K A +L+E LL ++ KR
Sbjct: 234 FPK-----------------------------ARDLVEKLLVLDATKRLGCEEMEGYGPL 264
Query: 242 STKPY 246
P+
Sbjct: 265 KAHPF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-48
Identities = 58/296 (19%), Positives = 105/296 (35%), Gaps = 36/296 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+EI IL H NI+ L S + ++FE++ DI ++ + +E +I Y
Sbjct: 50 KEISILNIARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSY 107
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVV 119
++Q+ L+ HS + H DI+ N++ +K+ +FG A G
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFT 165
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
Y PE+ + D+WS+G + LL G T + + I + +
Sbjct: 166 APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
+ + K++ A++ ++ LL E R TAS AL
Sbjct: 225 EAF-------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 240 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMS 295
+ K + + ++D R+ R G+S
Sbjct: 260 WLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG---GAIRSQKGVS 312
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-48
Identities = 47/240 (19%), Positives = 96/240 (40%), Gaps = 30/240 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E+ +LR+ H NI+ G T+ + +V ++ E + L + KF ++
Sbjct: 53 NEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 109
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 120
Q G+++ H++ ++HRD+K +N+ ++ + +K+ DFGLA + ++ +
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 121 LWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
+ + PE++ Y D+++ G V EL+ G+ +Q+ + P
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
D L + + P L+ L + +R LAS
Sbjct: 230 D-----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 163 bits (413), Expect = 5e-47
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
+E+ ILR++ HPNII+L+ + +LVF+ M+ + SE + +
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 115
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
M LL + H ++HRD+K N+L++++ +KL DFG + + G + L T
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTP 173
Query: 122 WYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
Y PE++ + + YG VD+WS G + LL G P R ++ L I
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
W D T +L+ L V+P KR TA AL
Sbjct: 234 FGSPEW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
Query: 237 ASEYF 241
A +F
Sbjct: 269 AHPFF 273
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 9e-47
Identities = 80/291 (27%), Positives = 149/291 (51%), Gaps = 24/291 (8%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQI 58
RE+++++ ++H NII L + T + + +YLV E M+ L ++ ++
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERM 121
Query: 59 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 118
+ Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T V
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 179
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
VT +YR PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 179 DDYWKKSKLPHATLFKPQQPYDS-------------SLRETFKDLPTTAVNLIETLLSVE 225
++ KK + + + Y + E K + A +L+ +L ++
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 226 PYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID-AKHREDARRKKV 275
P KR + AL Y + ++ + P K++D +H + ++ +
Sbjct: 299 PAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-45
Identities = 60/260 (23%), Positives = 107/260 (41%), Gaps = 34/260 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
RE+ IL+ + HPN+I L + ++ + L+ E + +E + ++
Sbjct: 62 REVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQPLTSRV 118
Q+L+G+ + HS + H D+K N+++ + V +K+ DFGLA+ + G+ +
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 177
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T + PE++ G D+WS+G + LL G G T+ E L + +
Sbjct: 178 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
D+Y+ + A + I LL +P KR T +L
Sbjct: 237 DEYF-------------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 239 EYFSTKPYACDLSSLPIYPP 258
+ K LSS +P
Sbjct: 272 PWIKPKDTQQALSSAWSHPQ 291
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-45
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 39/247 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQI 58
E+ +LR L HPNI++ I R + ++Y+V EY E + + E +
Sbjct: 52 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 111
Query: 59 KCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 113
M QL L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSF 170
Query: 114 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 173
+ V T +Y PE + Y D+WS+GC+ EL P ++ E KI +
Sbjct: 171 AKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE- 228
Query: 174 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233
K ++P+ +I +L+++ Y R +
Sbjct: 229 --------GKFRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVE 261
Query: 234 AALASEY 240
L +
Sbjct: 262 EILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-44
Identities = 62/271 (22%), Positives = 111/271 (40%), Gaps = 35/271 (12%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 59
M EI +L ++ HPNI+ L+ + S +YL+ + + ++ + ++E
Sbjct: 54 MENEIAVLHKIKHPNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDAS 110
Query: 60 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTS 116
+ Q+L +++ H G++HRD+K NLL + + + ++DFGL+ + G L++
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LST 168
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
T Y PE+L Y +VD WS+G + LL G P + + +I K
Sbjct: 169 ACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
YW D+ +A + I L+ +P KR T AL
Sbjct: 228 FDSPYW-------------------------DDISDSAKDFIRHLMEKDPEKRFTCEQAL 262
Query: 237 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHR 267
+ + + K+ AK +
Sbjct: 263 QHPWIAGDTALDKNIHQSVSEQIKKNFAKSK 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 48/244 (19%), Positives = 84/244 (34%), Gaps = 36/244 (14%)
Query: 3 REILILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
E +L+ L HPNI++ T + I LV E M ++
Sbjct: 57 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS 116
Query: 61 YMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSR 117
+ Q+L GL+ H+R ++HRD+K N+ + G +K+ D GLA +
Sbjct: 117 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAV 173
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 177
+ T + PE+ Y SVD+++ G E+ + Q+++ G
Sbjct: 174 IGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVK 230
Query: 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
P + K +IE + +R + L
Sbjct: 231 PASFD-------------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
Query: 238 SEYF 241
+F
Sbjct: 266 HAFF 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (370), Expect = 7e-41
Identities = 46/241 (19%), Positives = 90/241 (37%), Gaps = 30/241 (12%)
Query: 3 REILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
RE L+HP I+ + + Y+V EY++ + + + +
Sbjct: 56 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 115
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRV 118
+ L H G++HRD+K +N++++ +K+ DFG+A + + +
Sbjct: 116 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 178
T Y PE G + D++S+GCV E+L G+P G + V ++ + PP
Sbjct: 176 GTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238
+ L ++ L+ P R +A + +
Sbjct: 235 SARH-------------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRA 269
Query: 239 E 239
+
Sbjct: 270 D 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 62/308 (20%), Positives = 118/308 (38%), Gaps = 41/308 (13%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSC--SIYLVFEYMEH-DITGLL-SCPDIKFSEAQ 57
RE+ + R P+I+++ + + + + +V E ++ ++ + D F+E +
Sbjct: 53 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPL 114
M + +++ HS + HRD+K NLL +LKL DFG A + + +
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT- 171
Query: 115 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 174
+ T +Y PE+L Y S D+WS+G + LL G P + +
Sbjct: 172 -TPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
Query: 175 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234
++ P S + E K LI LL EP +R T +
Sbjct: 230 RMGQ--------------YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITE 268
Query: 235 ALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGM 294
+ + + + P++ + K R + ++++ T R +
Sbjct: 269 FMNHPWIMQ---STKVPQTPLHTSRVLKEDKERWEDVKEEM------TSALATMRVDYEQ 319
Query: 295 SKLAPVED 302
K+ +ED
Sbjct: 320 IKIKKIED 327
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (365), Expect = 2e-39
Identities = 57/278 (20%), Positives = 110/278 (39%), Gaps = 41/278 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+ ++ D P I+ + + + + + M FSEA ++ Y
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 113
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
+++ GLEH H+R V++RD+K +N+L++ G ++++D GLA + ++ + V T
Sbjct: 114 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHG 170
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
Y PE+L Y S D +S+GC+ +LL G + ++ H+I ++ + +
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP 229
Query: 183 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE--- 239
+L+E LL + +R A E
Sbjct: 230 -------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 240 --YFST----KPYACDLSSLPIYPPSKEIDAKHREDAR 271
+F + + P+ PP E++A D
Sbjct: 265 SPFFRSLDWQMVFLQKYPP-PLIPPRGEVNAADAFDIG 301
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 49/245 (20%), Positives = 97/245 (39%), Gaps = 37/245 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKC 60
E ++++L H +++L ++T IY++ EYME+ + L + IK + ++
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Q+ G+ R +HRD++ +N+LV++ K+ADFGLA
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 179
+ + PE + T + D+WS G + E++ G+ G T E + + +
Sbjct: 174 IKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------- 225
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA-- 237
++ +P + P L+ P R T +
Sbjct: 226 ------------GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
Query: 238 SEYFS 242
++F+
Sbjct: 265 EDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 54/265 (20%), Positives = 95/265 (35%), Gaps = 45/265 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--SCPDIKFSEAQIKC 60
+E ++++L H +++L +++ IY+V EYM Q+
Sbjct: 61 QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Q+ G+ + +HRD++ +N+LV V K+ADFGLA
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPD 179
+ + PE L + D+WS G + EL G+ G E L ++ + P
Sbjct: 178 IKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 236
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA-- 237
+ P + +L+ EP +R T A
Sbjct: 237 P----------------------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
Query: 238 SEYFSTKPYACDLSSLPIYPPSKEI 262
+YF+ S+ P Y P + +
Sbjct: 269 EDYFT--------STEPQYQPGENL 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (353), Expect = 3e-38
Identities = 55/274 (20%), Positives = 100/274 (36%), Gaps = 42/274 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
E L+L + HP II++ G I+++ +Y+E L +F K Y
Sbjct: 53 DERLMLSIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 110
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
++ LE+ HS+ +++RD+K N+L++ G +K+ DFG A + + T
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPD 166
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
Y PE++ Y S+D WS G + E+L G ++ KI P +
Sbjct: 167 YIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 225
Query: 183 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALA 237
+ +L+ L++ + +R
Sbjct: 226 ED-----------------------------VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256
Query: 238 SEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAR 271
+F + L S I P + + + D
Sbjct: 257 HPWFKEVVWE-KLLSRNIETPYEPPIQQGQGDTS 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-38
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 35/238 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE+ + LDH N+I+L G++ + + +V E + L F + Y
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 119
Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL N H R V
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPP 178
+ PE L T + + D W G E+ G+ G + LHKI K P
Sbjct: 177 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+D P N++ + +P R T A
Sbjct: 236 RP---------------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-38
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 33/236 (13%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
M + ++ +HP + + ++ +++ V EY+ KF ++
Sbjct: 50 MVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 107
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
Y +++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ + G + + T
Sbjct: 108 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGT 166
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
Y PE+LLG Y SVD WS G + E+LIG+ G+ E E H I P
Sbjct: 167 PDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR- 224
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
L A +L+ L EP KR +
Sbjct: 225 ----------------------------WLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 52/245 (21%), Positives = 89/245 (36%), Gaps = 44/245 (17%)
Query: 1 MAREILILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQ 57
+ E+++L+++ +I+L S L+ E E E
Sbjct: 54 VPMEVVLLKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEEL 111
Query: 58 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTS 116
+ + Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TD 168
Query: 117 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 176
T Y PPE + +G S +WS+G + +++ G + E+ + F+
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---- 224
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ + + +LI L++ P R T
Sbjct: 225 -------------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQ 253
Query: 237 ASEYF 241
+
Sbjct: 254 NHPWM 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 4e-37
Identities = 41/237 (17%), Positives = 86/237 (36%), Gaps = 37/237 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKC 60
E ++ +L H N+++L G+I +Y+V EYM + L S +
Sbjct: 49 AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 120
+ + +E+ +HRD+ N+LV+ + V K++DFGL +++ + +
Sbjct: 108 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLP 163
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 179
+ + PE L + D+WS G + E+ G+ + + ++ K
Sbjct: 164 VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------- 215
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+K P P +++ ++ R +
Sbjct: 216 ------------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 48/237 (20%), Positives = 93/237 (39%), Gaps = 33/237 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E ++ L H +++L G+ T I+++ EYM + + L +F Q+
Sbjct: 48 EEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 105
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ +E+ S+ LHRD+ N LVN++GV+K++DFGL+ + +
Sbjct: 106 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 180
+ PPE+L+ + + D+W+ G + E+ +GK + T E I
Sbjct: 166 RWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------- 214
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
A + +P ++ + + +R T L+
Sbjct: 215 ---------AQGLRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-36
Identities = 52/236 (22%), Positives = 89/236 (37%), Gaps = 33/236 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E ++ +L HP +++L G+ I LVFE+MEH ++ L F+ +
Sbjct: 49 EEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGM 106
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ G+ + V+HRD+ N LV V+K++DFG+ F T +
Sbjct: 107 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 180
+ PE+ + Y D+WS G + E+ GK + R+ E + I
Sbjct: 167 KWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---------- 215
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+T F+ +P + T ++ P R S L
Sbjct: 216 ---------STGFRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 51/237 (21%), Positives = 96/237 (40%), Gaps = 34/237 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
+E L +R+ DHP+I+KL G+IT ++++ E ++ L A + Y
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
QL L + S+ +HRDI N+LV++ +KL DFGL+ + + + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 122 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 180
+ PE + + + D+W G E+L+ G QG + + +I
Sbjct: 174 KWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------- 224
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
++ +P + P T +L+ + +P +R + A
Sbjct: 225 -GERLPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-35
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 33/237 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
E +L+ HP + L+ + + V EY + F+E + + Y
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYG 111
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
+++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL + + + T
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPE 170
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
Y PE+L DYG +VD W +G V E++ G+ + I P
Sbjct: 171 YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---- 225
Query: 183 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239
+ L A +L+ LL +P +R + A E
Sbjct: 226 -------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 4e-35
Identities = 45/247 (18%), Positives = 93/247 (37%), Gaps = 39/247 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
RE I+ +LD+P I++L G+ + ++ LV E + L + + +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 119
++Q+ G+++ + +HRD+ N+L+ N K++DFGL+ ++ + ++
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPP 178
L + PE + + D+WS G E L G+ + E + I +
Sbjct: 175 PLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------ 227
Query: 179 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AA 235
K+ + P + P L+ + R
Sbjct: 228 ---GKRMECP-------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQR 265
Query: 236 LASEYFS 242
+ + Y+S
Sbjct: 266 MRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-35
Identities = 42/247 (17%), Positives = 90/247 (36%), Gaps = 38/247 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
E ++++LD+P I+++ G+ + S LV E E + + I +
Sbjct: 57 AEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 113
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVT 120
+Q+ G+++ +HRD+ N+L+ + K++DFGL+ ++ + + T
Sbjct: 114 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 179
+ + PE + + D+WS G + E G+ +G E + K
Sbjct: 174 VKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------- 225
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AAL 236
++ P P +L+ + + R + L
Sbjct: 226 --GERMGCP-------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
Query: 237 ASEYFST 243
+ Y+
Sbjct: 265 RNYYYDV 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 7e-35
Identities = 41/238 (17%), Positives = 71/238 (29%), Gaps = 34/238 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
E + L I LV + + + LL KFS +
Sbjct: 49 DEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 107
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLANF------SNTGHR 111
Q+L ++ H + +++RDIK N L+ ++ + DFG+ F
Sbjct: 108 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+ + T Y LG + DL ++G VF L G QG K
Sbjct: 168 REKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 229
++ ++ + LRE P + ++
Sbjct: 227 RIG---------------------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-35
Identities = 56/265 (21%), Positives = 107/265 (40%), Gaps = 35/265 (13%)
Query: 3 REILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 61
E +L + P ++ L + ++L+ +Y+ +F+E +++ Y
Sbjct: 77 TERQVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 121
+ +++ LEH H G+++RDIK N+L+++ G + L DFGL+ + T+
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 122 WYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
Y P+++ G + + +VD WS+G + ELL G E +I +
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAA 235
Y +++ A +LI+ LL +P KR A
Sbjct: 255 YP-------------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
Query: 236 LASEYFSTKPYACDLSSLPIYPPSK 260
+F + DL++ + P K
Sbjct: 290 KEHLFFQKINWD-DLAAKKVPAPFK 313
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 1e-34
Identities = 52/240 (21%), Positives = 97/240 (40%), Gaps = 37/240 (15%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E I+ + DHPN+I LEG++T S + ++ E+ME+ + L D +F+ Q+
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-- 119
+ + G+++ +HRD+ N+LVN+ V K++DFGL+ F P + +
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 120 --TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGS 176
+ + PE + + + D+WS G V E++ G+ T + ++ I +
Sbjct: 194 KIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252
Query: 177 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
PP D P+ L+ + R +
Sbjct: 253 PPPM----------------------------DCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 1e-34
Identities = 41/242 (16%), Positives = 78/242 (32%), Gaps = 32/242 (13%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
+ E I + + I + +V E + + L + KFS +
Sbjct: 49 LHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL 107
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTG------HR 111
+Q++ +E+ HS+ +HRD+K N L+ ++ + DFGLA
Sbjct: 108 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 171
+ + T Y LG + DL S+G V +G QG + K
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 172 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231
++ ++ + + K P+ + S+ +
Sbjct: 227 RIS---------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265
Query: 232 AS 233
S
Sbjct: 266 YS 267
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 6e-34
Identities = 54/261 (20%), Positives = 100/261 (38%), Gaps = 42/261 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
E IL+ ++ P ++KLE ++Y+V EY+ +FSE + Y
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
Q++ E+ HS +++RD+K NLL++ +G +++ DFG A + + T
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPE 203
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
PE++L Y +VD W++G + E+ G P ++ KI P +
Sbjct: 204 ALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262
Query: 183 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALA 237
+L+ LL V+ KR +
Sbjct: 263 SD-----------------------------LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 238 SEYFSTKPYACDLSSLPIYPP 258
++F+T + + + P
Sbjct: 294 HKWFATTDWI-AIYQRKVEAP 313
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 51/248 (20%), Positives = 83/248 (33%), Gaps = 24/248 (9%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSC--SIYLVFEYMEHDI-------TGLLSCPDIKF 53
EI L H NI+ ++LV +Y EH + IK
Sbjct: 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL 105
Query: 54 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 112
+ + + + + + HRD+K N+LV G +AD GLA ++
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 113 --PLTSRVVTLWYRPPELLLGA-----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 165
RV T Y PE+L + + D++++G VF E+ I G E
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDY 224
Query: 166 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 225
QL + P + +K +P P E + + ++
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYAN 278
Query: 226 PYKRATAS 233
R TA
Sbjct: 279 GAARLTAL 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 4e-33
Identities = 56/257 (21%), Positives = 95/257 (36%), Gaps = 56/257 (21%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSE----- 55
E+ ++ +L H NI+ L G T S IYL+FEY + D+ L KFSE
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 146
Query: 56 -----------------AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 98
+ C+ Q+ G+E + +HRD+ N+LV + V+K+
Sbjct: 147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 206
Query: 99 DFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKP 156
DFGLA + + + + + + PE L Y D+WS G + E+ +G
Sbjct: 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVN 265
Query: 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216
G +K+ + FK QP
Sbjct: 266 PYPGIPVDANFYKLIQ------------------NGFKMDQP---------FYATEEIYI 298
Query: 217 LIETLLSVEPYKRATAS 233
++++ + + KR +
Sbjct: 299 IMQSCWAFDSRKRPSFP 315
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 9e-33
Identities = 38/234 (16%), Positives = 79/234 (33%), Gaps = 28/234 (11%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 62
+E +++ + HPN+++L G+ T I F + + L C + S +
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 63 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 122
Q+ +E+ + +HRD+ N LV ++K+ADFGL+ +
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 123 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 182
+ PE L + D+W+ G + E+ ++ Q++++ +
Sbjct: 182 WTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-- 238
Query: 183 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236
+ P L+ P R + +
Sbjct: 239 -------------------------EGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 8e-32
Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 57/257 (22%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH---------------------- 40
RE ++ D+PNI+KL G+ + L+FEYM +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 41 --DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 98
+ S S A+ C Q+ G+ + R +HRD+ N LV V+K+A
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182
Query: 99 DFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKP 156
DFGL+ N + + + + + + + PPE + Y D+W+ G V E+ G
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 216
G E ++ + D ++ ++ P N
Sbjct: 242 PYYGMAHEEVIYYVR----------------------------DGNILACPENCPLELYN 273
Query: 217 LIETLLSVEPYKRATAS 233
L+ S P R +
Sbjct: 274 LMRLCWSKLPADRPSFC 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (303), Expect = 6e-31
Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 50/306 (16%)
Query: 3 REILILRRLDHPNIIKLEGLITSRL-----------SCSIYLVFEYMEHDITGL---LSC 48
EI +L+R++ + K + + + + +++V + L
Sbjct: 58 DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY 117
Query: 49 PDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGV------LKLADFG 101
+K QLL GL++ H G++H DIK N+L+ +K+AD G
Sbjct: 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 177
Query: 102 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161
A + + + + +R YR PE+LLGA +G D+WS C+ EL+ G + +
Sbjct: 178 NACWYDEHYTNSIQTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPD 232
Query: 162 T------EVEQLHKIFKLCGSPPDDYWKKSKLPHATL-------------FKPQQPYDSS 202
+ + + +I +L G P + K F P + +
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292
Query: 203 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEI 262
+ KD + + +L ++P KRA A + + L I P +E+
Sbjct: 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD-----TLGMEEIRVPDREL 347
Query: 263 DAKHRE 268
+
Sbjct: 348 YGSGSD 353
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-30
Identities = 44/240 (18%), Positives = 87/240 (36%), Gaps = 35/240 (14%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E +I++ HPN++ L G I R S +V YM+H D+ + + + +
Sbjct: 77 TEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRV 118
Q+ G++ S+ +HRD+ N +++ + +K+ADFGLA T
Sbjct: 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 119 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 177
+ + + E L + D+WS G + EL+ G P + + +
Sbjct: 196 LPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----- 249
Query: 178 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
++ P + P ++ + R + S ++
Sbjct: 250 ----GRRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 8e-30
Identities = 44/255 (17%), Positives = 83/255 (32%), Gaps = 51/255 (20%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH------------------DIT 43
E+ +L L +H NI+ L G T ++ EY +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 44 GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 103
++ ++ + + Q+ G+ S+ +HRD+ N+L+ + + K+ DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 104 NFSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGR 161
+ + + PE + Y D+WS G EL +G G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 221
+ +K+ K + P ++++T
Sbjct: 252 PVDSKFYKMIKEGFRMLSP---------------------------EHAPAEMYDIMKTC 284
Query: 222 LSVEPYKRATASAAL 236
+P KR T +
Sbjct: 285 WDADPLKRPTFKQIV 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-29
Identities = 47/238 (19%), Positives = 89/238 (37%), Gaps = 33/238 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCY 61
E I+ + H NII+LEG+I+ + ++ EYME+ D +FS Q+
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 119
+ + G+++ + +HRD+ N+LVN+ V K++DFGL+ + + +
Sbjct: 116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 120 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 179
+ + PE + + D+WS G V E++ ++ K P
Sbjct: 176 PIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234
Query: 180 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
D P+ L+ E +R + ++
Sbjct: 235 P---------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 38/237 (16%), Positives = 79/237 (33%), Gaps = 33/237 (13%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 61
E ++ +D+P++ +L G+ + ++ L+ + M + + + +
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 120
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA ++
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 121 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 180
+ + E +L Y D+WS G EL+ GS P D
Sbjct: 177 IKWMALESILHRI-YTHQSDVWSYGVTVWELM--------------------TFGSKPYD 215
Query: 181 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237
S++ + P ++ ++ R +
Sbjct: 216 GIPASEISSILEKGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 53/254 (20%), Positives = 96/254 (37%), Gaps = 51/254 (20%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ +L +L HPNII L G R +YL EY H +
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 46 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 105
+ S Q+ + + G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 176
Query: 106 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEV 164
++ T + + + E L + Y + D+WS G + E++ +G G T
Sbjct: 177 QEVYVKK--TMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233
Query: 165 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224
E K+ + ++ ++P + +L+
Sbjct: 234 ELYEKLPQ-------------------GYRLEKP---------LNCDDEVYDLMRQCWRE 265
Query: 225 EPYKRATASAALAS 238
+PY+R + + L S
Sbjct: 266 KPYERPSFAQILVS 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 37/248 (14%), Positives = 87/248 (35%), Gaps = 43/248 (17%)
Query: 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPD---------IK 52
E +++ + ++++L G+++ ++ E M D+ L
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 53 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHR 111
S +++ ++ G+ + ++ +HRD+ N +V + +K+ DFG+ T +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 112 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKI 170
+ ++ + + PE L + D+WS G V E+ + QG + + L +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 171 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 230
+ L + + P L+ P R
Sbjct: 249 M----------------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280
Query: 231 TASAALAS 238
+ ++S
Sbjct: 281 SFLEIISS 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 49/252 (19%), Positives = 85/252 (33%), Gaps = 48/252 (19%)
Query: 3 REILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGL 45
E+ +++ + H NII L G T +Y++ EY
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 46 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 105
P+ + S + Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 106 SNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 164
+ T + + + + PE L Y D+WS G + E+ V
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 165 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 224
E+L K+ K + ++
Sbjct: 244 EELFKLLKEGHRMDKP---------------------------SNCTNELYMMMRDCWHA 276
Query: 225 EPYKRATASAAL 236
P +R T +
Sbjct: 277 VPSQRPTFKQLV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 7e-25
Identities = 43/254 (16%), Positives = 76/254 (29%), Gaps = 47/254 (18%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD----------------ITG 44
M+ +++ H N++ L G T + ++ E+ +
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 45 LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104
+ + CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 105 FSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRT 162
L + PE + Y D+WS G + E+ G
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222
E+ + K +
Sbjct: 242 IDEEFCRRLKEGTRMRAP---------------------------DYTTPEMYQTMLDCW 274
Query: 223 SVEPYKRATASAAL 236
EP +R T S +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 1e-16
Identities = 21/148 (14%), Positives = 50/148 (33%), Gaps = 25/148 (16%)
Query: 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 60
E L++L + K+ + ++ E ++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN------AVLMELIDAKELY-------RVRVENPDE 107
Query: 61 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR--- 117
++ +L + + RG++H D+ N+LV+ EG+ + DF + + + R
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVR 166
Query: 118 VVTLWYRPPELLLGATDYGPSVDLWSVG 145
+ ++ Y D+ S
Sbjct: 167 NIITYFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 529 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.67 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.47 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 83.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 83.83 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 83.6 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 81.18 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=420.97 Aligned_cols=249 Identities=41% Similarity=0.698 Sum_probs=215.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||+++++|.+ .+.+|||||||.++++..+......+++.+++.+++||+.||+|||++||+|||
T Consensus 48 ~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrD 125 (299)
T d1ua2a_ 48 LREIKLLQELSHPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125 (299)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHhCCCCCEeEEEeeecc--CCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceeccc
Confidence 589999999999999999999988 578999999999998888877788899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+|||++.++.+||+|||+|+...... ......+||++|+|||++.+...|+.++||||||||+|+|++|.+||.+.
T Consensus 126 iKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 126 LKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcceEEecCCCccccccCccccccCCCc-ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 99999999999999999999998765432 23445689999999999987777999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
++.+++.+|.+.+|.|+...|....- .....+.... ...+...+..+++++++||.+||+.||++||||.|+|+|||
T Consensus 205 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 99999999999999998877755322 1111111111 12245566789999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCC
Q 009654 241 FSTKPYACDLSSLPI 255 (529)
Q Consensus 241 f~~~~~~~~~~~~p~ 255 (529)
|++.|.+++...+|.
T Consensus 283 f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 283 FSNRPGPTPGCQLPR 297 (299)
T ss_dssp GTSSSCCCCSSSSCC
T ss_pred hCCCCCCCCCCCCCC
Confidence 999988887766653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=404.90 Aligned_cols=215 Identities=28% Similarity=0.398 Sum_probs=182.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||++++++.+ .+.+|||||||+++.|..++.....+++.+++.++.||+.||+|||++||+||
T Consensus 50 ~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHr 127 (271)
T d1nvra_ 50 IKKEICINKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127 (271)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccC
Confidence 3689999999999999999999998 67999999999997776666677789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||+||||+.+|.+||+|||+|+...... ....+..+||+.|+|||++.+...++.++||||||||||+|++|++||.
T Consensus 128 DiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 999999999999999999999998765432 2334567899999999999876656789999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+.......+....... ...+..+|+++++||.+||+.||++|||+.|+|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 261 (271)
T d1nvra_ 208 QPSDSCQEYSDWKEKKTY--------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 261 (271)
T ss_dssp SSSTTSHHHHHHHTTCTT--------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCChHHHHHHHHhcCCCC--------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 766544433333211111 112356899999999999999999999999999999
Q ss_pred ccCC
Q 009654 240 YFST 243 (529)
Q Consensus 240 ~f~~ 243 (529)
||+.
T Consensus 262 wf~~ 265 (271)
T d1nvra_ 262 WYNK 265 (271)
T ss_dssp TTTC
T ss_pred hhCc
Confidence 9974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=400.37 Aligned_cols=207 Identities=33% Similarity=0.509 Sum_probs=184.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||++++++.+ .+.+|||||||+++.+..++.....+++.+++.++.||+.||+|||++||+|||
T Consensus 54 ~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrD 131 (263)
T d2j4za1 54 RREVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRD 131 (263)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHhcCCCCCCeEEEEEEE--CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeee
Confidence 589999999999999999999998 678999999999977776665666899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||+|...... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.
T Consensus 132 iKp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 132 IKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCGGGEEECTTSCEEECCCCSCSCCCCC---CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccccceecCCCCEeecccceeeecCCC---cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 9999999999999999999999766543 3456689999999999987 46899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcccc
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 241 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f 241 (529)
+..+.+.+|.+.-... ...+|+++++||.+||+.||.+|||+.|+|+||||
T Consensus 208 ~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 208 TYQETYKRISRVEFTF-----------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp SHHHHHHHHHTTCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred CHHHHHHHHHcCCCCC-----------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 9988888876521111 13578999999999999999999999999999999
Q ss_pred CC
Q 009654 242 ST 243 (529)
Q Consensus 242 ~~ 243 (529)
+.
T Consensus 259 ~~ 260 (263)
T d2j4za1 259 TA 260 (263)
T ss_dssp HH
T ss_pred CC
Confidence 63
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=399.24 Aligned_cols=212 Identities=26% Similarity=0.444 Sum_probs=185.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|||||||+|+.+..+... ..+++.+++.|+.||+.||+|||++||+||
T Consensus 64 ~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHr 140 (293)
T d1yhwa1 64 IINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHR 140 (293)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 3689999999999999999999998 5789999999999877766543 479999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.+|.+||+|||+|+.+.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+
T Consensus 141 DiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcHHHeEECCCCcEeeccchhheeecccc-ccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 999999999999999999999998775432 23456789999999999987 5689999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+.+..+.... .+.. .....+|+++++||.+||+.||.+|||+.|+|+|||
T Consensus 219 ~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 219 ENPLRALYLIATNG-TPEL-------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp SCHHHHHHHHHHHC-SCCC-------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred CCHHHHHHHHHhCC-CCCC-------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 99888887776532 2211 112458899999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|+.
T Consensus 273 ~~~ 275 (293)
T d1yhwa1 273 LKI 275 (293)
T ss_dssp GGG
T ss_pred hCC
Confidence 974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=392.97 Aligned_cols=243 Identities=38% Similarity=0.678 Sum_probs=205.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|||||||.++++..+. .....+++.+++.++.||+.||+|||++||+|
T Consensus 48 ~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiH 125 (298)
T d1gz8a_ 48 AIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125 (298)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCcEEEecccccc--ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence 3589999999999999999999998 67999999999998776553 44567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+|||++.++.+||+|||+|+...... ......+||+.|+|||++.....++.++|||||||++|+|++|++||.
T Consensus 126 rDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp SCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCchheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 9999999999999999999999998765432 345567899999999999887778999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhcc
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 239 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~ 239 (529)
+.+..+++.++....+.+.+..|........................+..+++++++||.+||+.||.+|||+.|+|+||
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence 99999999999999999888777653221111111111112233455678899999999999999999999999999999
Q ss_pred ccCCCCC
Q 009654 240 YFSTKPY 246 (529)
Q Consensus 240 ~f~~~~~ 246 (529)
||+..+.
T Consensus 285 ff~~~~~ 291 (298)
T d1gz8a_ 285 FFQDVTK 291 (298)
T ss_dssp GGTTCCC
T ss_pred hhccCCC
Confidence 9987543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-49 Score=398.61 Aligned_cols=214 Identities=27% Similarity=0.447 Sum_probs=173.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|||||||+|+.|..++.....|++.++..++.||+.||+|||++||+||
T Consensus 54 ~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHr 131 (307)
T d1a06a_ 54 MENEIAVLHKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131 (307)
T ss_dssp -CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeE
Confidence 3589999999999999999999988 67899999999987666555566789999999999999999999999999999
Q ss_pred CCCCCcEEEc---cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 81 DIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 81 DIKp~NILl~---~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
||||+|||+. .++.+||+|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+|
T Consensus 132 DiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~P 208 (307)
T d1a06a_ 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPP 208 (307)
T ss_dssp CCCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EecccceeecccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCC
Confidence 9999999995 46899999999998765432 3456789999999999977 4699999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....|......++. ..++.+|+++++||.+||+.||.+|||+.|+|+
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 209 FYDENDAKLFEQILKAEYEFDS-------------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCSSHHHHHHHHHTTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHhccCCCCCC-------------------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 9999999888888763322211 123578999999999999999999999999999
Q ss_pred ccccCCC
Q 009654 238 SEYFSTK 244 (529)
Q Consensus 238 h~~f~~~ 244 (529)
||||+..
T Consensus 264 hp~~~~~ 270 (307)
T d1a06a_ 264 HPWIAGD 270 (307)
T ss_dssp STTTTSS
T ss_pred CHhhCCC
Confidence 9999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=397.62 Aligned_cols=215 Identities=28% Similarity=0.423 Sum_probs=183.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|||||||+|+.+..+....+.|++.+++.++.||+.||+|||++||+||
T Consensus 55 ~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHr 132 (288)
T d1uu3a_ 55 VTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHR 132 (288)
T ss_dssp HHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHcCCCCeeEEEEEEEE--CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcC
Confidence 3689999999999999999999988 57899999999997776665566789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||+||||+.+|.+||+|||+|+...... ....+..+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.
T Consensus 133 DiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC
Confidence 999999999999999999999998775432 233456789999999999987 468999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH-----
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA----- 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e----- 234 (529)
+.+..+.+.+|.+..... ...+++++++||.+||+.||.+|||++|
T Consensus 212 ~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 212 AGNEYLIFQKIIKLEYDF-----------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp CSSHHHHHHHHHTTCCCC-----------------------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred CcCHHHHHHHHHcCCCCC-----------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 999999988886521111 1357899999999999999999999987
Q ss_pred -HHhccccCCCCCC
Q 009654 235 -ALASEYFSTKPYA 247 (529)
Q Consensus 235 -~L~h~~f~~~~~~ 247 (529)
+++||||+...|.
T Consensus 263 ~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 263 PLKAHPFFESVTWE 276 (288)
T ss_dssp HHHTSGGGTTCCCT
T ss_pred HHHcCCccCCCCHH
Confidence 5889999876553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-48 Score=402.63 Aligned_cols=220 Identities=25% Similarity=0.383 Sum_probs=191.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|||||||+|+.|. .+....+++++.+++.|+.||+.||+|||++||+|
T Consensus 70 ~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiH 147 (350)
T d1koaa2 70 VRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 147 (350)
T ss_dssp HHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCee
Confidence 3689999999999999999999998 57999999999986654 45456668999999999999999999999999999
Q ss_pred cCCCCCcEEEcc--CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 80 RDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~--~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
|||||+||||+. +|.+||+|||+|+..... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+|
T Consensus 148 rDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~P 224 (350)
T d1koaa2 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSP 224 (350)
T ss_dssp CCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eeechhHeeeccCCCCeEEEeecchheecccc--cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCC
Confidence 999999999964 578999999999877653 23456789999999999987 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..|......++. ..+..+|+++++||.+||+.||.+|||+.|+|+
T Consensus 225 f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 225 FGGENDDETLRNVKSCDWNMDD-------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp SCCSSHHHHHHHHHHTCCCSCC-------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999775444332 223568999999999999999999999999999
Q ss_pred ccccCCCCCCCCC
Q 009654 238 SEYFSTKPYACDL 250 (529)
Q Consensus 238 h~~f~~~~~~~~~ 250 (529)
||||+...++...
T Consensus 280 hp~~~~~~~~~~~ 292 (350)
T d1koaa2 280 HPWLTPGNAPGRD 292 (350)
T ss_dssp STTTSCTTCCSCC
T ss_pred CcccCCCCCCCch
Confidence 9999976655443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=389.37 Aligned_cols=210 Identities=23% Similarity=0.340 Sum_probs=177.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEcc--CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG-- 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~g-- 76 (529)
|.+|+++|++|+|||||+++++|.+. ....+|||||||+++.+..++.....+++.+++.++.||+.||+|||++|
T Consensus 55 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~ 134 (270)
T d1t4ha_ 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134 (270)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 36899999999999999999998753 24578999999999888766666678999999999999999999999999
Q ss_pred CcccCCCCCcEEEc-cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC
Q 009654 77 VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 77 IvHrDIKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|+||||||+||||+ .++.+||+|||+|+..... .....+||+.|+|||++.+ .|+.++||||||||||+|++|+
T Consensus 135 IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~ 209 (270)
T d1t4ha_ 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSE 209 (270)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCC
Confidence 99999999999996 4789999999999865442 3456789999999999976 5999999999999999999999
Q ss_pred CCCCCCCHHHHH-HHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 156 PILQGRTEVEQL-HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 156 ~pf~g~~~~~~~-~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
+||.+......+ ..+.. +.++.. ....+++++++||.+||+.||++|||+.|
T Consensus 210 ~Pf~~~~~~~~~~~~i~~--~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~e 262 (270)
T d1t4ha_ 210 YPYSECQNAAQIYRRVTS--GVKPAS-------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKD 262 (270)
T ss_dssp CTTTTCSSHHHHHHHHTT--TCCCGG-------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCcccHHHHHHHHHc--CCCCcc-------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999876555443 44422 222211 12457889999999999999999999999
Q ss_pred HHhccccC
Q 009654 235 ALASEYFS 242 (529)
Q Consensus 235 ~L~h~~f~ 242 (529)
+|+||||+
T Consensus 263 ll~Hp~fk 270 (270)
T d1t4ha_ 263 LLNHAFFQ 270 (270)
T ss_dssp HHTSGGGC
T ss_pred HhCCcccC
Confidence 99999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-49 Score=398.30 Aligned_cols=209 Identities=28% Similarity=0.443 Sum_probs=184.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||+++++|.+ ...+|||||||.++++..+.....++++.+++.++.||+.||.|||++||+||
T Consensus 62 ~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHr 139 (309)
T d1u5ra_ 62 IIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139 (309)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence 3689999999999999999999988 57899999999998887766666789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCC--CCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+||||+.+|.+||+|||+|..... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||
T Consensus 140 DiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 140 DVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCcceEEECCCCCEEEeecccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999986543 2456899999999999652 35899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+.++......+. ....+|+++++||.+||+.||.+|||++++|+|
T Consensus 215 ~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 215 FNMNAMSALYHIAQNESPAL---------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TTSCHHHHHHHHHHSCCCCC---------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHhCCCCCC---------------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 99998888888765211110 013578999999999999999999999999999
Q ss_pred cccCC
Q 009654 239 EYFST 243 (529)
Q Consensus 239 ~~f~~ 243 (529)
|||..
T Consensus 268 p~~~~ 272 (309)
T d1u5ra_ 268 RFVLR 272 (309)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=396.42 Aligned_cols=214 Identities=26% Similarity=0.372 Sum_probs=183.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|||||||+++.+..+ ......|++.+++.++.||+.||.|||++||+|
T Consensus 56 ~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivH 133 (288)
T d2jfla1 56 YMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133 (288)
T ss_dssp THHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 5789999999999999999999988 5789999999999777655 344567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC----CCCCCCcchhhhhhHHHHHHHhCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~y~~~~DIWSlG~il~elltG~ 155 (529)
|||||+||||+.+|.+||+|||+|....... ......+||+.|+|||++.. ...|+.++|||||||+||+|++|+
T Consensus 134 rDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~ 212 (288)
T d2jfla1 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212 (288)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSS
T ss_pred eecChhheeECCCCCEEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCC
Confidence 9999999999999999999999997654221 12345689999999999852 345899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+..+.+.+|... .++. ......+|+++++||.+||+.||.+|||+.|+
T Consensus 213 ~Pf~~~~~~~~~~~i~~~--~~~~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 213 PPHHELNPMRVLLKIAKS--EPPT------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp CTTTTSCGGGHHHHHHHS--CCCC------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcC--CCCC------------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999999988888887662 2210 01124578999999999999999999999999
Q ss_pred HhccccCC
Q 009654 236 LASEYFST 243 (529)
Q Consensus 236 L~h~~f~~ 243 (529)
|+||||+.
T Consensus 267 l~hp~~~~ 274 (288)
T d2jfla1 267 LQHPFVTV 274 (288)
T ss_dssp TTSGGGCC
T ss_pred hcCcccCC
Confidence 99999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=398.46 Aligned_cols=212 Identities=25% Similarity=0.393 Sum_probs=188.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||+++++|.+ ...+|||||||+|+.+..++.....+++..++.|+.||+.||+|||++||+|||
T Consensus 53 ~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRD 130 (337)
T d1o6la_ 53 VTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130 (337)
T ss_dssp HHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHHHHHHHhCCCCCEEEEEeeecc--ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccc
Confidence 589999999999999999999998 679999999999988877776777899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||+|+...... ......+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+.
T Consensus 131 lKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 131 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCHHHeEecCCCCEEEeecccccccccCC-cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 99999999999999999999998664332 34556799999999999987 46999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+..+.+.+|....-.+ ...+|+++++||.+||+.||.+|+ ++.++|
T Consensus 209 ~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil 259 (337)
T d1o6la_ 209 DHERLFELILMEEIRF-----------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259 (337)
T ss_dssp SHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred CHHHHHHHHhcCCCCC-----------------------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHH
Confidence 9998888886622111 135889999999999999999999 499999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 260 ~Hp~f~~i~~ 269 (337)
T d1o6la_ 260 EHRFFLSINW 269 (337)
T ss_dssp TSGGGTTCCH
T ss_pred cCcccccCCH
Confidence 9999987544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=392.96 Aligned_cols=216 Identities=25% Similarity=0.396 Sum_probs=188.2
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
|.+|+.+|++|+|||||+++++|.+ ...+|||||||+++.+..++...+.+++.+++.++.||+.||+|||++||+||
T Consensus 60 ~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHr 137 (293)
T d1jksa_ 60 IEREVSILKEIQHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137 (293)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeec
Confidence 3689999999999999999999988 67999999999997777666556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCC----cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 81 DIKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 81 DIKp~NILl~~~g----~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||+|||++.++ .+||+|||++....... .....++|+.|+|||++.+ ..|+.++||||||||||+|++|.+
T Consensus 138 DiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp CCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccceEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCC
Confidence 9999999998776 49999999998776542 3456789999999999976 468999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+..|......++ ...+..+|+++++||.+||+.||.+|||++++|
T Consensus 215 Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 215 PFLGDTKQETLANVSAVNYEFE-------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp SSCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCC-------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9999999999988876433332 223357899999999999999999999999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...+
T Consensus 270 ~hp~~~~~~~ 279 (293)
T d1jksa_ 270 QHPWIKPKDT 279 (293)
T ss_dssp HSTTTCC---
T ss_pred cCcccCCCCh
Confidence 9999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-48 Score=400.77 Aligned_cols=213 Identities=28% Similarity=0.463 Sum_probs=188.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+|||||+++++|.+ ...+|||||||+|+.|. .+.....+|++.+++.++.||+.||.|||++||+||
T Consensus 74 ~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHR 151 (352)
T d1koba_ 74 KNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 151 (352)
T ss_dssp HHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 589999999999999999999988 67999999999986664 455556679999999999999999999999999999
Q ss_pred CCCCCcEEEc--cCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVN--NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~--~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+||||+ .+|.+||+|||+|...... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||
T Consensus 152 DiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 152 DIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp CCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ccccccccccccCCCeEEEeecccceecCCC--CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC
Confidence 9999999998 5689999999999887654 24456789999999999977 56999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+.+|......++.. .+..+|+++++||.+||+.||.+|||+.|+|+|
T Consensus 229 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 229 AGEDDLETLQNVKRCDWEFDED-------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSHHHHHHHHHHCCCCCCSS-------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999997754443322 235689999999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||+..
T Consensus 284 p~~~~~ 289 (352)
T d1koba_ 284 PWLKGD 289 (352)
T ss_dssp TTTSSC
T ss_pred HhhCCC
Confidence 999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.8e-48 Score=385.04 Aligned_cols=240 Identities=38% Similarity=0.677 Sum_probs=201.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+.+|++|+|||||+++++|.+ .+.+|+||||+.++++..+......+++.++..++.||+.||+|||++||+||
T Consensus 47 ~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHr 124 (286)
T d1ob3a_ 47 TIREISILKELKHSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124 (286)
T ss_dssp HHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhCCCCcEEeeeeeccc--CCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEec
Confidence 3689999999999999999999998 57899999999999988888878899999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+||||+.++.+||+|||++....... ......++|+.|+|||++.+...++.++|||||||++|||++|++||.+
T Consensus 125 DiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 125 DLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp CCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCceeeEcCCCCEEecccccceecccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 999999999999999999999998765432 2334557899999999998877889999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+++.++....|.++...|........................+..++++++|||.+||++||++|||+.|+|+|||
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 99999999999999999887776532211111111111112234455678999999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|++
T Consensus 284 f~~ 286 (286)
T d1ob3a_ 284 FKE 286 (286)
T ss_dssp GGC
T ss_pred cCc
Confidence 973
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=401.65 Aligned_cols=237 Identities=23% Similarity=0.301 Sum_probs=175.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~-~gIvH 79 (529)
+.+|+.+|++|+|||||+++++|.+ ...+|||||||+|+.+..++...+.+++..++.++.||+.||.|||+ +||+|
T Consensus 51 ~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiH 128 (322)
T d1s9ja_ 51 IIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 128 (322)
T ss_dssp HHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 3689999999999999999999998 57899999999997777666666789999999999999999999997 59999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
|||||+||||+.+|.+||+|||+|+..... ..++.+||++|+|||++.+ ..|+.++||||+|||+|||++|++||.
T Consensus 129 RDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred cccCHHHeeECCCCCEEEeeCCCccccCCC---ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999999866432 2356799999999999988 469999999999999999999999998
Q ss_pred CCCHHH-HHHHHHHHcCCCCchh----hhccCCCc-cccCCCCCCCcchhhhh---------ccCCcHHHHHHHHHhccC
Q 009654 160 GRTEVE-QLHKIFKLCGSPPDDY----WKKSKLPH-ATLFKPQQPYDSSLRET---------FKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 160 g~~~~~-~~~~I~~~~g~p~~~~----~~~~~l~~-~~~~~~~~~~~~~l~~~---------~~~~s~~~~dLi~~mL~~ 224 (529)
+.+..+ +...+....|.+.... +....... .....+.......+... -..++.++++||.+||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 284 (322)
T d1s9ja_ 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284 (322)
T ss_dssp CCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCC
Confidence 765433 2222222233222110 00000000 00000000000000000 023678999999999999
Q ss_pred CCCCCcCHHHHHhccccCC
Q 009654 225 EPYKRATASAALASEYFST 243 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~ 243 (529)
||.+||||.|+|+||||+.
T Consensus 285 dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 285 NPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp STTTSCCHHHHHTSHHHHH
T ss_pred ChhHCcCHHHHhhCHhhCc
Confidence 9999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=386.53 Aligned_cols=211 Identities=28% Similarity=0.443 Sum_probs=169.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----~~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
|.+|+.+|++|+|||||++++++.+.....+|||||||+++.|..++. ....+++.+++.++.||+.||.|||++|
T Consensus 50 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~ 129 (269)
T d2java1 50 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129 (269)
T ss_dssp HHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 368999999999999999999998765678999999999876665442 3457999999999999999999999976
Q ss_pred -----CcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 77 -----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 77 -----IvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
|+||||||+||||+.+|.+||+|||+|+...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|
T Consensus 130 ~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel 207 (269)
T d2java1 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYEL 207 (269)
T ss_dssp C---------CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHH
Confidence 9999999999999999999999999998775432 23456789999999999976 4699999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 152 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 152 ltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
++|.+||.+.+..+.+.+|... .++ .....+|+++.+||.+||+.||.+|||
T Consensus 208 ~tg~~Pf~~~~~~~~~~~i~~~--~~~--------------------------~~~~~~s~~l~~li~~~L~~dp~~Rps 259 (269)
T d2java1 208 CALMPPFTAFSQKELAGKIREG--KFR--------------------------RIPYRYSDELNEIITRMLNLKDYHRPS 259 (269)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHT--CCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhCCCCCCCCCHHHHHHHHHcC--CCC--------------------------CCCcccCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999998888888662 211 011357899999999999999999999
Q ss_pred HHHHHhcccc
Q 009654 232 ASAALASEYF 241 (529)
Q Consensus 232 a~e~L~h~~f 241 (529)
+.|+|+|||+
T Consensus 260 ~~ell~hp~i 269 (269)
T d2java1 260 VEEILENPLI 269 (269)
T ss_dssp HHHHHTSTTC
T ss_pred HHHHHhCCcC
Confidence 9999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.3e-48 Score=390.58 Aligned_cols=209 Identities=23% Similarity=0.373 Sum_probs=187.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|++|+|||||++++++.+ ...+|+|||||+|+.+..+......+++..++.++.||+.||+|||++||+|||
T Consensus 52 ~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrD 129 (316)
T d1fota_ 52 NDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129 (316)
T ss_dssp HHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HHHHHHHHhccCcChhheeeeEee--CCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccc
Confidence 589999999999999999999988 679999999999988887777777899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||+|+..... .+..+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.+.
T Consensus 130 iKp~NILl~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 130 LKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCchheeEcCCCCEEEecCccceEeccc----cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 9999999999999999999999876542 356789999999999976 46999999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+..+.+.+|....... ...+|+++++||.+||..||.+|+ |++++|
T Consensus 205 ~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il 255 (316)
T d1fota_ 205 NTMKTYEKILNAELRF-----------------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255 (316)
T ss_dssp SHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHH
Confidence 9999998887632111 135789999999999999999996 999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 256 ~Hp~f~~i~~ 265 (316)
T d1fota_ 256 NHPWFKEVVW 265 (316)
T ss_dssp TSGGGSSCCH
T ss_pred cCcccccCCH
Confidence 9999987544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=381.34 Aligned_cols=238 Identities=39% Similarity=0.689 Sum_probs=199.8
Q ss_pred HHHHHHHHhC---CCCCccceeeEEEcc---CCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRL---DHPNIIKLEGLITSR---LSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L---~HpnIvkl~~~~~~~---~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|+.| +|||||+++++|... ....+|+|||||+++++... ......+++..++.++.||+.||+|||+
T Consensus 55 ~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~ 134 (305)
T d1blxa_ 55 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134 (305)
T ss_dssp HHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 5799988877 799999999998642 23578999999999877543 3455679999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 154 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG 154 (529)
+||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||||||||+|||++|
T Consensus 135 ~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g 211 (305)
T d1blxa_ 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRR 211 (305)
T ss_dssp TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCEEecCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHC
Confidence 99999999999999999999999999998765433 34467789999999999987 5699999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
++||.+.+..+++.+|...+|.+....|..........+.... ...+...+..+++.+++||.+||.+||++||||.|
T Consensus 212 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcccc--ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 9999999999999999999999988877654332222221111 11233445678999999999999999999999999
Q ss_pred HHhccccCCC
Q 009654 235 ALASEYFSTK 244 (529)
Q Consensus 235 ~L~h~~f~~~ 244 (529)
+|+||||+..
T Consensus 290 ~L~Hpff~~i 299 (305)
T d1blxa_ 290 ALSHPYFQDL 299 (305)
T ss_dssp HHTSGGGTTC
T ss_pred HhcChhhcCc
Confidence 9999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=390.35 Aligned_cols=241 Identities=37% Similarity=0.573 Sum_probs=199.4
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc----CCCeEEEEEeccCCCchhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR----LSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHS 74 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~----~~~~~~lV~E~~~g~ll~~~---~~~~~~l~e~~~~~i~~Qll~gL~~LH~ 74 (529)
.+|+.+|++|+|||||+++++|... ...++|||||||+++++..+ ......|++.+++.++.||+.||+|||+
T Consensus 61 ~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~ 140 (350)
T d1q5ka_ 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140 (350)
T ss_dssp CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4899999999999999999998642 24568999999999866544 3456689999999999999999999999
Q ss_pred CCCcccCCCCCcEEEccCC-cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 75 RGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
+||+||||||+||||+.++ .+||+|||++...... ......+||+.|+|||++.+...|+.++||||+|||+|||++
T Consensus 141 ~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred cCCcccCCCcceEEEecCCCceeEecccchhhccCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhh
Confidence 9999999999999999875 8999999999876543 244567899999999999887789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
|.+||.+.+..+++..|++.+|.+..+.|............+...-..........+++++++||.+||.+||.+||||.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999999999999999999999988877654322111111111111112223456899999999999999999999999
Q ss_pred HHHhccccCCC
Q 009654 234 AALASEYFSTK 244 (529)
Q Consensus 234 e~L~h~~f~~~ 244 (529)
|+|+||||+..
T Consensus 299 e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 299 EACAHSFFDEL 309 (350)
T ss_dssp HHHTSGGGGGG
T ss_pred HHhcCHhhccc
Confidence 99999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-47 Score=393.39 Aligned_cols=209 Identities=25% Similarity=0.366 Sum_probs=186.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.|+|||||+++++|.+ ...+|+|||||.++.+..++...+.|++.+++.|+.||+.||.|||++||+|||
T Consensus 89 ~~E~~il~~l~hpnIv~~~~~~~~--~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRD 166 (350)
T d1rdqe_ 89 LNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166 (350)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHHcCCCcEeeccccccc--ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCc
Confidence 589999999999999999999988 678999999999987776666667899999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 161 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~ 161 (529)
|||+||||+.+|.+||+|||+|+..... ....+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.
T Consensus 167 IKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 167 LKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHcccCCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999877542 346789999999999987 56899999999999999999999999999
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHHHH
Q 009654 162 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAAL 236 (529)
Q Consensus 162 ~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e~L 236 (529)
+....+.+|......+ ...+++++.+||.+||..||.+|+ |++++|
T Consensus 242 ~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell 292 (350)
T d1rdqe_ 242 QPIQIYEKIVSGKVRF-----------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp SHHHHHHHHHHCCCCC-----------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred CHHHHHHHHhcCCCCC-----------------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHH
Confidence 9999998887632211 135789999999999999999995 999999
Q ss_pred hccccCCCCC
Q 009654 237 ASEYFSTKPY 246 (529)
Q Consensus 237 ~h~~f~~~~~ 246 (529)
+||||+...|
T Consensus 293 ~Hp~f~~~~~ 302 (350)
T d1rdqe_ 293 NHKWFATTDW 302 (350)
T ss_dssp TSGGGTTCCH
T ss_pred cCccccCCCH
Confidence 9999987554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-47 Score=379.84 Aligned_cols=213 Identities=31% Similarity=0.476 Sum_probs=186.6
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+ |||||+++++|.+ ++.+|||||||+++.|..++...+.+++.+++.|+.||+.||+|||++||+||
T Consensus 57 ~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHr 134 (277)
T d1phka_ 57 LKEVDILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR 134 (277)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhcCCCCeEEEEeeccc--CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCccc
Confidence 58999999996 9999999999998 67999999999986666555556689999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccC-----CCCCCCcchhhhhhHHHHHHHhCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGK 155 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~y~~~~DIWSlG~il~elltG~ 155 (529)
||||+||||+.++.+||+|||+++...... ..+..+||+.|+|||++.+ ...|+.++||||+|||||+|++|+
T Consensus 135 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 999999999999999999999998876543 3456789999999999852 345789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 156 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 156 ~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
+||.+.+..+.+..|......++ ...+..+|+++++||.+||+.||.+|||+.|+
T Consensus 213 ~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 213 PPFWHRKQMLMLRMIMSGNYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999998888877322221 12235789999999999999999999999999
Q ss_pred HhccccCC
Q 009654 236 LASEYFST 243 (529)
Q Consensus 236 L~h~~f~~ 243 (529)
|+||||+.
T Consensus 268 l~h~~~~~ 275 (277)
T d1phka_ 268 LAHPFFQQ 275 (277)
T ss_dssp TTSGGGCT
T ss_pred HcCHHHHH
Confidence 99999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=381.96 Aligned_cols=248 Identities=42% Similarity=0.717 Sum_probs=201.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC------CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 75 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~------~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~ 75 (529)
.+|+.+|++|+||||+++++++.... .+.+|+|||||.++++.........+++.+++.+++||+.||.|||++
T Consensus 57 ~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~ 136 (318)
T d3blha1 57 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136 (318)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC
Confidence 58999999999999999999986532 356899999999998888877788999999999999999999999999
Q ss_pred CCcccCCCCCcEEEccCCcEEEeccccccccCCCC---CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHH
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 152 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ell 152 (529)
||+||||||+||||+.++.+||+|||++..+.... .......+||++|+|||++.+...|+.++||||+|||+|+|+
T Consensus 137 ~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~ 216 (318)
T d3blha1 137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216 (318)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence 99999999999999999999999999997665322 123345689999999999988778999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCc-cccCCCCCCCcchhhhhc--cCCcHHHHHHHHHhccCCCCCC
Q 009654 153 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKR 229 (529)
Q Consensus 153 tG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~-~~~~~~~~~~~~~l~~~~--~~~s~~~~dLi~~mL~~dP~kR 229 (529)
+|++||.+.++.+.+..|....+.++...|....... .............+...+ ...+++++|||.+||++||++|
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R 296 (318)
T d3blha1 217 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296 (318)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTS
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHC
Confidence 9999999999999999999999998877665432111 111111111111122222 2347789999999999999999
Q ss_pred cCHHHHHhccccCCCCCCCC
Q 009654 230 ATASAALASEYFSTKPYACD 249 (529)
Q Consensus 230 ~ta~e~L~h~~f~~~~~~~~ 249 (529)
|||.|+|+||||++.|.|++
T Consensus 297 ~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 297 IDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp CCHHHHHHSGGGSSSSCCCC
T ss_pred cCHHHHHcChhhccCCCCCC
Confidence 99999999999998766543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=386.82 Aligned_cols=213 Identities=25% Similarity=0.367 Sum_probs=186.5
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~-~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+|||||+++++|.+ .+.+|||||||+|+.+..++ .....|++.+++.|+.||+.||+|||++||+||
T Consensus 49 ~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHr 126 (321)
T d1tkia_ 49 KKEISILNIARHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126 (321)
T ss_dssp HHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcc
Confidence 589999999999999999999998 57899999999986555444 444579999999999999999999999999999
Q ss_pred CCCCCcEEEccC--CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 81 DIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 81 DIKp~NILl~~~--g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||+||||+.+ +.+||+|||+++..... ......++|+.|+|||++.+ ..|+.++||||||||||+|++|.+||
T Consensus 127 DlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf 203 (321)
T d1tkia_ 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccceeecCCCceEEEEcccchhhccccC--CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCC
Confidence 999999999854 47999999999876543 23455688999999999876 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+.+|.+....++. ..++.+|+++++||.+||..||.+|||+.|+|+|
T Consensus 204 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 204 LAETNQQIIENIMNAEYTFDE-------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhCCCCCCh-------------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999885444433 3345789999999999999999999999999999
Q ss_pred cccCCC
Q 009654 239 EYFSTK 244 (529)
Q Consensus 239 ~~f~~~ 244 (529)
|||+..
T Consensus 259 p~~~~~ 264 (321)
T d1tkia_ 259 PWLKQK 264 (321)
T ss_dssp HHHHSC
T ss_pred HhhccC
Confidence 999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.8e-47 Score=391.97 Aligned_cols=213 Identities=23% Similarity=0.330 Sum_probs=179.5
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 82 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrDI 82 (529)
+|+.+|+.++|||||+++++|.+ .+.+|||||||+|+.|..++.....+++.+++.|+.||+.||+|||++||+||||
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~--~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDl 133 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 133 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHhcCCCCcEEEEEEEEEE--CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceee
Confidence 34677888899999999999988 5789999999998877766666678999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCCCC
Q 009654 83 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 162 (529)
Q Consensus 83 Kp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g~~ 162 (529)
||+||||+.+|.+||+|||+|+.+... .....+||+.|+|||++.+...|+.++||||||||||+|++|++||.+.+
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999877653 34556899999999999876779999999999999999999999998765
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC-----HHHHHh
Q 009654 163 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALA 237 (529)
Q Consensus 163 ~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t-----a~e~L~ 237 (529)
..+....+.. ....+. .....+|+++++||.+||+.||.+||| |+++|+
T Consensus 211 ~~~~~~~~~~-~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 211 TKDKHEIDRM-TLTMAV-------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSCHHHHHHH-SSSCCC-------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHHHHHh-cccCCC-------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 4433322222 111111 112468999999999999999999999 899999
Q ss_pred ccccCCCCC
Q 009654 238 SEYFSTKPY 246 (529)
Q Consensus 238 h~~f~~~~~ 246 (529)
||||+...|
T Consensus 265 Hp~f~~i~~ 273 (364)
T d1omwa3 265 SPFFRSLDW 273 (364)
T ss_dssp SGGGTTCCH
T ss_pred CccccCCCH
Confidence 999987654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=384.99 Aligned_cols=241 Identities=34% Similarity=0.625 Sum_probs=198.7
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC----CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL----SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~----~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+||.+|++|+|||||+++++|.... ...+|||||||+..+..... ..+|++..++.+++||+.||+|||++||
T Consensus 65 ~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~I 142 (346)
T d1cm8a_ 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGI 142 (346)
T ss_dssp HHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCC
Confidence 58999999999999999999998643 23689999999655444432 3479999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||+|+.... ..+..++|+.|+|||++.+...++.++||||+||++|+|++|++|
T Consensus 143 iHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p 218 (346)
T d1cm8a_ 143 IHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218 (346)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccccCcchhhcccccccccccccceeccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence 9999999999999999999999999987654 346678999999999998877789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCC--CCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
|.+.+..+++..+....+.++..+|............ ....-...+...+..+++++++||.+||..||.+|||+.|+
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei 298 (346)
T d1cm8a_ 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298 (346)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 9999999999999999999998877654321100000 00001122344556789999999999999999999999999
Q ss_pred HhccccCCCCCCC
Q 009654 236 LASEYFSTKPYAC 248 (529)
Q Consensus 236 L~h~~f~~~~~~~ 248 (529)
|+||||+......
T Consensus 299 L~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 299 LAHPYFESLHDTE 311 (346)
T ss_dssp HHSGGGTTTC---
T ss_pred hcChhhCcCCCcc
Confidence 9999998754443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=377.35 Aligned_cols=212 Identities=29% Similarity=0.456 Sum_probs=184.8
Q ss_pred HHHHHHHH-hCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILR-RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~-~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.++. .++|||||++++++.+ .+.+|||||||+++.+..++.....+++.+++.++.||+.||+|||++||+||
T Consensus 50 ~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHr 127 (320)
T d1xjda_ 50 MVEKRVLSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127 (320)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHHhCCCCcEEEEEEEEcc--CCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 45777665 6899999999999998 57899999999998887777677789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 160 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~g 160 (529)
||||+|||++.+|.+||+|||+++...... ...+..+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+
T Consensus 128 Dikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 128 DLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcccceeecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 999999999999999999999998665432 34456789999999999987 4699999999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH-HHHhcc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASE 239 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~-e~L~h~ 239 (529)
.+..+.+.+|.. +.+. + ...+|+++++||.+||+.||.+|||+. ++++||
T Consensus 206 ~~~~~~~~~i~~--~~~~--------------------~-------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp 256 (320)
T d1xjda_ 206 QDEEELFHSIRM--DNPF--------------------Y-------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256 (320)
T ss_dssp SSHHHHHHHHHH--CCCC--------------------C-------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred CCHHHHHHHHHc--CCCC--------------------C-------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence 999999888865 2221 0 135789999999999999999999995 899999
Q ss_pred ccCCCCC
Q 009654 240 YFSTKPY 246 (529)
Q Consensus 240 ~f~~~~~ 246 (529)
||+...|
T Consensus 257 ff~~~~~ 263 (320)
T d1xjda_ 257 LFREINW 263 (320)
T ss_dssp GGTTCCH
T ss_pred hhccCCH
Confidence 9986543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=364.34 Aligned_cols=239 Identities=39% Similarity=0.681 Sum_probs=203.2
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|+.++|||||+++++|.+ ...+++|+|++.++.+..+....+.+++.+++.++.||+.||+|||++||+|||
T Consensus 49 ~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrD 126 (292)
T d1unla_ 49 LREICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126 (292)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhcCcCCEEeecccccc--ccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeec
Confidence 589999999999999999999988 678999999999988888777788999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC-CCC
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQG 160 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p-f~g 160 (529)
|||+||||+.++.+||+|||.+....... .......+++.|+|||++.+...++.++||||+||++|+|++|+.| |.+
T Consensus 127 iKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 127 LKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred ccCcccccccCCceeeeecchhhcccCCC-ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 99999999999999999999998765432 2344557789999999998877789999999999999999998765 678
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccc
Q 009654 161 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 240 (529)
Q Consensus 161 ~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~ 240 (529)
.+..+++.++....+.+....|............+..............+++.+++||.+||++||.+||||+|+|+|||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred CCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 88899999999999998877765532221111122222233344556788999999999999999999999999999999
Q ss_pred cCC
Q 009654 241 FST 243 (529)
Q Consensus 241 f~~ 243 (529)
|++
T Consensus 286 f~~ 288 (292)
T d1unla_ 286 FSD 288 (292)
T ss_dssp GSS
T ss_pred hcC
Confidence 985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=383.25 Aligned_cols=218 Identities=24% Similarity=0.372 Sum_probs=173.0
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEcc--CCCeEEEEEeccCCCchhh-hcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGL-LSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRG 76 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~--~~~~~~lV~E~~~g~ll~~-~~~~-~~~l~e~~~~~i~~Qll~gL~~LH~~g 76 (529)
.+|+.++.++ +|||||+++++|++. ....+|||||||+|+.|.. +... ...|++.+++.|+.||+.||+|||++|
T Consensus 52 ~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~ 131 (335)
T d2ozaa1 52 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131 (335)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC
Confidence 5899987655 899999999999762 2467999999999865554 4332 357999999999999999999999999
Q ss_pred CcccCCCCCcEEEcc---CCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh
Q 009654 77 VLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 153 (529)
Q Consensus 77 IvHrDIKp~NILl~~---~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt 153 (529)
|+||||||+|||++. .+.+||+|||+|+...... .....+||+.|+|||++.+ ..|+.++||||||||||+|++
T Consensus 132 iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~llt 208 (335)
T d2ozaa1 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLC 208 (335)
T ss_dssp EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccccccccccccccccccceeeeccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhh
Confidence 999999999999985 4679999999998776542 3456789999999999976 469999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHH
Q 009654 154 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 233 (529)
Q Consensus 154 G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~ 233 (529)
|++||.+.+..+....+........ ..+. ...+..+|+++++||.+||+.||.+|||+.
T Consensus 209 g~~Pf~~~~~~~~~~~~~~~i~~~~------------------~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 267 (335)
T d2ozaa1 209 GYPPFYSNHGLAISPGMKTRIRMGQ------------------YEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267 (335)
T ss_dssp SSCSCEETTCC--------CCCSCS------------------SSCC---TTHHHHSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHHhcCC------------------CCCC---CcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999998776555554433211110 0011 122346899999999999999999999999
Q ss_pred HHHhccccCC
Q 009654 234 AALASEYFST 243 (529)
Q Consensus 234 e~L~h~~f~~ 243 (529)
++|+||||..
T Consensus 268 eil~hp~~~~ 277 (335)
T d2ozaa1 268 EFMNHPWIMQ 277 (335)
T ss_dssp HHHHSHHHHT
T ss_pred HHHcCHHhhC
Confidence 9999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=367.45 Aligned_cols=203 Identities=25% Similarity=0.383 Sum_probs=172.5
Q ss_pred HHHHHHHHhCC--CCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~--HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+ |||||+++++|.+ .+.+|+||||+.+ +++..++.....+++.+++.++.||+.||+|||++||+
T Consensus 55 ~~E~~il~~l~~~h~nIv~~~~~~~~--~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~ii 132 (273)
T d1xwsa_ 55 PMEVVLLKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 132 (273)
T ss_dssp EHHHHHHHHHCSSSCSBCCEEEEEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhccCCCCccEEEEEEee--CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 48999999996 9999999999988 5789999999986 45555555566899999999999999999999999999
Q ss_pred ccCCCCCcEEEccC-CcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 79 HRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
||||||+||||+.+ +.+||+|||+|+..... ..+..+||+.|+|||++.+...++.++|||||||+||+|++|++|
T Consensus 133 HrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 133 HRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCcccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence 99999999999854 79999999999876543 345678999999999998766678889999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+ .+.. +.. . ....+|+++++||.+||+.||++|||+.|+|+
T Consensus 210 f~~~~------~i~~--~~~--------------------~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 210 FEHDE------EIIR--GQV--------------------F-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSHH------HHHH--CCC--------------------C-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCch------HHhh--ccc--------------------C-------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 97642 2222 111 0 01358899999999999999999999999999
Q ss_pred ccccCCC
Q 009654 238 SEYFSTK 244 (529)
Q Consensus 238 h~~f~~~ 244 (529)
||||+..
T Consensus 255 hp~~~~~ 261 (273)
T d1xwsa_ 255 HPWMQDV 261 (273)
T ss_dssp SGGGSSC
T ss_pred CHhhCCC
Confidence 9999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=364.22 Aligned_cols=212 Identities=22% Similarity=0.337 Sum_probs=172.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ ..+|||||||+++.|.. +......+++.++..++.||+.||+|||++||+|
T Consensus 51 ~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivH 127 (276)
T d1uwha_ 51 FKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127 (276)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeeeeEEEec---cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEec
Confidence 4689999999999999999998754 46899999999866654 4455668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCC--CCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~--~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||||+||||+.++.+||+|||+|+...... ....+..+||+.|+|||++.+. ..|+.++|||||||+||||++|+.
T Consensus 128 rDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~ 207 (276)
T d1uwha_ 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207 (276)
T ss_dssp SCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCC
Confidence 9999999999999999999999998765432 2234566899999999999643 358999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+....+..+......++. +......+|+++.+||.+||+.||.+|||+.+++
T Consensus 208 Pf~~~~~~~~~~~~~~~~~~~p~-----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il 264 (276)
T d1uwha_ 208 PYSNINNRDQIIFMVGRGYLSPD-----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264 (276)
T ss_dssp TTTTCCCHHHHHHHHHHTSCCCC-----------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHhcCCCCCc-----------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 99998777666655543222211 1223356899999999999999999999999999
Q ss_pred hc
Q 009654 237 AS 238 (529)
Q Consensus 237 ~h 238 (529)
++
T Consensus 265 ~~ 266 (276)
T d1uwha_ 265 AS 266 (276)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-44 Score=365.31 Aligned_cols=240 Identities=30% Similarity=0.518 Sum_probs=190.7
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++| +||||++++++|.......+|+|||||.++.+..+. ..|++.+++.+++||+.||+|||++||+||
T Consensus 77 ~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHr 153 (328)
T d3bqca1 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHR 153 (328)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccc
Confidence 5899999999 599999999999876667899999999997766553 479999999999999999999999999999
Q ss_pred CCCCCcEEEccCC-cEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||+||||+.++ .+||+|||+|....... .....++|+.|+|||++.+...|+.++||||+||++|+|++|..||.
T Consensus 154 DiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccceEEcCCCCeeeecccccceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 9999999998765 69999999998776542 34667899999999999887789999999999999999999999886
Q ss_pred C-CCHHHHHHHHHHHcCCCCchhhhc-cCCCccccCC------CCCCCcc-hhhhhccCCcHHHHHHHHHhccCCCCCCc
Q 009654 160 G-RTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFK------PQQPYDS-SLRETFKDLPTTAVNLIETLLSVEPYKRA 230 (529)
Q Consensus 160 g-~~~~~~~~~I~~~~g~p~~~~~~~-~~l~~~~~~~------~~~~~~~-~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ 230 (529)
. .+..++...+...+|.+....|.. ........+. +...+.. ........++++++|||++||++||.+||
T Consensus 232 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 311 (328)
T d3bqca1 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311 (328)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc
Confidence 4 566677888888777654332221 1111111110 0000100 01122346889999999999999999999
Q ss_pred CHHHHHhccccCCCCC
Q 009654 231 TASAALASEYFSTKPY 246 (529)
Q Consensus 231 ta~e~L~h~~f~~~~~ 246 (529)
|++|+|+||||++..|
T Consensus 312 ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 312 TAREAMEHPYFYTVVK 327 (328)
T ss_dssp CHHHHHTSGGGTTSCC
T ss_pred CHHHHhcCcccCCCCC
Confidence 9999999999987543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=366.58 Aligned_cols=244 Identities=36% Similarity=0.585 Sum_probs=195.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+|||||++++++.... ...+|||++++.++|...+.. ..+++.+++.++.||+.||+|||++||+
T Consensus 54 ~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~ii 131 (345)
T d1pmea_ 54 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVL 131 (345)
T ss_dssp HHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 58999999999999999999987632 235677777666666655532 3799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||||+||||+.+|.+||+|||++........ ......+||+.|+|||++.....|+.++||||+||++|+|++|++
T Consensus 132 HRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~ 211 (345)
T d1pmea_ 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211 (345)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCC
Confidence 999999999999999999999999986644321 234566899999999999776778999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCcccc--CCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~--~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
||.+.+..++...+...++.+............... ..........+...++.+++++++||.+||++||.+||||.+
T Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999999998888887755433221111000 001111122345667789999999999999999999999999
Q ss_pred HHhccccCCCCCC
Q 009654 235 ALASEYFSTKPYA 247 (529)
Q Consensus 235 ~L~h~~f~~~~~~ 247 (529)
+|+||||+....+
T Consensus 292 ~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 292 ALAHPYLEQYYDP 304 (345)
T ss_dssp HHTSGGGTTTCCG
T ss_pred HhcCHhhccCCCC
Confidence 9999999865443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=366.15 Aligned_cols=239 Identities=33% Similarity=0.540 Sum_probs=189.0
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccC---CCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~---~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
.+|+.+|++|+|||||+++++|.... ....++||+|+.++.|..+.. ..+|++.+++.++.||+.||+|||++||+
T Consensus 65 ~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~gii 143 (348)
T d2gfsa1 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADII 143 (348)
T ss_dssp HHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 58999999999999999999986431 223344555566655555543 34799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 158 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~pf 158 (529)
||||||+|||++.+|.+|++|||++..... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||
T Consensus 144 HrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF 219 (348)
T d2gfsa1 144 HRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219 (348)
T ss_dssp CCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccCCccccccccccccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC
Confidence 999999999999999999999999976543 3456788999999999888777899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCcccc--CCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~--~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
.+.+.......|....+.++.+.+.......... ......-...+...+..+++++++||.+||..||.+||||.|+|
T Consensus 220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 9999999999999999988766554322111000 00000111233455678999999999999999999999999999
Q ss_pred hccccCCCC
Q 009654 237 ASEYFSTKP 245 (529)
Q Consensus 237 ~h~~f~~~~ 245 (529)
+||||++..
T Consensus 300 ~Hp~f~~~~ 308 (348)
T d2gfsa1 300 AHAYFAQYH 308 (348)
T ss_dssp TSGGGTTTC
T ss_pred cCHhhCCCC
Confidence 999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-44 Score=362.29 Aligned_cols=207 Identities=24% Similarity=0.403 Sum_probs=166.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ .+.+|||||||+++.+..+ ....+.+++.++..++.||+.||.|||++||+|
T Consensus 74 ~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH 151 (299)
T d1jpaa_ 74 FLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVH 151 (299)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCCccEEEEEee--CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCcc
Confidence 4689999999999999999999977 5689999999999877654 444567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC----CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-C
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-G 154 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G 154 (529)
|||||+||||+.++.+||+|||+++........ ......+|+.|+|||++.+ ..|+.++|||||||+||||++ |
T Consensus 152 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g 230 (299)
T d1jpaa_ 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYG 230 (299)
T ss_dssp SCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCC
Confidence 999999999999999999999999876543221 1223457899999999976 469999999999999999998 8
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHH
Q 009654 155 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 234 (529)
Q Consensus 155 ~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e 234 (529)
.+||.+.+..+.+..+......+. ...+|+++.+||.+||+.||.+|||+.+
T Consensus 231 ~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~e 282 (299)
T d1jpaa_ 231 ERPYWDMTNQDVINAIEQDYRLPP----------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQ 282 (299)
T ss_dssp CCTTTTCCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCC----------------------------CccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 999999999888887755221110 1357899999999999999999999999
Q ss_pred HHhc
Q 009654 235 ALAS 238 (529)
Q Consensus 235 ~L~h 238 (529)
++++
T Consensus 283 i~~~ 286 (299)
T d1jpaa_ 283 IVNT 286 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=361.11 Aligned_cols=209 Identities=21% Similarity=0.304 Sum_probs=175.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
|.+|+.+|++|+|||||++++++.+ +.+|||||||+++.+..+......+++.++..++.||+.||+|||++||+||
T Consensus 55 ~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr 131 (277)
T d1xbba_ 55 LLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131 (277)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccC
Confidence 4689999999999999999999865 3579999999998777766666789999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+|
T Consensus 132 DlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~P 210 (277)
T d1xbba_ 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKP 210 (277)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCC
Confidence 99999999999999999999999876543221 2234578999999999976 458999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH--
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA-- 235 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~-- 235 (529)
|.+.+..+....|.+ |..+ .....+|+++.+||.+||+.||.+|||+.++
T Consensus 211 f~~~~~~~~~~~i~~--~~~~--------------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 211 YRGMKGSEVTAMLEK--GERM--------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp STTCCHHHHHHHHHT--TCCC--------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHc--CCCC--------------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999988877777654 2211 0113578999999999999999999999998
Q ss_pred -Hhcccc
Q 009654 236 -LASEYF 241 (529)
Q Consensus 236 -L~h~~f 241 (529)
|+++|+
T Consensus 263 ~L~~~~~ 269 (277)
T d1xbba_ 263 RLRNYYY 269 (277)
T ss_dssp HHHHHHH
T ss_pred HhhCHHh
Confidence 556655
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=373.08 Aligned_cols=239 Identities=31% Similarity=0.557 Sum_probs=187.1
Q ss_pred HHHHHHHHhCCCCCccceeeEEEcc----CCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSR----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 77 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~----~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gI 77 (529)
.+|+.+|++|+|||||+++++|... ..+.+|+|||||.++++..+. ..+++.+++.+++||+.||.|||++||
T Consensus 64 ~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~gi 140 (355)
T d2b1pa1 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGI 140 (355)
T ss_dssp HHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhccc
Confidence 5899999999999999999999754 247899999999999887663 468999999999999999999999999
Q ss_pred cccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCCC
Q 009654 78 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 157 (529)
Q Consensus 78 vHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~p 157 (529)
+||||||+|||++.++.+||+|||+++..... ...+..++|+.|+|||++.+ ..|++++||||+||++|+|++|++|
T Consensus 141 iHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~p 217 (355)
T d2b1pa1 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKIL 217 (355)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCCccccccccccceeeechhhhhccccc--cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCC
Confidence 99999999999999999999999998766543 24456688999999999987 4699999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCc-----cccCCCCCCCc--------chhhhhccCCcHHHHHHHHHhccC
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-----ATLFKPQQPYD--------SSLRETFKDLPTTAVNLIETLLSV 224 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~-----~~~~~~~~~~~--------~~l~~~~~~~s~~~~dLi~~mL~~ 224 (529)
|.+.+...+..++....+.+..++|....... .........+. .........+++++++||.+||.+
T Consensus 218 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~ 297 (355)
T d2b1pa1 218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297 (355)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcC
Confidence 99999999999999999998888775422100 00000000000 000111223577899999999999
Q ss_pred CCCCCcCHHHHHhccccCCCCC
Q 009654 225 EPYKRATASAALASEYFSTKPY 246 (529)
Q Consensus 225 dP~kR~ta~e~L~h~~f~~~~~ 246 (529)
||++||||+|+|+||||+....
T Consensus 298 dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 298 DPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp STTTSCCHHHHHTSTTTGGGCC
T ss_pred ChhHCcCHHHHhcCcccCCCCC
Confidence 9999999999999999987543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=353.91 Aligned_cols=207 Identities=24% Similarity=0.365 Sum_probs=166.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ .+.+|||||||+++.+.. +......+++..+..++.||+.||+|||+++|+|
T Consensus 47 ~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiH 124 (263)
T d1sm2a_ 47 FIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 124 (263)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhcCCCCcccccceecc--CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceee
Confidence 4689999999999999999999987 567899999999876664 4455667999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+||||+.++.+||+|||+++..............||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||
T Consensus 125 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp TTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 9999999999999999999999998776544344445678999999999976 459999999999999999999 68888
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+..+......+ ....+++++.+||.+||+.||++|||++++|++
T Consensus 204 ~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 204 ENRSNSEVVEDISTGFRLY----------------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CSCCHHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCC----------------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 8888888888776521111 013468899999999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=359.22 Aligned_cols=210 Identities=21% Similarity=0.305 Sum_probs=178.1
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ +.+|||||||+++.+..+ ......+++.++..++.||+.||+|||++||+|
T Consensus 56 ~~~E~~il~~l~HpnIv~l~g~~~~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiH 132 (285)
T d1u59a_ 56 MMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132 (285)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCEeeEeeeecc---CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4689999999999999999999875 358999999998766654 455668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC--CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+||||+.++.+||+|||+++....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+
T Consensus 133 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp CCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCC
Confidence 99999999999999999999999987754322 22234578999999999976 468999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH-
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA- 235 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~- 235 (529)
||.+.+..+.+..|.+ |..+ +..+.+|+++.+||.+||+.||++|||+.++
T Consensus 212 Pf~~~~~~~~~~~i~~--~~~~--------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 212 PYKKMKGPEVMAFIEQ--GKRM--------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp TTTTCCTHHHHHHHHT--TCCC--------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHc--CCCC--------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999888887777754 2211 0114688999999999999999999999887
Q ss_pred --HhccccC
Q 009654 236 --LASEYFS 242 (529)
Q Consensus 236 --L~h~~f~ 242 (529)
|+|+|+.
T Consensus 264 ~~L~~~~~~ 272 (285)
T d1u59a_ 264 QRMRACYYS 272 (285)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 6788774
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=359.10 Aligned_cols=210 Identities=22% Similarity=0.369 Sum_probs=177.9
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||++++++.+ +.+|||||||+++.+..+... ..++++.++..++.||+.||.|||++||+
T Consensus 55 ~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~iv 131 (272)
T d1qpca_ 55 FLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131 (272)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhCCCCCEeEEEeeecc---CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4689999999999999999998755 457999999999877654332 23599999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||||+.++.+||+|||+|+..............+|+.|+|||++.+ ..|+.++|||||||+||||+| |.+|
T Consensus 132 HrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 99999999999999999999999999876554444556688999999999976 458999999999999999999 5677
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..+... ..+ .....+|+++.+||.+||+.||++|||+.++++
T Consensus 211 ~~~~~~~~~~~~i~~~--~~~--------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 211 YPGMTNPEVIQNLERG--YRM--------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp STTCCHHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhc--CCC--------------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8888887777777542 111 001357899999999999999999999999998
Q ss_pred --ccccC
Q 009654 238 --SEYFS 242 (529)
Q Consensus 238 --h~~f~ 242 (529)
++||+
T Consensus 263 ~L~~~ft 269 (272)
T d1qpca_ 263 VLEDFFT 269 (272)
T ss_dssp HHHHHHH
T ss_pred Hhhhhhh
Confidence 88886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-44 Score=358.68 Aligned_cols=216 Identities=21% Similarity=0.348 Sum_probs=174.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCC--CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~--~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++++|||||++++++.+... ..+|||||||+|+.+..+....+.+++.+++.++.||+.||+|||++||+
T Consensus 54 ~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ii 133 (277)
T d1o6ya_ 54 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII 133 (277)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 3689999999999999999999887432 35899999999987776666667899999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCC--CCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
||||||+||||+.++.++|+|||.+....... .......+||+.|+|||++.+ ..|++++||||||||||+|++|++
T Consensus 134 HrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp CCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCC
Confidence 99999999999999999999999987654322 223456789999999999976 468999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+.++......++ ......+|+++.+||.+||+.||.+||+..+.|
T Consensus 213 Pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l 267 (277)
T d1o6ya_ 213 PFTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267 (277)
T ss_dssp SCCCSSHHHHHHHHHHCCCCCG-------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred CCCCcCHHHHHHHHHhcCCCCC-------------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHH
Confidence 9999999988888766332222 122357899999999999999999999655566
Q ss_pred hccccC
Q 009654 237 ASEYFS 242 (529)
Q Consensus 237 ~h~~f~ 242 (529)
.|+|.+
T Consensus 268 ~~~l~r 273 (277)
T d1o6ya_ 268 RADLVR 273 (277)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 677753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-44 Score=357.06 Aligned_cols=206 Identities=19% Similarity=0.310 Sum_probs=170.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~--~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||+++++|.+ .+.+|||||||+++.+..++ .....+++..+..++.||+.||+|||++||+
T Consensus 60 ~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ii 137 (287)
T d1opja_ 60 FLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 137 (287)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhCCCCCEecCCccEee--CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 4689999999999999999999987 57899999999987665443 3456799999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCC-CC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~-~p 157 (529)
||||||+||||+.++.+||+|||+|+..........+...||+.|+|||++.+ ..|+.++|||||||++|||++|. ||
T Consensus 138 HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998776544344445568999999999876 46999999999999999999965 55
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+... ..+ .....+|+++++||.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~i~~~-~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 217 YPGIDLSQVYELLEKD-YRM---------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp STTCCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcchHHHHHHHHhcC-CCC---------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 5555555544444321 111 011367899999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=365.07 Aligned_cols=208 Identities=22% Similarity=0.290 Sum_probs=173.3
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCC-----------------------CCCCHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-----------------------IKFSEA 56 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~-----------------------~~l~e~ 56 (529)
+.+|+.+|++| +|||||++++++.+ .+.+|||||||+++.+..++... ..+++.
T Consensus 87 ~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 164 (325)
T d1rjba_ 87 LMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164 (325)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHH
T ss_pred HHHHHHHHHHhcCCCcEeEEEEEEee--CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHH
Confidence 35899999998 89999999999988 56899999999986666444221 358999
Q ss_pred HHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCC
Q 009654 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDY 135 (529)
Q Consensus 57 ~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y 135 (529)
++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ .....+||+.|+|||++.+ ..|
T Consensus 165 ~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~ 243 (325)
T d1rjba_ 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIY 243 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCC
Confidence 99999999999999999999999999999999999999999999999876543222 2335578999999999976 469
Q ss_pred CCcchhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHH
Q 009654 136 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 214 (529)
Q Consensus 136 ~~~~DIWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~ 214 (529)
+.++|||||||+||||++ |.+||.+.+..+.+.++......++ ....+|+++
T Consensus 244 ~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l 296 (325)
T d1rjba_ 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD---------------------------QPFYATEEI 296 (325)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC---------------------------CCTTCCHHH
T ss_pred CcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCCcCCHHH
Confidence 999999999999999997 8999999877777766655321111 113578999
Q ss_pred HHHHHHhccCCCCCCcCHHHHHhc
Q 009654 215 VNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 215 ~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
++||.+||+.||++|||++++++|
T Consensus 297 ~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 297 YIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=348.62 Aligned_cols=207 Identities=22% Similarity=0.340 Sum_probs=179.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.++++++|||||++++++.+ .+.+|+|||||+++.+..+ ......+++..+..++.||+.||.|||++||+|
T Consensus 46 ~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH 123 (258)
T d1k2pa_ 46 FIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123 (258)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCC
T ss_pred HHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccc
Confidence 4689999999999999999999987 5689999999998665544 555668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+||||+.++.+||+|||+++..............+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||
T Consensus 124 ~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf 202 (258)
T d1k2pa_ 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY 202 (258)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC
Confidence 9999999999999999999999998776554444556788999999999976 458999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+...+|......+. ...+++++.+||.+||+.||++|||+.++|+|
T Consensus 203 ~~~~~~~~~~~i~~~~~~~~----------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 203 ERFTNSETAEHIAQGLRLYR----------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTSCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhCCCCCC----------------------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999888888765221111 13578899999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=354.03 Aligned_cols=206 Identities=25% Similarity=0.408 Sum_probs=165.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ +.+|||||||+++.+.. +......+++.++..++.||+.||.|||++||+|
T Consensus 55 ~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiH 131 (273)
T d1mp8a_ 55 FLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 131 (273)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeec
Confidence 4689999999999999999999864 46899999999876654 4455668999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 158 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~pf 158 (529)
|||||+|||++.++.+||+|||+|+..........+..++|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||
T Consensus 132 rDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~ 210 (273)
T d1mp8a_ 132 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF 210 (273)
T ss_dssp SCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC
Confidence 9999999999999999999999998766544334456678999999999976 469999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 159 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 159 ~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
.+.+..+.+.++.. +..+ ...+.+|+++.+||.+||+.||.+|||+.+++++
T Consensus 211 ~~~~~~~~~~~i~~--~~~~--------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 211 QGVKNNDVIGRIEN--GERL--------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCGGGHHHHHHT--TCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHc--CCCC--------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99998888887755 2211 1124689999999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=361.24 Aligned_cols=217 Identities=24% Similarity=0.372 Sum_probs=181.8
Q ss_pred HHHHHHHHhCCC-CCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~H-pnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+.+|++|+| |||+++++++.+ ...+|+|||||.++.+..++.....+++..+..++.||+.||+|||++||+||
T Consensus 76 ~~E~~il~~l~h~pnIv~~~~~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHr 153 (322)
T d1vzoa_ 76 RTERQVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153 (322)
T ss_dssp CCHHHHHHHHHTCTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhccCCCeEEEeeeeecc--CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEec
Confidence 479999999966 899999999988 57899999999997777666666788999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCC-CCCCcchhhhhhHHHHHHHhCCCCCC
Q 009654 81 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQ 159 (529)
Q Consensus 81 DIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~y~~~~DIWSlG~il~elltG~~pf~ 159 (529)
||||+||||+.+|.+||+|||+++.+............||+.|+|||++.+.. .|+.++|||||||+||+|++|.+||.
T Consensus 154 DiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876554444455678999999999997643 47889999999999999999999998
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCc-----CHHH
Q 009654 160 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASA 234 (529)
Q Consensus 160 g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~-----ta~e 234 (529)
+.+..+....+.+....+.. .....+++++++||.+||++||.+|| |++|
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~e 288 (322)
T d1vzoa_ 234 VDGEKNSQAEISRRILKSEP-------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288 (322)
T ss_dssp CTTSCCCHHHHHHHHHHCCC-------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH
T ss_pred CCCHHHHHHHHHHhcccCCC-------------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHH
Confidence 87665555555443211110 01136899999999999999999999 5999
Q ss_pred HHhccccCCCC
Q 009654 235 ALASEYFSTKP 245 (529)
Q Consensus 235 ~L~h~~f~~~~ 245 (529)
+|+||||+...
T Consensus 289 il~Hpff~~i~ 299 (322)
T d1vzoa_ 289 IKEHLFFQKIN 299 (322)
T ss_dssp HHTSGGGTTCC
T ss_pred HHcCHhhcCCC
Confidence 99999998644
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=349.13 Aligned_cols=212 Identities=24% Similarity=0.366 Sum_probs=171.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~--~~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||++++++.+ +.+|+|||||+++.+..+.. ....+++.++..++.||+.||+|||++||+
T Consensus 59 ~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~iv 135 (285)
T d1fmka3 59 FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 135 (285)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhcccCCEeEEEEEEec---CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhee
Confidence 4689999999999999999999854 35799999999976654432 235699999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+||||+.++.+||+|||+++..........+...+|+.|+|||++.+ ..|+.++||||||||||||++ |.+|
T Consensus 136 H~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 99999999999999999999999998776554444556788999999999976 458999999999999999999 5677
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+....+.+..+......+ ....+|+++++||.+||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 215 YPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp STTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCC----------------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 78888888887776532111 11467899999999999999999999999988
Q ss_pred --ccccCCC
Q 009654 238 --SEYFSTK 244 (529)
Q Consensus 238 --h~~f~~~ 244 (529)
++||+..
T Consensus 267 ~L~~~~~~~ 275 (285)
T d1fmka3 267 FLEDYFTST 275 (285)
T ss_dssp HHHTTTSCS
T ss_pred HHhhhhcCC
Confidence 8899753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=342.93 Aligned_cols=206 Identities=24% Similarity=0.350 Sum_probs=165.4
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~-~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ ...+|+|||||.++++..+ ......+++.++..++.||+.||+|||++||+|
T Consensus 56 ~~~E~~il~~l~H~nIv~~~g~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiH 133 (283)
T d1mqba_ 56 FLGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133 (283)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhcCCCCEeeeeEEEec--CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccccccc
Confidence 4689999999999999999999987 5689999999999776644 445568999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhC-CC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG-~~ 156 (529)
|||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+ ..|+.++|||||||+||||++| .+
T Consensus 134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~ 212 (283)
T d1mqba_ 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGER 212 (283)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCC
Confidence 999999999999999999999999876543221 2234567999999999976 4699999999999999999985 66
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+..+....-.+ ....+|..+.+||.+||+.||++|||+.+++
T Consensus 213 ~~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil 264 (283)
T d1mqba_ 213 PYWELSNHEVMKAINDGFRLP----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIV 264 (283)
T ss_dssp TTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccCCHHHHHHHHhccCCCC----------------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHH
Confidence 677777777766664421111 1135789999999999999999999999998
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 265 ~ 265 (283)
T d1mqba_ 265 S 265 (283)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=347.00 Aligned_cols=206 Identities=18% Similarity=0.280 Sum_probs=170.8
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCC-CchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g-~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ ...++|+|||.+ +++..+......+++..+..++.||+.||+|||++||+|
T Consensus 58 ~~~E~~~l~~l~HpnIv~l~g~~~~---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiH 134 (317)
T d1xkka_ 58 ILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134 (317)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEec---CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 4689999999999999999999987 346777888876 555566666778999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC-CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
|||||+||||+.++.+||+|||+|+........ ......||+.|+|||++.+. .|+.++|||||||+||||+| |.+|
T Consensus 135 rDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p 213 (317)
T d1xkka_ 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKP 213 (317)
T ss_dssp SCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCC
Confidence 999999999999999999999999877654322 22345689999999999774 69999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+....+.... .++ ....+|+++.+||.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~i~~~~-~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 265 (317)
T d1xkka_ 214 YDGIPASEISSILEKGE-RLP---------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELII 265 (317)
T ss_dssp TTTSCGGGHHHHHHHTC-CCC---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC-CCC---------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence 99988777766665421 111 01357889999999999999999999999998
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
|
T Consensus 266 ~ 266 (317)
T d1xkka_ 266 E 266 (317)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=340.86 Aligned_cols=206 Identities=25% Similarity=0.344 Sum_probs=172.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~-~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+ ..+|+|||||+++.+. .+....+.|++.++..++.||+.||.|||++||+|
T Consensus 58 ~~~Ei~~l~~l~H~nIv~~~g~~~~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiH 134 (273)
T d1u46a_ 58 FIREVNAMHSLDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134 (273)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEee---cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEee
Confidence 4689999999999999999999965 3578999999986555 44445567999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCCC--CccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~ 156 (529)
|||||+||||+.++.+||+|||+++........ ......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+
T Consensus 135 rDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~ 213 (273)
T d1u46a_ 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQE 213 (273)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred eeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999877543221 2234467889999999987 468999999999999999998 899
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHH
Q 009654 157 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 236 (529)
Q Consensus 157 pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L 236 (529)
||.+.+..+.+.+|.+....++ ....+|+++.+||.+||+.||++|||+.+++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 214 PWIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp TTTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCcCHHHHHHHHHhCCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999888865322211 1246889999999999999999999999987
Q ss_pred h
Q 009654 237 A 237 (529)
Q Consensus 237 ~ 237 (529)
+
T Consensus 267 ~ 267 (273)
T d1u46a_ 267 D 267 (273)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=342.52 Aligned_cols=208 Identities=22% Similarity=0.289 Sum_probs=163.5
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----------------CCCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----------------~~~~l~e~~~~~i~~Q 64 (529)
.+|+.++.++ +|||||.+++++... ...+|+|||||+++.+..++. ....+++.++..++.|
T Consensus 64 ~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (299)
T d1ywna1 64 MSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 142 (299)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCeEEEeeeeeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHH
Confidence 4677788777 799999999988664 457899999999877665432 1235899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||+|||++||+||||||+||||+.++.+||+|||+|+....... ...+..+||+.|+|||++.+ ..|+.++||||
T Consensus 143 i~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS 221 (299)
T d1ywna1 143 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWS 221 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHH
T ss_pred HHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceee
Confidence 99999999999999999999999999999999999999986654322 23345689999999999977 46899999999
Q ss_pred hhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~elltG-~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
|||++|||++| .+||.+....+.+..+......++ ....+++++++||.+||
T Consensus 222 ~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl 274 (299)
T d1ywna1 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCW 274 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHT
T ss_pred hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHc
Confidence 99999999986 678988766555555544221111 11357899999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
+.||.+|||+.++|+|
T Consensus 275 ~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 275 HGEPSQRPTFSELVEH 290 (299)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=338.89 Aligned_cols=205 Identities=25% Similarity=0.323 Sum_probs=172.6
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMN 63 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~ 63 (529)
|.+|+.+|++| +|||||++++++.+ .+.+|||||||+++.+..++.. ...|++.++..++.
T Consensus 57 ~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 134 (309)
T d1fvra_ 57 FAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134 (309)
T ss_dssp HHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCCEeeEEEEEec--CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHH
Confidence 46899999999 79999999999988 5789999999998777655432 35799999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 64 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 64 Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..|+.++||||
T Consensus 135 qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwS 211 (309)
T d1fvra_ 135 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWS 211 (309)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHH
T ss_pred HHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc--cccceecCCcccchHHhcc-CCCCccceeeh
Confidence 99999999999999999999999999999999999999998665432 2234578999999999976 46899999999
Q ss_pred hhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~elltG-~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
||||+|||++| .+||.+.+..+.+..|.+. ..+ .....+++++.+||.+||
T Consensus 212 fGvil~ell~~~~~p~~~~~~~~~~~~i~~~--~~~--------------------------~~~~~~~~~~~~li~~cl 263 (309)
T d1fvra_ 212 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--YRL--------------------------EKPLNCDDEVYDLMRQCW 263 (309)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT--CCC--------------------------CCCTTBCHHHHHHHHHHT
T ss_pred hHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCC--------------------------CCCccCCHHHHHHHHHHc
Confidence 99999999996 5789999888887776442 111 011357899999999999
Q ss_pred cCCCCCCcCHHHHHhc
Q 009654 223 SVEPYKRATASAALAS 238 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~h 238 (529)
+.||++|||+.++|++
T Consensus 264 ~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 264 REKPYERPSFAQILVS 279 (309)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=335.20 Aligned_cols=206 Identities=24% Similarity=0.338 Sum_probs=172.0
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC------------------------CCCCCCHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC------------------------PDIKFSEA 56 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~------------------------~~~~l~e~ 56 (529)
|.+|+.+|++|+||||+++++++.+ ...+++|||||+++.+..++. ....|++.
T Consensus 63 ~~~E~~il~~l~h~niv~~~~~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 140 (301)
T d1lufa_ 63 FQREAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140 (301)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHH
T ss_pred HHHHHHHHHhcCCCCcccceeeecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHH
Confidence 4689999999999999999999987 568999999999876654432 12348999
Q ss_pred HHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCC-CCCccccccccccCCcccccCCCCC
Q 009654 57 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDY 135 (529)
Q Consensus 57 ~~~~i~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~y 135 (529)
++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...... ....+..++|+.|+|||++.+ ..|
T Consensus 141 ~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 219 (301)
T d1lufa_ 141 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRY 219 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCC
T ss_pred HHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCC
Confidence 999999999999999999999999999999999999999999999998654322 223345678999999999986 469
Q ss_pred CCcchhhhhhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHH
Q 009654 136 GPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 214 (529)
Q Consensus 136 ~~~~DIWSlG~il~elltG-~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~ 214 (529)
+.++||||||||+|||++| .+||.+.+..+.+..+.+. ..+ .....+|+++
T Consensus 220 t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~--~~~--------------------------~~p~~~~~~~ 271 (301)
T d1lufa_ 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG--NIL--------------------------ACPENCPLEL 271 (301)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CCC--------------------------CCCTTCCHHH
T ss_pred ChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC--CCC--------------------------CCCccchHHH
Confidence 9999999999999999998 4889999999988887552 211 1114688999
Q ss_pred HHHHHHhccCCCCCCcCHHHHHh
Q 009654 215 VNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 215 ~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
.+||.+||+.||++|||+.++++
T Consensus 272 ~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 272 YNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=332.48 Aligned_cols=204 Identities=19% Similarity=0.318 Sum_probs=164.6
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 78 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~--~~~l~e~~~~~i~~Qll~gL~~LH~~gIv 78 (529)
|.+|+.+|++|+|||||++++++.+. .+.+|||||||+++.+..++.. ...+++..+..++.||+.||.|||+.+|+
T Consensus 47 ~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~iv 125 (262)
T d1byga_ 47 FLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 125 (262)
T ss_dssp HHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCcee
Confidence 46899999999999999999998653 3568999999999777655432 23589999999999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHh-CCCC
Q 009654 79 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPI 157 (529)
Q Consensus 79 HrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ellt-G~~p 157 (529)
||||||+|||++.+|.+||+|||+++..... .....+|+.|+|||++.+ ..|+.++|||||||++|||++ |++|
T Consensus 126 H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p 200 (262)
T d1byga_ 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVP 200 (262)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999865442 234567899999999976 468999999999999999998 7999
Q ss_pred CCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHHHh
Q 009654 158 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 237 (529)
Q Consensus 158 f~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~ 237 (529)
|.+.+..+.+..|.+ +..+ +....+++++.+||.+||+.||.+|||+.++++
T Consensus 201 ~~~~~~~~~~~~i~~--~~~~--------------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 201 YPRIPLKDVVPRVEK--GYKM--------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp CTTSCGGGHHHHHTT--TCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHc--CCCC--------------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 998888777777643 1111 112357899999999999999999999999987
Q ss_pred c
Q 009654 238 S 238 (529)
Q Consensus 238 h 238 (529)
+
T Consensus 253 ~ 253 (262)
T d1byga_ 253 Q 253 (262)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=332.42 Aligned_cols=205 Identities=23% Similarity=0.356 Sum_probs=173.2
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCC----------------CCCCCHHHHHHHHHH
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQ 64 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~----------------~~~l~e~~~~~i~~Q 64 (529)
.+|+.++.++ +|||||+++++|.+ .+.+|+|||||+++.+..++.. ...+++.++..++.|
T Consensus 66 ~~e~~~l~~~~~HpnIv~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 143 (299)
T d1fgka_ 66 ISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 143 (299)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCeEEeccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHH
Confidence 5788899888 89999999999987 5689999999999777655432 246899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhh
Q 009654 65 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 143 (529)
Q Consensus 65 ll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWS 143 (529)
|+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......++|+.|+|||++.+ ..|+.++||||
T Consensus 144 i~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS 222 (299)
T d1fgka_ 144 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWS 222 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHH
T ss_pred HHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHH
Confidence 99999999999999999999999999999999999999987654322 23345678999999999976 46999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhc
Q 009654 144 VGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 222 (529)
Q Consensus 144 lG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL 222 (529)
||||+|||++ |.+||.+.+..+.+..+.. +..+ .....+|+++.+||.+||
T Consensus 223 ~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~--~~~~--------------------------~~p~~~~~~l~~li~~cl 274 (299)
T d1fgka_ 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKE--GHRM--------------------------DKPSNCTNELYMMMRDCW 274 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--TCCC--------------------------CCCSSCCHHHHHHHHHHT
T ss_pred hHHHHHHhccCCCCCCCCCCHHHHHHHHHc--CCCC--------------------------CCCccchHHHHHHHHHHc
Confidence 9999999998 7999998888777666543 2111 001357899999999999
Q ss_pred cCCCCCCcCHHHHHh
Q 009654 223 SVEPYKRATASAALA 237 (529)
Q Consensus 223 ~~dP~kR~ta~e~L~ 237 (529)
+.||.+|||+.++|+
T Consensus 275 ~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 275 HAVPSQRPTFKQLVE 289 (299)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCHhHCcCHHHHHH
Confidence 999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=333.53 Aligned_cols=207 Identities=21% Similarity=0.311 Sum_probs=173.0
Q ss_pred CHHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC------------------CCCCCCHHHHHHH
Q 009654 1 MAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC------------------PDIKFSEAQIKCY 61 (529)
Q Consensus 1 ~~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~------------------~~~~l~e~~~~~i 61 (529)
|.+|+.++++| +|||||++++++.+ ...+|||||||+++.+..++. ....+++.++..|
T Consensus 73 ~~~E~~~~~~l~~HpnIv~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 150 (311)
T d1t46a_ 73 LMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (311)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred HHHHHHHHHhccCCCCEEEEEEEEee--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHH
Confidence 36899999999 79999999999987 567899999999876665432 1236999999999
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcch
Q 009654 62 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 140 (529)
Q Consensus 62 ~~Qll~gL~~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~D 140 (529)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ...+..+||+.|+|||++.+ ..|+.++|
T Consensus 151 ~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 229 (311)
T d1t46a_ 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESD 229 (311)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCccc
Confidence 99999999999999999999999999999999999999999987654332 22345678999999999976 46899999
Q ss_pred hhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHH
Q 009654 141 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 219 (529)
Q Consensus 141 IWSlG~il~ellt-G~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~ 219 (529)
||||||++|||++ |.+||.+.+..+.+.++......+. ....+|+++.+||.
T Consensus 230 IwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~ 282 (311)
T d1t46a_ 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMK 282 (311)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHH
T ss_pred ccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHH
Confidence 9999999999998 7888888877777776665322211 01357899999999
Q ss_pred HhccCCCCCCcCHHHHHh
Q 009654 220 TLLSVEPYKRATASAALA 237 (529)
Q Consensus 220 ~mL~~dP~kR~ta~e~L~ 237 (529)
+||+.||++|||+.++|+
T Consensus 283 ~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 283 TCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhHCcCHHHHHH
Confidence 999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=328.90 Aligned_cols=208 Identities=19% Similarity=0.249 Sum_probs=167.3
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 79 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~-~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvH 79 (529)
|.+|+.+|++|+|||||++++++.+. ...+|+|||||+++.+.. +......+++..+..++.||+.||.|||+.||+|
T Consensus 75 ~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiH 153 (311)
T d1r0pa_ 75 FLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 153 (311)
T ss_dssp HHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCccc
Confidence 46899999999999999999998664 468999999999977765 4445567889999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHHHhCCC
Q 009654 80 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 156 (529)
Q Consensus 80 rDIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~elltG~~ 156 (529)
|||||+||||+.++.+||+|||+++....... .......||+.|+|||++.+ ..|+.++|||||||+||||++|..
T Consensus 154 rDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~ 232 (311)
T d1r0pa_ 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGA 232 (311)
T ss_dssp SCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCC
Confidence 99999999999999999999999987654322 12334578999999999876 468999999999999999999766
Q ss_pred CCCC-CCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcCHHHH
Q 009654 157 ILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 235 (529)
Q Consensus 157 pf~g-~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~ta~e~ 235 (529)
||.. .+..+....+.. |..+. ....+++++.+||.+||..||++|||+.|+
T Consensus 233 p~~~~~~~~~~~~~i~~--g~~~~--------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei 284 (311)
T d1r0pa_ 233 PPYPDVNTFDITVYLLQ--GRRLL--------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284 (311)
T ss_dssp CSCC------CHHHHHT--TCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHc--CCCCC--------------------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 6554 344444444433 21110 013578899999999999999999999999
Q ss_pred Hhc
Q 009654 236 LAS 238 (529)
Q Consensus 236 L~h 238 (529)
+++
T Consensus 285 ~~~ 287 (311)
T d1r0pa_ 285 VSR 287 (311)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=328.79 Aligned_cols=206 Identities=16% Similarity=0.239 Sum_probs=173.7
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcC----------CCCCCCHHHHHHHHHHHHHHHH
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC----------PDIKFSEAQIKCYMNQLLHGLE 70 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~----------~~~~l~e~~~~~i~~Qll~gL~ 70 (529)
|.+|+.+|++++|||||++++++.. ...+|||||||+++.+..++. ....+++.++..++.||+.||.
T Consensus 70 ~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~ 147 (308)
T d1p4oa_ 70 FLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147 (308)
T ss_dssp HHHHHHHGGGCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCEeeeeeEEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 4689999999999999999999977 567899999999876654432 2235799999999999999999
Q ss_pred HHHHCCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC-CCccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 71 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 71 ~LH~~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
|||+++|+||||||+||||+.++.+||+|||+++....... ......++|+.|+|||.+.+ ..|+.++|||||||+||
T Consensus 148 ~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 148 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred HHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHH
Confidence 99999999999999999999999999999999986654322 12234478999999999976 45899999999999999
Q ss_pred HHHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCC
Q 009654 150 ELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 228 (529)
Q Consensus 150 elltG-~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~k 228 (529)
||++| .+||.+.+..+.+..+.+.. .+ .....+|+.+.+||.+||+.||.+
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~--~~--------------------------~~p~~~~~~l~~li~~cl~~~P~~ 278 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGG--LL--------------------------DKPDNCPDMLFELMRMCWQYNPKM 278 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCC--CC--------------------------CCcccchHHHHHHHHHHcCCChhH
Confidence 99998 58999999988888876521 11 011357889999999999999999
Q ss_pred CcCHHHHHh
Q 009654 229 RATASAALA 237 (529)
Q Consensus 229 R~ta~e~L~ 237 (529)
|||+.++|+
T Consensus 279 RPs~~~il~ 287 (308)
T d1p4oa_ 279 RPSFLEIIS 287 (308)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-39 Score=321.07 Aligned_cols=220 Identities=19% Similarity=0.210 Sum_probs=169.5
Q ss_pred CHHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 1 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 1 ~~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
+.+|+++++.++|+|+|.++..+... ...+|+|||||++++...+......+++..+..++.||+.||+|||++||+||
T Consensus 49 ~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHr 127 (299)
T d1ckia_ 49 LHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 127 (299)
T ss_dssp HHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHccCCCcccEEEEEEec-CCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 35799999999877766655544333 57899999999998888777777789999999999999999999999999999
Q ss_pred CCCCCcEEEcc---CCcEEEeccccccccCCCCC------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHHHH
Q 009654 81 DIKGSNLLVNN---EGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 151 (529)
Q Consensus 81 DIKp~NILl~~---~g~vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~el 151 (529)
||||+|||++. +..+||+|||+|+.+..... ......+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 128 DiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHH
T ss_pred cCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHH
Confidence 99999999864 45799999999987754321 12345689999999999987 4599999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCCCCCcC
Q 009654 152 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 231 (529)
Q Consensus 152 ltG~~pf~g~~~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP~kR~t 231 (529)
++|.+||.+.........+........ ..........+|+++.+||.+||+.||.+||+
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~ 265 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEKKM---------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHHHH---------------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCC
T ss_pred HhCCCcccccchHHHHHHHHHhhcccC---------------------CCChhHhccCCCHHHHHHHHHHccCChhHCcC
Confidence 999999988765554443322111000 00012334678999999999999999999999
Q ss_pred HH---HHHhccccCC
Q 009654 232 AS---AALASEYFST 243 (529)
Q Consensus 232 a~---e~L~h~~f~~ 243 (529)
+. ++|+++|.+.
T Consensus 266 ~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 266 YSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHc
Confidence 87 4577877643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-37 Score=319.63 Aligned_cols=239 Identities=25% Similarity=0.403 Sum_probs=180.0
Q ss_pred HHHHHHHHhCC-----------CCCccceeeEEEccCCCeEEEEEeccCCCch---hhhcCCCCCCCHHHHHHHHHHHHH
Q 009654 2 AREILILRRLD-----------HPNIIKLEGLITSRLSCSIYLVFEYMEHDIT---GLLSCPDIKFSEAQIKCYMNQLLH 67 (529)
Q Consensus 2 ~rEi~iL~~L~-----------HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll---~~~~~~~~~l~e~~~~~i~~Qll~ 67 (529)
.+|+.+|+.|+ |||||++++++........++|++++..... .........+++..++.++.||+.
T Consensus 57 ~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~ 136 (362)
T d1q8ya_ 57 EDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136 (362)
T ss_dssp HHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHH
Confidence 57999998885 5789999999877656778888888765321 233345668999999999999999
Q ss_pred HHHHHHH-CCCcccCCCCCcEEEccCCc------EEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcch
Q 009654 68 GLEHCHS-RGVLHRDIKGSNLLVNNEGV------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 140 (529)
Q Consensus 68 gL~~LH~-~gIvHrDIKp~NILl~~~g~------vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~D 140 (529)
||+|||+ .||+||||||+||||+.++. +||+|||.+..... .....+||+.|+|||++.+ ..|+.++|
T Consensus 137 al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~D 211 (362)
T d1q8ya_ 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGAD 211 (362)
T ss_dssp HHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHH
T ss_pred HHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc----ccccccccccccChhhccc-cCCCcccc
Confidence 9999998 89999999999999987653 99999999976543 2356689999999999986 45899999
Q ss_pred hhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCCchhhhccCCCc----------cccCCCCCCCcchhh
Q 009654 141 LWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPH----------ATLFKPQQPYDSSLR 204 (529)
Q Consensus 141 IWSlG~il~elltG~~pf~g~~------~~~~~~~I~~~~g~p~~~~~~~~~l~~----------~~~~~~~~~~~~~l~ 204 (529)
|||+||++++|++|++||.+.. ..+.+..++..+|.++...+....... ........+......
T Consensus 212 iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred ccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc
Confidence 9999999999999999997543 456778888888988766554322210 000000001111111
Q ss_pred hh---ccCCcHHHHHHHHHhccCCCCCCcCHHHHHhccccCCCC
Q 009654 205 ET---FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 245 (529)
Q Consensus 205 ~~---~~~~s~~~~dLi~~mL~~dP~kR~ta~e~L~h~~f~~~~ 245 (529)
.. ....+++++|||.+||.+||.+||||.|||+||||+..+
T Consensus 292 ~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred cccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 11 124567899999999999999999999999999998543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=314.07 Aligned_cols=214 Identities=23% Similarity=0.253 Sum_probs=157.5
Q ss_pred HHHHHHHhCCCCCccceeeEEEccCC--CeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH------
Q 009654 3 REILILRRLDHPNIIKLEGLITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS------ 74 (529)
Q Consensus 3 rEi~iL~~L~HpnIvkl~~~~~~~~~--~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~------ 74 (529)
+|+..+++++|||||++++++.+... ..+|||||||+++.+..++.. ..+++.++..++.|++.||.|||+
T Consensus 46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~ 124 (303)
T d1vjya_ 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 35556667899999999999987532 368999999999777766543 379999999999999999999996
Q ss_pred --CCCcccCCCCCcEEEccCCcEEEeccccccccCCCCC---CCccccccccccCCcccccCCC-----CCCCcchhhhh
Q 009654 75 --RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSV 144 (529)
Q Consensus 75 --~gIvHrDIKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~-----~y~~~~DIWSl 144 (529)
+||+||||||+||||+.++.+||+|||++........ ......+||+.|+|||++.+.. .|+.++|||||
T Consensus 125 ~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred cCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 5999999999999999999999999999987654321 1234568999999999987632 25678999999
Q ss_pred hHHHHHHHhCCCCCCCCCH--------------HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCC
Q 009654 145 GCVFAELLIGKPILQGRTE--------------VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 210 (529)
Q Consensus 145 G~il~elltG~~pf~g~~~--------------~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 210 (529)
||+||||++|.+||..... .+.+.......+ +.|..+ . .......
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~p~~~--~--~~~~~~~ 263 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-----------------LRPNIP--N--RWQSCEA 263 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----------------CCCCCC--G--GGGGCHH
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc-----------------cCCCCC--c--ccCChHH
Confidence 9999999999988743221 111111111000 001000 0 0001123
Q ss_pred cHHHHHHHHHhccCCCCCCcCHHHHHhc
Q 009654 211 PTTAVNLIETLLSVEPYKRATASAALAS 238 (529)
Q Consensus 211 s~~~~dLi~~mL~~dP~kR~ta~e~L~h 238 (529)
+..+.+||.+||+.||++|||+.|++++
T Consensus 264 ~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 264 LRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 4568999999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-36 Score=304.44 Aligned_cols=209 Identities=20% Similarity=0.220 Sum_probs=170.6
Q ss_pred HHHHHHHHhCCC-CCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 009654 2 AREILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 80 (529)
Q Consensus 2 ~rEi~iL~~L~H-pnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHr 80 (529)
.+|+++++.|.| +||+.+++++.+ ....|+|||||++++...+......+++.++..++.|++.||+|||++||+||
T Consensus 48 ~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHr 125 (293)
T d1csna_ 48 RDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 125 (293)
T ss_dssp HHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred HHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceec
Confidence 579999999965 999999999887 67899999999888877776666789999999999999999999999999999
Q ss_pred CCCCCcEEEcc-----CCcEEEeccccccccCCCCC------CCccccccccccCCcccccCCCCCCCcchhhhhhHHHH
Q 009654 81 DIKGSNLLVNN-----EGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 149 (529)
Q Consensus 81 DIKp~NILl~~-----~g~vKl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG~il~ 149 (529)
||||+||||+. ++.+||+|||+|+.+..... ......+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 126 DiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ 204 (293)
T d1csna_ 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFM 204 (293)
T ss_dssp CCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHH
T ss_pred cCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHH
Confidence 99999999964 57899999999987653321 12335689999999999987 46999999999999999
Q ss_pred HHHhCCCCCCCCC---HHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCcchhhhhccCCcHHHHHHHHHhccCCC
Q 009654 150 ELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 226 (529)
Q Consensus 150 elltG~~pf~g~~---~~~~~~~I~~~~g~p~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLi~~mL~~dP 226 (529)
+|++|.+||.+.. ..+.+..+....-.+ ...+..+.+|+++.+||..|+..+|
T Consensus 205 elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~~~~l~~~~p~~l~~ii~~~~~~~~ 260 (293)
T d1csna_ 205 YFLRGSLPWQGLKAATNKQKYERIGEKKQST------------------------PLRELCAGFPEEFYKYMHYARNLAF 260 (293)
T ss_dssp HHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS------------------------CHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred HHHhCCCcCCCccchhHHHHHHHHHhccCCC------------------------ChHHhcCCCCHHHHHHHHHHhcCCc
Confidence 9999999998654 333344443321111 1133446789999999999999999
Q ss_pred CCCcCHHHHHh
Q 009654 227 YKRATASAALA 237 (529)
Q Consensus 227 ~kR~ta~e~L~ 237 (529)
.+||+.+.+.+
T Consensus 261 ~~rP~y~~l~~ 271 (293)
T d1csna_ 261 DATPDYDYLQG 271 (293)
T ss_dssp TCCCCHHHHHH
T ss_pred ccCcCHHHHHH
Confidence 99999776643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.69 E-value=2.4e-18 Score=159.81 Aligned_cols=125 Identities=17% Similarity=0.164 Sum_probs=90.3
Q ss_pred HHHHHHHHhCCCCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 009654 2 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 81 (529)
Q Consensus 2 ~rEi~iL~~L~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~~gIvHrD 81 (529)
.+|+.+|.++.|++|+..+++.. .+|||||++++.... +++..+..++.||+.+|.|||++||+|||
T Consensus 62 ~~e~~~l~~l~~~~v~~~~~~~~------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrD 128 (191)
T d1zara2 62 RNEFRALQKLQGLAVPKVYAWEG------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGD 128 (191)
T ss_dssp HHHHHHHHHTTTSSSCCEEEEET------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHccCCCcceEEEecC------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEcc
Confidence 36889999999999999876531 279999999865433 34555778999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeccccccccCCCCCCCccccccccccCCcccccCCCCCCCcchhhhhh
Q 009654 82 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 145 (529)
Q Consensus 82 IKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~y~~~~DIWSlG 145 (529)
|||+|||++++ .++|+|||+|..........+..+-.+ .-.+.+. ..|+.++|+||+.
T Consensus 129 iKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~---~~~~~f~--r~y~~~~d~~s~~ 186 (191)
T d1zara2 129 LSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR---NIITYFS--RTYRTEKDINSAI 186 (191)
T ss_dssp CSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH---HHHHHHH--HHHCCCCCHHHHH
T ss_pred CChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHH---HHHHHHc--CCCCCcccHHHHH
Confidence 99999999865 589999999976543321111000000 0011121 3588999999964
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.67 E-value=2.7e-05 Score=73.10 Aligned_cols=96 Identities=16% Similarity=0.116 Sum_probs=64.5
Q ss_pred HHHHHHHHhCC-CCCccceeeEEEccCCCeEEEEEeccCCCchhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH------
Q 009654 2 AREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS------ 74 (529)
Q Consensus 2 ~rEi~iL~~L~-HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ll~~~~~~~~~l~e~~~~~i~~Qll~gL~~LH~------ 74 (529)
.+|+.+|+.|. +=-+.+++.+..+ .+..|+||++++|..+....... .....++.++...|..||+
T Consensus 57 ~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~ 129 (263)
T d1j7la_ 57 EREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDC 129 (263)
T ss_dssp HHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTC
T ss_pred HHHHHHHHHHhccCCCCcEEEEEec--CCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCcccc
Confidence 57899988883 4346677776665 56889999999996654332111 1122234444444555553
Q ss_pred -----------------------------------------------------CCCcccCCCCCcEEEccCCcEEEeccc
Q 009654 75 -----------------------------------------------------RGVLHRDIKGSNLLVNNEGVLKLADFG 101 (529)
Q Consensus 75 -----------------------------------------------------~gIvHrDIKp~NILl~~~g~vKl~DFG 101 (529)
..++|+|+.|.|||+++++.+-|+||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe 209 (263)
T d1j7la_ 130 PYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG 209 (263)
T ss_dssp SCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred ccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeech
Confidence 126899999999999877667799999
Q ss_pred ccc
Q 009654 102 LAN 104 (529)
Q Consensus 102 la~ 104 (529)
.+.
T Consensus 210 ~a~ 212 (263)
T d1j7la_ 210 RSG 212 (263)
T ss_dssp TCE
T ss_pred hcc
Confidence 764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.35 E-value=0.00015 Score=67.45 Aligned_cols=28 Identities=29% Similarity=0.305 Sum_probs=24.6
Q ss_pred CcccCCCCCcEEEccCCcEEEecccccc
Q 009654 77 VLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 77 IvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7899999999999987667899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.06 E-value=0.0023 Score=63.82 Aligned_cols=28 Identities=18% Similarity=0.315 Sum_probs=24.5
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.++|+|+.|.|||++.+ .++|+||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence 58999999999999875 48999998774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.75 E-value=0.0053 Score=60.92 Aligned_cols=34 Identities=24% Similarity=0.239 Sum_probs=25.3
Q ss_pred HHHHHHHHhC-CCCCccceeeEEEccCCCeEEEEEeccCCC
Q 009654 2 AREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHD 41 (529)
Q Consensus 2 ~rEi~iL~~L-~HpnIvkl~~~~~~~~~~~~~lV~E~~~g~ 41 (529)
.+|+.+++.| .+.-..++++++.+ .+|+||++|.
T Consensus 92 ~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~efi~g~ 126 (395)
T d1nw1a_ 92 VAESVIFTLLSERHLGPKLYGIFSG------GRLEEYIPSR 126 (395)
T ss_dssp HHHHHHHHHHHHTTSSSCEEEEETT------EEEECCCCEE
T ss_pred HHHHHHHHHHHhCCCCCeEEEEcCC------ceEEEEeccc
Confidence 4799999999 45444578777643 6899999984
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.47 E-value=0.015 Score=55.25 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=26.7
Q ss_pred CCCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 75 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 75 ~gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
.||+|+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999764
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=83.89 E-value=0.083 Score=39.64 Aligned_cols=49 Identities=14% Similarity=0.129 Sum_probs=35.6
Q ss_pred ChHHHHHHHHHHHHhcCCCCCcccccccCCcccCCccccchhhhcccccc
Q 009654 299 PVEDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNA 348 (529)
Q Consensus 299 ~~~e~~~~~~~~~~~d~~~~g~~~~ee~~~~~~~~~~~~~~~~~~~~~~~ 348 (529)
++++++.+.+.|+.+|.|++|.|+.+|+.......+. .+..+...+...
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~ei~~~~~~ 49 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLGS-VTPDEVRRMMAE 49 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTT-CCHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhc-CCHHHHHHHHHH
Confidence 4688999999999999999999999998555544432 244455554433
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=83.83 E-value=0.32 Score=46.04 Aligned_cols=27 Identities=30% Similarity=0.356 Sum_probs=22.4
Q ss_pred CCcccCCCCCcEEEccCCcEEEecccccc
Q 009654 76 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 104 (529)
Q Consensus 76 gIvHrDIKp~NILl~~~g~vKl~DFGla~ 104 (529)
+++|+|+.+.|||+++ + ..++||+-|.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 6899999999999974 4 4589999764
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=83.60 E-value=0.11 Score=38.07 Aligned_cols=49 Identities=10% Similarity=-0.040 Sum_probs=36.5
Q ss_pred CChHHHHHHHHHHHHhcCCCCCcccccccCCcccCCccccchhhhcccc
Q 009654 298 APVEDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVK 346 (529)
Q Consensus 298 ~~~~e~~~~~~~~~~~d~~~~g~~~~ee~~~~~~~~~~~~~~~~~~~~~ 346 (529)
.+.+++..+++.|+.+|.+++|.|+.+|+.......+...++.+...+.
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~ 50 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 50 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHH
Confidence 3789999999999999999999999999855554444333344444444
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=81.18 E-value=0.13 Score=38.01 Aligned_cols=52 Identities=13% Similarity=0.046 Sum_probs=39.5
Q ss_pred CChHHHHHHHHHHHHhcCCCCCcccccccCCcccCCccccchhhhccccccC
Q 009654 298 APVEDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNAS 349 (529)
Q Consensus 298 ~~~~e~~~~~~~~~~~d~~~~g~~~~ee~~~~~~~~~~~~~~~~~~~~~~~~ 349 (529)
.+.+++..+.+.|+.+|.+++|.|+.+|+.......+...+..+...+....
T Consensus 4 lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~ 55 (77)
T d1f54a_ 4 LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55 (77)
T ss_dssp CCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 3789999999999999999999999999866555544444555665555443
|